
<html lang="en"     class="pb-page"  data-request-id="03fb558a-d2f2-45e6-b853-e71e6c6a8c54"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2018.61.issue-21;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/acs.jmedchem.8b00675;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Where Do Recent Small Molecule Clinical Development Candidates Come From?" /></meta><meta name="dc.Creator" content="Dean G.  Brown" /></meta><meta name="dc.Creator" content="Jonas  Boström" /></meta><meta name="dc.Description" content="An analysis of 66 published clinical candidates from Journal of Medicinal Chemistry has been conducted to shed light on which lead generation strategies are most frequently employed in identifying ..." /></meta><meta name="Description" content="An analysis of 66 published clinical candidates from Journal of Medicinal Chemistry has been conducted to shed light on which lead generation strategies are most frequently employed in identifying ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 19, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00675" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00675" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00675" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00675" /></link>
        
    
    

<title>Where Do Recent Small Molecule Clinical Development Candidates Come From? | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00675" /></meta><meta property="og:title" content="Where Do Recent Small Molecule Clinical Development Candidates Come From?" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0023.jpeg" /></meta><meta property="og:description" content="An analysis of 66 published clinical candidates from Journal of Medicinal Chemistry has been conducted to shed light on which lead generation strategies are most frequently employed in identifying drug candidates. The most frequent lead generation strategy (producing a drug candidate) was based on starting points derived from previously known compounds (43%) followed by random high throughput screening (29%). The remainder of approaches included focused screening, structure-based drug design (SBDD), fragment-based lead generation (FBLG), and DNA-encoded library screening (DEL). An analysis of physicochemical properties on the hit-to-clinical pairs shows an average increase in molecular weight (ΔMW = +85) but no change in lipophilicity (ΔclogP = −0.2), although exceptions are noted. The majority (&gt;50%) of clinical candidates were found to be structurally very different from their starting point and were more complex. Finally, several reports of noncovalent scaffolds modified by a covalent warhead using SBDD approaches are discussed." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00675"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00675">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-14/achre4.2021.54.issue-14/20210720/achre4.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-29/aamick.2021.13.issue-29/20210728/aamick.2021.13.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-14/acncdm.2021.12.issue-14/20210721/acncdm.2021.12.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-7/amlcef.2021.3.issue-7/20210705/amlcef.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-29/acsodf.2021.6.issue-29/20210727/acsodf.2021.6.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-29/ascecg.2021.9.issue-29/20210726/ascecg.2021.9.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-29/ancham.2021.93.issue-29/20210727/ancham.2021.93.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-29/bichaw.2021.60.issue-29/20210727/bichaw.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-27/cgeabj.2021.99.issue-27/20210726-01/cgeabj.2021.99.issue-27.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-7/cgdefu.2021.21.issue-7/20210707/cgdefu.2021.21.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-14/esthag.2021.55.issue-14/20210720/esthag.2021.55.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-29/iecred.2021.60.issue-29/20210728/iecred.2021.60.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-14/inocaj.2021.60.issue-14/20210719/inocaj.2021.60.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-29/jafcau.2021.69.issue-29/20210728/jafcau.2021.69.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-29/jacsat.2021.143.issue-29/20210728/jacsat.2021.143.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-7/jamsef.2021.32.issue-7/20210707/jamsef.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-29/langd5.2021.37.issue-29/20210727/langd5.2021.37.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-7/mpohbp.2021.18.issue-7/20210705/mpohbp.2021.18.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00675&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00675&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00675&amp;href=/doi/10.1021/acs.jmedchem.8b00675" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9442-9468</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b00598" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b01555" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Where Do Recent Small Molecule Clinical Development Candidates Come From?</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Dean G. Brown</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dean G. Brown</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Hit Discovery, Discovery Sciences, IMED Biotech Unit, AstraZeneca, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#412524202f6f23332e362f0120323533203b242f2422206f222e2c"><span class="__cf_email__" data-cfemail="385c5d5956165a4a574f5678594b4c4a59425d565d5b59165b5755">[email protected]</span></a>. Phone +1 484-639-4153.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dean+G.++Brown">Dean G. Brown</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7130-3928" title="Orcid link">http://orcid.org/0000-0002-7130-3928</a></div></div></span></li><span class="comma-separator"> and </span><li><span><span class="hlFld-ContribAuthor">Jonas Boström</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonas Boström</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Pepparedsleden 1, Gothenburg SE-431 83, Sweden</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonas++Bostr%C3%B6m">Jonas Boström</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00675&amp;href=/doi/10.1021%2Facs.jmedchem.8b00675" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9442–9468</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 19, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 April 2018</li><li><span class="item_label"><b>Published</b> online</span>19 June 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00675" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00675</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9442%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DDean%2BG.%2BBrown%252C%2BJonas%2BBostr%25C3%25B6m%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D21%26contentID%3Dacs.jmedchem.8b00675%26title%3DWhere%2BDo%2BRecent%2BSmall%2BMolecule%2BClinical%2BDevelopment%2BCandidates%2BCome%2BFrom%253F%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9468%26publicationDate%3DNovember%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00675"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">16595</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">52</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00675" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Where Do Recent Small Molecule Clinical Development Candidates Come From?&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Dean&quot;,&quot;last_name&quot;:&quot;G. Brown&quot;},{&quot;first_name&quot;:&quot;Jonas&quot;,&quot;last_name&quot;:&quot;Boström&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;9442-9468&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00675&quot;},&quot;abstract&quot;:&quot;An analysis of 66 published clinical candidates from Journal of Medicinal Chemistry has been conducted to shed light on which lead generation strategies are most frequently employed in identifying drug candidates. The most frequent lead generation strategy (producing a drug candidate) was based on starting points derived from previously known compounds (43%) followed by random high throughput screening (29%). The remainder of approaches included focused screening, structure-based drug design (SBDD), fragment-based lead generation (FBLG), and DNA-encoded library screening (DEL). An analysis of physicochemical properties on the hit-to-clinical pairs shows an average increase in molecular weight (ΔMW = +85) but no change in lipophilicity (ΔclogP = −0.2), although exceptions are noted. The majority (&gt;50%) of clinical candidates were found to be structurally very different from their starting point and were more complex. Finally, several reports of noncovalent scaffolds modified by a covalent warhead using SBDD ap&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00675&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00675" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00675&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00675" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00675&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00675" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00675&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00675&amp;href=/doi/10.1021/acs.jmedchem.8b00675" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00675" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00675" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00675&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00675%26sid%3Dliteratum%253Aachs%26pmid%3D29920198%26genre%3Darticle%26aulast%3DBrown%26date%3D2018%26atitle%3DWhere%2BDo%2BRecent%2BSmall%2BMolecule%2BClinical%2BDevelopment%2BCandidates%2BCome%2BFrom%253F%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D21%26spage%3D9442%26epage%3D9468%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292304" title="Optimization">Optimization</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a>,</li><li><a href="/action/doSearch?ConceptID=292202" title="Drug discovery">Drug discovery</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/jmcmar.2018.61.issue-21/20181108/jmcmar.2018.61.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0023.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">An analysis of 66 published clinical candidates from <i>Journal of Medicinal Chemistry</i> has been conducted to shed light on which lead generation strategies are most frequently employed in identifying drug candidates. The most frequent lead generation strategy (producing a drug candidate) was based on starting points derived from previously known compounds (43%) followed by random high throughput screening (29%). The remainder of approaches included focused screening, structure-based drug design (SBDD), fragment-based lead generation (FBLG), and DNA-encoded library screening (DEL). An analysis of physicochemical properties on the hit-to-clinical pairs shows an average increase in molecular weight (ΔMW = +85) but no change in lipophilicity (ΔclogP = −0.2), although exceptions are noted. The majority (>50%) of clinical candidates were found to be structurally very different from their starting point and were more complex. Finally, several reports of noncovalent scaffolds modified by a covalent warhead using SBDD approaches are discussed.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51814" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51814" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">One of the most important decisions a drug discovery team can make is the choice of lead generation strategy to identify chemical starting points.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1−3)</a> Traditional lead generation strategies have been random high throughput screening (HTS),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> fragment-based lead generation (FBLG),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> structure-based drug design (SBDD),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> utilization of known literature such as fast-follower or knowledge-based programs,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and more recently DNA-encoded library screening (DEL).<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The choice of which strategy to employ is dependent on multiple factors such as the technical demands for each approach, overall costs, and access to appropriate screening libraries or chemical starting points for each technology. Decisions and factors related to which biological assays to be used will dictate the direction of the program. For example, is a specific mode-of-action (MoA) desired? Is a biochemical screen or a cell-based screen or both considered to be required? What is the assay throughput? Can the inherent low signal-to-noise ratio in a large-scale HTS be justified, or should a higher quality but lower throughput screen be opted for? It should also be noted that where the technology allows, and if the resources are available, multiple lead generation strategies can be run together in an integrated fashion, termed “integrated lead generation”. The decision to start a lead generation campaign sets the wheels in motion toward unknown chemical starting points that may or may not lead to a successful clinical candidate. The quality of the starting point influences the way forward since a high-quality hit will inevitably shorten the discovery phases. Conversely, if the initial hit structure is low-quality (e.g., poor physical properties and pharmacokinetics, the presence of structural motifs known to cause problems, off-target liabilities, and, of course, poor potency), a long and complex multiparameter optimization will be required. Given the competitive nature of the pharmaceutical industry, many biological targets are being pursued in parallel by different groups, perhaps even using the same lead generation strategy or even working on the same chemical starting points. Given the endless possibilities of molecules to make and the fact that drug discovery is a multiparameter optimization process colored by subjectivity, the odds that two different research groups will end up with the same final compound is negligible. As described recently by Murcko, great medicinal chemists know the competitive landscape but “don’t panic over IP” since these endless possibilities of what can be made are not a frequent deterrent when embarking on a hit-to-lead program.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> However, broad patent claims can influence the freedom to operate and are a factor of consideration for selecting a scaffold for lead generation.</div><div class="NLM_p last">A literature study was undertaken to understand which approaches and the types of hit molecules associated with the delivery of clinical candidates. To obtain an understanding on structural modifications required when optimizing a hit to clinical candidate, molecular properties were compared. For example, were there significant discrepancies in physicochemical properties such as molecular weight (MW) and lipophilicity? Were any clinical candidates derived from just a one or two atom change from the lead starting point? Or do most clinical candidates reflect such significant lead optimization that they would be structurally unrecognizable from the initial hit? The aim of this study is to help address these types of questions and gain a better understanding of emerging lead generation strategies and possible impact on future drug discovery programs.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20505" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20505" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The examples and data used in this analysis of hit-to-clinical pairs were generated by manually extracting case studies from the <i>Journal of Medicinal Chemistry</i> between 2016 and 2017. Efforts were made to include as many reported clinical candidates as possible in this two-year time span. However, a few caveats should be noted. First, the definition of a clinical candidate is likely to differ between organizations. Second, no effort was made to distinguish between examples that just entered clinical development versus those that had achieved a first-in-human (FIH) or eventually obtained regulatory approval. Third, once a clinical candidate was identified, the original hit that provided the genesis of the chemistry campaign was determined; however, this was not always possible (i.e., information not available). The lead generation method was assigned to one of six categories (see <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), based on the descriptions used in the original manuscript. The categories were defined as the following.<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(1)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Random screen or high throughput screen (HTS): screening of small-molecules through collections of random compounds that can be large compound databases (10<sup>5</sup>–10<sup>6</sup>) for a large pharmaceutical organization but may also be smaller sets.</p></td></tr><tr class="li1"><td valign="top">(2)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Directed screen: screening of smaller sets of compounds that are selected based on prior knowledge of the target or chemical class. Also known as focused, targeted, or biased screening.</p></td></tr><tr class="li1"><td valign="top">(3)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Structure-based drug design (SBDD): in silico screening of compound collections, including the use of the target protein 3D structure, in this context used to generate novel chemical equity in a hit-finding campaign. Note that in general in silico project support in driving a hit-to-lead program from random screening efforts was not counted in this regard as “hit-finding”.</p></td></tr><tr class="li1"><td valign="top">(4)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Fragment screen or Fragment based lead generation (FBLG): typically libraries with a few thousand compounds of low molecular weights (<200 Da), screened at high concentrations.</p></td></tr><tr class="li1"><td valign="top">(5)</td><td colspan="5" valign="top" class="paragraph"><p class="last">DNA-encoded library screening (DEL): screening of very large collections (typically >10<sup>8</sup>) of small molecule compounds, using a technology that involves the conjugation of chemical compounds to DNA fragments.</p></td></tr><tr class="li1"><td valign="top">(6)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Known compounds: project started based on a prior disclosure of an active compound, endogenous ligand or previous program.</p></td></tr></table></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Distributions of the six sources of lead generation strategies: Known compounds, Random screen or high throughput screen (HTS), Fragment screen or Fragment based lead generation (FBLG), DNA Encoded Libraries (DEL), Structure based drug design (SBDD), Directed Screen for the 66 hit-to-candidate pairs in <i>J. Med. Chem.</i> 2016–2017.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Analysis of Hit-to-Clinical Pairs Reported <i>in J. Med. Chem.</i> 2016–2017<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">()</a><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">()</a><a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">()</a><a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">()</a><a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">()</a><a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">()</a><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">()</a><a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">()</a><a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">()</a><a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">()</a><a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">()</a><a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">()</a><a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">()</a><a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">()</a><a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">()</a><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">()</a><a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">()</a><a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">()</a><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">()</a><a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">()</a><a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">()</a><a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">()</a><a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">()</a><a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">()</a><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">()</a><a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">()</a><a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">()</a><a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">()</a><a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">()</a><a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">()</a><a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">()</a><a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">()</a><a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">()</a><a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">()</a><a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">()</a><a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">()</a><a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">()</a><a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">()</a><a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">()</a><a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">()</a><a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">()</a><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">()</a><a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">()</a><a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">()</a><a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">()</a><a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">()</a><a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">()</a><a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">()</a><a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">()</a><a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">()</a><a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">()</a><a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">()</a><a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">()</a><a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">()</a><a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">()</a><a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">()</a><a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">()</a><a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">()</a><a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">()</a><a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">()</a><a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">()</a><a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">()</a><a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">()</a><a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">()</a><a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">()</a><a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">()</a><a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">()</a><a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">()</a><a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">()</a><a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">()</a><a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">()</a><a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">()</a><a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">()</a><a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">()</a><a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">()</a><a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">()</a><a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">()</a><a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">()</a><a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">()</a><a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">()</a><a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">()</a><a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">()</a><a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">()</a><a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">()</a><a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">()</a><a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">()</a><a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">()</a><a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">()</a><a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">()</a><a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">()</a><a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">()</a><a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">()</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0024.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0012.gif" alt="" id="GRAPHIC-d7e356-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0013.gif" alt="" id="GRAPHIC-d7e357-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0014.gif" alt="" id="GRAPHIC-d7e358-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0015.gif" alt="" id="GRAPHIC-d7e359-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0016.gif" alt="" id="GRAPHIC-d7e360-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0017.gif" alt="" id="GRAPHIC-d7e361-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0018.gif" alt="" id="GRAPHIC-d7e362-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0019.gif" alt="" id="GRAPHIC-d7e363-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0020.gif" alt="" id="GRAPHIC-d7e365-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0021.gif" alt="" id="GRAPHIC-d7e366-autogenerated" /></img><div></div></div><div class="NLM_p last">If multiple lead-generation methods were used, those were assigned as multiple entries. It was observed that many programs used integrated SBDD in the context of advancing hit or lead compounds to candidate drugs. These examples were not counted as the initial hit-finding source. Structure-based drug design (SBDD) was consequently only assigned to those projects where it was used to identify novel hit starting points. The hit-to-clinical pairs were analyzed for their target class and disease area distribution. The pairs of molecules were evaluated against calculated physicochemical properties widely used in medicinal chemistry (clogP, log <i>D</i>, molecular weight, and the number of rotatable bonds).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Similarities based on maximum common substructures were calculated as described by Boström et al.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and molecular complexity according to the seminal description by Bertz.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21370" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21370" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The 66 hit-to-clinical pairs were collected and summarized in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. For each example, the “hit” or advanced lead is shown along with the clinical compound as well as the disease area and lead generation approach used. Overall, the most widely used lead generation approach was based upon utilization of a previously known compound (“Known”) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). See <a class="ref internalNav" href="#sec5" aria-label="Discussion">Discussion</a> section for specific examples. A little less than half (43%) of the clinical candidates described were derived from known starting points. This was followed by screening approaches, subdivided into random screening (29%), focused screening (8%), FBLG (5%), and DNA-encoded library screening (1%). Structure based drug design was used as an integral part of the hit-finding strategy for 14% of the cases examined in this study.</div><div class="NLM_p">The target class and disease area distribution for hit-to-clinical pairs are shown (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Approximately 30% of these case studies came from kinases as targets, followed by other enzymes (such as phosphodiesterases, transferases, proteases, etc.). GPCRs as targets made up 17% of this set, followed by epigenetic targets (9%). Although epigenetic targets may technically be called “other enzymes”, they were kept separate to highlight their emergence as a target class area. Other classes of targets were ion channels (9%), miscellaneous (9%), nuclear receptors (∼1.5%), and protein–protein interactions (∼1.5%). The disease area distribution (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b) was led by oncology (30%) followed by CNS/pain (18%), infection (13%), and metabolic diseases (12%).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Target class analysis (a) and disease area (b) analysis for the 66 hit-to-candidate pairs in <i>J. Med. Chem.</i> 2016–2017.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Physical Property Analysis</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61725" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61725" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">An analysis of clogP, clogD, MW, and rotatable bonds was conducted on the set of 66 hit-to-clinical pairs.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Only the categories “Known” compounds and “Random Screen” were analyzed due to smaller sample sizes of the other categories. The calculations were also restricted to those examples where a clear hit structure was identified (e.g., <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entries 28, 44, and 60 excluded). <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a–d contains the difference in a physical property for a given hit-to-clinical pair (e.g., ΔclogP, Δlog<i>D</i>, ΔMW and Δrotatable bonds), and changes are plotted as distributions. No significant change was observed in the ΔclogP when going from hit-to-clinical candidate for either of the two categories of “Known” compound or “Random Screen” (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>a, ΔclogP = −0.2). However, both categories demonstrated an increase in MW (ΔMW = +63 Da) for the previously known compounds category and ΔMW = +95 for the Random screen category. The overall average for the 66 compounds was +84. The number of rotatable bonds also increased by 1 (average = +1.2) in going from hit-to-clinical candidate, as would be expected with the MW increase.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Analysis of calculated physicochemical property changes for the 66 hit-to-candidate pairs in <i>J. Med. Chem.</i> 2016–2017 in “Known” starting points and “Random” screening categories.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">By analyzing the structural differences between hit-and-clinical lead pairs using <i>Tanimoto</i><sub><i>MCS</i></sub> as a measure of comparison, where it has been previously shown that compounds that have Tanimoto values of >0.8 disclose structurally similar ligand pairs, we could assess the degree of optimization required.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Both sets of “Known compounds” and “Random screen” were again compared, and the results are illustrated (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). In many cases, the optimized compound is structurally very different from the hit compound. Interestingly, the average was found to be around 0.5 for both sets. One might have assumed that the HTS hits should have required more structural changes, as compared to using a previously known compound as starting point. This was not the case as both sets are equally different from the initial starting points. Finally, calculated molecular complexities show that clinical candidates are on average indeed more complex than their corresponding starting point (see <a href="/doi/suppl/10.1021/acs.jmedchem.8b00675/suppl_file/jm8b00675_si_001.pdf" class="ext-link">Supporting Information</a>). When analyzing simple counts for the pairs, several observations were made. The number of heavy atoms increase by 6, from 27 to 33. On average four aliphatic atoms are added, and two aromatic atoms. Two hydrogen-bond acceptors are added on average, and the polar surface increases. The number of hydrogen-bond donors and fraction-sp<sup>3</sup> remains unchanged. Strikingly, in two-thirds (43/65) of the cases at least one heterocyclic nitrogen is added when going from hit to lead. Similarly, in one-third of the pairs (20/65) at least one fluorine atom is added during this development phase.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the Tanimoto maximum common substructure (Tanimoto-MCCS) for hit-to-clinical lead pairs in the “Known” starting point and “Random” screening categories.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Lead Generation from Screening Methods</h3><div class="NLM_p">High-throughput random screening strategies have been a cornerstone of successful drug discovery programs, harkening back to natural product screening success stories in the “golden era of drug discovery” leading to the discovery of many important antibiotics and other important drugs.<a onclick="showRef(event, 'ref108 ref109'); return false;" href="javascript:void(0);" class="ref ref108 ref109">(108,109)</a> As has been well documented, the capability to screen increasingly large numbers of compounds continues to improve across the industry. This has now become a routine part of the drug discovery process, including the recent incorporation into academic screening centers as well.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Screening technologies can employ a vast range of compounds, from billions of molecules for DEL,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> low millions for a typical HTS screen,<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> to hundreds or a few thousands for fragment screening.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Among some of the more interesting reports in this cohort are those that illustrate that successful campaigns can be done on relatively few compounds, illustrating that large screening libraries are not a requirement for finding quality hit starting points. For example, in a publication by Gilead, a small subset of 800 nonbasic heterocyclic compounds were screened to identify the hit molecule <b>1</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 34, and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).<a onclick="showRef(event, 'ref59 ref60'); return false;" href="javascript:void(0);" class="ref ref59 ref60">(59,60)</a> Subsequent efforts led to removal of the phenoxy phenyl groups as well as the para aniline groups resulting in lead structure <b>2</b> and ultimately to the clinical candidate GS-6615 (<b>3</b>). It should be noted that the clinical candidate in this example is quite distant from the initial hit structure (Tanimoto<sub>MCS</sub> = 0.17). This example illustrates that in some cases, a focused screening strategy, coupled with medicinal chemistry optimization, might be equally or perhaps even more effective than a large HTS, where costs of screening and time spent in triaging might offset the additional capacity. Maybe for this reason, focused screening sets (e.g., a few thousand compounds) are popular in practice, many of which can be purchased commercially.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Example of hit-clinical success from small, directed screening sets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Fragment-based lead generation has led to several successful examples of clinical candidates as evidenced in this analysis. Johnson and colleagues reviewed 27 recent examples of successful fragment-to-lead published case studies in 2015 as well as 28 in 2016.<a onclick="showRef(event, 'ref111 ref112'); return false;" href="javascript:void(0);" class="ref ref111 ref112">(111,112)</a> On the basis of their analysis, kinases were by far the largest target class reported in fragment-to-lead examples (33%), with only 4% GPCRs most likely owing to the challenge of using structure-based drug design of these targets. Advances in technology to generate stabilized membrane proteins may increase the use of FLBG in GPCR as target classes, with a recent example of protease-activated receptor 2 (PAR2) as a good case study on how both FBLG and DEL can be applied to these targets.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> A wide variety of screening techniques can be used in FBLG. For example, it was found that biochemical screens (28% of reported studies) followed by thermal shift (17%) and ligand observed NMR (17%) were the most frequently used techniques. Of the four cases documented in this report, three were identified by NMR methods (BET, BACE, and IRAK4)<a onclick="showRef(event, 'ref13 ref14 ref72 ref105'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref72 ref105">(13,14,72,105)</a> and one was identified in a thermal shift assay (BET).<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">Only one clinical candidate in this cohort was discovered by DNA-encoded library technology (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 63).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Of the lead generation technologies highlighted in this review, it is the most recent of the screening technologies<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and, as such, might require time and development to truly come of age and demonstrate impact on drug discovery. At least one other example of a known successful clinical candidate from this technology has been reported, namely, the soluble epoxide hydrolase inhibitor GSK2256294).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Another factor owing to the limited impact is that only a few of the large pharmaceutical companies and contract research organizations currently have access to the technology. There are also limitations to the types of chemistry that can be used to construct libraries on DNA. A review by Franzini and Randolph highlighted this as a current challenge, coupled with the limitations on large libraries to low MW and low lipophilicity.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Advances in library design with more diverse and compatible chemistry may likely lead to an increased application and could provide similar impact to other lead generation strategies covered in this review.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> Phenotypic Screens</h4><div class="NLM_p last">The opportunities and potential pitfalls of phenotypic based screening have been recently reviewed by Moffat et al.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Many successful drugs have been brought to the market through this approach.<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> However, very few examples are found in this set. Thus, most of the screens reported in this study utilize target-based biochemical screens. The Merck NS5A candidate is an exception (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 53),<a onclick="showRef(event, 'ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref90 ref91 ref92">(90−92)</a> where a viral replication assay not biased to any target or mechanism was used to identify a stilbene scaffold resulting in a lead series of compounds and clinical candidates. Another antiviral example comes from the HIV attachment inhibitor temsavir (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 56)<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> which was discovered by a phenotypic screen and later proposed to work via inhibition of HIV attachment. The Ebola compound discovered by Gilead and USAMRIID (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 55)<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> was also identified through a phenotypic cell based screen. Outside the infection therapeutic area, one compelling example was the discovery of small molecules that are splicing modifiers of the SMN2 gene. Implementation of a cell based (HEK293H) SMN2 mini-gene screen led to multiple chemical series, ultimately resulting in clinical candidate RG7800 after medicinal chemical optimization (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 49).<a onclick="showRef(event, 'ref83 ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref83 ref84 ref85">(83−85)</a> With the increased implementation of gene-editing technologies and access to patient-derived stem cells, phenotypic screening presents a very attractive method to more directly link the lead generation screen to the disease of interest. Since the clear majority of case studies in this article come from target-based biochemical screens, it does suggest that phenotypic screening, at the moment, is most beneficial to infection-based screens. Perhaps there are several reasons for this.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> One of the primary bottlenecks of phenotypic screens may arise from deconvolution of these hits, which can be significantly complicated and resource-intense. If indeed target identification is required by management in the pharmaceutical company (it is not a requirement by regulatory authorities) before proceeding to lead optimization, it can take an indefinite amount of time. Project teams may have to embark on a tool compound campaign to build tagged molecules for target pull-down and chemoproteomics experiments. There are many drugs where the mechanism of action is still not known, and not all diseases can be sorted under the “one target, one disease” theory. Humans are complex, and drugs are likely to affect several biochemical responses simultaneously, which in turn can cause feedback reactions on the effected pathways. A lesson learned from the fate of AstraZeneca’s drug pipeline prior to 2010 was that 40% of the AZ internal drug projects lacked a clear link between the main target and disease.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> Without knowledge of (or claiming to know) the mode-of-action, publication can be challenging, possibly limiting the number of examples in the scientific literature.</div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Do New Drugs Come Directly from Existing Hits?</h4><div class="NLM_p">There is one example in this analysis where the drug candidate appears to have been discovered directly in the screen, namely, the Ebola drug candidate GS-5734 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 55)<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> which was discovered by a directed screen of nucleoside analogs. It should be noted that the final drug candidate was ultimately the phosphoramidate prodrug of the screening hit. This highlights the difficulty in identifying drugs or “near-drugs” (e.g., prodrugs) directly from a screen.</div><div class="NLM_p last">The concept to screen drug and drug-like molecules or “pharmacologically active” compounds is an area of current interest.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Related to this, drug repurposing is where current drugs or clinical compounds are screened to identify new therapeutic opportunities. A review by Baker et al. has shown that two-thirds of all drugs have been evaluated in at least one other disease area.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Not surprisingly many successful examples are those where the disease area is related to the original one. However, there are cases where a drug has been repositioned for a completely different therapeutic area. For example, prednisolone from inflammatory disease to restless leg syndrome.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Although there are examples from the clinical setting of repurposing, it remains in question whether screening drug, drug-like, or pharmacologically active sets of compounds will lead to hits that can be optimized quickly into a clinical candidate. It is our belief that high-quality hits will shorten the discovery phases; however finding a “hit” derived from a clinical candidate will still require optimization of the target biology without loss of the drug-like properties in the process. In theory, drug and drug-like molecules will have been optimized for superior drug metabolism and disposition and as such, if hits are found from random screening, might progress much more quickly. However, to date, no comprehensive studies have been published on the advantages of screening these types of collections.</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Lead Generation from Known Starting Points</h3><div class="NLM_p">Follow-on drugs or “fast-follower” type approaches have been a staple in the pharmaceutical industry.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Many successful follow-on drugs have come to the market, one-third of which surprisingly receive priority review from the FDA, thus indicating that many follow-on drugs are potential “best-in-class” options.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> A fast-follower type approach often seeks to identify the minimal changes that provide both differentiation and opportunities to claim novelty and invention. To illustrate this, a review by Giordanetto et al. compared >50 structurally related first in class follow-on pairs and determined that there are frequently minimal differences in heavy atom counts (median, +2) between these pairs.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> It should be noted that fast follower programs may not always appear in the literature, and this may be due to several potential reasons. First, even if the new drugs may be novel by a patent examiner, the “discovery story” might have already been told from the first-in-class molecule and perhaps less compelling for publication within the scientific community. The second reason might be due to the risk of compromising an intellectual property claim, since it is difficult to claim that a structure is novel while at the same time documenting that it was the competitor compound that led to this discovery. Thus, it should be pointed out that we did not attribute the designation of “fast follower” to any of these examples but kept the designation very broad and restricted to the category of “Known” in order to avoid any incorrect assumptions.</div><div class="NLM_p">In some cases, the clinic candidate was immediately derived from another clinical candidate from the same company to improve on a particular profile. This is a common practice and backup strategy in many pharmaceutical R&D organizations. In these cases, the category was marked “Known”, but efforts were made to try and trace back to the original starting point where possible. One example is highlighted below (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>), where scientists at Merck first launched elbasvir as a NS5A inhibitor for HCV infections. This discovery was driven by knowledge of their screening hit <b>4</b>, along with emerging literature of others compounds in the field on the successful cyclization strategies to the advanced lead scaffolds.<a onclick="showRef(event, 'ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref90 ref91 ref92">(90−92)</a> A team at Merck recently reported ruzasvir <b>6</b> as a pan-genotype inhibitor, which was derived from the elbasvir scaffold <b>5</b>.<a onclick="showRef(event, 'ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref90 ref91 ref92">(90−92)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Example of hit-clinical success from known starting points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another example of improvement on an existing clinical is the antimalarial compound OZ439 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 58),<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> which also demonstrated the importance of physicochemical and synthetic insight on a key liability of the original clinical candidate. In this case, the stability of the ozonide functional group was a long sought after but elusive improvement which would lead to better plasma stability and corresponding improved therapeutic efficacy for this class of drugs. A transformational change was the introduction of an 8′-aryl ring, proposed to shift the conformational equilibrium of the cyclohexyl ring system to a more stable axial-peroxide conformation. It should be noted that in this case the physical property changes led to a dramatic increase in lipophobicity (clogP of 2.8 of starting compound versus clogP of 5.5 for final compound), a change that is not typically conducive in going from the hit to clinical candidate. It is often the case that reducing lipophilicity may also reduce metabolic and other unwanted liabilities.<a onclick="showRef(event, 'ref123 ref124 ref125'); return false;" href="javascript:void(0);" class="ref ref123 ref124 ref125">(123−125)</a> However, in this example, addition of the aryl group led to improved chemical stability and subsequently greatly improved plasma stability.</div><div class="NLM_p">A case study reported by a group at ARIAD demonstrated that the incorporation of “nontraditional” structural motifs can be a useful approach to go from hit to clinical candidate based on known scaffolds (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 15).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> In this case, a phosphine oxide was designed to interact in the hinge region replacing a sulfonamide, which led to brigatinib (AP26113), a potent and selective compound with favorable ADME properties. Although not directly identified in this cohort of examples, deuterium (with the first FDA approval given in 2017) and silicon are also potential nontraditional elements that have been used to try and advance existing clinical candidates and drugs.<a onclick="showRef(event, 'ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref126 ref127">(126,127)</a></div><div class="NLM_p">Another approach identified in the “Known” compound category was the strategy of combining two drug classes into one via tether as illustrated (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). The rationale behind the dual-acting compound was primarily to provide an improved activity over resistant bacterial strains. However, TNP-2092 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 60)<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> also demonstrated an unexpected synergy in vitro and in vivo, as compared to either of the two antibacterial agents. Ghasemi et al. have recently reviewed strategies and approaches to dual-acting compounds in this emerging area.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Example of hit-clinical success by building dual-acting compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A special class of dual-acting compounds utilizes the concept of targeted protein degradation (PROTACS); two target domains are tethered to one another in order to trigger protein degradation of the desired protein.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Although no examples were found in this cohort, the first clinical candidate was recently reported elsewhere.<a onclick="showRef(event, 'ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref130 ref131">(130,131)</a></div><div class="NLM_p">Endogenous ligands can also serve as useful starting points for lead generation. As an example, a research team at Eli Lilly has reported on three GPR40 agonists which are all clinical candidates. The most advanced compound is shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> (entry 25, <b>11</b> in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>)<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> along with the initial starting point <b>9</b> which served as the lead generation scaffold. This scaffold was ultimately inspired and initially designed based on the natural ligand DHA <b>8</b>, with conformational constraints leading to a potent GPR40 agonist series.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Example of hit-clinical candidate from endogenous ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Back-Up Candidates</h4><div class="NLM_p last">Very few cases of clinical candidate backups were identified in this analysis. One example is that by the group at BMS for a backup of the HCV compound asunaprevir (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 54).<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> This compound was discovered by an effort to find molecules with an improved cardiovascular profile of the original candidate using ex vivo models. There may be several reasons for the lack of backup clinical cases reported in the recent literature. One reason could be that these studies are not considered the most interesting publications by peer reviewers and/or journal editors (as discussed above) and perhaps do not receive the type of attention a first-time disclosure of a clinical candidate receives. It is also possible that publication of a backup candidate requires disclosing a flaw in the original compound which might be a competitive disadvantage once disclosed. Yet another reason is quite possibly a shift in pharmaceutical companies’ strategies, prioritizing “novel” programs, as compared to investing in back up candidates.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a></div></div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Integrated Lead Generation Approaches</h3><div class="NLM_p">Integrated lead generation approaches are those that utilize multiple lead generation campaigns in parallel and combine the knowledge from the various streams to identify the lead starting points. BMS-929075, a clinical candidate for hepatitis C virus, represents an example of a molecule derived from this “integrated lead generation” approach (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 52).<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> The project team utilized a random screening HTS hit (<b>13</b>) and combined it with the known ligands <b>12</b> and <b>14</b> in a structure-based drug design approach giving the lead scaffold <b>15</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>). This highlights the value of having access to HTS hits and X-ray structures and exploiting this information together with previously known compounds/scaffolds.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Example of integrated lead generation approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A group at Pfizer reported an integrated strategy to identify novel EZH2 starting points leading to a clinical candidate (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 12).<a onclick="showRef(event, 'ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref28 ref29">(28,29)</a> The strategy was built on the recognition of a known lactam motif (<b>17</b>) common to previously reported EZH2 inhibitors (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>). This knowledge was used in the construction of a small focused library, wherein hit structures such as <b>18</b> were discovered as the key starting point for further optimization efforts. Careful attention was placed on synthesizing library members within a selected clogP range (−1 to 3). Further ring constraint and aromatic substitution led to the final clinical candidate <b>19</b>. Development and discovery of new synthetic routes during a drug discovery campaign can also be the genesis of new hit structures and clinical candidates. A similar starting point (<b>20</b>), this time derived from HTS screening but also incorporating integrated approach with a known inhibitor, led to another EZH2 clinical candidate (<b>22</b>) by Constellation (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 13).<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> These examples highlight that structurally different clinical candidates can be obtained by medicinal chemistry expansion by two different companies, arguably starting from very similar starting points.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Examples of integrated lead generation strategies for EZH2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">New synthesis technologies can play an important role in advancing hits to leads and ultimately to clinical candidates. However, exploration of novel chemistry can also lead serendipitously to reasonable starting points. Wang et al. have described the search for novel PARP inhibitors, which resulted in the unexpected synthesis of the trans-diphenyl intermediate <b>24</b>, which upon cyclization led to extremely potent PARP inhibitors (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 20; <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Novel synthetic chemistry has played an important role in the history of medicinal chemistry, including those structures that were not originally intended by the chemists (e.g., discovery of benzodiazpines).<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Synthesis and the role of serendipity in lead generation strategies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Covalent Inhibitors</h3><div class="NLM_p">One strategy to leverage previously known compounds, which is gaining in popularity, is to introduce a covalent “warhead” with the aim to form a covalent bond to a neighboring cysteine or serine residue. Four examples of this strategy are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Two examples are shown against the EGFR receptor (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entries 8 and 9)<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> and one against FGFR (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 11).<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> The first example from Pfizer was derived from known EGFR inhibitors using a SBDD approach, whereas the example from Novartis was derived from an HTS biochemical screen on the kinase domain. Another example published by Pfizer highlighted that selectivity could be built in with the covalent approach, in this case JAK3 over other JAK subtypes, by utilizing the known published X-ray coordinates of tofacitinib and building in the right covalent warhead (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 61).<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> An important design element in this strategy is the introduction of an electrophile that is not reactive to more biologically prevalent nucleophiles such as glutathione but is selective toward a thiol or a serine residue on the target protein. Important factors such as the kinetics of the reaction, steric considerations, and electronics, which govern the addition, all play an important role in deciding which electrophiles are most appropriate for a given electrophilic warhead.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> It is notable that tofacitinib was used in the design of another Pfizer clinical candidate, in this case a pan-JAK compound. The molecular properties were also optimized toward inhaled or skin applications (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entry 62).<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div><div class="NLM_p last">It is interesting to note that there are no reported examples of clinical candidates emerging from a virtual screening approach. Computational methods were integrated into many of these programs, but none of these reported cases disclosed that the original hit was identified via a virtual screen such as docking approach or a ligand-based approach. We can speculate on several reasons for this observation. The first one is perhaps that the examples from “Known” compounds as starting points have benefited from virtual screening but it was not explicitly stated. Virtual screening techniques are also likely integrated into SBDD approaches once the lead has been identified as well.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Physical Properties</h3><div class="NLM_p">Keserü and Makara have reviewed a set of hit-to-lead pairs from 2000 to 2007.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> In their analysis, more than 80% of hit-to-lead pairs originated from HTS and ∼15% from focused screens (which include FBLG and VS). This paper serves as a useful benchmark for comparison on how physical properties change from the initial hits. One observation noted was that lipophilicity (as measured by log<i>P</i>) of HTS hits was significantly higher than those of non-HTS hits. The authors also discuss the challenges in progressing HTS hits without increasing hydrophobicity to achieve potency. Other analyses have been reported previously around the evolution of physicochemical properties going from hits to leads and from leads to clinical candidates. Morphy has studied in detail across the various target classes and further stratified by pharmacological action (e.g., antagonists, agonists, etc.) and hits compared to leads.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> They conclude from this paper that the nature of the endogenous ligand determines the physical property space of lead expansion. In all studies the median MW and clogP increase when optimizing hits to leads.</div><div class="NLM_p last">Analyzing the cohort of 66 hit-to-clinical candidate pairs reveals a slightly different picture. We see very little change on average in lipophilicity (as measured by clogP) when comparing “Random” screening and “Known” starting points with their corresponding candidate drug. In fact, the average clogP change was close to zero, with examples where it increased as well as decreased. Perhaps this is an indication that lead generation and screening collections have improved in quality since the previous analysis over a decade ago (2000–2007). However, it might also reflect the difference in hit-to-lead compared to hit-to-candidate profiles. If high MW and high log<i>P</i> lead to the closure of a lead series, and subsequent publication, this may lead an overabundance of these examples in the literature. Arguably the clinical candidates have passed a significant hurdle of multiparameter optimization and represent a unique set of molecules. Not all structural modifications from hit-to-clinical candidates were designed to improve potency and/or physical properties against a weak hit. Some cases are noted in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a> where the clinical candidate was derived from an already potent and/or optimized compound, but the key challenge was to either provide additional pharmacology (e.g., ALK/FAK inhibitor) or to remove a liability such as anti-target potency or metabolic stability. The molecular weight changes from hit-to-clinical candidate in this analysis are consistent with those hit-to-lead changes reported in the previous examples from Keserü and Morphy.<a onclick="showRef(event, 'ref133 ref134'); return false;" href="javascript:void(0);" class="ref ref133 ref134">(133,134)</a> Finally, it should be noted that the use of ligand efficiency measures (e.g., LE and/or LLE) appears to have significant impact on the trajectory of lead generation programs, but these are target-specific and not necessarily generically applied, as recently reported by Young and Leeson.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> The uptake of these efficiency metrics is becoming more widely used, and many of the examples of the hit-to-clinical pairs in this manuscript were optimized with an underlying strategy where these were included. Young and Leeson describe in detail many successful hit-to-lead and lead-to-clinical examples and outline four major strategies that enable project teams to achieve a successful trajectory (e.g., (a) seek “necessary” nitrogens,<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> (b) methylate, (b) fluorinate, and (d) hydroxylate) which benefited from the application.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Indeed several successful examples in this review have taken these general strategies (e.g., <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entries 4, 14, 19, 20, 24, etc.).</div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05128" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05128" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In summary the recent literature (<i>J. Med. Chem.</i> between 2016 and 2017) was curated to obtain a set of 66 hit-to-clinical candidate pairs. These were categorized into specific lead-generation approaches and analyzed for changes in properties and structural diversity. We observed that approximately half (46%) of the clinical drug examples originated from previously known compounds. These clinical candidates were not always fast-follower or part of back-up programs, as there were examples of from endogenous ligands, including examples tethering known drugs. The second largest category of clinical candidates was derived from random screening approaches (31%). Examples were also identified from focused screening, fragment-based lead generation, and DNA-encoded library screening, although their prevalence was low. Furthermore, an area of increasing interest is design of covalent compounds derived from known noncovalent ligands. Very few examples of clinical candidates derived from phenotypic screening were reported and none from virtual screening. An analysis of physicochemical properties indicated that molecular weight was typically the only significant change in going from hit-to-clinical candidate. The additional molecular weight added was on average +63 Da for the “Known” categories of compounds and +95 Da for the “Random” screening set. On average one rotatable bond was added, but little change in lipophilicity was observed (Δ log <i>D</i> = −0.2). Lipophilicity, as calculated by clogP, did not seem to be a significant property change. There were an equal number of examples that increased vs decreased lipophilicity in going from hit to clinical candidate. Overall this analysis demonstrated that using previously known compounds as starting points is a successful strategy and led to most clinical candidate compounds for this set. However, random screening approaches also deliver clinical candidates, and the strategy is advantageous when no known compounds exist or if a specific mode-of-action is desired. Other strategies also have demonstrated impact (e.g., FBLG and DEL), and their full potential may yet be realized. It may be a coincidence that no examples come from virtual screening, but we find this to be a curious observation since it is relatively inexpensive method with significant potential. It is also noted that drugs are rarely found straight from screening hit-finding campaign, and most clinical candidates are the result of significant chemistry optimization campaigns. In conclusion, this study provides a retrospective analysis of past trends that have led to successful clinical candidates and hopefully provides the framework for the exploitation of future opportunities.</div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18"><a href="/doi/suppl/10.1021/acs.jmedchem.8b00675" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04461" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04461" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b00675" class="ext-link">10.1021/acs.jmedchem.8b00675</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Tabulated changes in properties for entries 1–66 (<a href="/doi/suppl/10.1021/acs.jmedchem.8b00675/suppl_file/jm8b00675_si_001.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00675/suppl_file/jm8b00675_si_001.pdf">jm8b00675_si_001.pdf (411.6 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00675" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dean G. Brown</span> - <span class="hlFld-Affiliation affiliation">Hit
Discovery, Discovery Sciences, IMED Biotech Unit, AstraZeneca, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7130-3928" title="Orcid link">http://orcid.org/0000-0002-7130-3928</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#d6b2b3b7b8f8b4a4b9a1b896b7a5a2a4b7acb3b8b3b5b7f8b5b9bb"><span class="__cf_email__" data-cfemail="600405010e4e02120f170e2001131412011a050e0503014e030f0d">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonas Boström</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, Cardiovascular, Renal and Metabolism, IMED Biotech Unit, AstraZeneca, Pepparedsleden 1, Gothenburg SE-431 83, Sweden</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=bio1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Dean G. Brown</b> is Director of Chemistry at AstraZeneca within the Hit Discovery Department, Discovery Science IMED Biotech Unit. He obtained a B.S, in Chemistry at Abilene Christian University (Abilene, TX) and a Ph.D. at the University of Minnesota (Minneapolis) in Organic Chemistry. He has over 20 years of experience in industry with AstraZeneca. Dean has been responsible for building many new scientific programs in both neuroscience and infection, several of which have resulted in successful transition to clinical trials. His scientific interests are in lead generation, library design, DNA-encoded library screening, synthetic chemistry, and applications of computational chemistry. Dean is listed as an author or coauthor on more than 50 publications and patent applications in medicinal chemistry and drug design, including granted patents on clinical candidates.</p></figure></div><div class="bio"><figure id="" data-index="" class="article__inlineFigure"><h2 class="fig-label"></h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=bio2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jonas Boström</b> is currently working as Principal Scientist at AstraZeneca, Sweden. He obtained a M.Sc. in Chemistry at the University of Gothenburg in 1996 and a Ph.D. in Computational Medicinal Chemistry in 2000 at the University of Copenhagen, Denmark. Jonas has 20 years of experience in the pharmaceutical industry. He has coauthored 30+ publications, been named inventor on 15 patent specifications, and is a member in project teams delivering a number of clinic compounds, including one launched drug. Research interest includes all aspect of digitalizing chemistry, from synthetic methods, SAR, ultrafast virtual screening capabilities to the use of AI in drug design. Jonas is also Associate Professor at the University of Gothenburg and CEO of EduChem VR, a start-up gamifying chemistry education using virtual reality.</p></figure></div><div class="ack" id="ACK-d7e995-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86406" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86406" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Garry Pairaudeau for valuable discussions.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">FBLG</td><td class="NLM_def"><p class="first last">fragment-based lead generation</p></td></tr><tr><td class="NLM_term">CNS/pain</td><td class="NLM_def"><p class="first last">central nervous system and pain</p></td></tr><tr><td class="NLM_term">DEL</td><td class="NLM_def"><p class="first last">DNA-encoded library screening</p></td></tr><tr><td class="NLM_term">FIH</td><td class="NLM_def"><p class="first last">first-in-human</p></td></tr><tr><td class="NLM_term">GPCR</td><td class="NLM_def"><p class="first last">G-protein-coupled receptor</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">MoA</td><td class="NLM_def"><p class="first last">mode of action</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">SBDD</td><td class="NLM_def"><p class="first last">structure-based drug design</p></td></tr><tr><td class="NLM_term">VS</td><td class="NLM_def"><p class="first last">virtual screening.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21036" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21036" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 136 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span>; <span class="NLM_string-name">Brown, D.
G.</span></span> <span> </span><span class="NLM_article-title">Modern lead generation stratagies</span>. In  <i>Lead Generation: Methods and Strategies</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span>, <span class="NLM_string-name">Mannhold, R.</span>, <span class="NLM_string-name">Kubinyi, H.</span>, <span class="NLM_string-name">Folkers, G.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">33</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2F9783527677047.ch02" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=13-33&author=J.+Holenz&author=D.%0AG.+Brownauthor=J.+Holenz&author=R.+Mannhold&author=H.+Kubinyi&author=G.+Folkers&title=Lead+Generation%3A+Methods+and+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2F9783527677047.ch02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677047.ch02%26sid%3Dliteratum%253Aachs%26aulast%3DHolenz%26aufirst%3DJ.%26atitle%3DModern%2520lead%2520generation%2520stratagies%26btitle%3DLead%2520Generation%253A%2520Methods%2520and%2520Strategies%26aulast%3DHolenz%26aufirst%3DJ.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2016%26spage%3D13%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalindjian, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, K. L.</span></span> <span> </span><span class="NLM_article-title">Principles of early drug discovery</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">1239</span>– <span class="NLM_lpage">1249</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01127.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1111%2Fj.1476-5381.2010.01127.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=21091654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivF2lt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2011&pages=1239-1249&author=J.+P.+Hughesauthor=S.+Reesauthor=S.+B.+Kalindjianauthor=K.+L.+Philpott&title=Principles+of+early+drug+discovery&doi=10.1111%2Fj.1476-5381.2010.01127.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of early drug discovery</span></div><div class="casAuthors">Hughes, J. P.; Rees, S.; Kalindjian, S. B.; Philpott, K. L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1239-1249</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Developing a new drug from original idea to the launch of a finished product is a complex process which can take 12-15 years and cost in excess of $1 billion.  The idea for a target can come from a variety of sources including academic and clin. research and from the com. sector.  It may take many years to build up a body of supporting evidence before selecting a target for a costly drug discovery program.  Once a target was chosen, the pharmaceutical industry and more recently some academic centers have streamlined a no. of early processes to identify mols. which possess suitable characteristics to make acceptable drugs.  This review will look at key preclin. stages of the drug discovery process, from initial target identification and validation, through assay development, high throughput screening, hit identification, lead optimization and finally the selection of a candidate mol. for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCc74_F_90rVg90H21EOLACvtfcHk0lgflpPJoorQzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivF2lt7o%253D&md5=05a0016f45b155f9fb5822f5c7bcc35d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01127.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01127.x%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BP.%26aulast%3DRees%26aufirst%3DS.%26aulast%3DKalindjian%26aufirst%3DS.%2BB.%26aulast%3DPhilpott%26aufirst%3DK.%2BL.%26atitle%3DPrinciples%2520of%2520early%2520drug%2520discovery%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D162%26spage%3D1239%26epage%3D1249%26doi%3D10.1111%2Fj.1476-5381.2010.01127.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morphy, J. R.</span></span> <span> </span><span class="NLM_article-title">Historical strategies for lead generation</span>. <i>RSC Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1039/9781849734912-00111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1039%2F9781849734912-00111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=111-129&author=J.+R.+Morphy&title=Historical+strategies+for+lead+generation&doi=10.1039%2F9781849734912-00111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1039%2F9781849734912-00111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252F9781849734912-00111%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DJ.%2BR.%26atitle%3DHistorical%2520strategies%2520for%2520lead%2520generation%26jtitle%3DRSC%2520Drug%2520Discovery%26date%3D2012%26volume%3D21%26spage%3D111%26epage%3D129%26doi%3D10.1039%2F9781849734912-00111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, D.</span>; <span class="NLM_string-name">Dorange, I.</span></span> <span> </span><span class="NLM_article-title">Lead generation based on compound collection screening</span>. In  <i>Lead Generation: Methods and Strategies</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span>, <span class="NLM_string-name">Mannhold, R.</span>, <span class="NLM_string-name">Kubinyi, H.</span>, <span class="NLM_string-name">Folkers, G.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">132</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2F9783527677047.ch05" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=95-132&author=D.+Weigelt&author=I.+Dorangeauthor=J.+Holenz&author=R.+Mannhold&author=H.+Kubinyi&author=G.+Folkers&title=Lead+Generation%3A+Methods+and+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2F9783527677047.ch05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677047.ch05%26sid%3Dliteratum%253Aachs%26aulast%3DWeigelt%26aufirst%3DD.%26atitle%3DLead%2520generation%2520based%2520on%2520compound%2520collection%2520screening%26btitle%3DLead%2520Generation%253A%2520Methods%2520and%2520Strategies%26aulast%3DHolenz%26aufirst%3DJ.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2016%26spage%3D95%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Twenty years on: the impact of fragments on drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd.2016.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=27417849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=605-619&author=D.+A.+Erlansonauthor=S.+W.+Fesikauthor=R.+E.+Hubbardauthor=W.+Jahnkeauthor=H.+Jhoti&title=Twenty+years+on%3A+the+impact+of+fragments+on+drug+discovery&doi=10.1038%2Fnrd.2016.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years on: the impact of fragments on drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E.; Jahnke, Wolfgang; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream.  More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials.  FBDD has been widely applied in both academia and industry, as evidenced by the large no. of papers from universities, non-profit research institutions, biotechnol. companies and pharmaceutical companies.  Moreover, FBDD draws on a diverse range of disciplines, from biochem. and biophysics to computational and medicinal chem.  As the promise of FBDD strategies becomes increasingly realized, now is an opportune time to draw lessons and point the way to the future.  This Review briefly discusses how to design fragment libraries, how to select screening techniques and how to make the most of information gleaned from them.  It also shows how concepts from FBDD have permeated and enhanced drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXQhFttydkrVg90H21EOLACvtfcHk0lgu1VlsqIWuAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE&md5=fc2bcf0da6b7b1083a5ff263057cfa80</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.109%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DTwenty%2520years%2520on%253A%2520the%2520impact%2520of%2520fragments%2520on%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D605%26epage%3D619%26doi%3D10.1038%2Fnrd.2016.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moitessier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pottel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englebienne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbeil, C. R.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry projects requiring imaginative structure based drug design methods</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1646</span>– <span class="NLM_lpage">1657</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.6b00185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.6b00185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2016&pages=1646-1657&author=N.+Moitessierauthor=J.+Pottelauthor=E.+Therrienauthor=P.+Englebienneauthor=Z.+Liuauthor=A.+Tombergauthor=C.+R.+Corbeil&title=Medicinal+chemistry+projects+requiring+imaginative+structure+based+drug+design+methods&doi=10.1021%2Facs.accounts.6b00185"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.6b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.6b00185%26sid%3Dliteratum%253Aachs%26aulast%3DMoitessier%26aufirst%3DN.%26aulast%3DPottel%26aufirst%3DJ.%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DEnglebienne%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DTomberg%26aufirst%3DA.%26aulast%3DCorbeil%26aufirst%3DC.%2BR.%26atitle%3DMedicinal%2520chemistry%2520projects%2520requiring%2520imaginative%2520structure%2520based%2520drug%2520design%2520methods%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2016%26volume%3D49%26spage%3D1646%26epage%3D1657%26doi%3D10.1021%2Facs.accounts.6b00185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span>; <span class="NLM_string-name">Liu, Z.</span>; <span class="NLM_string-name">Holenz, J.</span>; <span class="NLM_string-name">Yang, H.</span></span> <span> </span><span class="NLM_article-title">Competitive intelligence-based lead generation and fast follower approaches</span>. In  <i>Lead Generation: Methods and Strategies</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span>, <span class="NLM_string-name">Mannhold, R.</span>, <span class="NLM_string-name">Kubinyi, H.</span>, <span class="NLM_string-name">Folkers, G.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">219</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2F9783527677047.ch08" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=183-219&author=Y.+Jiang&author=Z.+Liu&author=J.+Holenz&author=H.+Yangauthor=J.+Holenz&author=R.+Mannhold&author=H.+Kubinyi&author=G.+Folkers&title=Lead+Generation%3A+Methods+and+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F9783527677047.ch08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677047.ch08%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26atitle%3DCompetitive%2520intelligence-based%2520lead%2520generation%2520and%2520fast%2520follower%2520approaches%26btitle%3DLead%2520Generation%253A%2520Methods%2520and%2520Strategies%26aulast%3DHolenz%26aufirst%3DJ.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2016%26spage%3D183%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodnow, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefe, A. D.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd.2016.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=27932801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=131-147&author=R.+A.+Goodnowauthor=C.+E.+Dumelinauthor=A.+D.+Keefe&title=DNA-encoded+chemistry%3A+enabling+the+deeper+sampling+of+chemical+space&doi=10.1038%2Fnrd.2016.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span></div><div class="casAuthors">Goodnow, Robert A. Jr; Dumelin, Christoph E.; Keefe, Anthony D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-147</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA-encoded chem. library technologies are increasingly being adopted in drug discovery for hit and lead generation.  DNA-encoded chem. enables the exploration of chem. spaces four to five orders of magnitude more deeply than is achievable by traditional high-throughput screening methods.  Operation of this technol. requires developing a range of capabilities including aq. synthetic chem., building block acquisition, oligonucleotide conjugation, large-scale mol. biol. transformations, selection methodologies, PCR, sequencing, sequence data anal. and the anal. of large chem. spaces.  This Review provides an overview of the development and applications of DNA-encoded chem., highlighting the challenges and future directions for the use of this technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdEd70MeexerVg90H21EOLACvtfcHk0lhgxZNWutnSzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM&md5=7ca97b01d75e600378799baf77665c07</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.213%26sid%3Dliteratum%253Aachs%26aulast%3DGoodnow%26aufirst%3DR.%2BA.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DKeefe%26aufirst%3DA.%2BD.%26atitle%3DDNA-encoded%2520chemistry%253A%2520enabling%2520the%2520deeper%2520sampling%2520of%2520chemical%2520space%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D131%26epage%3D147%26doi%3D10.1038%2Fnrd.2016.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M.</span></span> <span> </span><span class="NLM_article-title">What makes a great medicinal chemist</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01445</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01445" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Murcko&title=What+makes+a+great+medicinal+chemist&doi=10.1021%2Facs.jmedchem.7b01445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01445%26sid%3Dliteratum%253Aachs%26aulast%3DMurcko%26aufirst%3DM.%26atitle%3DWhat%2520makes%2520a%2520great%2520medicinal%2520chemist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26doi%3D10.1021%2Facs.jmedchem.7b01445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span> <i>OEChem</i>; <span class="NLM_publisher-name">OpenEye Scientific Software,
Inc.</span>: <span class="NLM_publisher-loc">Santa Fe, NM, U.S.</span>; <a href="http://eyesopen.com/molprop-tk" class="extLink">http://eyesopen.com/molprop-tk</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+OEChem%3B+OpenEye+Scientific+Software%2C%0AInc.%3A+Santa+Fe%2C+NM%2C+U.S.%3B+http%3A%2F%2Feyesopen.com%2Fmolprop-tk."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DOEChem%26pub%3DOpenEye%2520Scientific%2520Software%252C%250AInc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, S.</span></span> <span> </span><span class="NLM_article-title">Do structurally similar molecules bind in a similar fashion?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6716</span>– <span class="NLM_lpage">6725</span>, <span class="refDoi"> DOI: 10.1021/jm060167o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060167o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6716-6725&author=J.+Bostr%C3%B6mauthor=A.+Hognerauthor=S.+Schmitt&title=Do+structurally+similar+molecules+bind+in+a+similar+fashion%3F&doi=10.1021%2Fjm060167o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm060167o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060167o%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DS.%26atitle%3DDo%2520structurally%2520similar%2520molecules%2520bind%2520in%2520a%2520similar%2520fashion%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6716%26epage%3D6725%26doi%3D10.1021%2Fjm060167o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertz, S. H.</span></span> <span> </span><span class="NLM_article-title">The first general index of molecular complexity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">3599</span>– <span class="NLM_lpage">3601</span>, <span class="refDoi"> DOI: 10.1021/ja00402a071</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00402a071" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADyaL3MXkt1Cjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1981&pages=3599-3601&author=S.+H.+Bertz&title=The+first+general+index+of+molecular+complexity&doi=10.1021%2Fja00402a071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The first general index of molecular complexity</span></div><div class="casAuthors">Bertz, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3599-601</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">An index of mol. complexity is introduced which is based upon the concepts of graph theory and information theory.  It is the only one extant that is completely general, being applicable to compds. contg. such features as branching, rings, multiple bonds, and heteroatoms.  It also reflects the sym. present in a mol.  All these features are important in synthetic anal., as illustrated by an example including sample calcns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXuz8eEH2Cl7Vg90H21EOLACvtfcHk0ljYxSJepFrxPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkt1Cjtbk%253D&md5=9a7602510035ab906839fd67a47148e7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fja00402a071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00402a071%26sid%3Dliteratum%253Aachs%26aulast%3DBertz%26aufirst%3DS.%2BH.%26atitle%3DThe%2520first%2520general%2520index%2520of%2520molecular%2520complexity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1981%26volume%3D103%26spage%3D3599%26epage%3D3601%26doi%3D10.1021%2Fja00402a071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soltwedel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantei, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holms, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClellan, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magoc, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warder, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajaraman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K. F.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based, structure-enabled discovery of novel pyridones and pyridone macrocycles as potent bromodomain and extra-terminal domain (BET) family bromodomain inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3828</span>– <span class="NLM_lpage">3850</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVygu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3828-3850&author=L.+Wangauthor=J.+K.+Prattauthor=T.+Soltwedelauthor=G.+S.+Sheppardauthor=S.+D.+Fidanzeauthor=D.+Liuauthor=L.+A.+Hasvoldauthor=R.+A.+Manteiauthor=J.+H.+Holmsauthor=W.+J.+McClellanauthor=M.+D.+Wendtauthor=C.+Wadaauthor=R.+Freyauthor=T.+M.+Hansenauthor=R.+Hubbardauthor=C.+H.+Parkauthor=L.+Liauthor=T.+J.+Magocauthor=D.+H.+Albertauthor=X.+Linauthor=S.+E.+Warderauthor=P.+Kovarauthor=X.+Huangauthor=D.+Wilcoxauthor=R.+Wangauthor=G.+Rajaramanauthor=A.+M.+Petrosauthor=C.+W.+Hutchinsauthor=S.+C.+Panchalauthor=C.+Sunauthor=S.+W.+Elmoreauthor=Y.+Shenauthor=W.+M.+Katiauthor=K.+F.+McDaniel&title=Fragment-Based%2C+structure-enabled+discovery+of+novel+pyridones+and+pyridone+macrocycles+as+potent+bromodomain+and+extra-terminal+domain+%28BET%29+family+bromodomain+inhibitors&doi=10.1021%2Facs.jmedchem.7b00017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors</span></div><div class="casAuthors">Wang, Le; Pratt, John K.; Soltwedel, Todd; Sheppard, George S.; Fidanze, Steven D.; Liu, Dachun; Hasvold, Lisa A.; Mantei, Robert A.; Holms, James H.; McClellan, William J.; Wendt, Michael D.; Wada, Carol; Frey, Robin; Hansen, T. Matthew; Hubbard, Robert; Park, Chang H.; Li, Leiming; Magoc, Terrance J.; Albert, Daniel H.; Lin, Xiaoyu; Warder, Scott E.; Kovar, Peter; Huang, Xiaoli; Wilcox, Denise; Wang, Rongqi; Rajaraman, Ganesh; Petros, Andrew M.; Hutchins, Charles W.; Panchal, Sanjay C.; Sun, Chaohong; Elmore, Steven W.; Shen, Yu; Kati, Warren M.; McDaniel, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3828-3850</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Members of the BET family of bromodomain contg. proteins have been identified as potential targets for blocking proliferation in a variety of cancer cell lines.  A 2-dimensional NMR fragment screen for binders to the bromodomains of BRD4 identified a Ph pyridazinone fragment with a weak binding affinity (I, Ki = 160 μM).  SAR investigation of fragment I, aided by X-ray structure-based design, enabled the synthesis of potent pyridone and macrocyclic pyridone inhibitors exhibiting single digit nanomolar potency in both biochem. and cell based assays, e.g. II.  Advanced analogs in these series exhibited high oral exposures in rodent PK studies and demonstrated significant tumor growth inhibition efficacy in mouse flank xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDaiYdyL4LtrVg90H21EOLACvtfcHk0lg0RbtgHSHe8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVygu7k%253D&md5=91750e660bafec08b8bcbe6bcd5e818f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DSoltwedel%26aufirst%3DT.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DHolms%26aufirst%3DJ.%2BH.%26aulast%3DMcClellan%26aufirst%3DW.%2BJ.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DWada%26aufirst%3DC.%26aulast%3DFrey%26aufirst%3DR.%26aulast%3DHansen%26aufirst%3DT.%2BM.%26aulast%3DHubbard%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWarder%26aufirst%3DS.%2BE.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DWilcox%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DRajaraman%26aufirst%3DG.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DPanchal%26aufirst%3DS.%2BC.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DKati%26aufirst%3DW.%2BM.%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26atitle%3DFragment-Based%252C%2520structure-enabled%2520discovery%2520of%2520novel%2520pyridones%2520and%2520pyridone%2520macrocycles%2520as%2520potent%2520bromodomain%2520and%2520extra-terminal%2520domain%2520%2528BET%2529%2520family%2520bromodomain%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3828%26epage%3D3850%26doi%3D10.1021%2Facs.jmedchem.7b00017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soltwedel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantei, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warder, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magoc, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajaraman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edalji, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/mivebresib), a potent and orally available bromodomain and extraterminal domain (BET) family bromodomain inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8369</span>– <span class="NLM_lpage">8384</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00746</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00746" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOjtrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8369-8384&author=K.+F.+McDanielauthor=W.+Wangauthor=T.+Soltwedelauthor=S.+D.+Fidanzeauthor=L.+A.+Hasvoldauthor=D.+Liuauthor=R.+A.+Manteiauthor=J.+K.+Prattauthor=G.+S.+Sheppardauthor=M.+H.+Buiauthor=E.+J.+Faivreauthor=X.+Huangauthor=L.+Liauthor=X.+Linauthor=R.+Wangauthor=S.+E.+Warderauthor=D.+Wilcoxauthor=D.+H.+Albertauthor=T.+J.+Magocauthor=G.+Rajaramanauthor=C.+H.+Parkauthor=C.+W.+Hutchinsauthor=J.+J.+Shenauthor=R.+P.+Edaljiauthor=C.+C.+Sunauthor=R.+Martinauthor=W.+Gaoauthor=S.+Wongauthor=G.+Fangauthor=S.+W.+Elmoreauthor=Y.+Shenauthor=W.+M.+Kati&title=Discovery+of+N-%284-%282%2C4-Difluorophenoxy%29-3-%286-methyl-7-oxo-6%2C7-dihydro-1H-pyrrolo%5B2%2C3-c%5Dpyridin-4-yl%29phenyl%29ethanesulfonamide+%28ABBV-075%2Fmivebresib%29%2C+a+potent+and+orally+available+bromodomain+and+extraterminal+domain+%28BET%29+family+bromodomain+inhibitor&doi=10.1021%2Facs.jmedchem.7b00746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor</span></div><div class="casAuthors">McDaniel, Keith F.; Wang, Le; Soltwedel, Todd; Fidanze, Steven D.; Hasvold, Lisa A.; Liu, Dachun; Mantei, Robert A.; Pratt, John K.; Sheppard, George S.; Bui, Mai H.; Faivre, Emily J.; Huang, Xiaoli; Li, Leiming; Lin, Xiaoyu; Wang, Rongqi; Warder, Scott E.; Wilcox, Denise; Albert, Daniel H.; Magoc, Terrance J.; Rajaraman, Ganesh; Park, Chang H.; Hutchins, Charles W.; Shen, Jianwei J.; Edalji, Rohinton P.; Sun, Chaohong C.; Martin, Ruth; Gao, Wenqing; Wong, Shekman; Fang, Guowei; Elmore, Steven W.; Shen, Yu; Kati, Warren M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8369-8384</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of bromodomain and extraterminal domain (BET) bromodomain inhibitors and their examn. in clin. studies, particularly in oncol. settings, has garnered substantial recent interest.  An effort to generate novel BET bromodomain inhibitors with excellent potency and drug metab. and pharmacokinetics (DMPK) properties was initiated based upon elaboration of a simple pyridone core.  Efforts to develop a bidentate interaction with a crit. asparagine residue resulted in the incorporation of a pyrrolopyridone core, which improved potency by 9-19-fold.  Addnl. structure-activity relationship (SAR) efforts aimed both at increasing potency and improving pharmacokinetic properties led to the discovery of the clin. candidate I (ABBV-075/mivebresib), which demonstrates excellent potency in biochem. and cellular assays, advantageous exposures and half-life both in animal models and in humans, and in vivo efficacy in mouse models of cancer progression and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom-8BkipNknbVg90H21EOLACvtfcHk0lg0RbtgHSHe8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOjtrbF&md5=16ea9e9ade8a22a6e99aeae16fd1bf9c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00746%26sid%3Dliteratum%253Aachs%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSoltwedel%26aufirst%3DT.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DBui%26aufirst%3DM.%2BH.%26aulast%3DFaivre%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWarder%26aufirst%3DS.%2BE.%26aulast%3DWilcox%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DRajaraman%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DShen%26aufirst%3DJ.%2BJ.%26aulast%3DEdalji%26aufirst%3DR.%2BP.%26aulast%3DSun%26aufirst%3DC.%2BC.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DKati%26aufirst%3DW.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282%252C4-Difluorophenoxy%2529-3-%25286-methyl-7-oxo-6%252C7-dihydro-1H-pyrrolo%255B2%252C3-c%255Dpyridin-4-yl%2529phenyl%2529ethanesulfonamide%2520%2528ABBV-075%252Fmivebresib%2529%252C%2520a%2520potent%2520and%2520orally%2520available%2520bromodomain%2520and%2520extraterminal%2520domain%2520%2528BET%2529%2520family%2520bromodomain%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8369%26epage%3D8384%26doi%3D10.1021%2Facs.jmedchem.7b00746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattersley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabow, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of a series of bivalent triazolopyridazine based bromodomain and extraterminal inhibitors: the discovery of (3<i>R</i>)-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7801</span>– <span class="NLM_lpage">7817</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtleiu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7801-7817&author=R.+H.+Bradburyauthor=R.+Callisauthor=G.+R.+Carrauthor=H.+Chenauthor=E.+Clarkauthor=L.+Feronauthor=S.+Glossopauthor=M.+A.+Grahamauthor=M.+Hattersleyauthor=C.+Jonesauthor=S.+G.+Lamontauthor=G.+Ouvryauthor=A.+Patelauthor=J.+Patelauthor=A.+A.+Rabowauthor=C.+A.+Robertsauthor=S.+Stokesauthor=N.+Strattonauthor=G.+E.+Walkerauthor=L.+Wardauthor=D.+Whalleyauthor=D.+Whittakerauthor=G.+Wrigleyauthor=M.+J.+Waring&title=Optimization+of+a+series+of+bivalent+triazolopyridazine+based+bromodomain+and+extraterminal+inhibitors%3A+the+discovery+of+%283R%29-4-%5B2-%5B4-%5B1-%283-methoxy-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-b%5Dpyridazin-6-yl%29-4-piperidyl%5Dphenoxy%5Dethyl%5D-1%2C3-dimethyl-piperazin-2-one+%28AZD5153%29&doi=10.1021%2Facs.jmedchem.6b00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3R)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)</span></div><div class="casAuthors">Bradbury, Robert H.; Callis, Rowena; Carr, Gregory R.; Chen, Huawei; Clark, Edwin; Feron, Lyman; Glossop, Steve; Graham, Mark A.; Hattersley, Maureen; Jones, Chris; Lamont, Scott G.; Ouvry, Gilles; Patel, Anil; Patel, Joe; Rabow, Alfred A.; Roberts, Craig A.; Stokes, Stephen; Stratton, Natalie; Walker, Graeme E.; Ward, Lara; Whalley, David; Whittaker, David; Wrigley, Gail; Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7801-7817</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here the authors report the discovery and optimization of a series of bivalent bromodomain and extraterminal inhibitors.  Starting with the observation of BRD4 activity of compds. from a previous program, the compds. were optimized for BRD4 potency and phys. properties.  The optimized compd. from this campaign exhibited excellent pharmacokinetic profile and exhibited high potency in vitro and in vivo effecting c-Myc downregulation and tumor growth inhibition in xenograft studies.  This compd. was selected as the development candidate AZD5153.  The series showed enhanced potency as a result of bivalent binding and a clear correlation between BRD4 activity and cellular potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFRSE33Jdb17Vg90H21EOLACvtfcHk0lh_UYhFE1eu9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtleiu7rK&md5=a91cdef7369dd1888c4948ba4fc9d72d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00070%26sid%3Dliteratum%253Aachs%26aulast%3DBradbury%26aufirst%3DR.%2BH.%26aulast%3DCallis%26aufirst%3DR.%26aulast%3DCarr%26aufirst%3DG.%2BR.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DE.%26aulast%3DFeron%26aufirst%3DL.%26aulast%3DGlossop%26aufirst%3DS.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DHattersley%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DLamont%26aufirst%3DS.%2BG.%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DRabow%26aufirst%3DA.%2BA.%26aulast%3DRoberts%26aufirst%3DC.%2BA.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DStratton%26aufirst%3DN.%26aulast%3DWalker%26aufirst%3DG.%2BE.%26aulast%3DWard%26aufirst%3DL.%26aulast%3DWhalley%26aufirst%3DD.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWrigley%26aufirst%3DG.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DOptimization%2520of%2520a%2520series%2520of%2520bivalent%2520triazolopyridazine%2520based%2520bromodomain%2520and%2520extraterminal%2520inhibitors%253A%2520the%2520discovery%2520of%2520%25283R%2529-4-%255B2-%255B4-%255B1-%25283-methoxy-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-b%255Dpyridazin-6-yl%2529-4-piperidyl%255Dphenoxy%255Dethyl%255D-1%252C3-dimethyl-piperazin-2-one%2520%2528AZD5153%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7801%26epage%3D7817%26doi%3D10.1021%2Facs.jmedchem.6b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehling, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaswani, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasveschuk, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaram, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmange, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">Identification of a benzoisoxazoloazepine Inhibitor (CPI-0610) of the bromodomain and extra-terminal (BET) family as a candidate for human clinical trials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1330</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1330-1339&author=B.+K.+Albrechtauthor=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=R.+G.+Vaswaniauthor=A.+Coteauthor=Y.+Leblancauthor=C.+G.+Nasveschukauthor=S.+Bellonauthor=L.+Bergeronauthor=R.+Campbellauthor=N.+Cantoneauthor=M.+R.+Cooperauthor=R.+T.+Cummingsauthor=H.+Jayaramauthor=S.+Joshiauthor=J.+A.+Mertzauthor=A.+Neissauthor=E.+Normantauthor=M.+O%E2%80%99Mearaauthor=E.+Pardoauthor=F.+Poyauthor=P.+Sandyauthor=J.+Supkoauthor=R.+J.+Simsauthor=J.-C.+Harmangeauthor=A.+M.+Taylorauthor=J.+E.+Audia&title=Identification+of+a+benzoisoxazoloazepine+Inhibitor+%28CPI-0610%29+of+the+bromodomain+and+extra-terminal+%28BET%29+family+as+a+candidate+for+human+clinical+trials&doi=10.1021%2Facs.jmedchem.5b01882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials</span></div><div class="casAuthors">Albrecht, Brian K.; Gehling, Victor S.; Hewitt, Michael C.; Vaswani, Rishi G.; Cote, Alexandre; Leblanc, Yves; Nasveschuk, Christopher G.; Bellon, Steve; Bergeron, Louise; Campbell, Robert; Cantone, Nico; Cooper, Michael R.; Cummings, Richard T.; Jayaram, Hariharan; Joshi, Shivangi; Mertz, Jennifer A.; Neiss, Adrianne; Normant, Emmanuel; O'Meara, Michael; Pardo, Eneida; Poy, Florence; Sandy, Peter; Supko, Jeffrey; Sims, Robert J.; Harmange, Jean-Christophe; Taylor, Alexander M.; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1330-1339</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, inhibition of the interaction between the bromodomain and extra-terminal domain (BET) family of chromatin adaptors and acetyl-lysine residues on chromatin has emerged as a promising approach to regulate the expression of important disease-relevant genes, including MYC, BCL-2, and NF-κB.  Here we describe the identification and characterization of a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor that attenuates BET-dependent gene expression in vivo, demonstrates antitumor efficacy in an MV-4-11 mouse xenograft model, and is currently undergoing human clin. trials for hematol. malignancies (CPI-0610).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40qjnYl4EZLVg90H21EOLACvtfcHk0lgRPztUyGQEXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D&md5=5e1c5aab26aa58844a9f6670a7bbd78b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01882%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DM.%2BR.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DSupko%26aufirst%3DJ.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DIdentification%2520of%2520a%2520benzoisoxazoloazepine%2520Inhibitor%2520%2528CPI-0610%2529%2520of%2520the%2520bromodomain%2520and%2520extra-terminal%2520%2528BET%2529%2520family%2520as%2520a%2520candidate%2520for%2520human%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1330%26epage%3D1339%26doi%3D10.1021%2Facs.jmedchem.5b01882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crosignani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottemanne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannelle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwenberghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordonnier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deroose, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greasley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, S.n E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negrerie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloweij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Eynde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel and selective indoleamine 2,3-dioxygenase (IDO-1) inhibitor 3-(5-fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and its characterization as a potential clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9617</span>– <span class="NLM_lpage">9629</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00974</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00974" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOns7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9617-9629&author=S.+Crosignaniauthor=P.+Binghamauthor=P.+Bottemanneauthor=H.+Cannelleauthor=S.+Cauwenberghsauthor=M.+Cordonnierauthor=D.+Dalvieauthor=F.+Derooseauthor=J.+L.+Fengauthor=B.+Gomesauthor=S.+Greasleyauthor=S.n+E.+Kaiserauthor=M.+Krausauthor=M.+Negrerieauthor=K.+Maegleyauthor=N.+Millerauthor=B.+W.+Murrayauthor=M.+Schneiderauthor=J.+Soloweijauthor=A.+E.+Stewartauthor=J.+Tumangauthor=V.+R.+Tortiauthor=B.+Van+Den+Eyndeauthor=M.+Wythes&title=Discovery+of+a+novel+and+selective+indoleamine+2%2C3-dioxygenase+%28IDO-1%29+inhibitor+3-%285-fluoro-1H-indol-3-yl%29pyrrolidine-2%2C5-dione+%28EOS200271%2FPF-06840003%29+and+its+characterization+as+a+potential+clinical+candidate&doi=10.1021%2Facs.jmedchem.7b00974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate</span></div><div class="casAuthors">Crosignani, Stefano; Bingham, Patrick; Bottemanne, Pauline; Cannelle, Helene; Cauwenberghs, Sandra; Cordonnier, Marie; Dalvie, Deepak; Deroose, Frederik; Feng, Jun Li; Gomes, Bruno; Greasley, Samantha; Kaiser, Stephen E.; Kraus, Manfred; Negrerie, Michel; Maegley, Karen; Miller, Nichol; Murray, Brion W.; Schneider, Manfred; Soloweij, James; Stewart, Albert E.; Tumang, Joseph; Torti, Vince R.; Van Den Eynde, Benoit; Wythes, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9617-9629</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumors use tryptophan-catabolizing enzymes such as indoleamine 2,3-dioxygenase (IDO-1) to induce an immunosuppressive environment.  IDO-1 is induced in response to inflammatory stimuli and promotes immune tolerance through effector T-cell anergy and enhanced Treg function.  As such, IDO-1 is a nexus for the induction of a key immunosuppressive mechanism and represents an important immunotherapeutic target in oncol.  Starting from HTS hit I, IDO-1 inhibitor II has been developed.  The structure-activity relationship around II is described and rationalized using the x-ray crystal structure of II bound to human IDO-1, which shows that II, differently from most of the IDO-1 inhibitors described so far, does not bind to the heme iron atom and has a novel binding mode.  Clin. candidate II shows good potency in an IDO-1 human whole blood assay and also shows a very favorable ADME profile leading to favorable predicted human pharmacokinetic properties, including a predicted half-life of 16-19 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogfHmZRAC-dLVg90H21EOLACvtfcHk0liWUh99bUSRLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOns7%252FK&md5=dc2e45c243aa22c100ccc39db9b5918a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00974%26sid%3Dliteratum%253Aachs%26aulast%3DCrosignani%26aufirst%3DS.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DCannelle%26aufirst%3DH.%26aulast%3DCauwenberghs%26aufirst%3DS.%26aulast%3DCordonnier%26aufirst%3DM.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDeroose%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DJ.%2BL.%26aulast%3DGomes%26aufirst%3DB.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DKaiser%26aufirst%3DS.n%2BE.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DNegrerie%26aufirst%3DM.%26aulast%3DMaegley%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DN.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DSoloweij%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTumang%26aufirst%3DJ.%26aulast%3DTorti%26aufirst%3DV.%2BR.%26aulast%3DVan%2BDen%2BEynde%26aufirst%3DB.%26aulast%3DWythes%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520and%2520selective%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO-1%2529%2520inhibitor%25203-%25285-fluoro-1H-indol-3-yl%2529pyrrolidine-2%252C5-dione%2520%2528EOS200271%252FPF-06840003%2529%2520and%2520its%2520characterization%2520as%2520a%2520potential%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9617%26epage%3D9629%26doi%3D10.1021%2Facs.jmedchem.7b00974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaufils, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cmiljanovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cmiljanovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnacker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borsari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebeisen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvelebil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rageot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span> <span> </span><span class="NLM_article-title">5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/mTOR inhibitor as clinical candidate in oncology</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7524</span>– <span class="NLM_lpage">7538</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00930</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00930" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7524-7538&author=F.+Beaufilsauthor=N.+Cmiljanovicauthor=V.+Cmiljanovicauthor=T.+Bohnackerauthor=A.+Meloneauthor=R.+Maroneauthor=E.+Jacksonauthor=X.+Zhangauthor=A.+Seleauthor=C.+Borsariauthor=J.+Mestanauthor=P.+Hebeisenauthor=P.+Hillmannauthor=B.+Gieseauthor=M.+Zvelebilauthor=D.+Fabbroauthor=R.+L.+Williamsauthor=D.+Rageotauthor=M.+P.+Wymann&title=5-%284%2C6-Dimorpholino-1%2C3%2C5-triazin-2-yl%29-4-%28trifluoromethyl%29pyridin-2-amine+%28PQR309%29%2C+a+potent%2C+brain-penetrant%2C+orally+bioavailable%2C+pan-class+I+PI3K%2FmTOR+inhibitor+as+clinical+candidate+in+oncology&doi=10.1021%2Facs.jmedchem.7b00930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology</span></div><div class="casAuthors">Beaufils, Florent; Cmiljanovic, Natasa; Cmiljanovic, Vladimir; Bohnacker, Thomas; Melone, Anna; Marone, Romina; Jackson, Eileen; Zhang, Xuxiao; Sele, Alexander; Borsari, Chiara; Mestan, Jurgen; Hebeisen, Paul; Hillmann, Petra; Giese, Bernd; Zvelebil, Marketa; Fabbro, Doriano; Williams, Roger L.; Rageot, Denise; Wymann, Matthias P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7524-7538</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase (PI3K) is deregulated in a wide variety of human tumors and triggers activation of protein kinase B (PKB/Akt) and mammalian target of rapamycin (mTOR).  Here we describe the preclin. characterization of compd. 1 (PQR309, bimiralisib), a potent 4,6-dimorpholino-1,3,5-triazine-based pan-class I PI3K inhibitor, which targets mTOR kinase in a balanced fashion at higher concns.  No off-target interactions were detected for 1 in a wide panel of protein kinase, enzyme, and receptor ligand assays.  Moreover, 1 did not bind tubulin, which was obsd. for the structurally related 4 (BKM120, buparlisib).  Compd. 1 is orally available, crosses the blood-brain barrier, and displayed favorable pharmacokinetic parameters in mice, rats, and dogs.  Compd. 1 demonstrated efficiency in inhibiting proliferation in tumor cell lines and a rat xenograft model.  This, together with the compd.'s safety profile, identifies 1 as a clin. candidate with a broad application range in oncol., including treatment of brain tumors or CNS metastasis.  Compd. 1 is currently in phase II clin. trials for advanced solid tumors and refractory lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtvYAarVqsarVg90H21EOLACvtfcHk0liWUh99bUSRLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurrP&md5=54d4db75f6a8bda3f12eaf1d196352fd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00930%26sid%3Dliteratum%253Aachs%26aulast%3DBeaufils%26aufirst%3DF.%26aulast%3DCmiljanovic%26aufirst%3DN.%26aulast%3DCmiljanovic%26aufirst%3DV.%26aulast%3DBohnacker%26aufirst%3DT.%26aulast%3DMelone%26aufirst%3DA.%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSele%26aufirst%3DA.%26aulast%3DBorsari%26aufirst%3DC.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DHebeisen%26aufirst%3DP.%26aulast%3DHillmann%26aufirst%3DP.%26aulast%3DGiese%26aufirst%3DB.%26aulast%3DZvelebil%26aufirst%3DM.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DRageot%26aufirst%3DD.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3D5-%25284%252C6-Dimorpholino-1%252C3%252C5-triazin-2-yl%2529-4-%2528trifluoromethyl%2529pyridin-2-amine%2520%2528PQR309%2529%252C%2520a%2520potent%252C%2520brain-penetrant%252C%2520orally%2520bioavailable%252C%2520pan-class%2520I%2520PI3K%252FmTOR%2520inhibitor%2520as%2520clinical%2520candidate%2520in%2520oncology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7524%26epage%3D7538%26doi%3D10.1021%2Facs.jmedchem.7b00930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augistin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gancia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivero, A. G.</span></span> <span> </span><span class="NLM_article-title">The rational design of selective benzoxazepin inhibitors of the α-isoform of phosphoinositide 3-kinase culminating in the identification of (<i>S</i>)-2-((2-(1-isopropyl-1<i>H</i>-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[<i>f</i>]imidazo[1,2-<i>d</i>][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01483</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=985-1002&author=T.+P.+Heffronauthor=R.+A.+Healdauthor=C.+Ndubakuauthor=B.+Weiauthor=M.+Augistinauthor=S.+Doauthor=K.+Edgarauthor=C.+Eigenbrotauthor=L.+Friedmanauthor=E.+Ganciaauthor=P.+S.+Jacksonauthor=G.+Jonesauthor=A.+Kolesnikovauthor=L.+B.+Leeauthor=J.+D.+Lesnickauthor=C.+Lewisauthor=N.+McLeanauthor=M.+Mortlauthor=J.+Nonomiyaauthor=J.+Pangauthor=S.+Priceauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=S.+T.+Stabenauthor=S.+Steinbacherauthor=V.+Tsuiauthor=J.+Wallinauthor=D.+Sampathauthor=A.+G.+Olivero&title=The+rational+design+of+selective+benzoxazepin+inhibitors+of+the+%CE%B1-isoform+of+phosphoinositide+3-kinase+culminating+in+the+identification+of+%28S%29-2-%28%282-%281-isopropyl-1H-1%2C2%2C4-triazol-5-yl%29-5%2C6-dihydrobenzo%5Bf%5Dimidazo%5B1%2C2-d%5D%5B1%2C4%5Doxazepin-9-yl%29oxy%29propanamide+%28GDC-0326%29&doi=10.1021%2Facs.jmedchem.5b01483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01483%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DHeald%26aufirst%3DR.%2BA.%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DAugistin%26aufirst%3DM.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DEdgar%26aufirst%3DK.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DGancia%26aufirst%3DE.%26aulast%3DJackson%26aufirst%3DP.%2BS.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DLesnick%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMcLean%26aufirst%3DN.%26aulast%3DMortl%26aufirst%3DM.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWallin%26aufirst%3DJ.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26atitle%3DThe%2520rational%2520design%2520of%2520selective%2520benzoxazepin%2520inhibitors%2520of%2520the%2520%25CE%25B1-isoform%2520of%2520phosphoinositide%25203-kinase%2520culminating%2520in%2520the%2520identification%2520of%2520%2528S%2529-2-%2528%25282-%25281-isopropyl-1H-1%252C2%252C4-triazol-5-yl%2529-5%252C6-dihydrobenzo%255Bf%255Dimidazo%255B1%252C2-d%255D%255B1%252C4%255Doxazepin-9-yl%2529oxy%2529propanamide%2520%2528GDC-0326%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D985%26epage%3D1002%26doi%3D10.1021%2Facs.jmedchem.5b01483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic acid (AA-115/APG-115): a potent and orally active murine double minute 2 (MDM2) inhibitor in clinical development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2819</span>– <span class="NLM_lpage">2839</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01665</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01665" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2819-2839&author=A.+Aguilarauthor=J.+Luauthor=L.+Liuauthor=D.+Duauthor=D.+Bernardauthor=D.+McEachernauthor=S.+Przybranowskiauthor=X.+Liauthor=R.+Luoauthor=B.+Wenauthor=D.+Sunauthor=H.+Wangauthor=J.+Wenauthor=G.+Wangauthor=Y.+Zhaiauthor=M.+Guoauthor=D.+Yangauthor=S.+Wang&title=Discovery+of+4-%28%283%E2%80%B2R%2C4%E2%80%B2S%2C5%E2%80%B2R%29-6%E2%80%B3-chloro-4%E2%80%B2-%283-chloro-2-fluorophenyl%29-1%E2%80%B2-ethyl-2%E2%80%B3-oxodispiro%5Bcyclohexane-1%2C2%E2%80%B2-pyrrolidine-3%E2%80%B2%2C3%E2%80%B3-indoline%5D-5%E2%80%B2-carboxamido%29bicyclo%5B2.2.2%5Doctane-1-carboxylic+acid+%28AA-115%2FAPG-115%29%3A+a+potent+and+orally+active+murine+double+minute+2+%28MDM2%29+inhibitor+in+clinical+development&doi=10.1021%2Facs.jmedchem.6b01665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4-((3'R,4'S,5'R)-6''-Chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2''-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development</span></div><div class="casAuthors">Aguilar, Angelo; Lu, Jianfeng; Liu, Liu; Du, Ding; Bernard, Denzil; McEachern, Donna; Przybranowski, Sally; Li, Xiaoqin; Luo, Ruijuan; Wen, Bo; Sun, Duxin; Wang, Hengbang; Wen, Jianfeng; Wang, Guangfeng; Zhai, Yifan; Guo, Ming; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2819-2839</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously reported the design of spirooxindoles with two identical substituents at the carbon-2 of the pyrrolidine core as potent MDM2 inhibitors.  In this paper the authors describe an extensive structure-activity relationship study of this class of MDM2 inhibitors, which led to the discovery of 60 (AA-115/APG-115, 4-((3R,4S,5R)-6''-chloro-4-(3-chloro-2-fluorophenyl)-1-ethyl-2''-oxodispiro[cyclohexane-1,2-pyrrolidine-3,3''-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic acid).  Compd. 60 has a very high affinity to MDM2 (Ki < 1 nM), potent cellular activity, and an excellent oral pharmacokinetic profile.  Compd. 60 is capable of achieving complete and long-lasting tumor regression in vivo and is currently in phase I clin. trials for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpodWycM_gQDrVg90H21EOLACvtfcHk0ljcfphN_uccYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWrsL0%253D&md5=d40265261f65df6babcd06fc0b30ca46</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01665%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDu%26aufirst%3DD.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DPrzybranowski%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DR.%26aulast%3DWen%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25204-%2528%25283%25E2%2580%25B2R%252C4%25E2%2580%25B2S%252C5%25E2%2580%25B2R%2529-6%25E2%2580%25B3-chloro-4%25E2%2580%25B2-%25283-chloro-2-fluorophenyl%2529-1%25E2%2580%25B2-ethyl-2%25E2%2580%25B3-oxodispiro%255Bcyclohexane-1%252C2%25E2%2580%25B2-pyrrolidine-3%25E2%2580%25B2%252C3%25E2%2580%25B3-indoline%255D-5%25E2%2580%25B2-carboxamido%2529bicyclo%255B2.2.2%255Doctane-1-carboxylic%2520acid%2520%2528AA-115%252FAPG-115%2529%253A%2520a%2520potent%2520and%2520orally%2520active%2520murine%2520double%2520minute%25202%2520%2528MDM2%2529%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2819%26epage%3D2839%26doi%3D10.1021%2Facs.jmedchem.6b01665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design of chemically stable, potent, and efficacious MDM2 inhibitors that exploit the retro-Mannich ring-opening-cyclization reaction mechanism in spiro-oxindoles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10486</span>– <span class="NLM_lpage">10498</span>, <span class="refDoi"> DOI: 10.1021/jm501541j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501541j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2nt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10486-10498&author=A.+Aguilarauthor=W.+Sunauthor=L.+Liuauthor=J.+Luauthor=D.+McEachernauthor=D.+Bernardauthor=J.+R.+Deschampsauthor=S.+Wang&title=Design+of+chemically+stable%2C+potent%2C+and+efficacious+MDM2+inhibitors+that+exploit+the+retro-Mannich+ring-opening-cyclization+reaction+mechanism+in+spiro-oxindoles&doi=10.1021%2Fjm501541j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Chemically Stable, Potent, and Efficacious MDM2 Inhibitors That Exploit the Retro-Mannich Ring-Opening-Cyclization Reaction Mechanism in Spiro-oxindoles</span></div><div class="casAuthors">Aguilar, Angelo; Sun, Wei; Liu, Liu; Lu, Jianfeng; McEachern, Donna; Bernard, Denzil; Deschamps, Jeffrey R.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10486-10498</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spiropyrrolidineoxindoles such as I (R = trans-4-hydroxycyclohexyl, 4-HO2CC6H4) were prepd. as inhibitors of the interaction between the proteins MDM2 and p53 for use as antitumor agents; the second-generation inhibitors incorporate sym. disubstitution in the pyrrolidine ring next to the spiro junction in order to facilitate isomerization via retro-Mannich/Mannich reactions to the more active stereoisomers (in which the aryl rings attached to the pyrrolidine are trans) as well as to improve stability in vitro and in vivo.  In particular, I (R = 4-HO2CC6H4) (MI-1061), which bound to MDM2 with a Ki value of 0.16 nM, showed excellent chem. stability and caused regression of human SJSA-1 xenograft tumors in mice.  The structures of diphenylhydroxyethyl spiropyrrolidineoxindole and spiropyrrolidineoxindolecarboxylate intermediates in the prepn. of I (R = trans-4-hydroxycyclohexyl, 4-HO2CC6H4) were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_es94k2y2-rVg90H21EOLACvtfcHk0ljcfphN_uccYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2nt73O&md5=6399fb5e19fc8d69e40e6fd19721e270</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm501541j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501541j%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520chemically%2520stable%252C%2520potent%252C%2520and%2520efficacious%2520MDM2%2520inhibitors%2520that%2520exploit%2520the%2520retro-Mannich%2520ring-opening-cyclization%2520reaction%2520mechanism%2520in%2520spiro-oxindoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10486%26epage%3D10498%26doi%3D10.1021%2Fjm501541j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">wang, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3432</span>– <span class="NLM_lpage">3435</span>, <span class="refDoi"> DOI: 10.1021/jm051122a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051122a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3432-3435&author=K.+Dingauthor=Y.+Luauthor=Z.+Nikolovska-Coleskaauthor=G.+Wangauthor=S.+Qiuauthor=S.+Shangaryauthor=W.+Gaoauthor=D.+Qinauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=P.+R.+Rollerauthor=S.+wang&title=Structure-based+design+of+spiro-oxindoles+as+potent%2C+specific+small-molecule+inhibitors+of+the+MDM2-p53+interaction&doi=10.1021%2Fjm051122a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Ding, Ke; Lu, Yipin; Nikolovska-Coleska, Zaneta; Wang, Guoping; Qiu, Su; Shangary, Sanjeev; Gao, Wei; Qin, Dongguang; Stuckey, Jeanne; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3432-3435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, specific, non-peptide small-mol. inhibitors of the MDM2-p53 interaction were successfully designed.  The most potent inhibitor (MI-63) has a Ki value of 3 nM binding to MDM2 and greater than 10,000-fold selectivity over Bcl-2/Bcl-xL proteins.  MI-63 is highly effective in activation of p53 function and in inhibition of cell growth in cancer cells with wild-type p53 status.  MI-63 has excellent specificity over cancer cells with deleted p53 and shows a minimal toxicity to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptppiErNrFXrVg90H21EOLACvtfcHk0ljcfphN_uccYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D&md5=186a2ba028ad9b8f71107aa1c2555421</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm051122a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051122a%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BR.%26aulast%3Dwang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520spiro-oxindoles%2520as%2520potent%252C%2520specific%2520small-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3432%26epage%3D3435%26doi%3D10.1021%2Fjm051122a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Planken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behenna, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, He.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho-Schultz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deal, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajiwala, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemkens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrich, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafontaine, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-((3<i>R</i>,4<i>R</i>)-4-fluoro-1-(6-((3-methoxy-1-methyl-1<i>H</i>-pyrazol-4-yl)amino)-9-methyl-9<i>H</i>-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through structure-based drug design: a high affinity irreversible inhibitor targeting oncogenic EGFR mutants with selectivity over wild-type EGFR</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3002</span>– <span class="NLM_lpage">3019</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01894</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01894" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3002-3019&author=S.+Plankenauthor=D.+C.+Behennaauthor=S.+K.+Nairauthor=T.+O.+Johnsonauthor=A.+Nagataauthor=C.+Almadenauthor=S.+Baileyauthor=T.+E.+Ballardauthor=L.+Bernierauthor=He.+Chengauthor=S.+Cho-Schultzauthor=D.+Dalvieauthor=J.+G.+Dealauthor=D.+M.+Dinhauthor=M.+P.+Edwardsauthor=R.+A.+Ferreauthor=K.+S.+Gajiwalaauthor=M.+Hemkensauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=J.+Matthewsauthor=B.+W.+Murrayauthor=S.+Niessenauthor=S.+T.+M.+Orrauthor=M.+Pairishauthor=N.+W.+Sachauthor=H.+Shenauthor=M.+Shiauthor=J.+Solowiejauthor=K.+Tranauthor=E.+Tsengauthor=P.+Viciniauthor=Y.+Wangauthor=S.+L.+Weinrichauthor=R.+Zhouauthor=M.+Zientekauthor=L.+Liuauthor=Y.+Luoauthor=S.+Xinauthor=C.+Zhangauthor=J.+Lafontaine&title=Discovery+of+N-%28%283R%2C4R%29-4-fluoro-1-%286-%28%283-methoxy-1-methyl-1H-pyrazol-4-yl%29amino%29-9-methyl-9H-purin-2-yl%29pyrrolidine-3-yl%29acrylamide+%28PF-06747775%29+through+structure-based+drug+design%3A+a+high+affinity+irreversible+inhibitor+targeting+oncogenic+EGFR+mutants+with+selectivity+over+wild-type+EGFR&doi=10.1021%2Facs.jmedchem.6b01894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR</span></div><div class="casAuthors">Planken, Simon; Behenna, Douglas C.; Nair, Sajiv K.; Johnson, Theodore O.; Nagata, Asako; Almaden, Chau; Bailey, Simon; Ballard, T. Eric; Bernier, Louise; Cheng, Hengmiao; Cho-Schultz, Sujin; Dalvie, Deepak; Deal, Judith G.; Dinh, Dac M.; Edwards, Martin P.; Ferre, Rose Ann; Gajiwala, Ketan S.; Hemkens, Michelle; Kania, Robert S.; Kath, John C.; Matthews, Jean; Murray, Brion W.; Niessen, Sherry; Orr, Suvi T. M.; Pairish, Mason; Sach, Neal W.; Shen, Hong; Shi, Manli; Solowiej, James; Tran, Khanh; Tseng, Elaine; Vicini, Paolo; Wang, Yuli; Weinrich, Scott L.; Zhou, Ru; Zientek, Michael; Liu, Longqing; Luo, Yiqin; Xin, Shuibo; Zhang, Chengyi; Lafontaine, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3002-3019</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutant epidermal growth factor receptor (EGFR) is a major driver of non-small-cell lung cancer (NSCLC).  Marketed first generation inhibitors, such as erlotinib, effect a transient beneficial response in EGFR mutant NSCLC patients before resistance mechanisms render these inhibitors ineffective.  Secondary oncogenic EGFR mutations account for approx. 50% of relapses, the most common being the gatekeeper T790M substitution that renders existing therapies ineffective.  The discovery of PF-06459988 (1), an irreversible pyrrolopyrimidine inhibitor of EGFR T790M mutants, was recently disclosed.  Herein, we describe our continued efforts to achieve potency across EGFR oncogenic mutations and improved kinome selectivity, resulting in the discovery of clin. candidate PF-06747775 (21), which provides potent EGFR activity against the four common mutants (exon 19 deletion (Del), L858R, and double mutants T790M/L858R and T790M/Del), selectivity over wild-type EGFR, and desirable ADME properties.  Compd. 21 is currently being evaluated in phase-I clin. trials of mutant EGFR driven NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1yLRt7MBSrbVg90H21EOLACvtfcHk0lj4uPLB_dIcvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmtrw%253D&md5=14a6700ed770621bdbd84f7931276f0e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01894%26sid%3Dliteratum%253Aachs%26aulast%3DPlanken%26aufirst%3DS.%26aulast%3DBehenna%26aufirst%3DD.%2BC.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DNagata%26aufirst%3DA.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DBernier%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DHe.%26aulast%3DCho-Schultz%26aufirst%3DS.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DFerre%26aufirst%3DR.%2BA.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DHemkens%26aufirst%3DM.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DMatthews%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DOrr%26aufirst%3DS.%2BT.%2BM.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DVicini%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWeinrich%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DXin%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLafontaine%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520N-%2528%25283R%252C4R%2529-4-fluoro-1-%25286-%2528%25283-methoxy-1-methyl-1H-pyrazol-4-yl%2529amino%2529-9-methyl-9H-purin-2-yl%2529pyrrolidine-3-yl%2529acrylamide%2520%2528PF-06747775%2529%2520through%2520structure-based%2520drug%2520design%253A%2520a%2520high%2520affinity%2520irreversible%2520inhibitor%2520targeting%2520oncogenic%2520EGFR%2520mutants%2520with%2520selectivity%2520over%2520wild-type%2520EGFR%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3002%26epage%3D3019%26doi%3D10.1021%2Facs.jmedchem.6b01894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lelais, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epple, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsilje, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anumolu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badiger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiDonato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juarez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manuia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michellys, P.-Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of (<i>R</i>, <i>E</i>)-N-(7-chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1<i>H</i>-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a novel, potent, and WT sparing covalent inhibitor of oncogenic (L858R, ex19del) and resistant (T790M) EGFR mutants for the treatment of EGFR mutant non-small-cell lung cancers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6671</span>– <span class="NLM_lpage">6689</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01985</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01985" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6671-6689&author=G.+Lelaisauthor=R.+Eppleauthor=T.+H.+Marsiljeauthor=Y.+O.+Longauthor=M.+McNeillauthor=B.+Chenauthor=W.+Luauthor=J.+Anumoluauthor=S.+Badigerauthor=B.+Bursulayaauthor=M.+DiDonatoauthor=R.+Fongauthor=J.+Juarezauthor=J.+Liauthor=M.+Manuiaauthor=D.+E.+Masonauthor=P.+Gordonauthor=T.+Groesslauthor=K.+Johnsonauthor=Y.+Jiaauthor=S.+Kasibhatlaauthor=C.+Liauthor=J.+Isbellauthor=G.+Spraggonauthor=S.+Benderauthor=P.-Y.+Michellys&title=Discovery+of+%28R%2C+E%29-N-%287-chloro-1-%281-%5B4-%28dimethylamino%29but-2-enoyl%5Dazepan-3-yl%29-1H-benzo%5Bd%5Dimidazol-2-yl%29-2-methylisonicotinamide+%28EGF816%29%2C+a+novel%2C+potent%2C+and+WT+sparing+covalent+inhibitor+of+oncogenic+%28L858R%2C+ex19del%29+and+resistant+%28T790M%29+EGFR+mutants+for+the+treatment+of+EGFR+mutant+non-small-cell+lung+cancers&doi=10.1021%2Facs.jmedchem.5b01985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01985%26sid%3Dliteratum%253Aachs%26aulast%3DLelais%26aufirst%3DG.%26aulast%3DEpple%26aufirst%3DR.%26aulast%3DMarsilje%26aufirst%3DT.%2BH.%26aulast%3DLong%26aufirst%3DY.%2BO.%26aulast%3DMcNeill%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DAnumolu%26aufirst%3DJ.%26aulast%3DBadiger%26aufirst%3DS.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DDiDonato%26aufirst%3DM.%26aulast%3DFong%26aufirst%3DR.%26aulast%3DJuarez%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DManuia%26aufirst%3DM.%26aulast%3DMason%26aufirst%3DD.%2BE.%26aulast%3DGordon%26aufirst%3DP.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DMichellys%26aufirst%3DP.-Y.%26atitle%3DDiscovery%2520of%2520%2528R%252C%2520E%2529-N-%25287-chloro-1-%25281-%255B4-%2528dimethylamino%2529but-2-enoyl%255Dazepan-3-yl%2529-1H-benzo%255Bd%255Dimidazol-2-yl%2529-2-methylisonicotinamide%2520%2528EGF816%2529%252C%2520a%2520novel%252C%2520potent%252C%2520and%2520WT%2520sparing%2520covalent%2520inhibitor%2520of%2520oncogenic%2520%2528L858R%252C%2520ex19del%2529%2520and%2520resistant%2520%2528T790M%2529%2520EGFR%2520mutants%2520for%2520the%2520treatment%2520of%2520EGFR%2520mutant%2520non-small-cell%2520lung%2520cancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6671%26epage%3D6689%26doi%3D10.1021%2Facs.jmedchem.5b01985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ebiike, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyohdoh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayase, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of [5-amino-1-(2-methyl-3<i>H</i>-benzimidazol-5-yl)pyrazol-4-yl]-(1<i>H</i>-indol-2-yl)methanone (CH5183284/Debio 1347), an orally available and selective fibroblast growth factor receptor (FGFR) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10586</span>– <span class="NLM_lpage">10600</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01156</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10586-10600&author=H.+Ebiikeauthor=N.+Takaauthor=M.+Matsushitaauthor=M.+Ohmoriauthor=K.+Takamiauthor=I.+Hyohdohauthor=M.+Kohchiauthor=T.+Hayaseauthor=H.+Nishiiauthor=K.+Morikamiauthor=Y.+Nakanishiauthor=N.+Akiyamaauthor=H.+Shindohauthor=N.+Ishiiauthor=T.+Isobeauthor=H.+Matsuoka&title=Discovery+of+%5B5-amino-1-%282-methyl-3H-benzimidazol-5-yl%29pyrazol-4-yl%5D-%281H-indol-2-yl%29methanone+%28CH5183284%2FDebio+1347%29%2C+an+orally+available+and+selective+fibroblast+growth+factor+receptor+%28FGFR%29+inhibitor&doi=10.1021%2Facs.jmedchem.6b01156"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01156%26sid%3Dliteratum%253Aachs%26aulast%3DEbiike%26aufirst%3DH.%26aulast%3DTaka%26aufirst%3DN.%26aulast%3DMatsushita%26aufirst%3DM.%26aulast%3DOhmori%26aufirst%3DM.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DHyohdoh%26aufirst%3DI.%26aulast%3DKohchi%26aufirst%3DM.%26aulast%3DHayase%26aufirst%3DT.%26aulast%3DNishii%26aufirst%3DH.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DAkiyama%26aufirst%3DN.%26aulast%3DShindoh%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DMatsuoka%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520%255B5-amino-1-%25282-methyl-3H-benzimidazol-5-yl%2529pyrazol-4-yl%255D-%25281H-indol-2-yl%2529methanone%2520%2528CH5183284%252FDebio%25201347%2529%252C%2520an%2520orally%2520available%2520and%2520selective%2520fibroblast%2520growth%2520factor%2520receptor%2520%2528FGFR%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10586%26epage%3D10600%26doi%3D10.1021%2Facs.jmedchem.6b01156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brameld, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venetsanakos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaStant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loughhead, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karr, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerritsen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, J. O.</span></span> <span> </span><span class="NLM_article-title">Discovery of the irreversible covalent FGFR inhibitor 8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8<i>H</i>)-one (PRN1371) for the treatment of solid tumors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6516</span>– <span class="NLM_lpage">6527</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00360</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00360" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVykt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6516-6527&author=K.+A.+Brameldauthor=T.+D.+Owensauthor=E.+Vernerauthor=E.+Venetsanakosauthor=J.+M.+Bradshawauthor=V.+T.+Phanauthor=D.+Tamauthor=K.+Leungauthor=J.+Shuauthor=J.+LaStantauthor=D.+G.+Loughheadauthor=T.+Tonauthor=D.+E.+Karrauthor=M.+E.+Gerritsenauthor=D.+M.+Goldsteinauthor=J.+O.+Funk&title=Discovery+of+the+irreversible+covalent+FGFR+inhibitor+8-%283-%284-acryloylpiperazin-1-yl%29propyl%29-6-%282%2C6-dichloro-3%2C5-dimethoxyphenyl%29-2-%28methylamino%29pyrido%5B2%2C3-d%5Dpyrimidin-7%288H%29-one+%28PRN1371%29+for+the+treatment+of+solid+tumors&doi=10.1021%2Facs.jmedchem.7b00360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors</span></div><div class="casAuthors">Brameld, Ken A.; Owens, Timothy D.; Verner, Erik; Venetsanakos, Eleni; Bradshaw, J. Michael; Phan, Vernon T.; Tam, Danny; Leung, Kwan; Shu, Jin; LaStant, Jacob; Loughhead, David G.; Ton, Tony; Karr, Dane E.; Gerritsen, Mary E.; Goldstein, David M.; Funk, Jens Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6516-6527</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant signaling of the FGF/FGFR pathway occurs frequently in cancers and is an oncogenic driver in many solid tumors.  Clin. validation of FGFR as a therapeutic target has been demonstrated in bladder, liver, lung, breast, and gastric cancers.  Our goal was to develop an irreversible covalent inhibitor of FGFR1-4 for use in oncol. indications.  An irreversible covalent binding mechanism imparts many desirable pharmacol. benefits including high potency, selectivity, and prolonged target inhibition.  Herein we report the structure-based design, medicinal chem. optimization, and unique ADME assays of our irreversible covalent drug discovery program which culminated in the discovery of compd. 34 (PRN1371), a highly selective and potent FGFR1-4 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpklTuvm1niy7Vg90H21EOLACvtfcHk0liIi9UYRdxI0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVykt7fK&md5=987069b645d5e0e36ccda5e5c81520b9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00360%26sid%3Dliteratum%253Aachs%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DVenetsanakos%26aufirst%3DE.%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26aulast%3DPhan%26aufirst%3DV.%2BT.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DShu%26aufirst%3DJ.%26aulast%3DLaStant%26aufirst%3DJ.%26aulast%3DLoughhead%26aufirst%3DD.%2BG.%26aulast%3DTon%26aufirst%3DT.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DGerritsen%26aufirst%3DM.%2BE.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DFunk%26aufirst%3DJ.%2BO.%26atitle%3DDiscovery%2520of%2520the%2520irreversible%2520covalent%2520FGFR%2520inhibitor%25208-%25283-%25284-acryloylpiperazin-1-yl%2529propyl%2529-6-%25282%252C6-dichloro-3%252C5-dimethoxyphenyl%2529-2-%2528methylamino%2529pyrido%255B2%252C3-d%255Dpyrimidin-7%25288H%2529-one%2520%2528PRN1371%2529%2520for%2520the%2520treatment%2520of%2520solid%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6516%26epage%3D6527%26doi%3D10.1021%2Facs.jmedchem.7b00360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamby, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, C. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, H. D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panek, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsewski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahring, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keiser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slintak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallak, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, A. M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships for a novel series of pyrido[2,3-<i>d</i>]pyrimidine tyrosine kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">2296</span>– <span class="NLM_lpage">2303</span>, <span class="refDoi"> DOI: 10.1021/jm970367n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970367n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2296-2303&author=J.+M.+Hambyauthor=C.+J.+C.+Connollyauthor=M.+C.+Schroederauthor=R.+T.+Wintersauthor=H.+D.+H.+Showalterauthor=R.+L.+Panekauthor=T.+C.+Majorauthor=B.+Olsewskiauthor=M.+J.+Ryanauthor=T.+Dahringauthor=G.+H.+Luauthor=J.+Keiserauthor=A.+Amarauthor=C.+Shenauthor=A.+J.+Krakerauthor=V.+Slintakauthor=J.+M.+Nelsonauthor=D.+W.+Fryauthor=L.+Bradfordauthor=H.+Hallakauthor=A.+M.+Doherty&title=Structure-activity+relationships+for+a+novel+series+of+pyrido%5B2%2C3-d%5Dpyrimidine+tyrosine+kinase+inhibitors&doi=10.1021%2Fjm970367n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships for a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors</span></div><div class="casAuthors">Hamby, James M.; Connolly, Cleo J. C.; Schroeder, Mel C.; Winters, R. Thomas; Showalter, H. D. Hollis; Panek, Robert L.; Major, Terry C.; Olsewski, Bronislawa; Ryan, Michael J.; Dahring, Tawny; Lu, Gina H.; Keiser, Joan; Amar, Aneesa; Shen, Cindy; Kraker, Alan J.; Slintak, Veronika; Nelson, James M.; Fry, David W.; Bradford, Laura; Hallak, Hussein; Doherty, Annette M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2296-2303</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Screening of a compd. library for inhibitors of the fibroblast growth factor (FGFr) and platelet-derived growth factor (PDGFr) receptor tyrosine kinases led to the development of a novel series of ATP competitive pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.  The initial lead, 1-[2-amino-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea (I; PD-089828), was found to be a broadly active tyrosine kinase inhibitor.  I inhibited the PDGFr, FGFr, EGFr, and c-src tyrosine kinases with IC50 values of 1.11, 0.13, 0.45, and 0.22 μM, resp.  Subsequent SAR studies led to the synthesis of new analogs with improved potency, soly., and bioavailability relative to the initial lead.  For example, the introduction of a [4-(diethylamino)butyl]amino side chain into the 2-position of I afforded a compd. (II) with enhanced potency and bioavailability.  II inhibited PDGF-stimulated vascular smooth muscle cell proliferation with an IC50 of 0.3 μM.  Furthermore, replacement of the 6-(2,6-dichlorophenyl) moiety of I with a 6-(3',5'-dimethoxyphenyl) functionality produced a highly selective FGFr tyrosine kinase inhibitor (III).  III inhibited the FGFr tyrosine kinase with an IC50 of 0.060 μM, whereas IC50s for the inhibition of the PDGFr, FGFr, EGFr, c-src, and InsR tyrosine kinases for this compd. were all greater than 50 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJdLcE9N0L8rVg90H21EOLACvtfcHk0liIi9UYRdxI0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKisLs%253D&md5=f68e00a123b8b450e647761ac1421d77</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm970367n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970367n%26sid%3Dliteratum%253Aachs%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DConnolly%26aufirst%3DC.%2BJ.%2BC.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DWinters%26aufirst%3DR.%2BT.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DPanek%26aufirst%3DR.%2BL.%26aulast%3DMajor%26aufirst%3DT.%2BC.%26aulast%3DOlsewski%26aufirst%3DB.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DDahring%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DG.%2BH.%26aulast%3DKeiser%26aufirst%3DJ.%26aulast%3DAmar%26aufirst%3DA.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DSlintak%26aufirst%3DV.%26aulast%3DNelson%26aufirst%3DJ.%2BM.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DBradford%26aufirst%3DL.%26aulast%3DHallak%26aufirst%3DH.%26aulast%3DDoherty%26aufirst%3DA.%2BM.%26atitle%3DStructure-activity%2520relationships%2520for%2520a%2520novel%2520series%2520of%2520pyrido%255B2%252C3-d%255Dpyrimidine%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2296%26epage%3D2303%26doi%3D10.1021%2Fjm970367n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kung, P.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajiwala, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grantner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gukasyan, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kephart, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krivacic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpf, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khamphavong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollins, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uryu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehnder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Optimization of orally bioavailable enhancer of zeste homolog 2 (EZH2) inhibitors using ligand and property-based design strategies: Identification of development candidate (<i>R</i>)-5,8-dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (PF-06821497)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01375</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01375" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFaqtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=650-665&author=P.-P.+Kungauthor=P.+Binghamauthor=A.+Broounauthor=M.+Collinsauthor=Y.-L.+Dengauthor=D.+Dinhauthor=C.+Fanauthor=K.+S.+Gajiwalaauthor=R.+Grantnerauthor=H.+J.+Gukasyanauthor=W.+Huauthor=B.+Huangauthor=R.+Kaniaauthor=E.+Kephartauthor=C.+Krivacicauthor=R.+A.+Kumpfauthor=P.+Khamphavongauthor=M.+Krausauthor=W.+Liuauthor=K.+A.+Maegleyauthor=L.+Nguyenauthor=S.+Renauthor=D.+Richterauthor=R.+A.+Rollinsauthor=N.+Sachauthor=S.+Sharmaauthor=J.+Sherrillauthor=J.+Spanglerauthor=A.+E.+Stewartauthor=S.+Suttonauthor=S.+Uryuauthor=D.+Verhelleauthor=H.+Wangauthor=S.+Wangauthor=M.+Wythesauthor=S.+Xinauthor=S.+Yamazakiauthor=H.+Zhuauthor=J.+Zhuauthor=L.+Zehnderauthor=M.+Edwards&title=Optimization+of+orally+bioavailable+enhancer+of+zeste+homolog+2+%28EZH2%29+inhibitors+using+ligand+and+property-based+design+strategies%3A+Identification+of+development+candidate+%28R%29-5%2C8-dichloro-7-%28methoxy%28oxetan-3-yl%29methyl%29-2-%28%284-methoxy-6-methyl-2-oxo-1%2C2-dihydropyridin-3-yl%29methyl%29-3%2C4-dihydroisoquinolin-1%282H%29-one+%28PF-06821497%29&doi=10.1021%2Facs.jmedchem.7b01375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497)</span></div><div class="casAuthors">Kung, Pei-Pei; Bingham, Patrick; Brooun, Alexei; Collins, Michael; Deng, Ya-Li; Dinh, Dac; Fan, Connie; Gajiwala, Ketan S.; Grantner, Rita; Gukasyan, Hovhannes J.; Hu, Wenyue; Huang, Buwen; Kania, Robert; Kephart, Susan E.; Krivacic, Cody; Kumpf, Robert A.; Khamphavong, Penney; Kraus, Manfred; Liu, Wei; Maegley, Karen A.; Nguyen, Lisa; Ren, Shijian; Richter, Dan; Rollins, Robert A.; Sach, Neal; Sharma, Shikhar; Sherrill, John; Spangler, Jillian; Stewart, Albert E.; Sutton, Scott; Uryu, Sean; Verhelle, Dominique; Wang, Hui; Wang, Shuiwang; Wythes, Martin; Xin, Shuibo; Yamazaki, Shinji; Zhu, Huichun; Zhu, JinJiang; Zehnder, Luke; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">650-665</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of lactam-derived EZH2 inhibitors was designed via ligand-based and physicochem.-property-based strategies to address metabolic stability and thermodn. soly. issues assocd. with previous lead compd. (I).  The new inhibitors incorporated an Sp3 hybridized carbon atom at the 7-position of the lactam moiety present in lead compd. (I) as a replacement for a dimethylisoxazole group.  This transformation enabled optimization of the physicochem. properties and potency compared to compd. (I).  Anal. of relationships between calcd. log D (clogD) values and in vitro metabolic stability and permeability parameters identified a clogD range that afforded an increased probability of achieving favorable ADME data in a single mol.  Compd. 23a (5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one) exhibited the best overlap of potency and pharmaceutical properties as well as robust tumor growth inhibition in vivo and was therefore advanced as a development candidate (PF-06821497).  A crystal structure of 23a in complex with the three-protein PRC2 complex enabled understanding of the key structural features required for optimal binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0-Aa0AZgXLVg90H21EOLACvtfcHk0lj5qhf5pBpGDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFaqtrzF&md5=96ff75b96f5eea2dc82013a6bad8096b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01375%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DY.-L.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DGrantner%26aufirst%3DR.%26aulast%3DGukasyan%26aufirst%3DH.%2BJ.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DKania%26aufirst%3DR.%26aulast%3DKephart%26aufirst%3DE.%26aulast%3DKrivacic%26aufirst%3DC.%26aulast%3DKumpf%26aufirst%3DR.%2BA.%26aulast%3DKhamphavong%26aufirst%3DP.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DRollins%26aufirst%3DR.%2BA.%26aulast%3DSach%26aufirst%3DN.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSherrill%26aufirst%3DJ.%26aulast%3DSpangler%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DUryu%26aufirst%3DS.%26aulast%3DVerhelle%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWythes%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZehnder%26aufirst%3DL.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DOptimization%2520of%2520orally%2520bioavailable%2520enhancer%2520of%2520zeste%2520homolog%25202%2520%2528EZH2%2529%2520inhibitors%2520using%2520ligand%2520and%2520property-based%2520design%2520strategies%253A%2520Identification%2520of%2520development%2520candidate%2520%2528R%2529-5%252C8-dichloro-7-%2528methoxy%2528oxetan-3-yl%2529methyl%2529-2-%2528%25284-methoxy-6-methyl-2-oxo-1%252C2-dihydropyridin-3-yl%2529methyl%2529-3%252C4-dihydroisoquinolin-1%25282H%2529-one%2520%2528PF-06821497%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D650%26epage%3D665%26doi%3D10.1021%2Facs.jmedchem.7b01375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kung, P.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braganza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gukasyan, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kephart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krivacic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpf, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlpine, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninkovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryskin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatlock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehnder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollins, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of pyridone-containing 3,4-dihydroisoquinoline-1(2<i>H</i>)-ones as a novel class of enhancer of zeste homolog 2 (EZH2) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8306</span>– <span class="NLM_lpage">8325</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8306-8325&author=P.-P.+Kungauthor=E.+Ruiauthor=S.+Bergqvistauthor=P.+Binghamauthor=J.+Braganzaauthor=M.+Collinsauthor=M.+Cuiauthor=W.+Diehlauthor=D.+Dinhauthor=C.+Fanauthor=V.+R.+Fantinauthor=H.+J.+Gukasyanauthor=W.+Huauthor=B.+Huangauthor=S.+Kephartauthor=C.+Krivacicauthor=R.+A.+Kumpfauthor=G.+Liauthor=K.+A.+Maegleyauthor=I.+McAlpineauthor=L.+Nguyenauthor=S.+Ninkovicauthor=M.+Ornelasauthor=M.+Ryskinauthor=S.+Scalesauthor=S.+Suttonauthor=J.+Tatlockauthor=D.+Verhelleauthor=F.+Wangauthor=P.+Wellsauthor=M.+Wythesauthor=S.+Yamazakiauthor=B.+Yipauthor=X.+Yuauthor=L.+Zehnderauthor=W.-G.+Zhangauthor=R.+A.+Rollinsauthor=M.+Edwards&title=Design+and+synthesis+of+pyridone-containing+3%2C4-dihydroisoquinoline-1%282H%29-ones+as+a+novel+class+of+enhancer+of+zeste+homolog+2+%28EZH2%29+inhibitors&doi=10.1021%2Facs.jmedchem.6b00515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors</span></div><div class="casAuthors">Kung, Pei-Pei; Rui, Eugene; Bergqvist, Simon; Bingham, Patrick; Braganza, John; Collins, Michael; Cui, Mei; Diehl, Wade; Dinh, Dac; Fan, Connie; Fantin, Valeria R.; Gukasyan, Hovhannes J.; Hu, Wenyue; Huang, Buwen; Kephart, Susan; Krivacic, Cody; Kumpf, Robert A.; Li, Gary; Maegley, Karen A.; McAlpine, Indrawan; Nguyen, Lisa; Ninkovic, Sacha; Ornelas, Martha; Ryskin, Michael; Scales, Stephanie; Sutton, Scott; Tatlock, John; Verhelle, Dominique; Wang, Fen; Wells, Peter; Wythes, Martin; Yamazaki, Shinji; Yip, Brian; Yu, Xiu; Zehnder, Luke; Zhang, Wei-Guo; Rollins, Robert A.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8306-8325</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new enhancer of zeste homolog 2 (EZH2) inhibitor series comprising a substituted Ph ring joined to a dimethylpyridone moiety via an amide linkage has been designed.  A preferential amide torsion that improved the binding properties of the compds. was identified for this series via computational anal.  Cyclization of the amide linker resulted in a six-membered lactam analog, compd. I.  This transformation significantly improved the ligand efficiency/potency of the cyclized compd. relative to its acyclic analog.  Addnl. optimization of the lactam-contg. EZH2 inhibitors focused on lipophilic efficiency (LipE) improvement, which provided compd. II.  Compd. II displayed improved LipE and on-target potency in both biochem. and cellular readouts relative to compd. I.  Inhibitor II also displayed robust in vivo antitumor growth activity and dose-dependent de-repression of EZH2 target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr50CIrIhlikrVg90H21EOLACvtfcHk0lisTkpvjUWyig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7rM&md5=eb6f2b053e5ba2c2d214d847ad8d9f1f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00515%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DRui%26aufirst%3DE.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DBraganza%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DGukasyan%26aufirst%3DH.%2BJ.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DKrivacic%26aufirst%3DC.%26aulast%3DKumpf%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DMcAlpine%26aufirst%3DI.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DOrnelas%26aufirst%3DM.%26aulast%3DRyskin%26aufirst%3DM.%26aulast%3DScales%26aufirst%3DS.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DVerhelle%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DWythes%26aufirst%3DM.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DYip%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZehnder%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DRollins%26aufirst%3DR.%2BA.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520pyridone-containing%25203%252C4-dihydroisoquinoline-1%25282H%2529-ones%2520as%2520a%2520novel%2520class%2520of%2520enhancer%2520of%2520zeste%2520homolog%25202%2520%2528EZH2%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8306%26epage%3D8325%26doi%3D10.1021%2Facs.jmedchem.6b00515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaswani, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehling, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasveschuk, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duplessis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmange, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Justin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span> <span> </span><span class="NLM_article-title">Identification of (<i>R</i>)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (CPI-1205), a potent and selective inhibitor of histone methyltransferase EZH2, suitable for Phase I clinical trials for B-Cell lymphomas</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9928</span>– <span class="NLM_lpage">9941</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01315</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01315" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yks77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9928-9941&author=R.+G.+Vaswaniauthor=V.+S.+Gehlingauthor=L.+A.+Dakinauthor=A.+S.+Cookauthor=C.+G.+Nasveschukauthor=M.+Duplessisauthor=P.+Iyerauthor=S.+Balasubramanianauthor=F.+Zhaoauthor=A.+C.+Goodauthor=R.+Campbellauthor=C.+Leeauthor=N.+Cantoneauthor=R.+T.+Cummingsauthor=E.+Normantauthor=S.+F.+Bellonauthor=B.+K.+Albrechtauthor=J.-C.+Harmangeauthor=P.+Trojerauthor=J.+E.+Audiaauthor=Y.+Zhangauthor=N.+Justinauthor=S.+Chenauthor=J.+R.+Wilsonauthor=S.+J.+Gamblin&title=Identification+of+%28R%29-N-%28%284-methoxy-6-methyl-2-oxo-1%2C2-dihydropyridin-3-yl%29methyl%29-2-methyl-1-%281-%281-%282%2C2%2C2-trifluoroethyl%29piperidin-4-yl%29ethyl%29-1H-indole-3-carboxamide+%28CPI-1205%29%2C+a+potent+and+selective+inhibitor+of+histone+methyltransferase+EZH2%2C+suitable+for+Phase+I+clinical+trials+for+B-Cell+lymphomas&doi=10.1021%2Facs.jmedchem.6b01315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas</span></div><div class="casAuthors">Vaswani, Rishi G.; Gehling, Victor S.; Dakin, Les A.; Cook, Andrew S.; Nasveschuk, Christopher G.; Duplessis, Martin; Iyer, Priyadarshini; Balasubramanian, Srividya; Zhao, Feng; Good, Andrew C.; Campbell, Robert; Lee, Christina; Cantone, Nico; Cummings, Richard T.; Normant, Emmanuel; Bellon, Steven F.; Albrecht, Brian K.; Harmange, Jean-Christophe; Trojer, Patrick; Audia, James E.; Zhang, Ying; Justin, Neil; Chen, Shuyang; Wilson, Jon R.; Gamblin, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9928-9941</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) has been shown to play a major role in transcriptional silencing in part by installing methylation marks on lysine 27 of histone 3.  Dysregulation of PRC2 function correlates with certain malignancies and poor prognosis.  EZH2 is the catalytic engine of the PRC2 complex and thus represents a key candidate oncol. target for pharmacol. intervention.  Here we report the optimization of our indole-based EZH2 inhibitor series that led to the identification of CPI-1205, a highly potent (biochem. IC50 = 0.002 μM, cellular EC50 = 0.032 μM) and selective inhibitor of EZH2.  This compd. demonstrates robust antitumor effects in a Karpas-422 xenograft model when dosed at 160 mg/kg BID and is currently in Phase I clin. trials.  Addnl., we disclose the co-crystal structure of our inhibitor series bound to the human PRC2 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrqnfg3FGdE7Vg90H21EOLACvtfcHk0lisTkpvjUWyig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yks77I&md5=4096fa91399fef88a7ec8aabb5aaee13</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01315%26sid%3Dliteratum%253Aachs%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DJustin%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DJ.%2BR.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DIdentification%2520of%2520%2528R%2529-N-%2528%25284-methoxy-6-methyl-2-oxo-1%252C2-dihydropyridin-3-yl%2529methyl%2529-2-methyl-1-%25281-%25281-%25282%252C2%252C2-trifluoroethyl%2529piperidin-4-yl%2529ethyl%2529-1H-indole-3-carboxamide%2520%2528CPI-1205%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520histone%2520methyltransferase%2520EZH2%252C%2520suitable%2520for%2520Phase%2520I%2520clinical%2520trials%2520for%2520B-Cell%2520lymphomas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9928%26epage%3D9941%26doi%3D10.1021%2Facs.jmedchem.6b01315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gehling, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaswani, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasveschuk, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duplessis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmange, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span></span> <span> </span><span class="NLM_article-title">Discovery, design, and synthesis of indole-based EZH2 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3644</span>– <span class="NLM_lpage">3649</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2015.06.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3644-3649&author=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=C.+G.+Nasveschukauthor=M.+Duplessisauthor=P.+Iyerauthor=S.+Balasubramanianauthor=F.+Zhaoauthor=A.+C.+Goodauthor=R.+Campbellauthor=C.+Leeauthor=L.+A.+Dakinauthor=A.+S.+Cookauthor=A.+Gagnonauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=R.+T.+Cummingsauthor=E.+Normantauthor=P.+Trojerauthor=B.+K.+Albrecht&title=Discovery%2C+design%2C+and+synthesis+of+indole-based+EZH2+inhibitors&doi=10.1016%2Fj.bmcl.2015.06.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.056%26sid%3Dliteratum%253Aachs%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%252C%2520design%252C%2520and%2520synthesis%2520of%2520indole-based%2520EZH2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3644%26epage%3D3649%26doi%3D10.1016%2Fj.bmcl.2015.06.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Learn, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingrich, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesaros, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrzanski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albom, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeles, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells-Knecht, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aimone, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruckheimer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ator, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, B. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate CEP-37440, a selective inhibitor of focal adhesion kinase (FAK) and anaplastic lymphoma kinase (ALK)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7478</span>– <span class="NLM_lpage">7496</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00487</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00487" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlaru77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7478-7496&author=G.+R.+Ottauthor=M.+Chengauthor=K.+S.+Learnauthor=J.+Wagnerauthor=D.+E.+Gingrichauthor=J.+G.+Liskoauthor=M.+Curryauthor=E.+F.+Mesarosauthor=A.+K.+Ghoseauthor=M.+R.+Quailauthor=W.+Wanauthor=L.+Luauthor=P.+Dobrzanskiauthor=M.+S.+Albomauthor=T.+S.+Angelesauthor=K.+Wells-Knechtauthor=Z.+Huangauthor=L.+D.+Aimoneauthor=E.+Bruckheimerauthor=N.+Andersonauthor=J.+Friedmanauthor=S.+V.+Fernandezauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=B.+D.+Dorsey&title=Discovery+of+clinical+candidate+CEP-37440%2C+a+selective+inhibitor+of+focal+adhesion+kinase+%28FAK%29+and+anaplastic+lymphoma+kinase+%28ALK%29&doi=10.1021%2Facs.jmedchem.6b00487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Ott, Gregory R.; Cheng, Mangeng; Learn, Keith S.; Wagner, Jason; Gingrich, Diane E.; Lisko, Joseph G.; Curry, Matthew; Mesaros, Eugen F.; Ghose, Arup K.; Quail, Matthew R.; Wan, Weihua; Lu, Lihui; Dobrzanski, Pawel; Albom, Mark S.; Angeles, Thelma S.; Wells-Knecht, Kevin; Huang, Zeqi; Aimone, Lisa D.; Bruckheimer, Elizabeth; Anderson, Nathan; Friedman, Jay; Fernandez, Sandra V.; Ator, Mark A.; Ruggeri, Bruce A.; Dorsey, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7478-7496</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Analogs structurally related to anaplastic lymphoma kinase (ALK) inhibitor (CEP-28122) were optimized for metabolic stability.  The results from this endeavor not only led to improved metabolic stability, pharmacokinetic parameters, and in vitro activity against clin. derived resistance mutations but also led to the incorporation of activity for focal adhesion kinase (FAK).  FAK activation, via amplification and/or overexpression, is characteristic of multiple invasive solid tumors and metastasis.  The discovery of the clin. stage, dual FAK/ALK inhibitor 27b (CEP-37440), including details surrounding SAR, in vitro/in vivo pharmacol., and pharmacokinetics, is reported herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Ojryum63_LVg90H21EOLACvtfcHk0lh_ko2_rlPHtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlaru77P&md5=3fcd1342d901b2379d0efbd118d3049f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00487%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DLearn%26aufirst%3DK.%2BS.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DLisko%26aufirst%3DJ.%2BG.%26aulast%3DCurry%26aufirst%3DM.%26aulast%3DMesaros%26aufirst%3DE.%2BF.%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DDobrzanski%26aufirst%3DP.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DWells-Knecht%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DBruckheimer%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DN.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DFernandez%26aufirst%3DS.%2BV.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%2520CEP-37440%252C%2520a%2520selective%2520inhibitor%2520of%2520focal%2520adhesion%2520kinase%2520%2528FAK%2529%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7478%26epage%3D7496%26doi%3D10.1021%2Facs.jmedchem.6b00487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzalone, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underiner, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeles, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albom, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aimone, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ator, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, B. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1021/ml100158s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100158s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=493-498&author=G.+R.+Ottauthor=R.+Tripathyauthor=M.+Chengauthor=R.+McHughauthor=A.+V.+Anzaloneauthor=T.+L.+Underinerauthor=M.+A.+Curryauthor=M.+R.+Quailauthor=L.+Luauthor=W.+Wanauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=L.+D.+Aimoneauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=B.+D.+Dorsey&title=Discovery+of+a+potent+inhibitor+of+anaplastic+lymphoma+kinase+with+in+vivo+antitumor+activity&doi=10.1021%2Fml100158s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity</span></div><div class="casAuthors">Ott, Gregory R.; Tripathy, Rabindranath; Cheng, Mangeng; McHugh, Robert; Anzalone, Andrew V.; Underiner, Ted L.; Curry, Matthew A.; Quail, Matthew R.; Lu, Lihui; Wan, Weihua; Angeles, Thelma S.; Albom, Mark S.; Aimone, Lisa D.; Ator, Mark A.; Ruggeri, Bruce A.; Dorsey, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">493-498</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel 7-amino-1,3,4,5-tetrahydrobenzo[b]azepin-2-one derivs. within the diaminopyrimidine class of kinase inhibitors were identified that target anaplastic lymphoma kinase (ALK).  These inhibitors are potent against ALK in an isolated enzyme assay and inhibit autophosphorylation of the oncogenic fusion protein NPM-ALK in anaplastic large cell lymphoma (ALCL) cell lines.  The lead inhibitor 15 (I), which incorporates a bicyclo[2.2.1]hept-5-ene ring system in place of an aryl moiety, activates the pro-apoptotic caspases (3 and 7) and displays selective cytotoxicity against ALK-pos. ALCL cells.  Furthermore, 15 provides more than 40-fold selectivity against the structurally related insulin receptor, is orally bioavailable in multiple species, and displays in vivo antitumor efficacy when dosed orally in ALK-pos. ALCL tumor xenografts in Scid mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof0qilbcAbZ7Vg90H21EOLACvtfcHk0lh_ko2_rlPHtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtrrJ&md5=15d4f7aea64f212338d8c9cd88a36c64</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fml100158s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100158s%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DTripathy%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DMcHugh%26aufirst%3DR.%26aulast%3DAnzalone%26aufirst%3DA.%2BV.%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26aulast%3DCurry%26aufirst%3DM.%2BA.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520with%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D493%26epage%3D498%26doi%3D10.1021%2Fml100158s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwight, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toms, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parillon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anjum, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wardwell, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohemmad, Q. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clackson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalgarno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakespeare, W. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of brigatinib (AP26113), a phosphine oxide-containing, potent, orally active inhibitor of anaplastic lymphoma kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4948</span>– <span class="NLM_lpage">4964</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlCgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4948-4964&author=W.-S.+Huangauthor=S.+Liuauthor=D.+Zouauthor=M.+Thomasauthor=Y.+Wangauthor=T.+Zhouauthor=J.+Romeroauthor=A.+Kohlmannauthor=F.+Liauthor=J.+Qiauthor=L.+Caiauthor=T.+A.+Dwightauthor=Y.+Xuauthor=R.+Xuauthor=R.+Doddauthor=A.+Tomsauthor=L.+Parillonauthor=X.+Luauthor=R.+Anjumauthor=S.+Zhangauthor=F.+Wangauthor=J.+Keatsauthor=S.+D.+Wardwellauthor=Y.+Ningauthor=Q.+Xuauthor=L.+E.+Moranauthor=Q.+K.+Mohemmadauthor=H.+G.+Jangauthor=T.+Clacksonauthor=N.+I.+Narasimhanauthor=V.+M.+Riveraauthor=X.+Zhuauthor=D.+Dalgarnoauthor=W.+C.+Shakespeare&title=Discovery+of+brigatinib+%28AP26113%29%2C+a+phosphine+oxide-containing%2C+potent%2C+orally+active+inhibitor+of+anaplastic+lymphoma+kinase&doi=10.1021%2Facs.jmedchem.6b00306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase</span></div><div class="casAuthors">Huang, Wei-Sheng; Liu, Shuangying; Zou, Dong; Thomas, Mathew; Wang, Yihan; Zhou, Tianjun; Romero, Jan; Kohlmann, Anna; Li, Feng; Qi, Jiwei; Cai, Lisi; Dwight, Timothy A.; Xu, Yongjin; Xu, Rongsong; Dodd, Rory; Toms, Angela; Parillon, Lois; Lu, Xiaohui; Anjum, Rana; Zhang, Sen; Wang, Frank; Keats, Jeffrey; Wardwell, Scott D.; Ning, Yaoyu; Xu, Qihong; Moran, Lauren E.; Mohemmad, Qurish K.; Jang, Hyun Gyung; Clackson, Tim; Narasimhan, Narayana I.; Rivera, Victor M.; Zhu, Xiaotian; Dalgarno, David; Shakespeare, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4948-4964</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the treatment of echinoderm microtubule-assocd. protein-like 4 (EML4)-anaplastic lymphoma kinase pos. (ALK+) non-small-cell lung cancer (NSCLC), secondary mutations within the ALK kinase domain have emerged as a major resistance mechanism to both first- and second-generation ALK inhibitors.  This report describes the design and synthesis of a series of 2,4-diarylaminopyrimidine-based potent and selective ALK inhibitors culminating in identification of the investigational clin. candidate brigatinib.  A unique structural feature of brigatinib is a phosphine oxide, an overlooked but novel hydrogen-bond acceptor that drives potency and selectivity in addn. to favorable ADME properties.  Brigatinib displayed low nanomolar IC50s against native ALK and all tested clin. relevant ALK mutants in both enzyme-based biochem. and cell-based viability assays and demonstrated efficacy in multiple ALK+ xenografts in mice, including Karpas-299 (anaplastic large-cell lymphomas [ALCL]) and H3122 (NSCLC).  Brigatinib represents the most clin. advanced phosphine oxide-contg. drug candidate to date and is currently being evaluated in a global phase 2 registration trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5_iqprSA4QbVg90H21EOLACvtfcHk0lhYTWj0UA4Ngg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlCgur8%253D&md5=4cb93ff587579c97fda8aff0c7d43317</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00306%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.-S.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZou%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DKohlmann%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DDwight%26aufirst%3DT.%2BA.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DDodd%26aufirst%3DR.%26aulast%3DToms%26aufirst%3DA.%26aulast%3DParillon%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DAnjum%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DWardwell%26aufirst%3DS.%2BD.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DMoran%26aufirst%3DL.%2BE.%26aulast%3DMohemmad%26aufirst%3DQ.%2BK.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DClackson%26aufirst%3DT.%26aulast%3DNarasimhan%26aufirst%3DN.%2BI.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26atitle%3DDiscovery%2520of%2520brigatinib%2520%2528AP26113%2529%252C%2520a%2520phosphine%2520oxide-containing%252C%2520potent%252C%2520orally%2520active%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4948%26epage%3D4964%26doi%3D10.1021%2Facs.jmedchem.6b00306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menichincheri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnaghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avanzi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buffa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceriani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorentini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgia, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchionni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orrenius, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panzeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesenti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saccardo, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanotti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsini, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Entrectinib: A new 3-aminoindazole as a potent anaplastic lymphoma kinase (ALK), c-ros oncogene 1 kinase (ROS1), and pan-tropomyosin receptor kinases (Pan-TRKs) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3392</span>– <span class="NLM_lpage">3408</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3392-3408&author=M.+Menichincheriauthor=E.+Ardiniauthor=P.+Magnaghiauthor=N.+Avanziauthor=P.+Banfiauthor=R.+Bossiauthor=L.+Buffaauthor=G.+Canevariauthor=L.+Cerianiauthor=M.+Colomboauthor=L.+Cortiauthor=D.+Donatiauthor=M.+Fasoliniauthor=E.+Felderauthor=C.+Fiorelliauthor=F.+Fiorentiniauthor=A.+Galvaniauthor=A.+Isacchiauthor=A.+L.+Borgiaauthor=C.+Marchionniauthor=M.+Nesiauthor=C.+Orreniusauthor=A.+Panzeriauthor=E.+Pesentiauthor=L.+Rusconiauthor=M.+B.+Saccardoauthor=E.+Vanottiauthor=E.+Perroneauthor=P.+Orsini&title=Discovery+of+Entrectinib%3A+A+new+3-aminoindazole+as+a+potent+anaplastic+lymphoma+kinase+%28ALK%29%2C+c-ros+oncogene+1+kinase+%28ROS1%29%2C+and+pan-tropomyosin+receptor+kinases+%28Pan-TRKs%29+inhibitor&doi=10.1021%2Facs.jmedchem.6b00064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor</span></div><div class="casAuthors">Menichincheri, Maria; Ardini, Elena; Magnaghi, Paola; Avanzi, Nilla; Banfi, Patrizia; Bossi, Roberto; Buffa, Laura; Canevari, Giulia; Ceriani, Lucio; Colombo, Maristella; Corti, Luca; Donati, Daniele; Fasolini, Marina; Felder, Eduard; Fiorelli, Claudio; Fiorentini, Francesco; Galvani, Arturo; Isacchi, Antonella; Borgia, Andrea Lombardi; Marchionni, Chiara; Nesi, Marcella; Orrenius, Christian; Panzeri, Achille; Pesenti, Enrico; Rusconi, Luisa; Saccardo, Maria Beatrice; Vanotti, Ermes; Perrone, Ettore; Orsini, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3392-3408</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase responsible for the development of different tumor types.  Despite the remarkable clin. activity of crizotinib (Xalkori), the first ALK inhibitor approved in 2011, the emergence of resistance mutations and of brain metastases frequently causes relapse in patients.  Within the ALK drug discovery program, the authors identified compd. I, a novel 3-aminoindazole active on ALK in biochem. and in cellular assays.  Its optimization led to compd. II (entrectinib), a potent orally available ALK inhibitor active on ALK-dependent cell lines, efficiently penetrant the blood-brain barrier (BBB) in different animal species and highly efficacious in in vivo xenograft models.  Moreover, entrectinib resulted to be strictly potent on the closely related tyrosine kinases ROS1 and TRKs recently found constitutively activated in several tumor types.  Entrectinib is currently undergoing phase I/II clin. trial for the treatment of patients affected by ALK-, ROS1-, and TRK-pos. tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU_xyLC5-GabVg90H21EOLACvtfcHk0lhYTWj0UA4Ngg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eitL8%253D&md5=140217fba2ac81d71600f7344f2d8a3e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00064%26sid%3Dliteratum%253Aachs%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBanfi%26aufirst%3DP.%26aulast%3DBossi%26aufirst%3DR.%26aulast%3DBuffa%26aufirst%3DL.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DCeriani%26aufirst%3DL.%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DFasolini%26aufirst%3DM.%26aulast%3DFelder%26aufirst%3DE.%26aulast%3DFiorelli%26aufirst%3DC.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DBorgia%26aufirst%3DA.%2BL.%26aulast%3DMarchionni%26aufirst%3DC.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DOrrenius%26aufirst%3DC.%26aulast%3DPanzeri%26aufirst%3DA.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DVanotti%26aufirst%3DE.%26aulast%3DPerrone%26aufirst%3DE.%26aulast%3DOrsini%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520Entrectinib%253A%2520A%2520new%25203-aminoindazole%2520as%2520a%2520potent%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%252C%2520c-ros%2520oncogene%25201%2520kinase%2520%2528ROS1%2529%252C%2520and%2520pan-tropomyosin%2520receptor%2520kinases%2520%2528Pan-TRKs%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3392%26epage%3D3408%26doi%3D10.1021%2Facs.jmedchem.6b00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ugolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenigsberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallée, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houtmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowinski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemecek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grapinet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacqué, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaisi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semiond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egile, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulaouic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schio, L.</span></span> <span> </span><span class="NLM_article-title">Discovery and pharmacokinetic and pharmacological properties of the potent and selective MET kinase inhibitor 1-{6-[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-<i>b</i>]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7066</span>– <span class="NLM_lpage">7074</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00280</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00280" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyit73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7066-7074&author=A.+Ugoliniauthor=M.+Kenigsbergauthor=A.+Rakauthor=F.+Vall%C3%A9eauthor=J.+Houtmannauthor=M.+Lowinskiauthor=C.+Capdevilaauthor=J.+Khiderauthor=E.+Albertauthor=N.+Martinetauthor=C.+Nemecekauthor=S.+Grapinetauthor=E.+Bacqu%C3%A9author=M.+Roesnerauthor=C.+Delaisiauthor=L.+Calvetauthor=F.+Boncheauthor=D.+Semiondauthor=C.+Egileauthor=H.+Goulaouicauthor=L.+Schio&title=Discovery+and+pharmacokinetic+and+pharmacological+properties+of+the+potent+and+selective+MET+kinase+inhibitor+1-%7B6-%5B6-%284-fluorophenyl%29-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-b%5Dpyridazin-3-ylsulfanyl%5Dbenzothiazol-2-yl%7D-3-%282-morpholin-4-ylethyl%29urea+%28SAR125844%29&doi=10.1021%2Facs.jmedchem.6b00280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)</span></div><div class="casAuthors">Ugolini, Antonio; Kenigsberg, Mireille; Rak, Alexey; Vallee, Francois; Houtmann, Jacques; Lowinski, Maryse; Capdevila, Cecile; Khider, Jean; Albert, Eva; Martinet, Nathalie; Nemecek, Conception; Grapinet, Sandrine; Bacque, Eric; Roesner, Manfred; Delaisi, Christine; Calvet, Loreley; Bonche, Fabrice; Semiond, Dorothee; Egile, Coumaran; Goulaouic, Helene; Schio, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7066-7074</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The HGF/MET pathway is frequently activated in a variety of cancer types.  Several selective small mol. inhibitors of the MET kinase are currently in clin. evaluation, in particular for NSCLC, liver, and gastric cancer patients.  We report herein the discovery of a series of triazolopyridazines that are selective inhibitors of wild-type (WT) MET kinase and several clin. relevant mutants.  We provide insight into their mode of binding and report unprecedented crystal structures of the Y1230H variant.  A multiparametric chem. optimization approach allowed the identification of compd. 12 (SAR125844) as a development candidate.  In this chem. series, absence of CYP3A4 inhibition was obtained at the expense of satisfactory oral absorption.  Compd. 12, a promising parenteral agent for the treatment of MET-dependent cancers, promoted sustained target engagement at tolerated doses in a human xenograft tumor model.  Preclin. pharmacokinetics conducted in several species were predictive for the obsd. pharmacokinetic behavior of 12 in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0viMRg7UIrVg90H21EOLACvtfcHk0lhrYmmOWaQ4eg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyit73M&md5=9c8a040424abb6774987d04cadfafb24</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00280%26sid%3Dliteratum%253Aachs%26aulast%3DUgolini%26aufirst%3DA.%26aulast%3DKenigsberg%26aufirst%3DM.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVall%25C3%25A9e%26aufirst%3DF.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DLowinski%26aufirst%3DM.%26aulast%3DCapdevila%26aufirst%3DC.%26aulast%3DKhider%26aufirst%3DJ.%26aulast%3DAlbert%26aufirst%3DE.%26aulast%3DMartinet%26aufirst%3DN.%26aulast%3DNemecek%26aufirst%3DC.%26aulast%3DGrapinet%26aufirst%3DS.%26aulast%3DBacqu%25C3%25A9%26aufirst%3DE.%26aulast%3DRoesner%26aufirst%3DM.%26aulast%3DDelaisi%26aufirst%3DC.%26aulast%3DCalvet%26aufirst%3DL.%26aulast%3DBonche%26aufirst%3DF.%26aulast%3DSemiond%26aufirst%3DD.%26aulast%3DEgile%26aufirst%3DC.%26aulast%3DGoulaouic%26aufirst%3DH.%26aulast%3DSchio%26aufirst%3DL.%26atitle%3DDiscovery%2520and%2520pharmacokinetic%2520and%2520pharmacological%2520properties%2520of%2520the%2520potent%2520and%2520selective%2520MET%2520kinase%2520inhibitor%25201-%257B6-%255B6-%25284-fluorophenyl%2529-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-b%255Dpyridazin-3-ylsulfanyl%255Dbenzothiazol-2-yl%257D-3-%25282-morpholin-4-ylethyl%2529urea%2520%2528SAR125844%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7066%26epage%3D7074%26doi%3D10.1021%2Facs.jmedchem.6b00280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broome, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choquette, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coxon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussault, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potashman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teffera, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmange, J.-C.</span></span> <span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-6-(1-(8-Fluoro-6-(1-methly-1H-pyrazol-4-yl)-[1,2,4]triazol[4,3-<i>a</i>]pyridine-3-yl)-3-(2-methoxyethoxy)-1,6-napthyridin-5(6<i>H</i>)-one (AMG 337), a potent and selective inhibitor of MET with high unbound target coverage and robust in vivo antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2328</span>– <span class="NLM_lpage">2342</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2328-2342&author=A.+A.+Boezioauthor=K.+W.+Copelandauthor=K.+Rexauthor=B.+K.+Albrechtauthor=D.+Bauerauthor=S.+F.+Bellonauthor=C.+Boezioauthor=M.+A.+Broomeauthor=D.+Choquetteauthor=A.+Coxonauthor=I.+Dussaultauthor=S.+Hiraiauthor=R.+Lewisauthor=M.-H.+J.+Linauthor=J.+Lohmanauthor=J.+Liuauthor=E.+A.+Petersonauthor=M.+Potashmanauthor=R.+Shimanovichauthor=Y.+Tefferaauthor=D.+A.+Whittingtonauthor=K.+R.+Vaidaauthor=J.-C.+Harmange&title=Discovery+of+%28R%29-6-%281-%288-Fluoro-6-%281-methly-1H-pyrazol-4-yl%29-%5B1%2C2%2C4%5Dtriazol%5B4%2C3-a%5Dpyridine-3-yl%29-3-%282-methoxyethoxy%29-1%2C6-napthyridin-5%286H%29-one+%28AMG+337%29%2C+a+potent+and+selective+inhibitor+of+MET+with+high+unbound+target+coverage+and+robust+in+vivo+antitumor+activity&doi=10.1021%2Facs.jmedchem.5b01716"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01716%26sid%3Dliteratum%253Aachs%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DCopeland%26aufirst%3DK.%2BW.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DBroome%26aufirst%3DM.%2BA.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DLohman%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26atitle%3DDiscovery%2520of%2520%2528R%2529-6-%25281-%25288-Fluoro-6-%25281-methly-1H-pyrazol-4-yl%2529-%255B1%252C2%252C4%255Dtriazol%255B4%252C3-a%255Dpyridine-3-yl%2529-3-%25282-methoxyethoxy%2529-1%252C6-napthyridin-5%25286H%2529-one%2520%2528AMG%2520337%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520MET%2520with%2520high%2520unbound%2520target%2520coverage%2520and%2520robust%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2328%26epage%3D2342%26doi%3D10.1021%2Facs.jmedchem.5b01716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blake, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudino, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunsaker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacheco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robarge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahidi-Latham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stults, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of (<i>S</i>)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1<i>H</i>-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1<i>H</i>)-one (GDC-0994), an extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor in early clinical development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5650</span>– <span class="NLM_lpage">5660</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00389</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00389" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XoslOrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5650-5660&author=J.+F.+Blakeauthor=M.+Burkardauthor=J.+Chanauthor=H.+Chenauthor=K.-J.+Chouauthor=D.+Diazauthor=D.+A.+Dudleyauthor=J.+J.+Gaudinoauthor=S.+E.+Gouldauthor=J.+Grinaauthor=T.+Hunsakerauthor=L.+Liuauthor=M.+Martinsonauthor=D.+Morenoauthor=L.+Muellerauthor=C.+Orrauthor=P.+Pachecoauthor=A.+Qinauthor=K.+Rasorauthor=L.+Renauthor=K.+Robargeauthor=S.+Shahidi-Lathamauthor=J.+Stultsauthor=F.+Sullivanauthor=W.+Wangauthor=J.+Yinauthor=A.+Zhouauthor=M.+Belvinauthor=M.+Merchantauthor=J.+Moffatauthor=J.+B.+Schwarz&title=Discovery+of+%28S%29-1-%281-%284-chloro-3-fluorophenyl%29-2-hydroxyethyl%29-4-%282-%28%281-methyl-1H-pyrazol-5-yl%29amino%29pyrimidin-4-yl%29pyridin-2%281H%29-one+%28GDC-0994%29%2C+an+extracellular+signal-regulated+kinase+1%2F2+%28ERK1%2F2%29+inhibitor+in+early+clinical+development&doi=10.1021%2Facs.jmedchem.6b00389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development</span></div><div class="casAuthors">Blake, James F.; Burkard, Michael; Chan, Jocelyn; Chen, Huifen; Chou, Kang-Jye; Diaz, Dolores; Dudley, Danette A.; Gaudino, John J.; Gould, Stephen E.; Grina, Jonas; Hunsaker, Thomas; Liu, Lichuan; Martinson, Matthew; Moreno, David; Mueller, Lars; Orr, Christine; Pacheco, Patricia; Qin, Ann; Rasor, Kevin; Ren, Li; Robarge, Kirk; Shahidi-Latham, Sheerin; Stults, Jeffrey; Sullivan, Francis; Wang, Weiru; Yin, Jianping; Zhou, Aihe; Belvin, Marcia; Merchant, Mark; Moffat, John; Schwarz, Jacob B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5650-5660</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The extracellular signal-regulated kinases ERK1/2 represent an essential node within the RAS/RAF/MEK/ERK signaling cascade that is commonly activated by oncogenic mutations in BRAF or RAS or by upstream oncogenic signaling.  While targeting upstream nodes with RAF and MEK inhibitors has proven effective clin., resistance frequently develops through reactivation of the pathway.  Simultaneous targeting of multiple nodes in the pathway, such as MEK and ERK, offers the prospect of enhanced efficacy as well as reduced potential for acquired resistance.  Described herein is the discovery and characterization of GDC-0994 (22), an orally bioavailable small mol. inhibitor selective for ERK kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk9rgPtXHF4rVg90H21EOLACvtfcHk0lhQbeLJ4fxeHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XoslOrsLs%253D&md5=6d2d52dabea4d443ddee2959df6d45f1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00389%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DJ.%2BF.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChou%26aufirst%3DK.-J.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DDudley%26aufirst%3DD.%2BA.%26aulast%3DGaudino%26aufirst%3DJ.%2BJ.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DGrina%26aufirst%3DJ.%26aulast%3DHunsaker%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMartinson%26aufirst%3DM.%26aulast%3DMoreno%26aufirst%3DD.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DOrr%26aufirst%3DC.%26aulast%3DPacheco%26aufirst%3DP.%26aulast%3DQin%26aufirst%3DA.%26aulast%3DRasor%26aufirst%3DK.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DRobarge%26aufirst%3DK.%26aulast%3DShahidi-Latham%26aufirst%3DS.%26aulast%3DStults%26aufirst%3DJ.%26aulast%3DSullivan%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DBelvin%26aufirst%3DM.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520%2528S%2529-1-%25281-%25284-chloro-3-fluorophenyl%2529-2-hydroxyethyl%2529-4-%25282-%2528%25281-methyl-1H-pyrazol-5-yl%2529amino%2529pyrimidin-4-yl%2529pyridin-2%25281H%2529-one%2520%2528GDC-0994%2529%252C%2520an%2520extracellular%2520signal-regulated%2520kinase%25201%252F2%2520%2528ERK1%252F2%2529%2520inhibitor%2520in%2520early%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5650%26epage%3D5660%26doi%3D10.1021%2Facs.jmedchem.6b00389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blake, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudino, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chicarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siedem, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolakowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dean, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacheco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahidi-Latham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5,6,7,8-tetrahydropyrido[3,4-<i>d</i>]pyrimidine inhibitors of Erk2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2635</span>– <span class="NLM_lpage">2639</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2014.04.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2635-2639&author=J.+F.+Blakeauthor=J.+J.+Gaudinoauthor=J.+De+Meeseauthor=P.+Mohrauthor=M.+Chicarelliauthor=H.+Tianauthor=R.+Garreyauthor=A.+Thomasauthor=C.+S.+Siedemauthor=M.+B.+Welchauthor=G.+Kolakowskiauthor=R.+Kausauthor=M.+Burkardauthor=M.+Martinsonauthor=H.+Chenauthor=B.+deanauthor=D.+A.+Dudleyauthor=S.+E.+Gouldauthor=P.+Pachecoauthor=S.+Shahidi-Lathamauthor=W.+Wangauthor=K.+Westauthor=J.+Yinauthor=J.+Moffatauthor=J.+B.+Schwarz&title=Discovery+of+5%2C6%2C7%2C8-tetrahydropyrido%5B3%2C4-d%5Dpyrimidine+inhibitors+of+Erk2&doi=10.1016%2Fj.bmcl.2014.04.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DJ.%2BF.%26aulast%3DGaudino%26aufirst%3DJ.%2BJ.%26aulast%3DDe%2BMeese%26aufirst%3DJ.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DChicarelli%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DGarrey%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DSiedem%26aufirst%3DC.%2BS.%26aulast%3DWelch%26aufirst%3DM.%2BB.%26aulast%3DKolakowski%26aufirst%3DG.%26aulast%3DKaus%26aufirst%3DR.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DMartinson%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3Ddean%26aufirst%3DB.%26aulast%3DDudley%26aufirst%3DD.%2BA.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DPacheco%26aufirst%3DP.%26aulast%3DShahidi-Latham%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%25205%252C6%252C7%252C8-tetrahydropyrido%255B3%252C4-d%255Dpyrimidine%2520inhibitors%2520of%2520Erk2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2635%26epage%3D2639%26doi%3D10.1016%2Fj.bmcl.2014.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyagi-Scharber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post, L. E.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of (8<i>S</i>,9<i>R</i>)-5-fluoro-8-(4-fluorophenyl)-9-(1-methly-1<i>H</i>-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3<i>H</i>-pyrido[4,3,2-]dephthalazin-3-one (BMN 673, talazoparib), a novel, highly potent, and orally efficacious poly(ADP-ribose) polymerase-1/2 inhibitor, as an anticancer agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01498</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01498" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=335-357&author=B.+Wangauthor=D.+Chuauthor=Y.+Fengauthor=Y.+Shenauthor=M.+Aoyagi-Scharberauthor=L.+E.+Post&title=Discovery+and+characterization+of+%288S%2C9R%29-5-fluoro-8-%284-fluorophenyl%29-9-%281-methly-1H-1%2C2%2C4-triazol-5-yl%29-2%2C7%2C8%2C9-tetrahydro-3H-pyrido%5B4%2C3%2C2-%5Ddephthalazin-3-one+%28BMN+673%2C+talazoparib%29%2C+a+novel%2C+highly+potent%2C+and+orally+efficacious+poly%28ADP-ribose%29+polymerase-1%2F2+inhibitor%2C+as+an+anticancer+agent&doi=10.1021%2Facs.jmedchem.5b01498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01498%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DChu%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DAoyagi-Scharber%26aufirst%3DM.%26aulast%3DPost%26aufirst%3DL.%2BE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520%25288S%252C9R%2529-5-fluoro-8-%25284-fluorophenyl%2529-9-%25281-methly-1H-1%252C2%252C4-triazol-5-yl%2529-2%252C7%252C8%252C9-tetrahydro-3H-pyrido%255B4%252C3%252C2-%255Ddephthalazin-3-one%2520%2528BMN%2520673%252C%2520talazoparib%2529%252C%2520a%2520novel%252C%2520highly%2520potent%252C%2520and%2520orally%2520efficacious%2520poly%2528ADP-ribose%2529%2520polymerase-1%252F2%2520inhibitor%252C%2520as%2520an%2520anticancer%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D335%26epage%3D357%26doi%3D10.1021%2Facs.jmedchem.5b01498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Salvo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagabukuro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacre-Salem, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goble, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyes, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzmaurice, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gichuru, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jochnowitz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levorse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ormes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanfiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamlynny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struthers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of vibegron: a potent and selective β3 adrenergic receptor agonist for the treatment of overactive bladder</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01372</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01372" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVyrurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=609-623&author=S.+D.+Edmondsonauthor=C.+Zhuauthor=N.+F.+Karauthor=J.+Di+Salvoauthor=H.+Nagabukuroauthor=B.+Sacre-Salemauthor=K.+Dingleyauthor=R.+Bergerauthor=S.+D.+Gobleauthor=G.+Morrielloauthor=B.+Harperauthor=C.+R.+Moyesauthor=D.-M.+Shenauthor=L.+Wangauthor=R.+Ballauthor=A.+Fitzmauriceauthor=T.+Frenklauthor=L.+N.+Gichuruauthor=S.+Haauthor=A.+L.+Hurleyauthor=N.+Jochnowitzauthor=D.+Levorseauthor=S.+Mistryauthor=R.+R.+Millerauthor=J.+Ormesauthor=G.+M.+Salituroauthor=A.+Sanfizauthor=A.+S.+Stevensonauthor=K.+Villaauthor=B.+Zamlynnyauthor=S.+Greenauthor=M.+Struthersauthor=A.+E.+Weber&title=Discovery+of+vibegron%3A+a+potent+and+selective+%CE%B23+adrenergic+receptor+agonist+for+the+treatment+of+overactive+bladder&doi=10.1021%2Facs.jmedchem.5b01372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder</span></div><div class="casAuthors">Edmondson, Scott D.; Zhu, Cheng; Kar, Nam Fung; Di Salvo, Jerry; Nagabukuro, Hiroshi; Sacre-Salem, Beatrice; Dingley, Karen; Berger, Richard; Goble, Stephen D.; Morriello, Gregori; Harper, Bart; Moyes, Christopher R.; Shen, Dong-Ming; Wang, Liping; Ball, Richard; Fitzmaurice, Aileen; Frenkl, Tara; Gichuru, Loise N.; Ha, Sookhee; Hurley, Amanda L.; Jochnowitz, Nina; Levorse, Dorothy; Mistry, Shruty; Miller, Randy R.; Ormes, James; Salituro, Gino M.; Sanfiz, Anthony; Stevenson, Andra S.; Villa, Katherine; Zamlynny, Beata; Green, Stuart; Struthers, Mary; Weber, Ann E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">609-623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of vibegron, a potent and selective human β3-AR agonist for the treatment of overactive bladder (OAB), is described.  An early-generation clin. β3-AR agonist MK-0634 (3) exhibited efficacy in humans for the treatment of OAB, but development was discontinued due to unacceptable structure-based toxicity in preclin. species.  Optimization of a series of second-generation pyrrolidine-derived β3-AR agonists included reducing the risk for phospholipidosis, the risk of formation of disproportionate human metabolites, and the risk of formation of high levels of circulating metabolites in preclin. species.  These efforts resulted in the discovery of vibegron, which possesses improved druglike properties and an overall superior preclin. profile compared to MK-0634.  Structure-activity relationships leading to the discovery of vibegron and a summary of its preclin. profile are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTKGFhBOdMNbVg90H21EOLACvtfcHk0ljryzvv6bbkNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVyrurjM&md5=89410d04a67540aa78e73e7312867ef3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01372%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DKar%26aufirst%3DN.%2BF.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DNagabukuro%26aufirst%3DH.%26aulast%3DSacre-Salem%26aufirst%3DB.%26aulast%3DDingley%26aufirst%3DK.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DGoble%26aufirst%3DS.%2BD.%26aulast%3DMorriello%26aufirst%3DG.%26aulast%3DHarper%26aufirst%3DB.%26aulast%3DMoyes%26aufirst%3DC.%2BR.%26aulast%3DShen%26aufirst%3DD.-M.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBall%26aufirst%3DR.%26aulast%3DFitzmaurice%26aufirst%3DA.%26aulast%3DFrenkl%26aufirst%3DT.%26aulast%3DGichuru%26aufirst%3DL.%2BN.%26aulast%3DHa%26aufirst%3DS.%26aulast%3DHurley%26aufirst%3DA.%2BL.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DLevorse%26aufirst%3DD.%26aulast%3DMistry%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DOrmes%26aufirst%3DJ.%26aulast%3DSalituro%26aufirst%3DG.%2BM.%26aulast%3DSanfiz%26aufirst%3DA.%26aulast%3DStevenson%26aufirst%3DA.%2BS.%26aulast%3DVilla%26aufirst%3DK.%26aulast%3DZamlynny%26aufirst%3DB.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DStruthers%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDiscovery%2520of%2520vibegron%253A%2520a%2520potent%2520and%2520selective%2520%25CE%25B23%2520adrenergic%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520overactive%2520bladder%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D609%26epage%3D623%26doi%3D10.1021%2Facs.jmedchem.5b01372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakauchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagabukuro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a novel, selective, and orally active α1D adrenoceptor antagonist with antiurinary frequency effects: reducing human Ether-a-go-go-Related Gene (hERG) liabilities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2989</span>– <span class="NLM_lpage">3002</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01528</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01528" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2989-3002&author=N.+Sakauchiauthor=Y.+Koharaauthor=A.+Satoauthor=T.+Suzakiauthor=Y.+Imaiauthor=Y.+Okabeauthor=S.+Imaiauthor=R.+Saikawaauthor=H.+Nagabukuroauthor=H.+Kunoauthor=H.+Fujitaauthor=I.+Kamoauthor=M.+Yoshida&title=Discovery+of+5-chloro-1-%285-chloro-2-%28methylsulfonyl%29benzyl%29-2-imino-1%2C2-dihydropyridine-3-carboxamide+%28TAK-259%29+as+a+novel%2C+selective%2C+and+orally+active+%CE%B11D+adrenoceptor+antagonist+with+antiurinary+frequency+effects%3A+reducing+human+Ether-a-go-go-Related+Gene+%28hERG%29+liabilities&doi=10.1021%2Facs.jmedchem.5b01528"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01528%26sid%3Dliteratum%253Aachs%26aulast%3DSakauchi%26aufirst%3DN.%26aulast%3DKohara%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DSuzaki%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DOkabe%26aufirst%3DY.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DSaikawa%26aufirst%3DR.%26aulast%3DNagabukuro%26aufirst%3DH.%26aulast%3DKuno%26aufirst%3DH.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DKamo%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25205-chloro-1-%25285-chloro-2-%2528methylsulfonyl%2529benzyl%2529-2-imino-1%252C2-dihydropyridine-3-carboxamide%2520%2528TAK-259%2529%2520as%2520a%2520novel%252C%2520selective%252C%2520and%2520orally%2520active%2520%25CE%25B11D%2520adrenoceptor%2520antagonist%2520with%2520antiurinary%2520frequency%2520effects%253A%2520reducing%2520human%2520Ether-a-go-go-Related%2520Gene%2520%2528hERG%2529%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2989%26epage%3D3002%26doi%3D10.1021%2Facs.jmedchem.5b01528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rucker, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chianelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alper, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutnick, D.l</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmeits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phimister, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laffitte, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of tropifexor (LJN452), a highly potent non-bile acid FXR agonist for the treatment of cholestatic liver diseases and nonalcoholic steatohepatitis (NASH)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9960</span>– <span class="NLM_lpage">9973</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00907</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWqur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9960-9973&author=D.+C.+Tullyauthor=P.+V.+Ruckerauthor=D.+Chianelliauthor=J.+Williamsauthor=A.+Vidalauthor=P.+B.+Alperauthor=D.l+Mutnickauthor=B.+Bursulayaauthor=J.+Schmeitsauthor=X.+Wuauthor=D.+Baoauthor=J.+Zollauthor=Y.+Kimauthor=T.+Groesslauthor=P.+McNamaraauthor=H.+M.+Seidelauthor=V.+Molteniauthor=B.+Liuauthor=A.+Phimisterauthor=S.+B.+Josephauthor=B.+Laffitte&title=Discovery+of+tropifexor+%28LJN452%29%2C+a+highly+potent+non-bile+acid+FXR+agonist+for+the+treatment+of+cholestatic+liver+diseases+and+nonalcoholic+steatohepatitis+%28NASH%29&doi=10.1021%2Facs.jmedchem.7b00907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43aR"><div class="casContent"><span class="casTitleNuber">43a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)</span></div><div class="casAuthors">Tully, David C.; Rucker, Paul V.; Chianelli, Donatella; Williams, Jennifer; Vidal, Agnes; Alper, Phil B.; Mutnick, Daniel; Bursulaya, Badry; Schmeits, James; Wu, Xiangdong; Bao, Dingjiu; Zoll, Jocelyn; Kim, Young; Groessl, Todd; McNamara, Peter; Seidel, H. Martin; Molteni, Valentina; Liu, Bo; Phimister, Andrew; Joseph, Sean B.; Laffitte, Bryan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9960-9973</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The farnesoid X receptor (FXR) is a nuclear receptor that acts as a master regulator of bile acid metab. and signaling.  Activation of FXR inhibits bile acid synthesis and increases bile acid conjugation, transport, and excretion, thereby protecting the liver from the harmful effects of bile accumulation, leading to considerable interest in FXR as a therapeutic target for the treatment of cholestasis and nonalcoholic steatohepatitis.  We identified a novel series of highly potent non-bile acid FXR agonists that introduce a bicyclic nortropine-substituted benzothiazole carboxylic acid moiety onto a trisubstituted isoxazole scaffold.  Herein, we report the discovery of 1 (tropifexor, LJN452), a novel and highly potent agonist of FXR.  Potent in vivo activity was demonstrated in rodent PD models by measuring the induction of FXR target genes in various tissues.  Tropifexor has advanced into phase 2 human clin. trials in patients with NASH and PBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxfWFxWHQF97Vg90H21EOLACvtfcHk0ljHpU8sV5Ta0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWqur7P&md5=4b7a31f2e17645f3831c4dcbf34dd46c</span></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00907%26sid%3Dliteratum%253Aachs%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DChianelli%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DVidal%26aufirst%3DA.%26aulast%3DAlper%26aufirst%3DP.%2BB.%26aulast%3DMutnick%26aufirst%3DD.l%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DSchmeits%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DZoll%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DMcNamara%26aufirst%3DP.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMolteni%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DPhimister%26aufirst%3DA.%26aulast%3DJoseph%26aufirst%3DS.%2BB.%26aulast%3DLaffitte%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520tropifexor%2520%2528LJN452%2529%252C%2520a%2520highly%2520potent%2520non-bile%2520acid%2520FXR%2520agonist%2520for%2520the%2520treatment%2520of%2520cholestatic%2520liver%2520diseases%2520and%2520nonalcoholic%2520steatohepatitis%2520%2528NASH%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9960%26epage%3D9973%26doi%3D10.1021%2Facs.jmedchem.7b00907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueno, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agejas Francisco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manninen, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocchinfuso, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montrose-Rafizadeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannady, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stille, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raddad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reidy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, L. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of 6-(4-{[5-cyclopropyl-3-(2,6-dichlorophenyl)- isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1<i>H</i>-indole-3-carboxylic acid: A novel FXR agonist for the treatment of dyslipidemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9768</span>– <span class="NLM_lpage">9772</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01161</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01161" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9768-9772&author=M.+J.+Geninauthor=A.+B.+Buenoauthor=J.+Agejas+Franciscoauthor=P.+R.+Manninenauthor=W.+P.+Bocchinfusoauthor=C.+Montrose-Rafizadehauthor=E.+A.+Cannadyauthor=T.+M.+Jonesauthor=J.+R.+Stilleauthor=E.+Raddadauthor=C.+Reidyauthor=A.+Coxauthor=M.+D.+Michaelauthor=L.+F.+Michael&title=Discovery+of+6-%284-%7B%5B5-cyclopropyl-3-%282%2C6-dichlorophenyl%29-+isoxazol-4-yl%5Dmethoxy%7Dpiperidin-1-yl%29-1-methyl-1H-indole-3-carboxylic+acid%3A+A+novel+FXR+agonist+for+the+treatment+of+dyslipidemia&doi=10.1021%2Facs.jmedchem.5b01161"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01161%26sid%3Dliteratum%253Aachs%26aulast%3DGenin%26aufirst%3DM.%2BJ.%26aulast%3DBueno%26aufirst%3DA.%2BB.%26aulast%3DAgejas%2BFrancisco%26aufirst%3DJ.%26aulast%3DManninen%26aufirst%3DP.%2BR.%26aulast%3DBocchinfuso%26aufirst%3DW.%2BP.%26aulast%3DMontrose-Rafizadeh%26aufirst%3DC.%26aulast%3DCannady%26aufirst%3DE.%2BA.%26aulast%3DJones%26aufirst%3DT.%2BM.%26aulast%3DStille%26aufirst%3DJ.%2BR.%26aulast%3DRaddad%26aufirst%3DE.%26aulast%3DReidy%26aufirst%3DC.%26aulast%3DCox%26aufirst%3DA.%26aulast%3DMichael%26aufirst%3DM.%2BD.%26aulast%3DMichael%26aufirst%3DL.%2BF.%26atitle%3DDiscovery%2520of%25206-%25284-%257B%255B5-cyclopropyl-3-%25282%252C6-dichlorophenyl%2529-%2520isoxazol-4-yl%255Dmethoxy%257Dpiperidin-1-yl%2529-1-methyl-1H-indole-3-carboxylic%2520acid%253A%2520A%2520novel%2520FXR%2520agonist%2520for%2520the%2520treatment%2520of%2520dyslipidemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9768%26epage%3D9772%26doi%3D10.1021%2Facs.jmedchem.5b01161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayeem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seethala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleczka, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and SAR studies of novel polycyclic acids as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type1 (11β-HSD-1)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6699</span>– <span class="NLM_lpage">6704</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2011.09.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6699-6704&author=X.-Y.+Yeauthor=S.+Y.+Chenauthor=A.+Nayeemauthor=R.+Gollaauthor=R.+Seethalaauthor=M.+Wangauthor=T.+Harperauthor=B.+G.+Sleczkaauthor=Y.-X.+Liauthor=B.+Heauthor=M.+Kirbyauthor=D.+A.+Gordonauthor=J.+A.+Robl&title=Design%2C+synthesis%2C+and+SAR+studies+of+novel+polycyclic+acids+as+potent+and+selective+inhibitors+of+human+11%CE%B2-hydroxysteroid+dehydrogenase+type1+%2811%CE%B2-HSD-1%29&doi=10.1016%2Fj.bmcl.2011.09.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.055%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DX.-Y.%26aulast%3DChen%26aufirst%3DS.%2BY.%26aulast%3DNayeem%26aufirst%3DA.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHarper%26aufirst%3DT.%26aulast%3DSleczka%26aufirst%3DB.%2BG.%26aulast%3DLi%26aufirst%3DY.-X.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DGordon%26aufirst%3DD.%2BA.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520SAR%2520studies%2520of%2520novel%2520polycyclic%2520acids%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520human%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type1%2520%252811%25CE%25B2-HSD-1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6699%26epage%3D6704%26doi%3D10.1016%2Fj.bmcl.2011.09.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayeem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponticiello, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrity, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apedo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seethala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleczka, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, M.k</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leahy, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMarco, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaringe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 2-((2<i>S</i>,6<i>S</i>)-2-phenyl-6-hydroxyadamantan-2-yl)-1-(3′-hydroxyazetidin-1-yl)ethanone [BMS-816336], an orally active novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4932</span>– <span class="NLM_lpage">4948</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4932-4948&author=X.-Y.+Yeauthor=S.+Y.+Chenauthor=S.+Wuauthor=D.+S.+Yoonauthor=H.+Wangauthor=Z.+Hongauthor=S.+P.+O%E2%80%99Connorauthor=J.+Liauthor=J.+J.+Liauthor=L.+J.+Kennedyauthor=S.+J.+Walkerauthor=A.+Nayeemauthor=S.+Sheriffauthor=D.+M.+Camacauthor=V.+Ramamurthyauthor=P.+E.+Morinauthor=R.+Zeboauthor=J.+R.+Taylorauthor=N.+N.+Morganauthor=R.+P.+Ponticielloauthor=T.+Harrityauthor=A.+Apedoauthor=R.+Gollaauthor=R.+Seethalaauthor=M.+Wangauthor=T.+W.+Harperauthor=B.+G.+Sleczkaauthor=B.+Heauthor=M.k+Kirbyauthor=D.+K.+Leahyauthor=J.+Liauthor=R.+L.+Hansonauthor=Z.+Guoauthor=Y.-X.+Liauthor=J.+D.+DiMarcoauthor=R.+Scaringeauthor=B.+Maxwellauthor=F.+Moulinauthor=J.+C.+Barrishauthor=D.+A.+Gordonauthor=J.+A.+Robl&title=Discovery+of+clinical+candidate+2-%28%282S%2C6S%29-2-phenyl-6-hydroxyadamantan-2-yl%29-1-%283%E2%80%B2-hydroxyazetidin-1-yl%29ethanone+%5BBMS-816336%5D%2C+an+orally+active+novel+selective+11%CE%B2-hydroxysteroid+dehydrogenase+type+1+inhibitor&doi=10.1021%2Facs.jmedchem.7b00211"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00211%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DX.-Y.%26aulast%3DChen%26aufirst%3DS.%2BY.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%2BP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DKennedy%26aufirst%3DL.%2BJ.%26aulast%3DWalker%26aufirst%3DS.%2BJ.%26aulast%3DNayeem%26aufirst%3DA.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DCamac%26aufirst%3DD.%2BM.%26aulast%3DRamamurthy%26aufirst%3DV.%26aulast%3DMorin%26aufirst%3DP.%2BE.%26aulast%3DZebo%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DJ.%2BR.%26aulast%3DMorgan%26aufirst%3DN.%2BN.%26aulast%3DPonticiello%26aufirst%3DR.%2BP.%26aulast%3DHarrity%26aufirst%3DT.%26aulast%3DApedo%26aufirst%3DA.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHarper%26aufirst%3DT.%2BW.%26aulast%3DSleczka%26aufirst%3DB.%2BG.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DKirby%26aufirst%3DM.k%26aulast%3DLeahy%26aufirst%3DD.%2BK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHanson%26aufirst%3DR.%2BL.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.-X.%26aulast%3DDiMarco%26aufirst%3DJ.%2BD.%26aulast%3DScaringe%26aufirst%3DR.%26aulast%3DMaxwell%26aufirst%3DB.%26aulast%3DMoulin%26aufirst%3DF.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DGordon%26aufirst%3DD.%2BA.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25202-%2528%25282S%252C6S%2529-2-phenyl-6-hydroxyadamantan-2-yl%2529-1-%25283%25E2%2580%25B2-hydroxyazetidin-1-yl%2529ethanone%2520%255BBMS-816336%255D%252C%2520an%2520orally%2520active%2520novel%2520selective%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4932%26epage%3D4948%26doi%3D10.1021%2Facs.jmedchem.7b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamdouchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warshawsky, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Baillie, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilbur, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahl, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel
Lewis, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardona, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">CR, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neathery, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouaichi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diseroad, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweetana, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yumibe, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montrose-Rafizadeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of LY3104607: A potent and selective G protein-coupled receptor 40 (GPR40) agonist with optimized pharmacokinetic properties to support once daily oral treatment in patients with type 2 diabetes mellitus</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">934</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=934-945&author=C.+Hamdouchiauthor=P.+Maitiauthor=A.+M.+Warshawskyauthor=A.+C.+De+Baillieauthor=K.+A.+Ottoauthor=K.+L.+Wilburauthor=S.+D.+Kahlauthor=A.+P.+Patel%0ALewisauthor=G.+R.+Cardonaauthor=R.+W.+Zinkauthor=K.+Chenauthor=S.+CRauthor=J.+P.+Lineswalaauthor=G.+L.+Neatheryauthor=C.+Bouaichiauthor=B.+A.+Diseroadauthor=A.+N.+Campbellauthor=S.+A.+Sweetanaauthor=L.+A.+Adamsauthor=O.+Cabreraauthor=X.+Maauthor=N.+P.+Yumibeauthor=C.+Montrose-Rafizadehauthor=Y.+Chenauthor=A.+R.+Miller&title=Discovery+of+LY3104607%3A+A+potent+and+selective+G+protein-coupled+receptor+40+%28GPR40%29+agonist+with+optimized+pharmacokinetic+properties+to+support+once+daily+oral+treatment+in+patients+with+type+2+diabetes+mellitus&doi=10.1021%2Facs.jmedchem.7b01411"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01411%26sid%3Dliteratum%253Aachs%26aulast%3DHamdouchi%26aufirst%3DC.%26aulast%3DMaiti%26aufirst%3DP.%26aulast%3DWarshawsky%26aufirst%3DA.%2BM.%26aulast%3DDe%2BBaillie%26aufirst%3DA.%2BC.%26aulast%3DOtto%26aufirst%3DK.%2BA.%26aulast%3DWilbur%26aufirst%3DK.%2BL.%26aulast%3DKahl%26aufirst%3DS.%2BD.%26aulast%3DPatel%2BLewis%26aufirst%3DA.%2BP.%26aulast%3DCardona%26aufirst%3DG.%2BR.%26aulast%3DZink%26aufirst%3DR.%2BW.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCR%26aufirst%3DS.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DNeathery%26aufirst%3DG.%2BL.%26aulast%3DBouaichi%26aufirst%3DC.%26aulast%3DDiseroad%26aufirst%3DB.%2BA.%26aulast%3DCampbell%26aufirst%3DA.%2BN.%26aulast%3DSweetana%26aufirst%3DS.%2BA.%26aulast%3DAdams%26aufirst%3DL.%2BA.%26aulast%3DCabrera%26aufirst%3DO.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DYumibe%26aufirst%3DN.%2BP.%26aulast%3DMontrose-Rafizadeh%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DA.%2BR.%26atitle%3DDiscovery%2520of%2520LY3104607%253A%2520A%2520potent%2520and%2520selective%2520G%2520protein-coupled%2520receptor%252040%2520%2528GPR40%2529%2520agonist%2520with%2520optimized%2520pharmacokinetic%2520properties%2520to%2520support%2520once%2520daily%2520oral%2520treatment%2520in%2520patients%2520with%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D934%26epage%3D945%26doi%3D10.1021%2Facs.jmedchem.7b01411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamdouchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahl, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel Lewis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardona, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eessalu, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficorilli, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcelo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilbur, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweetana, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belin, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannady, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yumibe, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montrose-Rafizadeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifel Miller, A.</span></span> <span> </span><span class="NLM_article-title">The discovery, preclinical, and early clinical development of potent and selective GPR40 agonists for the treatment of type 2 diabetes mellitus (LY2881835, LY2922083, and LY2922470)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10891</span>– <span class="NLM_lpage">10916</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00892</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00892" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10891-10916&author=C.+Hamdouchiauthor=S.+D.+Kahlauthor=A.+Patel+Lewisauthor=G.+R.+Cardonaauthor=R.+W.+Zinkauthor=K.+Chenauthor=T.+E.+Eessaluauthor=J.+V.+Ficorilliauthor=M.+C.+Marceloauthor=K.+A.+Ottoauthor=K.+L.+Wilburauthor=J.+P.+Lineswalaauthor=J.+L.+Piperauthor=D.+S.+Coffeyauthor=S.+A.+Sweetanaauthor=J.+V.+Haasauthor=D.+A.+Brooksauthor=E.+J.+Prattauthor=R.+M.+Belinauthor=M.+A.+Deegauthor=X.+Maauthor=E.+A.+Cannadyauthor=J.+T.+Johnsonauthor=N.+P.+Yumibeauthor=Q.+Chenauthor=P.+Maitiauthor=C.+Montrose-Rafizadehauthor=Y.+Chenauthor=A.+Reifel+Miller&title=The+discovery%2C+preclinical%2C+and+early+clinical+development+of+potent+and+selective+GPR40+agonists+for+the+treatment+of+type+2+diabetes+mellitus+%28LY2881835%2C+LY2922083%2C+and+LY2922470%29&doi=10.1021%2Facs.jmedchem.6b00892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00892%26sid%3Dliteratum%253Aachs%26aulast%3DHamdouchi%26aufirst%3DC.%26aulast%3DKahl%26aufirst%3DS.%2BD.%26aulast%3DPatel%2BLewis%26aufirst%3DA.%26aulast%3DCardona%26aufirst%3DG.%2BR.%26aulast%3DZink%26aufirst%3DR.%2BW.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DEessalu%26aufirst%3DT.%2BE.%26aulast%3DFicorilli%26aufirst%3DJ.%2BV.%26aulast%3DMarcelo%26aufirst%3DM.%2BC.%26aulast%3DOtto%26aufirst%3DK.%2BA.%26aulast%3DWilbur%26aufirst%3DK.%2BL.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DPiper%26aufirst%3DJ.%2BL.%26aulast%3DCoffey%26aufirst%3DD.%2BS.%26aulast%3DSweetana%26aufirst%3DS.%2BA.%26aulast%3DHaas%26aufirst%3DJ.%2BV.%26aulast%3DBrooks%26aufirst%3DD.%2BA.%26aulast%3DPratt%26aufirst%3DE.%2BJ.%26aulast%3DBelin%26aufirst%3DR.%2BM.%26aulast%3DDeeg%26aufirst%3DM.%2BA.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DCannady%26aufirst%3DE.%2BA.%26aulast%3DJohnson%26aufirst%3DJ.%2BT.%26aulast%3DYumibe%26aufirst%3DN.%2BP.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DMaiti%26aufirst%3DP.%26aulast%3DMontrose-Rafizadeh%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DReifel%2BMiller%26aufirst%3DA.%26atitle%3DThe%2520discovery%252C%2520preclinical%252C%2520and%2520early%2520clinical%2520development%2520of%2520potent%2520and%2520selective%2520GPR40%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%2520%2528LY2881835%252C%2520LY2922083%252C%2520and%2520LY2922470%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10891%26epage%3D10916%26doi%3D10.1021%2Facs.jmedchem.6b00892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1<i>H</i>-indole-3-carboxylic acid (PF-06409577), a direct activator of adenosine monophosphate-activated protein kinase (AMPK), for the potential treatment of diabetic nephropathy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8068</span>– <span class="NLM_lpage">8081</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00866</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00866" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8068-8081&author=K.+O.+Cameronauthor=D.+W.+Kungauthor=A.+S.+Kalgutkarauthor=R.+G.+Kurumbailauthor=R.+Millerauthor=C.+T.+Salattoauthor=J.+Wardauthor=J.+M.+Withkaauthor=S.+K.+Bhattacharyaauthor=M.+Boehmauthor=K.+A.+Borzilleriauthor=J.+A.+Brownauthor=M.+Calabreseauthor=N.+L.+Caspersauthor=E.+Cokorinosauthor=E.+L.+Connauthor=M.+S.+Dowlingauthor=D.+J.+Edmondsauthor=H.+Engauthor=D.+P.+Fernandoauthor=R.+Frisbieauthor=D.+Hepworthauthor=J.+Landroauthor=Y.+Maoauthor=F.+Rajamohanauthor=A.+R.+Reyesauthor=C.+R.+Roseauthor=T.+Ryderauthor=A.+Shavnyaauthor=A.+C.+Smithauthor=M.+Tuauthor=A.+C.+Wolfordauthor=J.+Xiao&title=Discovery+and+preclinical+characterization+of+6-chloro-5-%5B4-%281-hydroxycyclobutyl%29phenyl%5D-1H-indole-3-carboxylic+acid+%28PF-06409577%29%2C+a+direct+activator+of+adenosine+monophosphate-activated+protein+kinase+%28AMPK%29%2C+for+the+potential+treatment+of+diabetic+nephropathy&doi=10.1021%2Facs.jmedchem.6b00866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy</span></div><div class="casAuthors">Cameron, Kimberly O.; Kung, Daniel W.; Kalgutkar, Amit S.; Kurumbail, Ravi G.; Miller, Russell; Salatto, Christopher T.; Ward, Jessica; Withka, Jane M.; Bhattacharya, Samit K.; Boehm, Markus; Borzilleri, Kris A.; Brown, Janice A.; Calabrese, Matthew; Caspers, Nicole L.; Cokorinos, Emily; Conn, Edward L.; Dowling, Matthew S.; Edmonds, David J.; Eng, Heather; Fernando, Dilinie P.; Frisbie, Richard; Hepworth, David; Landro, James; Mao, Yuxia; Rajamohan, Francis; Reyes, Allan R.; Rose, Colin R.; Ryder, Tim; Shavnya, Andre; Smith, Aaron C.; Tu, Meihua; Wolford, Angela C.; Xiao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8068-8081</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine monophosphate-activated protein kinase (AMPK) is a protein kinase involved in maintaining energy homeostasis within cells.  On the basis of human genetic assocn. data, AMPK activators were pursued for the treatment of diabetic nephropathy.  Identification of an indazole amide high throughput screening (HTS) hit followed by truncation to its minimal pharmacophore provided an indazole acid lead compd.  Optimization of the core and aryl appendage improved oral absorption and culminated in the identification of indole acid, PF-06409577 (7).  Compd. 7 was advanced to first-in-human trials for the treatment of diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUC3BGd-8kbVg90H21EOLACvtfcHk0liF5soZNFJBNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI&md5=0b70014081c86df1cf3d713ab943d39c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00866%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCalabrese%26aufirst%3DM.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DFrisbie%26aufirst%3DR.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DLandro%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DXiao%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%25206-chloro-5-%255B4-%25281-hydroxycyclobutyl%2529phenyl%255D-1H-indole-3-carboxylic%2520acid%2520%2528PF-06409577%2529%252C%2520a%2520direct%2520activator%2520of%2520adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%252C%2520for%2520the%2520potential%2520treatment%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8068%26epage%3D8081%26doi%3D10.1021%2Facs.jmedchem.6b00866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clairmont, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commerford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwak, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szklennik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Wu, M. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable benzimidazole diacylglycerol acyltransferase 1 (DGAT1) inhibitor that suppresses body weight gain in diet-induced obese dogs and postprandial triglycerides in humans</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4657</span>– <span class="NLM_lpage">4664</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00173</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00173" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4657-4664&author=K.+Nakajimaauthor=R.+Chatelainauthor=K.+B.+Clairmontauthor=R.+Commerfordauthor=G.+M.+Coppolaauthor=T.+Danielsauthor=C.+J.+Forsterauthor=T.+A.+Gilmoreauthor=Y.+Gongauthor=M.+Jainauthor=A.+Kanterauthor=Y.+Kwakauthor=J.+Liauthor=C.+D.+Meyersauthor=A.+D.+Neubertauthor=P.+Szklennikauthor=V.+Tedescoauthor=J.+Thompsonauthor=D.+Truongauthor=Q.+Yangauthor=B.+K.+Hubbardauthor=M.+H.+Serrano-Wu&title=Discovery+of+an+orally+bioavailable+benzimidazole+diacylglycerol+acyltransferase+1+%28DGAT1%29+inhibitor+that+suppresses+body+weight+gain+in+diet-induced+obese+dogs+and+postprandial+triglycerides+in+humans&doi=10.1021%2Facs.jmedchem.7b00173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans</span></div><div class="casAuthors">Nakajima, Katsumasa; Chatelain, Ricardo; Clairmont, Kevin B.; Commerford, Renee; Coppola, Gary M.; Daniels, Thomas; Forster, Cornelia J.; Gilmore, Thomas A.; Gong, Yongjin; Jain, Monish; Kanter, Aaron; Kwak, Youngshin; Li, Jingzhou; Meyers, Charles D.; Neubert, Alan D.; Szklennik, Paul; Tedesco, Vivienne; Thompson, James; Truong, David; Yang, Qing; Hubbard, Brian K.; Serrano-Wu, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4657-4664</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modification of a gut restricted class of benzimidazole DGAT1 inhibitor I led to II with good oral bioavailability.  The key structural changes to I include bioisosteric replacement of the amide with oxadiazole and α,α-dimethylation of the carboxylic acid, improving DGAT1 potency and gut permeability.  Since DGAT1 is expressed in the small intestine, both I and II can suppress postprandial triglycerides during acute oral lipid challenges in rats and dogs.  Interestingly, only II was found to be effective in suppressing body wt. gain relative to control in a diet induced obese dog model, suggesting the importance of systemic inhibition of DGAT1 for body wt. control. II has advanced to clin. investigation and successfully suppressed postprandial triglycerides during an acute meal challenge in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0TGwRfGzoarVg90H21EOLACvtfcHk0lgLIdrjAt15AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wmt7Y%253D&md5=2583c74a8cf9478075df49cacc72864b</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00173%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DChatelain%26aufirst%3DR.%26aulast%3DClairmont%26aufirst%3DK.%2BB.%26aulast%3DCommerford%26aufirst%3DR.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DDaniels%26aufirst%3DT.%26aulast%3DForster%26aufirst%3DC.%2BJ.%26aulast%3DGilmore%26aufirst%3DT.%2BA.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DKanter%26aufirst%3DA.%26aulast%3DKwak%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMeyers%26aufirst%3DC.%2BD.%26aulast%3DNeubert%26aufirst%3DA.%2BD.%26aulast%3DSzklennik%26aufirst%3DP.%26aulast%3DTedesco%26aufirst%3DV.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DTruong%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DHubbard%26aufirst%3DB.%2BK.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%2520benzimidazole%2520diacylglycerol%2520acyltransferase%25201%2520%2528DGAT1%2529%2520inhibitor%2520that%2520suppresses%2520body%2520weight%2520gain%2520in%2520diet-induced%2520obese%2520dogs%2520and%2520postprandial%2520triglycerides%2520in%2520humans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4657%26epage%3D4664%26doi%3D10.1021%2Facs.jmedchem.7b00173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Wu, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clairmont, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commerford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juedes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullarkey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocheford, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, B. K.</span></span> <span> </span><span class="NLM_article-title">Intestinally targeted diacylglycerol acyltransferase 1 (DGAT1) inhibitors robustly suppress postprandial triglycerides</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1021/ml3000512</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3000512" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFWktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=411-415&author=M.+H.+Serrano-Wuauthor=G.+M.+Coppolaauthor=Y.+Gongauthor=A.+D.+Neubertauthor=R.+Chatelainauthor=K.+B.+Clairmontauthor=R.+Commerfordauthor=T.+Coskerauthor=T.+Danielsauthor=Y.+Houauthor=M.+Jainauthor=M.+Juedesauthor=L.+Liauthor=T.+Mullarkeyauthor=E.+Rochefordauthor=M.+J.+Sungauthor=A.+Tylerauthor=Q.+Yangauthor=T.+Yoonauthor=B.+K.+Hubbard&title=Intestinally+targeted+diacylglycerol+acyltransferase+1+%28DGAT1%29+inhibitors+robustly+suppress+postprandial+triglycerides&doi=10.1021%2Fml3000512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides</span></div><div class="casAuthors">Serrano-Wu, Michael H.; Coppola, Gary M.; Gong, Yongjin; Neubert, Alan D.; Chatelain, Ricardo; Clairmont, Kevin B.; Commerford, Renee; Cosker, Theresa; Daniels, Thomas; Hou, Ying; Jain, Monish; Juedes, Marlene; Li, Lisha; Mullarkey, Tara; Rocheford, Erik; Sung, Moo Je; Tyler, Andrew; Yang, Qing; Yoon, Taeyoung; Hubbard, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-415</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High DGAT1 expression levels in the small intestine highlight the crit. role this enzyme plays in nutrient absorption.  Identification of inhibitors which predominantly inhibit DGAT1 in the gut is an attractive drug discovery strategy with anticipated benefits of reduced systemic toxicity.  In this report we describe our discovery and optimization of DGAT1 inhibitors whose plasma exposure is minimized by the action of transporters, including the P-glycoprotein transporter.  The impact of this unique absorption profile on efficacy in rat and dog efficacy models is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ukV18hQAlrVg90H21EOLACvtfcHk0lgLIdrjAt15AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFWktLk%253D&md5=4296446fcf69fdf96acf38156c84b950</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml3000512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000512%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DNeubert%26aufirst%3DA.%2BD.%26aulast%3DChatelain%26aufirst%3DR.%26aulast%3DClairmont%26aufirst%3DK.%2BB.%26aulast%3DCommerford%26aufirst%3DR.%26aulast%3DCosker%26aufirst%3DT.%26aulast%3DDaniels%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DJuedes%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMullarkey%26aufirst%3DT.%26aulast%3DRocheford%26aufirst%3DE.%26aulast%3DSung%26aufirst%3DM.%2BJ.%26aulast%3DTyler%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DYoon%26aufirst%3DT.%26aulast%3DHubbard%26aufirst%3DB.%2BK.%26atitle%3DIntestinally%2520targeted%2520diacylglycerol%2520acyltransferase%25201%2520%2528DGAT1%2529%2520inhibitors%2520robustly%2520suppress%2520postprandial%2520triglycerides%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D411%26epage%3D415%26doi%3D10.1021%2Fml3000512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loefberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Unge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judkins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benthem, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennerberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenwall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gennemark, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogner, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of (3-(4-(2-oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone (AZD1979), a Melanin Concentrating Hormone Receptor 1 (MCHr1) antagonist with favorable physicochemical properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2497</span>– <span class="NLM_lpage">2511</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01654</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01654" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFCnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2497-2511&author=A.+Johanssonauthor=C.+Loefbergauthor=M.+Antonssonauthor=S.+von+Ungeauthor=M.+A.+Hayesauthor=R.+Judkinsauthor=K.+Plojauthor=L.+Benthemauthor=D.+Lindenauthor=P.+Brodinauthor=M.+Wennerbergauthor=M.+Fredenwallauthor=L.+Liauthor=J.+Perssonauthor=R.+Bergmanauthor=A.+Pettersenauthor=P.+Gennemarkauthor=A.+Hogner&title=Discovery+of+%283-%284-%282-oxa-6-azaspiro%5B3.3%5Dheptan-6-ylmethyl%29phenoxy%29azetidin-1-yl%29%285-%284-methoxyphenyl%29-1%2C3%2C4-oxadiazol-2-yl%29methanone+%28AZD1979%29%2C+a+Melanin+Concentrating+Hormone+Receptor+1+%28MCHr1%29+antagonist+with+favorable+physicochemical+properties&doi=10.1021%2Facs.jmedchem.5b01654"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (3-(4-(2-Oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone (AZD1979), a Melanin Concentrating Hormone Receptor 1 (MCHr1) Antagonist with Favorable Physicochemical Properties</span></div><div class="casAuthors">Johansson, Anders; Loefberg, Christian; Antonsson, Madeleine; von Unge, Sverker; Hayes, Martin A.; Judkins, Robert; Ploj, Karolina; Benthem, Lambertus; Linden, Daniel; Brodin, Peter; Wennerberg, Marie; Fredenwall, Marlene; Li, Lanna; Persson, Joachim; Bergman, Rolf; Pettersen, Anna; Gennemark, Peter; Hogner, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2497-2511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of melanin concg. hormone receptor 1 (MCHr1) antagonists were the starting point for a drug discovery program that culminated in the discovery of 103 (AZD1979).  The lead optimization program was conducted with a focus on reducing lipophilicity and understanding the physicochem. properties governing CNS exposure and undesired off-target pharmacol. such as hERG interactions.  An integrated approach was taken where the key assay was ex vivo receptor occupancy in mice.  The candidate compd. 103 displayed appropriate lipophilicity for a CNS indication and showed excellent permeability with no efflux.  Preclin. GLP toxicol. and safety pharmacol. studies were without major findings and 103 was taken into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJJvE6-qb7C7Vg90H21EOLACvtfcHk0lgLIdrjAt15AA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFCnsg%253D%253D&md5=98ac16f6fd4be62e681f2ebb094e985e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01654%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DLoefberg%26aufirst%3DC.%26aulast%3DAntonsson%26aufirst%3DM.%26aulast%3Dvon%2BUnge%26aufirst%3DS.%26aulast%3DHayes%26aufirst%3DM.%2BA.%26aulast%3DJudkins%26aufirst%3DR.%26aulast%3DPloj%26aufirst%3DK.%26aulast%3DBenthem%26aufirst%3DL.%26aulast%3DLinden%26aufirst%3DD.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DWennerberg%26aufirst%3DM.%26aulast%3DFredenwall%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DPersson%26aufirst%3DJ.%26aulast%3DBergman%26aufirst%3DR.%26aulast%3DPettersen%26aufirst%3DA.%26aulast%3DGennemark%26aufirst%3DP.%26aulast%3DHogner%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520%25283-%25284-%25282-oxa-6-azaspiro%255B3.3%255Dheptan-6-ylmethyl%2529phenoxy%2529azetidin-1-yl%2529%25285-%25284-methoxyphenyl%2529-1%252C3%252C4-oxadiazol-2-yl%2529methanone%2520%2528AZD1979%2529%252C%2520a%2520Melanin%2520Concentrating%2520Hormone%2520Receptor%25201%2520%2528MCHr1%2529%2520antagonist%2520with%2520favorable%2520physicochemical%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2497%26epage%3D2511%26doi%3D10.1021%2Facs.jmedchem.5b01654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwat, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apedo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozarth, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toussaint, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stetsko, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudmundsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crain, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chacko, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiffert, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of a parenteral small molecule coagulation factor XIa inhibitor clinical candidate (BMS-962212)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9703</span>– <span class="NLM_lpage">9723</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01171</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01171" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslent7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9703-9723&author=D.+J.+P.+Pintoauthor=M.+J.+Orwatauthor=L.+M.+Smithauthor=M.+L.+Quanauthor=P.+Y.+S.+Lamauthor=K.+A.+Rossiauthor=A.+Apedoauthor=J.+M.+Bozarthauthor=Y.+Wuauthor=J.+J.+Zhengauthor=B.+Xinauthor=N.+Toussaintauthor=P.+Stetskoauthor=O.+Gudmundssonauthor=B.+Maxwellauthor=E.+J.+Crainauthor=P.+C.+Wongauthor=Z.+Louauthor=T.+W.+Harperauthor=S.+A.+Chackoauthor=J.+E.+Myersauthor=S.+Sheriffauthor=H.+Zhangauthor=X.+Houauthor=A.+Mathurauthor=D.+A.+Seiffertauthor=R.+R.+Wexlerauthor=J.+M.+Luettgenauthor=W.+R.+Ewing&title=Discovery+of+a+parenteral+small+molecule+coagulation+factor+XIa+inhibitor+clinical+candidate+%28BMS-962212%29&doi=10.1021%2Facs.jmedchem.7b01171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212)</span></div><div class="casAuthors">Pinto, Donald J. P.; Orwat, Michael J.; Smith, Leon M.; Quan, Mimi L.; Lam, Patrick Y. S.; Rossi, Karen A.; Apedo, Atsu; Bozarth, Jeffrey M.; Wu, Yiming; Zheng, Joanna J.; Xin, Baomin; Toussaint, Nathalie; Stetsko, Paul; Gudmundsson, Olafur; Maxwell, Brad; Crain, Earl J.; Wong, Pancras C.; Lou, Zhen; Harper, Timothy W.; Chacko, Silvi A.; Myers, Joseph E.; Sheriff, Steven; Zhang, Huiping; Hou, Xiaoping; Mathur, Arvind; Seiffert, Dietmar A.; Wexler, Ruth R.; Luettgen, Joseph M.; Ewing, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9703-9723</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Factor XIa (FXIa) is a blood coagulation enzyme that is involved in the amplification of thrombin generation.  Mounting evidence suggests that direct inhibition of FXIa can block pathol. thrombus formation while preserving normal hemostasis.  Preclin. studies using a variety of approaches to reduce FXIa activity, including direct inhibitors of FXIa, have demonstrated good antithrombotic efficacy without increasing bleeding.  Based on this potential, the authors targeted the efforts at identifying potent inhibitors of FXIa with a focus on discovering an acute antithrombotic agent for use in a hospital setting.  Herein the authors describe the discovery of a potent FXIa clin. candidate, I (FXIa Ki = 0.7 nM), with excellent preclin. efficacy in thrombosis models and aq. soly. suitable for i.v. administration.  BMS-962212 is a reversible, direct, and highly selective small mol. inhibitor of FXIa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDjxJ_bitf6rVg90H21EOLACvtfcHk0liVQ9UMfYgRaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslent7bE&md5=8873c054b79778fe7c45daa2eda64084</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01171%26sid%3Dliteratum%253Aachs%26aulast%3DPinto%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DOrwat%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BM.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DApedo%26aufirst%3DA.%26aulast%3DBozarth%26aufirst%3DJ.%2BM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26aulast%3DXin%26aufirst%3DB.%26aulast%3DToussaint%26aufirst%3DN.%26aulast%3DStetsko%26aufirst%3DP.%26aulast%3DGudmundsson%26aufirst%3DO.%26aulast%3DMaxwell%26aufirst%3DB.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DHarper%26aufirst%3DT.%2BW.%26aulast%3DChacko%26aufirst%3DS.%2BA.%26aulast%3DMyers%26aufirst%3DJ.%2BE.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DSeiffert%26aufirst%3DD.%2BA.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520parenteral%2520small%2520molecule%2520coagulation%2520factor%2520XIa%2520inhibitor%2520clinical%2520candidate%2520%2528BMS-962212%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9703%26epage%3D9723%26doi%3D10.1021%2Facs.jmedchem.7b01171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debenham, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen-Duggan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibarkh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salowe, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonatore, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visco, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-[bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">11039</span>– <span class="NLM_lpage">11049</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01242</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01242" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=11039-11049&author=J.+S.+Debenhamauthor=C.+Madsen-Dugganauthor=M.+J.+Clementsauthor=T.+F.+Walshauthor=J.+T.+Kuetheauthor=M.+Reibarkhauthor=S.+P.+Saloweauthor=L.+M.+Sonatoreauthor=R.+Hajduauthor=J.+A.+Milliganauthor=D.+M.+Viscoauthor=D.+Zhouauthor=R.+B.+Linghamauthor=D.+Stickensauthor=J.+A.+DeMartinoauthor=X.+Tongauthor=M.+Wolffauthor=J.+Pangauthor=R.+R.+Millerauthor=E.+C.+Shererauthor=J.+J.+Hale&title=Discovery+of+N-%5Bbis%284-methoxyphenyl%29methyl%5D-4-hydroxy-2-%28pyridazin-3-yl%29pyrimidine-5-carboxamide+%28MK-8617%29%2C+an+orally+active+pan-inhibitor+of+hypoxia-inducible+factor+prolyl+hydroxylase+1-3+%28HIF+PHD1-3%29+for+the+treatment+of+anemia&doi=10.1021%2Facs.jmedchem.6b01242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia</span></div><div class="casAuthors">Debenham, John S.; Madsen-Duggan, Christina; Clements, Matthew J.; Walsh, Thomas F.; Kuethe, Jeffrey T.; Reibarkh, Mikhail; Salowe, Scott P.; Sonatore, Lisa M.; Hajdu, Richard; Milligan, James A.; Visco, Denise M.; Zhou, Dan; Lingham, Russell B.; Stickens, Dominique; DeMartino, Julie A.; Tong, Xinchun; Wolff, Michael; Pang, Jianmei; Miller, Randy R.; Sherer, Edward C.; Hale, Jeffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11039-11049</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of novel 4-hydroxy-2-(heterocyclic)pyrimidine-5-carboxamide inhibitors of hypoxia-inducible factor (HIF) prolyl hydroxylases (PHD) are described.  These are potent, selective, orally bioavailable across several species and are active in stimulating erythropoiesis.  Mouse and rat studies showed hematol. changes with elevations of plasma EPO and circulating reticulocytes following single oral dose administration while 4 wk QD po administration in rat elevated Hb levels.  A major focus of the optimization process was to decrease the long half-life obsd. in higher species with early compds.  These efforts led to the identification of 28 (MK-8617) which has advanced to human clin. trials for anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhs63u66yCX7Vg90H21EOLACvtfcHk0liVQ9UMfYgRaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN&md5=7acb236af3ca035b010a203f7234a5b7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01242%26sid%3Dliteratum%253Aachs%26aulast%3DDebenham%26aufirst%3DJ.%2BS.%26aulast%3DMadsen-Duggan%26aufirst%3DC.%26aulast%3DClements%26aufirst%3DM.%2BJ.%26aulast%3DWalsh%26aufirst%3DT.%2BF.%26aulast%3DKuethe%26aufirst%3DJ.%2BT.%26aulast%3DReibarkh%26aufirst%3DM.%26aulast%3DSalowe%26aufirst%3DS.%2BP.%26aulast%3DSonatore%26aufirst%3DL.%2BM.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DVisco%26aufirst%3DD.%2BM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DLingham%26aufirst%3DR.%2BB.%26aulast%3DStickens%26aufirst%3DD.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520N-%255Bbis%25284-methoxyphenyl%2529methyl%255D-4-hydroxy-2-%2528pyridazin-3-yl%2529pyrimidine-5-carboxamide%2520%2528MK-8617%2529%252C%2520an%2520orally%2520active%2520pan-inhibitor%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%25201-3%2520%2528HIF%2520PHD1-3%2529%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D11039%26epage%3D11049%26doi%3D10.1021%2Facs.jmedchem.6b01242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desroy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housseman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joncour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labeguere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassot, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picolet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annoot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjardet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakselman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncoroni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tallec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottereaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandervoort, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auberval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrvacic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oste, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Aar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckmann, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a first-in-class autotaxin inhibitor undergoing clinical evaluation for the treatment of idiopathic pulmonary fibrosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3580</span>– <span class="NLM_lpage">3590</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3580-3590&author=N.+Desroyauthor=C.+Houssemanauthor=X.+Bockauthor=A.+Joncourauthor=N.+Bienvenuauthor=L.+Cherelauthor=V.+Labeguereauthor=E.+Rondetauthor=C.+Peixotoauthor=J.-M.+Grassotauthor=O.+Picoletauthor=D.+Annootauthor=N.+Triballeauauthor=A.+Monjardetauthor=E.+Wakselmanauthor=V.+Roncoroniauthor=S.+Le+Tallecauthor=R.+Blanqueauthor=C.+Cottereauxauthor=N.+Vandervoortauthor=T.+Christopheauthor=P.+Mollatauthor=M.+Lamersauthor=M.+Aubervalauthor=B.+Hrvacicauthor=J.+Ralicauthor=L.+Osteauthor=E.+van+der%0AAarauthor=R.+Brysauthor=B.+Heckmann&title=Discovery+of+2-%5B%5B2-ethyl-6-%5B4-%5B2-%283-hydroxyazetidin-1-yl%29-2-oxoethyl%5Dpiperazin-1-yl%5D-8-methylimidazo%5B1%2C2-a%5Dpyridin-3-yl%5Dmethylamino%5D-4-%284-fluorophenyl%29thiazole-5-carbonitrile+%28GLPG1690%29%2C+a+first-in-class+autotaxin+inhibitor+undergoing+clinical+evaluation+for+the+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.1021%2Facs.jmedchem.7b00032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Desroy, Nicolas; Housseman, Christopher; Bock, Xavier; Joncour, Agnes; Bienvenu, Natacha; Cherel, Laetitia; Labeguere, Virginie; Rondet, Emilie; Peixoto, Christophe; Grassot, Jean-Marie; Picolet, Olivier; Annoot, Denis; Triballeau, Nicolas; Monjardet, Alain; Wakselman, Emanuelle; Roncoroni, Veronique; Le Tallec, Sandrine; Blanque, Roland; Cottereaux, Celine; Vandervoort, Nele; Christophe, Thierry; Mollat, Patrick; Lamers, Marieke; Auberval, Marielle; Hrvacic, Boska; Ralic, Jovica; Oste, Line; van der Aar, Ellen; Brys, Reginald; Heckmann, Bertrand</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3580-3590</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin is a circulating enzyme with a major role in the prodn. of lysophosphatic acid (LPA) species in blood.  A role for the autotaxin/LPA axis has been suggested in many disease areas including pulmonary fibrosis.  Structural modifications of the known autotaxin inhibitor lead compd. 1, to attenuate hERG inhibition, remove CYP3A4 time-dependent inhibition, and improve pharmacokinetic properties, led to the identification of clin. candidate GLPG1690 (11).  Compd. 11 was able to cause a sustained redn. of LPA levels in plasma in vivo and was shown to be efficacious in a bleomycin-induced pulmonary fibrosis model in mice and in reducing extracellular matrix deposition in the lung while also reducing LPA 18:2 content in bronchoalveolar lavage fluid.  Compd. 11 is currently being evaluated in an exploratory phase 2a study in idiopathic pulmonary fibrosis patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMGaRp0Gq5ErVg90H21EOLACvtfcHk0lhhjgm2z5pE7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCntL8%253D&md5=1038c79f5085e5719e9f1f2141941bb6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00032%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26aulast%3DHousseman%26aufirst%3DC.%26aulast%3DBock%26aufirst%3DX.%26aulast%3DJoncour%26aufirst%3DA.%26aulast%3DBienvenu%26aufirst%3DN.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DLabeguere%26aufirst%3DV.%26aulast%3DRondet%26aufirst%3DE.%26aulast%3DPeixoto%26aufirst%3DC.%26aulast%3DGrassot%26aufirst%3DJ.-M.%26aulast%3DPicolet%26aufirst%3DO.%26aulast%3DAnnoot%26aufirst%3DD.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3DMonjardet%26aufirst%3DA.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DRoncoroni%26aufirst%3DV.%26aulast%3DLe%2BTallec%26aufirst%3DS.%26aulast%3DBlanque%26aufirst%3DR.%26aulast%3DCottereaux%26aufirst%3DC.%26aulast%3DVandervoort%26aufirst%3DN.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DMollat%26aufirst%3DP.%26aulast%3DLamers%26aufirst%3DM.%26aulast%3DAuberval%26aufirst%3DM.%26aulast%3DHrvacic%26aufirst%3DB.%26aulast%3DRalic%26aufirst%3DJ.%26aulast%3DOste%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DHeckmann%26aufirst%3DB.%26atitle%3DDiscovery%2520of%25202-%255B%255B2-ethyl-6-%255B4-%255B2-%25283-hydroxyazetidin-1-yl%2529-2-oxoethyl%255Dpiperazin-1-yl%255D-8-methylimidazo%255B1%252C2-a%255Dpyridin-3-yl%255Dmethylamino%255D-4-%25284-fluorophenyl%2529thiazole-5-carbonitrile%2520%2528GLPG1690%2529%252C%2520a%2520first-in-class%2520autotaxin%2520inhibitor%2520undergoing%2520clinical%2520evaluation%2520for%2520the%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3580%26epage%3D3590%26doi%3D10.1021%2Facs.jmedchem.7b00032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joncour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desroy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housseman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labeguere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annoot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepissier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengeveld, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilzak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjardet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakselman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncoroni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tallec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galien, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandervoort, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrath, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohlkonig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soror, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touitou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleury, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercheval, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Aar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckmann, B.</span></span> <span> </span><span class="NLM_article-title">Discovery, structure-activity relationship, and binding mode of an imidazo[1,2-<i>a</i>]pyridine series of autotaxin inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7371</span>– <span class="NLM_lpage">7392</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WitLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7371-7392&author=A.+Joncourauthor=N.+Desroyauthor=C.+Houssemanauthor=X.+Bockauthor=N.+Bienvenuauthor=L.+Cherelauthor=V.+Labeguereauthor=C.+Peixotoauthor=D.+Annootauthor=L.+Lepissierauthor=J.+Heiermannauthor=W.+J.+Hengeveldauthor=G.+Pilzakauthor=A.+Monjardetauthor=E.+Wakselmanauthor=V.+Roncoroniauthor=S.+Le+Tallecauthor=R.+Galienauthor=C.+Davidauthor=N.+Vandervoortauthor=T.+Christopheauthor=K.+Conrathauthor=M.+Jansauthor=A.+Wohlkonigauthor=S.+Sororauthor=J.+Steyaertauthor=R.+Touitouauthor=D.+Fleuryauthor=L.+Verchevalauthor=P.+Mollatauthor=N.+Triballeauauthor=E.+van+der+Aarauthor=R.+Brysauthor=B.+Heckmann&title=Discovery%2C+structure-activity+relationship%2C+and+binding+mode+of+an+imidazo%5B1%2C2-a%5Dpyridine+series+of+autotaxin+inhibitors&doi=10.1021%2Facs.jmedchem.7b00647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors</span></div><div class="casAuthors">Joncour, Agnes; Desroy, Nicolas; Housseman, Christopher; Bock, Xavier; Bienvenu, Natacha; Cherel, Laetitia; Labeguere, Virginie; Peixoto, Christophe; Annoot, Denis; Lepissier, Luce; Heiermann, Jorg; Hengeveld, Willem Jan; Pilzak, Gregor; Monjardet, Alain; Wakselman, Emanuelle; Roncoroni, Veronique; Le Tallec, Sandrine; Galien, Rene; David, Christelle; Vandervoort, Nele; Christophe, Thierry; Conrath, Katja; Jans, Mia; Wohlkonig, Alexandre; Soror, Sameh; Steyaert, Jan; Touitou, Robert; Fleury, Damien; Vercheval, Lionel; Mollat, Patrick; Triballeau, Nicolas; van der Aar, Ellen; Brys, Reginald; Heckmann, Bertrand</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7371-7392</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a secreted enzyme playing a major role in the prodn. of lysophosphatidic acid (LPA) in blood through hydrolysis of lysophosphatidyl choline (LPC).  The ATX-LPA signaling axis arouses a high interest in the drug discovery industry as it has been implicated in several diseases including cancer, fibrotic diseases and inflammation among others.  An imidazo[1,2-a]pyridine series of ATX inhibitors was identified out of a high throughput screening (HTS).  A co-crystal structure with one of these compds. and ATX revealed a novel binding mode with occupancy of the hydrophobic pocket and channel of ATX but no interaction with zinc ions of the catalytic site.  Exploration of the structure-activity relationship led to compds. displaying high activity in biochem. and plasma assays, exemplified by compd. I.  Compd. I was also able to decrease the plasma LPA levels upon oral administration to rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY6dK8UCSEyLVg90H21EOLACvtfcHk0lgX800SAxLh1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WitLvN&md5=2c08b3017e0bc0183c9e8e1911ddab0d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00647%26sid%3Dliteratum%253Aachs%26aulast%3DJoncour%26aufirst%3DA.%26aulast%3DDesroy%26aufirst%3DN.%26aulast%3DHousseman%26aufirst%3DC.%26aulast%3DBock%26aufirst%3DX.%26aulast%3DBienvenu%26aufirst%3DN.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DLabeguere%26aufirst%3DV.%26aulast%3DPeixoto%26aufirst%3DC.%26aulast%3DAnnoot%26aufirst%3DD.%26aulast%3DLepissier%26aufirst%3DL.%26aulast%3DHeiermann%26aufirst%3DJ.%26aulast%3DHengeveld%26aufirst%3DW.%2BJ.%26aulast%3DPilzak%26aufirst%3DG.%26aulast%3DMonjardet%26aufirst%3DA.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DRoncoroni%26aufirst%3DV.%26aulast%3DLe%2BTallec%26aufirst%3DS.%26aulast%3DGalien%26aufirst%3DR.%26aulast%3DDavid%26aufirst%3DC.%26aulast%3DVandervoort%26aufirst%3DN.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DConrath%26aufirst%3DK.%26aulast%3DJans%26aufirst%3DM.%26aulast%3DWohlkonig%26aufirst%3DA.%26aulast%3DSoror%26aufirst%3DS.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DTouitou%26aufirst%3DR.%26aulast%3DFleury%26aufirst%3DD.%26aulast%3DVercheval%26aufirst%3DL.%26aulast%3DMollat%26aufirst%3DP.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DHeckmann%26aufirst%3DB.%26atitle%3DDiscovery%252C%2520structure-activity%2520relationship%252C%2520and%2520binding%2520mode%2520of%2520an%2520imidazo%255B1%252C2-a%255Dpyridine%2520series%2520of%2520autotaxin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7371%26epage%3D7392%26doi%3D10.1021%2Facs.jmedchem.7b00647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lönn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Käck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Poël, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannesson, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of second generation reversible covalent DPPP1 inhibitors leading to an oxazepan amdidoacetonitrile based clinical candidate (AZD7986)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9457</span>– <span class="NLM_lpage">9472</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9457-9472&author=K.+Doyleauthor=H.+L%C3%B6nnauthor=H.+K%C3%A4ckauthor=A.+Van+de+Po%C3%ABlauthor=S.+Swallowauthor=P.+Gardinerauthor=S.+Connollyauthor=J.+Rootauthor=C.+Wikellauthor=G.+Dahlauthor=K.+Stenvallauthor=P.+Johannesson&title=Discovery+of+second+generation+reversible+covalent+DPPP1+inhibitors+leading+to+an+oxazepan+amdidoacetonitrile+based+clinical+candidate+%28AZD7986%29&doi=10.1021%2Facs.jmedchem.6b01127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01127%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DK.%26aulast%3DL%25C3%25B6nn%26aufirst%3DH.%26aulast%3DK%25C3%25A4ck%26aufirst%3DH.%26aulast%3DVan%2Bde%2BPo%25C3%25ABl%26aufirst%3DA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGardiner%26aufirst%3DP.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DWikell%26aufirst%3DC.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DJohannesson%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520second%2520generation%2520reversible%2520covalent%2520DPPP1%2520inhibitors%2520leading%2520to%2520an%2520oxazepan%2520amdidoacetonitrile%2520based%2520clinical%2520candidate%2520%2528AZD7986%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9457%26epage%3D9472%26doi%3D10.1021%2Facs.jmedchem.6b01127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biggadike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalmas
Wilk, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbon, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermitage, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessey, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillegas, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarides, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewell, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallett, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priest, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quint, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitaram, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsitoura, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of 6-amino-2-{[(1<i>S</i>)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a highly potent and selective intranasal Toll-Like Receptor 7 agonist for the treatment of asthma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1711</span>– <span class="NLM_lpage">1726</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1aksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1711-1726&author=K.+Biggadikeauthor=M.+Ahmedauthor=D.+I.+Ballauthor=D.+M.+Coeauthor=D.+A.+Dalmas%0AWilkauthor=C.+D.+Edwardsauthor=B.+H.+Gibbonauthor=C.+J.+Hardyauthor=S.+A.+Hermitageauthor=J.+O.+Hesseyauthor=A.+E.+Hillegasauthor=S.+C.+Hughesauthor=L.+Lazaridesauthor=X.+Q.+Lewellauthor=A.+Lucasauthor=D.+N.+Mallettauthor=M.+A.+Priceauthor=F.+M.+Priestauthor=D.+J.+Quintauthor=P.+Shahauthor=A.+Sitaramauthor=S.+A.+Smithauthor=R.+Stockerauthor=N.+A.+Trivediauthor=D.+C.+Tsitouraauthor=V.+Weller&title=Discovery+of+6-amino-2-%7B%5B%281S%29-1-methylbutyl%5Doxy%7D-9-%5B5-%281-piperidinyl%29pentyl%5D-7%2C9-dihydro-8H-purin-8-one+%28GSK2245035%29%2C+a+highly+potent+and+selective+intranasal+Toll-Like+Receptor+7+agonist+for+the+treatment+of+asthma&doi=10.1021%2Facs.jmedchem.5b01647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma</span></div><div class="casAuthors">Biggadike, Keith; Ahmed, Mahbub; Ball, Doug I.; Coe, Diane M.; Dalmas Wilk, Deidre A.; Edwards, Chris D.; Gibbon, Bob H.; Hardy, Charlotte J.; Hermitage, Stephen A.; Hessey, Joanne O.; Hillegas, Aimee E.; Hughes, Stephen C.; Lazarides, Linos; Lewell, Xiao Q.; Lucas, Amanda; Mallett, David N.; Price, Mark A.; Priest, Fiona M.; Quint, Diana J.; Shah, Poonam; Sitaram, Anesh; Smith, Stephen A.; Stocker, Richard; Trivedi, Naimisha A.; Tsitoura, Daphne C.; Weller, Victoria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1711-1726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Induction of IFNα in the upper airways via activation of TLR7 represents a novel immunomodulatory approach to the treatment of allergic asthma.  Exploration of 8-oxoadenine derivs. bearing satd. oxygen or nitrogen heterocycles in the N-9 substituent has revealed a remarkable selective enhancement in IFNα inducing potency in the nitrogen series.  Further potency enhancement was achieved with the novel (S)-pentyloxy substitution at C-2 leading to the selection of GSK2245035 (32) as an intranasal development candidate.  In human cell cultures, compd. 32 resulted in suppression of Th2 cytokine responses to allergens, while in vivo intranasal administration at very low doses led to local upregulation of TLR7-mediated cytokines (IP-10).  Target engagement was confirmed in humans following single intranasal doses of 32 of ≥20 ng, and reproducible pharmacol. response was demonstrated following repeat intranasal dosing at weekly intervals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFXegjfTmmgLVg90H21EOLACvtfcHk0lgX800SAxLh1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1aksrk%253D&md5=adab143ac46a049054d9ee4f52cf6292</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01647%26sid%3Dliteratum%253Aachs%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DBall%26aufirst%3DD.%2BI.%26aulast%3DCoe%26aufirst%3DD.%2BM.%26aulast%3DDalmas%2BWilk%26aufirst%3DD.%2BA.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DGibbon%26aufirst%3DB.%2BH.%26aulast%3DHardy%26aufirst%3DC.%2BJ.%26aulast%3DHermitage%26aufirst%3DS.%2BA.%26aulast%3DHessey%26aufirst%3DJ.%2BO.%26aulast%3DHillegas%26aufirst%3DA.%2BE.%26aulast%3DHughes%26aufirst%3DS.%2BC.%26aulast%3DLazarides%26aufirst%3DL.%26aulast%3DLewell%26aufirst%3DX.%2BQ.%26aulast%3DLucas%26aufirst%3DA.%26aulast%3DMallett%26aufirst%3DD.%2BN.%26aulast%3DPrice%26aufirst%3DM.%2BA.%26aulast%3DPriest%26aufirst%3DF.%2BM.%26aulast%3DQuint%26aufirst%3DD.%2BJ.%26aulast%3DShah%26aufirst%3DP.%26aulast%3DSitaram%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DStocker%26aufirst%3DR.%26aulast%3DTrivedi%26aufirst%3DN.%2BA.%26aulast%3DTsitoura%26aufirst%3DD.%2BC.%26aulast%3DWeller%26aufirst%3DV.%26atitle%3DDiscovery%2520of%25206-amino-2-%257B%255B%25281S%2529-1-methylbutyl%255Doxy%257D-9-%255B5-%25281-piperidinyl%2529pentyl%255D-7%252C9-dihydro-8H-purin-8-one%2520%2528GSK2245035%2529%252C%2520a%2520highly%2520potent%2520and%2520selective%2520intranasal%2520Toll-Like%2520Receptor%25207%2520agonist%2520for%2520the%2520treatment%2520of%2520asthma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1711%26epage%3D1726%26doi%3D10.1021%2Facs.jmedchem.5b01647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elzein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koltun, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhill, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corkey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notte, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataramani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bizri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirakawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahlig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhalla, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soohoo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belardinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, M. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of dihydrobenzoxazepinone (GS-6615) late sodium current inhibitor (Late <i>I</i><sub>Na</sub>i), a phase II agent with demonstrated preclinical anti-ischemic and antiarrhythmic properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9005</span>– <span class="NLM_lpage">9017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00939</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00939" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9005-9017&author=J.+A.+Zablockiauthor=E.+Elzeinauthor=X.+Liauthor=D.+O.+Koltunauthor=E.+Q.+Parkhillauthor=T.+Kobayashiauthor=R.+Martinezauthor=B.+Corkeyauthor=H.+Jiangauthor=T.+Perryauthor=R.+Kallaauthor=G.+T.+Notteauthor=O.+Saundersauthor=M.+Graupeauthor=Y.+Luauthor=C.+Venkataramaniauthor=J.+Guerreroauthor=J.+Perryauthor=M.+Osierauthor=R.+Strickleyauthor=G.+Liuauthor=W.-Q.+Wangauthor=L.+Huauthor=X.-J.+Liauthor=N.+El-Bizriauthor=R.+Hirakawaauthor=K.+Kahligauthor=C.+Xieauthor=C.+H.+Liauthor=A.+K.+Dhallaauthor=S.+Rajamaniauthor=N.+Mollovaauthor=D.+Soohooauthor=E.-I.+Lepistauthor=B.+Murrayauthor=G.+Rhodesauthor=L.+Belardinelliauthor=M.+C.+Desai&title=Discovery+of+dihydrobenzoxazepinone+%28GS-6615%29+late+sodium+current+inhibitor+%28Late+INai%29%2C+a+phase+II+agent+with+demonstrated+preclinical+anti-ischemic+and+antiarrhythmic+properties&doi=10.1021%2Facs.jmedchem.6b00939"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00939%26sid%3Dliteratum%253Aachs%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DKoltun%26aufirst%3DD.%2BO.%26aulast%3DParkhill%26aufirst%3DE.%2BQ.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DCorkey%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DKalla%26aufirst%3DR.%26aulast%3DNotte%26aufirst%3DG.%2BT.%26aulast%3DSaunders%26aufirst%3DO.%26aulast%3DGraupe%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DVenkataramani%26aufirst%3DC.%26aulast%3DGuerrero%26aufirst%3DJ.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DOsier%26aufirst%3DM.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DW.-Q.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.-J.%26aulast%3DEl-Bizri%26aufirst%3DN.%26aulast%3DHirakawa%26aufirst%3DR.%26aulast%3DKahlig%26aufirst%3DK.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%2BH.%26aulast%3DDhalla%26aufirst%3DA.%2BK.%26aulast%3DRajamani%26aufirst%3DS.%26aulast%3DMollova%26aufirst%3DN.%26aulast%3DSoohoo%26aufirst%3DD.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMurray%26aufirst%3DB.%26aulast%3DRhodes%26aufirst%3DG.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DDesai%26aufirst%3DM.%2BC.%26atitle%3DDiscovery%2520of%2520dihydrobenzoxazepinone%2520%2528GS-6615%2529%2520late%2520sodium%2520current%2520inhibitor%2520%2528Late%2520INai%2529%252C%2520a%2520phase%2520II%2520agent%2520with%2520demonstrated%2520preclinical%2520anti-ischemic%2520and%2520antiarrhythmic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9005%26epage%3D9017%26doi%3D10.1021%2Facs.jmedchem.6b00939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koltun, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhill, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elzein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notte, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avila, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Maxwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhalla, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belardinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of triazolopyridinone GS-462808, a late sodium current inhibitor (Late <i>I</i><sub>Na</sub>i) of the cardiac Nav1.5 channel with improved efficacy and potency relative to ranolazine</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3202</span>– <span class="NLM_lpage">3206</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2016.03.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3202-3206&author=D.+O.+Koltunauthor=E.+Q.+Parkhillauthor=E.+Elzeinauthor=T.+Kobayashiauthor=G.+T.+Notteauthor=R.+Kallaauthor=R.+H.+Jiangauthor=X.+Liauthor=T.+D.+Perryauthor=B.+Avilaauthor=W.-Q.+Wangauthor=C.+Smith-Maxwellauthor=A.+K.+Dhallaauthor=S.+Rajamaniauthor=B.+Staffordauthor=J.+Tangauthor=N.+Mollovaauthor=L.+Belardinelliauthor=J.+A.+Zablocki&title=Discovery+of+triazolopyridinone+GS-462808%2C+a+late+sodium+current+inhibitor+%28Late+INai%29+of+the+cardiac+Nav1.5+channel+with+improved+efficacy+and+potency+relative+to+ranolazine&doi=10.1016%2Fj.bmcl.2016.03.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.101%26sid%3Dliteratum%253Aachs%26aulast%3DKoltun%26aufirst%3DD.%2BO.%26aulast%3DParkhill%26aufirst%3DE.%2BQ.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DNotte%26aufirst%3DG.%2BT.%26aulast%3DKalla%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DR.%2BH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPerry%26aufirst%3DT.%2BD.%26aulast%3DAvila%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DW.-Q.%26aulast%3DSmith-Maxwell%26aufirst%3DC.%26aulast%3DDhalla%26aufirst%3DA.%2BK.%26aulast%3DRajamani%26aufirst%3DS.%26aulast%3DStafford%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMollova%26aufirst%3DN.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520triazolopyridinone%2520GS-462808%252C%2520a%2520late%2520sodium%2520current%2520inhibitor%2520%2528Late%2520INai%2529%2520of%2520the%2520cardiac%2520Nav1.5%2520channel%2520with%2520improved%2520efficacy%2520and%2520potency%2520relative%2520to%2520ranolazine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3202%26epage%3D3206%26doi%3D10.1016%2Fj.bmcl.2016.03.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mummadi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhondi, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subray, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaram, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajugowda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumaraguru, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beldona, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adisechen, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sale, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putlur, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimalakonda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandlekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampulla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, H. J.</span></span> <span> </span><span class="NLM_article-title">Selective I<sub>Kur</sub> inhibitors for the potential treatment of atrial fibrillation: optimization of the phenyl quinazoline series leading to clinical candidate 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3795</span>– <span class="NLM_lpage">3803</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01889</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01889" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1amurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3795-3803&author=P.+Gunagaauthor=J.+Lloydauthor=S.+Mummadiauthor=A.+Banerjeeauthor=N.+K.+Dhondiauthor=J.+Hennanauthor=V.+Subrayauthor=R.+Jayaramauthor=N.+Rajugowdaauthor=K.+U.+Reddyauthor=D.+Kumaraguruauthor=U.+Mandalauthor=D.+Beldonaauthor=A.+K.+Adisechenauthor=N.+Yadavauthor=J.+Warrierauthor=J.+A.+Johnsonauthor=H.+Saleauthor=S.+P.+Putlurauthor=A.+Saxenaauthor=A.+Chimalakondaauthor=S.+Mandlekarauthor=M.+Conderauthor=D.+Xingauthor=A.+K.+Guptaauthor=A.+Guptaauthor=R.+Rampullaauthor=A.+Mathurauthor=P.+Levesqueauthor=R.+R.+Wexlerauthor=H.+J.+Finlay&title=Selective+IKur+inhibitors+for+the+potential+treatment+of+atrial+fibrillation%3A+optimization+of+the+phenyl+quinazoline+series+leading+to+clinical+candidate+5-%5B5-phenyl-4-%28pyridin-2-ylmethylamino%29quinazolin-2-yl%5Dpyridine-3-sulfonamide&doi=10.1021%2Facs.jmedchem.6b01889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Selective IKur Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide</span></div><div class="casAuthors">Gunaga, Prashantha; Lloyd, John; Mummadi, Somanadham; Banerjee, Abhisek; Dhondi, Naveen Kumar; Hennan, James; Subray, Veena; Jayaram, Ramya; Rajugowda, Nagendra; Umamaheshwar Reddy, Kommuri; Kumaraguru, Duraimurugan; Mandal, Umasankar; Beldona, Dasthagiri; Adisechen, Ashok Kumar; Yadav, Navnath; Warrier, Jayakumar; Johnson, James A.; Sale, Harinath; Putlur, Siva Prasad; Saxena, Ajay; Chimalakonda, Anjaneya; Mandlekar, Sandhya; Conder, MaryLee; Xing, Dezhi; Gupta, Arun Kumar; Gupta, Anuradha; Rampulla, Richard; Mathur, Arvind; Levesque, Paul; Wexler, Ruth R.; Finlay, Heather J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3795-3803</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have recently disclosed 5-phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine (I) as a potent IKur current blocker with selectivity vs. hERG, Na and Ca channels and an acceptable preclin. PK profile.  On further characterization in vivo, Compd. I demonstrated an unacceptable level of brain penetration.  In an effort to reduce the level of brain penetration while maintaining the overall profile, SAR was developed at the C2' position for a series of close analogs by employing hydrogen bond donors.  As a result, 5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)pyridine-3-sulfonamide (II) was identified as the lead compd. in this series.  Compd. II showed robust effects in rabbit and canine pharmacodynamic models and an acceptable cross-species pharmacokinetic profile and was advanced as the clin. candidate.  Further optimization of II to mitigate pH dependent absorption resulted in identification of the corresponding phosphoramide prodrug (29) with an improved soly. and pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV9CqURuGN1bVg90H21EOLACvtfcHk0li8Wx_UhFO3Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1amurY%253D&md5=b7ed8bdb99e632bcd42107f2b913d7e8</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01889%26sid%3Dliteratum%253Aachs%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DLloyd%26aufirst%3DJ.%26aulast%3DMummadi%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DDhondi%26aufirst%3DN.%2BK.%26aulast%3DHennan%26aufirst%3DJ.%26aulast%3DSubray%26aufirst%3DV.%26aulast%3DJayaram%26aufirst%3DR.%26aulast%3DRajugowda%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DK.%2BU.%26aulast%3DKumaraguru%26aufirst%3DD.%26aulast%3DMandal%26aufirst%3DU.%26aulast%3DBeldona%26aufirst%3DD.%26aulast%3DAdisechen%26aufirst%3DA.%2BK.%26aulast%3DYadav%26aufirst%3DN.%26aulast%3DWarrier%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26aulast%3DSale%26aufirst%3DH.%26aulast%3DPutlur%26aufirst%3DS.%2BP.%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DChimalakonda%26aufirst%3DA.%26aulast%3DMandlekar%26aufirst%3DS.%26aulast%3DConder%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DRampulla%26aufirst%3DR.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DLevesque%26aufirst%3DP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26atitle%3DSelective%2520IKur%2520inhibitors%2520for%2520the%2520potential%2520treatment%2520of%2520atrial%2520fibrillation%253A%2520optimization%2520of%2520the%2520phenyl%2520quinazoline%2520series%2520leading%2520to%2520clinical%2520candidate%25205-%255B5-phenyl-4-%2528pyridin-2-ylmethylamino%2529quinazolin-2-yl%255Dpyridine-3-sulfonamide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3795%26epage%3D3803%26doi%3D10.1021%2Facs.jmedchem.6b01889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhondi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimalakonda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandlekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conder, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sale, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-phenyl-<i>N</i>-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a potent I<sub>Kur</sub> inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00117</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00117" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFejsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=831-834&author=H.+J.+Finlayauthor=J.+A.+Johnsonauthor=J.+L.+Lloydauthor=J.+Jiangauthor=J.+Neelsauthor=P.+Gunagaauthor=A.+Banerjeeauthor=N.+Dhondiauthor=A.+Chimalakondaauthor=S.+Mandlekarauthor=M.+L.+Conderauthor=H.+Saleauthor=D.+Xingauthor=P.+Levesqueauthor=R.+R.+Wexler&title=Discovery+of+5-phenyl-N-%28pyridin-2-ylmethyl%29-2-%28pyrimidin-5-yl%29quinazolin-4-amine+as+a+potent+IKur+inhibitor&doi=10.1021%2Facsmedchemlett.6b00117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a Potent IKur Inhibitor</span></div><div class="casAuthors">Finlay, Heather J.; Johnson, James A.; Lloyd, John L.; Jiang, Ji; Neels, James; Gunaga, Prashantha; Banerjee, Abhisek; Dhondi, Naveen; Chimalakonda, Anjaneya; Mandlekar, Sandhya; Conder, Mary Lee; Sale, Harinath; Xing, Dezhi; Levesque, Paul; Wexler, Ruth R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">831-834</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of phenylquinazoline inhibitors of Kv 1.5 is disclosed.  The series was optimized for Kv 1.5 potency, selectivity vs. hERG, pharmacokinetic exposure, and pharmacodynamic potency. 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine (13k) was identified as a potent and ion channel selective inhibitor with robust efficacy in the preclin. rat ventricular effective refractory period (VERP) model and the rabbit atrial effective refractory period (AERP) model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowoHx2-YhyXrVg90H21EOLACvtfcHk0li8Wx_UhFO3Dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFejsLs%253D&md5=ed5e06e1f6e389b05da7f1ae780063e7</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00117%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26aulast%3DLloyd%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DNeels%26aufirst%3DJ.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DDhondi%26aufirst%3DN.%26aulast%3DChimalakonda%26aufirst%3DA.%26aulast%3DMandlekar%26aufirst%3DS.%26aulast%3DConder%26aufirst%3DM.%2BL.%26aulast%3DSale%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DD.%26aulast%3DLevesque%26aufirst%3DP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26atitle%3DDiscovery%2520of%25205-phenyl-N-%2528pyridin-2-ylmethyl%2529-2-%2528pyrimidin-5-yl%2529quinazolin-4-amine%2520as%2520a%2520potent%2520IKur%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D831%26epage%3D834%26doi%3D10.1021%2Facsmedchemlett.6b00117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatman, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sage, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharbaoui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakya, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido Montalban, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behan, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shifrina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leakakos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidarov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semple, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-(((1<i>r</i>,4<i>r</i>)-4-(((4-chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate (ralinepag): an orally active prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00871</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXms12gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=913-927&author=T.-A.+Tranauthor=B.+Kramerauthor=Y.-J.+Shinauthor=P.+Vallarauthor=P.+D.+Boatmanauthor=N.+Zouauthor=C.+R.+Sageauthor=T.+Gharbaouiauthor=A.+Krishnanauthor=B.+Palauthor=S.+R.+Shakyaauthor=A.+Garrido+Montalbanauthor=J.+W.+Adamsauthor=J.+Ramirezauthor=D.+P.+Behanauthor=A.+Shifrinaauthor=A.+Blackburnauthor=T.+Leakakosauthor=Y.+Shiauthor=M.+Morganauthor=A.+Sadequeauthor=W.+Chenauthor=D.+J.+Unettauthor=I.+Gaidarovauthor=X.+Chenauthor=S.+Changauthor=H.-H.+Shuauthor=S.-F.+Tungauthor=G.+Semple&title=Discovery+of+2-%28%28%281r%2C4r%29-4-%28%28%284-chlorophenyl%29%28phenyl%29carbamoyl%29oxy%29methyl%29cyclohexyl%29methoxy%29acetate+%28ralinepag%29%3A+an+orally+active+prostacyclin+receptor+agonist+for+the+treatment+of+pulmonary+arterial+hypertension&doi=10.1021%2Facs.jmedchem.6b00871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-(((1r,4r)-4-(((4-Chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate (Ralinepag): An Orally Active Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension</span></div><div class="casAuthors">Tran, Thuy-Anh; Kramer, Bryan; Shin, Young-Jun; Vallar, Pureza; Boatman, P. Douglas; Zou, Ning; Sage, Carleton R.; Gharbaoui, Tawfik; Krishnan, Ashwin; Pal, Biman; Shakya, Sagar R.; Garrido Montalban, Antonio; Adams, John W.; Ramirez, Juan; Behan, Dominic P.; Shifrina, Anna; Blackburn, Anthony; Leakakos, Tina; Shi, Yunqing; Morgan, Michael; Sadeque, Abu; Chen, Weichao; Unett, David J.; Gaidarov, Ibragim; Chen, Xiaohua; Chang, Steve; Shu, Hsin-Hui; Tung, Shiu-Feng; Semple, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">913-927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and synthesis of a new series of potent non-prostanoid IP receptor agonists that showed oral efficacy in the rat monocrotaline model of pulmonary arterial hypertension (PAH) are described.  Detailed profiling of a no. of analogs resulted in the identification of 5c (ralinepag) that has good selectivity in both binding and functional assays with respect to most members of the prostanoid receptor family and a more modest 30- to 50-fold selectivity over the EP3 receptor.  In the authors' hands, its potency and efficacy are comparable or superior to MRE269 (the active metabolite of the clin. compd. NS-304) with respect to in vitro IP receptor dependent cAMP accumulation assays.  Ralinepag had an excellent PK profile across species.  Enterohepatic recirculation most probably contributes to a concn.-time profile after oral administration in the cynomolgus monkey that showed a very low peak-to-trough ratio.  Following the identification of an acceptable solid form, ralinepag was selected for further development for the treatment of PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXvfp2ZN4i1bVg90H21EOLACvtfcHk0lh7Ej-nrIvX8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXms12gsw%253D%253D&md5=f37ba4106466f0ed724cd78db4b5b366</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00871%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.-A.%26aulast%3DKramer%26aufirst%3DB.%26aulast%3DShin%26aufirst%3DY.-J.%26aulast%3DVallar%26aufirst%3DP.%26aulast%3DBoatman%26aufirst%3DP.%2BD.%26aulast%3DZou%26aufirst%3DN.%26aulast%3DSage%26aufirst%3DC.%2BR.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DPal%26aufirst%3DB.%26aulast%3DShakya%26aufirst%3DS.%2BR.%26aulast%3DGarrido%2BMontalban%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%2BW.%26aulast%3DRamirez%26aufirst%3DJ.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DShifrina%26aufirst%3DA.%26aulast%3DBlackburn%26aufirst%3DA.%26aulast%3DLeakakos%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DShu%26aufirst%3DH.-H.%26aulast%3DTung%26aufirst%3DS.-F.%26aulast%3DSemple%26aufirst%3DG.%26atitle%3DDiscovery%2520of%25202-%2528%2528%25281r%252C4r%2529-4-%2528%2528%25284-chlorophenyl%2529%2528phenyl%2529carbamoyl%2529oxy%2529methyl%2529cyclohexyl%2529methoxy%2529acetate%2520%2528ralinepag%2529%253A%2520an%2520orally%2520active%2520prostacyclin%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D913%26epage%3D927%26doi%3D10.1021%2Facs.jmedchem.6b00871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaufils, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binnie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouillot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clapham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haslam, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liddle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirguet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowat, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiberghien, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trottet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uings, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mole, D. J.</span></span> <span> </span><span class="NLM_article-title">Development of a series of kynurenine 3-monooxygenase inhibitors leading to a clinical candidate for the treatment of acute pancreatitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3383</span>– <span class="NLM_lpage">3404</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3383-3404&author=A.+L.+Walkerauthor=N.+Ancellinauthor=B.+Beaufilsauthor=M.+Bergealauthor=M.+Binnieauthor=A.+Bouillotauthor=D.+Claphamauthor=A.+Denisauthor=C.+P.+Haslamauthor=D.+S.+Holmesauthor=J.+P.+Hutchinsonauthor=J.+Liddleauthor=A.+McBrideauthor=O.+Mirguetauthor=C.+G.+Mowatauthor=P.+Rowlandauthor=N.+Tiberghienauthor=L.+Trottetauthor=I.+Uingsauthor=S.+P.+Websterauthor=X.+Zhengauthor=D.+J.+Mole&title=Development+of+a+series+of+kynurenine+3-monooxygenase+inhibitors+leading+to+a+clinical+candidate+for+the+treatment+of+acute+pancreatitis&doi=10.1021%2Facs.jmedchem.7b00055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00055%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DBeaufils%26aufirst%3DB.%26aulast%3DBergeal%26aufirst%3DM.%26aulast%3DBinnie%26aufirst%3DM.%26aulast%3DBouillot%26aufirst%3DA.%26aulast%3DClapham%26aufirst%3DD.%26aulast%3DDenis%26aufirst%3DA.%26aulast%3DHaslam%26aufirst%3DC.%2BP.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DHutchinson%26aufirst%3DJ.%2BP.%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DMcBride%26aufirst%3DA.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DMowat%26aufirst%3DC.%2BG.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DTiberghien%26aufirst%3DN.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DUings%26aufirst%3DI.%26aulast%3DWebster%26aufirst%3DS.%2BP.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMole%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520of%2520a%2520series%2520of%2520kynurenine%25203-monooxygenase%2520inhibitors%2520leading%2520to%2520a%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520acute%2520pancreatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3383%26epage%3D3404%26doi%3D10.1021%2Facs.jmedchem.7b00055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanoff, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourdet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, E.</span></span> <span> </span><span class="NLM_article-title">Identification of the clinical candidate (<i>R</i>)-(1-(4-fluorophenyl)-6-((1-methyl-1<i>H</i>-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A selective glucocorticoid receptor (GR) antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3405</span>– <span class="NLM_lpage">3421</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00162</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00162" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3405-3421&author=H.+J.+Huntauthor=J.+K.+Belanoffauthor=I.+Waltersauthor=B.+Gourdetauthor=J.+Thomasauthor=N.+Bartonauthor=J.+Unittauthor=T.+Phillipsauthor=D.+Swiftauthor=E.+Eaton&title=Identification+of+the+clinical+candidate+%28R%29-%281-%284-fluorophenyl%29-6-%28%281-methyl-1H-pyrazol-4-yl%29sulfonyl%29-4%2C4a%2C5%2C6%2C7%2C8-hexahydro-1H-pyrazolo%5B3%2C4-g%5Disoquinolin-4a-yl%29%284-%28trifluoromethyl%29pyridin-2-yl%29methanone+%28CORT125134%29%3A+A+selective+glucocorticoid+receptor+%28GR%29+antagonist&doi=10.1021%2Facs.jmedchem.7b00162"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00162%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DH.%2BJ.%26aulast%3DBelanoff%26aufirst%3DJ.%2BK.%26aulast%3DWalters%26aufirst%3DI.%26aulast%3DGourdet%26aufirst%3DB.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DBarton%26aufirst%3DN.%26aulast%3DUnitt%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DSwift%26aufirst%3DD.%26aulast%3DEaton%26aufirst%3DE.%26atitle%3DIdentification%2520of%2520the%2520clinical%2520candidate%2520%2528R%2529-%25281-%25284-fluorophenyl%2529-6-%2528%25281-methyl-1H-pyrazol-4-yl%2529sulfonyl%2529-4%252C4a%252C5%252C6%252C7%252C8-hexahydro-1H-pyrazolo%255B3%252C4-g%255Disoquinolin-4a-yl%2529%25284-%2528trifluoromethyl%2529pyridin-2-yl%2529methanone%2520%2528CORT125134%2529%253A%2520A%2520selective%2520glucocorticoid%2520receptor%2520%2528GR%2529%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3405%26epage%3D3421%26doi%3D10.1021%2Facs.jmedchem.7b00162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crackett, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyke, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanoff, J. K.</span></span> <span> </span><span class="NLM_article-title">8-Benzensulfonyl-8<i>a</i>-benzyl-hexahydro-2<i>H</i>-isoquinoline-6-ones as selective glucocorticoid receptor antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5704</span>– <span class="NLM_lpage">5708</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.07.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2007.07.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5704-5708&author=R.+D.+Clarkauthor=N.+C.+Rayauthor=P.+Blaneyauthor=P.+H.+Crackettauthor=C.+Hurleyauthor=K.+Williamsauthor=H.+J.+Dykeauthor=D.+E.+Clarkauthor=P.+M.+Lockeyauthor=R.+Devosauthor=M.+Wongauthor=A.+Whiteauthor=J.+K.+Belanoff&title=8-Benzensulfonyl-8a-benzyl-hexahydro-2H-isoquinoline-6-ones+as+selective+glucocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmcl.2007.07.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.07.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.07.055%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BD.%26aulast%3DRay%26aufirst%3DN.%2BC.%26aulast%3DBlaney%26aufirst%3DP.%26aulast%3DCrackett%26aufirst%3DP.%2BH.%26aulast%3DHurley%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DLockey%26aufirst%3DP.%2BM.%26aulast%3DDevos%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DBelanoff%26aufirst%3DJ.%2BK.%26atitle%3D8-Benzensulfonyl-8a-benzyl-hexahydro-2H-isoquinoline-6-ones%2520as%2520selective%2520glucocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5704%26epage%3D5708%26doi%3D10.1016%2Fj.bmcl.2007.07.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable, brain-penetrating, in vivo active phosphodiesterase 2A inhibitor lead series for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7658</span>– <span class="NLM_lpage">7676</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GhurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7658-7676&author=S.+Mikamiauthor=S.+Sasakiauthor=Y.+Asanoauthor=O.+Ujikawaauthor=S.+Fukumotoauthor=K.+Nakashimaauthor=H.+Okiauthor=N.+Kamiguchiauthor=H.+Imadaauthor=H.+Iwashitaauthor=T.+Taniguchi&title=Discovery+of+an+orally+bioavailable%2C+brain-penetrating%2C+in+vivo+active+phosphodiesterase+2A+inhibitor+lead+series+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Facs.jmedchem.7b00709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable, Brain-Penetrating, in Vivo Active Phosphodiesterase 2A Inhibitor Lead Series for the Treatment of Cognitive Disorders</span></div><div class="casAuthors">Mikami, Satoshi; Sasaki, Shigekazu; Asano, Yasutomi; Ujikawa, Osamu; Fukumoto, Shoji; Nakashima, Kosuke; Oki, Hideyuki; Kamiguchi, Naomi; Imada, Haruka; Iwashita, Hiroki; Taniguchi, Takahiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7658-7676</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the authors describe the discovery of a potent, selective, brain-penetrating, in vivo active phosphodiesterase (PDE) 2A inhibitor lead series.  To identify high-quality leads suitable for optimization and enable validation of the physiol. function of PDE2A in vivo, structural modifications of the high-throughput screening hit were performed.  The lead generation efforts revealed three key potency-enhancing functionalities with minimal increases in mol. wt. (MW) and no change in topol. polar surface area (TPSA).  Combining these structural elements led to the identification of 6-methyl-N-((1R)-1-(4-(trifluoromethoxy)phenyl)propyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (38a), a mol. with the desired balance of preclin. properties.  Further characterization by cocrystal structure anal. of (38a) bound to PDE2A uncovered a unique binding mode and provided insights into its obsd. potency and PDE selectivity.  Compd. (38a) significantly elevated 3',5'-cGMP levels in mouse brain following oral administration, thus validating this compd. as a useful pharmacol. tool and an attractive lead for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXk4ZjO3RKAbVg90H21EOLACvtfcHk0lj2YSV7d0WBDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GhurrO&md5=361f9ce22899da731673ed86ade3f8aa</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00709%26sid%3Dliteratum%253Aachs%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DFukumoto%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DImada%26aufirst%3DH.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%252C%2520brain-penetrating%252C%2520in%2520vivo%2520active%2520phosphodiesterase%25202A%2520inhibitor%2520lead%2520series%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7658%26epage%3D7676%26doi%3D10.1021%2Facs.jmedchem.7b00709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokubo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate <i>N</i>-((1<i>S</i>)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1<i>H</i>)-carboxamide (TAK-915): A highly potent, selective, and brain-penetrating phosphodiesterase 2A inhibitor for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7677</span>– <span class="NLM_lpage">7702</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSmtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7677-7702&author=S.+Mikamiauthor=S.+Nakamuraauthor=T.+Ashizawaauthor=I.+Nomuraauthor=M.+Kawasakiauthor=S.+Sasakiauthor=H.+Okiauthor=H.+Kokuboauthor=I.+D.+Hoffmanauthor=H.+Zouauthor=N.+Uchiyamaauthor=K.+Nakashimaauthor=N.+Kamiguchiauthor=H.+Imadaauthor=N.+Suzukiauthor=H.+Iwashitaauthor=T.+Taniguchi&title=Discovery+of+clinical+candidate+N-%28%281S%29-1-%283-fluoro-4-%28trifluoromethoxy%29phenyl%29-2-methoxyethyl%29-7-methoxy-2-oxo-2%2C3-dihydropyrido%5B2%2C3-b%5Dpyrazine-4%281H%29-carboxamide+%28TAK-915%29%3A+A+highly+potent%2C+selective%2C+and+brain-penetrating+phosphodiesterase+2A+inhibitor+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Facs.jmedchem.7b00807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders</span></div><div class="casAuthors">Mikami, Satoshi; Nakamura, Shinji; Ashizawa, Tomoko; Nomura, Izumi; Kawasaki, Masanori; Sasaki, Shigekazu; Oki, Hideyuki; Kokubo, Hironori; Hoffman, Isaac D.; Zou, Hua; Uchiyama, Noriko; Nakashima, Kosuke; Kamiguchi, Naomi; Imada, Haruka; Suzuki, Noriko; Iwashita, Hiroki; Taniguchi, Takahiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7677-7702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) 2A inhibitors have emerged as a novel mechanism with potential therapeutic option to ameliorate cognitive dysfunction in schizophrenia or Alzheimer's disease through upregulation of cyclic nucleotides in the brain, and thereby achieve potentiation of cyclic nucleotide signaling pathways.  This article details the expedited optimization of the authors' recently disclosed pyrazolo[1,5-a]pyrimidine lead compd. 4b, leading to the discovery of clin. candidate 36 (I) (TAK-915), which demonstrates an appropriate combination of potency, PDE selectivity, and favorable pharmacokinetic (PK) properties, including brain penetration.  Successful identification of 36 was realized through application of structure-based drug design (SBDD) to further improve potency and PDE selectivity, coupled with prospective design focused on physicochem. properties to deliver brain penetration.  Oral administration of 36 demonstrated significant elevation of 3',5'-cGMP levels in mouse brains, and improved cognitive performance in a novel object recognition task in rats.  Consequently, compd. 36 was advanced into human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCUw5grC_66rVg90H21EOLACvtfcHk0lj2YSV7d0WBDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSmtL3I&md5=f87cb3ac86b6299fc90e336b88ea2a21</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00807%26sid%3Dliteratum%253Aachs%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DAshizawa%26aufirst%3DT.%26aulast%3DNomura%26aufirst%3DI.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKokubo%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DI.%2BD.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DImada%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%2520N-%2528%25281S%2529-1-%25283-fluoro-4-%2528trifluoromethoxy%2529phenyl%2529-2-methoxyethyl%2529-7-methoxy-2-oxo-2%252C3-dihydropyrido%255B2%252C3-b%255Dpyrazine-4%25281H%2529-carboxamide%2520%2528TAK-915%2529%253A%2520A%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrating%2520phosphodiesterase%25202A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7677%26epage%3D7702%26doi%3D10.1021%2Facs.jmedchem.7b00807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyser, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1149-1164&author=P.+Liauthor=H.+Zhengauthor=J.+Zhaoauthor=L.+Zhangauthor=W.+Yaoauthor=H.+Zhuauthor=J.+D.+Beardauthor=K.+Idaauthor=W.+Laneauthor=G.+Snellauthor=S.+Sogabeauthor=C.+J.+Heyserauthor=G.+L.+Snyderauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+E.+Davisauthor=L.+P.+Wennogle&title=Discovery+of+potent+and+selective+inhibitors+of+phosphodiesterase+1+for+the+treatment+of+cognitive+impairment+associated+with+neurodegenerative+and+neuropsychiatric+diseases&doi=10.1021%2Facs.jmedchem.5b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases</span></div><div class="casAuthors">Li, Peng; Zheng, Hailin; Zhao, Jun; Zhang, Lei; Yao, Wei; Zhu, Hongwen; Beard, J. David; Ida, Koh; Lane, Weston; Snell, Gyorgy; Sogabe, Satoshi; Heyser, Charles J.; Snyder, Gretchen L.; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert E.; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1149-1164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A diverse set of 3-aminopyrazolo[3,4-d]pyrimidinones was designed and synthesized.  The structure-activity relationships of these polycyclic compds. as phosphodiesterase 1 (PDE1) inhibitors were studied along with their physicochem. and pharmacokinetic properties.  Systematic optimizations of this novel scaffold culminated in the identification of a clin. candidate I, which exhibited picomolar inhibitory potency for PDE1, demonstrated excellent selectivity against all other PDE families and showed good efficacy in vivo.  Currently, this investigational new drug is in Phase I clin. development and being considered for the treatment of several indications including cognitive deficits assocd. with schizophrenia and Alzheimer's disease, movement disorders, attention deficit and hyperactivity disorders, and other central nervous system (CNS) and non-CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqQuMoLsXnbVg90H21EOLACvtfcHk0lj2YSV7d0WBDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D&md5=73741521722dc906869ffa3504ceaf2e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01751%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBeard%26aufirst%3DJ.%2BD.%26aulast%3DIda%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DHeyser%26aufirst%3DC.%2BJ.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosphodiesterase%25201%2520for%2520the%2520treatment%2520of%2520cognitive%2520impairment%2520associated%2520with%2520neurodegenerative%2520and%2520neuropsychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1149%26epage%3D1164%26doi%3D10.1021%2Facs.jmedchem.5b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccaro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleven, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of polycyclic pyrazolo[3,4-<i>d</i>]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">4372</span>– <span class="NLM_lpage">4377</span>, <span class="refDoi"> DOI: 10.1021/jm970495b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970495b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4372-4377&author=Y.+Xiaauthor=S.+Chackalamannilauthor=M.+Czarnieckiauthor=H.+Tsaiauthor=H.+Vaccaroauthor=R.+Clevenauthor=J.+Cookauthor=A.+Fawziauthor=R.+Watkinsauthor=H.+Zhang&title=Synthesis+and+evaluation+of+polycyclic+pyrazolo%5B3%2C4-d%5Dpyrimidines+as+PDE1+and+PDE5+cGMP+phosphodiesterase+inhibitors&doi=10.1021%2Fjm970495b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm970495b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970495b%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DVaccaro%26aufirst%3DH.%26aulast%3DCleven%26aufirst%3DR.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DFawzi%26aufirst%3DA.%26aulast%3DWatkins%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520polycyclic%2520pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520PDE1%2520and%2520PDE5%2520cGMP%2520phosphodiesterase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4372%26epage%3D4377%26doi%3D10.1021%2Fjm970495b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambhampati, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraf, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badange, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyala, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojja, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reballi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasti, V.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1<i>H</i>-indole dimesylate monohydrate (SUVN-502): A novel, potent, selective and orally active serotonin 6 (5-HT6) receptor antagonist for potential treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1843-1859&author=R.+Nirogiauthor=A.+Shindeauthor=R.+S.+Kambhampatiauthor=A.+R.+Mohammedauthor=S.+K.+Sarafauthor=R.+K.+Badangeauthor=T.+R.+Bandyalaauthor=V.+Bhattaauthor=K.+Bojjaauthor=V.+Reballiauthor=R.+Subramanianauthor=V.+Benadeauthor=R.+C.+Palacharlaauthor=G.+Bhyrapuneniauthor=P.+Jayarajanauthor=V.+Goyalauthor=V.+Jasti&title=Discovery+and+development+of+1-%5B%282-bromophenyl%29sulfonyl%5D-5-methoxy-3-%5B%284-methyl-1-piperazinyl%29methyl%5D-1H-indole+dimesylate+monohydrate+%28SUVN-502%29%3A+A+novel%2C+potent%2C+selective+and+orally+active+serotonin+6+%285-HT6%29+receptor+antagonist+for+potential+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b01662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Nirogi, Ramakrishna; Shinde, Anil; Kambhampati, Rama Sastry; Mohammed, Abdul Rasheed; Saraf, Sangram Keshari; Badange, Rajesh kumar; Bandyala, Thrinath Reddy; Bhatta, Venugopalarao; Bojja, Kumar; Reballi, Veena; Subramanian, Ramkumar; Benade, Vijay; Palacharla, Raghava Choudary; Bhyrapuneni, Gopinadh; Jayarajan, Pradeep; Goyal, Vinod; Jasti, Venkat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1843-1859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a novel series of 3-(piperazinylmethyl) indole derivs. as 5-hydroxytryptamine-6 receptor (5-HT6R) antagonists resulted in identification of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate (5al, SUVN-502) as a clin. candidate for potential treatment of cognitive disorders.  It has high affinity at human 5-HT6R (Ki = 2.04 nM) and selectivity over 100 target sites which include receptors, enzymes, peptides, growth factors, ion channels, steroids, immunol. factors, second messengers, and prostaglandins.  It has high selectivity over 5-HT2A receptor.  It is orally bioavailable and brain penetrant with robust preclin. efficacy.  The combination of 5al, donepezil, and memantine (triple combination) produces synergistic effects in extracellular levels of acetylcholine in the ventral hippocampus.  Preclin. efficacy in triple combination and high selectivity over 5-HT2A receptors are the differentiating features which culminated in selection of 5al for further development.  The Phase-1 evaluation of safety and pharmacokinetics has been completed, allowing for the initiation of a Phase-2 proof of concept study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_gw476vRgPbVg90H21EOLACvtfcHk0ljTgZSyEwnQPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D&md5=26e4f0c1c34255ce2c2ef3bbf3c06a85</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01662%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DShinde%26aufirst%3DA.%26aulast%3DKambhampati%26aufirst%3DR.%2BS.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DSaraf%26aufirst%3DS.%2BK.%26aulast%3DBadange%26aufirst%3DR.%2BK.%26aulast%3DBandyala%26aufirst%3DT.%2BR.%26aulast%3DBhatta%26aufirst%3DV.%26aulast%3DBojja%26aufirst%3DK.%26aulast%3DReballi%26aufirst%3DV.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DJayarajan%26aufirst%3DP.%26aulast%3DGoyal%26aufirst%3DV.%26aulast%3DJasti%26aufirst%3DV.%26atitle%3DDiscovery%2520and%2520development%2520of%25201-%255B%25282-bromophenyl%2529sulfonyl%255D-5-methoxy-3-%255B%25284-methyl-1-piperazinyl%2529methyl%255D-1H-indole%2520dimesylate%2520monohydrate%2520%2528SUVN-502%2529%253A%2520A%2520novel%252C%2520potent%252C%2520selective%2520and%2520orally%2520active%2520serotonin%25206%2520%25285-HT6%2529%2520receptor%2520antagonist%2520for%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1843%26epage%3D1859%26doi%3D10.1021%2Facs.jmedchem.6b01662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)-a β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29-a+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0ligOJVCT3vy0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529-a%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez
Botella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresis, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfort, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loya, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Althaus, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span> <span> </span><span class="NLM_article-title">Neuroactive steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1<i>H</i>-pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A clinical next generation neuroactive steroid positive allosteric modulator of the (γ-aminobutyric acid)<sub>A</sub> receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7810</span>– <span class="NLM_lpage">7819</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00846</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00846" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A280%3ADC%252BC1cfitFSgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7810-7819&author=G.+Martinez%0ABotellaauthor=F.+G.+Salituroauthor=B.+L.+Harrisonauthor=R.+T.+Beresisauthor=Z.+Baiauthor=M.-J.+Blancoauthor=G.+M.+Belfortauthor=J.+Daiauthor=C.+M.+Loyaauthor=M.+A.+Ackleyauthor=A.+L.+Althausauthor=S.+J.+Grossmanauthor=E.+Hoffmannauthor=J.+J.+Dohertyauthor=A.+J.+Robichaud&title=Neuroactive+steroids.+2.+3%CE%B1-Hydroxy-3%CE%B2-methyl-21-%284-cyano-1H-pyrazol-1%E2%80%B2-yl%29-19-nor-5%CE%B2-pregnan-20-one+%28SAGE-217%29%3A+A+clinical+next+generation+neuroactive+steroid+positive+allosteric+modulator+of+the+%28%CE%B3-aminobutyric+acid%29A+receptor&doi=10.1021%2Facs.jmedchem.7b00846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor</span></div><div class="casAuthors">Martinez Botella Gabriel; Salituro Francesco G; Harrison Boyd L; Blanco Maria-Jesus; Belfort Gabriel M; Dai Jing; Loya Carlos M; Ackley Michael A; Althaus Alison L; Grossman Scott J; Hoffmann Ethan; Doherty James J; Robichaud Albert J; Beresis Richard T; Bai Zhu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7810-7819</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Certain classes of neuroactive steroids (NASs) are positive allosteric modulators (PAM) of synaptic and extrasynaptic GABAA receptors.  Herein, we report new SAR insights in a series of 5β-nor-19-pregnan-20-one analogues bearing substituted pyrazoles and triazoles at C-21, culminating in the discovery of 3α-hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217, 3), a potent GABAA receptor modulator at both synaptic and extrasynaptic receptor subtypes, with excellent oral DMPK properties.  Compound 3 has completed a phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) clinical trial and is currently being studied in parallel phase 2 clinical trials for the treatment of postpartum depression (PPD), major depressive disorder (MDD), and essential tremor (ET).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTiySZLUBmmmoUSrryheKE6fW6udTcc2eYC5fdC7UOX9rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfitFSgsg%253D%253D&md5=d9cb22ed2087152aa0e67d0906faa583</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00846%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%2BBotella%26aufirst%3DG.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DBeresis%26aufirst%3DR.%2BT.%26aulast%3DBai%26aufirst%3DZ.%26aulast%3DBlanco%26aufirst%3DM.-J.%26aulast%3DBelfort%26aufirst%3DG.%2BM.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DLoya%26aufirst%3DC.%2BM.%26aulast%3DAckley%26aufirst%3DM.%2BA.%26aulast%3DAlthaus%26aufirst%3DA.%2BL.%26aulast%3DGrossman%26aufirst%3DS.%2BJ.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DNeuroactive%2520steroids.%25202.%25203%25CE%25B1-Hydroxy-3%25CE%25B2-methyl-21-%25284-cyano-1H-pyrazol-1%25E2%2580%25B2-yl%2529-19-nor-5%25CE%25B2-pregnan-20-one%2520%2528SAGE-217%2529%253A%2520A%2520clinical%2520next%2520generation%2520neuroactive%2520steroid%2520positive%2520allosteric%2520modulator%2520of%2520the%2520%2528%25CE%25B3-aminobutyric%2520acid%2529A%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7810%26epage%3D7819%26doi%3D10.1021%2Facs.jmedchem.7b00846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 4-[2-(5-amino-1<i>H</i>-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): design and optimization of diaryl ether aryl sulfonamides as selective inhibitors of NaV1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7029-7042&author=N.+A.+Swainauthor=D.+Batchelorauthor=S.+Beaudoinauthor=B.+M.+Bechleauthor=P.+A.+Bradleyauthor=A.+D.+Brownauthor=B.+Brownauthor=K.+J.+Butcherauthor=R.+P.+Buttauthor=M.+L.+Chapmanauthor=S.+Dentonauthor=D.+Ellisauthor=S.+R.+G.+Galanauthor=S.+M.+Gaulierauthor=B.+S.+Greenerauthor=M.+J.+de+Grootauthor=M.+S.+Glossopauthor=I.+K.+Gurrellauthor=J.+Hannamauthor=M.+S.+Johnsonauthor=Z.+Linauthor=C.+J.+Markworthauthor=B.+E.+Marronauthor=D.+S.+Millanauthor=S.+Nakagawaauthor=A.+Pikeauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=S.+J.+Ransleyauthor=S.+M.+Reisterauthor=K.+Sasakiauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=C.+W.+West&title=Discovery+of+clinical+candidate+4-%5B2-%285-amino-1H-pyrazol-4-yl%29-4-chlorophenoxy%5D-5-chloro-2-fluoro-N-1%2C3-thiazol-4-ylbenzenesulfonamide+%28PF-05089771%29%3A+design+and+optimization+of+diaryl+ether+aryl+sulfonamides+as+selective+inhibitors+of+NaV1.7&doi=10.1021%2Facs.jmedchem.7b00598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7</span></div><div class="casAuthors">Swain, Nigel. A.; Batchelor, Dave; Beaudoin, Serge; Bechle, Bruce M.; Bradley, Paul A.; Brown, Alan D.; Brown, Bruce; Butcher, Ken J.; Butt, Richard P.; Chapman, Mark L.; Denton, Stephen; Ellis, David; Galan, Sebastien R. G.; Gaulier, Steven M.; Greener, Ben S.; de Groot, Marcel J.; Glossop, Mel S.; Gurrell, Ian K.; Hannam, Jo; Johnson, Matthew S.; Lin, Zhixin; Markworth, Christopher J.; Marron, Brian E.; Millan, David S.; Nakagawa, Shoko; Pike, Andy; Printzenhoff, David; Rawson, David J.; Ransley, Sarah J.; Reister, Steven M.; Sasaki, Kosuke; Storer, R. Ian; Stupple, Paul A.; West, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7029-7042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of acidic diaryl ether heterocyclic sulfonamides that are potent and sub-type selective NaV1.7 inhibitors is described.  Optimization of early lead matter focused on removal of structural alerts, improving metabolic stability and reducing cytochrome P 450 inhibition driven drug-drug interaction concerns to deliver the desired balance of preclin. in vitro properties.  Concerns over non-metabolic routes of clearance, variable clearance in pre-clin. species and subsequent low confidence human pharmacokinetic predictions led to the decision to conduct a human microdose study to det. clin. pharmacokinetics.  The design strategies and results from pre-clin. PK and clin. human microdose PK data are described leading to the discovery of the first sub-type selective NaV1.7 inhibitor clin. candidate PF-05089771 (34) which binds to a site in the voltage sensing domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpST6i8wDUALbVg90H21EOLACvtfcHk0ljkWCUf_qoZWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM&md5=93761c8e8e16cea4db2c9cff6e315e57</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00598%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%26aulast%3DBeaudoin%26aufirst%3DS.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBradley%26aufirst%3DP.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DDenton%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DS.%2BR.%2BG.%26aulast%3DGaulier%26aufirst%3DS.%2BM.%26aulast%3DGreener%26aufirst%3DB.%2BS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DHannam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRansley%26aufirst%3DS.%2BJ.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWest%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25204-%255B2-%25285-amino-1H-pyrazol-4-yl%2529-4-chlorophenoxy%255D-5-chloro-2-fluoro-N-1%252C3-thiazol-4-ylbenzenesulfonamide%2520%2528PF-05089771%2529%253A%2520design%2520and%2520optimization%2520of%2520diaryl%2520ether%2520aryl%2520sulfonamides%2520as%2520selective%2520inhibitors%2520of%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7029%26epage%3D7042%26doi%3D10.1021%2Facs.jmedchem.7b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skerratt, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilsland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bungay, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morao, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedderman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, G.</span></span> <span> </span><span class="NLM_article-title">The discovery of a potent, selective, and peripherally restricted Pan-Trk inhibitor (PF-06273340) for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10084</span>– <span class="NLM_lpage">10099</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10084-10099&author=S.+E.+Skerrattauthor=M.+Andrewsauthor=S.+K.+Bagalauthor=J.+Bilslandauthor=D.+Brownauthor=P.+J.+Bungayauthor=S.+Coleauthor=K.+R.+Gibsonauthor=R.+Jonesauthor=I.+Moraoauthor=A.+Neddermanauthor=K.+Omotoauthor=C.+Robinsonauthor=T.+Ryckmansauthor=K.+Skinnerauthor=P.+Stuppleauthor=G.+Waldron&title=The+discovery+of+a+potent%2C+selective%2C+and+peripherally+restricted+Pan-Trk+inhibitor+%28PF-06273340%29+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.6b00850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain</span></div><div class="casAuthors">Skerratt, Sarah E.; Andrews, Mark; Bagal, Sharan K.; Bilsland, James; Brown, David; Bungay, Peter J.; Cole, Susan; Gibson, Karl R.; Jones, Russell; Morao, Inaki; Nedderman, Angus; Omoto, Kiyoyuki; Robinson, Colin; Ryckmans, Thomas; Skinner, Kimberly; Stupple, Paul; Waldron, Gareth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10084-10099</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neurotrophin family of growth factors, comprised of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT3) and neurotrophin 4 (NT4), is implicated in the physiol. of chronic pain.  Given the clin. efficacy of anti-NGF monoclonal antibody (mAb) therapies, there is significant interest in the development of small mol. modulators of neurotrophin activity.  Neurotrophins signal through the tropomyosin related kinase (Trk) family of tyrosine kinase receptors, hence Trk kinase inhibition represents a potentially "druggable" point of intervention.  To deliver the safety profile required for chronic, non-life threatening pain indications, highly kinase-selective Trk inhibitors with minimal brain availability are sought.  Herein the authors describe how the use of SBDD, 2D QSAR models and Matched Mol. Pair data in compd. design enabled the delivery of the highly potent, kinase-selective and peripherally restricted clin. candidate PF-06273340.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo67CFmGAkmRrVg90H21EOLACvtfcHk0ljkWCUf_qoZWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjsbfL&md5=f8c904a92c1716062c217fefe2374ce6</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00850%26sid%3Dliteratum%253Aachs%26aulast%3DSkerratt%26aufirst%3DS.%2BE.%26aulast%3DAndrews%26aufirst%3DM.%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DBilsland%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DK.%2BR.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMorao%26aufirst%3DI.%26aulast%3DNedderman%26aufirst%3DA.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSkinner%26aufirst%3DK.%26aulast%3DStupple%26aufirst%3DP.%26aulast%3DWaldron%26aufirst%3DG.%26atitle%3DThe%2520discovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520peripherally%2520restricted%2520Pan-Trk%2520inhibitor%2520%2528PF-06273340%2529%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10084%26epage%3D10099%26doi%3D10.1021%2Facs.jmedchem.6b00850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson Gray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tantawy, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(5-fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A novel negative allosteric modulator of metabotropic glutamate receptor subtype 5 selected for clinical evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5072</span>– <span class="NLM_lpage">5085</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00410</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00410" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotFOrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5072-5085&author=A.+S.+Feltsauthor=A.+L.+Rodriguezauthor=A.+L.+Blobaumauthor=R.+D.+Morrisonauthor=B.+S.+Batesauthor=A.+Thompson+Grayauthor=J.+M.+Rookauthor=M.+N.+Tantawyauthor=F.+W.+Byersauthor=S.+Changauthor=D.+F.+Venableauthor=V.+B.+Luscombeauthor=G.+D.+Tamagnanauthor=C.+M.+Niswenderauthor=J.+S.+Danielsauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitte&title=Discovery+of+N-%285-fluoropyridin-2-yl%29-6-methyl-4-%28pyrimidin-5-yloxy%29picolinamide+%28VU0424238%29%3A+A+novel+negative+allosteric+modulator+of+metabotropic+glutamate+receptor+subtype+5+selected+for+clinical+evaluation&doi=10.1021%2Facs.jmedchem.7b00410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation</span></div><div class="casAuthors">Felts, Andrew S.; Rodriguez, Alice L.; Blobaum, Anna L.; Morrison, Ryan D.; Bates, Brittney S.; Thompson Gray, Analisa; Rook, Jerri M.; Tantawy, Mohammed N.; Byers, Frank W.; Chang, Sichen; Venable, Daryl F.; Luscombe, Vincent B.; Tamagnan, Gilles D.; Niswender, Colleen M.; Daniels, J. Scott; Jones, Carrie K.; Conn, P. Jeffrey; Lindsley, Craig W.; Emmitte, Kyle A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5072-5085</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Preclin. evidence in support of the potential utility of mGlu5 NAMs for the treatment of a variety of psychiatric and neurodegenerative disorders is extensive, and multiple such mols. have entered clin. trials.  Despite some promising results from clin. studies, no small mol. mGlu5 NAM has yet to reach market.  Here the authors present the discovery and evaluation of N-(5-fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (27, VU0424238), a compd. selected for clin. evaluation.  Compd. 27 is more than 900-fold selective for mGlu5 vs. the other mGlu receptors, and binding studies established a Ki value of 4.4 nM at a known allosteric binding site.  Compd. 27 had a clearance of 19.3 and 15.5 mL/min/kg in rats and cynomolgus monkeys, resp.  Imaging studies using a known mGlu5 PET ligand demonstrated 50% receptor occupancy at an oral dose of 0.8 mg/kg in rats and an i.v. dose of 0.06 mg/kg in baboons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDMhcNY9dn7LVg90H21EOLACvtfcHk0lhexPsHojLBYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotFOrsrc%253D&md5=e08ce58e7194b36bd5bd7b1e2f59e897</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00410%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DThompson%2BGray%26aufirst%3DA.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DTantawy%26aufirst%3DM.%2BN.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DLuscombe%26aufirst%3DV.%2BB.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520N-%25285-fluoropyridin-2-yl%2529-6-methyl-4-%2528pyrimidin-5-yloxy%2529picolinamide%2520%2528VU0424238%2529%253A%2520A%2520novel%2520negative%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520selected%2520for%2520clinical%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5072%26epage%3D5085%26doi%3D10.1021%2Facs.jmedchem.7b00410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manka, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5779</span>– <span class="NLM_lpage">5785</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2013.09.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5779-5785&author=A.+S.+Feltsauthor=A.+L.+Rodriguezauthor=R.+D.+Morrisonauthor=D.+F.+Venableauthor=J.+T.+Mankaauthor=B.+S.+Batesauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitte&title=Discovery+of+VU0409106%3A+A+negative+allosteric+modulator+of+mGlu5+with+activity+in+a+mouse+model+of+anxiety&doi=10.1016%2Fj.bmcl.2013.09.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DManka%26aufirst%3DJ.%2BT.%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520VU0409106%253A%2520A%2520negative%2520allosteric%2520modulator%2520of%2520mGlu5%2520with%2520activity%2520in%2520a%2520mouse%2520model%2520of%2520anxiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5779%26epage%3D5785%26doi%3D10.1016%2Fj.bmcl.2013.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis, SAR and pharmacological characterization of brain penetrant P2X7 receptor antagonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00089</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00089" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=671-676&author=B.+M.+Savallauthor=D.+Wuauthor=M.+De+Angelisauthor=N.+I.+Carruthersauthor=H.+Aoauthor=Q.+Wangauthor=B.+Lordauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Synthesis%2C+SAR+and+pharmacological+characterization+of+brain+penetrant+P2X7+receptor+antagonists&doi=10.1021%2Facsmedchemlett.5b00089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00089%26sid%3Dliteratum%253Aachs%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%252C%2520SAR%2520and%2520pharmacological%2520characterization%2520of%2520brain%2520penetrant%2520P2X7%2520receptor%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D671%26epage%3D676%26doi%3D10.1021%2Facsmedchemlett.5b00089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceusters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorak, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudriakova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otieno, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickenden, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span> <span> </span><span class="NLM_article-title">4-Methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-c]pyridine-based P2X7 receptor antagonists: optimization of pharmacokinetic properties leading to the identification of a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4559</span>– <span class="NLM_lpage">4572</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4559-4572&author=M.+A.+Letavicauthor=B.+M.+Savallauthor=B.+D.+Allisonauthor=L.+Aluisioauthor=J.+I.+Andresauthor=M.+De+Angelisauthor=H.+Aoauthor=D.+A.+Beauchampauthor=P.+Bonaventureauthor=S.+Bryantauthor=N.+I.+Carruthersauthor=M.+Ceustersauthor=K.+J.+Coeauthor=C.+A.+Dvorakauthor=I.+C.+Fraserauthor=C.+F.+Gelinauthor=T.+Koudriakovaauthor=J.+Liangauthor=B.+Lordauthor=T.+W.+Lovenbergauthor=M.+A.+Otienoauthor=F.+Schoetensauthor=D.+M.+Swansonauthor=Q.+Wangauthor=A.+D.+Wickendenauthor=A.+Bhattacharya&title=4-Methyl-6%2C7-dihydro-4H-triazolo%5B4%2C5-c%5Dpyridine-based+P2X7+receptor+antagonists%3A+optimization+of+pharmacokinetic+properties+leading+to+the+identification+of+a+clinical+candidate&doi=10.1021%2Facs.jmedchem.7b00408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate</span></div><div class="casAuthors">Letavic, Michael A.; Savall, Brad M.; Allison, Brett D.; Aluisio, Leah; Andres, Jose Ignacio; De Angelis, Meri; Ao, Hong; Beauchamp, Derek A.; Bonaventure, Pascal; Bryant, Stewart; Carruthers, Nicholas I.; Ceusters, Marc; Coe, Kevin J.; Dvorak, Curt A.; Fraser, Ian C.; Gelin, Christine F.; Koudriakova, Tatiana; Liang, Jimmy; Lord, Brian; Lovenberg, Timothy W.; Otieno, Monicah A.; Schoetens, Freddy; Swanson, Devin M.; Wang, Qi; Wickenden, Alan D.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4559-4572</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and preclin. characterization of novel 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are potent and selective brain penetrant P2X7 antagonists are described.  Optimization efforts based on previously disclosed unsubstituted 6,7-dihydro-4H-triazolo[4,5-c]pyridines, Me substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazines, and several other series lead to the identification of a series of 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are selective P2X7 antagonists with potency at the rodent and human P2X7 ion channels.  These novel P2X7 antagonists have suitable physicochem. properties, and several analogs have an excellent pharmacokinetic profile, good partitioning into the CNS and show robust in vivo target engagement after oral dosing.  Improvements in metabolic stability led to the identification of JNJ-54175446 (I) as a candidate for clin. development.  The drug discovery efforts and strategies that resulted in the identification of the clin. candidate are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx8e5Sq5aYbVg90H21EOLACvtfcHk0lhZSlC_Vpiv4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D&md5=5b5465d8f64d527da6647997efe34aee</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00408%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DAllison%26aufirst%3DB.%2BD.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBeauchamp%26aufirst%3DD.%2BA.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DBryant%26aufirst%3DS.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DFraser%26aufirst%3DI.%2BC.%26aulast%3DGelin%26aufirst%3DC.%2BF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DOtieno%26aufirst%3DM.%2BA.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DSwanson%26aufirst%3DD.%2BM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3D4-Methyl-6%252C7-dihydro-4H-triazolo%255B4%252C5-c%255Dpyridine-based%2520P2X7%2520receptor%2520antagonists%253A%2520optimization%2520of%2520pharmacokinetic%2520properties%2520leading%2520to%2520the%2520identification%2520of%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4559%26epage%3D4572%26doi%3D10.1021%2Facs.jmedchem.7b00408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span>; <span class="NLM_string-name">Munoz-Muriedas, J.</span>; <span class="NLM_string-name">Sime, M.</span>; <span class="NLM_string-name">Steadman, J. G. A.</span>; <span class="NLM_string-name">Thewlis, R. E. A.</span>; <span class="NLM_string-name">Trani, G.</span>; <span class="NLM_string-name">Walter, D. S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Tetrahydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazine Derivatives for use as P2X7 Modulators</span>. <span class="NLM_patent">WO 2010125102 A1</span>, November 4, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+K.+Dean&author=J.+Munoz-Muriedas&author=M.+Sime&author=J.+G.+A.+Steadman&author=R.+E.+A.+Thewlis&author=G.+Trani&author=D.+S.+Walter&title=Preparation+of+Tetrahydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazine+Derivatives+for+use+as+P2X7+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DD.%2BK.%26atitle%3DPreparation%2520of%2520Tetrahydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazine%2520Derivatives%2520for%2520use%2520as%2520P2X7%2520Modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of P2X7 antagonists with a focus on CNS indications</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3838</span>– <span class="NLM_lpage">3845</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2016.06.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=27426304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOitL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3838-3845&author=J.+C.+Rechauthor=A.+Bhattacharyaauthor=M.+A.+Letavicauthor=B.+M.+Savall&title=The+evolution+of+P2X7+antagonists+with+a+focus+on+CNS+indications&doi=10.1016%2Fj.bmcl.2016.06.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of P2X7 antagonists with a focus on CNS indications</span></div><div class="casAuthors">Rech, Jason C.; Bhattacharya, Anindya; Letavic, Michael A.; Savall, Brad M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3838-3845</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The P2X7 receptor is an ATP-gated nonselective cation channel that has been linked to a no. of inflammatory diseases.  Activation of the P2X7 receptor by elevated levels of ATP results in the release of proinflammatory cytokines and elevated levels of these cytokines has been assocd. with a variety of disease states.  A no. of research groups in both industry and academia have explored the identification of P2X7R antagonists as therapeutic agents.  Much of this early effort focused on the treatment of diseases related to peripheral inflammation and resulted in several clin. candidates, none of which were advanced to market.  The emerging role of the P2X7 receptor in neuroinflammation and related diseases has resulted in a shift in medicinal chem. efforts toward the development of centrally penetrant antagonists.  This review will highlight the biol. supporting the role of P2X7 in diseases related to neuroinflammation and review the recent medicinal chem. efforts to identify centrally penetrant antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaLGUAKgul7Vg90H21EOLACvtfcHk0lhZSlC_Vpiv4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOitL3L&md5=04046ec16457c856c96dd50632b96efe</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26atitle%3DThe%2520evolution%2520of%2520P2X7%2520antagonists%2520with%2520a%2520focus%2520on%2520CNS%2520indications%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3838%26epage%3D3845%26doi%3D10.1016%2Fj.bmcl.2016.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrovian, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soyode-Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorak, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudriakova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepassi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallacher, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">A dipolar cycloaddition reaction to access 6-methyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-c]pyridines enables the discovery synthesis and preclinical profiling of a P2X7 antagonist clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=207-223&issue=1&author=C.+C.+Chrovianauthor=A.+Soyode-Johnsonauthor=A.+A.+Petersonauthor=C.+F.+Gelinauthor=X.+Dengauthor=C.+A.+Dvorakauthor=N.+I.+Carruthersauthor=B.+Lordauthor=I.+Fraserauthor=L.+Aluisioauthor=K.+J.+Coeauthor=B.+Scottauthor=T.+Koudriakovaauthor=F.+Schoetensauthor=K.+Sepassiauthor=D.+J.+Gallacherauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=A+dipolar+cycloaddition+reaction+to+access+6-methyl-4%2C5%2C6%2C7-tetrahydro-1H-%5B1%2C2%2C3%5Dtriazolo%5B4%2C5-c%5Dpyridines+enables+the+discovery+synthesis+and+preclinical+profiling+of+a+P2X7+antagonist+clinical+candidate&doi=10.1021%2Facs.jmedchem.7b01279"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01279%26sid%3Dliteratum%253Aachs%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DSoyode-Johnson%26aufirst%3DA.%26aulast%3DPeterson%26aufirst%3DA.%2BA.%26aulast%3DGelin%26aufirst%3DC.%2BF.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DGallacher%26aufirst%3DD.%2BJ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DA%2520dipolar%2520cycloaddition%2520reaction%2520to%2520access%25206-methyl-4%252C5%252C6%252C7-tetrahydro-1H-%255B1%252C2%252C3%255Dtriazolo%255B4%252C5-c%255Dpyridines%2520enables%2520the%2520discovery%2520synthesis%2520and%2520preclinical%2520profiling%2520of%2520a%2520P2X7%2520antagonist%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D1%26spage%3D207%26epage%3D223%26doi%3D10.1021%2Facs.jmedchem.7b01279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ratni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weetall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naryshkin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paushkin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turpoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woll, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazirani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuerck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muster, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, F.</span></span> <span> </span><span class="NLM_article-title">Specific correction of alternative survival motor neuron 2 splicing by small molecules: discovery of a potential novel medicine to treat spinal muscular atrophy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6086</span>– <span class="NLM_lpage">6100</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00459</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00459" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6086-6100&author=H.+Ratniauthor=G.+M.+Karpauthor=M.+Weetallauthor=N.+A.+Naryshkinauthor=S.+V.+Paushkinauthor=K.+S.+Chenauthor=K.+D.+McCarthyauthor=H.+Qiauthor=A.+Turpoffauthor=M.+G.+Wollauthor=X.+Zhangauthor=N.+Zhangauthor=T.+Yangauthor=A.+Dakkaauthor=P.+Vaziraniauthor=X.+Zhaoauthor=E.+Pinardauthor=L.+Greenauthor=P.+David-Piersonauthor=D.+Tuerckauthor=A.+Poirierauthor=W.+Musterauthor=S.+Kirchnerauthor=L.+Muellerauthor=I.+Gerlachauthor=F.+Metzger&title=Specific+correction+of+alternative+survival+motor+neuron+2+splicing+by+small+molecules%3A+discovery+of+a+potential+novel+medicine+to+treat+spinal+muscular+atrophy&doi=10.1021%2Facs.jmedchem.6b00459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Correction of Alternative Survival Motor Neuron 2 Splicing by Small Molecules: Discovery of a Potential Novel Medicine To Treat Spinal Muscular Atrophy</span></div><div class="casAuthors">Ratni, Hasane; Karp, Gary M.; Weetall, Marla; Naryshkin, Nikolai A.; Paushkin, Sergey V.; Chen, Karen S.; McCarthy, Kathleen D.; Qi, Hongyan; Turpoff, Anthony; Woll, Matthew G.; Zhang, Xiaoyan; Zhang, Nanjing; Yang, Tianle; Dakka, Amal; Vazirani, Priya; Zhao, Xin; Pinard, Emmanuel; Green, Luke; David-Pierson, Pascale; Tuerck, Dietrich; Poirier, Agnes; Muster, Wolfgang; Kirchner, Stephan; Mueller, Lutz; Gerlach, Irene; Metzger, Friedrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6086-6100</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spinal muscular atrophy (SMA) is the leading genetic cause of infant and toddler mortality, and there is currently no approved therapy available.  SMA is caused by mutation or deletion of the survival motor neuron 1 (SMN1) gene.  These mutations or deletions result in low levels of functional SMN protein.  SMN2, a paralogous gene to SMN1, undergoes alternative splicing and exclusion of exon 7, producing an unstable, truncated SMNΔ7 protein.  Herein, we report the identification of a pyridopyrimidinone series of small mols. that modify the alternative splicing of SMN2, increasing the prodn. of full-length SMN2 mRNA.  Upon oral administration of our small mols., the levels of full-length SMN protein were restored in two mouse models of SMA.  In-depth lead optimization in the pyridopyrimidinone series culminated in the selection of compd. 3 (RG7800) (I), the first small mol. SMN2 splicing modifier to enter human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDRpxc7_n787Vg90H21EOLACvtfcHk0ljqg1E_UpOMkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWgurw%253D&md5=14431b4127804cc623c2365298ad849b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00459%26sid%3Dliteratum%253Aachs%26aulast%3DRatni%26aufirst%3DH.%26aulast%3DKarp%26aufirst%3DG.%2BM.%26aulast%3DWeetall%26aufirst%3DM.%26aulast%3DNaryshkin%26aufirst%3DN.%2BA.%26aulast%3DPaushkin%26aufirst%3DS.%2BV.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DMcCarthy%26aufirst%3DK.%2BD.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DTurpoff%26aufirst%3DA.%26aulast%3DWoll%26aufirst%3DM.%2BG.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DDakka%26aufirst%3DA.%26aulast%3DVazirani%26aufirst%3DP.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DTuerck%26aufirst%3DD.%26aulast%3DPoirier%26aufirst%3DA.%26aulast%3DMuster%26aufirst%3DW.%26aulast%3DKirchner%26aufirst%3DS.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DGerlach%26aufirst%3DI.%26aulast%3DMetzger%26aufirst%3DF.%26atitle%3DSpecific%2520correction%2520of%2520alternative%2520survival%2520motor%2520neuron%25202%2520splicing%2520by%2520small%2520molecules%253A%2520discovery%2520of%2520a%2520potential%2520novel%2520medicine%2520to%2520treat%2520spinal%2520muscular%2520atrophy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6086%26epage%3D6100%26doi%3D10.1021%2Facs.jmedchem.6b00459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naryshkin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weetall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, K. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woll, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbeta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazirani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharyya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheedy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turpoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifillis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colacino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almstead, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peltz, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mull, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynes, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontoura, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haehnke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmucki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaramakrishnan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, C.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paushkin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, F.</span></span> <span> </span><span class="NLM_article-title">SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">693</span>, <span class="refDoi"> DOI: 10.1126/science.1250127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1126%2Fscience.1250127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=25104390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12gtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2014&pages=688-693&author=N.+A.+Naryshkinauthor=M.+Weetallauthor=A.+Dakkaauthor=J.+Narasimhanauthor=X.+Zhaoauthor=Z.+Fengauthor=K.+K.+Y.+Lingauthor=G.+M.+Karpauthor=H.+Qiauthor=M.+G.+Wollauthor=G.+Chenauthor=N.+Zhangauthor=V.+Gabbetaauthor=P.+Vaziraniauthor=A.+Bhattacharyyaauthor=B.+Furiaauthor=N.+Risherauthor=J.+Sheedyauthor=R.+Kongauthor=J.+Maauthor=A.+Turpoffauthor=C.-S.+Leeauthor=X.+Zhangauthor=Y.-C.+Moonauthor=P.+Trifillisauthor=E.+M.+Welchauthor=J.+M.+Colacinoauthor=J.+Babiakauthor=N.+G.+Almsteadauthor=S.+W.+Peltzauthor=L.+A.+Engauthor=K.+S.+Chenauthor=J.+L.+Mullauthor=M.+S.+Lynesauthor=L.+L.+Rubinauthor=P.+Fontouraauthor=L.+Santarelliauthor=D.+Haehnkeauthor=K.+D.+McCarthyauthor=R.+Schmuckiauthor=M.+Ebelingauthor=M.+Sivaramakrishnanauthor=C.-P.+Koauthor=S.+V.+Paushkinauthor=H.+Ratniauthor=I.+Gerlachauthor=A.+Ghoshauthor=F.+Metzger&title=SMN2+splicing+modifiers+improve+motor+function+and+longevity+in+mice+with+spinal+muscular+atrophy&doi=10.1126%2Fscience.1250127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy</span></div><div class="casAuthors">Naryshkin, Nikolai A.; Weetall, Marla; Dakka, Amal; Narasimhan, Jana; Zhao, Xin; Feng, Zhihua; Ling, Karen K. Y.; Karp, Gary M.; Qi, Hongyan; Woll, Matthew G.; Chen, Guangming; Zhang, Nanjing; Gabbeta, Vijayalakshmi; Vazirani, Priya; Bhattacharyya, Anuradha; Furia, Bansri; Risher, Nicole; Sheedy, Josephine; Kong, Ronald; Ma, Jiyuan; Turpoff, Anthony; Lee, Chang-Sun; Zhang, Xiaoyan; Moon, Young-Choon; Trifillis, Panayiota; Welch, Ellen M.; Colacino, Joseph M.; Babiak, John; Almstead, Neil G.; Peltz, Stuart W.; Eng, Loren A.; Chen, Karen S.; Mull, Jesse L.; Lynes, Maureen S.; Rubin, Lee L.; Fontoura, Paulo; Santarelli, Luca; Haehnke, Daniel; McCarthy, Kathleen D.; Schmucki, Roland; Ebeling, Martin; Sivaramakrishnan, Manaswini; Ko, Chien-Ping; Paushkin, Sergey V.; Ratni, Hasane; Gerlach, Irene; Ghosh, Anirvan; Metzger, Friedrich</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">6197</span>),
    <span class="NLM_cas:pages">688-693</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Spinal muscular atrophy (SMA) is a genetic disease caused by mutation or deletion of the survival of motor neuron 1 (SMN1) gene.  A paralogous gene in humans, SMN2, produces low, insufficient levels of functional SMN protein due to alternative splicing that truncates the transcript.  The decreased levels of SMN protein lead to progressive neuromuscular degeneration and high rates of mortality.  Through chem. screening and optimization, we identified orally available small mols. that shift the balance of SMN2 splicing toward the prodn. of full-length SMN2 mRNA with high selectivity.  Administration of these compds. to Δ7 mice, a model of severe SMA, led to an increase in SMN protein levels, improvement of motor function, and protection of the neuromuscular circuit.  These compds. also extended the life span of the mice.  Selective SMN2 splicing modifiers may have therapeutic potential for patients with SMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxZ8QSg5KSzLVg90H21EOLACvtfcHk0ljqg1E_UpOMkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12gtLfO&md5=f321c411bb384f95a9fe4d4debcbb195</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1126%2Fscience.1250127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1250127%26sid%3Dliteratum%253Aachs%26aulast%3DNaryshkin%26aufirst%3DN.%2BA.%26aulast%3DWeetall%26aufirst%3DM.%26aulast%3DDakka%26aufirst%3DA.%26aulast%3DNarasimhan%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DLing%26aufirst%3DK.%2BK.%2BY.%26aulast%3DKarp%26aufirst%3DG.%2BM.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DWoll%26aufirst%3DM.%2BG.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DGabbeta%26aufirst%3DV.%26aulast%3DVazirani%26aufirst%3DP.%26aulast%3DBhattacharyya%26aufirst%3DA.%26aulast%3DFuria%26aufirst%3DB.%26aulast%3DRisher%26aufirst%3DN.%26aulast%3DSheedy%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DTurpoff%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DC.-S.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoon%26aufirst%3DY.-C.%26aulast%3DTrifillis%26aufirst%3DP.%26aulast%3DWelch%26aufirst%3DE.%2BM.%26aulast%3DColacino%26aufirst%3DJ.%2BM.%26aulast%3DBabiak%26aufirst%3DJ.%26aulast%3DAlmstead%26aufirst%3DN.%2BG.%26aulast%3DPeltz%26aufirst%3DS.%2BW.%26aulast%3DEng%26aufirst%3DL.%2BA.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DMull%26aufirst%3DJ.%2BL.%26aulast%3DLynes%26aufirst%3DM.%2BS.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DFontoura%26aufirst%3DP.%26aulast%3DSantarelli%26aufirst%3DL.%26aulast%3DHaehnke%26aufirst%3DD.%26aulast%3DMcCarthy%26aufirst%3DK.%2BD.%26aulast%3DSchmucki%26aufirst%3DR.%26aulast%3DEbeling%26aufirst%3DM.%26aulast%3DSivaramakrishnan%26aufirst%3DM.%26aulast%3DKo%26aufirst%3DC.-P.%26aulast%3DPaushkin%26aufirst%3DS.%2BV.%26aulast%3DRatni%26aufirst%3DH.%26aulast%3DGerlach%26aufirst%3DI.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DMetzger%26aufirst%3DF.%26atitle%3DSMN2%2520splicing%2520modifiers%2520improve%2520motor%2520function%2520and%2520longevity%2520in%2520mice%2520with%2520spinal%2520muscular%2520atrophy%26jtitle%3DScience%26date%3D2014%26volume%3D345%26spage%3D688%26epage%3D693%26doi%3D10.1126%2Fscience.1250127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woll, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turpoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almstead, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naryshkin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbeta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheedy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weetall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, G. M.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of small molecule splicing modifiers of survival motor neuron 2 as a treatment for spinal muscular atrophy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6070</span>– <span class="NLM_lpage">6085</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00460</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00460" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6070-6085&author=M.+G.+Wollauthor=H.+Qiauthor=A.+Turpoffauthor=N.+Zhangauthor=X.+Zhangauthor=G.+Chenauthor=C.+Liauthor=S.+Huangauthor=T.+Yangauthor=Y.-C.+Moonauthor=C.-S.+Leeauthor=S.+Choiauthor=N.+G.+Almsteadauthor=N.+A.+Naryshkinauthor=A.+Dakkaauthor=J.+Narasimhanauthor=V.+Gabbetaauthor=E.+Welchauthor=X.+Zhaoauthor=N.+Risherauthor=J.+Sheedyauthor=M.+Weetallauthor=G.+M.+Karp&title=Discovery+and+optimization+of+small+molecule+splicing+modifiers+of+survival+motor+neuron+2+as+a+treatment+for+spinal+muscular+atrophy&doi=10.1021%2Facs.jmedchem.6b00460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular Atrophy</span></div><div class="casAuthors">Woll, Matthew G.; Qi, Hongyan; Turpoff, Anthony; Zhang, Nanjing; Zhang, Xiaoyan; Chen, Guangming; Li, Chunshi; Huang, Song; Yang, Tianle; Moon, Young-Choon; Lee, Chang-Sun; Choi, Soongyu; Almstead, Neil G.; Naryshkin, Nikolai A.; Dakka, Amal; Narasimhan, Jana; Gabbeta, Vijayalakshmi; Welch, Ellen; Zhao, Xin; Risher, Nicole; Sheedy, Josephine; Weetall, Marla; Karp, Gary M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6070-6085</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The underlying cause of spinal muscular atrophy (SMA) is a deficiency of the survival motor neuron (SMN) protein.  Starting from hits identified in a high-throughput screening campaign and through structure-activity relationship investigations, we have developed small mols. that potently shift the alternative splicing of the SMN2 exon 7, resulting in increased prodn. of the full-length SMN mRNA and protein.  Three novel chem. series, represented by compds. 9, 14, and 20, have been optimized to increase the level of SMN protein by >50% in SMA patient-derived fibroblasts at concns. of <160 nM.  Daily administration of these compds. to severe SMA Δ7 mice results in an increased prodn. of SMN protein in disease-relevant tissues and a significant increase in median survival time in a dose-dependent manner.  Our work supports the development of an orally administered small mol. for the treatment of patients with SMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF6iU-0q9serVg90H21EOLACvtfcHk0lhgi6L_Ys1O8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWgur0%253D&md5=9b32bd7380625b6ddd3e97479f98e79b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00460%26sid%3Dliteratum%253Aachs%26aulast%3DWoll%26aufirst%3DM.%2BG.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DTurpoff%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DMoon%26aufirst%3DY.-C.%26aulast%3DLee%26aufirst%3DC.-S.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DAlmstead%26aufirst%3DN.%2BG.%26aulast%3DNaryshkin%26aufirst%3DN.%2BA.%26aulast%3DDakka%26aufirst%3DA.%26aulast%3DNarasimhan%26aufirst%3DJ.%26aulast%3DGabbeta%26aufirst%3DV.%26aulast%3DWelch%26aufirst%3DE.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DRisher%26aufirst%3DN.%26aulast%3DSheedy%26aufirst%3DJ.%26aulast%3DWeetall%26aufirst%3DM.%26aulast%3DKarp%26aufirst%3DG.%2BM.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520small%2520molecule%2520splicing%2520modifiers%2520of%2520survival%2520motor%2520neuron%25202%2520as%2520a%2520treatment%2520for%2520spinal%2520muscular%2520atrophy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6070%26epage%3D6085%26doi%3D10.1021%2Facs.jmedchem.6b00460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otsuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shioya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunoya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyoshi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komeno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habashita, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a 1-methyl-3,4-dihydronaphthalene-based sphingosine-1-phosphate (S1P) receptor agonist ceralifimod (ONO-4641). A S<sub>1</sub>P<sub>1</sub> and S1P<sub>5</sub> selective agonist for the treatment of autoimmune diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9508</span>– <span class="NLM_lpage">9530</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00785</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00785" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9508-9530&author=H.+Kurataauthor=K.+Kusumiauthor=K.+Otsukiauthor=R.+Suzukiauthor=M.+Kuronoauthor=T.+Komiyaauthor=H.+Hagiyaauthor=H.+Mizunoauthor=H.+Shioyaauthor=T.+Onoauthor=Y.+Takadaauthor=T.+Maedaauthor=N.+Matsunagaauthor=T.+Kondoauthor=S.+Tominagaauthor=K.+Nunoyaauthor=H.+Kiyoshiauthor=M.+Komenoauthor=S.+Nakadeauthor=H.+Habashita&title=Discovery+of+a+1-methyl-3%2C4-dihydronaphthalene-based+sphingosine-1-phosphate+%28S1P%29+receptor+agonist+ceralifimod+%28ONO-4641%29.+A+S1P1+and+S1P5+selective+agonist+for+the+treatment+of+autoimmune+diseases&doi=10.1021%2Facs.jmedchem.7b00785"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00785%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DS.%26aulast%3DNunoya%26aufirst%3DK.%26aulast%3DKiyoshi%26aufirst%3DH.%26aulast%3DKomeno%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520a%25201-methyl-3%252C4-dihydronaphthalene-based%2520sphingosine-1-phosphate%2520%2528S1P%2529%2520receptor%2520agonist%2520ceralifimod%2520%2528ONO-4641%2529.%2520A%2520S1P1%2520and%2520S1P5%2520selective%2520agonist%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9508%26epage%3D9530%26doi%3D10.1021%2Facs.jmedchem.7b00785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bezençon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remeň, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capeleto, B.</span></span> <span> </span><span class="NLM_article-title">Discovery and evaluation of Ca<sub>V</sub>3.1-selective T-type calcium channel blockers</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5322</span>– <span class="NLM_lpage">5325</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2017.09.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=29066309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs12lu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5322-5325&author=O.+Bezen%C3%A7onauthor=L.+Reme%C5%88author=S.+Richardauthor=C.+Rochauthor=M.+Kesslerauthor=R.+Moonauthor=J.+Mawetauthor=E.+A.+Ertelauthor=T.+Pfeiferauthor=B.+Capeleto&title=Discovery+and+evaluation+of+CaV3.1-selective+T-type+calcium+channel+blockers&doi=10.1016%2Fj.bmcl.2017.09.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and evaluation of Cav3.1-selective T-type calcium channel blockers</span></div><div class="casAuthors">Bezencon, Olivier; Remen, Lubos; Richard, Sylvia; Roch, Catherine; Kessler, Melanie; Moon, Richard; Mawet, Jacques; Ertel, Eric A.; Pfeifer, Thomas; Capeleto, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5322-5325</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors identified and characterized a series of pyrazole amides as potent, selective Cav3.1-blockers.  This series culminated with the identification of pyrazole amides (I) and (II), with excellent potencies and/or selectivities toward the Cav3.2- and Cav3.3-channels.  This compd. displays poor DMPK properties, making its use difficult for in vivo applications.  Nevertheless, this compd. as well as analogous ones are well-suited for in vitro studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-J6_wLd5WF7Vg90H21EOLACvtfcHk0lhsCVUSrP5kWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs12lu7jK&md5=c64ab553e9c4b62d8f25573538ebfa6d</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.063%26sid%3Dliteratum%253Aachs%26aulast%3DBezen%25C3%25A7on%26aufirst%3DO.%26aulast%3DReme%25C5%2588%26aufirst%3DL.%26aulast%3DRichard%26aufirst%3DS.%26aulast%3DRoch%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DM.%26aulast%3DMoon%26aufirst%3DR.%26aulast%3DMawet%26aufirst%3DJ.%26aulast%3DErtel%26aufirst%3DE.%2BA.%26aulast%3DPfeifer%26aufirst%3DT.%26aulast%3DCapeleto%26aufirst%3DB.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520CaV3.1-selective%2520T-type%2520calcium%2520channel%2520blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5322%26epage%3D5325%26doi%3D10.1016%2Fj.bmcl.2017.09.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bezençon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegrist, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corminboeuf, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymond, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kanter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toeroek-Schafroth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moccia, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capeleto, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent, selective T-type calcium channel blocker as a drug candidate for the treatment of generalized epilepsies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9769</span>– <span class="NLM_lpage">9789</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyrsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9769-9789&author=O.+Bezen%C3%A7onauthor=B.+Heidmannauthor=R.+Siegristauthor=S.+Stammauthor=S.+Richardauthor=D.+Pozziauthor=O.+Corminboeufauthor=C.+Rochauthor=M.+Kesslerauthor=E.+A.+Ertelauthor=I.+Reymondauthor=T.+Pfeiferauthor=R.+de+Kanterauthor=M.+Toeroek-Schafrothauthor=L.+G.+Mocciaauthor=J.+Mawetauthor=R.+Moonauthor=M.+Reyauthor=B.+Capeletoauthor=E.+Fournier&title=Discovery+of+a+potent%2C+selective+T-type+calcium+channel+blocker+as+a+drug+candidate+for+the+treatment+of+generalized+epilepsies&doi=10.1021%2Facs.jmedchem.7b01236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies</span></div><div class="casAuthors">Bezencon, Olivier; Heidmann, Bibia; Siegrist, Romain; Stamm, Simon; Richard, Sylvia; Pozzi, Davide; Corminboeuf, Olivier; Roch, Catherine; Kessler, Melanie; Ertel, Eric A.; Reymond, Isabelle; Pfeifer, Thomas; de Kanter, Ruben; Toeroek-Schafroth, Michael; Moccia, Luca G.; Mawet, Jacques; Moon, Richard; Rey, Markus; Capeleto, Bruno; Fournier, Elvire</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9769-9789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the discovery and pharmacol. characterization of N-(1-benzyl-1H-pyrazol-3-yl)-2-phenylacetamide derivs. as potent, selective, brain-penetrating T-type calcium channel blockers.  Optimization focused mainly on soly., brain penetration, and the search for an aminopyrazole metabolite that would be neg. in an Ames test.  This resulted in the prepn. and complete characterization of compd. 66b (ACT-709478 (N-(1-((5-cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl)-2-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)acetamide)), which has been selected as a clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJoSIvutRz1bVg90H21EOLACvtfcHk0lhsCVUSrP5kWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyrsL7L&md5=78907d325d5476978c4b37ec86bc2f11</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01236%26sid%3Dliteratum%253Aachs%26aulast%3DBezen%25C3%25A7on%26aufirst%3DO.%26aulast%3DHeidmann%26aufirst%3DB.%26aulast%3DSiegrist%26aufirst%3DR.%26aulast%3DStamm%26aufirst%3DS.%26aulast%3DRichard%26aufirst%3DS.%26aulast%3DPozzi%26aufirst%3DD.%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DRoch%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DM.%26aulast%3DErtel%26aufirst%3DE.%2BA.%26aulast%3DReymond%26aufirst%3DI.%26aulast%3DPfeifer%26aufirst%3DT.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DToeroek-Schafroth%26aufirst%3DM.%26aulast%3DMoccia%26aufirst%3DL.%2BG.%26aulast%3DMawet%26aufirst%3DJ.%26aulast%3DMoon%26aufirst%3DR.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DCapeleto%26aufirst%3DB.%26aulast%3DFournier%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%2520T-type%2520calcium%2520channel%2520blocker%2520as%2520a%2520drug%2520candidate%2520for%2520the%2520treatment%2520of%2520generalized%2520epilepsies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9769%26epage%3D9789%26doi%3D10.1021%2Facs.jmedchem.7b01236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beno, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parcella, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant-Young, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anjanappa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bora, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanumegowda, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haskell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colston, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raybon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santone, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of a hepatitis C virus NS5B replicase palm site allosteric inhibitor (BMS-929075) advanced to phase 1 clinical studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4369</span>– <span class="NLM_lpage">4385</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00328</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00328" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFWqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4369-4385&author=K.-S.+Yeungauthor=B.+R.+Benoauthor=K.+Parcellaauthor=J.+A.+Benderauthor=K.+A.+Grant-Youngauthor=A.+Nickelauthor=P.+Gunagaauthor=P.+Anjanappaauthor=R.+O.+Boraauthor=K.+Selvakumarauthor=K.+Rigatauthor=Y.-K.+Wangauthor=M.+Liuauthor=J.+Lemmauthor=K.+Mosureauthor=S.+Sheriffauthor=C.+Wanauthor=M.+Witmerauthor=K.+Kishauthor=U.+Hanumegowdaauthor=X.+Zhuoauthor=Y.-Z.+Shuauthor=D.+Parkerauthor=R.+Haskellauthor=A.+Ngauthor=Q.+Gaoauthor=E.+Colstonauthor=J.+Raybonauthor=D.+M.+Graselaauthor=K.+Santoneauthor=M.+Gaoauthor=N.+A.+Meanwellauthor=M.+Sinzauthor=M.+G.+Soarsauthor=J.+O.+Knipeauthor=S.+B.+Robertsauthor=J.+F.+Kadow&title=Discovery+of+a+hepatitis+C+virus+NS5B+replicase+palm+site+allosteric+inhibitor+%28BMS-929075%29+advanced+to+phase+1+clinical+studies&doi=10.1021%2Facs.jmedchem.7b00328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies</span></div><div class="casAuthors">Yeung, Kap-Sun; Beno, Brett R.; Parcella, Kyle; Bender, John A.; Grant-Young, Katherine A.; Nickel, Andrew; Gunaga, Prashantha; Anjanappa, Prakash; Bora, Rajesh Onkardas; Selvakumar, Kumaravel; Rigat, Karen; Wang, Ying-Kai; Liu, Mengping; Lemm, Julie; Mosure, Kathy; Sheriff, Steven; Wan, Changhong; Witmer, Mark; Kish, Kevin; Hanumegowda, Umesh; Zhuo, Xiaoliang; Shu, Yue-Zhong; Parker, Dawn; Haskell, Roy; Ng, Alicia; Gao, Qi; Colston, Elizabeth; Raybon, Joseph; Grasela, Dennis M.; Santone, Kenneth; Gao, Min; Meanwell, Nicholas A.; Sinz, Michael; Soars, Matthew G.; Knipe, Jay O.; Roberts, Susan B.; Kadow, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4369-4385</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) NS5B replicase is a prime target for the development of direct-acting antiviral drugs for the treatment of chronic HCV infection.  Inspired by the overlay of bound structures of three structurally distinct NS5B palm site allosteric inhibitors, the high-throughput screening hit anthranilic acid 4, the known benzofuran analog 5, and the benzothiadiazine deriv. 6, an optimization process utilizing the simple benzofuran template 7 as a starting point for a fragment growing approach was pursued.  A delicate balance of mol. properties achieved via disciplined lipophilicity changes was essential to achieve both high affinity binding and a stringent targeted absorption, distribution, metab., and excretion profile.  These efforts led to the discovery of BMS-929075 (37), which maintained ligand efficiency relative to early leads, demonstrated efficacy in a triple combination regimen in HCV replicon cells, and exhibited consistently high oral bioavailability and pharmacokinetic parameters across preclin. animal species.  The human PK properties from the Phase I clin. studies of 37 were better than anticipated and suggest promising potential for QD administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ0KsD9y5uorVg90H21EOLACvtfcHk0liQFaYZ1mqVsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFWqtbY%253D&md5=354b41a850bfa225b52baeddb1cb59b0</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00328%26sid%3Dliteratum%253Aachs%26aulast%3DYeung%26aufirst%3DK.-S.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DParcella%26aufirst%3DK.%26aulast%3DBender%26aufirst%3DJ.%2BA.%26aulast%3DGrant-Young%26aufirst%3DK.%2BA.%26aulast%3DNickel%26aufirst%3DA.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DAnjanappa%26aufirst%3DP.%26aulast%3DBora%26aufirst%3DR.%2BO.%26aulast%3DSelvakumar%26aufirst%3DK.%26aulast%3DRigat%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLemm%26aufirst%3DJ.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DC.%26aulast%3DWitmer%26aufirst%3DM.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DHanumegowda%26aufirst%3DU.%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DShu%26aufirst%3DY.-Z.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DHaskell%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DColston%26aufirst%3DE.%26aulast%3DRaybon%26aufirst%3DJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DSantone%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSinz%26aufirst%3DM.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DDiscovery%2520of%2520a%2520hepatitis%2520C%2520virus%2520NS5B%2520replicase%2520palm%2520site%2520allosteric%2520inhibitor%2520%2528BMS-929075%2529%2520advanced%2520to%2520phase%25201%2520clinical%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4369%26epage%3D4385%26doi%3D10.1021%2Facs.jmedchem.7b00328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bystol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, K.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartwright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of ruzasvir (MK-8408): a potent, pan-genotype HCV NS5A inhibitor with optimized activity against common resistance-associated polymorphisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01310</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01310" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslygt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=290-306&author=L.+Tongauthor=W.+Yuauthor=L.+Chenauthor=O.+Selyutinauthor=M.+P.+Dwyerauthor=A.+G.+Nairauthor=R.+Mazzolaauthor=J.-H.+Kimauthor=D.+Shaauthor=J.+Yinauthor=R.+T.+Ruckauthor=I.+W.+Daviesauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zanauthor=R.+Liuauthor=S.+Agrawalauthor=E.+Xiaauthor=S.+Curryauthor=P.+McMonagleauthor=K.+Bystolauthor=F.+Lahserauthor=D.+Carrauthor=L.+Rokoszauthor=P.+Ingravalloauthor=S.+Chenauthor=K.-I.+Fengauthor=M.+Cartwrightauthor=E.+Asante-Appiahauthor=J.+A.+Kozlowski&title=Discovery+of+ruzasvir+%28MK-8408%29%3A+a+potent%2C+pan-genotype+HCV+NS5A+inhibitor+with+optimized+activity+against+common+resistance-associated+polymorphisms&doi=10.1021%2Facs.jmedchem.6b01310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms</span></div><div class="casAuthors">Tong, Ling; Yu, Wensheng; Chen, Lei; Selyutin, Oleg; Dwyer, Michael P.; Nair, Anilkumar G.; Mazzola, Robert; Kim, Jae-Hun; Sha, Deyou; Yin, Jingjun; Ruck, Rebecca T.; Davies, Ian W.; Hu, Bin; Zhong, Bin; Hao, Jinglai; Ji, Tao; Zan, Shuai; Liu, Rong; Agrawal, Sony; Xia, Ellen; Curry, Stephanie; McMonagle, Patricia; Bystol, Karin; Lahser, Frederick; Carr, Donna; Rokosz, Laura; Ingravallo, Paul; Chen, Shiying; Feng, Kung-I.; Cartwright, Mark; Asante-Appiah, Ernest; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">290-306</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the research that led to the discovery of compd. 40 (ruzasvir, MK-8408), a pan-genotypic HCV nonstructural protein 5A (NS5A) inhibitor with a "flat" GT1 mutant profile.  This NS5A inhibitor contains a unique tetracyclic indole core, while maintaining the imidazole-proline-valine Moc motifs of the authors' previous NS5A inhibitors.  Compd. 40 is currently in early clin. trials and is under evaluation as part of an all-oral DAA regimen for the treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5FD27q2S7fLVg90H21EOLACvtfcHk0liQFaYZ1mqVsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslygt7jN&md5=6224e41b940abfb96cda518ecebf3e0f</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01310%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DSha%26aufirst%3DD.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DRuck%26aufirst%3DR.%2BT.%26aulast%3DDavies%26aufirst%3DI.%2BW.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DBystol%26aufirst%3DK.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DK.-I.%26aulast%3DCartwright%26aufirst%3DM.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520ruzasvir%2520%2528MK-8408%2529%253A%2520a%2520potent%252C%2520pan-genotype%2520HCV%2520NS5A%2520inhibitor%2520with%2520optimized%2520activity%2520against%2520common%2520resistance-associated%2520polymorphisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D290%26epage%3D306%26doi%3D10.1021%2Facs.jmedchem.6b01310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soll, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-8742: An HCV NS5A inhibitor with broad genotype activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1930</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2Fcmdc.201300343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=24127258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SkurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1930-1940&author=C.+A.+Coburnauthor=P.+T.+Meinkeauthor=W.+Changauthor=C.+M.+Fandozziauthor=D.+J.+Grahamauthor=B.+Huauthor=Q.+Huangauthor=S.+Kargmanauthor=J.+Kozlowskiauthor=R.+Liuauthor=J.+A.+McCauleyauthor=A.+A.+Nomeirauthor=R.+M.+Sollauthor=J.+P.+Vaccaauthor=D.+Wangauthor=H.+Wuauthor=B.+Zhongauthor=D.+B.+Olsenauthor=S.+W.+Ludmerer&title=Discovery+of+MK-8742%3A+An+HCV+NS5A+inhibitor+with+broad+genotype+activity&doi=10.1002%2Fcmdc.201300343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-8742: An HCV NS5A inhibitor with broad genotype activity</span></div><div class="casAuthors">Coburn, Craig A.; Meinke, Peter T.; Chang, Wei; Fandozzi, Christine M.; Graham, Donald J.; Hu, Bin; Huang, Qian; Kargman, Stacia; Kozlowski, Joseph; Liu, Rong; McCauley, John A.; Nomeir, Amin A.; Soll, Richard M.; Vacca, Joseph P.; Wang, Dahai; Wu, Hao; Zhong, Bin; Olsen, David B.; Ludmerer, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1930-1940</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The NS5A protein plays a crit. role in the replication of HCV and has been the focus of numerous research efforts over the past few years.  NS5A inhibitors have shown impressive in vitro potency profiles in HCV replicon assays, making them attractive components for inclusion in all oral combination regimens.  Early work in the NS5A arena led to the discovery of our first clin. candidate, MK-4882 [2-((S)-pyrrolidin-2-yl)-5-(2-(4-(5-((S)-pyrrolidin-2-yl)-1H-imidazol-2-yl)phenyl)benzofuran-5-yl)-1H-imidazole].  While preclin. proof-of-concept studies in HCV-infected chimpanzees harboring chronic genotype 1 infections resulted in significant decreases in viral load after both single- and multiple-dose treatments, viral breakthrough proved to be a concern, thus necessitating the development of compds. with increased potency against a no. of genotypes and NS5A resistance mutations.  Modification of the MK-4882 core scaffold by introduction of a cyclic constraint afforded a series of tetracyclic inhibitors, which showed improved virol. profiles.  Herein we describe the research efforts that led to the discovery of MK-8742, a tetracyclic indole-based NS5A inhibitor, which is currently in phase 2b clin. trials as part of an all-oral, interferon-free regimen for the treatment of HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqknZKO01aZlLVg90H21EOLACvtfcHk0lgnovRQSCn_gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SkurzN&md5=2f2b3ed2281c43e39b24d4197b9f57ee</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300343%26sid%3Dliteratum%253Aachs%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DNomeir%26aufirst%3DA.%2BA.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520MK-8742%253A%2520An%2520HCV%2520NS5A%2520inhibitor%2520with%2520broad%2520genotype%2520activity%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1930%26epage%3D1940%26doi%3D10.1002%2Fcmdc.201300343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conte, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ercolani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francesco, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neddermann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliaccio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stansfield, I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of piperazinyl-N-phenlybenzamides as inhibitors of hepatitis C RNA replication in cell culture</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1779</span>– <span class="NLM_lpage">1783</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2009.01.066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1779-1783&author=I.+Conteauthor=C.+Giulianoauthor=C.+Ercolaniauthor=F.+Narjesauthor=U.+Kochauthor=M.+Rowleyauthor=S.+Altamuraauthor=R.+D.+Francescoauthor=P.+Neddermannauthor=G.+Migliaccioauthor=I.+Stansfield&title=Synthesis+and+SAR+of+piperazinyl-N-phenlybenzamides+as+inhibitors+of+hepatitis+C+RNA+replication+in+cell+culture&doi=10.1016%2Fj.bmcl.2009.01.066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.066%26sid%3Dliteratum%253Aachs%26aulast%3DConte%26aufirst%3DI.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DErcolani%26aufirst%3DC.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DFrancesco%26aufirst%3DR.%2BD.%26aulast%3DNeddermann%26aufirst%3DP.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DStansfield%26aufirst%3DI.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520piperazinyl-N-phenlybenzamides%2520as%2520inhibitors%2520of%2520hepatitis%2520C%2520RNA%2520replication%2520in%2520cell%2520culture%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1779%26epage%3D1783%26doi%3D10.1016%2Fj.bmcl.2009.01.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mull, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venables, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sit, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocuzza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilder, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampulla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friborg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheaffer, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schartman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donoso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinz, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvyaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tredup, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klei, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockett, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhee, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scola, P. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent acyclic, tripeptidic, acyl sulfonamide inhibitor of Hepatitis C Virus NS3 protease as a back-up to Asunaprevir with the potential for once-daily dosing</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8042</span>– <span class="NLM_lpage">8060</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00821</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00821" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtl2rsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8042-8060&author=L.-Q.+Sunauthor=E.+Mullauthor=B.+Zhengauthor=S.+D%E2%80%99Andreaauthor=Q.+Zhaoauthor=A.+X.+Wangauthor=N.+Sinauthor=B.+L.+Venablesauthor=S.-Y.+Sitauthor=Y.+Chenauthor=J.+Chenauthor=A.+Cocuzzaauthor=D.+M.+Bilderauthor=A.+Mathurauthor=R.+Rampullaauthor=B.-C.+Chenauthor=T.+Palaniauthor=S.+Ganesanauthor=P.+N.+Arunachalamauthor=P.+Falkauthor=S.+Levineauthor=C.+Chenauthor=J.+Friborgauthor=F.+Yuauthor=D.+Hernandezauthor=A.+K.+Sheafferauthor=J.+O.+Knipeauthor=Y.-H.+Hanauthor=R.+Schartmanauthor=M.+Donosoauthor=K.+Mosureauthor=M.+W.+Sinzauthor=T.+Zvyagaauthor=R.+Rajamaniauthor=K.+Kishauthor=J.+Tredupauthor=H.+E.+Kleiauthor=Q.+Gaoauthor=A.+Ngauthor=L.+Muellerauthor=D.+M.+Graselaauthor=S.+Adamsauthor=J.+Loyauthor=P.+C.+Levesqueauthor=H.+Sunauthor=H.+Shiauthor=L.+Sunauthor=W.+Warnerauthor=D.+Liauthor=J.+Zhuauthor=Y.-K.+Wangauthor=H.+Fangauthor=M.+I.+Cockettauthor=N.+A.+Meanwellauthor=F.+McPheeauthor=P.+M.+Scola&title=Discovery+of+a+potent+acyclic%2C+tripeptidic%2C+acyl+sulfonamide+inhibitor+of+Hepatitis+C+Virus+NS3+protease+as+a+back-up+to+Asunaprevir+with+the+potential+for+once-daily+dosing&doi=10.1021%2Facs.jmedchem.6b00821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing</span></div><div class="casAuthors">Sun, Li-Qiang; Mull, Eric; Zheng, Barbara; D'Andrea, Stanley; Zhao, Qian; Wang, Alan Xiangdong; Sin, Ny; Venables, Brian L.; Sit, Sing-Yuen; Chen, Yan; Chen, Jie; Cocuzza, Anthony; Bilder, Donna M.; Mathur, Arvind; Rampulla, Richard; Chen, Bang-Chi; Palani, Theerthagiri; Ganesan, Sivakumar; Arunachalam, Pirama Nayagam; Falk, Paul; Levine, Steven; Chen, Chaoqun; Friborg, Jacques; Yu, Fei; Hernandez, Dennis; Sheaffer, Amy K.; Knipe, Jay O.; Han, Yong-Hae; Schartman, Richard; Donoso, Maria; Mosure, Kathy; Sinz, Michael W.; Zvyaga, Tatyana; Rajamani, Ramkumar; Kish, Kevin; Tredup, Jeffrey; Klei, Herbert E.; Gao, Qi; Ng, Alicia; Mueller, Luciano; Grasela, Dennis M.; Adams, Stephen; Loy, James; Levesque, Paul C.; Sun, Huabin; Shi, Hong; Sun, Lucy; Warner, William; Li, Danshi; Zhu, Jialong; Wang, Ying-Kai; Fang, Hua; Cockett, Mark I.; Meanwell, Nicholas A.; McPhee, Fiona; Scola, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8042-8060</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of a back-up to the hepatitis C virus NS3 protease inhibitor asunaprevir is described.  The objective of this work was the identification of a drug with antiviral properties and toxicol. parameters similar to asunaprevir, but with a preclin. pharmacokinetic (PK) profile that was predictive of once-daily dosing.  Crit. to this discovery process was the employment of an ex vivo cardiovascular (CV) model which served to identify compds. that, like asunaprevir, were free of the CV liabilities that resulted in the discontinuation of BMS-605339 from clin. trials.  Structure-activity relationships (SARs) at each of the structural subsites in asunaprevir were explored with substantial improvement in PK through modifications at the P1 site, while potency gains were found with small, but rationally designed structural changes to P4.  Addnl. modifications at P3 were required to optimize the CV profile, and these combined SARs led to the discovery of BMS-890068 I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAfdJwdSryH7Vg90H21EOLACvtfcHk0lgnovRQSCn_gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtl2rsrnK&md5=9d87037fcf23ef830e7ea02a6c6f2f8b</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00821%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DMull%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DA.%2BX.%26aulast%3DSin%26aufirst%3DN.%26aulast%3DVenables%26aufirst%3DB.%2BL.%26aulast%3DSit%26aufirst%3DS.-Y.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCocuzza%26aufirst%3DA.%26aulast%3DBilder%26aufirst%3DD.%2BM.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DRampulla%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DPalani%26aufirst%3DT.%26aulast%3DGanesan%26aufirst%3DS.%26aulast%3DArunachalam%26aufirst%3DP.%2BN.%26aulast%3DFalk%26aufirst%3DP.%26aulast%3DLevine%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DFriborg%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DHan%26aufirst%3DY.-H.%26aulast%3DSchartman%26aufirst%3DR.%26aulast%3DDonoso%26aufirst%3DM.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSinz%26aufirst%3DM.%2BW.%26aulast%3DZvyaga%26aufirst%3DT.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DTredup%26aufirst%3DJ.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DLoy%26aufirst%3DJ.%26aulast%3DLevesque%26aufirst%3DP.%2BC.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWarner%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DCockett%26aufirst%3DM.%2BI.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DScola%26aufirst%3DP.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520acyclic%252C%2520tripeptidic%252C%2520acyl%2520sulfonamide%2520inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520NS3%2520protease%2520as%2520a%2520back-up%2520to%2520Asunaprevir%2520with%2520the%2520potential%2520for%2520once-daily%2520dosing%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8042%26epage%3D8060%26doi%3D10.1021%2Facs.jmedchem.6b00821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloveva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stray, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rheingold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-<i>f</i>][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1648</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01594</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01594" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1648-1661&author=D.+Siegelauthor=H.+C.+Huiauthor=E.+Doerfflerauthor=M.+O.+Clarkeauthor=K.+Chunauthor=L.+Zhangauthor=S.+Nevilleauthor=E.+Carraauthor=W.+Lewauthor=B.+Rossauthor=Q.+Wangauthor=L.+Wolfeauthor=R.+Jordanauthor=V.+Solovevaauthor=J.+Knoxauthor=J.+Perryauthor=M.+Perronauthor=K.+M.+Strayauthor=O.+Barauskasauthor=J.+Y.+Fengauthor=Y.+Xuauthor=G.+Leeauthor=A.+L.+Rheingoldauthor=A.+S.+Rayauthor=R.+Bannisterauthor=R.+Strickleyauthor=S.+Swaminathanauthor=W.+A.+Leeauthor=S.+Bavariauthor=T.+Cihlarauthor=M.+K.+Loauthor=T.+K.+Warrenauthor=R.+L.+Mackman&title=Discovery+and+synthesis+of+a+phosphoramidate+prodrug+of+a+pyrrolo%5B2%2C1-f%5D%5Btriazin-4-amino%5D+adenine+C-nucleoside+%28GS-5734%29+for+the+treatment+of+Ebola+and+emerging+viruses&doi=10.1021%2Facs.jmedchem.6b01594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses</span></div><div class="casAuthors">Siegel, Dustin; Hui, Hon C.; Doerffler, Edward; Clarke, Michael O.; Chun, Kwon; Zhang, Lijun; Neville, Sean; Carra, Ernest; Lew, Willard; Ross, Bruce; Wang, Queenie; Wolfe, Lydia; Jordan, Robert; Soloveva, Veronica; Knox, John; Perry, Jason; Perron, Michel; Stray, Kirsten M.; Barauskas, Ona; Feng, Joy Y.; Xu, Yili; Lee, Gary; Rheingold, Arnold L.; Ray, Adrian S.; Bannister, Roy; Strickley, Robert; Swaminathan, Swami; Lee, William A.; Bavari, Sina; Cihlar, Tomas; Lo, Michael K.; Warren, Travis K.; Mackman, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1648-1661</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent Ebola virus (EBOV) outbreak in West Africa was the largest recorded in history with over 28,000 cases, resulting in >11,000 deaths including >500 healthcare workers.  A focused screening and lead optimization effort identified 4b (GS-5734) with anti-EBOV EC50 = 86 nM in macrophages as the clin. candidate.  Structure activity relationships established that the 1'-CN group and C-linked nucleobase were crit. for optimal anti-EBOV potency and selectivity against host polymerases.  A robust diastereoselective synthesis provided sufficient quantities of 4b to enable preclin. efficacy in a non-human-primate EBOV challenge model.  Once-daily 10 mg/kg iv treatment on days 3-14 postinfection had a significant effect on viremia and mortality, resulting in 100% survival of infected treated animals [ Nature 2016, 531, 381-385].  A phase 2 study (PREVAIL IV) is currently enrolling and will evaluate the effect of 4b on viral shedding from sanctuary sites in EBOV survivors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfWkPjn__gILVg90H21EOLACvtfcHk0lhZVN08_Zn4fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjsb4%253D&md5=b2a05cfeb4fd30fbca0d1d584ddcc220</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01594%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DHui%26aufirst%3DH.%2BC.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DChun%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNeville%26aufirst%3DS.%26aulast%3DCarra%26aufirst%3DE.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DRoss%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWolfe%26aufirst%3DL.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DSoloveva%26aufirst%3DV.%26aulast%3DKnox%26aufirst%3DJ.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DStray%26aufirst%3DK.%2BM.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DRheingold%26aufirst%3DA.%2BL.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%2BA.%26aulast%3DBavari%26aufirst%3DS.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520a%2520phosphoramidate%2520prodrug%2520of%2520a%2520pyrrolo%255B2%252C1-f%255D%255Btriazin-4-amino%255D%2520adenine%2520C-nucleoside%2520%2528GS-5734%2529%2520for%2520the%2520treatment%2520of%2520Ebola%2520and%2520emerging%2520viruses%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1648%26epage%3D1661%26doi%3D10.1021%2Facs.jmedchem.6b01594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowicka-Sans, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastgate, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HIV-1 attachment: The discovery and development of Temsavir and its prodrug Fostemsavir</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01337</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01337" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWnt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=62-80&author=N.+A.+Meanwellauthor=M.+R.+Krystalauthor=B.+Nowicka-Sansauthor=D.+R.+Langleyauthor=D.+A.+Conlonauthor=M.+D.+Eastgateauthor=D.+M.+Graselaauthor=P.+Timminsauthor=T.+Wangauthor=J.+F.+Kadow&title=Inhibitors+of+HIV-1+attachment%3A+The+discovery+and+development+of+Temsavir+and+its+prodrug+Fostemsavir&doi=10.1021%2Facs.jmedchem.7b01337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir</span></div><div class="casAuthors">Meanwell, Nicholas A.; Krystal, Mark R.; Nowicka-Sans, Beata; Langley, David R.; Conlon, David A.; Eastgate, Martin D.; Grasela, Dennis M.; Timmins, Peter; Wang, Tao; Kadow, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-80</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Human immunodeficiency virus-1 (HIV-1) infection currently requires lifelong therapy with drugs that are used in combination to control viremia.  The indole-3-glyoxamide 6 was discovered as an inhibitor of HIV-1 infectivity using a phenotypic screen and derivs. of this compd. were found to interfere with the HIV-1 entry process by stabilizing a conformation of the virus gp120 protein not recognized by the host cell CD4 receptor.  An extensive optimization program led to the identification of temsavir (31), which exhibited an improved antiviral and pharmacokinetic profile compared to 6 and was explored in phase 3 clin. trials as the phosphonooxymethyl deriv. fostemsavir (35), a prodrug designed to address dissoln.- and soly.-limited absorption issues.  In this drug annotation, the authors summarize the structure-activity and structure-liability studies leading to the discovery of 31 and the clin. studies conducted with 35 that entailed the development of an extended release formulation suitable for phase 3 clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOcSXTLXS7p7Vg90H21EOLACvtfcHk0lhZVN08_Zn4fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWnt7fP&md5=e36e5e0ac4ec79860c757a3bce6d0837</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01337%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKrystal%26aufirst%3DM.%2BR.%26aulast%3DNowicka-Sans%26aufirst%3DB.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DConlon%26aufirst%3DD.%2BA.%26aulast%3DEastgate%26aufirst%3DM.%2BD.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DTimmins%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DInhibitors%2520of%2520HIV-1%2520attachment%253A%2520The%2520discovery%2520and%2520development%2520of%2520Temsavir%2520and%2520its%2520prodrug%2520Fostemsavir%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D62%26epage%3D80%26doi%3D10.1021%2Facs.jmedchem.7b01337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dousson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, F.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amador, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaric, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caillet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Costa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lioure, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosinovsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayes, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poddesu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargiu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liuzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moussa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakubik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standring, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of the aryl-phospho-indole IDX899, a highly potent anti-HIV non-nucleoside reverse transcriptase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1891</span>– <span class="NLM_lpage">1898</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1891-1898&author=C.+Doussonauthor=F.-R.+Alexandreauthor=A.+Amadorauthor=S.+Bonaricauthor=S.+Botauthor=C.+Cailletauthor=T.+Convardauthor=D.+da+Costaauthor=M.-P.+Lioureauthor=A.+Rolandauthor=E.+Rosinovskyauthor=S.+Maldonadoauthor=C.+Parsyauthor=C.+Trochetauthor=R.+Storerauthor=A.+Stewartauthor=J.+Wangauthor=B.+A.+Mayesauthor=C.+Musiuauthor=B.+Poddesuauthor=L.+Vargiuauthor=M.+Liuzziauthor=A.+Moussaauthor=J.+Jakubikauthor=L.+Hubbardauthor=M.+Seiferauthor=D.+Standring&title=Discovery+of+the+aryl-phospho-indole+IDX899%2C+a+highly+potent+anti-HIV+non-nucleoside+reverse+transcriptase+inhibitor&doi=10.1021%2Facs.jmedchem.5b01430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor</span></div><div class="casAuthors">Dousson, Cyril; Alexandre, Francois-Rene; Amador, Agnes; Bonaric, Severine; Bot, Stephanie; Caillet, Catherine; Convard, Thierry; da Costa, Daniel; Lioure, Marie-Pierre; Roland, Arlene; Rosinovsky, Elodie; Maldonado, Sebastien; Parsy, Christophe; Trochet, Christophe; Storer, Richard; Stewart, Alistair; Wang, Jingyang; Mayes, Benjamin A.; Musiu, Chiara; Poddesu, Barbara; Vargiu, Luana; Liuzzi, Michel; Moussa, Adel; Jakubik, Jocelyn; Hubbard, Luke; Seifer, Maria; Standring, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1891-1898</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we describe the design, synthesis, biol. evaluation, and identification of a clin. candidate non-nucleoside reverse transcriptase inhibitors (NNRTIs) with a novel aryl-phospho-indole (APhI) scaffold.  NNRTIs are recommended components of highly active antiretroviral therapy (HAART) for the treatment of HIV-1.  Since a major problem assocd. with NNRTI treatment is the emergence of drug resistant virus, this work focused on optimization of the APhI against clin. relevant HIV-1 Y181C and K103N mutants and the Y181C/K103N double mutant.  Optimization of the phosphinate aryl substituent led to the discovery of the 3-Me,5-acrylonitrile-Ph analog RP-13s (IDX899) having an EC50 of 11 nM against the Y181C/K103N double mutant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf8LXVc78xiLVg90H21EOLACvtfcHk0lhT8oHtJYcOyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWlur0%253D&md5=48e69317dd5bd8d677eb9ccf59ebdbe0</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01430%26sid%3Dliteratum%253Aachs%26aulast%3DDousson%26aufirst%3DC.%26aulast%3DAlexandre%26aufirst%3DF.-R.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBonaric%26aufirst%3DS.%26aulast%3DBot%26aufirst%3DS.%26aulast%3DCaillet%26aufirst%3DC.%26aulast%3DConvard%26aufirst%3DT.%26aulast%3Dda%2BCosta%26aufirst%3DD.%26aulast%3DLioure%26aufirst%3DM.-P.%26aulast%3DRoland%26aufirst%3DA.%26aulast%3DRosinovsky%26aufirst%3DE.%26aulast%3DMaldonado%26aufirst%3DS.%26aulast%3DParsy%26aufirst%3DC.%26aulast%3DTrochet%26aufirst%3DC.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DStewart%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMayes%26aufirst%3DB.%2BA.%26aulast%3DMusiu%26aufirst%3DC.%26aulast%3DPoddesu%26aufirst%3DB.%26aulast%3DVargiu%26aufirst%3DL.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DJakubik%26aufirst%3DJ.%26aulast%3DHubbard%26aufirst%3DL.%26aulast%3DSeifer%26aufirst%3DM.%26aulast%3DStandring%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520the%2520aryl-phospho-indole%2520IDX899%252C%2520a%2520highly%2520potent%2520anti-HIV%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1891%26epage%3D1898%26doi%3D10.1021%2Facs.jmedchem.5b01430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, F.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amador, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caillet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakubik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poddesu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargiu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liuzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standring, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dousson, C. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1021/jm101142k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101142k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCrtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=392-395&author=F.-R.+Alexandreauthor=A.+Amadorauthor=S.+Botauthor=C.+Cailletauthor=T.+Convardauthor=J.+Jakubikauthor=C.+Musiuauthor=B.+Poddesuauthor=L.+Vargiuauthor=M.+Liuzziauthor=A.+Rolandauthor=M.+Seiferauthor=D.+Standringauthor=R.+Storerauthor=C.+B.+Dousson&title=Synthesis+and+biological+evaluation+of+aryl-phospho-indole+as+novel+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors&doi=10.1021%2Fjm101142k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Aryl-phospho-indole as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors</span></div><div class="casAuthors">Alexandre, Francois-Rene; Amador, Agnes; Bot, Stephanie; Caillet, Catherine; Convard, Thierry; Jakubik, Jocelyn; Musiu, Chiara; Poddesu, Barbara; Vargiu, Luana; Liuzzi, Michel; Roland, Arlene; Seifer, Maria; Standring, David; Storer, Richard; Dousson, Cyril B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">392-395</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Aryl-phospho-indole (API) non-nucleoside reverse transcriptase inhibitors of HIV-1 were developed.  Chem. variation in the P linker led to the discovery of Me 2-(aminocarbonyl)-5-chloro-1H-indol-3-yl(phenyl)phosphinate (14; shown as I), which possessed excellent potency against wild-type HIV-1 as well as viruses bearing K103N and Y181C single mutants in the reverse transcriptase gene.  Chiral sepn. of the enantiomers of 14 showed that only the R enantiomer retained the activity.  The pharmacokinetic, soly., and metabolic properties of 14 were assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG8eWrOof4XLVg90H21EOLACvtfcHk0lhT8oHtJYcOyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCrtL%252FF&md5=59af41ba5ed16faa28921c793ceb404f</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm101142k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101142k%26sid%3Dliteratum%253Aachs%26aulast%3DAlexandre%26aufirst%3DF.-R.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBot%26aufirst%3DS.%26aulast%3DCaillet%26aufirst%3DC.%26aulast%3DConvard%26aufirst%3DT.%26aulast%3DJakubik%26aufirst%3DJ.%26aulast%3DMusiu%26aufirst%3DC.%26aulast%3DPoddesu%26aufirst%3DB.%26aulast%3DVargiu%26aufirst%3DL.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DRoland%26aufirst%3DA.%26aulast%3DSeifer%26aufirst%3DM.%26aulast%3DStandring%26aufirst%3DD.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DDousson%26aufirst%3DC.%2BB.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520aryl-phospho-indole%2520as%2520novel%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D392%26epage%3D395%26doi%3D10.1021%2Fjm101142k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamaraj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulbule, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, F. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanasekaran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hein, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papastogiannidis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urwyler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vennerstrom, J. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of the antimalarial ozonide artefenomel (OZ439)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2654</span>– <span class="NLM_lpage">2668</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslaitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2654-2668&author=Y.+Dongauthor=X.+Wangauthor=S.+Kamarajauthor=V.+J.+Bulbuleauthor=F.+C.+K.+Chiuauthor=J.+Cholletauthor=M.+Dhanasekaranauthor=C.+D.+Heinauthor=P.+Papastogiannidisauthor=J.+Morizziauthor=D.+M.+Shacklefordauthor=H.+Barkerauthor=E.+Ryanauthor=C.+Scheurerauthor=Y.+Tangauthor=Q.+Zhaoauthor=L.+Zhouauthor=K.+L.+Whiteauthor=H.+Urwylerauthor=W.+N.+Charmanauthor=H.+Matileauthor=S.+Wittlinauthor=S.+A.+Charmanauthor=J.+L.+Vennerstrom&title=Structure-activity+relationship+of+the+antimalarial+ozonide+artefenomel+%28OZ439%29&doi=10.1021%2Facs.jmedchem.6b01586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)</span></div><div class="casAuthors">Dong, Yuxiang; Wang, Xiaofang; Kamaraj, Sriraghavan; Bulbule, Vivek J.; Chiu, Francis C. K.; Chollet, Jacques; Dhanasekaran, Manickam; Hein, Christopher D.; Papastogiannidis, Petros; Morizzi, Julia; Shackleford, David M.; Barker, Helena; Ryan, Eileen; Scheurer, Christian; Tang, Yuanqing; Zhao, Qingjie; Zhou, Lin; White, Karen L.; Urwyler, Heinrich; Charman, William N.; Matile, Hugues; Wittlin, Sergio; Charman, Susan A.; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2654-2668</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Building on insights gained from the discovery of the antimalarial ozonide arterolane (OZ277), we now describe the structure-activity relationship (SAR) of the antimalarial ozonide artefenomel (OZ439).  Primary and secondary amino ozonides had higher metabolic stabilities than tertiary amino ozonides, consistent with their higher pKa and lower log D7.4 values.  For primary amino ozonides, addn. of polar functional groups decreased in vivo antimalarial efficacy.  For secondary amino ozonides, addnl. functional groups had variable effects on metabolic stability and efficacy, but the most effective members of this series also had the highest log D7.4 values.  For tertiary amino ozonides, addn. of polar functional groups with H-bond donors increased metabolic stability but decreased in vivo antimalarial efficacy.  Primary and tertiary amino ozonides with cycloalkyl and heterocycle substructures were superior to their acyclic counterparts.  The high curative efficacy of these ozonides was most often assocd. with high and prolonged plasma exposure, but exposure on its own did not explain the presence or absence of either curative efficacy or in vivo toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoblykxGQ8NbVg90H21EOLACvtfcHk0ljoQRgEalIFuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslaitQ%253D%253D&md5=132212a3a83d1065f72151984f7c4c27</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01586%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKamaraj%26aufirst%3DS.%26aulast%3DBulbule%26aufirst%3DV.%2BJ.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DDhanasekaran%26aufirst%3DM.%26aulast%3DHein%26aufirst%3DC.%2BD.%26aulast%3DPapastogiannidis%26aufirst%3DP.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DBarker%26aufirst%3DH.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DStructure-activity%2520relationship%2520of%2520the%2520antimalarial%2520ozonide%2520artefenomel%2520%2528OZ439%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2654%26epage%3D2668%26doi%3D10.1021%2Facs.jmedchem.6b01586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, Y. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemparte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and specific <i>M. tuberculosis</i> leucyl-tRNA synthetase inhibitor: (<i>S</i>)-3-(aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[<i>c</i>][1,2]oxaborol-1(3H)-ol (GSK656)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8011</span>– <span class="NLM_lpage">8026</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00631</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00631" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8011-8026&author=X.+Liauthor=V.+Hernandezauthor=F.+L.+Rockauthor=W.+Choiauthor=Y.+S.+L.+Makauthor=M.+Mohanauthor=W.+Maoauthor=Y.+Zhouauthor=E.+E.+Easomauthor=J.+J.+Plattnerauthor=W.+Zouauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=I.+Giordanoauthor=A.+Mendoza-Losanaauthor=C.+Alemparteauthor=J.+Rullasauthor=I.+Angulo-Barturenauthor=S.+Crouchauthor=F.+Ortegaauthor=D.+Barrosauthor=M.+R.+K.+Alley&title=Discovery+of+a+potent+and+specific+M.+tuberculosis+leucyl-tRNA+synthetase+inhibitor%3A+%28S%29-3-%28aminomethyl%29-4-chloro-7-%282-hydroxyethoxy%29benzo%5Bc%5D%5B1%2C2%5Doxaborol-1%283H%29-ol+%28GSK656%29&doi=10.1021%2Facs.jmedchem.7b00631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and specific M. tuberculosis leucyl-tRNA synthetase inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)</span></div><div class="casAuthors">Li, Xianfeng; Hernandez, Vincent; Rock, Fernando L.; Choi, Wai; Mak, Yvonne S. L.; Mohan, Manisha; Mao, Weimin; Zhou, Yasheen; Easom, Eric E.; Plattner, Jacob J.; Zou, Wuxin; Perez-Herran, Esther; Giordano, Ilaria; Mendoza-Losana, Alfonso; Alemparte, Carlos; Rullas, Joaquin; Angulo-Barturen, Inigo; Crouch, Sabrinia; Ortega, Fatima; Barros, David; Alley, M. R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8011-8026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic boronate monoesters I (X = Cl, Br; R1, R2 = alkoxy, aryloxy, 2-hydroxyethyl; R1R2 = OCH2O, OCH2CH2O) were prepd. by cyclization of substituted 2-boronobenzaldehydes with nitromethane with subsequent nitro-group redn. and examd. in vitro for their inhibition of M. tuberculosis leucyl-tRNA synthetase (Mtb LeuRS) and in vivo in a mouse model of acute TB infection.  There is an urgent need to develop new and safer antitubercular agents that possess a novel mode of action.  We synthesized and evaluated a novel series of 3-aminomethyl 4-halogen benzoxaboroles as Mycobacterium tuberculosis (Mtb) leucyl-tRNA synthetase (LeuRS) inhibitors.  A no. of Mtb LeuRS inhibitors were identified that demonstrated good antitubercular activity with high selectivity over human mitochondrial and cytoplasmic LeuRS.  Further evaluation of these Mtb LeuRS inhibitors by in vivo pharmacokinetics (PK) and murine tuberculosis (TB) efficacy models led to the discovery of GSK3036656 (abbreviated as GSK656).  This mol. shows potent inhibition of Mtb LeuRS (IC50 = 0.20 μM) and in vitro antitubercular activity (Mtb H37Rv MIC = 0.08 μM).  Addnl., it is highly selective for the Mtb LeuRS enzyme with IC50 of >300 μM and 132 μM for human mitochondrial LeuRS and human cytoplasmic LeuRS, resp.  In addn., it exhibits remarkable PK profiles and efficacy against Mtb in mouse TB infection models with superior tolerability over initial leads.  This compd. has been progressed to clin. development for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2t6WBCJKOrVg90H21EOLACvtfcHk0ljoQRgEalIFuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ&md5=c5626f1a1028f79e175a07cb6c01ec44</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00631%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DMak%26aufirst%3DY.%2BS.%2BL.%26aulast%3DMohan%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DAlemparte%26aufirst%3DC.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DCrouch%26aufirst%3DS.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520specific%2520M.%2520tuberculosis%2520leucyl-tRNA%2520synthetase%2520inhibitor%253A%2520%2528S%2529-3-%2528aminomethyl%2529-4-chloro-7-%25282-hydroxyethoxy%2529benzo%255Bc%255D%255B1%252C2%255Doxaborol-1%25283H%2529-ol%2520%2528GSK656%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8011%26epage%3D8026%26doi%3D10.1021%2Facs.jmedchem.7b00631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, A. S.</span></span> <span> </span><span class="NLM_article-title">Development of a dual-acting antibacterial agent (TNP-2092) for the treatment of persistent bacterial infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6645</span>– <span class="NLM_lpage">6657</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00485</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGjtLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6645-6657&author=Z.+Maauthor=A.+S.+Lynch&title=Development+of+a+dual-acting+antibacterial+agent+%28TNP-2092%29+for+the+treatment+of+persistent+bacterial+infections&doi=10.1021%2Facs.jmedchem.6b00485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections</span></div><div class="casAuthors">Ma, Zhenkun; Lynch, Anthony Simon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6645-6657</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The clin. management of prosthetic joint infections and other persistent bacterial infections represents a major unmet medical need.  The rifamycins are one of the most potent antibiotic classes against persistent bacterial infections, but bacteria can develop resistance to rifamycins rapidly and the clin. utility of the rifamycin class is typically limited to antibiotic combinations to minimize the development of resistance.  To develop a better therapy against persistent bacterial infections, a series of rifamycin based bifunctional mols. were designed, synthesized, and evaluated with the goal to identify a dual-acting drug that maintains the potent activity of rifamycins against persistent pathogens and at the same time minimize the development of rifamycin resistance.  TNP-2092 was identified as a drug candidate and is currently in an early stage of clin. development for the treatment of prosthetic joint infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohWz-3Ax6Pr7Vg90H21EOLACvtfcHk0lh1-fEZTloFhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGjtLvK&md5=ab1dbd2eefc19496ed12d695bc093285</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00485%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLynch%26aufirst%3DA.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520dual-acting%2520antibacterial%2520agent%2520%2528TNP-2092%2529%2520for%2520the%2520treatment%2520of%2520persistent%2520bacterial%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6645%26epage%3D6657%26doi%3D10.1021%2Facs.jmedchem.6b00485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jussif, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unwalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langille, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Design of a janus kinase 3 (JAK3) specific inhibitor 1-((2<i>S</i>,5<i>R</i>)-5-((7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) allowing for the interrogation of JAK3 signaling in humans</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1971</span>– <span class="NLM_lpage">1993</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1971-1993&author=A.+Thorarensenauthor=M.+E.+Dowtyauthor=M.+E.+Bankerauthor=B.+Jubaauthor=J.+Jussifauthor=T.+Linauthor=F.+Vincentauthor=R.+M.+Czerwinskiauthor=A.+Casimiro-Garciaauthor=R.+Unwallaauthor=J.+I.+Trujilloauthor=S.+Liangauthor=P.+Balboauthor=Y.+Cheauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+Haywardauthor=J.+Montgomeryauthor=L.+Leungauthor=X.+Yangauthor=S.+Soucyauthor=M.+Hegenauthor=J.+Coeauthor=J.+Langilleauthor=F.+Vajdosauthor=J.+Chrencikauthor=J.-B.+Telliez&title=Design+of+a+janus+kinase+3+%28JAK3%29+specific+inhibitor+1-%28%282S%2C5R%29-5-%28%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29amino%29-2-methylpiperidin-1-yl%29prop-2-en-1-one+%28PF-06651600%29+allowing+for+the+interrogation+of+JAK3+signaling+in+humans&doi=10.1021%2Facs.jmedchem.6b01694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans</span></div><div class="casAuthors">Thorarensen, Atli; Dowty, Martin E.; Banker, Mary Ellen; Juba, Brian; Jussif, Jason; Lin, Tsung; Vincent, Fabien; Czerwinski, Robert M.; Casimiro-Garcia, Agustin; Unwalla, Ray; Trujillo, John I.; Liang, Sidney; Balbo, Paul; Che, Ye; Gilbert, Adam M.; Brown, Matthew F.; Hayward, Matthew; Montgomery, Justin; Leung, Louis; Yang, Xin; Soucy, Sarah; Hegen, Martin; Coe, Jotham; Langille, Jonathan; Vajdos, Felix; Chrencik, Jill; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1971-1993</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant work has been dedicated to the discovery of JAK kinase inhibitors resulting in several compds. entering clin. development and two FDA approved NMEs.  However, despite significant effort during the past two decades, identification of highly selective JAK3 inhibitors has eluded the scientific community.  A significant effort within the research organization has resulted in the identification of the first orally active JAK3 specific inhibitor, which achieves JAK isoform specificity through covalent interaction with a unique JAK3 residue Cys-909.  The relatively rapid resynthesis rate of the JAK3 enzyme presented a unique challenge in the design of covalent inhibitors with appropriate pharmacodynamics properties coupled with limited unwanted off-target reactivity.  This effort resulted in the identification of PF-06651600 I, a potent and low clearance compd. with demonstrated in vivo efficacy.  The favorable efficacy and safety profile of this specific JAK3 inhibitor I led to its evaluation in several human clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodS6VFIL07nrVg90H21EOLACvtfcHk0lh1-fEZTloFhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D&md5=d1ab749203fae07f89463f97518e3db8</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01694%26sid%3Dliteratum%253Aachs%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DJuba%26aufirst%3DB.%26aulast%3DJussif%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DBalbo%26aufirst%3DP.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DHayward%26aufirst%3DM.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DSoucy%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DChrencik%26aufirst%3DJ.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDesign%2520of%2520a%2520janus%2520kinase%25203%2520%2528JAK3%2529%2520specific%2520inhibitor%25201-%2528%25282S%252C5R%2529-5-%2528%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529amino%2529-2-methylpiperidin-1-yl%2529prop-2-en-1-one%2520%2528PF-06651600%2529%2520allowing%2520for%2520the%2520interrogation%2520of%2520JAK3%2520signaling%2520in%2520humans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1971%26epage%3D1993%26doi%3D10.1021%2Facs.jmedchem.6b01694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabnis, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortum, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a pan-janus kinase inhibitor clinical candidate (PF-06263276) suitable for inhaled and topical delivery for the treatment of inflammatory diseases of the lungs and skin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01634</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01634" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSnsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=767-786&author=P.+Jonesauthor=R.+I.+Storerauthor=Y.+A.+Sabnisauthor=F.+M.+Wakenhutauthor=G.+A.+Whitlockauthor=K.+S.+Englandauthor=T.+Mukaiyamaauthor=C.+M.+Dehnhardtauthor=J.+W.+Coeauthor=S.+W.+Kortumauthor=J.+E.+Chrencikauthor=D.+G.+Brownauthor=R.+M.+Jonesauthor=J.+R.+Murphyauthor=T.+Yeohauthor=P.+Morganauthor=I.+Kilty&title=Design+and+synthesis+of+a+pan-janus+kinase+inhibitor+clinical+candidate+%28PF-06263276%29+suitable+for+inhaled+and+topical+delivery+for+the+treatment+of+inflammatory+diseases+of+the+lungs+and+skin&doi=10.1021%2Facs.jmedchem.6b01634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin</span></div><div class="casAuthors">Jones, Peter; Storer, R. Ian; Sabnis, Yogesh A.; Wakenhut, Florian M.; Whitlock, Gavin A.; England, Katherine S.; Mukaiyama, Takasuke; Dehnhardt, Christoph M.; Coe, Jotham W.; Kortum, Steve W.; Chrencik, Jill E.; Brown, David G.; Jones, Rhys M.; Murphy, John R.; Yeoh, Thean; Morgan, Paul; Kilty, Iain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">767-786</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a structure-based computational method for identification of structurally novel JAK inhibitors predicted to bind beyond the ATP binding site, a potent series of indazoles was identified as selective pan-JAK inhibitors with a type 1.5 binding mode.  Optimization of the series for potency and increased duration of action commensurate with inhaled or topical delivery resulted in PF-06263276 which was advanced into clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEt2oMBlGsBbVg90H21EOLACvtfcHk0lh1-fEZTloFhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSnsr3J&md5=a69247c21ff53a3b7d9c63cf0af72101</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01634%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DWakenhut%26aufirst%3DF.%2BM.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26aulast%3DEngland%26aufirst%3DK.%2BS.%26aulast%3DMukaiyama%26aufirst%3DT.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DKortum%26aufirst%3DS.%2BW.%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DMurphy%26aufirst%3DJ.%2BR.%26aulast%3DYeoh%26aufirst%3DT.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DKilty%26aufirst%3DI.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520pan-janus%2520kinase%2520inhibitor%2520clinical%2520candidate%2520%2528PF-06263276%2529%2520suitable%2520for%2520inhaled%2520and%2520topical%2520delivery%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%2520of%2520the%2520lungs%2520and%2520skin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D767%26epage%3D786%26doi%3D10.1021%2Facs.jmedchem.6b01634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vossenkamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1247-1261&author=P.+A.+Harrisauthor=S.+B.+Bergerauthor=J.+U.+Jeongauthor=R.+Nagillaauthor=D.+Bandyopadhyayauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=J.+Kangauthor=V.+Kasparcovaauthor=B.+W.+Kingauthor=R.+Lehrauthor=Y.+Lanauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=T.+T.+MacDonaldauthor=N.+A.+Millerauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+Rahmanauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=R.+R.+Singhausauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=A.+Vossenkamperauthor=P.+Wardauthor=D.+D.+Wisnoskiauthor=D.+Zhangauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Discovery+of+a+first-in-class+receptor+interacting+protein+1+%28RIP1%29+kinase+specific+clinical+candidate+%28GSK2982772%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facs.jmedchem.6b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases</span></div><div class="casAuthors">Harris, Philip A.; Berger, Scott B.; Jeong, Jae U.; Nagilla, Rakesh; Bandyopadhyay, Deepak; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Eidam, Patrick M.; Finger, Joshua N.; Hoffman, Sandra J.; Kang, James; Kasparcova, Viera; King, Bryan W.; Lehr, Ruth; Lan, Yunfeng; Leister, Lara K.; Lich, John D.; MacDonald, Thomas T.; Miller, Nathan A.; Ouellette, Michael T.; Pao, Christina S.; Rahman, Attiq; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Schaeffer, Michelle C.; Sehon, Clark A.; Singhaus, Robert R.; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Vossenkamper, Anna; Ward, Paris; Wisnoski, David D.; Zhang, Daohua; Marquis, Robert W.; Gough, Peter J.; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1247-1261</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases.  Small-mol. inhibitors of RIP1 kinase that are suitable for advancement into the clinic have yet to be described.  Herein, the authors report the lead optimization of a benzoxazepinone hit from a DNA-encoded library and the discovery and profile of clin. candidate GSK2982772 (compd. I), currently in phase 2a clin. studies for psoriasis, rheumatoid arthritis, and ulcerative colitis.  Compd. I potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses.  Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous prodn. of cytokines from human ulcerative colitis explants.  The highly favorable physicochem. and ADMET properties of I, combined with high potency, led to a predicted low oral dose in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGRDTQv-vs7Vg90H21EOLACvtfcHk0ljtNvZkJi06AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D&md5=ee0c3c60bb1351dff696490ac9edb1cc</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01751%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMacDonald%26aufirst%3DT.%2BT.%26aulast%3DMiller%26aufirst%3DN.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSinghaus%26aufirst%3DR.%2BR.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DVossenkamper%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520specific%2520clinical%2520candidate%2520%2528GSK2982772%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1247%26epage%3D1261%26doi%3D10.1021%2Facs.jmedchem.6b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-{4-[5-(4-fluorophenyl)-3-methyl-2-methylsulfanyl-3<i>H</i>-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a dual p38α MAPK/PDE-4 inhibitor with activity against TNFα-related diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5290</span>– <span class="NLM_lpage">5305</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVSjtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5290-5305&author=W.+Albrechtauthor=A.+Ungerauthor=S.+M.+Bauerauthor=S.+A.+Laufer&title=Discovery+of+N-%7B4-%5B5-%284-fluorophenyl%29-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl%5D-pyridin-2-yl%7D-acetamide+%28CBS-3595%29%2C+a+dual+p38%CE%B1+MAPK%2FPDE-4+inhibitor+with+activity+against+TNF%CE%B1-related+diseases&doi=10.1021%2Facs.jmedchem.6b01647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-{4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a Dual p38α MAPK/PDE-4 Inhibitor with Activity against TNFα-Related Diseases</span></div><div class="casAuthors">Albrecht, Wolfgang; Unger, Anke; Bauer, Silke M.; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5290-5305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The anti-inflammatory potential of p38 mitogen-activated protein kinase (MAPK) inhibitors was coincidentally expanded to a dual inhibition of p38α MAPK and phosphodiesterase 4 (PDE4), and the potential benefits arising from the blockage of both inflammation-related enzymes were thoroughly investigated.  The most promising compd., CBS-3595 (1), was successively evaluated in in vitro expts. as well as in ex vivo and in vivo preclin. studies after administration of 1 to rodents, dogs, and monkeys.  The resulting data clearly indicated a potent suppression of tumor necrosis factor alpha release.  For reconfirming the findings of the animal studies when administering 1 to healthy human volunteers, a phase I clin. trial was conducted.  Apart from further information regarding the pharmacokinetic and pharmacodynamic characteristics of 1, it was demonstrated that dual inhibition of p38α MAPK and PDE4 is able to synergistically attenuate the excessive anti-inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn0tCfKq3bG7Vg90H21EOLACvtfcHk0lh-RKooyCWhwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVSjtrvL&md5=fb0a040161db70ade8a3032b0c978537</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01647%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DW.%26aulast%3DUnger%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DDiscovery%2520of%2520N-%257B4-%255B5-%25284-fluorophenyl%2529-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl%255D-pyridin-2-yl%257D-acetamide%2520%2528CBS-3595%2529%252C%2520a%2520dual%2520p38%25CE%25B1%2520MAPK%252FPDE-4%2520inhibitor%2520with%2520activity%2520against%2520TNF%25CE%25B1-related%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5290%26epage%3D5305%26doi%3D10.1021%2Facs.jmedchem.6b01647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambler, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscoe, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bree, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodfuehrer, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dower, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drozda, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrin, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hope, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papaioannou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samardjiev, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samas, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soutter, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohbach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symanowicz, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomason, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzupek, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 1-{[(2<i>S</i>,3<i>S</i>,4<i>S</i>)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a potent, selective inhibitor of interleukin-1 receptor associated kinase 4 (IRAK4), by fragment-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5521</span>– <span class="NLM_lpage">5542</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5521-5542&author=K.+L.+Leeauthor=C.+M.+Amblerauthor=D.+R.+Andersonauthor=B.+P.+Boscoeauthor=A.+G.+Breeauthor=J.+I.+Brodfuehrerauthor=J.+S.+Changauthor=C.+Choiauthor=S.+Chungauthor=K.+J.+Curranauthor=J.+E.+Dayauthor=C.+M.+Dehnhardtauthor=K.+Dowerauthor=S.+E.+Drozdaauthor=R.+K.+Frisbieauthor=L.+K.+Gavrinauthor=J.+A.+Goldbergauthor=S.+Hanauthor=M.+Hegenauthor=D.+Hepworthauthor=H.+R.+Hopeauthor=S.+Kamtekarauthor=I.+C.+Kiltyauthor=A.+Leeauthor=L.-L.+Linauthor=F.+E.+Loveringauthor=M.+D.+Loweauthor=J.+P.+Mathiasauthor=H.+M.+Morganauthor=E.+A.+Murphyauthor=N.+Papaioannouauthor=A.+Patnyauthor=B.+S.+Pierceauthor=V.+R.+Raoauthor=E.+Saiahauthor=I.+J.+Samardjievauthor=B.+M.+Samasauthor=M.+W.+H.+Shenauthor=J.+H.+Shinauthor=H.+H.+Soutterauthor=J.+W.+Strohbachauthor=P.+T.+Symanowiczauthor=J.+R.+Thomasonauthor=J.+D.+Trzupekauthor=R.+Vargasauthor=F.+Vincentauthor=J.+Yanauthor=C.+W.+Zapfauthor=S.+W.+Wright&title=Discovery+of+clinical+candidate+1-%7B%5B%282S%2C3S%2C4S%29-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%5Dmethoxy%7D-7-methoxyisoquinoline-6-carboxamide+%28PF-06650833%29%2C+a+potent%2C+selective+inhibitor+of+interleukin-1+receptor+associated+kinase+4+%28IRAK4%29%2C+by+fragment-based+drug+design&doi=10.1021%2Facs.jmedchem.7b00231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design</span></div><div class="casAuthors">Lee, Katherine L.; Ambler, Catherine M.; Anderson, David R.; Boscoe, Brian P.; Bree, Andrea G.; Brodfuehrer, Joanne I.; Chang, Jeanne S.; Choi, Chulho; Chung, Seungwon; Curran, Kevin J.; Day, Jacqueline E.; Dehnhardt, Christoph M.; Dower, Ken; Drozda, Susan E.; Frisbie, Richard K.; Gavrin, Lori K.; Goldberg, Joel A.; Han, Seungil; Hegen, Martin; Hepworth, David; Hope, Heidi R.; Kamtekar, Satwik; Kilty, Iain C.; Lee, Arthur; Lin, Lih-Ling; Lovering, Frank E.; Lowe, Michael D.; Mathias, John P.; Morgan, Heidi M.; Murphy, Elizabeth A.; Papaioannou, Nikolaos; Patny, Akshay; Pierce, Betsy S.; Rao, Vikram R.; Saiah, Eddine; Samardjiev, Ivan J.; Samas, Brian M.; Shen, Marina W. H.; Shin, Julia H.; Soutter, Holly H.; Strohbach, Joseph W.; Symanowicz, Peter T.; Thomason, Jennifer R.; Trzupek, John D.; Vargas, Richard; Vincent, Fabien; Yan, Jiangli; Zapf, Christoph W.; Wright, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5521-5542</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through fragment-based drug design focused on engaging the active site of IRAK4 and leveraging three-dimensional topol. in a ligand-efficient manner, a micromolar hit identified from a screen of a Pfizer fragment library was optimized to afford IRAK4 inhibitors with nanomolar potency in cellular assays.  The medicinal chem. effort featured the judicious placement of lipophilicity, informed by cocrystal structures with IRAK4 and optimization of ADME properties to deliver clin. candidate I.  This compd. benefitted from a 5-unit increase in lipophilic efficiency from the fragment hit, excellent kinase selectivity, and pharmacokinetic properties suitable for oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrCep64bhMbVg90H21EOLACvtfcHk0lh-RKooyCWhwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D&md5=9771ad2d33089f6ef3dba3556536ff1a</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00231%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BL.%26aulast%3DAmbler%26aufirst%3DC.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DBree%26aufirst%3DA.%2BG.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%2BI.%26aulast%3DChang%26aufirst%3DJ.%2BS.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DCurran%26aufirst%3DK.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DDower%26aufirst%3DK.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DFrisbie%26aufirst%3DR.%2BK.%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DGoldberg%26aufirst%3DJ.%2BA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DKilty%26aufirst%3DI.%2BC.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.-L.%26aulast%3DLovering%26aufirst%3DF.%2BE.%26aulast%3DLowe%26aufirst%3DM.%2BD.%26aulast%3DMathias%26aufirst%3DJ.%2BP.%26aulast%3DMorgan%26aufirst%3DH.%2BM.%26aulast%3DMurphy%26aufirst%3DE.%2BA.%26aulast%3DPapaioannou%26aufirst%3DN.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DRao%26aufirst%3DV.%2BR.%26aulast%3DSaiah%26aufirst%3DE.%26aulast%3DSamardjiev%26aufirst%3DI.%2BJ.%26aulast%3DSamas%26aufirst%3DB.%2BM.%26aulast%3DShen%26aufirst%3DM.%2BW.%2BH.%26aulast%3DShin%26aufirst%3DJ.%2BH.%26aulast%3DSoutter%26aufirst%3DH.%2BH.%26aulast%3DStrohbach%26aufirst%3DJ.%2BW.%26aulast%3DSymanowicz%26aufirst%3DP.%2BT.%26aulast%3DThomason%26aufirst%3DJ.%2BR.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DR.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DWright%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25201-%257B%255B%25282S%252C3S%252C4S%2529-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%255Dmethoxy%257D-7-methoxyisoquinoline-6-carboxamide%2520%2528PF-06650833%2529%252C%2520a%2520potent%252C%2520selective%2520inhibitor%2520of%2520interleukin-1%2520receptor%2520associated%2520kinase%25204%2520%2528IRAK4%2529%252C%2520by%2520fragment-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5521%26epage%3D5542%26doi%3D10.1021%2Facs.jmedchem.7b00231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watterson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucca, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langevine, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin Bertrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traeger, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattoli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermeier, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Discenza, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arienzo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimrich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillooly, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulicicchio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galella, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckelbauer, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampulla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 6-fluoro-5-(<i>R</i>)-(3-(<i>S</i>)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)-2-methylphenyl)-2-(<i>S</i>)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1<i>H</i>-carbazole-8-carboxamide (BMS-986142): A reversible inhibitor of Bruton’s tyrosine kinase (BTK) conformationally constrained by two locked atropisomers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9173</span>– <span class="NLM_lpage">9200</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01088</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKjsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9173-9200&author=S.+H.+Wattersonauthor=G.+V.+De+Luccaauthor=Q.+Shiauthor=C.+M.+Langevineauthor=Q.+Liuauthor=D.+G.+Battauthor=M.+Beaudoin+Bertrandauthor=H.+Gongauthor=J.+Daiauthor=S.+Yipauthor=P.+Liauthor=D.+Sunauthor=D.-R.+Wuauthor=C.+Wangauthor=Y.+Zhangauthor=S.+C.+Traegerauthor=M.+A.+Pattoliauthor=S.+Skalaauthor=L.+Chengauthor=M.+T.+Obermeierauthor=R.+Vickeryauthor=L.+N.+Discenzaauthor=C.+J.+D%E2%80%99Arienzoauthor=Y.+Zhangauthor=E.+Heimrichauthor=K.+M.+Gilloolyauthor=T.+L.+Taylorauthor=C.+Pulicicchioauthor=K.+W.+McIntyreauthor=M.+A.+Galellaauthor=A.+J.+Tebbenauthor=J.+K.+Muckelbauerauthor=C.+Y.+Changauthor=R.+Rampullaauthor=A.+Mathurauthor=L.+Salter-Cidauthor=J.+C.+Barrishauthor=P.+H.+Carterauthor=A.+Furaauthor=J.+R.+Burkeauthor=J.+A.+Tino&title=Discovery+of+6-fluoro-5-%28R%29-%283-%28S%29-%288-fluoro-1-methyl-2%2C4-dioxo-1%2C2-dihydroquinazolin-3%284H%29-yl%29-2-methylphenyl%29-2-%28S%29-%282-hydroxypropan-2-yl%29-2%2C3%2C4%2C9-tetrahydro-1H-carbazole-8-carboxamide+%28BMS-986142%29%3A+A+reversible+inhibitor+of+Bruton%E2%80%99s+tyrosine+kinase+%28BTK%29+conformationally+constrained+by+two+locked+atropisomers&doi=10.1021%2Facs.jmedchem.6b01088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton's Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers</span></div><div class="casAuthors">Watterson, Scott H.; De Lucca, George V.; Shi, Qing; Langevine, Charles M.; Liu, Qingjie; Batt, Douglas G.; Beaudoin Bertrand, Myra; Gong, Hua; Dai, Jun; Yip, Shiuhang; Li, Peng; Sun, Dawn; Wu, Dauh-Rurng; Wang, Chunlei; Zhang, Yingru; Traeger, Sarah C.; Pattoli, Mark A.; Skala, Stacey; Cheng, Lihong; Obermeier, Mary T.; Vickery, Rodney; Discenza, Lorell N.; D'Arienzo, Celia J.; Zhang, Yifan; Heimrich, Elizabeth; Gillooly, Kathleen M.; Taylor, Tracy L.; Pulicicchio, Claudine; McIntyre, Kim W.; Galella, Michael A.; Tebben, Andy J.; Muckelbauer, Jodi K.; Chang, ChiehYing; Rampulla, Richard; Mathur, Arvind; Salter-Cid, Luisa; Barrish, Joel C.; Carter, Percy H.; Fura, Aberra; Burke, James R.; Tino, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9173-9200</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bruton's tyrosine kinase (BTK), a nonreceptor tyrosine kinase, is a member of the Tec family of kinases.  BTK plays an essential role in B cell receptor (BCR)-mediated signaling as well as Fcγ receptor signaling in monocytes and Fcε receptor signaling in mast cells and basophils, all of which have been implicated in the pathophysiol. of autoimmune disease.  As a result, inhibition of BTK is anticipated to provide an effective strategy for the clin. treatment of autoimmune diseases such as lupus and rheumatoid arthritis.  This article details the structure-activity relationships (SAR) leading to a novel series of highly potent and selective carbazole and tetrahydrocarbazole based, reversible inhibitors of BTK.  Of particular interest is that two atropisomeric centers were rotationally locked to provide a single, stable atropisomer, resulting in enhanced potency and selectivity as well as a redn. in safety liabilities.  With significantly enhanced potency and selectivity, excellent in vivo properties and efficacy, and a very desirable tolerability and safety profile, 14f (BMS-986142) was advanced into clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpBAygRAsYrVg90H21EOLACvtfcHk0ljKXvkVGGGchg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKjsrfF&md5=91098abc802521b9ad91563d20ac5893</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01088%26sid%3Dliteratum%253Aachs%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DDe%2BLucca%26aufirst%3DG.%2BV.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DLangevine%26aufirst%3DC.%2BM.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DBatt%26aufirst%3DD.%2BG.%26aulast%3DBeaudoin%2BBertrand%26aufirst%3DM.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DYip%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DD.-R.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26aulast%3DPattoli%26aufirst%3DM.%2BA.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DObermeier%26aufirst%3DM.%2BT.%26aulast%3DVickery%26aufirst%3DR.%26aulast%3DDiscenza%26aufirst%3DL.%2BN.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHeimrich%26aufirst%3DE.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DTaylor%26aufirst%3DT.%2BL.%26aulast%3DPulicicchio%26aufirst%3DC.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DGalella%26aufirst%3DM.%2BA.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DRampulla%26aufirst%3DR.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DTino%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%25206-fluoro-5-%2528R%2529-%25283-%2528S%2529-%25288-fluoro-1-methyl-2%252C4-dioxo-1%252C2-dihydroquinazolin-3%25284H%2529-yl%2529-2-methylphenyl%2529-2-%2528S%2529-%25282-hydroxypropan-2-yl%2529-2%252C3%252C4%252C9-tetrahydro-1H-carbazole-8-carboxamide%2520%2528BMS-986142%2529%253A%2520A%2520reversible%2520inhibitor%2520of%2520Bruton%25E2%2580%2599s%2520tyrosine%2520kinase%2520%2528BTK%2529%2520conformationally%2520constrained%2520by%2520two%2520locked%2520atropisomers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9173%26epage%3D9200%26doi%3D10.1021%2Facs.jmedchem.6b01088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippy, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckelbauer, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J. A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton’s tyrosine kinase (BTK) and janus kinase (JAK2)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4265</span>– <span class="NLM_lpage">4269</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2015.07.102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4265-4269&author=Q.+Liuauthor=D.+G.+Battauthor=J.+S.+Lippyauthor=N.+Surtiauthor=A.+J.+Tebbenauthor=J.+K.+Muckelbauerauthor=L.+Chenauthor=Y.+Anauthor=C.+Changauthor=M.+Pokrossauthor=Z.+Yangauthor=H.+Wangauthor=J.+R.+Burkeauthor=P.+H.+Carterauthor=J.+A.+Tino&title=Design+and+synthesis+of+carbazole+carboxamides+as+promising+inhibitors+of+Bruton%E2%80%99s+tyrosine+kinase+%28BTK%29+and+janus+kinase+%28JAK2%29&doi=10.1016%2Fj.bmcl.2015.07.102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.102%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DBatt%26aufirst%3DD.%2BG.%26aulast%3DLippy%26aufirst%3DJ.%2BS.%26aulast%3DSurti%26aufirst%3DN.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DPokross%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DTino%26aufirst%3DJ.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520carbazole%2520carboxamides%2520as%2520promising%2520inhibitors%2520of%2520Bruton%25E2%2580%2599s%2520tyrosine%2520kinase%2520%2528BTK%2529%2520and%2520janus%2520kinase%2520%2528JAK2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4265%26epage%3D4269%26doi%3D10.1016%2Fj.bmcl.2015.07.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs over 30 years from 1981 to 2010</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1021/np200906s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200906s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=311-335&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+30+years+from+1981+to+2010&doi=10.1021%2Fnp200906s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fnp200906s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200906s%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%252030%2520years%2520from%25201981%2520to%25202010%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D311%26epage%3D335%26doi%3D10.1021%2Fnp200906s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macarron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojanic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirovic, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garyantes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzen, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paslay, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schopfer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sittampalam, G. S.</span></span> <span> </span><span class="NLM_article-title">Impact of high-throughput screening in biomedical research</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1038/nrd3368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd3368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=21358738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=188-195&author=R.+Macarronauthor=M.+N.+Banksauthor=D.+Bojanicauthor=D.+J.+Burnsauthor=D.+A.+Cirovicauthor=T.+Garyantesauthor=D.+V.+S.+Greenauthor=R.+P.+Hertzbergauthor=W.+P.+Janzenauthor=J.+W.+Paslayauthor=U.+Schopferauthor=G.+S.+Sittampalam&title=Impact+of+high-throughput+screening+in+biomedical+research&doi=10.1038%2Fnrd3368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of high-throughput screening in biomedical research</span></div><div class="casAuthors">Macarron, Ricardo; Banks, Martyn N.; Bojanic, Dejan; Burns, David J.; Cirovic, Dragan A.; Garyantes, Tina; Green, Darren V. S.; Hertzberg, Robert P.; Janzen, William P.; Paslay, Jeff W.; Schopfer, Ulrich; Sittampalam, G. Sitta</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">188-195</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  High-throughput screening (HTS) has been postulated in several quarters to be a contributory factor to the decline in productivity in the pharmaceutical industry.  Moreover, it has been blamed for stifling the creativity that drug discovery demands.  In this article, we aim to dispel these myths and present the case for the use of HTS as part of a proven scientific tool kit, the wider use of which is essential for the discovery of new chemotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLnrSVehADbLVg90H21EOLACvtfcHk0li1hjjXKjYRNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D&md5=cb9853227506f3a3d774791cff9fd79d</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fnrd3368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3368%26sid%3Dliteratum%253Aachs%26aulast%3DMacarron%26aufirst%3DR.%26aulast%3DBanks%26aufirst%3DM.%2BN.%26aulast%3DBojanic%26aufirst%3DD.%26aulast%3DBurns%26aufirst%3DD.%2BJ.%26aulast%3DCirovic%26aufirst%3DD.%2BA.%26aulast%3DGaryantes%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%26aulast%3DHertzberg%26aufirst%3DR.%2BP.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DPaslay%26aufirst%3DJ.%2BW.%26aulast%3DSchopfer%26aufirst%3DU.%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26atitle%3DImpact%2520of%2520high-throughput%2520screening%2520in%2520biomedical%2520research%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D188%26epage%3D195%26doi%3D10.1038%2Fnrd3368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wassermann, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camargo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span> <span> </span><span class="NLM_article-title">Composition and applications of focus libraries to phenotypic assays</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.3389/fphar.2014.00164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.3389%2Ffphar.2014.00164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=24478702" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1-12&author=A.+M.+Wassermannauthor=L.+M.+Camargoauthor=D.+S.+Auld&title=Composition+and+applications+of+focus+libraries+to+phenotypic+assays&doi=10.3389%2Ffphar.2014.00164"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2014.00164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2014.00164%26sid%3Dliteratum%253Aachs%26aulast%3DWassermann%26aufirst%3DA.%2BM.%26aulast%3DCamargo%26aufirst%3DL.%2BM.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26atitle%3DComposition%2520and%2520applications%2520of%2520focus%2520libraries%2520to%2520phenotypic%2520assays%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D5%26spage%3D1%26epage%3D12%26doi%3D10.3389%2Ffphar.2014.00164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-lead medicincal chemistry publications in 2015</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=89-99&author=C.+N.+Johnsonauthor=D.+A.+Erlansonauthor=C.+W.+Murrayauthor=D.+C.+Rees&title=Fragment-to-lead+medicincal+chemistry+publications+in+2015&doi=10.1021%2Facs.jmedchem.6b01123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01123%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DFragment-to-lead%2520medicincal%2520chemistry%2520publications%2520in%25202015%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D89%26epage%3D99%26doi%3D10.1021%2Facs.jmedchem.6b01123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-lead medicinal chemistry publications in 2016</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1774</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslentrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1774-1784&author=C.+N.+Johnsonauthor=D.+A.+Erlansonauthor=W.+Jahnkeauthor=P.+N.+Mortensonauthor=D.+C.+Rees&title=Fragment-to-lead+medicinal+chemistry+publications+in+2016&doi=10.1021%2Facs.jmedchem.7b01298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2016</span></div><div class="casAuthors">Johnson, Christopher N.; Erlanson, Daniel A.; Jahnke, Wolfgang; Mortenson, Paul N.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1774-1784</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The popularity of fragment-based drug discovery (FBDD) is demonstrated by the no. of recent successful fragment-to-lead (F2L) publications.  This Miniperspective provides a tabulated summary of the F2L literature published in the year 2016, along with discussion of general trends.  It uses the same format as our summary of the 2015 literature and is intended to be a resource for both FBDD practitioners and medicinal chemists in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDiwnepXDgrbVg90H21EOLACvtfcHk0li1hjjXKjYRNg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslentrfP&md5=861d9adf1530250a060fc254ca7b493c</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01298%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DFragment-to-lead%2520medicinal%2520chemistry%2520publications%2520in%25202016%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1774%26epage%3D1784%26doi%3D10.1021%2Facs.jmedchem.7b01298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiez-Vandal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggeler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grebner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermansson, N.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jazayeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prihandoko, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soutter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troast, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiggin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhukov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, N.</span></span> <span> </span><span class="NLM_article-title">Structural insight into allosteric modulation of protease-activated receptor-2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>545</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1038/nature22309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnature22309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=545&publication_year=2017&pages=112-115&author=R.+K.+Y.+Chengauthor=C.+Fiez-Vandalauthor=O.+Schlenkerauthor=K.+Edmanauthor=B.+Aggelerauthor=D.+G.+Brownauthor=G.+Brownauthor=R.+Cookeauthor=C.+E.+Dumelinauthor=A.+S.+Dor%C3%A9author=S.+Geschwindnerauthor=C.+Grebnerauthor=N.-O.+Hermanssonauthor=A.+Jazayeriauthor=P.+Johanssonauthor=L.+Leongauthor=R.+Prihandokoauthor=M.+Rappasauthor=H.+Soutterauthor=A.+Snijderauthor=L.+Sundstr%C3%B6mauthor=B.+Tehanauthor=P.+Thorntonauthor=D.+Troastauthor=G.+Wigginauthor=A.+Zhukovauthor=F.+H.+Marshallauthor=N.+Dekker&title=Structural+insight+into+allosteric+modulation+of+protease-activated+receptor-2&doi=10.1038%2Fnature22309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fnature22309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22309%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DR.%2BK.%2BY.%26aulast%3DFiez-Vandal%26aufirst%3DC.%26aulast%3DSchlenker%26aufirst%3DO.%26aulast%3DEdman%26aufirst%3DK.%26aulast%3DAggeler%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DBrown%26aufirst%3DG.%26aulast%3DCooke%26aufirst%3DR.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DGrebner%26aufirst%3DC.%26aulast%3DHermansson%26aufirst%3DN.-O.%26aulast%3DJazayeri%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DLeong%26aufirst%3DL.%26aulast%3DPrihandoko%26aufirst%3DR.%26aulast%3DRappas%26aufirst%3DM.%26aulast%3DSoutter%26aufirst%3DH.%26aulast%3DSnijder%26aufirst%3DA.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DL.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DThornton%26aufirst%3DP.%26aulast%3DTroast%26aufirst%3DD.%26aulast%3DWiggin%26aufirst%3DG.%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DDekker%26aufirst%3DN.%26atitle%3DStructural%2520insight%2520into%2520allosteric%2520modulation%2520of%2520protease-activated%2520receptor-2%26jtitle%3DNature%26date%3D2017%26volume%3D545%26spage%3D112%26epage%3D115%26doi%3D10.1038%2Fnature22309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span> <span> </span><span class="NLM_article-title">Discovering drugs with DNA-encoded library technology: From concept to clinic with an inhibitor of soluble epoxide hydrolase</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1002/cbic.201700014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2Fcbic.201700014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=28281333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=837-842&author=S.+L.+Belyanskayaauthor=Y.+Dingauthor=J.+F.+Callahanauthor=A.+L.+Lazaarauthor=D.+I.+Israel&title=Discovering+drugs+with+DNA-encoded+library+technology%3A+From+concept+to+clinic+with+an+inhibitor+of+soluble+epoxide+hydrolase&doi=10.1002%2Fcbic.201700014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Belyanskaya, Svetlana L.; Ding, Yun; Callahan, James F.; Lazaar, Aili L.; Israel, David I.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">837-842</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">DNA-encoded chem. library technol. was developed with the vision of its becoming a transformational platform for drug discovery.  The hope was that a new paradigm for the discovery of low-mol.-wt. drugs would be enabled by combining the vast mol. diversity achievable with combinatorial chem., the information-encoding attributes of DNA, the power of mol. biol., and a streamlined selection-based discovery process.  Here, we describe the discovery and early clin. development of GSK2256294, an inhibitor of sol. epoxide hydrolase (sEH, EPHX2), by using encoded-library technol. (ELT).  GSK2256294 is an orally bioavailable, potent and selective inhibitor of sEH that has a long half life and produced no serious adverse events in a first-time-in-human clin. study.  To our knowledge, GSK2256294 is the first mol. discovered from this technol. to enter human clin. testing and represents a realization of the vision that DNA-encoded chem. library technol. can efficiently yield mols. with favorable properties that can be readily progressed into high-quality drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7WTPZp2SE0rVg90H21EOLACvtfcHk0liQC_L5E7H-eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D&md5=a34e28c8817864356f6ff689e9236940</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201700014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201700014%26sid%3Dliteratum%253Aachs%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26atitle%3DDiscovering%2520drugs%2520with%2520DNA-encoded%2520library%2520technology%253A%2520From%2520concept%2520to%2520clinic%2520with%2520an%2520inhibitor%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DChemBioChem%26date%3D2017%26volume%3D18%26spage%3D837%26epage%3D842%26doi%3D10.1002%2Fcbic.201700014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franzini, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, C.</span></span> <span> </span><span class="NLM_article-title">Chemical space of DNA-encoded libraries</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6629</span>– <span class="NLM_lpage">6644</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01874</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01874" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVOlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6629-6644&author=R.+M.+Franziniauthor=C.+Randolph&title=Chemical+space+of+DNA-encoded+libraries&doi=10.1021%2Facs.jmedchem.5b01874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Space of DNA-Encoded Libraries</span></div><div class="casAuthors">Franzini, Raphael M.; Randolph, Cassie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6629-6644</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, DNA-encoded chem. libraries (DECLs) have attracted considerable attention as a potential discovery tool in drug development.  Screening encoded libraries may offer advantages over conventional hit discovery approaches and has the potential to complement such methods in pharmaceutical research.  As a result of the increased application of encoded libraries in drug discovery, a growing no. of hit compds. are emerging in scientific literature.  In this review we evaluate reported encoded library-derived structures and identify general trends of these compds. in relation to library design parameters.  We in particular emphasize the combinatorial nature of these libraries.  Generally, the reported mols. demonstrate the ability of this technol. to afford hits suitable for further lead development, and on the basis of them, we derive guidelines for DECL design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLvieeEe9dd7Vg90H21EOLACvtfcHk0liQC_L5E7H-eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVOlsbg%253D&md5=f037f9866a0161730c9f34a105ca34c8</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01874%26sid%3Dliteratum%253Aachs%26aulast%3DFranzini%26aufirst%3DR.%2BM.%26aulast%3DRandolph%26aufirst%3DC.%26atitle%3DChemical%2520space%2520of%2520DNA-encoded%2520libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6629%26epage%3D6644%26doi%3D10.1021%2Facs.jmedchem.5b01874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prunotto, M.</span></span> <span> </span><span class="NLM_article-title">Opportunities and challenges in phenotypic drug discovery; an industry perspective</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd.2017.111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=531-543&author=J.+G.+Moffatauthor=F.+Vincentauthor=J.+A.+Leeauthor=J.+Ederauthor=M.+Prunotto&title=Opportunities+and+challenges+in+phenotypic+drug+discovery%3B+an+industry+perspective&doi=10.1038%2Fnrd.2017.111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.111%26sid%3Dliteratum%253Aachs%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DPrunotto%26aufirst%3DM.%26atitle%3DOpportunities%2520and%2520challenges%2520in%2520phenotypic%2520drug%2520discovery%253B%2520an%2520industry%2520perspective%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D531%26epage%3D543%26doi%3D10.1038%2Fnrd.2017.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, E. L.</span></span> <span> </span><span class="NLM_article-title">Neoclassic drug discovery: The case for lead generation using phenotypic and functional approaches</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1177/1087057113506118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1177%2F1087057113506118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=24080259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslWitrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=1143-1155&author=J.+A.+Leeauthor=E.+L.+Berg&title=Neoclassic+drug+discovery%3A+The+case+for+lead+generation+using+phenotypic+and+functional+approaches&doi=10.1177%2F1087057113506118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches</span></div><div class="casAuthors">Lee, Jonathan A.; Berg, Ellen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1143-1155, 13</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Innovation and new mol. entity prodn. by the pharmaceutical industry has been below expectations.  Surprisingly, more first-in-class small-mol. drugs approved by the U.S.  Food and Drug Administration (FDA) between 1999 and 2008 were identified by functional phenotypic lead generation strategies reminiscent of pre-genomics pharmacol. than contemporary mol. targeted strategies that encompass the vast majority of lead generation efforts.  This observation, in conjunction with the difficulty in validating mol. targets for drug discovery, has diminished the impact of the "genomics revolution" and has led to a growing grassroots movement and now broader trend in pharma to reconsider the use of modern physiol.-based or phenotypic drug discovery (PDD) strategies.  This "From the Guest Editors" column provides an introduction and overview of the two-part special issues of Journal of Biomol. Screening on PDD.  Terminol. and the business case for use of PDD are defined.  Key issues such as assay performance, chem. optimization, target identification, and challenges to the organization and implementation of PDD are discussed.  Possible solns. for these challenges and a new neoclassic vision for PDD that combines phenotypic and functional approaches with technol. innovations resulting from the genomics-driven era of target-based drug discovery (TDD) are also described.  Finally, an overview of the manuscripts in this special edition is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGlmN5UDYSTrVg90H21EOLACvtfcHk0lhsPjZffNLJOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslWitrrK&md5=dca3c682cd685cd7a24d8784c8aec8c4</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1177%2F1087057113506118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057113506118%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DBerg%26aufirst%3DE.%2BL.%26atitle%3DNeoclassic%2520drug%2520discovery%253A%2520The%2520case%2520for%2520lead%2520generation%2520using%2520phenotypic%2520and%2520functional%2520approaches%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2013%26volume%3D18%26spage%3D1143%26epage%3D1155%26doi%3D10.1177%2F1087057113506118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satterthwaite, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M. N.</span></span> <span> </span><span class="NLM_article-title">Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1038/nrd4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd4309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=24833294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVyqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=419-431&author=D.+Cookauthor=D.+Brownauthor=R.+Alexanderauthor=R.+Marchauthor=P.+Morganauthor=G.+Satterthwaiteauthor=M.+N.+Pangalos&title=Lessons+learned+from+the+fate+of+AstraZeneca%E2%80%99s+drug+pipeline%3A+a+five-dimensional+framework&doi=10.1038%2Fnrd4309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework</span></div><div class="casAuthors">Cook, David; Brown, Dearg; Alexander, Robert; March, Ruth; Morgan, Paul; Satterthwaite, Gemma; Pangalos, Menelas N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-431</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Maintaining research and development (R&D) productivity at a sustainable level is one of the main challenges currently facing the pharmaceutical industry.  In this article, we discuss the results of a comprehensive longitudinal review of AstraZeneca's small-mol. drug projects from 2005 to 2010.  The anal. allowed us to establish a framework based on the five most important tech. determinants of project success and pipeline quality, which we describe as the five 'R's: the right target, the right patient, the right tissue, the right safety and the right com. potential.  A sixth factor - the right culture - is also crucial in encouraging effective decision-making based on these tech. determinants.  AstraZeneca is currently applying this framework to guide its R&D teams, and although it is too early to demonstrate whether this has improved the company's R&D productivity, we present our data and anal. here in the hope that it may assist the industry overall in addressing this key challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4yhPFZOUNO7Vg90H21EOLACvtfcHk0lhsPjZffNLJOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVyqtrw%253D&md5=746a86c7223f170f7e6c4f9817760e5b</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1038%2Fnrd4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4309%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMarch%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DSatterthwaite%26aufirst%3DG.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26atitle%3DLessons%2520learned%2520from%2520the%2520fate%2520of%2520AstraZeneca%25E2%2580%2599s%2520drug%2520pipeline%253A%2520a%2520five-dimensional%2520framework%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D419%26epage%3D431%26doi%3D10.1038%2Fnrd4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dandapani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosse, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span> <span> </span><span class="NLM_article-title">Selecting, acquiring, and using small molecule libraries for high-throughput screening</span>. <i>Curr. Protoc. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1002/9780470559277.ch110252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2F9780470559277.ch110252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=26705509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A280%3ADC%252BC2srjvVOktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=177-191&author=S.+Dandapaniauthor=G.+Rosseauthor=N.+Southallauthor=J.+M.+Salvinoauthor=C.+J.+Thomas&title=Selecting%2C+acquiring%2C+and+using+small+molecule+libraries+for+high-throughput+screening&doi=10.1002%2F9780470559277.ch110252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Selecting, Acquiring, and Using Small Molecule Libraries for High-Throughput Screening</span></div><div class="casAuthors">Dandapani Sivaraman; Rosse Gerard; Southall Noel; Thomas Craig J; Salvino Joseph M</div><div class="citationInfo"><span class="NLM_cas:title">Current protocols in chemical biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-191</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The selection, acquisition and use of high quality small molecule libraries for screening is an essential aspect of drug discovery and chemical biology programs.  Screening libraries continue to evolve as researchers gain a greater appreciation of the suitability of small molecules for specific biological targets, processes and environments.  The decisions surrounding the make-up of any given small molecule library is informed by a multitude of variables and opinions vary on best-practices.  The fitness of any collection relies upon upfront filtering to avoiding problematic compounds, assess appropriate physicochemical properties, install the ideal level of structural uniqueness and determine the desired extent of molecular complexity.  These criteria are under constant evaluation and revision as academic and industrial organizations seek out collections that yield ever improving results from their screening portfolios.  Practical questions including cost, compound management, screening sophistication and assay objective also play a significant role in the choice of library composition.  This overview attempts to offer advice to all organizations engaged in small molecule screening based upon current best practices and theoretical considerations in library selection and acquisition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQOmw0z6h9kY3yKPtYViAGfW6udTcc2eacaCG_mbXuJLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srjvVOktQ%253D%253D&md5=1658f6aed4b38cc1274ab5721c819e6c</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1002%2F9780470559277.ch110252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470559277.ch110252%26sid%3Dliteratum%253Aachs%26aulast%3DDandapani%26aufirst%3DS.%26aulast%3DRosse%26aufirst%3DG.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DSelecting%252C%2520acquiring%252C%2520and%2520using%2520small%2520molecule%2520libraries%2520for%2520high-throughput%2520screening%26jtitle%3DCurr.%2520Protoc.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D4%26spage%3D177%26epage%3D191%26doi%3D10.1002%2F9780470559277.ch110252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tropsha, A.</span></span> <span> </span><span class="NLM_article-title">A bibliometric review of drug repurposing</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2018.01.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.drudis.2018.01.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=29330123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsF2itr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=661-672&author=N.+C.+Bakerauthor=S.+Ekinsauthor=A.+J.+Williamsauthor=A.+Tropsha&title=A+bibliometric+review+of+drug+repurposing&doi=10.1016%2Fj.drudis.2018.01.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">A bibliometric review of drug repurposing</span></div><div class="casAuthors">Baker, Nancy C.; Ekins, Sean; Williams, Antony J.; Tropsha, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">661-672</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  We have conducted a bibliometric review of drug repurposing by scanning >25 million papers in PubMed and using text-mining methods to gather, count and analyze chem.-disease therapeutic relationships.  We find that > 60% of the ∼35,000 drugs or drug candidates identified in our study have been tried in more than one disease, including 189 drugs that have been tried in > 300 diseases each.  Whereas in the majority of cases these drugs were applied in therapeutic areas close to their original use, there have been striking, and perhaps instructive, successful attempts of drug repurposing for unexpected, novel therapeutic areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqognIZ9tedorVg90H21EOLACvtfcHk0lhsPjZffNLJOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsF2itr0%253D&md5=23c110face2733b9d84d4d7c51a49409</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2018.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2018.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DN.%2BC.%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DA.%2BJ.%26aulast%3DTropsha%26aufirst%3DA.%26atitle%3DA%2520bibliometric%2520review%2520of%2520drug%2520repurposing%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26spage%3D661%26epage%3D672%26doi%3D10.1016%2Fj.drudis.2018.01.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DiMasi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faden, L. B.</span></span> <span> </span><span class="NLM_article-title">Competitiveness in follow on drug R&D: A race or limitation?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1038/nrd3296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd3296" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=23-27&author=J.+A.+DiMasiauthor=L.+B.+Faden&title=Competitiveness+in+follow+on+drug+R%26D%3A+A+race+or+limitation%3F&doi=10.1038%2Fnrd3296"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Fnrd3296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3296%26sid%3Dliteratum%253Aachs%26aulast%3DDiMasi%26aufirst%3DJ.%2BA.%26aulast%3DFaden%26aufirst%3DL.%2BB.%26atitle%3DCompetitiveness%2520in%2520follow%2520on%2520drug%2520R%2526D%253A%2520A%2520race%2520or%2520limitation%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D23%26epage%3D27%26doi%3D10.1038%2Fnrd3296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span> <span> </span><span class="NLM_article-title">Follow-on drugs: How far should chemists look?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.drudis.2011.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=21658467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A280%3ADC%252BC3MjlsFOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=722-732&author=F.+Giordanettoauthor=J.+Bostr%C3%B6mauthor=C.+Tyrchan&title=Follow-on+drugs%3A+How+far+should+chemists+look%3F&doi=10.1016%2Fj.drudis.2011.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Follow-on drugs: how far should chemists look?</span></div><div class="casAuthors">Giordanetto Fabrizio; Bostrom Jonas; Tyrchan Christian</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">722-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A major remark made by observers relates to the focus of the pharmaceutical industry on 'me-too' drugs rather than 'first-in-class' drugs, the latter are considered to be 'truly' innovative medicines.  Although the subject is heavily debated, chemists in project teams around the globe are routinely following up compounds from competitors.  An important strategic consideration is the degree of chemical modification of the original structure required for success.  Here, we present an analysis of the DiMasi and Faden set of first-in-class and follow-on drug pairs (n=74); showing that 70% of them are structurally very similar, meaning that they are characterized by minimal structural variations.  This highlights the fact that even simple atomic variations can cause drastic changes in molecular properties responsible for therapeutic advantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9-qG0lyy9NOLt9HypzAgQfW6udTcc2eYS7f2n7IdYbLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjlsFOmtQ%253D%253D&md5=dd6c836d380d44bb7c704e3bd39cc99e</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DTyrchan%26aufirst%3DC.%26atitle%3DFollow-on%2520drugs%253A%2520How%2520far%2520should%2520chemists%2520look%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D722%26epage%3D732%26doi%3D10.1016%2Fj.drudis.2011.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, A-E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarimont, C.</span></span> <span> </span><span class="NLM_article-title">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03280-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2FS1359-6446%2804%2903280-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=15574318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1020-1028&author=A-E.+F.+Nassarauthor=A.+M.+Kamelauthor=C.+Clarimont&title=Improving+the+decision-making+process+in+the+structural+modification+of+drug+candidates%3A+enhancing+metabolic+stability&doi=10.1016%2FS1359-6446%2804%2903280-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span></div><div class="casAuthors">Nassar, Alaa-Eldin F.; Kamel, Amin M.; Clarimont, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1020-1028</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.  The activity-exposure-toxicity relationship, which can be described as the rule of three', presents the single most difficult challenge in the design of drug candidates and their subsequent advancement to the development stage.  ADME studies are widely used in drug discovery to optimize the balance of properties necessary to convert lead candidates into drugs that are safe and effective for humans.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokn5ucRSES-rVg90H21EOLACvtfcHk0lgKB1KiSlf2cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL&md5=67a85a167b62f0ea4e9f43d25f3e0866</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903280-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903280-5%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA-E.%2BF.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DClarimont%26aufirst%3DC.%26atitle%3DImproving%2520the%2520decision-making%2520process%2520in%2520the%2520structural%2520modification%2520of%2520drug%2520candidates%253A%2520enhancing%2520metabolic%2520stability%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D1020%26epage%3D1028%26doi%3D10.1016%2FS1359-6446%2804%2903280-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgKB1KiSlf2cQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Molecular property design: does everyone get it?</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">725</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00157</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00157" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=722-725&author=P.+D.+Leesonauthor=R.+J.+Young&title=Molecular+property+design%3A+does+everyone+get+it%3F&doi=10.1021%2Facsmedchemlett.5b00157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Property Design: Does Everyone Get It?</span></div><div class="casAuthors">Leeson, Paul D.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">722-725</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The principles of mol. property optimization in drug design have been understood for decades, yet much drug discovery activity today is conducted at the periphery of historical druglike property space.  Lead optimization trajectories aimed at reducing physicochem. risk, assisted by ligand efficiency metrics, could help to reduce clin. attrition rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_t8gIn79arVg90H21EOLACvtfcHk0lix24c3saC8Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D&md5=5a807a8d049ce8cf4adc186891a9234d</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00157%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DMolecular%2520property%2520design%253A%2520does%2520everyone%2520get%2520it%253F%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D722%26epage%3D725%26doi%3D10.1021%2Facsmedchemlett.5b00157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">FDA approves first deuterated drug</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">305</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd.2017.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVCjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=305&author=A.+Mullard&title=FDA+approves+first+deuterated+drug&doi=10.1038%2Fnrd.2017.89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">FDA approves dupilumab for severe eczema</span></div><div class="casAuthors">Mullard, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">305</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUum9oBjWLmbVg90H21EOLACvtfcHk0lix24c3saC8Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVCjtbo%253D&md5=361e2f015369489f80b032336b38d849</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.89%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DFDA%2520approves%2520first%2520deuterated%2520drug%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D305%26doi%3D10.1038%2Fnrd.2017.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, D. S.</span></span> <span> </span><span class="NLM_article-title">Quest for novel chemical entities through incorporation of silicon in drug scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3779</span>– <span class="NLM_lpage">3798</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00718</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00718" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3779-3798&author=R.+Rameshauthor=D.+S.+Reddy&title=Quest+for+novel+chemical+entities+through+incorporation+of+silicon+in+drug+scaffolds&doi=10.1021%2Facs.jmedchem.7b00718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds</span></div><div class="casAuthors">Ramesh, Remya; Reddy, D. Srinivasa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3779-3798</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to optimize a lead mol. for further development, bioisosteric replacements are generally adopted as one of the strategies.  Silicon appears to be the right choice as a carbon isostere because of the similarity in chem. properties.  Silicon can be strategically introduced in a mol. to modulate its druglike properties, providing medicinal chemists with an unconventional strategy for replacing a carbon atom.  Silicon can also be introduced to replace other heteroatoms and can act as a surrogate of functional groups such as olefin and amide as well.  The present Perspective focuses on the opportunities that silicon incorporation offers in drug discovery, with an emphasis on case studies where introduction of silicon has created a benefit over its analog.  We have tried to highlight all the recent developments in the field and briefly discuss the challenges assocd. with them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjk4JZC1BTKLVg90H21EOLACvtfcHk0lix24c3saC8Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsbvM&md5=fa3da0fddb955d156d410eb68030e78a</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00718%26sid%3Dliteratum%253Aachs%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DReddy%26aufirst%3DD.%2BS.%26atitle%3DQuest%2520for%2520novel%2520chemical%2520entities%2520through%2520incorporation%2520of%2520silicon%2520in%2520drug%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3779%26epage%3D3798%26doi%3D10.1021%2Facs.jmedchem.7b00718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdolmaleki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghasemi, J. B.</span></span> <span> </span><span class="NLM_article-title">Dual-acting of hybrid compounds – A new dawn in the discovery of multi-target drugs: lead generation approaches</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1096</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160927151144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.2174%2F1568026616666160927151144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=27697056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVOqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=1096-1114&author=A.+Abdolmalekiauthor=J.+B.+Ghasemi&title=Dual-acting+of+hybrid+compounds+%E2%80%93+A+new+dawn+in+the+discovery+of+multi-target+drugs%3A+lead+generation+approaches&doi=10.2174%2F1568026616666160927151144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-acting of Hybrid Compounds - A New Dawn in the Discovery of Multi-target Drugs: Lead Generation Approaches</span></div><div class="casAuthors">Abdolmaleki, Azizeh; Ghasemi, Jahan B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1096-1114</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Finding high quality beginning compds. is a crit. job at the start of the lead generation stage for multi-target drug discovery (MTDD).  Designing hybrid compds. as selective multitarget chem. entity is a challenge, opportunity, and new idea to better act against specific multiple targets.  One hybrid mol. is formed by two (or more) pharmacophore group's participation.  So, these new compds. often exhibit two or more activities going about as multi-target drugs (mtdrugs) and may have superior safety or efficacy.  Application of integrating a range of information and sophisticated new in silico, bioinformatics, structural biol., pharmacogenomics methods may be useful to discover/design, and synthesis of the new hybrid mols.  In this regard, many rational and screening approaches have followed by medicinal chemists for the lead generation in MTDD.  Here, we review some popular lead generation approaches that have been used for designing multiple ligands (DMLs).  This paper focuses on dual- acting chem. entities that incorporate a part of two drugs or bioactive compds. to compose hybrid mols.  Also, it presents some of key concepts and limitations/strengths of lead generation methods by comparing combination framework method with screening approaches.  Besides, a no. of examples to represent applications of hybrid mols. in the drug discovery are included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm8Nd5jc8EqrVg90H21EOLACvtfcHk0ljJhUDNS_tE2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVOqtro%253D&md5=c80d6ba718dd9695d538842adec6a7f7</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160927151144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160927151144%26sid%3Dliteratum%253Aachs%26aulast%3DAbdolmaleki%26aufirst%3DA.%26aulast%3DGhasemi%26aufirst%3DJ.%2BB.%26atitle%3DDual-acting%2520of%2520hybrid%2520compounds%2520%25E2%2580%2593%2520A%2520new%2520dawn%2520in%2520the%2520discovery%2520of%2520multi-target%2520drugs%253A%2520lead%2520generation%2520approaches%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D1096%26epage%3D1114%26doi%3D10.2174%2F1568026616666160927151144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cromm, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Targeted protein degradation: from chemical biology to drug discovery</span>. <i>Cell Chem. Bio.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1190</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.05.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.chembiol.2017.05.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=28648379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1181-1190&author=P.+M.+Crommauthor=C.+M.+Crews&title=Targeted+protein+degradation%3A+from+chemical+biology+to+drug+discovery&doi=10.1016%2Fj.chembiol.2017.05.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Protein Degradation: from Chemical Biology to Drug Discovery</span></div><div class="casAuthors">Cromm, Philipp M.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1181-1190</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Traditional pharmaceutical drug discovery is almost exclusively focused on directly controlling protein activity to cure diseases.  Modulators of protein activity, esp. inhibitors, are developed and applied at high concn. to achieve maximal effects.  Thereby, reduced bioavailability and off-target effects can hamper compd. efficacy.  Nucleic acid-based strategies that control protein function by affecting expression have emerged as an alternative.  However, metabolic stability and broad bioavailability represent development hurdles that remain to be overcome for these approaches.  More recently, utilizing the cell's own protein destruction machinery for selective degrdn. of essential drivers of human disorders has opened up a new and exciting area of drug discovery.  Small-mol.-induced proteolysis of selected substrates offers the potential of reaching beyond the limitations of the current pharmaceutical paradigm to expand the druggable target space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrosuhmnPE0RrVg90H21EOLACvtfcHk0ljJhUDNS_tE2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtrrO&md5=3c8c6d9488396d5eb08ca51cee20bbf4</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DCromm%26aufirst%3DP.%2BM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DTargeted%2520protein%2520degradation%253A%2520from%2520chemical%2520biology%2520to%2520drug%2520discovery%26jtitle%3DCell%2520Chem.%2520Bio.%26date%3D2017%26volume%3D24%26spage%3D1181%26epage%3D1190%26doi%3D10.1016%2Fj.chembiol.2017.05.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><a href="http://arvinas.com/press-releases/arvinas-nominates-oral-clinical-candidate-androgen-receptor-degrader-program/" class="extLink">http://arvinas.com/press-releases/arvinas-nominates-oral-clinical-candidate-androgen-receptor-degrader-program/</a> (accessed Feb 21, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Farvinas.com%2Fpress-releases%2Farvinas-nominates-oral-clinical-candidate-androgen-receptor-degrader-program%2F+%28accessed+Feb+21%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, L. H.</span></span> <span> </span><span class="NLM_article-title">The benzodiazepine story</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1021/jm00187a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00187a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADyaE1MXkvVSjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1979&pages=1-6&author=L.+H.+Sternbach&title=The+benzodiazepine+story&doi=10.1021%2Fjm00187a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">The benzodiazepine story</span></div><div class="casAuthors">Sternbach, Leo H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A lecture on the development of centrally acting 1,4-benzodiazepines with 24 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO04EjgluwzLVg90H21EOLACvtfcHk0ljJhUDNS_tE2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXkvVSjsA%253D%253D&md5=27408ad7dcf65729a97a2d48a8158949</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm00187a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00187a001%26sid%3Dliteratum%253Aachs%26aulast%3DSternbach%26aufirst%3DL.%2BH.%26atitle%3DThe%2520benzodiazepine%2520story%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1979%26volume%3D22%26spage%3D1%26epage%3D6%26doi%3D10.1021%2Fjm00187a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harki, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummond, K. M.</span></span> <span> </span><span class="NLM_article-title">Covalent modifiers: A chemical perspective on the reactivity of α-β-unsaturated thiols via hetero-Michael addition reactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=839-885&author=P.+A.+Jacksonauthor=J.+C.+Widenauthor=D.+A.+Harkiauthor=K.+M.+Brummond&title=Covalent+modifiers%3A+A+chemical+perspective+on+the+reactivity+of+%CE%B1-%CE%B2-unsaturated+thiols+via+hetero-Michael+addition+reactions&doi=10.1021%2Facs.jmedchem.6b00788"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00788%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DP.%2BA.%26aulast%3DWiden%26aufirst%3DJ.%2BC.%26aulast%3DHarki%26aufirst%3DD.%2BA.%26aulast%3DBrummond%26aufirst%3DK.%2BM.%26atitle%3DCovalent%2520modifiers%253A%2520A%2520chemical%2520perspective%2520on%2520the%2520reactivity%2520of%2520%25CE%25B1-%25CE%25B2-unsaturated%2520thiols%2520via%2520hetero-Michael%2520addition%2520reactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D839%26epage%3D885%26doi%3D10.1021%2Facs.jmedchem.6b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keserü, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makara, G. M.</span></span> <span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1038/nrd2796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd2796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=19247303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVShtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keser%C3%BCauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates&doi=10.1038%2Fnrd2796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lead discovery strategies on the properties of drug candidates</span></div><div class="casAuthors">Keserue, Gyoergy M.; Makara, Gergely M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-212</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the widespread acceptance of guidelines related to desirable physicochem. properties of potential small-mol. drugs, key properties - such as lipophilicity - of recently developed clin. candidates and advanced lead compds. have been shown to differ significantly from those of historical leads and drugs.  By analyzing the physicochem. properties of a large database of hits and corresponding leads identified in the past decade, we show that this undesirable phenomenon can be traced back to the nature of high-throughput screening hits and hit-to-lead optimization practices.  Conceptual and organizational adjustments may be required to enable a smooth lead-evolution process that reduces the chance of high compd.-related attrition in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm799LMqiX77Vg90H21EOLACvtfcHk0ljJhUDNS_tE2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVShtbk%253D&md5=568338bed79969979b8590cd03bb4481</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1038%2Fnrd2796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2796%26sid%3Dliteratum%253Aachs%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212%26doi%3D10.1038%2Fnrd2796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morphy, R.</span></span> <span> </span><span class="NLM_article-title">The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2969</span>– <span class="NLM_lpage">2978</span>, <span class="refDoi"> DOI: 10.1021/jm0512185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0512185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlOit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2969-2978&author=R.+Morphy&title=The+influence+of+target+family+and+functional+activity+on+the+physicochemical+properties+of+pre-clinical+compounds&doi=10.1021%2Fjm0512185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">The Influence of Target Family and Functional Activity on the Physicochemical Properties of Pre-Clinical Compounds</span></div><div class="casAuthors">Morphy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2969-2978</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The target families of greatest interest in drug discovery can be differentiated on the basis of the physicochem. properties of their preclin. ligands.  The ligands for peptidergic targets, such as peptide G protein-coupled receptors (GPCRs) and integrin receptors, possess significantly higher median property values than those for aminergic targets, such as monoamine transporters and GPCRs.  The ligands for peptide GPCRs were found to be less efficient, in terms of their binding energy per unit of mol. wt. or lipophilicity, than ligands for monoamine GPCRs.  The changes in the property values during the optimization process were found to vary only slightly across the target families, with the main determinant of the drug-likeness of the optimized compds. being the profile of the starting compds.  Agonists for monoamine GPCRs, opioid receptors and ion channels were typically smaller and less lipophilic than the antagonists, but there was no difference between the agonists and the antagonists for peptide GPCRs and nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0EegclZUHNbVg90H21EOLACvtfcHk0lgbxjowrTbv4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlOit7g%253D&md5=fcf63bff570d58d56492b46ddecb5eb1</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fjm0512185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0512185%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DThe%2520influence%2520of%2520target%2520family%2520and%2520functional%2520activity%2520on%2520the%2520physicochemical%2520properties%2520of%2520pre-clinical%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2969%26epage%3D2978%26doi%3D10.1021%2Fjm0512185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span>; <span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">Mapping the efficiency and physicochemical trajectories of successful optimizations</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00180</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+J.+Young&author=P.+D.+Leeson&title=Mapping+the+efficiency+and+physicochemical+trajectories+of+successful+optimizations&doi=10.1021%2Facs.jmedchem.8b00180"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DMapping%2520the%2520efficiency%2520and%2520physicochemical%2520trajectories%2520of%2520successful%2520optimizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26doi%3D10.1021%2Facs.jmedchem.8b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, D. T.</span></span> <span> </span><span class="NLM_article-title">The necessary nitrogen atom: a versatile high-impact design element for multiparameter optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3552</span>– <span class="NLM_lpage">3579</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3552-3579&author=L.+D.+Penningtonauthor=D.+T.+Moustakas&title=The+necessary+nitrogen+atom%3A+a+versatile+high-impact+design+element+for+multiparameter+optimization&doi=10.1021%2Facs.jmedchem.6b01807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span></div><div class="casAuthors">Pennington, Lewis D.; Moustakas, Demetri T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3552-3579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a continued desire in biomedical research to reduce the no. and duration of design cycles required to optimize lead compds. into high-quality chem. probes or safe and efficacious drug candidates.  The insightful application of impactful mol. design elements is one approach toward achieving this goal.  The replacement of a CH group with a N atom in arom. and heteroarom. ring systems can have many important effects on mol. and physicochem. properties and intra- and intermol. interactions that can translate to improved pharmacol. profiles.  In this Perspective, the "necessary nitrogen atom" is shown to be a versatile high-impact design element for multiparameter optimization, wherein ≥10-, 100-, or 1000-fold improvement in a variety of key pharmacol. parameters can be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZLKZMgt6IbVg90H21EOLACvtfcHk0lgbxjowrTbv4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D&md5=002aaee48995e7954647a1f75183db4d</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%2BT.%26atitle%3DThe%2520necessary%2520nitrogen%2520atom%253A%2520a%2520versatile%2520high-impact%2520design%2520element%2520for%2520multiparameter%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3552%26epage%3D3579%26doi%3D10.1021%2Facs.jmedchem.6b01807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43a'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 52 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">SahaIshika</span><span class="NLM_role">Graduate Student Researcher</span><a class="email" href="/cdn-cgi/l/email-protection#0a63796263616b796b626b4a6d247f69666b246f6e7f"><span class="nobrWithWbr"><span class="__cf_email__" data-cfemail="274e544f4e4c4654464f46674009">[email protected]</span><wbr></wbr>ucla.<wbr></wbr>edu</span></a><span class="hlFld-ContribAuthor ">HarranPatrick G.</span><span class="NLM_role">D.J. & J.M. Cram Chair in Organic Chemistry</span><a class="email" href="/cdn-cgi/l/email-protection#264e475454474866454e434b0853454a4708434253"><span class="nobrWithWbr"><span class="__cf_email__" data-cfemail="94fcf5e6e6f5fad4f7fcf1f9ba">[email protected]</span><wbr></wbr>ucla.<wbr></wbr>edu</span></a>Dr. Jonathan Bohmann, Department of Pharmaceuticals and Bioengineering, Southwest Research Institute, <div class="author-comment"><p class="first last">A great introduction to the topic of virtual screening, which is often seen as a black box.  It does a good job weaving a lot of material together. The molecular simulation community has needed a book like this for a long time. It is honest about the pitfalls of VS while pointing to reasons why VS is needed and the positive impacts on early drug discovery programs, where resources are generally scarce.</p></div><span class="NLM_string-name hlFld-ContribAuthor">Ryan Gumpper, Postdoctoral Researcher, University of North Carolina at Chapel Hill</span><div class="author-comment"><p class="first last">I would recommend this work to young graduate students starting in the field and anyone who is interested in expanding their knowledge in the field.</p></div>. </span><span class="cited-content_cbyCitation_article-title">Virtual Screening for Chemists. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1021/acsinfocus.7e5001" title="DOI URL">https://doi.org/10.1021/acsinfocus.7e5001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfocus.7e5001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfocus.7e5001%26sid%3Dliteratum%253Aachs%26atitle%3DVirtual%252BScreening%252Bfor%252BChemists%26aulast%3DSaha%26aufirst%3DIshika%26date%3D2021%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul D. Leeson, A. Patricia Bento, Anna Gaulton, Anne Hersey, Emma J. Manners, Chris J. Radoux, <span class="NLM_string-name hlFld-ContribAuthor">Andrew R. Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Target-Based Evaluation of “Drug-Like” Properties and Ligand Efficiencies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7210-7230. <a href="https://doi.org/10.1021/acs.jmedchem.1c00416" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00416</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00416%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTarget-Based%252BEvaluation%252Bof%252B%2525E2%252580%25259CDrug-Like%2525E2%252580%25259D%252BProperties%252Band%252BLigand%252BEfficiencies%26aulast%3DLeeson%26aufirst%3DPaul%2BD.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D08032021%26date%3D13052021%26volume%3D64%26issue%3D11%26spage%3D7210%26epage%3D7230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wenji Su, Rui Ge, Duanchen Ding, Wenhua Chen, Wenqing Wang, Hao Yan, Weikun Wang, Youlang Yuan, Huan Liu, Meng Zhang, Jiyuan Zhang, Qisheng Shu, Alexander L. Satz, <span class="NLM_string-name hlFld-ContribAuthor">Letian Kuai</span>. </span><span class="cited-content_cbyCitation_article-title">Triaging of DNA-Encoded Library Selection Results by High-Throughput Resynthesis of DNA–Conjugate and Affinity Selection Mass Spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Bioconjugate Chemistry</span><span> <strong>2021,</strong> <em>32 </em>
                                    (5)
                                     , 1001-1007. <a href="https://doi.org/10.1021/acs.bioconjchem.1c00170" title="DOI URL">https://doi.org/10.1021/acs.bioconjchem.1c00170</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.bioconjchem.1c00170&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.bioconjchem.1c00170%26sid%3Dliteratum%253Aachs%26jtitle%3DBioconjugate%2520Chemistry%26atitle%3DTriaging%252Bof%252BDNA-Encoded%252BLibrary%252BSelection%252BResults%252Bby%252BHigh-Throughput%252BResynthesis%252Bof%252BDNA%2525E2%252580%252593Conjugate%252Band%252BAffinity%252BSelection%252BMass%252BSpectrometry%26aulast%3DSu%26aufirst%3DWenji%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D30032021%26date%3D22042021%26date%3D29042021%26volume%3D32%26issue%3D5%26spage%3D1001%26epage%3D1007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Xing Ling, Weiwei Lu, Lin Miao, Lisa A. Marcaurelle, Xuan Wang, Yun Ding, <span class="NLM_string-name hlFld-ContribAuthor">Xiaojie Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Divergent On-DNA Transformations from DNA-Linked Piperidones. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.1c00670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.1c00670%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDivergent%252BOn-DNA%252BTransformations%252Bfrom%252BDNA-Linked%252BPiperidones%26aulast%3DLing%26aufirst%3DXing%26date%3D2021%26date%3D2021%26date%3D21032021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marta Serafini, Sarah Cargnin, Alberto Massarotti, Gian Cesare Tron, Tracey Pirali, <span class="NLM_string-name hlFld-ContribAuthor">Armando A. Genazzani</span>. </span><span class="cited-content_cbyCitation_article-title">What’s in a Name? Drug Nomenclature and Medicinal Chemistry Trends using INN Publications. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (8)
                                     , 4410-4429. <a href="https://doi.org/10.1021/acs.jmedchem.1c00181" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00181</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00181%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DWhat%2525E2%252580%252599s%252Bin%252Ba%252BName%25253F%252BDrug%252BNomenclature%252Band%252BMedicinal%252BChemistry%252BTrends%252Busing%252BINN%252BPublications%26aulast%3DSerafini%26aufirst%3DMarta%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D01022021%26date%3D13042021%26volume%3D64%26issue%3D8%26spage%3D4410%26epage%3D4429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Iain D. G. Campuzano, <span class="NLM_string-name hlFld-ContribAuthor">Wendy Sandoval</span>. </span><span class="cited-content_cbyCitation_article-title">Denaturing and Native Mass Spectrometric Analytics for Biotherapeutic Drug Discovery Research: Historical, Current, and Future Personal Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Society for Mass Spectrometry</span><span> <strong>2021</strong>, Article ASAP.</span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jasms.1c00036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjasms.1c00036%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Society%2520for%2520Mass%2520Spectrometry%26atitle%3DDenaturing%252Band%252BNative%252BMass%252BSpectrometric%252BAnalytics%252Bfor%252BBiotherapeutic%252BDrug%252BDiscovery%252BResearch%25253A%252BHistorical%25252C%252BCurrent%25252C%252Band%252BFuture%252BPersonal%252BPerspectives%26aulast%3DCampuzano%26aufirst%3DIain%2BD.%2BG.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D29012021%26date%3D05042021%26date%3D25032021%26volume%3D0%26issue%3D0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Roy González-Alemán, Nicolas Chevrollier, Manuel Simoes, Luis Montero-Cabrera, <span class="NLM_string-name hlFld-ContribAuthor">Fabrice Leclerc</span>. </span><span class="cited-content_cbyCitation_article-title">MCSS-Based Predictions of Binding Mode and Selectivity of Nucleotide Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2021,</strong> <em>17 </em>
                                    (4)
                                     , 2599-2618. <a href="https://doi.org/10.1021/acs.jctc.0c01339" title="DOI URL">https://doi.org/10.1021/acs.jctc.0c01339</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.0c01339&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.0c01339%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DMCSS-Based%252BPredictions%252Bof%252BBinding%252BMode%252Band%252BSelectivity%252Bof%252BNucleotide%252BLigands%26aulast%3DGonz%25C3%25A1lez-Alem%25C3%25A1n%26aufirst%3DRoy%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D28122020%26date%3D25032021%26volume%3D17%26issue%3D4%26spage%3D2599%26epage%3D2618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Heike J. Wobst</span>. </span><span class="cited-content_cbyCitation_article-title">A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 2312-2338. <a href="https://doi.org/10.1021/acs.jmedchem.0c01516" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01516</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01516%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BDecade%252Bof%252BFDA-Approved%252BDrugs%252B%2525282010%2525E2%252580%2525932019%252529%25253A%252BTrends%252Band%252BFuture%252BDirections%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30082020%26date%3D22022021%26volume%3D64%26issue%3D5%26spage%3D2312%26epage%3D2338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher A. Reiher, David P. Schuman, Nicholas Simmons, <span class="NLM_string-name hlFld-ContribAuthor">Scott E. Wolkenberg</span>. </span><span class="cited-content_cbyCitation_article-title">Trends in Hit-to-Lead Optimization Following DNA-Encoded Library Screens. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>12 </em>
                                    (3)
                                     , 343-350. <a href="https://doi.org/10.1021/acsmedchemlett.0c00615" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.0c00615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.0c00615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.0c00615%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTrends%252Bin%252BHit-to-Lead%252BOptimization%252BFollowing%252BDNA-Encoded%252BLibrary%252BScreens%26aulast%3DReiher%26aufirst%3DChristopher%2BA.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22112020%26date%3D28012021%26date%3D11022021%26volume%3D12%26issue%3D3%26spage%3D343%26epage%3D350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Scott A. Busby, Seth Carbonneau, John Concannon, Christoph E. Dumelin, YounKyoung Lee, Shin Numao, Nicole Renaud, Thomas M. Smith, <span class="NLM_string-name hlFld-ContribAuthor">Douglas S. Auld</span>. </span><span class="cited-content_cbyCitation_article-title">Advancements in Assay Technologies and Strategies to Enable Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2020,</strong> <em>15 </em>
                                    (10)
                                     , 2636-2648. <a href="https://doi.org/10.1021/acschembio.0c00495" title="DOI URL">https://doi.org/10.1021/acschembio.0c00495</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.0c00495&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.0c00495%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DAdvancements%252Bin%252BAssay%252BTechnologies%252Band%252BStrategies%252Bto%252BEnable%252BDrug%252BDiscovery%26aulast%3DBusby%26aufirst%3DScott%2BA.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D19062020%26date%3D03092020%26date%3D18092020%26date%3D03092020%26volume%3D15%26issue%3D10%26spage%3D2636%26epage%3D2648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Matthew D. Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">High-Throughput Screening for the Discovery of Enzyme Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (19)
                                     , 10742-10772. <a href="https://doi.org/10.1021/acs.jmedchem.0c00523" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00523%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHigh-Throughput%252BScreening%252Bfor%252Bthe%252BDiscovery%252Bof%252BEnzyme%252BInhibitors%26aulast%3DLloyd%26aufirst%3DMatthew%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D30032020%26date%3D10062020%26date%3D20052020%26volume%3D63%26issue%3D19%26spage%3D10742%26epage%3D10772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Edward J. Griffen, Alexander G. Dossetter, <span class="NLM_string-name hlFld-ContribAuthor">Andrew G. Leach</span>. </span><span class="cited-content_cbyCitation_article-title">Chemists: AI Is Here; Unite To Get the Benefits. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (16)
                                     , 8695-8704. <a href="https://doi.org/10.1021/acs.jmedchem.0c00163" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00163</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00163%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DChemists%25253A%252BAI%252BIs%252BHere%25253B%252BUnite%252BTo%252BGet%252Bthe%252BBenefits%26aulast%3DGriffen%26aufirst%3DEdward%2BJ.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D29012020%26date%3D11062020%26date%3D27052020%26volume%3D63%26issue%3D16%26spage%3D8695%26epage%3D8704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Minsoo Song, <span class="NLM_string-name hlFld-ContribAuthor">Gil Tae Hwang</span>. </span><span class="cited-content_cbyCitation_article-title">DNA-Encoded Library Screening as Core Platform Technology in Drug Discovery: Its Synthetic Method Development and Applications in DEL Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (13)
                                     , 6578-6599. <a href="https://doi.org/10.1021/acs.jmedchem.9b01782" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01782</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01782&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01782%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDNA-Encoded%252BLibrary%252BScreening%252Bas%252BCore%252BPlatform%252BTechnology%252Bin%252BDrug%252BDiscovery%25253A%252BIts%252BSynthetic%252BMethod%252BDevelopment%252Band%252BApplications%252Bin%252BDEL%252BSynthesis%26aulast%3DSong%26aufirst%3DMinsoo%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D28102019%26date%3D19022020%26date%3D10022020%26volume%3D63%26issue%3D13%26spage%3D6578%26epage%3D6599" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Antimo Gioiello, Alessandro Piccinno, Anna Maria Lozza, <span class="NLM_string-name hlFld-ContribAuthor">Bruno Cerra</span>. </span><span class="cited-content_cbyCitation_article-title">The Medicinal Chemistry in the Era of Machines and Automation: Recent Advances in Continuous Flow Technology. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (13)
                                     , 6624-6647. <a href="https://doi.org/10.1021/acs.jmedchem.9b01956" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01956</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01956&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01956%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BMedicinal%252BChemistry%252Bin%252Bthe%252BEra%252Bof%252BMachines%252Band%252BAutomation%25253A%252BRecent%252BAdvances%252Bin%252BContinuous%252BFlow%252BTechnology%26aulast%3DGioiello%26aufirst%3DAntimo%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D25112019%26date%3D21022020%26date%3D12022020%26volume%3D63%26issue%3D13%26spage%3D6624%26epage%3D6647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, Graham F. Smith, <span class="NLM_string-name hlFld-ContribAuthor">Heike J. Wobst</span>. </span><span class="cited-content_cbyCitation_article-title">Promiscuity of in Vitro Secondary Pharmacology Assays and Implications for Lead Optimization Strategies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (12)
                                     , 6251-6275. <a href="https://doi.org/10.1021/acs.jmedchem.9b01625" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01625</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01625%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPromiscuity%252Bof%252Bin%252BVitro%252BSecondary%252BPharmacology%252BAssays%252Band%252BImplications%252Bfor%252BLead%252BOptimization%252BStrategies%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D30092019%26date%3D26112019%26date%3D12112019%26volume%3D63%26issue%3D12%26spage%3D6251%26epage%3D6275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Carles Perez, Daniel Soler, Robert Soliva, <span class="NLM_string-name hlFld-ContribAuthor">Victor Guallar</span>. </span><span class="cited-content_cbyCitation_article-title">FragPELE: Dynamic Ligand Growing within a Binding Site. A Novel Tool for Hit-To-Lead Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2020,</strong> <em>60 </em>
                                    (3)
                                     , 1728-1736. <a href="https://doi.org/10.1021/acs.jcim.9b00938" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00938%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DFragPELE%25253A%252BDynamic%252BLigand%252BGrowing%252Bwithin%252Ba%252BBinding%252BSite.%252BA%252BNovel%252BTool%252Bfor%252BHit-To-Lead%252BDrug%252BDesign%26aulast%3DPerez%26aufirst%3DCarles%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D08102019%26date%3D18022020%26date%3D06022020%26volume%3D60%26issue%3D3%26spage%3D1728%26epage%3D1736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dean G. Brown, <span class="NLM_string-name hlFld-ContribAuthor">Heike J. Wobst</span>. </span><span class="cited-content_cbyCitation_article-title">Opportunities and Challenges in Phenotypic Screening for Neurodegenerative Disease Research. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 1823-1840. <a href="https://doi.org/10.1021/acs.jmedchem.9b00797" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00797%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOpportunities%252Band%252BChallenges%252Bin%252BPhenotypic%252BScreening%252Bfor%252BNeurodegenerative%252BDisease%252BResearch%26aulast%3DBrown%26aufirst%3DDean%2BG.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D15052019%26date%3D18072019%26date%3D03072019%26volume%3D63%26issue%3D5%26spage%3D1823%26epage%3D1840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Flavio Ballante, Axel Rudling, Alexey Zeifman, Andreas Luttens, Duy Duc Vo, John J. Irwin, Jan Kihlberg, Jose Brea, Maria Isabel Loza, <span class="NLM_string-name hlFld-ContribAuthor">Jens Carlsson</span>. </span><span class="cited-content_cbyCitation_article-title">Docking Finds GPCR Ligands in Dark Chemical Matter. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 613-620. <a href="https://doi.org/10.1021/acs.jmedchem.9b01560" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01560</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01560%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDocking%252BFinds%252BGPCR%252BLigands%252Bin%252BDark%252BChemical%252BMatter%26aulast%3DBallante%26aufirst%3DFlavio%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D18092019%26date%3D13012020%26date%3D17122019%26volume%3D63%26issue%3D2%26spage%3D613%26epage%3D620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Junting Zhou, Xueyang Jiang, Siyu He, Hongli Jiang, Feng Feng, Wenyuan Liu, Wei Qu, <span class="NLM_string-name hlFld-ContribAuthor">Haopeng Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (20)
                                     , 8881-8914. <a href="https://doi.org/10.1021/acs.jmedchem.9b00017" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b00017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b00017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252BDesign%252Bof%252BMultitarget-Directed%252BLigands%25253A%252BStrategies%252Band%252BEmerging%252BParadigms%26aulast%3DZhou%26aufirst%3DJunting%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D04012019%26date%3D28052019%26date%3D13052019%26volume%3D62%26issue%3D20%26spage%3D8881%26epage%3D8914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Niclas Ståhl, Göran Falkman, Alexander Karlsson, Gunnar Mathiason, <span class="NLM_string-name hlFld-ContribAuthor">Jonas Boström</span>. </span><span class="cited-content_cbyCitation_article-title">Deep Reinforcement Learning for Multiparameter Optimization in de novo Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2019,</strong> <em>59 </em>
                                    (7)
                                     , 3166-3176. <a href="https://doi.org/10.1021/acs.jcim.9b00325" title="DOI URL">https://doi.org/10.1021/acs.jcim.9b00325</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.9b00325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.9b00325%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDeep%252BReinforcement%252BLearning%252Bfor%252BMultiparameter%252BOptimization%252Bin%252Bde%252Bnovo%252BDrug%252BDesign%26aulast%3DSt%25C3%25A5hl%26aufirst%3DNiclas%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D18042019%26date%3D05072019%26date%3D19062019%26volume%3D59%26issue%3D7%26spage%3D3166%26epage%3D3176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wesley
G. Cochrane, Marie L. Malone, Vuong Q. Dang, Valerie Cavett, Alexander L. Satz, <span class="NLM_string-name hlFld-ContribAuthor">Brian M. Paegel</span>. </span><span class="cited-content_cbyCitation_article-title">Activity-Based DNA-Encoded Library Screening. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2019,</strong> <em>21 </em>
                                    (5)
                                     , 425-435. <a href="https://doi.org/10.1021/acscombsci.9b00037" title="DOI URL">https://doi.org/10.1021/acscombsci.9b00037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.9b00037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.9b00037%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DActivity-Based%252BDNA-Encoded%252BLibrary%252BScreening%26aulast%3DCochrane%26aufirst%3DWesley%2BG.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26022019%26date%3D29032019%26date%3D18032019%26volume%3D21%26issue%3D5%26spage%3D425%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Paul N. Mortenson, Daniel A. Erlanson, Iwan J. P. de Esch, Wolfgang Jahnke, <span class="NLM_string-name hlFld-ContribAuthor">Christopher N. Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-to-Lead Medicinal Chemistry Publications in 2017. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (8)
                                     , 3857-3872. <a href="https://doi.org/10.1021/acs.jmedchem.8b01472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-to-Lead%252BMedicinal%252BChemistry%252BPublications%252Bin%252B2017%26aulast%3DMortenson%26aufirst%3DPaul%2BN.%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D21092018%26date%3D21112018%26volume%3D62%26issue%3D8%26spage%3D3857%26epage%3D3872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kostas  Papadopoulos</span>, <span class="hlFld-ContribAuthor ">Kathryn A.  Giblin</span>, <span class="hlFld-ContribAuthor ">Jon Paul  Janet</span>, <span class="hlFld-ContribAuthor ">Atanas  Patronov</span>, <span class="hlFld-ContribAuthor ">Ola  Engkvist</span>. </span><span class="cited-content_cbyCitation_article-title">De novo design with deep generative models based on 3D similarity scoring. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2021,</strong> <em>44 </em>, 116308. <a href="https://doi.org/10.1016/j.bmc.2021.116308" title="DOI URL">https://doi.org/10.1016/j.bmc.2021.116308</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2021.116308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2021.116308%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDe%252Bnovo%252Bdesign%252Bwith%252Bdeep%252Bgenerative%252Bmodels%252Bbased%252Bon%252B3D%252Bsimilarity%252Bscoring%26aulast%3DPapadopoulos%26aufirst%3DKostas%26date%3D2021%26volume%3D44%26spage%3D116308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucia  Furiassi</span>, <span class="hlFld-ContribAuthor ">Emily J.  Tonogai</span>, <span class="hlFld-ContribAuthor ">Paul J.  Hergenrother</span>. </span><span class="cited-content_cbyCitation_article-title">Limonin as a Starting Point for the Construction of Compounds with High Scaffold Diversity. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2021,</strong> <em>133 </em>
                                    (29)
                                     , 16255-16264. <a href="https://doi.org/10.1002/ange.202104228" title="DOI URL">https://doi.org/10.1002/ange.202104228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202104228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202104228%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DLimonin%252Bas%252Ba%252BStarting%252BPoint%252Bfor%252Bthe%252BConstruction%252Bof%252BCompounds%252Bwith%252BHigh%252BScaffold%252BDiversity%26aulast%3DFuriassi%26aufirst%3DLucia%26date%3D2021%26date%3D2021%26volume%3D133%26issue%3D29%26spage%3D16255%26epage%3D16264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucia  Furiassi</span>, <span class="hlFld-ContribAuthor ">Emily J.  Tonogai</span>, <span class="hlFld-ContribAuthor ">Paul J.  Hergenrother</span>. </span><span class="cited-content_cbyCitation_article-title">Limonin as a Starting Point for the Construction of Compounds with High Scaffold Diversity. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2021,</strong> <em>60 </em>
                                    (29)
                                     , 16119-16128. <a href="https://doi.org/10.1002/anie.202104228" title="DOI URL">https://doi.org/10.1002/anie.202104228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202104228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202104228%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DLimonin%252Bas%252Ba%252BStarting%252BPoint%252Bfor%252Bthe%252BConstruction%252Bof%252BCompounds%252Bwith%252BHigh%252BScaffold%252BDiversity%26aulast%3DFuriassi%26aufirst%3DLucia%26date%3D2021%26date%3D2021%26volume%3D60%26issue%3D29%26spage%3D16119%26epage%3D16128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stefano A.  Serapian</span>, <span class="hlFld-ContribAuthor ">Carlos  Sanchez-Martín</span>, <span class="hlFld-ContribAuthor ">Elisabetta  Moroni</span>, <span class="hlFld-ContribAuthor ">Andrea  Rasola</span>, <span class="hlFld-ContribAuthor ">Giorgio  Colombo</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives. </span><span class="cited-content_cbyCitation_journal-name">Trends in Pharmacological Sciences</span><span> <strong>2021,</strong> <em>42 </em>
                                    (7)
                                     , 566-576. <a href="https://doi.org/10.1016/j.tips.2021.04.003" title="DOI URL">https://doi.org/10.1016/j.tips.2021.04.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tips.2021.04.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tips.2021.04.003%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Pharmacological%2520Sciences%26atitle%3DTargeting%252Bthe%252Bmitochondrial%252Bchaperone%252BTRAP1%25253A%252Bstrategies%252Band%252Btherapeutic%252Bperspectives%26aulast%3DSerapian%26aufirst%3DStefano%2BA.%26date%3D2021%26volume%3D42%26issue%3D7%26spage%3D566%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fei  Ma</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">Shuning  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuang  Gu</span>, <span class="hlFld-ContribAuthor ">Tingting  Tan</span>, <span class="hlFld-ContribAuthor ">Wanting  Chen</span>, <span class="hlFld-ContribAuthor ">Shuyue  Wang</span>, <span class="hlFld-ContribAuthor ">Peixiang  Ma</span>, <span class="hlFld-ContribAuthor ">Hongtao  Xu</span>, <span class="hlFld-ContribAuthor ">Guang  Yang</span>, <span class="hlFld-ContribAuthor ">Richard A.  Lerner</span>. </span><span class="cited-content_cbyCitation_article-title">DNA‐Encoded Libraries: Hydrazide as a Pluripotent Precursor for On‐DNA Synthesis of Various Azole Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2021,</strong> <em>27 </em>
                                    (31)
                                     , 8214-8220. <a href="https://doi.org/10.1002/chem.202100850" title="DOI URL">https://doi.org/10.1002/chem.202100850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202100850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202100850%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DDNA%2525E2%252580%252590Encoded%252BLibraries%25253A%252BHydrazide%252Bas%252Ba%252BPluripotent%252BPrecursor%252Bfor%252BOn%2525E2%252580%252590DNA%252BSynthesis%252Bof%252BVarious%252BAzole%252BDerivatives%26aulast%3DMa%26aufirst%3DFei%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D31%26spage%3D8214%26epage%3D8220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sravani  Sana</span>, <span class="hlFld-ContribAuthor ">Velma Ganga  Reddy</span>, <span class="hlFld-ContribAuthor ">T.  Srinivasa Reddy</span>, <span class="hlFld-ContribAuthor ">Ramya  Tokala</span>, <span class="hlFld-ContribAuthor ">Rahul  Kumar</span>, <span class="hlFld-ContribAuthor ">Suresh K.  Bhargava</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Cinnamide derived pyrimidine-benzimidazole hybrids as tubulin inhibitors: Synthesis, in silico and cell growth inhibition studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>110 </em>, 104765. <a href="https://doi.org/10.1016/j.bioorg.2021.104765" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104765%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DCinnamide%252Bderived%252Bpyrimidine-benzimidazole%252Bhybrids%252Bas%252Btubulin%252Binhibitors%25253A%252BSynthesis%25252C%252Bin%252Bsilico%252Band%252Bcell%252Bgrowth%252Binhibition%252Bstudies%26aulast%3DSana%26aufirst%3DSravani%26date%3D2021%26volume%3D110%26spage%3D104765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniele  Carettoni</span>, <span class="hlFld-ContribAuthor ">Benjamin  Bader</span>. </span><span class="cited-content_cbyCitation_article-title">Assay Development and High‐Throughput Screening. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-42. <a href="https://doi.org/10.1002/0471266949.bmc165.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc165.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc165.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc165.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DAssay%252BDevelopment%252Band%252BHigh%2525E2%252580%252590Throughput%252BScreening%26aulast%3DCarettoni%26aufirst%3DDaniele%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D42%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Recent progress in natural product-based inhibitor screening with enzymatic fluorescent probes. </span><span class="cited-content_cbyCitation_journal-name">Analytical Methods</span><span> <strong>2021,</strong> <em>13 </em>
                                    (15)
                                     , 1778-1787. <a href="https://doi.org/10.1039/D1AY00245G" title="DOI URL">https://doi.org/10.1039/D1AY00245G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1AY00245G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1AY00245G%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Methods%26atitle%3DRecent%252Bprogress%252Bin%252Bnatural%252Bproduct-based%252Binhibitor%252Bscreening%252Bwith%252Benzymatic%252Bfluorescent%252Bprobes%26aulast%3DChen%26aufirst%3DYi%26date%3D2021%26date%3D2021%26volume%3D13%26issue%3D15%26spage%3D1778%26epage%3D1787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiong  Zhang</span>, <span class="hlFld-ContribAuthor ">Jiajia  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Modular Click Chemistry Library: Searching for Better Functions. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2021,</strong> <em>39 </em>
                                    (4)
                                     , 1025-1027. <a href="https://doi.org/10.1002/cjoc.202000596" title="DOI URL">https://doi.org/10.1002/cjoc.202000596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.202000596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.202000596%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DModular%252BClick%252BChemistry%252BLibrary%25253A%252BSearching%252Bfor%252BBetter%252BFunctions%26aulast%3DZhang%26aufirst%3DJiong%26date%3D2021%26date%3D2021%26volume%3D39%26issue%3D4%26spage%3D1025%26epage%3D1027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuan  Wang</span>, <span class="hlFld-ContribAuthor ">Jiaxiang  Liu</span>, <span class="hlFld-ContribAuthor ">Ziqin  Yan</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Liu</span>, <span class="hlFld-ContribAuthor ">Sixiu  Liu</span>, <span class="hlFld-ContribAuthor ">Yanrui  Suo</span>, <span class="hlFld-ContribAuthor ">Weiwei  Lu</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Yue</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Yujun  Zhao</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Dongcheng  Dai</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Lu</span>. </span><span class="cited-content_cbyCitation_article-title">Diversified strategy for the synthesis of DNA-encoded oxindole libraries. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2021,</strong> <em>12 </em>
                                    (8)
                                     , 2841-2847. <a href="https://doi.org/10.1039/D0SC06696F" title="DOI URL">https://doi.org/10.1039/D0SC06696F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0SC06696F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0SC06696F%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DDiversified%252Bstrategy%252Bfor%252Bthe%252Bsynthesis%252Bof%252BDNA-encoded%252Boxindole%252Blibraries%26aulast%3DWang%26aufirst%3DXuan%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D8%26spage%3D2841%26epage%3D2847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saman  Honarnejad</span>, <span class="hlFld-ContribAuthor ">Stan  van Boeckel</span>, <span class="hlFld-ContribAuthor ">Helma  van den Hurk</span>, <span class="hlFld-ContribAuthor ">Steven  van Helden</span>. </span><span class="cited-content_cbyCitation_article-title">Hit Discovery for Public Target Programs in the European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2021,</strong> <em>26 </em>
                                    (2)
                                     , 192-204. <a href="https://doi.org/10.1177/2472555220942765" title="DOI URL">https://doi.org/10.1177/2472555220942765</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555220942765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555220942765%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DHit%252BDiscovery%252Bfor%252BPublic%252BTarget%252BPrograms%252Bin%252Bthe%252BEuropean%252BLead%252BFactory%25253A%252BExperiences%252Band%252BOutput%252Bfrom%252BAssay%252BDevelopment%252Band%252BUltra-High-Throughput%252BScreening%26aulast%3DHonarnejad%26aufirst%3DSaman%26date%3D2021%26date%3D2020%26volume%3D26%26issue%3D2%26spage%3D192%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Bremner</span>. </span><span class="cited-content_cbyCitation_article-title">Antibacterial Combinations. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 21-49. <a href="https://doi.org/10.1007/978-981-16-0999-2_2" title="DOI URL">https://doi.org/10.1007/978-981-16-0999-2_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-16-0999-2_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-16-0999-2_2%26sid%3Dliteratum%253Aachs%26atitle%3DAntibacterial%252BCombinations%26aulast%3DBremner%26aufirst%3DJohn%26date%3D2021%26date%3D2021%26spage%3D21%26epage%3D49%26pub%3DSpringer%2520Singapore%26atitle%3DMultiple%252BAction-Based%252BDesign%252BApproaches%252Bto%252BAntibacterials%26aulast%3DBremner%26aufirst%3DJohn%26date%3D2021%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoine  Daina</span>, <span class="hlFld-ContribAuthor ">Ute F.  Röhrig</span>, <span class="hlFld-ContribAuthor ">Vincent  Zoete</span>. </span><span class="cited-content_cbyCitation_article-title">Computer-Aided Drug Design for Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 386-401. <a href="https://doi.org/10.1016/B978-0-12-801238-3.11670-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-801238-3.11670-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-801238-3.11670-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-801238-3.11670-8%26sid%3Dliteratum%253Aachs%26atitle%3DComputer-Aided%252BDrug%252BDesign%252Bfor%252BCancer%252BTherapy%26aulast%3DDaina%26aufirst%3DAntoine%26date%3D2021%26spage%3D386%26epage%3D401%26pub%3DElsevier%26atitle%3DSystems%252BMedicine%26date%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew  Baxter</span>. </span><span class="cited-content_cbyCitation_article-title">Holistic Assessment of Compound Properties—In Vitro to In Vivo Pharmacology. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-820472-6.00016-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-820472-6.00016-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-820472-6.00016-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-820472-6.00016-5%26sid%3Dliteratum%253Aachs%26atitle%3DHolistic%252BAssessment%252Bof%252BCompound%252BProperties%2525E2%252580%252594In%252BVitro%252Bto%252BIn%252BVivo%252BPharmacology%26aulast%3DBaxter%26aufirst%3DAndrew%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BBiomedical%252BSciences%26date%3D2021%26volume%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petar  Ristoski</span>, <span class="hlFld-ContribAuthor ">Dmitry Yu  Zubarev</span>, <span class="hlFld-ContribAuthor ">Anna Lisa  Gentile</span>, <span class="hlFld-ContribAuthor ">Nathaniel  Park</span>, <span class="hlFld-ContribAuthor ">Daniel  Sanders</span>, <span class="hlFld-ContribAuthor ">Daniel  Gruhl</span>, <span class="hlFld-ContribAuthor ">Linda  Kato</span>, <span class="hlFld-ContribAuthor ">Steve  Welch</span>. </span><span class="cited-content_cbyCitation_article-title">Expert-in-the-loop AI for Polymer Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 2701-2708. <a href="https://doi.org/10.1145/3340531.3416020" title="DOI URL">https://doi.org/10.1145/3340531.3416020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1145/3340531.3416020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1145%2F3340531.3416020%26sid%3Dliteratum%253Aachs%26atitle%3DExpert-in-the-loop%252BAI%252Bfor%252BPolymer%252BDiscovery%26aulast%3DRistoski%26aufirst%3DPetar%26date%3D2020%26date%3D2020%26spage%3D2701%26epage%3D2708%26pub%3DACM%26atitle%3DProceedings%252Bof%252Bthe%252B29th%252BACM%252BInternational%252BConference%252Bon%252BInformation%252B%252526%252BKnowledge%252BManagement%26aulast%3Dd%2527Aquin%26aufirst%3DMathieu%26date%3D2020%26volume%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bruno  David</span>, <span class="hlFld-ContribAuthor ">Antonio  Grondin</span>, <span class="hlFld-ContribAuthor ">Philippe  Schambel</span>, <span class="hlFld-ContribAuthor ">Marc  Vitorino</span>, <span class="hlFld-ContribAuthor ">Denis  Zeyer</span>. </span><span class="cited-content_cbyCitation_article-title">Plant natural fragments, an innovative approach for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Phytochemistry Reviews</span><span> <strong>2020,</strong> <em>19 </em>
                                    (5)
                                     , 1141-1156. <a href="https://doi.org/10.1007/s11101-019-09612-4" title="DOI URL">https://doi.org/10.1007/s11101-019-09612-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11101-019-09612-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11101-019-09612-4%26sid%3Dliteratum%253Aachs%26jtitle%3DPhytochemistry%2520Reviews%26atitle%3DPlant%252Bnatural%252Bfragments%25252C%252Ban%252Binnovative%252Bapproach%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DDavid%26aufirst%3DBruno%26date%3D2020%26date%3D2019%26volume%3D19%26issue%3D5%26spage%3D1141%26epage%3D1156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sravani  Sana</span>, <span class="hlFld-ContribAuthor ">Velma Ganga  Reddy</span>, <span class="hlFld-ContribAuthor ">Sonal  Bhandari</span>, <span class="hlFld-ContribAuthor ">T. Srinivasa  Reddy</span>, <span class="hlFld-ContribAuthor ">Ramya  Tokala</span>, <span class="hlFld-ContribAuthor ">Akash P.  Sakla</span>, <span class="hlFld-ContribAuthor ">Suresh K.  Bhargava</span>, <span class="hlFld-ContribAuthor ">Nagula  Shankaraiah</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>200 </em>, 112457. <a href="https://doi.org/10.1016/j.ejmech.2020.112457" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112457%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploration%252Bof%252Bcarbamide%252Bderived%252Bpyrimidine-thioindole%252Bconjugates%252Bas%252Bpotential%252BVEGFR-2%252Binhibitors%252Bwith%252Banti-angiogenesis%252Beffect%26aulast%3DSana%26aufirst%3DSravani%26date%3D2020%26volume%3D200%26spage%3D112457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingxin  Li</span>, <span class="hlFld-ContribAuthor ">CongBao  Kang</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanisms of Action for Small Molecules Revealed by Structural Biology in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (15)
                                     , 5262. <a href="https://doi.org/10.3390/ijms21155262" title="DOI URL">https://doi.org/10.3390/ijms21155262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21155262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21155262%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DMechanisms%252Bof%252BAction%252Bfor%252BSmall%252BMolecules%252BRevealed%252Bby%252BStructural%252BBiology%252Bin%252BDrug%252BDiscovery%26aulast%3DLi%26aufirst%3DQingxin%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D15%26spage%3D5262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Drug Targets. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 1-96. <a href="https://doi.org/10.1002/9781119607311.ch1" title="DOI URL">https://doi.org/10.1002/9781119607311.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119607311.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119607311.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DDrug%252BTargets%26date%3D2020%26date%3D2020%26spage%3D1%26epage%3D96%26pub%3DWiley%26atitle%3DMedicinal%252BChemistry%252Bfor%252BPractitioners%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2020%26date%3D2020%26volume%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert  Cheng</span>. </span><span class="cited-content_cbyCitation_article-title">Towards an Optimal Sample Delivery Method for Serial Crystallography at XFEL. </span><span class="cited-content_cbyCitation_journal-name">Crystals</span><span> <strong>2020,</strong> <em>10 </em>
                                    (3)
                                     , 215. <a href="https://doi.org/10.3390/cryst10030215" title="DOI URL">https://doi.org/10.3390/cryst10030215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cryst10030215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcryst10030215%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystals%26atitle%3DTowards%252Ban%252BOptimal%252BSample%252BDelivery%252BMethod%252Bfor%252BSerial%252BCrystallography%252Bat%252BXFEL%26aulast%3DCheng%26aufirst%3DRobert%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D3%26spage%3D215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Madsen</span>, <span class="hlFld-ContribAuthor ">Carlos  Azevedo</span>, <span class="hlFld-ContribAuthor ">Iolanda  Micco</span>, <span class="hlFld-ContribAuthor ">Lars Kolster  Petersen</span>, <span class="hlFld-ContribAuthor ">Nils Jakob Vest  Hansen</span>. </span><span class="cited-content_cbyCitation_article-title">An overview of DNA-encoded libraries: A versatile tool for drug discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 181-249. <a href="https://doi.org/10.1016/bs.pmch.2020.03.001" title="DOI URL">https://doi.org/10.1016/bs.pmch.2020.03.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2020.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2020.03.001%26sid%3Dliteratum%253Aachs%26atitle%3DAn%252Boverview%252Bof%252BDNA-encoded%252Blibraries%25253A%252BA%252Bversatile%252Btool%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DMadsen%26aufirst%3DDaniel%26date%3D2020%26spage%3D181%26epage%3D249%26pub%3DElsevier%26date%3D2020%26volume%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Whitney L.  Petrilli</span>, <span class="hlFld-ContribAuthor ">Gregory C.  Adam</span>, <span class="hlFld-ContribAuthor ">Roman S.  Erdmann</span>, <span class="hlFld-ContribAuthor ">Pravien  Abeywickrema</span>, <span class="hlFld-ContribAuthor ">Vijayalakshmi  Agnani</span>, <span class="hlFld-ContribAuthor ">Xi  Ai</span>, <span class="hlFld-ContribAuthor ">Jen  Baysarowich</span>, <span class="hlFld-ContribAuthor ">Noel  Byrne</span>, <span class="hlFld-ContribAuthor ">John P.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Wonsuk  Chang</span>, <span class="hlFld-ContribAuthor ">Edward  DiNunzio</span>, <span class="hlFld-ContribAuthor ">Zhe  Feng</span>, <span class="hlFld-ContribAuthor ">Rachael  Ford</span>, <span class="hlFld-ContribAuthor ">Sookhee  Ha</span>, <span class="hlFld-ContribAuthor ">Yongcheng  Huang</span>, <span class="hlFld-ContribAuthor ">Brian  Hubbard</span>, <span class="hlFld-ContribAuthor ">Jennifer M.  Johnston</span>, <span class="hlFld-ContribAuthor ">Michael  Kavana</span>, <span class="hlFld-ContribAuthor ">Jean-Marie  Lisnock</span>, <span class="hlFld-ContribAuthor ">Rui  Liang</span>, <span class="hlFld-ContribAuthor ">Jun  Lu</span>, <span class="hlFld-ContribAuthor ">Zhijian  Lu</span>, <span class="hlFld-ContribAuthor ">Juncai  Meng</span>, <span class="hlFld-ContribAuthor ">Peter  Orth</span>, <span class="hlFld-ContribAuthor ">Oksana  Palyha</span>, <span class="hlFld-ContribAuthor ">Gopal  Parthasarathy</span>, <span class="hlFld-ContribAuthor ">Scott P.  Salowe</span>, <span class="hlFld-ContribAuthor ">Sujata  Sharma</span>, <span class="hlFld-ContribAuthor ">Jennifer  Shipman</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Soisson</span>, <span class="hlFld-ContribAuthor ">Alison M.  Strack</span>, <span class="hlFld-ContribAuthor ">Hyewon  Youm</span>, <span class="hlFld-ContribAuthor ">Kake  Zhao</span>, <span class="hlFld-ContribAuthor ">Deborah L.  Zink</span>, <span class="hlFld-ContribAuthor ">Hratch  Zokian</span>, <span class="hlFld-ContribAuthor ">George H.  Addona</span>, <span class="hlFld-ContribAuthor ">Karen  Akinsanya</span>, <span class="hlFld-ContribAuthor ">James R.  Tata</span>, <span class="hlFld-ContribAuthor ">Yusheng  Xiong</span>, <span class="hlFld-ContribAuthor ">Jason E.  Imbriglio</span>. </span><span class="cited-content_cbyCitation_article-title">From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9. </span><span class="cited-content_cbyCitation_journal-name">Cell Chemical Biology</span><span> <strong>2020,</strong> <em>27 </em>
                                    (1)
                                     , 32-40.e3. <a href="https://doi.org/10.1016/j.chembiol.2019.10.002" title="DOI URL">https://doi.org/10.1016/j.chembiol.2019.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.chembiol.2019.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.chembiol.2019.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Chemical%2520Biology%26atitle%3DFrom%252BScreening%252Bto%252BTargeted%252BDegradation%25253A%252BStrategies%252Bfor%252Bthe%252BDiscovery%252Band%252BOptimization%252Bof%252BSmall%252BMolecule%252BLigands%252Bfor%252BPCSK9%26aulast%3DPetrilli%26aufirst%3DWhitney%2BL.%26date%3D2020%26volume%3D27%26issue%3D1%26spage%3D32%26epage%3D40.e3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramesh  Akkina</span>, <span class="hlFld-ContribAuthor ">Robert  Garry</span>, <span class="hlFld-ContribAuthor ">Christian  Bréchot</span>, <span class="hlFld-ContribAuthor ">Heinz  Ellerbrok</span>, <span class="hlFld-ContribAuthor ">Hideki  Hasegawa</span>, <span class="hlFld-ContribAuthor ">Luis  Menéndez-Arias</span>, <span class="hlFld-ContribAuthor ">Natalia  Mercer</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, <span class="hlFld-ContribAuthor ">Victor  Romanowski</span>, <span class="hlFld-ContribAuthor ">Joaquim  Segalés</span>, <span class="hlFld-ContribAuthor ">Anders  Vahlne</span>. </span><span class="cited-content_cbyCitation_article-title">2019 meeting of the global virus network. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2019,</strong> <em>172 </em>, 104645. <a href="https://doi.org/10.1016/j.antiviral.2019.104645" title="DOI URL">https://doi.org/10.1016/j.antiviral.2019.104645</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2019.104645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2019.104645%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3D2019%252Bmeeting%252Bof%252Bthe%252Bglobal%252Bvirus%252Bnetwork%26aulast%3DAkkina%26aufirst%3DRamesh%26date%3D2019%26volume%3D172%26spage%3D104645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gerhard  Hessler</span>, <span class="hlFld-ContribAuthor ">Christoph  Grebner</span>, <span class="hlFld-ContribAuthor ">Hans  Matter</span>. </span><span class="cited-content_cbyCitation_article-title">Computational Approaches for Target Inference. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 277-322. <a href="https://doi.org/10.1002/9783527818242.ch10" title="DOI URL">https://doi.org/10.1002/9783527818242.ch10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527818242.ch10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527818242.ch10%26sid%3Dliteratum%253Aachs%26atitle%3DComputational%252BApproaches%252Bfor%252BTarget%252BInference%26aulast%3DHessler%26aufirst%3DGerhard%26date%3D2019%26date%3D2019%26spage%3D277%26epage%3D322%26pub%3DWiley%26atitle%3DTarget%252BDiscovery%252Band%252BValidation%26aulast%3DPlowright%26aufirst%3DAlleyn%2BT%26date%3D2019%26date%3D2019%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shenaz B.  Bunally</span>, <span class="hlFld-ContribAuthor ">Christopher N.  Luscombe</span>, <span class="hlFld-ContribAuthor ">Robert J.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Using Physicochemical Measurements to Influence Better Compound Design. </span><span class="cited-content_cbyCitation_journal-name">SLAS DISCOVERY: Advancing the Science of Drug Discovery</span><span> <strong>2019,</strong> <em>24 </em>
                                    (8)
                                     , 791-801. <a href="https://doi.org/10.1177/2472555219859845" title="DOI URL">https://doi.org/10.1177/2472555219859845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/2472555219859845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F2472555219859845%26sid%3Dliteratum%253Aachs%26jtitle%3DSLAS%2520DISCOVERY%253A%2520Advancing%2520the%2520Science%2520of%2520Drug%2520Discovery%26atitle%3DUsing%252BPhysicochemical%252BMeasurements%252Bto%252BInfluence%252BBetter%252BCompound%252BDesign%26aulast%3DBunally%26aufirst%3DShenaz%2BB.%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D8%26spage%3D791%26epage%3D801" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philip J.  Chevis</span>, <span class="hlFld-ContribAuthor ">Sirilak  Wangngae</span>, <span class="hlFld-ContribAuthor ">Thanaphat  Thaima</span>, <span class="hlFld-ContribAuthor ">Anthony W.  Carroll</span>, <span class="hlFld-ContribAuthor ">Anthony C.  Willis</span>, <span class="hlFld-ContribAuthor ">Mookda  Pattarawarapan</span>, <span class="hlFld-ContribAuthor ">Stephen G.  Pyne</span>. </span><span class="cited-content_cbyCitation_article-title">Highly diastereoselective synthesis of enantioenriched
              anti
              -α-allyl-β-fluoroamines. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (43)
                                     , 6050-6053. <a href="https://doi.org/10.1039/C9CC02765C" title="DOI URL">https://doi.org/10.1039/C9CC02765C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC02765C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC02765C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DHighly%252Bdiastereoselective%252Bsynthesis%252Bof%252Benantioenriched%252Banti%252B-%2525CE%2525B1-allyl-%2525CE%2525B2-fluoroamines%26aulast%3DChevis%26aufirst%3DPhilip%2BJ.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D43%26spage%3D6050%26epage%3D6053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco V.  Reddavide</span>, <span class="hlFld-ContribAuthor ">Meiying  Cui</span>, <span class="hlFld-ContribAuthor ">Weilin  Lin</span>, <span class="hlFld-ContribAuthor ">Naiqiang  Fu</span>, <span class="hlFld-ContribAuthor ">Stephan  Heiden</span>, <span class="hlFld-ContribAuthor ">Helena  Andrade</span>, <span class="hlFld-ContribAuthor ">Michael  Thompson</span>, <span class="hlFld-ContribAuthor ">Yixin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Second generation DNA-encoded dynamic combinatorial chemical libraries. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2019,</strong> <em>55 </em>
                                    (26)
                                     , 3753-3756. <a href="https://doi.org/10.1039/C9CC01429B" title="DOI URL">https://doi.org/10.1039/C9CC01429B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CC01429B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CC01429B%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DSecond%252Bgeneration%252BDNA-encoded%252Bdynamic%252Bcombinatorial%252Bchemical%252Blibraries%26aulast%3DReddavide%26aufirst%3DFrancesco%2BV.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D26%26spage%3D3753%26epage%3D3756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Markus  Follmann</span>, <span class="hlFld-ContribAuthor ">Hans  Briem</span>, <span class="hlFld-ContribAuthor ">Andreas  Steinmeyer</span>, <span class="hlFld-ContribAuthor ">Alexander  Hillisch</span>, <span class="hlFld-ContribAuthor ">Monika H.  Schmitt</span>, <span class="hlFld-ContribAuthor ">Helmut  Haning</span>, <span class="hlFld-ContribAuthor ">Heinrich  Meier</span>. </span><span class="cited-content_cbyCitation_article-title">An approach towards enhancement of a screening library: The Next Generation Library Initiative (NGLI) at Bayer — against all odds?. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2019,</strong> <em>24 </em>
                                    (3)
                                     , 668-672. <a href="https://doi.org/10.1016/j.drudis.2018.12.003" title="DOI URL">https://doi.org/10.1016/j.drudis.2018.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2018.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2018.12.003%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DAn%252Bapproach%252Btowards%252Benhancement%252Bof%252Ba%252Bscreening%252Blibrary%25253A%252BThe%252BNext%252BGeneration%252BLibrary%252BInitiative%252B%252528NGLI%252529%252Bat%252BBayer%252B%2525E2%252580%252594%252Bagainst%252Ball%252Bodds%25253F%26aulast%3DFollmann%26aufirst%3DMarkus%26date%3D2019%26volume%3D24%26issue%3D3%26spage%3D668%26epage%3D672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martina  Hrast</span>, <span class="hlFld-ContribAuthor ">Kaja  Rožman</span>, <span class="hlFld-ContribAuthor ">Iza  Ogris</span>, <span class="hlFld-ContribAuthor ">Veronika  Škedelj</span>, <span class="hlFld-ContribAuthor ">Delphine  Patin</span>, <span class="hlFld-ContribAuthor ">Matej  Sova</span>, <span class="hlFld-ContribAuthor ">Hélène  Barreteau</span>, <span class="hlFld-ContribAuthor ">Stanislav  Gobec</span>, <span class="hlFld-ContribAuthor ">Simona Golič  Grdadolnik</span>, <span class="hlFld-ContribAuthor ">Anamarija  Zega</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of the published kinase inhibitor set to identify multiple inhibitors of bacterial ATP-dependent mur ligases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2019,</strong> <em>34 </em>
                                    (1)
                                     , 1010-1017. <a href="https://doi.org/10.1080/14756366.2019.1608981" title="DOI URL">https://doi.org/10.1080/14756366.2019.1608981</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2019.1608981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2019.1608981%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DEvaluation%252Bof%252Bthe%252Bpublished%252Bkinase%252Binhibitor%252Bset%252Bto%252Bidentify%252Bmultiple%252Binhibitors%252Bof%252Bbacterial%252BATP-dependent%252Bmur%252Bligases%26aulast%3DHrast%26aufirst%3DMartina%26date%3D2019%26date%3D2019%26volume%3D34%26issue%3D1%26spage%3D1010%26epage%3D1017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucas  Defelipe</span>, <span class="hlFld-ContribAuthor ">Juan  Arcon</span>, <span class="hlFld-ContribAuthor ">Carlos  Modenutti</span>, <span class="hlFld-ContribAuthor ">Marcelo  Marti</span>, <span class="hlFld-ContribAuthor ">Adrián  Turjanski</span>, <span class="hlFld-ContribAuthor ">Xavier  Barril</span>. </span><span class="cited-content_cbyCitation_article-title">Solvents to Fragments to Drugs: MD Applications in Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (12)
                                     , 3269. <a href="https://doi.org/10.3390/molecules23123269" title="DOI URL">https://doi.org/10.3390/molecules23123269</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23123269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23123269%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSolvents%252Bto%252BFragments%252Bto%252BDrugs%25253A%252BMD%252BApplications%252Bin%252BDrug%252BDesign%26aulast%3DDefelipe%26aufirst%3DLucas%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D12%26spage%3D3269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0023.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Distributions of the six sources of lead generation strategies: Known compounds, Random screen or high throughput screen (HTS), Fragment screen or Fragment based lead generation (FBLG), DNA Encoded Libraries (DEL), Structure based drug design (SBDD), Directed Screen for the 66 hit-to-candidate pairs in <i>J. Med. Chem.</i> 2016–2017.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Target class analysis (a) and disease area (b) analysis for the 66 hit-to-candidate pairs in <i>J. Med. Chem.</i> 2016–2017.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Analysis of calculated physicochemical property changes for the 66 hit-to-candidate pairs in <i>J. Med. Chem.</i> 2016–2017 in “Known” starting points and “Random” screening categories.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Comparison of the Tanimoto maximum common substructure (Tanimoto-MCCS) for hit-to-clinical lead pairs in the “Known” starting point and “Random” screening categories.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Example of hit-clinical success from small, directed screening sets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Example of hit-clinical success from known starting points.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Example of hit-clinical success by building dual-acting compounds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Example of hit-clinical candidate from endogenous ligand.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Example of integrated lead generation approach.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Examples of integrated lead generation strategies for EZH2 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/medium/jm-2018-006754_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Synthesis and the role of serendipity in lead generation strategies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-21/acs.jmedchem.8b00675/20181101/images/large/jm-2018-006754_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00675&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i23">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24583" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24583" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 136 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span>; <span class="NLM_string-name">Brown, D.
G.</span></span> <span> </span><span class="NLM_article-title">Modern lead generation stratagies</span>. In  <i>Lead Generation: Methods and Strategies</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span>, <span class="NLM_string-name">Mannhold, R.</span>, <span class="NLM_string-name">Kubinyi, H.</span>, <span class="NLM_string-name">Folkers, G.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">33</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2F9783527677047.ch02" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=13-33&author=J.+Holenz&author=D.%0AG.+Brownauthor=J.+Holenz&author=R.+Mannhold&author=H.+Kubinyi&author=G.+Folkers&title=Lead+Generation%3A+Methods+and+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1002%2F9783527677047.ch02&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677047.ch02%26sid%3Dliteratum%253Aachs%26aulast%3DHolenz%26aufirst%3DJ.%26atitle%3DModern%2520lead%2520generation%2520stratagies%26btitle%3DLead%2520Generation%253A%2520Methods%2520and%2520Strategies%26aulast%3DHolenz%26aufirst%3DJ.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2016%26spage%3D13%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalindjian, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Philpott, K. L.</span></span> <span> </span><span class="NLM_article-title">Principles of early drug discovery</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">1239</span>– <span class="NLM_lpage">1249</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01127.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1111%2Fj.1476-5381.2010.01127.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=21091654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivF2lt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2011&pages=1239-1249&author=J.+P.+Hughesauthor=S.+Reesauthor=S.+B.+Kalindjianauthor=K.+L.+Philpott&title=Principles+of+early+drug+discovery&doi=10.1111%2Fj.1476-5381.2010.01127.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Principles of early drug discovery</span></div><div class="casAuthors">Hughes, J. P.; Rees, S.; Kalindjian, S. B.; Philpott, K. L.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1239-1249</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Developing a new drug from original idea to the launch of a finished product is a complex process which can take 12-15 years and cost in excess of $1 billion.  The idea for a target can come from a variety of sources including academic and clin. research and from the com. sector.  It may take many years to build up a body of supporting evidence before selecting a target for a costly drug discovery program.  Once a target was chosen, the pharmaceutical industry and more recently some academic centers have streamlined a no. of early processes to identify mols. which possess suitable characteristics to make acceptable drugs.  This review will look at key preclin. stages of the drug discovery process, from initial target identification and validation, through assay development, high throughput screening, hit identification, lead optimization and finally the selection of a candidate mol. for clin. development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCc74_F_90rVg90H21EOLACvtfcHk0liNd3zD9BdHjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivF2lt7o%253D&md5=05a0016f45b155f9fb5822f5c7bcc35d</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01127.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01127.x%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BP.%26aulast%3DRees%26aufirst%3DS.%26aulast%3DKalindjian%26aufirst%3DS.%2BB.%26aulast%3DPhilpott%26aufirst%3DK.%2BL.%26atitle%3DPrinciples%2520of%2520early%2520drug%2520discovery%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D162%26spage%3D1239%26epage%3D1249%26doi%3D10.1111%2Fj.1476-5381.2010.01127.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morphy, J. R.</span></span> <span> </span><span class="NLM_article-title">Historical strategies for lead generation</span>. <i>RSC Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">111</span>– <span class="NLM_lpage">129</span>, <span class="refDoi"> DOI: 10.1039/9781849734912-00111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1039%2F9781849734912-00111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2012&pages=111-129&author=J.+R.+Morphy&title=Historical+strategies+for+lead+generation&doi=10.1039%2F9781849734912-00111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1039%2F9781849734912-00111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252F9781849734912-00111%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DJ.%2BR.%26atitle%3DHistorical%2520strategies%2520for%2520lead%2520generation%26jtitle%3DRSC%2520Drug%2520Discovery%26date%3D2012%26volume%3D21%26spage%3D111%26epage%3D129%26doi%3D10.1039%2F9781849734912-00111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Weigelt, D.</span>; <span class="NLM_string-name">Dorange, I.</span></span> <span> </span><span class="NLM_article-title">Lead generation based on compound collection screening</span>. In  <i>Lead Generation: Methods and Strategies</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span>, <span class="NLM_string-name">Mannhold, R.</span>, <span class="NLM_string-name">Kubinyi, H.</span>, <span class="NLM_string-name">Folkers, G.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">132</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2F9783527677047.ch05" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=95-132&author=D.+Weigelt&author=I.+Dorangeauthor=J.+Holenz&author=R.+Mannhold&author=H.+Kubinyi&author=G.+Folkers&title=Lead+Generation%3A+Methods+and+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2F9783527677047.ch05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677047.ch05%26sid%3Dliteratum%253Aachs%26aulast%3DWeigelt%26aufirst%3DD.%26atitle%3DLead%2520generation%2520based%2520on%2520compound%2520collection%2520screening%26btitle%3DLead%2520Generation%253A%2520Methods%2520and%2520Strategies%26aulast%3DHolenz%26aufirst%3DJ.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2016%26spage%3D95%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fesik, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jhoti, H.</span></span> <span> </span><span class="NLM_article-title">Twenty years on: the impact of fragments on drug discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">619</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd.2016.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=27417849" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=605-619&author=D.+A.+Erlansonauthor=S.+W.+Fesikauthor=R.+E.+Hubbardauthor=W.+Jahnkeauthor=H.+Jhoti&title=Twenty+years+on%3A+the+impact+of+fragments+on+drug+discovery&doi=10.1038%2Fnrd.2016.109"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Twenty years on: the impact of fragments on drug discovery</span></div><div class="casAuthors">Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E.; Jahnke, Wolfgang; Jhoti, Harren</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">605-619</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">After 20 years of sometimes quiet growth, fragment-based drug discovery (FBDD) has become mainstream.  More than 30 drug candidates derived from fragments have entered the clinic, with two approved and several more in advanced trials.  FBDD has been widely applied in both academia and industry, as evidenced by the large no. of papers from universities, non-profit research institutions, biotechnol. companies and pharmaceutical companies.  Moreover, FBDD draws on a diverse range of disciplines, from biochem. and biophysics to computational and medicinal chem.  As the promise of FBDD strategies becomes increasingly realized, now is an opportune time to draw lessons and point the way to the future.  This Review briefly discusses how to design fragment libraries, how to select screening techniques and how to make the most of information gleaned from them.  It also shows how concepts from FBDD have permeated and enhanced drug discovery efforts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrXQhFttydkrVg90H21EOLACvtfcHk0lgQzbQ7SnH1oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Gisb%252FE&md5=fc2bcf0da6b7b1083a5ff263057cfa80</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.109%26sid%3Dliteratum%253Aachs%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DHubbard%26aufirst%3DR.%2BE.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DJhoti%26aufirst%3DH.%26atitle%3DTwenty%2520years%2520on%253A%2520the%2520impact%2520of%2520fragments%2520on%2520drug%2520discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2016%26volume%3D15%26spage%3D605%26epage%3D619%26doi%3D10.1038%2Fnrd.2016.109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moitessier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pottel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Therrien, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Englebienne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomberg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbeil, C. R.</span></span> <span> </span><span class="NLM_article-title">Medicinal chemistry projects requiring imaginative structure based drug design methods</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1646</span>– <span class="NLM_lpage">1657</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.6b00185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.6b00185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2016&pages=1646-1657&author=N.+Moitessierauthor=J.+Pottelauthor=E.+Therrienauthor=P.+Englebienneauthor=Z.+Liuauthor=A.+Tombergauthor=C.+R.+Corbeil&title=Medicinal+chemistry+projects+requiring+imaginative+structure+based+drug+design+methods&doi=10.1021%2Facs.accounts.6b00185"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.6b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.6b00185%26sid%3Dliteratum%253Aachs%26aulast%3DMoitessier%26aufirst%3DN.%26aulast%3DPottel%26aufirst%3DJ.%26aulast%3DTherrien%26aufirst%3DE.%26aulast%3DEnglebienne%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DTomberg%26aufirst%3DA.%26aulast%3DCorbeil%26aufirst%3DC.%2BR.%26atitle%3DMedicinal%2520chemistry%2520projects%2520requiring%2520imaginative%2520structure%2520based%2520drug%2520design%2520methods%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2016%26volume%3D49%26spage%3D1646%26epage%3D1657%26doi%3D10.1021%2Facs.accounts.6b00185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span>; <span class="NLM_string-name">Liu, Z.</span>; <span class="NLM_string-name">Holenz, J.</span>; <span class="NLM_string-name">Yang, H.</span></span> <span> </span><span class="NLM_article-title">Competitive intelligence-based lead generation and fast follower approaches</span>. In  <i>Lead Generation: Methods and Strategies</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holenz, J.</span>, <span class="NLM_string-name">Mannhold, R.</span>, <span class="NLM_string-name">Kubinyi, H.</span>, <span class="NLM_string-name">Folkers, G.</span></span>, Eds.; <span class="NLM_publisher-name">Wiley-VCH Verlag GmbH & Co. KGaA</span>: <span class="NLM_publisher-loc">Weinheim, Germany</span>, <span class="NLM_year">2016</span>; pp  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">219</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2F9783527677047.ch08" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=183-219&author=Y.+Jiang&author=Z.+Liu&author=J.+Holenz&author=H.+Yangauthor=J.+Holenz&author=R.+Mannhold&author=H.+Kubinyi&author=G.+Folkers&title=Lead+Generation%3A+Methods+and+Strategies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2F9783527677047.ch08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527677047.ch08%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DY.%26atitle%3DCompetitive%2520intelligence-based%2520lead%2520generation%2520and%2520fast%2520follower%2520approaches%26btitle%3DLead%2520Generation%253A%2520Methods%2520and%2520Strategies%26aulast%3DHolenz%26aufirst%3DJ.%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26date%3D2016%26spage%3D183%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goodnow, R. A.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keefe, A. D.</span></span> <span> </span><span class="NLM_article-title">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1038/nrd.2016.213</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd.2016.213" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=27932801" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=131-147&author=R.+A.+Goodnowauthor=C.+E.+Dumelinauthor=A.+D.+Keefe&title=DNA-encoded+chemistry%3A+enabling+the+deeper+sampling+of+chemical+space&doi=10.1038%2Fnrd.2016.213"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">DNA-encoded chemistry: enabling the deeper sampling of chemical space</span></div><div class="casAuthors">Goodnow, Robert A. Jr; Dumelin, Christoph E.; Keefe, Anthony D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-147</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  DNA-encoded chem. library technologies are increasingly being adopted in drug discovery for hit and lead generation.  DNA-encoded chem. enables the exploration of chem. spaces four to five orders of magnitude more deeply than is achievable by traditional high-throughput screening methods.  Operation of this technol. requires developing a range of capabilities including aq. synthetic chem., building block acquisition, oligonucleotide conjugation, large-scale mol. biol. transformations, selection methodologies, PCR, sequencing, sequence data anal. and the anal. of large chem. spaces.  This Review provides an overview of the development and applications of DNA-encoded chem., highlighting the challenges and future directions for the use of this technol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdEd70MeexerVg90H21EOLACvtfcHk0lgQzbQ7SnH1oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKkurjM&md5=7ca97b01d75e600378799baf77665c07</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2016.213&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2016.213%26sid%3Dliteratum%253Aachs%26aulast%3DGoodnow%26aufirst%3DR.%2BA.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DKeefe%26aufirst%3DA.%2BD.%26atitle%3DDNA-encoded%2520chemistry%253A%2520enabling%2520the%2520deeper%2520sampling%2520of%2520chemical%2520space%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D131%26epage%3D147%26doi%3D10.1038%2Fnrd.2016.213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murcko, M.</span></span> <span> </span><span class="NLM_article-title">What makes a great medicinal chemist</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01445</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01445" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=M.+Murcko&title=What+makes+a+great+medicinal+chemist&doi=10.1021%2Facs.jmedchem.7b01445"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01445%26sid%3Dliteratum%253Aachs%26aulast%3DMurcko%26aufirst%3DM.%26atitle%3DWhat%2520makes%2520a%2520great%2520medicinal%2520chemist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26doi%3D10.1021%2Facs.jmedchem.7b01445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span> <i>OEChem</i>; <span class="NLM_publisher-name">OpenEye Scientific Software,
Inc.</span>: <span class="NLM_publisher-loc">Santa Fe, NM, U.S.</span>; <a href="http://eyesopen.com/molprop-tk" class="extLink">http://eyesopen.com/molprop-tk</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+OEChem%3B+OpenEye+Scientific+Software%2C%0AInc.%3A+Santa+Fe%2C+NM%2C+U.S.%3B+http%3A%2F%2Feyesopen.com%2Fmolprop-tk."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DOEChem%26pub%3DOpenEye%2520Scientific%2520Software%252C%250AInc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitt, S.</span></span> <span> </span><span class="NLM_article-title">Do structurally similar molecules bind in a similar fashion?</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">6716</span>– <span class="NLM_lpage">6725</span>, <span class="refDoi"> DOI: 10.1021/jm060167o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm060167o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6716-6725&author=J.+Bostr%C3%B6mauthor=A.+Hognerauthor=S.+Schmitt&title=Do+structurally+similar+molecules+bind+in+a+similar+fashion%3F&doi=10.1021%2Fjm060167o"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fjm060167o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060167o%26sid%3Dliteratum%253Aachs%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DHogner%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DS.%26atitle%3DDo%2520structurally%2520similar%2520molecules%2520bind%2520in%2520a%2520similar%2520fashion%253F%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6716%26epage%3D6725%26doi%3D10.1021%2Fjm060167o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertz, S. H.</span></span> <span> </span><span class="NLM_article-title">The first general index of molecular complexity</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">3599</span>– <span class="NLM_lpage">3601</span>, <span class="refDoi"> DOI: 10.1021/ja00402a071</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja00402a071" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADyaL3MXkt1Cjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1981&pages=3599-3601&author=S.+H.+Bertz&title=The+first+general+index+of+molecular+complexity&doi=10.1021%2Fja00402a071"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">The first general index of molecular complexity</span></div><div class="casAuthors">Bertz, Steven H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">103</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3599-601</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    </div><div class="casAbstract">An index of mol. complexity is introduced which is based upon the concepts of graph theory and information theory.  It is the only one extant that is completely general, being applicable to compds. contg. such features as branching, rings, multiple bonds, and heteroatoms.  It also reflects the sym. present in a mol.  All these features are important in synthetic anal., as illustrated by an example including sample calcns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXuz8eEH2Cl7Vg90H21EOLACvtfcHk0lgWPgPTPv-LAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXkt1Cjtbk%253D&md5=9a7602510035ab906839fd67a47148e7</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fja00402a071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00402a071%26sid%3Dliteratum%253Aachs%26aulast%3DBertz%26aufirst%3DS.%2BH.%26atitle%3DThe%2520first%2520general%2520index%2520of%2520molecular%2520complexity%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1981%26volume%3D103%26spage%3D3599%26epage%3D3601%26doi%3D10.1021%2Fja00402a071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soltwedel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantei, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holms, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McClellan, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wendt, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magoc, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warder, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajaraman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petros, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panchal, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K. F.</span></span> <span> </span><span class="NLM_article-title">Fragment-Based, structure-enabled discovery of novel pyridones and pyridone macrocycles as potent bromodomain and extra-terminal domain (BET) family bromodomain inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3828</span>– <span class="NLM_lpage">3850</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00017</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsVygu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3828-3850&author=L.+Wangauthor=J.+K.+Prattauthor=T.+Soltwedelauthor=G.+S.+Sheppardauthor=S.+D.+Fidanzeauthor=D.+Liuauthor=L.+A.+Hasvoldauthor=R.+A.+Manteiauthor=J.+H.+Holmsauthor=W.+J.+McClellanauthor=M.+D.+Wendtauthor=C.+Wadaauthor=R.+Freyauthor=T.+M.+Hansenauthor=R.+Hubbardauthor=C.+H.+Parkauthor=L.+Liauthor=T.+J.+Magocauthor=D.+H.+Albertauthor=X.+Linauthor=S.+E.+Warderauthor=P.+Kovarauthor=X.+Huangauthor=D.+Wilcoxauthor=R.+Wangauthor=G.+Rajaramanauthor=A.+M.+Petrosauthor=C.+W.+Hutchinsauthor=S.+C.+Panchalauthor=C.+Sunauthor=S.+W.+Elmoreauthor=Y.+Shenauthor=W.+M.+Katiauthor=K.+F.+McDaniel&title=Fragment-Based%2C+structure-enabled+discovery+of+novel+pyridones+and+pyridone+macrocycles+as+potent+bromodomain+and+extra-terminal+domain+%28BET%29+family+bromodomain+inhibitors&doi=10.1021%2Facs.jmedchem.7b00017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-Based, Structure-Enabled Discovery of Novel Pyridones and Pyridone Macrocycles as Potent Bromodomain and Extra-Terminal Domain (BET) Family Bromodomain Inhibitors</span></div><div class="casAuthors">Wang, Le; Pratt, John K.; Soltwedel, Todd; Sheppard, George S.; Fidanze, Steven D.; Liu, Dachun; Hasvold, Lisa A.; Mantei, Robert A.; Holms, James H.; McClellan, William J.; Wendt, Michael D.; Wada, Carol; Frey, Robin; Hansen, T. Matthew; Hubbard, Robert; Park, Chang H.; Li, Leiming; Magoc, Terrance J.; Albert, Daniel H.; Lin, Xiaoyu; Warder, Scott E.; Kovar, Peter; Huang, Xiaoli; Wilcox, Denise; Wang, Rongqi; Rajaraman, Ganesh; Petros, Andrew M.; Hutchins, Charles W.; Panchal, Sanjay C.; Sun, Chaohong; Elmore, Steven W.; Shen, Yu; Kati, Warren M.; McDaniel, Keith F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3828-3850</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Members of the BET family of bromodomain contg. proteins have been identified as potential targets for blocking proliferation in a variety of cancer cell lines.  A 2-dimensional NMR fragment screen for binders to the bromodomains of BRD4 identified a Ph pyridazinone fragment with a weak binding affinity (I, Ki = 160 μM).  SAR investigation of fragment I, aided by X-ray structure-based design, enabled the synthesis of potent pyridone and macrocyclic pyridone inhibitors exhibiting single digit nanomolar potency in both biochem. and cell based assays, e.g. II.  Advanced analogs in these series exhibited high oral exposures in rodent PK studies and demonstrated significant tumor growth inhibition efficacy in mouse flank xenograft models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDaiYdyL4LtrVg90H21EOLACvtfcHk0lgWPgPTPv-LAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsVygu7k%253D&md5=91750e660bafec08b8bcbe6bcd5e818f</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00017%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DL.%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DSoltwedel%26aufirst%3DT.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DHolms%26aufirst%3DJ.%2BH.%26aulast%3DMcClellan%26aufirst%3DW.%2BJ.%26aulast%3DWendt%26aufirst%3DM.%2BD.%26aulast%3DWada%26aufirst%3DC.%26aulast%3DFrey%26aufirst%3DR.%26aulast%3DHansen%26aufirst%3DT.%2BM.%26aulast%3DHubbard%26aufirst%3DR.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWarder%26aufirst%3DS.%2BE.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DWilcox%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DRajaraman%26aufirst%3DG.%26aulast%3DPetros%26aufirst%3DA.%2BM.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DPanchal%26aufirst%3DS.%2BC.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DKati%26aufirst%3DW.%2BM.%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26atitle%3DFragment-Based%252C%2520structure-enabled%2520discovery%2520of%2520novel%2520pyridones%2520and%2520pyridone%2520macrocycles%2520as%2520potent%2520bromodomain%2520and%2520extra-terminal%2520domain%2520%2528BET%2529%2520family%2520bromodomain%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3828%26epage%3D3850%26doi%3D10.1021%2Facs.jmedchem.7b00017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McDaniel, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soltwedel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidanze, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasvold, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mantei, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheppard, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bui, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faivre, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warder, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcox, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magoc, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajaraman, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchins, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edalji, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elmore, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kati, W. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/mivebresib), a potent and orally available bromodomain and extraterminal domain (BET) family bromodomain inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8369</span>– <span class="NLM_lpage">8384</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00746</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00746" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOjtrbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8369-8384&author=K.+F.+McDanielauthor=W.+Wangauthor=T.+Soltwedelauthor=S.+D.+Fidanzeauthor=L.+A.+Hasvoldauthor=D.+Liuauthor=R.+A.+Manteiauthor=J.+K.+Prattauthor=G.+S.+Sheppardauthor=M.+H.+Buiauthor=E.+J.+Faivreauthor=X.+Huangauthor=L.+Liauthor=X.+Linauthor=R.+Wangauthor=S.+E.+Warderauthor=D.+Wilcoxauthor=D.+H.+Albertauthor=T.+J.+Magocauthor=G.+Rajaramanauthor=C.+H.+Parkauthor=C.+W.+Hutchinsauthor=J.+J.+Shenauthor=R.+P.+Edaljiauthor=C.+C.+Sunauthor=R.+Martinauthor=W.+Gaoauthor=S.+Wongauthor=G.+Fangauthor=S.+W.+Elmoreauthor=Y.+Shenauthor=W.+M.+Kati&title=Discovery+of+N-%284-%282%2C4-Difluorophenoxy%29-3-%286-methyl-7-oxo-6%2C7-dihydro-1H-pyrrolo%5B2%2C3-c%5Dpyridin-4-yl%29phenyl%29ethanesulfonamide+%28ABBV-075%2Fmivebresib%29%2C+a+potent+and+orally+available+bromodomain+and+extraterminal+domain+%28BET%29+family+bromodomain+inhibitor&doi=10.1021%2Facs.jmedchem.7b00746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide (ABBV-075/Mivebresib), a Potent and Orally Available Bromodomain and Extraterminal Domain (BET) Family Bromodomain Inhibitor</span></div><div class="casAuthors">McDaniel, Keith F.; Wang, Le; Soltwedel, Todd; Fidanze, Steven D.; Hasvold, Lisa A.; Liu, Dachun; Mantei, Robert A.; Pratt, John K.; Sheppard, George S.; Bui, Mai H.; Faivre, Emily J.; Huang, Xiaoli; Li, Leiming; Lin, Xiaoyu; Wang, Rongqi; Warder, Scott E.; Wilcox, Denise; Albert, Daniel H.; Magoc, Terrance J.; Rajaraman, Ganesh; Park, Chang H.; Hutchins, Charles W.; Shen, Jianwei J.; Edalji, Rohinton P.; Sun, Chaohong C.; Martin, Ruth; Gao, Wenqing; Wong, Shekman; Fang, Guowei; Elmore, Steven W.; Shen, Yu; Kati, Warren M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8369-8384</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of bromodomain and extraterminal domain (BET) bromodomain inhibitors and their examn. in clin. studies, particularly in oncol. settings, has garnered substantial recent interest.  An effort to generate novel BET bromodomain inhibitors with excellent potency and drug metab. and pharmacokinetics (DMPK) properties was initiated based upon elaboration of a simple pyridone core.  Efforts to develop a bidentate interaction with a crit. asparagine residue resulted in the incorporation of a pyrrolopyridone core, which improved potency by 9-19-fold.  Addnl. structure-activity relationship (SAR) efforts aimed both at increasing potency and improving pharmacokinetic properties led to the discovery of the clin. candidate I (ABBV-075/mivebresib), which demonstrates excellent potency in biochem. and cellular assays, advantageous exposures and half-life both in animal models and in humans, and in vivo efficacy in mouse models of cancer progression and inflammation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom-8BkipNknbVg90H21EOLACvtfcHk0ljJEKaPSJyqAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOjtrbF&md5=16ea9e9ade8a22a6e99aeae16fd1bf9c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00746%26sid%3Dliteratum%253Aachs%26aulast%3DMcDaniel%26aufirst%3DK.%2BF.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DSoltwedel%26aufirst%3DT.%26aulast%3DFidanze%26aufirst%3DS.%2BD.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DPratt%26aufirst%3DJ.%2BK.%26aulast%3DSheppard%26aufirst%3DG.%2BS.%26aulast%3DBui%26aufirst%3DM.%2BH.%26aulast%3DFaivre%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWarder%26aufirst%3DS.%2BE.%26aulast%3DWilcox%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DD.%2BH.%26aulast%3DMagoc%26aufirst%3DT.%2BJ.%26aulast%3DRajaraman%26aufirst%3DG.%26aulast%3DPark%26aufirst%3DC.%2BH.%26aulast%3DHutchins%26aufirst%3DC.%2BW.%26aulast%3DShen%26aufirst%3DJ.%2BJ.%26aulast%3DEdalji%26aufirst%3DR.%2BP.%26aulast%3DSun%26aufirst%3DC.%2BC.%26aulast%3DMartin%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DKati%26aufirst%3DW.%2BM.%26atitle%3DDiscovery%2520of%2520N-%25284-%25282%252C4-Difluorophenoxy%2529-3-%25286-methyl-7-oxo-6%252C7-dihydro-1H-pyrrolo%255B2%252C3-c%255Dpyridin-4-yl%2529phenyl%2529ethanesulfonamide%2520%2528ABBV-075%252Fmivebresib%2529%252C%2520a%2520potent%2520and%2520orally%2520available%2520bromodomain%2520and%2520extraterminal%2520domain%2520%2528BET%2529%2520family%2520bromodomain%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8369%26epage%3D8384%26doi%3D10.1021%2Facs.jmedchem.7b00746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattersley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamont, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouvry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabow, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stokes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whalley, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittaker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigley, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waring, M. J.</span></span> <span> </span><span class="NLM_article-title">Optimization of a series of bivalent triazolopyridazine based bromodomain and extraterminal inhibitors: the discovery of (3<i>R</i>)-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7801</span>– <span class="NLM_lpage">7817</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00070</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00070" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtleiu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7801-7817&author=R.+H.+Bradburyauthor=R.+Callisauthor=G.+R.+Carrauthor=H.+Chenauthor=E.+Clarkauthor=L.+Feronauthor=S.+Glossopauthor=M.+A.+Grahamauthor=M.+Hattersleyauthor=C.+Jonesauthor=S.+G.+Lamontauthor=G.+Ouvryauthor=A.+Patelauthor=J.+Patelauthor=A.+A.+Rabowauthor=C.+A.+Robertsauthor=S.+Stokesauthor=N.+Strattonauthor=G.+E.+Walkerauthor=L.+Wardauthor=D.+Whalleyauthor=D.+Whittakerauthor=G.+Wrigleyauthor=M.+J.+Waring&title=Optimization+of+a+series+of+bivalent+triazolopyridazine+based+bromodomain+and+extraterminal+inhibitors%3A+the+discovery+of+%283R%29-4-%5B2-%5B4-%5B1-%283-methoxy-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-b%5Dpyridazin-6-yl%29-4-piperidyl%5Dphenoxy%5Dethyl%5D-1%2C3-dimethyl-piperazin-2-one+%28AZD5153%29&doi=10.1021%2Facs.jmedchem.6b00070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3R)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153)</span></div><div class="casAuthors">Bradbury, Robert H.; Callis, Rowena; Carr, Gregory R.; Chen, Huawei; Clark, Edwin; Feron, Lyman; Glossop, Steve; Graham, Mark A.; Hattersley, Maureen; Jones, Chris; Lamont, Scott G.; Ouvry, Gilles; Patel, Anil; Patel, Joe; Rabow, Alfred A.; Roberts, Craig A.; Stokes, Stephen; Stratton, Natalie; Walker, Graeme E.; Ward, Lara; Whalley, David; Whittaker, David; Wrigley, Gail; Waring, Michael J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7801-7817</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here the authors report the discovery and optimization of a series of bivalent bromodomain and extraterminal inhibitors.  Starting with the observation of BRD4 activity of compds. from a previous program, the compds. were optimized for BRD4 potency and phys. properties.  The optimized compd. from this campaign exhibited excellent pharmacokinetic profile and exhibited high potency in vitro and in vivo effecting c-Myc downregulation and tumor growth inhibition in xenograft studies.  This compd. was selected as the development candidate AZD5153.  The series showed enhanced potency as a result of bivalent binding and a clear correlation between BRD4 activity and cellular potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFRSE33Jdb17Vg90H21EOLACvtfcHk0ljJEKaPSJyqAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtleiu7rK&md5=a91cdef7369dd1888c4948ba4fc9d72d</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00070%26sid%3Dliteratum%253Aachs%26aulast%3DBradbury%26aufirst%3DR.%2BH.%26aulast%3DCallis%26aufirst%3DR.%26aulast%3DCarr%26aufirst%3DG.%2BR.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DClark%26aufirst%3DE.%26aulast%3DFeron%26aufirst%3DL.%26aulast%3DGlossop%26aufirst%3DS.%26aulast%3DGraham%26aufirst%3DM.%2BA.%26aulast%3DHattersley%26aufirst%3DM.%26aulast%3DJones%26aufirst%3DC.%26aulast%3DLamont%26aufirst%3DS.%2BG.%26aulast%3DOuvry%26aufirst%3DG.%26aulast%3DPatel%26aufirst%3DA.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DRabow%26aufirst%3DA.%2BA.%26aulast%3DRoberts%26aufirst%3DC.%2BA.%26aulast%3DStokes%26aufirst%3DS.%26aulast%3DStratton%26aufirst%3DN.%26aulast%3DWalker%26aufirst%3DG.%2BE.%26aulast%3DWard%26aufirst%3DL.%26aulast%3DWhalley%26aufirst%3DD.%26aulast%3DWhittaker%26aufirst%3DD.%26aulast%3DWrigley%26aufirst%3DG.%26aulast%3DWaring%26aufirst%3DM.%2BJ.%26atitle%3DOptimization%2520of%2520a%2520series%2520of%2520bivalent%2520triazolopyridazine%2520based%2520bromodomain%2520and%2520extraterminal%2520inhibitors%253A%2520the%2520discovery%2520of%2520%25283R%2529-4-%255B2-%255B4-%255B1-%25283-methoxy-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-b%255Dpyridazin-6-yl%2529-4-piperidyl%255Dphenoxy%255Dethyl%255D-1%252C3-dimethyl-piperazin-2-one%2520%2528AZD5153%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7801%26epage%3D7817%26doi%3D10.1021%2Facs.jmedchem.6b00070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehling, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hewitt, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaswani, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leblanc, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasveschuk, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeron, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaram, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mertz, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neiss, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Meara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poy, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sims, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmange, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span> <span> </span><span class="NLM_article-title">Identification of a benzoisoxazoloazepine Inhibitor (CPI-0610) of the bromodomain and extra-terminal (BET) family as a candidate for human clinical trials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1330</span>– <span class="NLM_lpage">1339</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01882</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01882" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1330-1339&author=B.+K.+Albrechtauthor=V.+S.+Gehlingauthor=M.+C.+Hewittauthor=R.+G.+Vaswaniauthor=A.+Coteauthor=Y.+Leblancauthor=C.+G.+Nasveschukauthor=S.+Bellonauthor=L.+Bergeronauthor=R.+Campbellauthor=N.+Cantoneauthor=M.+R.+Cooperauthor=R.+T.+Cummingsauthor=H.+Jayaramauthor=S.+Joshiauthor=J.+A.+Mertzauthor=A.+Neissauthor=E.+Normantauthor=M.+O%E2%80%99Mearaauthor=E.+Pardoauthor=F.+Poyauthor=P.+Sandyauthor=J.+Supkoauthor=R.+J.+Simsauthor=J.-C.+Harmangeauthor=A.+M.+Taylorauthor=J.+E.+Audia&title=Identification+of+a+benzoisoxazoloazepine+Inhibitor+%28CPI-0610%29+of+the+bromodomain+and+extra-terminal+%28BET%29+family+as+a+candidate+for+human+clinical+trials&doi=10.1021%2Facs.jmedchem.5b01882"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Benzoisoxazoloazepine Inhibitor (CPI-0610) of the Bromodomain and Extra-Terminal (BET) Family as a Candidate for Human Clinical Trials</span></div><div class="casAuthors">Albrecht, Brian K.; Gehling, Victor S.; Hewitt, Michael C.; Vaswani, Rishi G.; Cote, Alexandre; Leblanc, Yves; Nasveschuk, Christopher G.; Bellon, Steve; Bergeron, Louise; Campbell, Robert; Cantone, Nico; Cooper, Michael R.; Cummings, Richard T.; Jayaram, Hariharan; Joshi, Shivangi; Mertz, Jennifer A.; Neiss, Adrianne; Normant, Emmanuel; O'Meara, Michael; Pardo, Eneida; Poy, Florence; Sandy, Peter; Supko, Jeffrey; Sims, Robert J.; Harmange, Jean-Christophe; Taylor, Alexander M.; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1330-1339</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, inhibition of the interaction between the bromodomain and extra-terminal domain (BET) family of chromatin adaptors and acetyl-lysine residues on chromatin has emerged as a promising approach to regulate the expression of important disease-relevant genes, including MYC, BCL-2, and NF-κB.  Here we describe the identification and characterization of a potent and selective benzoisoxazoloazepine BET bromodomain inhibitor that attenuates BET-dependent gene expression in vivo, demonstrates antitumor efficacy in an MV-4-11 mouse xenograft model, and is currently undergoing human clin. trials for hematol. malignancies (CPI-0610).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp40qjnYl4EZLVg90H21EOLACvtfcHk0liLdY5-9yCrrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFKjs7g%253D&md5=5e1c5aab26aa58844a9f6670a7bbd78b</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01882&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01882%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DHewitt%26aufirst%3DM.%2BC.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DCote%26aufirst%3DA.%26aulast%3DLeblanc%26aufirst%3DY.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DBellon%26aufirst%3DS.%26aulast%3DBergeron%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DCooper%26aufirst%3DM.%2BR.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DJayaram%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DS.%26aulast%3DMertz%26aufirst%3DJ.%2BA.%26aulast%3DNeiss%26aufirst%3DA.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DO%25E2%2580%2599Meara%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DE.%26aulast%3DPoy%26aufirst%3DF.%26aulast%3DSandy%26aufirst%3DP.%26aulast%3DSupko%26aufirst%3DJ.%26aulast%3DSims%26aufirst%3DR.%2BJ.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DTaylor%26aufirst%3DA.%2BM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DIdentification%2520of%2520a%2520benzoisoxazoloazepine%2520Inhibitor%2520%2528CPI-0610%2529%2520of%2520the%2520bromodomain%2520and%2520extra-terminal%2520%2528BET%2529%2520family%2520as%2520a%2520candidate%2520for%2520human%2520clinical%2520trials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1330%26epage%3D1339%26doi%3D10.1021%2Facs.jmedchem.5b01882" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crosignani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bottemanne, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannelle, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cauwenberghs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cordonnier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deroose, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greasley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, S.n E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negrerie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloweij, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tumang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torti, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Den Eynde, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a novel and selective indoleamine 2,3-dioxygenase (IDO-1) inhibitor 3-(5-fluoro-1<i>H</i>-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and its characterization as a potential clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9617</span>– <span class="NLM_lpage">9629</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00974</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00974" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslOns7%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9617-9629&author=S.+Crosignaniauthor=P.+Binghamauthor=P.+Bottemanneauthor=H.+Cannelleauthor=S.+Cauwenberghsauthor=M.+Cordonnierauthor=D.+Dalvieauthor=F.+Derooseauthor=J.+L.+Fengauthor=B.+Gomesauthor=S.+Greasleyauthor=S.n+E.+Kaiserauthor=M.+Krausauthor=M.+Negrerieauthor=K.+Maegleyauthor=N.+Millerauthor=B.+W.+Murrayauthor=M.+Schneiderauthor=J.+Soloweijauthor=A.+E.+Stewartauthor=J.+Tumangauthor=V.+R.+Tortiauthor=B.+Van+Den+Eyndeauthor=M.+Wythes&title=Discovery+of+a+novel+and+selective+indoleamine+2%2C3-dioxygenase+%28IDO-1%29+inhibitor+3-%285-fluoro-1H-indol-3-yl%29pyrrolidine-2%2C5-dione+%28EOS200271%2FPF-06840003%29+and+its+characterization+as+a+potential+clinical+candidate&doi=10.1021%2Facs.jmedchem.7b00974"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione (EOS200271/PF-06840003) and Its Characterization as a Potential Clinical Candidate</span></div><div class="casAuthors">Crosignani, Stefano; Bingham, Patrick; Bottemanne, Pauline; Cannelle, Helene; Cauwenberghs, Sandra; Cordonnier, Marie; Dalvie, Deepak; Deroose, Frederik; Feng, Jun Li; Gomes, Bruno; Greasley, Samantha; Kaiser, Stephen E.; Kraus, Manfred; Negrerie, Michel; Maegley, Karen; Miller, Nichol; Murray, Brion W.; Schneider, Manfred; Soloweij, James; Stewart, Albert E.; Tumang, Joseph; Torti, Vince R.; Van Den Eynde, Benoit; Wythes, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9617-9629</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Tumors use tryptophan-catabolizing enzymes such as indoleamine 2,3-dioxygenase (IDO-1) to induce an immunosuppressive environment.  IDO-1 is induced in response to inflammatory stimuli and promotes immune tolerance through effector T-cell anergy and enhanced Treg function.  As such, IDO-1 is a nexus for the induction of a key immunosuppressive mechanism and represents an important immunotherapeutic target in oncol.  Starting from HTS hit I, IDO-1 inhibitor II has been developed.  The structure-activity relationship around II is described and rationalized using the x-ray crystal structure of II bound to human IDO-1, which shows that II, differently from most of the IDO-1 inhibitors described so far, does not bind to the heme iron atom and has a novel binding mode.  Clin. candidate II shows good potency in an IDO-1 human whole blood assay and also shows a very favorable ADME profile leading to favorable predicted human pharmacokinetic properties, including a predicted half-life of 16-19 h.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogfHmZRAC-dLVg90H21EOLACvtfcHk0liLdY5-9yCrrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslOns7%252FK&md5=dc2e45c243aa22c100ccc39db9b5918a</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00974&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00974%26sid%3Dliteratum%253Aachs%26aulast%3DCrosignani%26aufirst%3DS.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DBottemanne%26aufirst%3DP.%26aulast%3DCannelle%26aufirst%3DH.%26aulast%3DCauwenberghs%26aufirst%3DS.%26aulast%3DCordonnier%26aufirst%3DM.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDeroose%26aufirst%3DF.%26aulast%3DFeng%26aufirst%3DJ.%2BL.%26aulast%3DGomes%26aufirst%3DB.%26aulast%3DGreasley%26aufirst%3DS.%26aulast%3DKaiser%26aufirst%3DS.n%2BE.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DNegrerie%26aufirst%3DM.%26aulast%3DMaegley%26aufirst%3DK.%26aulast%3DMiller%26aufirst%3DN.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DSchneider%26aufirst%3DM.%26aulast%3DSoloweij%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DTumang%26aufirst%3DJ.%26aulast%3DTorti%26aufirst%3DV.%2BR.%26aulast%3DVan%2BDen%2BEynde%26aufirst%3DB.%26aulast%3DWythes%26aufirst%3DM.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520and%2520selective%2520indoleamine%25202%252C3-dioxygenase%2520%2528IDO-1%2529%2520inhibitor%25203-%25285-fluoro-1H-indol-3-yl%2529pyrrolidine-2%252C5-dione%2520%2528EOS200271%252FPF-06840003%2529%2520and%2520its%2520characterization%2520as%2520a%2520potential%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9617%26epage%3D9629%26doi%3D10.1021%2Facs.jmedchem.7b00974" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beaufils, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cmiljanovic, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cmiljanovic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bohnacker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marone, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sele, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borsari, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mestan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hebeisen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillmann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giese, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvelebil, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fabbro, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rageot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wymann, M. P.</span></span> <span> </span><span class="NLM_article-title">5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a potent, brain-penetrant, orally bioavailable, pan-class I PI3K/mTOR inhibitor as clinical candidate in oncology</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7524</span>– <span class="NLM_lpage">7538</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00930</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00930" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7524-7538&author=F.+Beaufilsauthor=N.+Cmiljanovicauthor=V.+Cmiljanovicauthor=T.+Bohnackerauthor=A.+Meloneauthor=R.+Maroneauthor=E.+Jacksonauthor=X.+Zhangauthor=A.+Seleauthor=C.+Borsariauthor=J.+Mestanauthor=P.+Hebeisenauthor=P.+Hillmannauthor=B.+Gieseauthor=M.+Zvelebilauthor=D.+Fabbroauthor=R.+L.+Williamsauthor=D.+Rageotauthor=M.+P.+Wymann&title=5-%284%2C6-Dimorpholino-1%2C3%2C5-triazin-2-yl%29-4-%28trifluoromethyl%29pyridin-2-amine+%28PQR309%29%2C+a+potent%2C+brain-penetrant%2C+orally+bioavailable%2C+pan-class+I+PI3K%2FmTOR+inhibitor+as+clinical+candidate+in+oncology&doi=10.1021%2Facs.jmedchem.7b00930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">5-(4,6-Dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine (PQR309), a Potent, Brain-Penetrant, Orally Bioavailable, Pan-Class I PI3K/mTOR Inhibitor as Clinical Candidate in Oncology</span></div><div class="casAuthors">Beaufils, Florent; Cmiljanovic, Natasa; Cmiljanovic, Vladimir; Bohnacker, Thomas; Melone, Anna; Marone, Romina; Jackson, Eileen; Zhang, Xuxiao; Sele, Alexander; Borsari, Chiara; Mestan, Jurgen; Hebeisen, Paul; Hillmann, Petra; Giese, Bernd; Zvelebil, Marketa; Fabbro, Doriano; Williams, Roger L.; Rageot, Denise; Wymann, Matthias P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7524-7538</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphoinositide 3-kinase (PI3K) is deregulated in a wide variety of human tumors and triggers activation of protein kinase B (PKB/Akt) and mammalian target of rapamycin (mTOR).  Here we describe the preclin. characterization of compd. 1 (PQR309, bimiralisib), a potent 4,6-dimorpholino-1,3,5-triazine-based pan-class I PI3K inhibitor, which targets mTOR kinase in a balanced fashion at higher concns.  No off-target interactions were detected for 1 in a wide panel of protein kinase, enzyme, and receptor ligand assays.  Moreover, 1 did not bind tubulin, which was obsd. for the structurally related 4 (BKM120, buparlisib).  Compd. 1 is orally available, crosses the blood-brain barrier, and displayed favorable pharmacokinetic parameters in mice, rats, and dogs.  Compd. 1 demonstrated efficiency in inhibiting proliferation in tumor cell lines and a rat xenograft model.  This, together with the compd.'s safety profile, identifies 1 as a clin. candidate with a broad application range in oncol., including treatment of brain tumors or CNS metastasis.  Compd. 1 is currently in phase II clin. trials for advanced solid tumors and refractory lymphoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtvYAarVqsarVg90H21EOLACvtfcHk0lhI_Y89-tNqpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKhurrP&md5=54d4db75f6a8bda3f12eaf1d196352fd</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00930%26sid%3Dliteratum%253Aachs%26aulast%3DBeaufils%26aufirst%3DF.%26aulast%3DCmiljanovic%26aufirst%3DN.%26aulast%3DCmiljanovic%26aufirst%3DV.%26aulast%3DBohnacker%26aufirst%3DT.%26aulast%3DMelone%26aufirst%3DA.%26aulast%3DMarone%26aufirst%3DR.%26aulast%3DJackson%26aufirst%3DE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DSele%26aufirst%3DA.%26aulast%3DBorsari%26aufirst%3DC.%26aulast%3DMestan%26aufirst%3DJ.%26aulast%3DHebeisen%26aufirst%3DP.%26aulast%3DHillmann%26aufirst%3DP.%26aulast%3DGiese%26aufirst%3DB.%26aulast%3DZvelebil%26aufirst%3DM.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DR.%2BL.%26aulast%3DRageot%26aufirst%3DD.%26aulast%3DWymann%26aufirst%3DM.%2BP.%26atitle%3D5-%25284%252C6-Dimorpholino-1%252C3%252C5-triazin-2-yl%2529-4-%2528trifluoromethyl%2529pyridin-2-amine%2520%2528PQR309%2529%252C%2520a%2520potent%252C%2520brain-penetrant%252C%2520orally%2520bioavailable%252C%2520pan-class%2520I%2520PI3K%252FmTOR%2520inhibitor%2520as%2520clinical%2520candidate%2520in%2520oncology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7524%26epage%3D7538%26doi%3D10.1021%2Facs.jmedchem.7b00930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heffron, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heald, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ndubaku, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augistin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Do, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edgar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eigenbrot, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gancia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolesnikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lesnick, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLean, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortl, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonomiya, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prior, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salphati, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sideris, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staben, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbacher, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsui, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampath, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olivero, A. G.</span></span> <span> </span><span class="NLM_article-title">The rational design of selective benzoxazepin inhibitors of the α-isoform of phosphoinositide 3-kinase culminating in the identification of (<i>S</i>)-2-((2-(1-isopropyl-1<i>H</i>-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[<i>f</i>]imidazo[1,2-<i>d</i>][1,4]oxazepin-9-yl)oxy)propanamide (GDC-0326)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">985</span>– <span class="NLM_lpage">1002</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01483</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01483" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=985-1002&author=T.+P.+Heffronauthor=R.+A.+Healdauthor=C.+Ndubakuauthor=B.+Weiauthor=M.+Augistinauthor=S.+Doauthor=K.+Edgarauthor=C.+Eigenbrotauthor=L.+Friedmanauthor=E.+Ganciaauthor=P.+S.+Jacksonauthor=G.+Jonesauthor=A.+Kolesnikovauthor=L.+B.+Leeauthor=J.+D.+Lesnickauthor=C.+Lewisauthor=N.+McLeanauthor=M.+Mortlauthor=J.+Nonomiyaauthor=J.+Pangauthor=S.+Priceauthor=W.+W.+Priorauthor=L.+Salphatiauthor=S.+Siderisauthor=S.+T.+Stabenauthor=S.+Steinbacherauthor=V.+Tsuiauthor=J.+Wallinauthor=D.+Sampathauthor=A.+G.+Olivero&title=The+rational+design+of+selective+benzoxazepin+inhibitors+of+the+%CE%B1-isoform+of+phosphoinositide+3-kinase+culminating+in+the+identification+of+%28S%29-2-%28%282-%281-isopropyl-1H-1%2C2%2C4-triazol-5-yl%29-5%2C6-dihydrobenzo%5Bf%5Dimidazo%5B1%2C2-d%5D%5B1%2C4%5Doxazepin-9-yl%29oxy%29propanamide+%28GDC-0326%29&doi=10.1021%2Facs.jmedchem.5b01483"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01483&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01483%26sid%3Dliteratum%253Aachs%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DHeald%26aufirst%3DR.%2BA.%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DWei%26aufirst%3DB.%26aulast%3DAugistin%26aufirst%3DM.%26aulast%3DDo%26aufirst%3DS.%26aulast%3DEdgar%26aufirst%3DK.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DFriedman%26aufirst%3DL.%26aulast%3DGancia%26aufirst%3DE.%26aulast%3DJackson%26aufirst%3DP.%2BS.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DKolesnikov%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DL.%2BB.%26aulast%3DLesnick%26aufirst%3DJ.%2BD.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DMcLean%26aufirst%3DN.%26aulast%3DMortl%26aufirst%3DM.%26aulast%3DNonomiya%26aufirst%3DJ.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DS.%26aulast%3DPrior%26aufirst%3DW.%2BW.%26aulast%3DSalphati%26aufirst%3DL.%26aulast%3DSideris%26aufirst%3DS.%26aulast%3DStaben%26aufirst%3DS.%2BT.%26aulast%3DSteinbacher%26aufirst%3DS.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DWallin%26aufirst%3DJ.%26aulast%3DSampath%26aufirst%3DD.%26aulast%3DOlivero%26aufirst%3DA.%2BG.%26atitle%3DThe%2520rational%2520design%2520of%2520selective%2520benzoxazepin%2520inhibitors%2520of%2520the%2520%25CE%25B1-isoform%2520of%2520phosphoinositide%25203-kinase%2520culminating%2520in%2520the%2520identification%2520of%2520%2528S%2529-2-%2528%25282-%25281-isopropyl-1H-1%252C2%252C4-triazol-5-yl%2529-5%252C6-dihydrobenzo%255Bf%255Dimidazo%255B1%252C2-d%255D%255B1%252C4%255Doxazepin-9-yl%2529oxy%2529propanamide%2520%2528GDC-0326%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D985%26epage%3D1002%26doi%3D10.1021%2Facs.jmedchem.5b01483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of 4-((3′<i>R</i>,4′<i>S</i>,5′<i>R</i>)-6″-chloro-4′-(3-chloro-2-fluorophenyl)-1′-ethyl-2″-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3″-indoline]-5′-carboxamido)bicyclo[2.2.2]octane-1-carboxylic acid (AA-115/APG-115): a potent and orally active murine double minute 2 (MDM2) inhibitor in clinical development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2819</span>– <span class="NLM_lpage">2839</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01665</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01665" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWrsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2819-2839&author=A.+Aguilarauthor=J.+Luauthor=L.+Liuauthor=D.+Duauthor=D.+Bernardauthor=D.+McEachernauthor=S.+Przybranowskiauthor=X.+Liauthor=R.+Luoauthor=B.+Wenauthor=D.+Sunauthor=H.+Wangauthor=J.+Wenauthor=G.+Wangauthor=Y.+Zhaiauthor=M.+Guoauthor=D.+Yangauthor=S.+Wang&title=Discovery+of+4-%28%283%E2%80%B2R%2C4%E2%80%B2S%2C5%E2%80%B2R%29-6%E2%80%B3-chloro-4%E2%80%B2-%283-chloro-2-fluorophenyl%29-1%E2%80%B2-ethyl-2%E2%80%B3-oxodispiro%5Bcyclohexane-1%2C2%E2%80%B2-pyrrolidine-3%E2%80%B2%2C3%E2%80%B3-indoline%5D-5%E2%80%B2-carboxamido%29bicyclo%5B2.2.2%5Doctane-1-carboxylic+acid+%28AA-115%2FAPG-115%29%3A+a+potent+and+orally+active+murine+double+minute+2+%28MDM2%29+inhibitor+in+clinical+development&doi=10.1021%2Facs.jmedchem.6b01665"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 4-((3'R,4'S,5'R)-6''-Chloro-4'-(3-chloro-2-fluorophenyl)-1'-ethyl-2''-oxodispiro[cyclohexane-1,2'-pyrrolidine-3',3''-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic Acid (AA-115/APG-115): A Potent and Orally Active Murine Double Minute 2 (MDM2) Inhibitor in Clinical Development</span></div><div class="casAuthors">Aguilar, Angelo; Lu, Jianfeng; Liu, Liu; Du, Ding; Bernard, Denzil; McEachern, Donna; Przybranowski, Sally; Li, Xiaoqin; Luo, Ruijuan; Wen, Bo; Sun, Duxin; Wang, Hengbang; Wen, Jianfeng; Wang, Guangfeng; Zhai, Yifan; Guo, Ming; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2819-2839</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors previously reported the design of spirooxindoles with two identical substituents at the carbon-2 of the pyrrolidine core as potent MDM2 inhibitors.  In this paper the authors describe an extensive structure-activity relationship study of this class of MDM2 inhibitors, which led to the discovery of 60 (AA-115/APG-115, 4-((3R,4S,5R)-6''-chloro-4-(3-chloro-2-fluorophenyl)-1-ethyl-2''-oxodispiro[cyclohexane-1,2-pyrrolidine-3,3''-indoline]-5'-carboxamido)bicyclo[2.2.2]octane-1-carboxylic acid).  Compd. 60 has a very high affinity to MDM2 (Ki < 1 nM), potent cellular activity, and an excellent oral pharmacokinetic profile.  Compd. 60 is capable of achieving complete and long-lasting tumor regression in vivo and is currently in phase I clin. trials for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpodWycM_gQDrVg90H21EOLACvtfcHk0lj_zIbvMOM3gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWrsL0%253D&md5=d40265261f65df6babcd06fc0b30ca46</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01665&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01665%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DDu%26aufirst%3DD.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DPrzybranowski%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DR.%26aulast%3DWen%26aufirst%3DB.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%25204-%2528%25283%25E2%2580%25B2R%252C4%25E2%2580%25B2S%252C5%25E2%2580%25B2R%2529-6%25E2%2580%25B3-chloro-4%25E2%2580%25B2-%25283-chloro-2-fluorophenyl%2529-1%25E2%2580%25B2-ethyl-2%25E2%2580%25B3-oxodispiro%255Bcyclohexane-1%252C2%25E2%2580%25B2-pyrrolidine-3%25E2%2580%25B2%252C3%25E2%2580%25B3-indoline%255D-5%25E2%2580%25B2-carboxamido%2529bicyclo%255B2.2.2%255Doctane-1-carboxylic%2520acid%2520%2528AA-115%252FAPG-115%2529%253A%2520a%2520potent%2520and%2520orally%2520active%2520murine%2520double%2520minute%25202%2520%2528MDM2%2529%2520inhibitor%2520in%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2819%26epage%3D2839%26doi%3D10.1021%2Facs.jmedchem.6b01665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernard, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deschamps, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Design of chemically stable, potent, and efficacious MDM2 inhibitors that exploit the retro-Mannich ring-opening-cyclization reaction mechanism in spiro-oxindoles</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">10486</span>– <span class="NLM_lpage">10498</span>, <span class="refDoi"> DOI: 10.1021/jm501541j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501541j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitV2nt73O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=10486-10498&author=A.+Aguilarauthor=W.+Sunauthor=L.+Liuauthor=J.+Luauthor=D.+McEachernauthor=D.+Bernardauthor=J.+R.+Deschampsauthor=S.+Wang&title=Design+of+chemically+stable%2C+potent%2C+and+efficacious+MDM2+inhibitors+that+exploit+the+retro-Mannich+ring-opening-cyclization+reaction+mechanism+in+spiro-oxindoles&doi=10.1021%2Fjm501541j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Chemically Stable, Potent, and Efficacious MDM2 Inhibitors That Exploit the Retro-Mannich Ring-Opening-Cyclization Reaction Mechanism in Spiro-oxindoles</span></div><div class="casAuthors">Aguilar, Angelo; Sun, Wei; Liu, Liu; Lu, Jianfeng; McEachern, Donna; Bernard, Denzil; Deschamps, Jeffrey R.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10486-10498</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spiropyrrolidineoxindoles such as I (R = trans-4-hydroxycyclohexyl, 4-HO2CC6H4) were prepd. as inhibitors of the interaction between the proteins MDM2 and p53 for use as antitumor agents; the second-generation inhibitors incorporate sym. disubstitution in the pyrrolidine ring next to the spiro junction in order to facilitate isomerization via retro-Mannich/Mannich reactions to the more active stereoisomers (in which the aryl rings attached to the pyrrolidine are trans) as well as to improve stability in vitro and in vivo.  In particular, I (R = 4-HO2CC6H4) (MI-1061), which bound to MDM2 with a Ki value of 0.16 nM, showed excellent chem. stability and caused regression of human SJSA-1 xenograft tumors in mice.  The structures of diphenylhydroxyethyl spiropyrrolidineoxindole and spiropyrrolidineoxindolecarboxylate intermediates in the prepn. of I (R = trans-4-hydroxycyclohexyl, 4-HO2CC6H4) were detd. by X-ray crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_es94k2y2-rVg90H21EOLACvtfcHk0lj_zIbvMOM3gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitV2nt73O&md5=6399fb5e19fc8d69e40e6fd19721e270</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm501541j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501541j%26sid%3Dliteratum%253Aachs%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DSun%26aufirst%3DW.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DBernard%26aufirst%3DD.%26aulast%3DDeschamps%26aufirst%3DJ.%2BR.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520chemically%2520stable%252C%2520potent%252C%2520and%2520efficacious%2520MDM2%2520inhibitors%2520that%2520exploit%2520the%2520retro-Mannich%2520ring-opening-cyclization%2520reaction%2520mechanism%2520in%2520spiro-oxindoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D10486%26epage%3D10498%26doi%3D10.1021%2Fjm501541j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolovska-Coleska, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shangary, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krajewski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roller, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">wang, S.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">3432</span>– <span class="NLM_lpage">3435</span>, <span class="refDoi"> DOI: 10.1021/jm051122a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm051122a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=3432-3435&author=K.+Dingauthor=Y.+Luauthor=Z.+Nikolovska-Coleskaauthor=G.+Wangauthor=S.+Qiuauthor=S.+Shangaryauthor=W.+Gaoauthor=D.+Qinauthor=J.+Stuckeyauthor=K.+Krajewskiauthor=P.+R.+Rollerauthor=S.+wang&title=Structure-based+design+of+spiro-oxindoles+as+potent%2C+specific+small-molecule+inhibitors+of+the+MDM2-p53+interaction&doi=10.1021%2Fjm051122a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of Spiro-oxindoles as Potent, Specific Small-Molecule Inhibitors of the MDM2-p53 Interaction</span></div><div class="casAuthors">Ding, Ke; Lu, Yipin; Nikolovska-Coleska, Zaneta; Wang, Guoping; Qiu, Su; Shangary, Sanjeev; Gao, Wei; Qin, Dongguang; Stuckey, Jeanne; Krajewski, Krzysztof; Roller, Peter P.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3432-3435</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, specific, non-peptide small-mol. inhibitors of the MDM2-p53 interaction were successfully designed.  The most potent inhibitor (MI-63) has a Ki value of 3 nM binding to MDM2 and greater than 10,000-fold selectivity over Bcl-2/Bcl-xL proteins.  MI-63 is highly effective in activation of p53 function and in inhibition of cell growth in cancer cells with wild-type p53 status.  MI-63 has excellent specificity over cancer cells with deleted p53 and shows a minimal toxicity to normal cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptppiErNrFXrVg90H21EOLACvtfcHk0lj_zIbvMOM3gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFKksrc%253D&md5=186a2ba028ad9b8f71107aa1c2555421</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm051122a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm051122a%26sid%3Dliteratum%253Aachs%26aulast%3DDing%26aufirst%3DK.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DShangary%26aufirst%3DS.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DD.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BR.%26aulast%3Dwang%26aufirst%3DS.%26atitle%3DStructure-based%2520design%2520of%2520spiro-oxindoles%2520as%2520potent%252C%2520specific%2520small-molecule%2520inhibitors%2520of%2520the%2520MDM2-p53%2520interaction%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D3432%26epage%3D3435%26doi%3D10.1021%2Fjm051122a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Planken, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behenna, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almaden, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ballard, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, He.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho-Schultz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalvie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deal, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferre, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajiwala, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemkens, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kath, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matthews, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niessen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, S. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pairish, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solowiej, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tseng, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinrich, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zientek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafontaine, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-((3<i>R</i>,4<i>R</i>)-4-fluoro-1-(6-((3-methoxy-1-methyl-1<i>H</i>-pyrazol-4-yl)amino)-9-methyl-9<i>H</i>-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through structure-based drug design: a high affinity irreversible inhibitor targeting oncogenic EGFR mutants with selectivity over wild-type EGFR</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3002</span>– <span class="NLM_lpage">3019</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01894</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01894" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFOmtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3002-3019&author=S.+Plankenauthor=D.+C.+Behennaauthor=S.+K.+Nairauthor=T.+O.+Johnsonauthor=A.+Nagataauthor=C.+Almadenauthor=S.+Baileyauthor=T.+E.+Ballardauthor=L.+Bernierauthor=He.+Chengauthor=S.+Cho-Schultzauthor=D.+Dalvieauthor=J.+G.+Dealauthor=D.+M.+Dinhauthor=M.+P.+Edwardsauthor=R.+A.+Ferreauthor=K.+S.+Gajiwalaauthor=M.+Hemkensauthor=R.+S.+Kaniaauthor=J.+C.+Kathauthor=J.+Matthewsauthor=B.+W.+Murrayauthor=S.+Niessenauthor=S.+T.+M.+Orrauthor=M.+Pairishauthor=N.+W.+Sachauthor=H.+Shenauthor=M.+Shiauthor=J.+Solowiejauthor=K.+Tranauthor=E.+Tsengauthor=P.+Viciniauthor=Y.+Wangauthor=S.+L.+Weinrichauthor=R.+Zhouauthor=M.+Zientekauthor=L.+Liuauthor=Y.+Luoauthor=S.+Xinauthor=C.+Zhangauthor=J.+Lafontaine&title=Discovery+of+N-%28%283R%2C4R%29-4-fluoro-1-%286-%28%283-methoxy-1-methyl-1H-pyrazol-4-yl%29amino%29-9-methyl-9H-purin-2-yl%29pyrrolidine-3-yl%29acrylamide+%28PF-06747775%29+through+structure-based+drug+design%3A+a+high+affinity+irreversible+inhibitor+targeting+oncogenic+EGFR+mutants+with+selectivity+over+wild-type+EGFR&doi=10.1021%2Facs.jmedchem.6b01894"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-((3R,4R)-4-Fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidine-3-yl)acrylamide (PF-06747775) through Structure-Based Drug Design: A High Affinity Irreversible Inhibitor Targeting Oncogenic EGFR Mutants with Selectivity over Wild-Type EGFR</span></div><div class="casAuthors">Planken, Simon; Behenna, Douglas C.; Nair, Sajiv K.; Johnson, Theodore O.; Nagata, Asako; Almaden, Chau; Bailey, Simon; Ballard, T. Eric; Bernier, Louise; Cheng, Hengmiao; Cho-Schultz, Sujin; Dalvie, Deepak; Deal, Judith G.; Dinh, Dac M.; Edwards, Martin P.; Ferre, Rose Ann; Gajiwala, Ketan S.; Hemkens, Michelle; Kania, Robert S.; Kath, John C.; Matthews, Jean; Murray, Brion W.; Niessen, Sherry; Orr, Suvi T. M.; Pairish, Mason; Sach, Neal W.; Shen, Hong; Shi, Manli; Solowiej, James; Tran, Khanh; Tseng, Elaine; Vicini, Paolo; Wang, Yuli; Weinrich, Scott L.; Zhou, Ru; Zientek, Michael; Liu, Longqing; Luo, Yiqin; Xin, Shuibo; Zhang, Chengyi; Lafontaine, Jennifer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3002-3019</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mutant epidermal growth factor receptor (EGFR) is a major driver of non-small-cell lung cancer (NSCLC).  Marketed first generation inhibitors, such as erlotinib, effect a transient beneficial response in EGFR mutant NSCLC patients before resistance mechanisms render these inhibitors ineffective.  Secondary oncogenic EGFR mutations account for approx. 50% of relapses, the most common being the gatekeeper T790M substitution that renders existing therapies ineffective.  The discovery of PF-06459988 (1), an irreversible pyrrolopyrimidine inhibitor of EGFR T790M mutants, was recently disclosed.  Herein, we describe our continued efforts to achieve potency across EGFR oncogenic mutations and improved kinome selectivity, resulting in the discovery of clin. candidate PF-06747775 (21), which provides potent EGFR activity against the four common mutants (exon 19 deletion (Del), L858R, and double mutants T790M/L858R and T790M/Del), selectivity over wild-type EGFR, and desirable ADME properties.  Compd. 21 is currently being evaluated in phase-I clin. trials of mutant EGFR driven NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1yLRt7MBSrbVg90H21EOLACvtfcHk0livOVSLfBIgSw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFOmtrw%253D&md5=14a6700ed770621bdbd84f7931276f0e</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01894%26sid%3Dliteratum%253Aachs%26aulast%3DPlanken%26aufirst%3DS.%26aulast%3DBehenna%26aufirst%3DD.%2BC.%26aulast%3DNair%26aufirst%3DS.%2BK.%26aulast%3DJohnson%26aufirst%3DT.%2BO.%26aulast%3DNagata%26aufirst%3DA.%26aulast%3DAlmaden%26aufirst%3DC.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DBallard%26aufirst%3DT.%2BE.%26aulast%3DBernier%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DHe.%26aulast%3DCho-Schultz%26aufirst%3DS.%26aulast%3DDalvie%26aufirst%3DD.%26aulast%3DDeal%26aufirst%3DJ.%2BG.%26aulast%3DDinh%26aufirst%3DD.%2BM.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DFerre%26aufirst%3DR.%2BA.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DHemkens%26aufirst%3DM.%26aulast%3DKania%26aufirst%3DR.%2BS.%26aulast%3DKath%26aufirst%3DJ.%2BC.%26aulast%3DMatthews%26aufirst%3DJ.%26aulast%3DMurray%26aufirst%3DB.%2BW.%26aulast%3DNiessen%26aufirst%3DS.%26aulast%3DOrr%26aufirst%3DS.%2BT.%2BM.%26aulast%3DPairish%26aufirst%3DM.%26aulast%3DSach%26aufirst%3DN.%2BW.%26aulast%3DShen%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DM.%26aulast%3DSolowiej%26aufirst%3DJ.%26aulast%3DTran%26aufirst%3DK.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DVicini%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWeinrich%26aufirst%3DS.%2BL.%26aulast%3DZhou%26aufirst%3DR.%26aulast%3DZientek%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DXin%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLafontaine%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520N-%2528%25283R%252C4R%2529-4-fluoro-1-%25286-%2528%25283-methoxy-1-methyl-1H-pyrazol-4-yl%2529amino%2529-9-methyl-9H-purin-2-yl%2529pyrrolidine-3-yl%2529acrylamide%2520%2528PF-06747775%2529%2520through%2520structure-based%2520drug%2520design%253A%2520a%2520high%2520affinity%2520irreversible%2520inhibitor%2520targeting%2520oncogenic%2520EGFR%2520mutants%2520with%2520selectivity%2520over%2520wild-type%2520EGFR%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3002%26epage%3D3019%26doi%3D10.1021%2Facs.jmedchem.6b01894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lelais, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epple, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsilje, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, Y. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNeill, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anumolu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badiger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiDonato, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juarez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manuia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mason, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasibhatla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spraggon, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michellys, P.-Y.</span></span> <span> </span><span class="NLM_article-title">Discovery of (<i>R</i>, <i>E</i>)-N-(7-chloro-1-(1-[4-(dimethylamino)but-2-enoyl]azepan-3-yl)-1<i>H</i>-benzo[d]imidazol-2-yl)-2-methylisonicotinamide (EGF816), a novel, potent, and WT sparing covalent inhibitor of oncogenic (L858R, ex19del) and resistant (T790M) EGFR mutants for the treatment of EGFR mutant non-small-cell lung cancers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6671</span>– <span class="NLM_lpage">6689</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01985</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01985" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6671-6689&author=G.+Lelaisauthor=R.+Eppleauthor=T.+H.+Marsiljeauthor=Y.+O.+Longauthor=M.+McNeillauthor=B.+Chenauthor=W.+Luauthor=J.+Anumoluauthor=S.+Badigerauthor=B.+Bursulayaauthor=M.+DiDonatoauthor=R.+Fongauthor=J.+Juarezauthor=J.+Liauthor=M.+Manuiaauthor=D.+E.+Masonauthor=P.+Gordonauthor=T.+Groesslauthor=K.+Johnsonauthor=Y.+Jiaauthor=S.+Kasibhatlaauthor=C.+Liauthor=J.+Isbellauthor=G.+Spraggonauthor=S.+Benderauthor=P.-Y.+Michellys&title=Discovery+of+%28R%2C+E%29-N-%287-chloro-1-%281-%5B4-%28dimethylamino%29but-2-enoyl%5Dazepan-3-yl%29-1H-benzo%5Bd%5Dimidazol-2-yl%29-2-methylisonicotinamide+%28EGF816%29%2C+a+novel%2C+potent%2C+and+WT+sparing+covalent+inhibitor+of+oncogenic+%28L858R%2C+ex19del%29+and+resistant+%28T790M%29+EGFR+mutants+for+the+treatment+of+EGFR+mutant+non-small-cell+lung+cancers&doi=10.1021%2Facs.jmedchem.5b01985"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01985%26sid%3Dliteratum%253Aachs%26aulast%3DLelais%26aufirst%3DG.%26aulast%3DEpple%26aufirst%3DR.%26aulast%3DMarsilje%26aufirst%3DT.%2BH.%26aulast%3DLong%26aufirst%3DY.%2BO.%26aulast%3DMcNeill%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DAnumolu%26aufirst%3DJ.%26aulast%3DBadiger%26aufirst%3DS.%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DDiDonato%26aufirst%3DM.%26aulast%3DFong%26aufirst%3DR.%26aulast%3DJuarez%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DManuia%26aufirst%3DM.%26aulast%3DMason%26aufirst%3DD.%2BE.%26aulast%3DGordon%26aufirst%3DP.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DKasibhatla%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DSpraggon%26aufirst%3DG.%26aulast%3DBender%26aufirst%3DS.%26aulast%3DMichellys%26aufirst%3DP.-Y.%26atitle%3DDiscovery%2520of%2520%2528R%252C%2520E%2529-N-%25287-chloro-1-%25281-%255B4-%2528dimethylamino%2529but-2-enoyl%255Dazepan-3-yl%2529-1H-benzo%255Bd%255Dimidazol-2-yl%2529-2-methylisonicotinamide%2520%2528EGF816%2529%252C%2520a%2520novel%252C%2520potent%252C%2520and%2520WT%2520sparing%2520covalent%2520inhibitor%2520of%2520oncogenic%2520%2528L858R%252C%2520ex19del%2529%2520and%2520resistant%2520%2528T790M%2529%2520EGFR%2520mutants%2520for%2520the%2520treatment%2520of%2520EGFR%2520mutant%2520non-small-cell%2520lung%2520cancers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6671%26epage%3D6689%26doi%3D10.1021%2Facs.jmedchem.5b01985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ebiike, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsushita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohmori, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyohdoh, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayase, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakanishi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of [5-amino-1-(2-methyl-3<i>H</i>-benzimidazol-5-yl)pyrazol-4-yl]-(1<i>H</i>-indol-2-yl)methanone (CH5183284/Debio 1347), an orally available and selective fibroblast growth factor receptor (FGFR) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10586</span>– <span class="NLM_lpage">10600</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01156</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01156" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10586-10600&author=H.+Ebiikeauthor=N.+Takaauthor=M.+Matsushitaauthor=M.+Ohmoriauthor=K.+Takamiauthor=I.+Hyohdohauthor=M.+Kohchiauthor=T.+Hayaseauthor=H.+Nishiiauthor=K.+Morikamiauthor=Y.+Nakanishiauthor=N.+Akiyamaauthor=H.+Shindohauthor=N.+Ishiiauthor=T.+Isobeauthor=H.+Matsuoka&title=Discovery+of+%5B5-amino-1-%282-methyl-3H-benzimidazol-5-yl%29pyrazol-4-yl%5D-%281H-indol-2-yl%29methanone+%28CH5183284%2FDebio+1347%29%2C+an+orally+available+and+selective+fibroblast+growth+factor+receptor+%28FGFR%29+inhibitor&doi=10.1021%2Facs.jmedchem.6b01156"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01156%26sid%3Dliteratum%253Aachs%26aulast%3DEbiike%26aufirst%3DH.%26aulast%3DTaka%26aufirst%3DN.%26aulast%3DMatsushita%26aufirst%3DM.%26aulast%3DOhmori%26aufirst%3DM.%26aulast%3DTakami%26aufirst%3DK.%26aulast%3DHyohdoh%26aufirst%3DI.%26aulast%3DKohchi%26aufirst%3DM.%26aulast%3DHayase%26aufirst%3DT.%26aulast%3DNishii%26aufirst%3DH.%26aulast%3DMorikami%26aufirst%3DK.%26aulast%3DNakanishi%26aufirst%3DY.%26aulast%3DAkiyama%26aufirst%3DN.%26aulast%3DShindoh%26aufirst%3DH.%26aulast%3DIshii%26aufirst%3DN.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DMatsuoka%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520%255B5-amino-1-%25282-methyl-3H-benzimidazol-5-yl%2529pyrazol-4-yl%255D-%25281H-indol-2-yl%2529methanone%2520%2528CH5183284%252FDebio%25201347%2529%252C%2520an%2520orally%2520available%2520and%2520selective%2520fibroblast%2520growth%2520factor%2520receptor%2520%2528FGFR%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10586%26epage%3D10600%26doi%3D10.1021%2Facs.jmedchem.6b01156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brameld, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venetsanakos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phan, V. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaStant, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loughhead, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karr, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerritsen, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funk, J. O.</span></span> <span> </span><span class="NLM_article-title">Discovery of the irreversible covalent FGFR inhibitor 8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8<i>H</i>)-one (PRN1371) for the treatment of solid tumors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6516</span>– <span class="NLM_lpage">6527</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00360</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00360" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVykt7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6516-6527&author=K.+A.+Brameldauthor=T.+D.+Owensauthor=E.+Vernerauthor=E.+Venetsanakosauthor=J.+M.+Bradshawauthor=V.+T.+Phanauthor=D.+Tamauthor=K.+Leungauthor=J.+Shuauthor=J.+LaStantauthor=D.+G.+Loughheadauthor=T.+Tonauthor=D.+E.+Karrauthor=M.+E.+Gerritsenauthor=D.+M.+Goldsteinauthor=J.+O.+Funk&title=Discovery+of+the+irreversible+covalent+FGFR+inhibitor+8-%283-%284-acryloylpiperazin-1-yl%29propyl%29-6-%282%2C6-dichloro-3%2C5-dimethoxyphenyl%29-2-%28methylamino%29pyrido%5B2%2C3-d%5Dpyrimidin-7%288H%29-one+%28PRN1371%29+for+the+treatment+of+solid+tumors&doi=10.1021%2Facs.jmedchem.7b00360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors</span></div><div class="casAuthors">Brameld, Ken A.; Owens, Timothy D.; Verner, Erik; Venetsanakos, Eleni; Bradshaw, J. Michael; Phan, Vernon T.; Tam, Danny; Leung, Kwan; Shu, Jin; LaStant, Jacob; Loughhead, David G.; Ton, Tony; Karr, Dane E.; Gerritsen, Mary E.; Goldstein, David M.; Funk, Jens Oliver</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">6516-6527</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Aberrant signaling of the FGF/FGFR pathway occurs frequently in cancers and is an oncogenic driver in many solid tumors.  Clin. validation of FGFR as a therapeutic target has been demonstrated in bladder, liver, lung, breast, and gastric cancers.  Our goal was to develop an irreversible covalent inhibitor of FGFR1-4 for use in oncol. indications.  An irreversible covalent binding mechanism imparts many desirable pharmacol. benefits including high potency, selectivity, and prolonged target inhibition.  Herein we report the structure-based design, medicinal chem. optimization, and unique ADME assays of our irreversible covalent drug discovery program which culminated in the discovery of compd. 34 (PRN1371), a highly selective and potent FGFR1-4 inhibitor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpklTuvm1niy7Vg90H21EOLACvtfcHk0lj8PInKzQgUnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVykt7fK&md5=987069b645d5e0e36ccda5e5c81520b9</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00360%26sid%3Dliteratum%253Aachs%26aulast%3DBrameld%26aufirst%3DK.%2BA.%26aulast%3DOwens%26aufirst%3DT.%2BD.%26aulast%3DVerner%26aufirst%3DE.%26aulast%3DVenetsanakos%26aufirst%3DE.%26aulast%3DBradshaw%26aufirst%3DJ.%2BM.%26aulast%3DPhan%26aufirst%3DV.%2BT.%26aulast%3DTam%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DShu%26aufirst%3DJ.%26aulast%3DLaStant%26aufirst%3DJ.%26aulast%3DLoughhead%26aufirst%3DD.%2BG.%26aulast%3DTon%26aufirst%3DT.%26aulast%3DKarr%26aufirst%3DD.%2BE.%26aulast%3DGerritsen%26aufirst%3DM.%2BE.%26aulast%3DGoldstein%26aufirst%3DD.%2BM.%26aulast%3DFunk%26aufirst%3DJ.%2BO.%26atitle%3DDiscovery%2520of%2520the%2520irreversible%2520covalent%2520FGFR%2520inhibitor%25208-%25283-%25284-acryloylpiperazin-1-yl%2529propyl%2529-6-%25282%252C6-dichloro-3%252C5-dimethoxyphenyl%2529-2-%2528methylamino%2529pyrido%255B2%252C3-d%255Dpyrimidin-7%25288H%2529-one%2520%2528PRN1371%2529%2520for%2520the%2520treatment%2520of%2520solid%2520tumors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6516%26epage%3D6527%26doi%3D10.1021%2Facs.jmedchem.7b00360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamby, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, C. J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winters, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Showalter, H. D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panek, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Major, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsewski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahring, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keiser, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraker, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slintak, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fry, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallak, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, A. M.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationships for a novel series of pyrido[2,3-<i>d</i>]pyrimidine tyrosine kinase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">2296</span>– <span class="NLM_lpage">2303</span>, <span class="refDoi"> DOI: 10.1021/jm970367n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970367n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADyaK2sXktlKisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=2296-2303&author=J.+M.+Hambyauthor=C.+J.+C.+Connollyauthor=M.+C.+Schroederauthor=R.+T.+Wintersauthor=H.+D.+H.+Showalterauthor=R.+L.+Panekauthor=T.+C.+Majorauthor=B.+Olsewskiauthor=M.+J.+Ryanauthor=T.+Dahringauthor=G.+H.+Luauthor=J.+Keiserauthor=A.+Amarauthor=C.+Shenauthor=A.+J.+Krakerauthor=V.+Slintakauthor=J.+M.+Nelsonauthor=D.+W.+Fryauthor=L.+Bradfordauthor=H.+Hallakauthor=A.+M.+Doherty&title=Structure-activity+relationships+for+a+novel+series+of+pyrido%5B2%2C3-d%5Dpyrimidine+tyrosine+kinase+inhibitors&doi=10.1021%2Fjm970367n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationships for a Novel Series of Pyrido[2,3-d]pyrimidine Tyrosine Kinase Inhibitors</span></div><div class="casAuthors">Hamby, James M.; Connolly, Cleo J. C.; Schroeder, Mel C.; Winters, R. Thomas; Showalter, H. D. Hollis; Panek, Robert L.; Major, Terry C.; Olsewski, Bronislawa; Ryan, Michael J.; Dahring, Tawny; Lu, Gina H.; Keiser, Joan; Amar, Aneesa; Shen, Cindy; Kraker, Alan J.; Slintak, Veronika; Nelson, James M.; Fry, David W.; Bradford, Laura; Hallak, Hussein; Doherty, Annette M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2296-2303</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Screening of a compd. library for inhibitors of the fibroblast growth factor (FGFr) and platelet-derived growth factor (PDGFr) receptor tyrosine kinases led to the development of a novel series of ATP competitive pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.  The initial lead, 1-[2-amino-6-(2,6-dichlorophenyl)pyrido[2,3-d]pyrimidin-7-yl]-3-tert-butylurea (I; PD-089828), was found to be a broadly active tyrosine kinase inhibitor.  I inhibited the PDGFr, FGFr, EGFr, and c-src tyrosine kinases with IC50 values of 1.11, 0.13, 0.45, and 0.22 μM, resp.  Subsequent SAR studies led to the synthesis of new analogs with improved potency, soly., and bioavailability relative to the initial lead.  For example, the introduction of a [4-(diethylamino)butyl]amino side chain into the 2-position of I afforded a compd. (II) with enhanced potency and bioavailability.  II inhibited PDGF-stimulated vascular smooth muscle cell proliferation with an IC50 of 0.3 μM.  Furthermore, replacement of the 6-(2,6-dichlorophenyl) moiety of I with a 6-(3',5'-dimethoxyphenyl) functionality produced a highly selective FGFr tyrosine kinase inhibitor (III).  III inhibited the FGFr tyrosine kinase with an IC50 of 0.060 μM, whereas IC50s for the inhibition of the PDGFr, FGFr, EGFr, c-src, and InsR tyrosine kinases for this compd. were all greater than 50 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJdLcE9N0L8rVg90H21EOLACvtfcHk0li9e_qGBsvXQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlKisLs%253D&md5=f68e00a123b8b450e647761ac1421d77</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm970367n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970367n%26sid%3Dliteratum%253Aachs%26aulast%3DHamby%26aufirst%3DJ.%2BM.%26aulast%3DConnolly%26aufirst%3DC.%2BJ.%2BC.%26aulast%3DSchroeder%26aufirst%3DM.%2BC.%26aulast%3DWinters%26aufirst%3DR.%2BT.%26aulast%3DShowalter%26aufirst%3DH.%2BD.%2BH.%26aulast%3DPanek%26aufirst%3DR.%2BL.%26aulast%3DMajor%26aufirst%3DT.%2BC.%26aulast%3DOlsewski%26aufirst%3DB.%26aulast%3DRyan%26aufirst%3DM.%2BJ.%26aulast%3DDahring%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DG.%2BH.%26aulast%3DKeiser%26aufirst%3DJ.%26aulast%3DAmar%26aufirst%3DA.%26aulast%3DShen%26aufirst%3DC.%26aulast%3DKraker%26aufirst%3DA.%2BJ.%26aulast%3DSlintak%26aufirst%3DV.%26aulast%3DNelson%26aufirst%3DJ.%2BM.%26aulast%3DFry%26aufirst%3DD.%2BW.%26aulast%3DBradford%26aufirst%3DL.%26aulast%3DHallak%26aufirst%3DH.%26aulast%3DDoherty%26aufirst%3DA.%2BM.%26atitle%3DStructure-activity%2520relationships%2520for%2520a%2520novel%2520series%2520of%2520pyrido%255B2%252C3-d%255Dpyrimidine%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D2296%26epage%3D2303%26doi%3D10.1021%2Fjm970367n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kung, P.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooun, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gajiwala, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grantner, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gukasyan, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kania, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kephart, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krivacic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpf, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khamphavong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richter, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollins, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sach, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherrill, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spangler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uryu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehnder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Optimization of orally bioavailable enhancer of zeste homolog 2 (EZH2) inhibitors using ligand and property-based design strategies: Identification of development candidate (<i>R</i>)-5,8-dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2<i>H</i>)-one (PF-06821497)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">650</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01375</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01375" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFaqtrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=650-665&author=P.-P.+Kungauthor=P.+Binghamauthor=A.+Broounauthor=M.+Collinsauthor=Y.-L.+Dengauthor=D.+Dinhauthor=C.+Fanauthor=K.+S.+Gajiwalaauthor=R.+Grantnerauthor=H.+J.+Gukasyanauthor=W.+Huauthor=B.+Huangauthor=R.+Kaniaauthor=E.+Kephartauthor=C.+Krivacicauthor=R.+A.+Kumpfauthor=P.+Khamphavongauthor=M.+Krausauthor=W.+Liuauthor=K.+A.+Maegleyauthor=L.+Nguyenauthor=S.+Renauthor=D.+Richterauthor=R.+A.+Rollinsauthor=N.+Sachauthor=S.+Sharmaauthor=J.+Sherrillauthor=J.+Spanglerauthor=A.+E.+Stewartauthor=S.+Suttonauthor=S.+Uryuauthor=D.+Verhelleauthor=H.+Wangauthor=S.+Wangauthor=M.+Wythesauthor=S.+Xinauthor=S.+Yamazakiauthor=H.+Zhuauthor=J.+Zhuauthor=L.+Zehnderauthor=M.+Edwards&title=Optimization+of+orally+bioavailable+enhancer+of+zeste+homolog+2+%28EZH2%29+inhibitors+using+ligand+and+property-based+design+strategies%3A+Identification+of+development+candidate+%28R%29-5%2C8-dichloro-7-%28methoxy%28oxetan-3-yl%29methyl%29-2-%28%284-methoxy-6-methyl-2-oxo-1%2C2-dihydropyridin-3-yl%29methyl%29-3%2C4-dihydroisoquinolin-1%282H%29-one+%28PF-06821497%29&doi=10.1021%2Facs.jmedchem.7b01375"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization of Orally Bioavailable Enhancer of Zeste Homolog 2 (EZH2) Inhibitors Using Ligand and Property-Based Design Strategies: Identification of Development Candidate (R)-5,8-Dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one (PF-06821497)</span></div><div class="casAuthors">Kung, Pei-Pei; Bingham, Patrick; Brooun, Alexei; Collins, Michael; Deng, Ya-Li; Dinh, Dac; Fan, Connie; Gajiwala, Ketan S.; Grantner, Rita; Gukasyan, Hovhannes J.; Hu, Wenyue; Huang, Buwen; Kania, Robert; Kephart, Susan E.; Krivacic, Cody; Kumpf, Robert A.; Khamphavong, Penney; Kraus, Manfred; Liu, Wei; Maegley, Karen A.; Nguyen, Lisa; Ren, Shijian; Richter, Dan; Rollins, Robert A.; Sach, Neal; Sharma, Shikhar; Sherrill, John; Spangler, Jillian; Stewart, Albert E.; Sutton, Scott; Uryu, Sean; Verhelle, Dominique; Wang, Hui; Wang, Shuiwang; Wythes, Martin; Xin, Shuibo; Yamazaki, Shinji; Zhu, Huichun; Zhu, JinJiang; Zehnder, Luke; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">650-665</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of lactam-derived EZH2 inhibitors was designed via ligand-based and physicochem.-property-based strategies to address metabolic stability and thermodn. soly. issues assocd. with previous lead compd. (I).  The new inhibitors incorporated an Sp3 hybridized carbon atom at the 7-position of the lactam moiety present in lead compd. (I) as a replacement for a dimethylisoxazole group.  This transformation enabled optimization of the physicochem. properties and potency compared to compd. (I).  Anal. of relationships between calcd. log D (clogD) values and in vitro metabolic stability and permeability parameters identified a clogD range that afforded an increased probability of achieving favorable ADME data in a single mol.  Compd. 23a (5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1(2H)-one) exhibited the best overlap of potency and pharmaceutical properties as well as robust tumor growth inhibition in vivo and was therefore advanced as a development candidate (PF-06821497).  A crystal structure of 23a in complex with the three-protein PRC2 complex enabled understanding of the key structural features required for optimal binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro0-Aa0AZgXLVg90H21EOLACvtfcHk0li9e_qGBsvXQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFaqtrzF&md5=96ff75b96f5eea2dc82013a6bad8096b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01375%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DBrooun%26aufirst%3DA.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DDeng%26aufirst%3DY.-L.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DGajiwala%26aufirst%3DK.%2BS.%26aulast%3DGrantner%26aufirst%3DR.%26aulast%3DGukasyan%26aufirst%3DH.%2BJ.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DKania%26aufirst%3DR.%26aulast%3DKephart%26aufirst%3DE.%26aulast%3DKrivacic%26aufirst%3DC.%26aulast%3DKumpf%26aufirst%3DR.%2BA.%26aulast%3DKhamphavong%26aufirst%3DP.%26aulast%3DKraus%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DRen%26aufirst%3DS.%26aulast%3DRichter%26aufirst%3DD.%26aulast%3DRollins%26aufirst%3DR.%2BA.%26aulast%3DSach%26aufirst%3DN.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSherrill%26aufirst%3DJ.%26aulast%3DSpangler%26aufirst%3DJ.%26aulast%3DStewart%26aufirst%3DA.%2BE.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DUryu%26aufirst%3DS.%26aulast%3DVerhelle%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DWythes%26aufirst%3DM.%26aulast%3DXin%26aufirst%3DS.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DZehnder%26aufirst%3DL.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DOptimization%2520of%2520orally%2520bioavailable%2520enhancer%2520of%2520zeste%2520homolog%25202%2520%2528EZH2%2529%2520inhibitors%2520using%2520ligand%2520and%2520property-based%2520design%2520strategies%253A%2520Identification%2520of%2520development%2520candidate%2520%2528R%2529-5%252C8-dichloro-7-%2528methoxy%2528oxetan-3-yl%2529methyl%2529-2-%2528%25284-methoxy-6-methyl-2-oxo-1%252C2-dihydropyridin-3-yl%2529methyl%2529-3%252C4-dihydroisoquinolin-1%25282H%2529-one%2520%2528PF-06821497%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D650%26epage%3D665%26doi%3D10.1021%2Facs.jmedchem.7b01375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kung, P.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rui, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergqvist, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bingham, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braganza, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinh, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantin, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gukasyan, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kephart, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krivacic, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumpf, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maegley, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McAlpine, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ninkovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ornelas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryskin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatlock, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhelle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wythes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamazaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zehnder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rollins, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, M.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of pyridone-containing 3,4-dihydroisoquinoline-1(2<i>H</i>)-ones as a novel class of enhancer of zeste homolog 2 (EZH2) inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8306</span>– <span class="NLM_lpage">8325</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00515</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00515" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8306-8325&author=P.-P.+Kungauthor=E.+Ruiauthor=S.+Bergqvistauthor=P.+Binghamauthor=J.+Braganzaauthor=M.+Collinsauthor=M.+Cuiauthor=W.+Diehlauthor=D.+Dinhauthor=C.+Fanauthor=V.+R.+Fantinauthor=H.+J.+Gukasyanauthor=W.+Huauthor=B.+Huangauthor=S.+Kephartauthor=C.+Krivacicauthor=R.+A.+Kumpfauthor=G.+Liauthor=K.+A.+Maegleyauthor=I.+McAlpineauthor=L.+Nguyenauthor=S.+Ninkovicauthor=M.+Ornelasauthor=M.+Ryskinauthor=S.+Scalesauthor=S.+Suttonauthor=J.+Tatlockauthor=D.+Verhelleauthor=F.+Wangauthor=P.+Wellsauthor=M.+Wythesauthor=S.+Yamazakiauthor=B.+Yipauthor=X.+Yuauthor=L.+Zehnderauthor=W.-G.+Zhangauthor=R.+A.+Rollinsauthor=M.+Edwards&title=Design+and+synthesis+of+pyridone-containing+3%2C4-dihydroisoquinoline-1%282H%29-ones+as+a+novel+class+of+enhancer+of+zeste+homolog+2+%28EZH2%29+inhibitors&doi=10.1021%2Facs.jmedchem.6b00515"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Pyridone-Containing 3,4-Dihydroisoquinoline-1(2H)-ones as a Novel Class of Enhancer of Zeste Homolog 2 (EZH2) Inhibitors</span></div><div class="casAuthors">Kung, Pei-Pei; Rui, Eugene; Bergqvist, Simon; Bingham, Patrick; Braganza, John; Collins, Michael; Cui, Mei; Diehl, Wade; Dinh, Dac; Fan, Connie; Fantin, Valeria R.; Gukasyan, Hovhannes J.; Hu, Wenyue; Huang, Buwen; Kephart, Susan; Krivacic, Cody; Kumpf, Robert A.; Li, Gary; Maegley, Karen A.; McAlpine, Indrawan; Nguyen, Lisa; Ninkovic, Sacha; Ornelas, Martha; Ryskin, Michael; Scales, Stephanie; Sutton, Scott; Tatlock, John; Verhelle, Dominique; Wang, Fen; Wells, Peter; Wythes, Martin; Yamazaki, Shinji; Yip, Brian; Yu, Xiu; Zehnder, Luke; Zhang, Wei-Guo; Rollins, Robert A.; Edwards, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">8306-8325</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new enhancer of zeste homolog 2 (EZH2) inhibitor series comprising a substituted Ph ring joined to a dimethylpyridone moiety via an amide linkage has been designed.  A preferential amide torsion that improved the binding properties of the compds. was identified for this series via computational anal.  Cyclization of the amide linker resulted in a six-membered lactam analog, compd. I.  This transformation significantly improved the ligand efficiency/potency of the cyclized compd. relative to its acyclic analog.  Addnl. optimization of the lactam-contg. EZH2 inhibitors focused on lipophilic efficiency (LipE) improvement, which provided compd. II.  Compd. II displayed improved LipE and on-target potency in both biochem. and cellular readouts relative to compd. I.  Inhibitor II also displayed robust in vivo antitumor growth activity and dose-dependent de-repression of EZH2 target genes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr50CIrIhlikrVg90H21EOLACvtfcHk0ljuFbMUeFPDgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlamt7rM&md5=eb6f2b053e5ba2c2d214d847ad8d9f1f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00515%26sid%3Dliteratum%253Aachs%26aulast%3DKung%26aufirst%3DP.-P.%26aulast%3DRui%26aufirst%3DE.%26aulast%3DBergqvist%26aufirst%3DS.%26aulast%3DBingham%26aufirst%3DP.%26aulast%3DBraganza%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DM.%26aulast%3DDiehl%26aufirst%3DW.%26aulast%3DDinh%26aufirst%3DD.%26aulast%3DFan%26aufirst%3DC.%26aulast%3DFantin%26aufirst%3DV.%2BR.%26aulast%3DGukasyan%26aufirst%3DH.%2BJ.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DKephart%26aufirst%3DS.%26aulast%3DKrivacic%26aufirst%3DC.%26aulast%3DKumpf%26aufirst%3DR.%2BA.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMaegley%26aufirst%3DK.%2BA.%26aulast%3DMcAlpine%26aufirst%3DI.%26aulast%3DNguyen%26aufirst%3DL.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DOrnelas%26aufirst%3DM.%26aulast%3DRyskin%26aufirst%3DM.%26aulast%3DScales%26aufirst%3DS.%26aulast%3DSutton%26aufirst%3DS.%26aulast%3DTatlock%26aufirst%3DJ.%26aulast%3DVerhelle%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DWells%26aufirst%3DP.%26aulast%3DWythes%26aufirst%3DM.%26aulast%3DYamazaki%26aufirst%3DS.%26aulast%3DYip%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DZehnder%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DRollins%26aufirst%3DR.%2BA.%26aulast%3DEdwards%26aufirst%3DM.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520pyridone-containing%25203%252C4-dihydroisoquinoline-1%25282H%2529-ones%2520as%2520a%2520novel%2520class%2520of%2520enhancer%2520of%2520zeste%2520homolog%25202%2520%2528EZH2%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8306%26epage%3D8325%26doi%3D10.1021%2Facs.jmedchem.6b00515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vaswani, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gehling, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasveschuk, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duplessis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantone, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmange, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Justin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamblin, S. J.</span></span> <span> </span><span class="NLM_article-title">Identification of (<i>R</i>)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1<i>H</i>-indole-3-carboxamide (CPI-1205), a potent and selective inhibitor of histone methyltransferase EZH2, suitable for Phase I clinical trials for B-Cell lymphomas</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9928</span>– <span class="NLM_lpage">9941</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01315</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01315" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1yks77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9928-9941&author=R.+G.+Vaswaniauthor=V.+S.+Gehlingauthor=L.+A.+Dakinauthor=A.+S.+Cookauthor=C.+G.+Nasveschukauthor=M.+Duplessisauthor=P.+Iyerauthor=S.+Balasubramanianauthor=F.+Zhaoauthor=A.+C.+Goodauthor=R.+Campbellauthor=C.+Leeauthor=N.+Cantoneauthor=R.+T.+Cummingsauthor=E.+Normantauthor=S.+F.+Bellonauthor=B.+K.+Albrechtauthor=J.-C.+Harmangeauthor=P.+Trojerauthor=J.+E.+Audiaauthor=Y.+Zhangauthor=N.+Justinauthor=S.+Chenauthor=J.+R.+Wilsonauthor=S.+J.+Gamblin&title=Identification+of+%28R%29-N-%28%284-methoxy-6-methyl-2-oxo-1%2C2-dihydropyridin-3-yl%29methyl%29-2-methyl-1-%281-%281-%282%2C2%2C2-trifluoroethyl%29piperidin-4-yl%29ethyl%29-1H-indole-3-carboxamide+%28CPI-1205%29%2C+a+potent+and+selective+inhibitor+of+histone+methyltransferase+EZH2%2C+suitable+for+Phase+I+clinical+trials+for+B-Cell+lymphomas&doi=10.1021%2Facs.jmedchem.6b01315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas</span></div><div class="casAuthors">Vaswani, Rishi G.; Gehling, Victor S.; Dakin, Les A.; Cook, Andrew S.; Nasveschuk, Christopher G.; Duplessis, Martin; Iyer, Priyadarshini; Balasubramanian, Srividya; Zhao, Feng; Good, Andrew C.; Campbell, Robert; Lee, Christina; Cantone, Nico; Cummings, Richard T.; Normant, Emmanuel; Bellon, Steven F.; Albrecht, Brian K.; Harmange, Jean-Christophe; Trojer, Patrick; Audia, James E.; Zhang, Ying; Justin, Neil; Chen, Shuyang; Wilson, Jon R.; Gamblin, Steven J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9928-9941</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Polycomb repressive complex 2 (PRC2) has been shown to play a major role in transcriptional silencing in part by installing methylation marks on lysine 27 of histone 3.  Dysregulation of PRC2 function correlates with certain malignancies and poor prognosis.  EZH2 is the catalytic engine of the PRC2 complex and thus represents a key candidate oncol. target for pharmacol. intervention.  Here we report the optimization of our indole-based EZH2 inhibitor series that led to the identification of CPI-1205, a highly potent (biochem. IC50 = 0.002 μM, cellular EC50 = 0.032 μM) and selective inhibitor of EZH2.  This compd. demonstrates robust antitumor effects in a Karpas-422 xenograft model when dosed at 160 mg/kg BID and is currently in Phase I clin. trials.  Addnl., we disclose the co-crystal structure of our inhibitor series bound to the human PRC2 complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrqnfg3FGdE7Vg90H21EOLACvtfcHk0ljuFbMUeFPDgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1yks77I&md5=4096fa91399fef88a7ec8aabb5aaee13</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01315%26sid%3Dliteratum%253Aachs%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DCantone%26aufirst%3DN.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DJustin%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DJ.%2BR.%26aulast%3DGamblin%26aufirst%3DS.%2BJ.%26atitle%3DIdentification%2520of%2520%2528R%2529-N-%2528%25284-methoxy-6-methyl-2-oxo-1%252C2-dihydropyridin-3-yl%2529methyl%2529-2-methyl-1-%25281-%25281-%25282%252C2%252C2-trifluoroethyl%2529piperidin-4-yl%2529ethyl%2529-1H-indole-3-carboxamide%2520%2528CPI-1205%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520histone%2520methyltransferase%2520EZH2%252C%2520suitable%2520for%2520Phase%2520I%2520clinical%2520trials%2520for%2520B-Cell%2520lymphomas%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9928%26epage%3D9941%26doi%3D10.1021%2Facs.jmedchem.6b01315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gehling, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaswani, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasveschuk, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duplessis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balasubramanian, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Good, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakin, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagnon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmange, J.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trojer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span></span> <span> </span><span class="NLM_article-title">Discovery, design, and synthesis of indole-based EZH2 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3644</span>– <span class="NLM_lpage">3649</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.06.056</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2015.06.056" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=3644-3649&author=V.+S.+Gehlingauthor=R.+G.+Vaswaniauthor=C.+G.+Nasveschukauthor=M.+Duplessisauthor=P.+Iyerauthor=S.+Balasubramanianauthor=F.+Zhaoauthor=A.+C.+Goodauthor=R.+Campbellauthor=C.+Leeauthor=L.+A.+Dakinauthor=A.+S.+Cookauthor=A.+Gagnonauthor=J.-C.+Harmangeauthor=J.+E.+Audiaauthor=R.+T.+Cummingsauthor=E.+Normantauthor=P.+Trojerauthor=B.+K.+Albrecht&title=Discovery%2C+design%2C+and+synthesis+of+indole-based+EZH2+inhibitors&doi=10.1016%2Fj.bmcl.2015.06.056"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.06.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.06.056%26sid%3Dliteratum%253Aachs%26aulast%3DGehling%26aufirst%3DV.%2BS.%26aulast%3DVaswani%26aufirst%3DR.%2BG.%26aulast%3DNasveschuk%26aufirst%3DC.%2BG.%26aulast%3DDuplessis%26aufirst%3DM.%26aulast%3DIyer%26aufirst%3DP.%26aulast%3DBalasubramanian%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DF.%26aulast%3DGood%26aufirst%3DA.%2BC.%26aulast%3DCampbell%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DDakin%26aufirst%3DL.%2BA.%26aulast%3DCook%26aufirst%3DA.%2BS.%26aulast%3DGagnon%26aufirst%3DA.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DCummings%26aufirst%3DR.%2BT.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DTrojer%26aufirst%3DP.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26atitle%3DDiscovery%252C%2520design%252C%2520and%2520synthesis%2520of%2520indole-based%2520EZH2%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D3644%26epage%3D3649%26doi%3D10.1016%2Fj.bmcl.2015.06.056" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Learn, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gingrich, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lisko, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mesaros, E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghose, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dobrzanski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albom, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeles, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells-Knecht, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aimone, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruckheimer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ator, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, B. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate CEP-37440, a selective inhibitor of focal adhesion kinase (FAK) and anaplastic lymphoma kinase (ALK)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7478</span>– <span class="NLM_lpage">7496</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00487</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00487" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtlaru77P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7478-7496&author=G.+R.+Ottauthor=M.+Chengauthor=K.+S.+Learnauthor=J.+Wagnerauthor=D.+E.+Gingrichauthor=J.+G.+Liskoauthor=M.+Curryauthor=E.+F.+Mesarosauthor=A.+K.+Ghoseauthor=M.+R.+Quailauthor=W.+Wanauthor=L.+Luauthor=P.+Dobrzanskiauthor=M.+S.+Albomauthor=T.+S.+Angelesauthor=K.+Wells-Knechtauthor=Z.+Huangauthor=L.+D.+Aimoneauthor=E.+Bruckheimerauthor=N.+Andersonauthor=J.+Friedmanauthor=S.+V.+Fernandezauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=B.+D.+Dorsey&title=Discovery+of+clinical+candidate+CEP-37440%2C+a+selective+inhibitor+of+focal+adhesion+kinase+%28FAK%29+and+anaplastic+lymphoma+kinase+%28ALK%29&doi=10.1021%2Facs.jmedchem.6b00487"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate CEP-37440, a Selective Inhibitor of Focal Adhesion Kinase (FAK) and Anaplastic Lymphoma Kinase (ALK)</span></div><div class="casAuthors">Ott, Gregory R.; Cheng, Mangeng; Learn, Keith S.; Wagner, Jason; Gingrich, Diane E.; Lisko, Joseph G.; Curry, Matthew; Mesaros, Eugen F.; Ghose, Arup K.; Quail, Matthew R.; Wan, Weihua; Lu, Lihui; Dobrzanski, Pawel; Albom, Mark S.; Angeles, Thelma S.; Wells-Knecht, Kevin; Huang, Zeqi; Aimone, Lisa D.; Bruckheimer, Elizabeth; Anderson, Nathan; Friedman, Jay; Fernandez, Sandra V.; Ator, Mark A.; Ruggeri, Bruce A.; Dorsey, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7478-7496</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Analogs structurally related to anaplastic lymphoma kinase (ALK) inhibitor (CEP-28122) were optimized for metabolic stability.  The results from this endeavor not only led to improved metabolic stability, pharmacokinetic parameters, and in vitro activity against clin. derived resistance mutations but also led to the incorporation of activity for focal adhesion kinase (FAK).  FAK activation, via amplification and/or overexpression, is characteristic of multiple invasive solid tumors and metastasis.  The discovery of the clin. stage, dual FAK/ALK inhibitor 27b (CEP-37440), including details surrounding SAR, in vitro/in vivo pharmacol., and pharmacokinetics, is reported herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9Ojryum63_LVg90H21EOLACvtfcHk0lhdldvyvUUNPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtlaru77P&md5=3fcd1342d901b2379d0efbd118d3049f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00487%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DLearn%26aufirst%3DK.%2BS.%26aulast%3DWagner%26aufirst%3DJ.%26aulast%3DGingrich%26aufirst%3DD.%2BE.%26aulast%3DLisko%26aufirst%3DJ.%2BG.%26aulast%3DCurry%26aufirst%3DM.%26aulast%3DMesaros%26aufirst%3DE.%2BF.%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DDobrzanski%26aufirst%3DP.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DWells-Knecht%26aufirst%3DK.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DBruckheimer%26aufirst%3DE.%26aulast%3DAnderson%26aufirst%3DN.%26aulast%3DFriedman%26aufirst%3DJ.%26aulast%3DFernandez%26aufirst%3DS.%2BV.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%2520CEP-37440%252C%2520a%2520selective%2520inhibitor%2520of%2520focal%2520adhesion%2520kinase%2520%2528FAK%2529%2520and%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7478%26epage%3D7496%26doi%3D10.1021%2Facs.jmedchem.6b00487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ott, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McHugh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anzalone, A. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Underiner, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quail, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angeles, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albom, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aimone, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ator, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruggeri, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorsey, B. D.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1021/ml100158s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml100158s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=493-498&author=G.+R.+Ottauthor=R.+Tripathyauthor=M.+Chengauthor=R.+McHughauthor=A.+V.+Anzaloneauthor=T.+L.+Underinerauthor=M.+A.+Curryauthor=M.+R.+Quailauthor=L.+Luauthor=W.+Wanauthor=T.+S.+Angelesauthor=M.+S.+Albomauthor=L.+D.+Aimoneauthor=M.+A.+Atorauthor=B.+A.+Ruggeriauthor=B.+D.+Dorsey&title=Discovery+of+a+potent+inhibitor+of+anaplastic+lymphoma+kinase+with+in+vivo+antitumor+activity&doi=10.1021%2Fml100158s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Inhibitor of Anaplastic Lymphoma Kinase with in Vivo Antitumor Activity</span></div><div class="casAuthors">Ott, Gregory R.; Tripathy, Rabindranath; Cheng, Mangeng; McHugh, Robert; Anzalone, Andrew V.; Underiner, Ted L.; Curry, Matthew A.; Quail, Matthew R.; Lu, Lihui; Wan, Weihua; Angeles, Thelma S.; Albom, Mark S.; Aimone, Lisa D.; Ator, Mark A.; Ruggeri, Bruce A.; Dorsey, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">493-498</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel 7-amino-1,3,4,5-tetrahydrobenzo[b]azepin-2-one derivs. within the diaminopyrimidine class of kinase inhibitors were identified that target anaplastic lymphoma kinase (ALK).  These inhibitors are potent against ALK in an isolated enzyme assay and inhibit autophosphorylation of the oncogenic fusion protein NPM-ALK in anaplastic large cell lymphoma (ALCL) cell lines.  The lead inhibitor 15 (I), which incorporates a bicyclo[2.2.1]hept-5-ene ring system in place of an aryl moiety, activates the pro-apoptotic caspases (3 and 7) and displays selective cytotoxicity against ALK-pos. ALCL cells.  Furthermore, 15 provides more than 40-fold selectivity against the structurally related insulin receptor, is orally bioavailable in multiple species, and displays in vivo antitumor efficacy when dosed orally in ALK-pos. ALCL tumor xenografts in Scid mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGof0qilbcAbZ7Vg90H21EOLACvtfcHk0lgkH5et1xGQbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jtrrJ&md5=15d4f7aea64f212338d8c9cd88a36c64</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fml100158s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml100158s%26sid%3Dliteratum%253Aachs%26aulast%3DOtt%26aufirst%3DG.%2BR.%26aulast%3DTripathy%26aufirst%3DR.%26aulast%3DCheng%26aufirst%3DM.%26aulast%3DMcHugh%26aufirst%3DR.%26aulast%3DAnzalone%26aufirst%3DA.%2BV.%26aulast%3DUnderiner%26aufirst%3DT.%2BL.%26aulast%3DCurry%26aufirst%3DM.%2BA.%26aulast%3DQuail%26aufirst%3DM.%2BR.%26aulast%3DLu%26aufirst%3DL.%26aulast%3DWan%26aufirst%3DW.%26aulast%3DAngeles%26aufirst%3DT.%2BS.%26aulast%3DAlbom%26aufirst%3DM.%2BS.%26aulast%3DAimone%26aufirst%3DL.%2BD.%26aulast%3DAtor%26aufirst%3DM.%2BA.%26aulast%3DRuggeri%26aufirst%3DB.%2BA.%26aulast%3DDorsey%26aufirst%3DB.%2BD.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%2520with%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D493%26epage%3D498%26doi%3D10.1021%2Fml100158s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohlmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwight, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toms, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parillon, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anjum, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keats, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wardwell, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ning, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moran, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohemmad, Q. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clackson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalgarno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakespeare, W. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of brigatinib (AP26113), a phosphine oxide-containing, potent, orally active inhibitor of anaplastic lymphoma kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">4948</span>– <span class="NLM_lpage">4964</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00306</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00306" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XntlCgur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=4948-4964&author=W.-S.+Huangauthor=S.+Liuauthor=D.+Zouauthor=M.+Thomasauthor=Y.+Wangauthor=T.+Zhouauthor=J.+Romeroauthor=A.+Kohlmannauthor=F.+Liauthor=J.+Qiauthor=L.+Caiauthor=T.+A.+Dwightauthor=Y.+Xuauthor=R.+Xuauthor=R.+Doddauthor=A.+Tomsauthor=L.+Parillonauthor=X.+Luauthor=R.+Anjumauthor=S.+Zhangauthor=F.+Wangauthor=J.+Keatsauthor=S.+D.+Wardwellauthor=Y.+Ningauthor=Q.+Xuauthor=L.+E.+Moranauthor=Q.+K.+Mohemmadauthor=H.+G.+Jangauthor=T.+Clacksonauthor=N.+I.+Narasimhanauthor=V.+M.+Riveraauthor=X.+Zhuauthor=D.+Dalgarnoauthor=W.+C.+Shakespeare&title=Discovery+of+brigatinib+%28AP26113%29%2C+a+phosphine+oxide-containing%2C+potent%2C+orally+active+inhibitor+of+anaplastic+lymphoma+kinase&doi=10.1021%2Facs.jmedchem.6b00306"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Brigatinib (AP26113), a Phosphine Oxide-Containing, Potent, Orally Active Inhibitor of Anaplastic Lymphoma Kinase</span></div><div class="casAuthors">Huang, Wei-Sheng; Liu, Shuangying; Zou, Dong; Thomas, Mathew; Wang, Yihan; Zhou, Tianjun; Romero, Jan; Kohlmann, Anna; Li, Feng; Qi, Jiwei; Cai, Lisi; Dwight, Timothy A.; Xu, Yongjin; Xu, Rongsong; Dodd, Rory; Toms, Angela; Parillon, Lois; Lu, Xiaohui; Anjum, Rana; Zhang, Sen; Wang, Frank; Keats, Jeffrey; Wardwell, Scott D.; Ning, Yaoyu; Xu, Qihong; Moran, Lauren E.; Mohemmad, Qurish K.; Jang, Hyun Gyung; Clackson, Tim; Narasimhan, Narayana I.; Rivera, Victor M.; Zhu, Xiaotian; Dalgarno, David; Shakespeare, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4948-4964</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In the treatment of echinoderm microtubule-assocd. protein-like 4 (EML4)-anaplastic lymphoma kinase pos. (ALK+) non-small-cell lung cancer (NSCLC), secondary mutations within the ALK kinase domain have emerged as a major resistance mechanism to both first- and second-generation ALK inhibitors.  This report describes the design and synthesis of a series of 2,4-diarylaminopyrimidine-based potent and selective ALK inhibitors culminating in identification of the investigational clin. candidate brigatinib.  A unique structural feature of brigatinib is a phosphine oxide, an overlooked but novel hydrogen-bond acceptor that drives potency and selectivity in addn. to favorable ADME properties.  Brigatinib displayed low nanomolar IC50s against native ALK and all tested clin. relevant ALK mutants in both enzyme-based biochem. and cell-based viability assays and demonstrated efficacy in multiple ALK+ xenografts in mice, including Karpas-299 (anaplastic large-cell lymphomas [ALCL]) and H3122 (NSCLC).  Brigatinib represents the most clin. advanced phosphine oxide-contg. drug candidate to date and is currently being evaluated in a global phase 2 registration trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5_iqprSA4QbVg90H21EOLACvtfcHk0lgkH5et1xGQbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntlCgur8%253D&md5=4cb93ff587579c97fda8aff0c7d43317</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00306&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00306%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DW.-S.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZou%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DT.%26aulast%3DRomero%26aufirst%3DJ.%26aulast%3DKohlmann%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DQi%26aufirst%3DJ.%26aulast%3DCai%26aufirst%3DL.%26aulast%3DDwight%26aufirst%3DT.%2BA.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DDodd%26aufirst%3DR.%26aulast%3DToms%26aufirst%3DA.%26aulast%3DParillon%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DAnjum%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DKeats%26aufirst%3DJ.%26aulast%3DWardwell%26aufirst%3DS.%2BD.%26aulast%3DNing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DMoran%26aufirst%3DL.%2BE.%26aulast%3DMohemmad%26aufirst%3DQ.%2BK.%26aulast%3DJang%26aufirst%3DH.%2BG.%26aulast%3DClackson%26aufirst%3DT.%26aulast%3DNarasimhan%26aufirst%3DN.%2BI.%26aulast%3DRivera%26aufirst%3DV.%2BM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DDalgarno%26aufirst%3DD.%26aulast%3DShakespeare%26aufirst%3DW.%2BC.%26atitle%3DDiscovery%2520of%2520brigatinib%2520%2528AP26113%2529%252C%2520a%2520phosphine%2520oxide-containing%252C%2520potent%252C%2520orally%2520active%2520inhibitor%2520of%2520anaplastic%2520lymphoma%2520kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D4948%26epage%3D4964%26doi%3D10.1021%2Facs.jmedchem.6b00306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menichincheri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ardini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnaghi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avanzi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banfi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bossi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buffa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canevari, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceriani, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colombo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fasolini, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Felder, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiorentini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galvani, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borgia, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchionni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nesi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orrenius, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panzeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pesenti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rusconi, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saccardo, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanotti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrone, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orsini, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of Entrectinib: A new 3-aminoindazole as a potent anaplastic lymphoma kinase (ALK), c-ros oncogene 1 kinase (ROS1), and pan-tropomyosin receptor kinases (Pan-TRKs) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">3392</span>– <span class="NLM_lpage">3408</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00064</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00064" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1eitL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=3392-3408&author=M.+Menichincheriauthor=E.+Ardiniauthor=P.+Magnaghiauthor=N.+Avanziauthor=P.+Banfiauthor=R.+Bossiauthor=L.+Buffaauthor=G.+Canevariauthor=L.+Cerianiauthor=M.+Colomboauthor=L.+Cortiauthor=D.+Donatiauthor=M.+Fasoliniauthor=E.+Felderauthor=C.+Fiorelliauthor=F.+Fiorentiniauthor=A.+Galvaniauthor=A.+Isacchiauthor=A.+L.+Borgiaauthor=C.+Marchionniauthor=M.+Nesiauthor=C.+Orreniusauthor=A.+Panzeriauthor=E.+Pesentiauthor=L.+Rusconiauthor=M.+B.+Saccardoauthor=E.+Vanottiauthor=E.+Perroneauthor=P.+Orsini&title=Discovery+of+Entrectinib%3A+A+new+3-aminoindazole+as+a+potent+anaplastic+lymphoma+kinase+%28ALK%29%2C+c-ros+oncogene+1+kinase+%28ROS1%29%2C+and+pan-tropomyosin+receptor+kinases+%28Pan-TRKs%29+inhibitor&doi=10.1021%2Facs.jmedchem.6b00064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor</span></div><div class="casAuthors">Menichincheri, Maria; Ardini, Elena; Magnaghi, Paola; Avanzi, Nilla; Banfi, Patrizia; Bossi, Roberto; Buffa, Laura; Canevari, Giulia; Ceriani, Lucio; Colombo, Maristella; Corti, Luca; Donati, Daniele; Fasolini, Marina; Felder, Eduard; Fiorelli, Claudio; Fiorentini, Francesco; Galvani, Arturo; Isacchi, Antonella; Borgia, Andrea Lombardi; Marchionni, Chiara; Nesi, Marcella; Orrenius, Christian; Panzeri, Achille; Pesenti, Enrico; Rusconi, Luisa; Saccardo, Maria Beatrice; Vanotti, Ermes; Perrone, Ettore; Orsini, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3392-3408</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase responsible for the development of different tumor types.  Despite the remarkable clin. activity of crizotinib (Xalkori), the first ALK inhibitor approved in 2011, the emergence of resistance mutations and of brain metastases frequently causes relapse in patients.  Within the ALK drug discovery program, the authors identified compd. I, a novel 3-aminoindazole active on ALK in biochem. and in cellular assays.  Its optimization led to compd. II (entrectinib), a potent orally available ALK inhibitor active on ALK-dependent cell lines, efficiently penetrant the blood-brain barrier (BBB) in different animal species and highly efficacious in in vivo xenograft models.  Moreover, entrectinib resulted to be strictly potent on the closely related tyrosine kinases ROS1 and TRKs recently found constitutively activated in several tumor types.  Entrectinib is currently undergoing phase I/II clin. trial for the treatment of patients affected by ALK-, ROS1-, and TRK-pos. tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU_xyLC5-GabVg90H21EOLACvtfcHk0ljqD_FEugRvAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1eitL8%253D&md5=140217fba2ac81d71600f7344f2d8a3e</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00064%26sid%3Dliteratum%253Aachs%26aulast%3DMenichincheri%26aufirst%3DM.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DMagnaghi%26aufirst%3DP.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBanfi%26aufirst%3DP.%26aulast%3DBossi%26aufirst%3DR.%26aulast%3DBuffa%26aufirst%3DL.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DCeriani%26aufirst%3DL.%26aulast%3DColombo%26aufirst%3DM.%26aulast%3DCorti%26aufirst%3DL.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DFasolini%26aufirst%3DM.%26aulast%3DFelder%26aufirst%3DE.%26aulast%3DFiorelli%26aufirst%3DC.%26aulast%3DFiorentini%26aufirst%3DF.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DBorgia%26aufirst%3DA.%2BL.%26aulast%3DMarchionni%26aufirst%3DC.%26aulast%3DNesi%26aufirst%3DM.%26aulast%3DOrrenius%26aufirst%3DC.%26aulast%3DPanzeri%26aufirst%3DA.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DSaccardo%26aufirst%3DM.%2BB.%26aulast%3DVanotti%26aufirst%3DE.%26aulast%3DPerrone%26aufirst%3DE.%26aulast%3DOrsini%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520Entrectinib%253A%2520A%2520new%25203-aminoindazole%2520as%2520a%2520potent%2520anaplastic%2520lymphoma%2520kinase%2520%2528ALK%2529%252C%2520c-ros%2520oncogene%25201%2520kinase%2520%2528ROS1%2529%252C%2520and%2520pan-tropomyosin%2520receptor%2520kinases%2520%2528Pan-TRKs%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D3392%26epage%3D3408%26doi%3D10.1021%2Facs.jmedchem.6b00064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ugolini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenigsberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallée, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houtmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowinski, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albert, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinet, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemecek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grapinet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacqué, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roesner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaisi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonche, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semiond, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egile, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goulaouic, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schio, L.</span></span> <span> </span><span class="NLM_article-title">Discovery and pharmacokinetic and pharmacological properties of the potent and selective MET kinase inhibitor 1-{6-[6-(4-fluorophenyl)-[1,2,4]triazolo[4,3-<i>b</i>]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">7066</span>– <span class="NLM_lpage">7074</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00280</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00280" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVyit73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=7066-7074&author=A.+Ugoliniauthor=M.+Kenigsbergauthor=A.+Rakauthor=F.+Vall%C3%A9eauthor=J.+Houtmannauthor=M.+Lowinskiauthor=C.+Capdevilaauthor=J.+Khiderauthor=E.+Albertauthor=N.+Martinetauthor=C.+Nemecekauthor=S.+Grapinetauthor=E.+Bacqu%C3%A9author=M.+Roesnerauthor=C.+Delaisiauthor=L.+Calvetauthor=F.+Boncheauthor=D.+Semiondauthor=C.+Egileauthor=H.+Goulaouicauthor=L.+Schio&title=Discovery+and+pharmacokinetic+and+pharmacological+properties+of+the+potent+and+selective+MET+kinase+inhibitor+1-%7B6-%5B6-%284-fluorophenyl%29-%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-b%5Dpyridazin-3-ylsulfanyl%5Dbenzothiazol-2-yl%7D-3-%282-morpholin-4-ylethyl%29urea+%28SAR125844%29&doi=10.1021%2Facs.jmedchem.6b00280"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Pharmacokinetic and Pharmacological Properties of the Potent and Selective MET Kinase Inhibitor 1-{6-[6-(4-Fluorophenyl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]benzothiazol-2-yl}-3-(2-morpholin-4-ylethyl)urea (SAR125844)</span></div><div class="casAuthors">Ugolini, Antonio; Kenigsberg, Mireille; Rak, Alexey; Vallee, Francois; Houtmann, Jacques; Lowinski, Maryse; Capdevila, Cecile; Khider, Jean; Albert, Eva; Martinet, Nathalie; Nemecek, Conception; Grapinet, Sandrine; Bacque, Eric; Roesner, Manfred; Delaisi, Christine; Calvet, Loreley; Bonche, Fabrice; Semiond, Dorothee; Egile, Coumaran; Goulaouic, Helene; Schio, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7066-7074</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The HGF/MET pathway is frequently activated in a variety of cancer types.  Several selective small mol. inhibitors of the MET kinase are currently in clin. evaluation, in particular for NSCLC, liver, and gastric cancer patients.  We report herein the discovery of a series of triazolopyridazines that are selective inhibitors of wild-type (WT) MET kinase and several clin. relevant mutants.  We provide insight into their mode of binding and report unprecedented crystal structures of the Y1230H variant.  A multiparametric chem. optimization approach allowed the identification of compd. 12 (SAR125844) as a development candidate.  In this chem. series, absence of CYP3A4 inhibition was obtained at the expense of satisfactory oral absorption.  Compd. 12, a promising parenteral agent for the treatment of MET-dependent cancers, promoted sustained target engagement at tolerated doses in a human xenograft tumor model.  Preclin. pharmacokinetics conducted in several species were predictive for the obsd. pharmacokinetic behavior of 12 in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH0viMRg7UIrVg90H21EOLACvtfcHk0ljqD_FEugRvAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVyit73M&md5=9c8a040424abb6774987d04cadfafb24</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00280&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00280%26sid%3Dliteratum%253Aachs%26aulast%3DUgolini%26aufirst%3DA.%26aulast%3DKenigsberg%26aufirst%3DM.%26aulast%3DRak%26aufirst%3DA.%26aulast%3DVall%25C3%25A9e%26aufirst%3DF.%26aulast%3DHoutmann%26aufirst%3DJ.%26aulast%3DLowinski%26aufirst%3DM.%26aulast%3DCapdevila%26aufirst%3DC.%26aulast%3DKhider%26aufirst%3DJ.%26aulast%3DAlbert%26aufirst%3DE.%26aulast%3DMartinet%26aufirst%3DN.%26aulast%3DNemecek%26aufirst%3DC.%26aulast%3DGrapinet%26aufirst%3DS.%26aulast%3DBacqu%25C3%25A9%26aufirst%3DE.%26aulast%3DRoesner%26aufirst%3DM.%26aulast%3DDelaisi%26aufirst%3DC.%26aulast%3DCalvet%26aufirst%3DL.%26aulast%3DBonche%26aufirst%3DF.%26aulast%3DSemiond%26aufirst%3DD.%26aulast%3DEgile%26aufirst%3DC.%26aulast%3DGoulaouic%26aufirst%3DH.%26aulast%3DSchio%26aufirst%3DL.%26atitle%3DDiscovery%2520and%2520pharmacokinetic%2520and%2520pharmacological%2520properties%2520of%2520the%2520potent%2520and%2520selective%2520MET%2520kinase%2520inhibitor%25201-%257B6-%255B6-%25284-fluorophenyl%2529-%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-b%255Dpyridazin-3-ylsulfanyl%255Dbenzothiazol-2-yl%257D-3-%25282-morpholin-4-ylethyl%2529urea%2520%2528SAR125844%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D7066%26epage%3D7074%26doi%3D10.1021%2Facs.jmedchem.6b00280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Copeland, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rex, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellon, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boezio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broome, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choquette, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coxon, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dussault, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.-H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lohman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potashman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimanovich, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teffera, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittington, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaida, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harmange, J.-C.</span></span> <span> </span><span class="NLM_article-title">Discovery of (<i>R</i>)-6-(1-(8-Fluoro-6-(1-methly-1H-pyrazol-4-yl)-[1,2,4]triazol[4,3-<i>a</i>]pyridine-3-yl)-3-(2-methoxyethoxy)-1,6-napthyridin-5(6<i>H</i>)-one (AMG 337), a potent and selective inhibitor of MET with high unbound target coverage and robust in vivo antitumor activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2328</span>– <span class="NLM_lpage">2342</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01716</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01716" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2328-2342&author=A.+A.+Boezioauthor=K.+W.+Copelandauthor=K.+Rexauthor=B.+K.+Albrechtauthor=D.+Bauerauthor=S.+F.+Bellonauthor=C.+Boezioauthor=M.+A.+Broomeauthor=D.+Choquetteauthor=A.+Coxonauthor=I.+Dussaultauthor=S.+Hiraiauthor=R.+Lewisauthor=M.-H.+J.+Linauthor=J.+Lohmanauthor=J.+Liuauthor=E.+A.+Petersonauthor=M.+Potashmanauthor=R.+Shimanovichauthor=Y.+Tefferaauthor=D.+A.+Whittingtonauthor=K.+R.+Vaidaauthor=J.-C.+Harmange&title=Discovery+of+%28R%29-6-%281-%288-Fluoro-6-%281-methly-1H-pyrazol-4-yl%29-%5B1%2C2%2C4%5Dtriazol%5B4%2C3-a%5Dpyridine-3-yl%29-3-%282-methoxyethoxy%29-1%2C6-napthyridin-5%286H%29-one+%28AMG+337%29%2C+a+potent+and+selective+inhibitor+of+MET+with+high+unbound+target+coverage+and+robust+in+vivo+antitumor+activity&doi=10.1021%2Facs.jmedchem.5b01716"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01716%26sid%3Dliteratum%253Aachs%26aulast%3DBoezio%26aufirst%3DA.%2BA.%26aulast%3DCopeland%26aufirst%3DK.%2BW.%26aulast%3DRex%26aufirst%3DK.%26aulast%3DAlbrecht%26aufirst%3DB.%2BK.%26aulast%3DBauer%26aufirst%3DD.%26aulast%3DBellon%26aufirst%3DS.%2BF.%26aulast%3DBoezio%26aufirst%3DC.%26aulast%3DBroome%26aufirst%3DM.%2BA.%26aulast%3DChoquette%26aufirst%3DD.%26aulast%3DCoxon%26aufirst%3DA.%26aulast%3DDussault%26aufirst%3DI.%26aulast%3DHirai%26aufirst%3DS.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DM.-H.%2BJ.%26aulast%3DLohman%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DPeterson%26aufirst%3DE.%2BA.%26aulast%3DPotashman%26aufirst%3DM.%26aulast%3DShimanovich%26aufirst%3DR.%26aulast%3DTeffera%26aufirst%3DY.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DVaida%26aufirst%3DK.%2BR.%26aulast%3DHarmange%26aufirst%3DJ.-C.%26atitle%3DDiscovery%2520of%2520%2528R%2529-6-%25281-%25288-Fluoro-6-%25281-methly-1H-pyrazol-4-yl%2529-%255B1%252C2%252C4%255Dtriazol%255B4%252C3-a%255Dpyridine-3-yl%2529-3-%25282-methoxyethoxy%2529-1%252C6-napthyridin-5%25286H%2529-one%2520%2528AMG%2520337%2529%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520MET%2520with%2520high%2520unbound%2520target%2520coverage%2520and%2520robust%2520in%2520vivo%2520antitumor%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2328%26epage%3D2342%26doi%3D10.1021%2Facs.jmedchem.5b01716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blake, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, K.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudino, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grina, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunsaker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreno, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacheco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robarge, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahidi-Latham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stults, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belvin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merchant, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of (<i>S</i>)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1<i>H</i>-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1<i>H</i>)-one (GDC-0994), an extracellular signal-regulated kinase 1/2 (ERK1/2) inhibitor in early clinical development</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">5650</span>– <span class="NLM_lpage">5660</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00389</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00389" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XoslOrsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=5650-5660&author=J.+F.+Blakeauthor=M.+Burkardauthor=J.+Chanauthor=H.+Chenauthor=K.-J.+Chouauthor=D.+Diazauthor=D.+A.+Dudleyauthor=J.+J.+Gaudinoauthor=S.+E.+Gouldauthor=J.+Grinaauthor=T.+Hunsakerauthor=L.+Liuauthor=M.+Martinsonauthor=D.+Morenoauthor=L.+Muellerauthor=C.+Orrauthor=P.+Pachecoauthor=A.+Qinauthor=K.+Rasorauthor=L.+Renauthor=K.+Robargeauthor=S.+Shahidi-Lathamauthor=J.+Stultsauthor=F.+Sullivanauthor=W.+Wangauthor=J.+Yinauthor=A.+Zhouauthor=M.+Belvinauthor=M.+Merchantauthor=J.+Moffatauthor=J.+B.+Schwarz&title=Discovery+of+%28S%29-1-%281-%284-chloro-3-fluorophenyl%29-2-hydroxyethyl%29-4-%282-%28%281-methyl-1H-pyrazol-5-yl%29amino%29pyrimidin-4-yl%29pyridin-2%281H%29-one+%28GDC-0994%29%2C+an+extracellular+signal-regulated+kinase+1%2F2+%28ERK1%2F2%29+inhibitor+in+early+clinical+development&doi=10.1021%2Facs.jmedchem.6b00389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development</span></div><div class="casAuthors">Blake, James F.; Burkard, Michael; Chan, Jocelyn; Chen, Huifen; Chou, Kang-Jye; Diaz, Dolores; Dudley, Danette A.; Gaudino, John J.; Gould, Stephen E.; Grina, Jonas; Hunsaker, Thomas; Liu, Lichuan; Martinson, Matthew; Moreno, David; Mueller, Lars; Orr, Christine; Pacheco, Patricia; Qin, Ann; Rasor, Kevin; Ren, Li; Robarge, Kirk; Shahidi-Latham, Sheerin; Stults, Jeffrey; Sullivan, Francis; Wang, Weiru; Yin, Jianping; Zhou, Aihe; Belvin, Marcia; Merchant, Mark; Moffat, John; Schwarz, Jacob B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5650-5660</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The extracellular signal-regulated kinases ERK1/2 represent an essential node within the RAS/RAF/MEK/ERK signaling cascade that is commonly activated by oncogenic mutations in BRAF or RAS or by upstream oncogenic signaling.  While targeting upstream nodes with RAF and MEK inhibitors has proven effective clin., resistance frequently develops through reactivation of the pathway.  Simultaneous targeting of multiple nodes in the pathway, such as MEK and ERK, offers the prospect of enhanced efficacy as well as reduced potential for acquired resistance.  Described herein is the discovery and characterization of GDC-0994 (22), an orally bioavailable small mol. inhibitor selective for ERK kinase activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrk9rgPtXHF4rVg90H21EOLACvtfcHk0li1TRTxcxd52Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XoslOrsLs%253D&md5=6d2d52dabea4d443ddee2959df6d45f1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00389%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DJ.%2BF.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DChou%26aufirst%3DK.-J.%26aulast%3DDiaz%26aufirst%3DD.%26aulast%3DDudley%26aufirst%3DD.%2BA.%26aulast%3DGaudino%26aufirst%3DJ.%2BJ.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DGrina%26aufirst%3DJ.%26aulast%3DHunsaker%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMartinson%26aufirst%3DM.%26aulast%3DMoreno%26aufirst%3DD.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DOrr%26aufirst%3DC.%26aulast%3DPacheco%26aufirst%3DP.%26aulast%3DQin%26aufirst%3DA.%26aulast%3DRasor%26aufirst%3DK.%26aulast%3DRen%26aufirst%3DL.%26aulast%3DRobarge%26aufirst%3DK.%26aulast%3DShahidi-Latham%26aufirst%3DS.%26aulast%3DStults%26aufirst%3DJ.%26aulast%3DSullivan%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DA.%26aulast%3DBelvin%26aufirst%3DM.%26aulast%3DMerchant%26aufirst%3DM.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520%2528S%2529-1-%25281-%25284-chloro-3-fluorophenyl%2529-2-hydroxyethyl%2529-4-%25282-%2528%25281-methyl-1H-pyrazol-5-yl%2529amino%2529pyrimidin-4-yl%2529pyridin-2%25281H%2529-one%2520%2528GDC-0994%2529%252C%2520an%2520extracellular%2520signal-regulated%2520kinase%25201%252F2%2520%2528ERK1%252F2%2529%2520inhibitor%2520in%2520early%2520clinical%2520development%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D5650%26epage%3D5660%26doi%3D10.1021%2Facs.jmedchem.6b00389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blake, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaudino, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Meese, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohr, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chicarelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siedem, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolakowski, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaus, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burkard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">dean, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dudley, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gould, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pacheco, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahidi-Latham, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5,6,7,8-tetrahydropyrido[3,4-<i>d</i>]pyrimidine inhibitors of Erk2</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">2635</span>– <span class="NLM_lpage">2639</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2014.04.068" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=2635-2639&author=J.+F.+Blakeauthor=J.+J.+Gaudinoauthor=J.+De+Meeseauthor=P.+Mohrauthor=M.+Chicarelliauthor=H.+Tianauthor=R.+Garreyauthor=A.+Thomasauthor=C.+S.+Siedemauthor=M.+B.+Welchauthor=G.+Kolakowskiauthor=R.+Kausauthor=M.+Burkardauthor=M.+Martinsonauthor=H.+Chenauthor=B.+deanauthor=D.+A.+Dudleyauthor=S.+E.+Gouldauthor=P.+Pachecoauthor=S.+Shahidi-Lathamauthor=W.+Wangauthor=K.+Westauthor=J.+Yinauthor=J.+Moffatauthor=J.+B.+Schwarz&title=Discovery+of+5%2C6%2C7%2C8-tetrahydropyrido%5B3%2C4-d%5Dpyrimidine+inhibitors+of+Erk2&doi=10.1016%2Fj.bmcl.2014.04.068"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DBlake%26aufirst%3DJ.%2BF.%26aulast%3DGaudino%26aufirst%3DJ.%2BJ.%26aulast%3DDe%2BMeese%26aufirst%3DJ.%26aulast%3DMohr%26aufirst%3DP.%26aulast%3DChicarelli%26aufirst%3DM.%26aulast%3DTian%26aufirst%3DH.%26aulast%3DGarrey%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DA.%26aulast%3DSiedem%26aufirst%3DC.%2BS.%26aulast%3DWelch%26aufirst%3DM.%2BB.%26aulast%3DKolakowski%26aufirst%3DG.%26aulast%3DKaus%26aufirst%3DR.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DMartinson%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DH.%26aulast%3Ddean%26aufirst%3DB.%26aulast%3DDudley%26aufirst%3DD.%2BA.%26aulast%3DGould%26aufirst%3DS.%2BE.%26aulast%3DPacheco%26aufirst%3DP.%26aulast%3DShahidi-Latham%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DMoffat%26aufirst%3DJ.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%25205%252C6%252C7%252C8-tetrahydropyrido%255B3%252C4-d%255Dpyrimidine%2520inhibitors%2520of%2520Erk2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D2635%26epage%3D2639%26doi%3D10.1016%2Fj.bmcl.2014.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aoyagi-Scharber, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Post, L. E.</span></span> <span> </span><span class="NLM_article-title">Discovery and characterization of (8<i>S</i>,9<i>R</i>)-5-fluoro-8-(4-fluorophenyl)-9-(1-methly-1<i>H</i>-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3<i>H</i>-pyrido[4,3,2-]dephthalazin-3-one (BMN 673, talazoparib), a novel, highly potent, and orally efficacious poly(ADP-ribose) polymerase-1/2 inhibitor, as an anticancer agent</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">335</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01498</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01498" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=335-357&author=B.+Wangauthor=D.+Chuauthor=Y.+Fengauthor=Y.+Shenauthor=M.+Aoyagi-Scharberauthor=L.+E.+Post&title=Discovery+and+characterization+of+%288S%2C9R%29-5-fluoro-8-%284-fluorophenyl%29-9-%281-methly-1H-1%2C2%2C4-triazol-5-yl%29-2%2C7%2C8%2C9-tetrahydro-3H-pyrido%5B4%2C3%2C2-%5Ddephthalazin-3-one+%28BMN+673%2C+talazoparib%29%2C+a+novel%2C+highly+potent%2C+and+orally+efficacious+poly%28ADP-ribose%29+polymerase-1%2F2+inhibitor%2C+as+an+anticancer+agent&doi=10.1021%2Facs.jmedchem.5b01498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01498%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DChu%26aufirst%3DD.%26aulast%3DFeng%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DAoyagi-Scharber%26aufirst%3DM.%26aulast%3DPost%26aufirst%3DL.%2BE.%26atitle%3DDiscovery%2520and%2520characterization%2520of%2520%25288S%252C9R%2529-5-fluoro-8-%25284-fluorophenyl%2529-9-%25281-methly-1H-1%252C2%252C4-triazol-5-yl%2529-2%252C7%252C8%252C9-tetrahydro-3H-pyrido%255B4%252C3%252C2-%255Ddephthalazin-3-one%2520%2528BMN%2520673%252C%2520talazoparib%2529%252C%2520a%2520novel%252C%2520highly%2520potent%252C%2520and%2520orally%2520efficacious%2520poly%2528ADP-ribose%2529%2520polymerase-1%252F2%2520inhibitor%252C%2520as%2520an%2520anticancer%2520agent%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D335%26epage%3D357%26doi%3D10.1021%2Facs.jmedchem.5b01498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kar, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Salvo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagabukuro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacre-Salem, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingley, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goble, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morriello, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyes, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, D.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzmaurice, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gichuru, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jochnowitz, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levorse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mistry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ormes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanfiz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zamlynny, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struthers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, A. E.</span></span> <span> </span><span class="NLM_article-title">Discovery of vibegron: a potent and selective β3 adrenergic receptor agonist for the treatment of overactive bladder</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">609</span>– <span class="NLM_lpage">623</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01372</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01372" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2MXitVyrurjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=609-623&author=S.+D.+Edmondsonauthor=C.+Zhuauthor=N.+F.+Karauthor=J.+Di+Salvoauthor=H.+Nagabukuroauthor=B.+Sacre-Salemauthor=K.+Dingleyauthor=R.+Bergerauthor=S.+D.+Gobleauthor=G.+Morrielloauthor=B.+Harperauthor=C.+R.+Moyesauthor=D.-M.+Shenauthor=L.+Wangauthor=R.+Ballauthor=A.+Fitzmauriceauthor=T.+Frenklauthor=L.+N.+Gichuruauthor=S.+Haauthor=A.+L.+Hurleyauthor=N.+Jochnowitzauthor=D.+Levorseauthor=S.+Mistryauthor=R.+R.+Millerauthor=J.+Ormesauthor=G.+M.+Salituroauthor=A.+Sanfizauthor=A.+S.+Stevensonauthor=K.+Villaauthor=B.+Zamlynnyauthor=S.+Greenauthor=M.+Struthersauthor=A.+E.+Weber&title=Discovery+of+vibegron%3A+a+potent+and+selective+%CE%B23+adrenergic+receptor+agonist+for+the+treatment+of+overactive+bladder&doi=10.1021%2Facs.jmedchem.5b01372"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Vibegron: A Potent and Selective β3 Adrenergic Receptor Agonist for the Treatment of Overactive Bladder</span></div><div class="casAuthors">Edmondson, Scott D.; Zhu, Cheng; Kar, Nam Fung; Di Salvo, Jerry; Nagabukuro, Hiroshi; Sacre-Salem, Beatrice; Dingley, Karen; Berger, Richard; Goble, Stephen D.; Morriello, Gregori; Harper, Bart; Moyes, Christopher R.; Shen, Dong-Ming; Wang, Liping; Ball, Richard; Fitzmaurice, Aileen; Frenkl, Tara; Gichuru, Loise N.; Ha, Sookhee; Hurley, Amanda L.; Jochnowitz, Nina; Levorse, Dorothy; Mistry, Shruty; Miller, Randy R.; Ormes, James; Salituro, Gino M.; Sanfiz, Anthony; Stevenson, Andra S.; Villa, Katherine; Zamlynny, Beata; Green, Stuart; Struthers, Mary; Weber, Ann E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">609-623</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of vibegron, a potent and selective human β3-AR agonist for the treatment of overactive bladder (OAB), is described.  An early-generation clin. β3-AR agonist MK-0634 (3) exhibited efficacy in humans for the treatment of OAB, but development was discontinued due to unacceptable structure-based toxicity in preclin. species.  Optimization of a series of second-generation pyrrolidine-derived β3-AR agonists included reducing the risk for phospholipidosis, the risk of formation of disproportionate human metabolites, and the risk of formation of high levels of circulating metabolites in preclin. species.  These efforts resulted in the discovery of vibegron, which possesses improved druglike properties and an overall superior preclin. profile compared to MK-0634.  Structure-activity relationships leading to the discovery of vibegron and a summary of its preclin. profile are described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTKGFhBOdMNbVg90H21EOLACvtfcHk0ljmzl1PfRsfxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXitVyrurjM&md5=89410d04a67540aa78e73e7312867ef3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01372&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01372%26sid%3Dliteratum%253Aachs%26aulast%3DEdmondson%26aufirst%3DS.%2BD.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DKar%26aufirst%3DN.%2BF.%26aulast%3DDi%2BSalvo%26aufirst%3DJ.%26aulast%3DNagabukuro%26aufirst%3DH.%26aulast%3DSacre-Salem%26aufirst%3DB.%26aulast%3DDingley%26aufirst%3DK.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DGoble%26aufirst%3DS.%2BD.%26aulast%3DMorriello%26aufirst%3DG.%26aulast%3DHarper%26aufirst%3DB.%26aulast%3DMoyes%26aufirst%3DC.%2BR.%26aulast%3DShen%26aufirst%3DD.-M.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DBall%26aufirst%3DR.%26aulast%3DFitzmaurice%26aufirst%3DA.%26aulast%3DFrenkl%26aufirst%3DT.%26aulast%3DGichuru%26aufirst%3DL.%2BN.%26aulast%3DHa%26aufirst%3DS.%26aulast%3DHurley%26aufirst%3DA.%2BL.%26aulast%3DJochnowitz%26aufirst%3DN.%26aulast%3DLevorse%26aufirst%3DD.%26aulast%3DMistry%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DOrmes%26aufirst%3DJ.%26aulast%3DSalituro%26aufirst%3DG.%2BM.%26aulast%3DSanfiz%26aufirst%3DA.%26aulast%3DStevenson%26aufirst%3DA.%2BS.%26aulast%3DVilla%26aufirst%3DK.%26aulast%3DZamlynny%26aufirst%3DB.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DStruthers%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DA.%2BE.%26atitle%3DDiscovery%2520of%2520vibegron%253A%2520a%2520potent%2520and%2520selective%2520%25CE%25B23%2520adrenergic%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520overactive%2520bladder%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D609%26epage%3D623%26doi%3D10.1021%2Facs.jmedchem.5b01372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sakauchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okabe, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saikawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagabukuro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamo, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-chloro-1-(5-chloro-2-(methylsulfonyl)benzyl)-2-imino-1,2-dihydropyridine-3-carboxamide (TAK-259) as a novel, selective, and orally active α1D adrenoceptor antagonist with antiurinary frequency effects: reducing human Ether-a-go-go-Related Gene (hERG) liabilities</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2989</span>– <span class="NLM_lpage">3002</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01528</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01528" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2989-3002&author=N.+Sakauchiauthor=Y.+Koharaauthor=A.+Satoauthor=T.+Suzakiauthor=Y.+Imaiauthor=Y.+Okabeauthor=S.+Imaiauthor=R.+Saikawaauthor=H.+Nagabukuroauthor=H.+Kunoauthor=H.+Fujitaauthor=I.+Kamoauthor=M.+Yoshida&title=Discovery+of+5-chloro-1-%285-chloro-2-%28methylsulfonyl%29benzyl%29-2-imino-1%2C2-dihydropyridine-3-carboxamide+%28TAK-259%29+as+a+novel%2C+selective%2C+and+orally+active+%CE%B11D+adrenoceptor+antagonist+with+antiurinary+frequency+effects%3A+reducing+human+Ether-a-go-go-Related+Gene+%28hERG%29+liabilities&doi=10.1021%2Facs.jmedchem.5b01528"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01528%26sid%3Dliteratum%253Aachs%26aulast%3DSakauchi%26aufirst%3DN.%26aulast%3DKohara%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DA.%26aulast%3DSuzaki%26aufirst%3DT.%26aulast%3DImai%26aufirst%3DY.%26aulast%3DOkabe%26aufirst%3DY.%26aulast%3DImai%26aufirst%3DS.%26aulast%3DSaikawa%26aufirst%3DR.%26aulast%3DNagabukuro%26aufirst%3DH.%26aulast%3DKuno%26aufirst%3DH.%26aulast%3DFujita%26aufirst%3DH.%26aulast%3DKamo%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25205-chloro-1-%25285-chloro-2-%2528methylsulfonyl%2529benzyl%2529-2-imino-1%252C2-dihydropyridine-3-carboxamide%2520%2528TAK-259%2529%2520as%2520a%2520novel%252C%2520selective%252C%2520and%2520orally%2520active%2520%25CE%25B11D%2520adrenoceptor%2520antagonist%2520with%2520antiurinary%2520frequency%2520effects%253A%2520reducing%2520human%2520Ether-a-go-go-Related%2520Gene%2520%2528hERG%2529%2520liabilities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2989%26epage%3D3002%26doi%3D10.1021%2Facs.jmedchem.5b01528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rucker, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chianelli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vidal, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alper, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutnick, D.l</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bursulaya, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmeits, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoll, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groessl, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidel, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molteni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phimister, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joseph, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laffitte, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of tropifexor (LJN452), a highly potent non-bile acid FXR agonist for the treatment of cholestatic liver diseases and nonalcoholic steatohepatitis (NASH)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9960</span>– <span class="NLM_lpage">9973</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00907</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVWqur7P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9960-9973&author=D.+C.+Tullyauthor=P.+V.+Ruckerauthor=D.+Chianelliauthor=J.+Williamsauthor=A.+Vidalauthor=P.+B.+Alperauthor=D.l+Mutnickauthor=B.+Bursulayaauthor=J.+Schmeitsauthor=X.+Wuauthor=D.+Baoauthor=J.+Zollauthor=Y.+Kimauthor=T.+Groesslauthor=P.+McNamaraauthor=H.+M.+Seidelauthor=V.+Molteniauthor=B.+Liuauthor=A.+Phimisterauthor=S.+B.+Josephauthor=B.+Laffitte&title=Discovery+of+tropifexor+%28LJN452%29%2C+a+highly+potent+non-bile+acid+FXR+agonist+for+the+treatment+of+cholestatic+liver+diseases+and+nonalcoholic+steatohepatitis+%28NASH%29&doi=10.1021%2Facs.jmedchem.7b00907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43aR"><div class="casContent"><span class="casTitleNuber">43a</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH)</span></div><div class="casAuthors">Tully, David C.; Rucker, Paul V.; Chianelli, Donatella; Williams, Jennifer; Vidal, Agnes; Alper, Phil B.; Mutnick, Daniel; Bursulaya, Badry; Schmeits, James; Wu, Xiangdong; Bao, Dingjiu; Zoll, Jocelyn; Kim, Young; Groessl, Todd; McNamara, Peter; Seidel, H. Martin; Molteni, Valentina; Liu, Bo; Phimister, Andrew; Joseph, Sean B.; Laffitte, Bryan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">9960-9973</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The farnesoid X receptor (FXR) is a nuclear receptor that acts as a master regulator of bile acid metab. and signaling.  Activation of FXR inhibits bile acid synthesis and increases bile acid conjugation, transport, and excretion, thereby protecting the liver from the harmful effects of bile accumulation, leading to considerable interest in FXR as a therapeutic target for the treatment of cholestasis and nonalcoholic steatohepatitis.  We identified a novel series of highly potent non-bile acid FXR agonists that introduce a bicyclic nortropine-substituted benzothiazole carboxylic acid moiety onto a trisubstituted isoxazole scaffold.  Herein, we report the discovery of 1 (tropifexor, LJN452), a novel and highly potent agonist of FXR.  Potent in vivo activity was demonstrated in rodent PD models by measuring the induction of FXR target genes in various tissues.  Tropifexor has advanced into phase 2 human clin. trials in patients with NASH and PBC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxfWFxWHQF97Vg90H21EOLACvtfcHk0ljmzl1PfRsfxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVWqur7P&md5=4b7a31f2e17645f3831c4dcbf34dd46c</span></div><a href="/servlet/linkout?suffix=cit43a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00907%26sid%3Dliteratum%253Aachs%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DRucker%26aufirst%3DP.%2BV.%26aulast%3DChianelli%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DJ.%26aulast%3DVidal%26aufirst%3DA.%26aulast%3DAlper%26aufirst%3DP.%2BB.%26aulast%3DMutnick%26aufirst%3DD.l%26aulast%3DBursulaya%26aufirst%3DB.%26aulast%3DSchmeits%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DBao%26aufirst%3DD.%26aulast%3DZoll%26aufirst%3DJ.%26aulast%3DKim%26aufirst%3DY.%26aulast%3DGroessl%26aufirst%3DT.%26aulast%3DMcNamara%26aufirst%3DP.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMolteni%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DPhimister%26aufirst%3DA.%26aulast%3DJoseph%26aufirst%3DS.%2BB.%26aulast%3DLaffitte%26aufirst%3DB.%26atitle%3DDiscovery%2520of%2520tropifexor%2520%2528LJN452%2529%252C%2520a%2520highly%2520potent%2520non-bile%2520acid%2520FXR%2520agonist%2520for%2520the%2520treatment%2520of%2520cholestatic%2520liver%2520diseases%2520and%2520nonalcoholic%2520steatohepatitis%2520%2528NASH%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9960%26epage%3D9973%26doi%3D10.1021%2Facs.jmedchem.7b00907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bueno, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agejas Francisco, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manninen, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocchinfuso, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montrose-Rafizadeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannady, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stille, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raddad, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reidy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michael, L. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of 6-(4-{[5-cyclopropyl-3-(2,6-dichlorophenyl)- isoxazol-4-yl]methoxy}piperidin-1-yl)-1-methyl-1<i>H</i>-indole-3-carboxylic acid: A novel FXR agonist for the treatment of dyslipidemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9768</span>– <span class="NLM_lpage">9772</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01161</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01161" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9768-9772&author=M.+J.+Geninauthor=A.+B.+Buenoauthor=J.+Agejas+Franciscoauthor=P.+R.+Manninenauthor=W.+P.+Bocchinfusoauthor=C.+Montrose-Rafizadehauthor=E.+A.+Cannadyauthor=T.+M.+Jonesauthor=J.+R.+Stilleauthor=E.+Raddadauthor=C.+Reidyauthor=A.+Coxauthor=M.+D.+Michaelauthor=L.+F.+Michael&title=Discovery+of+6-%284-%7B%5B5-cyclopropyl-3-%282%2C6-dichlorophenyl%29-+isoxazol-4-yl%5Dmethoxy%7Dpiperidin-1-yl%29-1-methyl-1H-indole-3-carboxylic+acid%3A+A+novel+FXR+agonist+for+the+treatment+of+dyslipidemia&doi=10.1021%2Facs.jmedchem.5b01161"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01161&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01161%26sid%3Dliteratum%253Aachs%26aulast%3DGenin%26aufirst%3DM.%2BJ.%26aulast%3DBueno%26aufirst%3DA.%2BB.%26aulast%3DAgejas%2BFrancisco%26aufirst%3DJ.%26aulast%3DManninen%26aufirst%3DP.%2BR.%26aulast%3DBocchinfuso%26aufirst%3DW.%2BP.%26aulast%3DMontrose-Rafizadeh%26aufirst%3DC.%26aulast%3DCannady%26aufirst%3DE.%2BA.%26aulast%3DJones%26aufirst%3DT.%2BM.%26aulast%3DStille%26aufirst%3DJ.%2BR.%26aulast%3DRaddad%26aufirst%3DE.%26aulast%3DReidy%26aufirst%3DC.%26aulast%3DCox%26aufirst%3DA.%26aulast%3DMichael%26aufirst%3DM.%2BD.%26aulast%3DMichael%26aufirst%3DL.%2BF.%26atitle%3DDiscovery%2520of%25206-%25284-%257B%255B5-cyclopropyl-3-%25282%252C6-dichlorophenyl%2529-%2520isoxazol-4-yl%255Dmethoxy%257Dpiperidin-1-yl%2529-1-methyl-1H-indole-3-carboxylic%2520acid%253A%2520A%2520novel%2520FXR%2520agonist%2520for%2520the%2520treatment%2520of%2520dyslipidemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9768%26epage%3D9772%26doi%3D10.1021%2Facs.jmedchem.5b01161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayeem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seethala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleczka, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and SAR studies of novel polycyclic acids as potent and selective inhibitors of human 11β-hydroxysteroid dehydrogenase type1 (11β-HSD-1)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">6699</span>– <span class="NLM_lpage">6704</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.09.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2011.09.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=6699-6704&author=X.-Y.+Yeauthor=S.+Y.+Chenauthor=A.+Nayeemauthor=R.+Gollaauthor=R.+Seethalaauthor=M.+Wangauthor=T.+Harperauthor=B.+G.+Sleczkaauthor=Y.-X.+Liauthor=B.+Heauthor=M.+Kirbyauthor=D.+A.+Gordonauthor=J.+A.+Robl&title=Design%2C+synthesis%2C+and+SAR+studies+of+novel+polycyclic+acids+as+potent+and+selective+inhibitors+of+human+11%CE%B2-hydroxysteroid+dehydrogenase+type1+%2811%CE%B2-HSD-1%29&doi=10.1016%2Fj.bmcl.2011.09.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.09.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.09.055%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DX.-Y.%26aulast%3DChen%26aufirst%3DS.%2BY.%26aulast%3DNayeem%26aufirst%3DA.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHarper%26aufirst%3DT.%26aulast%3DSleczka%26aufirst%3DB.%2BG.%26aulast%3DLi%26aufirst%3DY.-X.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DKirby%26aufirst%3DM.%26aulast%3DGordon%26aufirst%3DD.%2BA.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520SAR%2520studies%2520of%2520novel%2520polycyclic%2520acids%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520human%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type1%2520%252811%25CE%25B2-HSD-1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D6699%26epage%3D6704%26doi%3D10.1016%2Fj.bmcl.2011.09.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ye, X.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayeem, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camac, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramamurthy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morin, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zebo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, N. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ponticiello, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrity, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apedo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seethala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sleczka, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, M.k</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leahy, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DiMarco, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaringe, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moulin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gordon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robl, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 2-((2<i>S</i>,6<i>S</i>)-2-phenyl-6-hydroxyadamantan-2-yl)-1-(3′-hydroxyazetidin-1-yl)ethanone [BMS-816336], an orally active novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4932</span>– <span class="NLM_lpage">4948</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00211</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00211" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4932-4948&author=X.-Y.+Yeauthor=S.+Y.+Chenauthor=S.+Wuauthor=D.+S.+Yoonauthor=H.+Wangauthor=Z.+Hongauthor=S.+P.+O%E2%80%99Connorauthor=J.+Liauthor=J.+J.+Liauthor=L.+J.+Kennedyauthor=S.+J.+Walkerauthor=A.+Nayeemauthor=S.+Sheriffauthor=D.+M.+Camacauthor=V.+Ramamurthyauthor=P.+E.+Morinauthor=R.+Zeboauthor=J.+R.+Taylorauthor=N.+N.+Morganauthor=R.+P.+Ponticielloauthor=T.+Harrityauthor=A.+Apedoauthor=R.+Gollaauthor=R.+Seethalaauthor=M.+Wangauthor=T.+W.+Harperauthor=B.+G.+Sleczkaauthor=B.+Heauthor=M.k+Kirbyauthor=D.+K.+Leahyauthor=J.+Liauthor=R.+L.+Hansonauthor=Z.+Guoauthor=Y.-X.+Liauthor=J.+D.+DiMarcoauthor=R.+Scaringeauthor=B.+Maxwellauthor=F.+Moulinauthor=J.+C.+Barrishauthor=D.+A.+Gordonauthor=J.+A.+Robl&title=Discovery+of+clinical+candidate+2-%28%282S%2C6S%29-2-phenyl-6-hydroxyadamantan-2-yl%29-1-%283%E2%80%B2-hydroxyazetidin-1-yl%29ethanone+%5BBMS-816336%5D%2C+an+orally+active+novel+selective+11%CE%B2-hydroxysteroid+dehydrogenase+type+1+inhibitor&doi=10.1021%2Facs.jmedchem.7b00211"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00211%26sid%3Dliteratum%253Aachs%26aulast%3DYe%26aufirst%3DX.-Y.%26aulast%3DChen%26aufirst%3DS.%2BY.%26aulast%3DWu%26aufirst%3DS.%26aulast%3DYoon%26aufirst%3DD.%2BS.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DS.%2BP.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DJ.%2BJ.%26aulast%3DKennedy%26aufirst%3DL.%2BJ.%26aulast%3DWalker%26aufirst%3DS.%2BJ.%26aulast%3DNayeem%26aufirst%3DA.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DCamac%26aufirst%3DD.%2BM.%26aulast%3DRamamurthy%26aufirst%3DV.%26aulast%3DMorin%26aufirst%3DP.%2BE.%26aulast%3DZebo%26aufirst%3DR.%26aulast%3DTaylor%26aufirst%3DJ.%2BR.%26aulast%3DMorgan%26aufirst%3DN.%2BN.%26aulast%3DPonticiello%26aufirst%3DR.%2BP.%26aulast%3DHarrity%26aufirst%3DT.%26aulast%3DApedo%26aufirst%3DA.%26aulast%3DGolla%26aufirst%3DR.%26aulast%3DSeethala%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHarper%26aufirst%3DT.%2BW.%26aulast%3DSleczka%26aufirst%3DB.%2BG.%26aulast%3DHe%26aufirst%3DB.%26aulast%3DKirby%26aufirst%3DM.k%26aulast%3DLeahy%26aufirst%3DD.%2BK.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DHanson%26aufirst%3DR.%2BL.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DY.-X.%26aulast%3DDiMarco%26aufirst%3DJ.%2BD.%26aulast%3DScaringe%26aufirst%3DR.%26aulast%3DMaxwell%26aufirst%3DB.%26aulast%3DMoulin%26aufirst%3DF.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DGordon%26aufirst%3DD.%2BA.%26aulast%3DRobl%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25202-%2528%25282S%252C6S%2529-2-phenyl-6-hydroxyadamantan-2-yl%2529-1-%25283%25E2%2580%25B2-hydroxyazetidin-1-yl%2529ethanone%2520%255BBMS-816336%255D%252C%2520an%2520orally%2520active%2520novel%2520selective%252011%25CE%25B2-hydroxysteroid%2520dehydrogenase%2520type%25201%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4932%26epage%3D4948%26doi%3D10.1021%2Facs.jmedchem.7b00211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamdouchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warshawsky, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Baillie, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilbur, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahl, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel
Lewis, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardona, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">CR, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neathery, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouaichi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diseroad, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweetana, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yumibe, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montrose-Rafizadeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of LY3104607: A potent and selective G protein-coupled receptor 40 (GPR40) agonist with optimized pharmacokinetic properties to support once daily oral treatment in patients with type 2 diabetes mellitus</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">934</span>– <span class="NLM_lpage">945</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=934-945&author=C.+Hamdouchiauthor=P.+Maitiauthor=A.+M.+Warshawskyauthor=A.+C.+De+Baillieauthor=K.+A.+Ottoauthor=K.+L.+Wilburauthor=S.+D.+Kahlauthor=A.+P.+Patel%0ALewisauthor=G.+R.+Cardonaauthor=R.+W.+Zinkauthor=K.+Chenauthor=S.+CRauthor=J.+P.+Lineswalaauthor=G.+L.+Neatheryauthor=C.+Bouaichiauthor=B.+A.+Diseroadauthor=A.+N.+Campbellauthor=S.+A.+Sweetanaauthor=L.+A.+Adamsauthor=O.+Cabreraauthor=X.+Maauthor=N.+P.+Yumibeauthor=C.+Montrose-Rafizadehauthor=Y.+Chenauthor=A.+R.+Miller&title=Discovery+of+LY3104607%3A+A+potent+and+selective+G+protein-coupled+receptor+40+%28GPR40%29+agonist+with+optimized+pharmacokinetic+properties+to+support+once+daily+oral+treatment+in+patients+with+type+2+diabetes+mellitus&doi=10.1021%2Facs.jmedchem.7b01411"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01411%26sid%3Dliteratum%253Aachs%26aulast%3DHamdouchi%26aufirst%3DC.%26aulast%3DMaiti%26aufirst%3DP.%26aulast%3DWarshawsky%26aufirst%3DA.%2BM.%26aulast%3DDe%2BBaillie%26aufirst%3DA.%2BC.%26aulast%3DOtto%26aufirst%3DK.%2BA.%26aulast%3DWilbur%26aufirst%3DK.%2BL.%26aulast%3DKahl%26aufirst%3DS.%2BD.%26aulast%3DPatel%2BLewis%26aufirst%3DA.%2BP.%26aulast%3DCardona%26aufirst%3DG.%2BR.%26aulast%3DZink%26aufirst%3DR.%2BW.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCR%26aufirst%3DS.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DNeathery%26aufirst%3DG.%2BL.%26aulast%3DBouaichi%26aufirst%3DC.%26aulast%3DDiseroad%26aufirst%3DB.%2BA.%26aulast%3DCampbell%26aufirst%3DA.%2BN.%26aulast%3DSweetana%26aufirst%3DS.%2BA.%26aulast%3DAdams%26aufirst%3DL.%2BA.%26aulast%3DCabrera%26aufirst%3DO.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DYumibe%26aufirst%3DN.%2BP.%26aulast%3DMontrose-Rafizadeh%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMiller%26aufirst%3DA.%2BR.%26atitle%3DDiscovery%2520of%2520LY3104607%253A%2520A%2520potent%2520and%2520selective%2520G%2520protein-coupled%2520receptor%252040%2520%2528GPR40%2529%2520agonist%2520with%2520optimized%2520pharmacokinetic%2520properties%2520to%2520support%2520once%2520daily%2520oral%2520treatment%2520in%2520patients%2520with%2520type%25202%2520diabetes%2520mellitus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D934%26epage%3D945%26doi%3D10.1021%2Facs.jmedchem.7b01411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamdouchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahl, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel Lewis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cardona, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zink, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eessalu, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ficorilli, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcelo, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilbur, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piper, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffey, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweetana, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haas, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratt, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belin, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deeg, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cannady, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yumibe, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maiti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montrose-Rafizadeh, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reifel Miller, A.</span></span> <span> </span><span class="NLM_article-title">The discovery, preclinical, and early clinical development of potent and selective GPR40 agonists for the treatment of type 2 diabetes mellitus (LY2881835, LY2922083, and LY2922470)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10891</span>– <span class="NLM_lpage">10916</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00892</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00892" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10891-10916&author=C.+Hamdouchiauthor=S.+D.+Kahlauthor=A.+Patel+Lewisauthor=G.+R.+Cardonaauthor=R.+W.+Zinkauthor=K.+Chenauthor=T.+E.+Eessaluauthor=J.+V.+Ficorilliauthor=M.+C.+Marceloauthor=K.+A.+Ottoauthor=K.+L.+Wilburauthor=J.+P.+Lineswalaauthor=J.+L.+Piperauthor=D.+S.+Coffeyauthor=S.+A.+Sweetanaauthor=J.+V.+Haasauthor=D.+A.+Brooksauthor=E.+J.+Prattauthor=R.+M.+Belinauthor=M.+A.+Deegauthor=X.+Maauthor=E.+A.+Cannadyauthor=J.+T.+Johnsonauthor=N.+P.+Yumibeauthor=Q.+Chenauthor=P.+Maitiauthor=C.+Montrose-Rafizadehauthor=Y.+Chenauthor=A.+Reifel+Miller&title=The+discovery%2C+preclinical%2C+and+early+clinical+development+of+potent+and+selective+GPR40+agonists+for+the+treatment+of+type+2+diabetes+mellitus+%28LY2881835%2C+LY2922083%2C+and+LY2922470%29&doi=10.1021%2Facs.jmedchem.6b00892"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00892&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00892%26sid%3Dliteratum%253Aachs%26aulast%3DHamdouchi%26aufirst%3DC.%26aulast%3DKahl%26aufirst%3DS.%2BD.%26aulast%3DPatel%2BLewis%26aufirst%3DA.%26aulast%3DCardona%26aufirst%3DG.%2BR.%26aulast%3DZink%26aufirst%3DR.%2BW.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DEessalu%26aufirst%3DT.%2BE.%26aulast%3DFicorilli%26aufirst%3DJ.%2BV.%26aulast%3DMarcelo%26aufirst%3DM.%2BC.%26aulast%3DOtto%26aufirst%3DK.%2BA.%26aulast%3DWilbur%26aufirst%3DK.%2BL.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DPiper%26aufirst%3DJ.%2BL.%26aulast%3DCoffey%26aufirst%3DD.%2BS.%26aulast%3DSweetana%26aufirst%3DS.%2BA.%26aulast%3DHaas%26aufirst%3DJ.%2BV.%26aulast%3DBrooks%26aufirst%3DD.%2BA.%26aulast%3DPratt%26aufirst%3DE.%2BJ.%26aulast%3DBelin%26aufirst%3DR.%2BM.%26aulast%3DDeeg%26aufirst%3DM.%2BA.%26aulast%3DMa%26aufirst%3DX.%26aulast%3DCannady%26aufirst%3DE.%2BA.%26aulast%3DJohnson%26aufirst%3DJ.%2BT.%26aulast%3DYumibe%26aufirst%3DN.%2BP.%26aulast%3DChen%26aufirst%3DQ.%26aulast%3DMaiti%26aufirst%3DP.%26aulast%3DMontrose-Rafizadeh%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DReifel%2BMiller%26aufirst%3DA.%26atitle%3DThe%2520discovery%252C%2520preclinical%252C%2520and%2520early%2520clinical%2520development%2520of%2520potent%2520and%2520selective%2520GPR40%2520agonists%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%2520mellitus%2520%2528LY2881835%252C%2520LY2922083%252C%2520and%2520LY2922470%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10891%26epage%3D10916%26doi%3D10.1021%2Facs.jmedchem.6b00892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cameron, K. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalgutkar, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salatto, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Withka, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boehm, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borzilleri, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calabrese, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caspers, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cokorinos, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowling, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmonds, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernando, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landro, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamohan, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reyes, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shavnya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolford, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and preclinical characterization of 6-chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1<i>H</i>-indole-3-carboxylic acid (PF-06409577), a direct activator of adenosine monophosphate-activated protein kinase (AMPK), for the potential treatment of diabetic nephropathy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8068</span>– <span class="NLM_lpage">8081</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00866</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00866" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8068-8081&author=K.+O.+Cameronauthor=D.+W.+Kungauthor=A.+S.+Kalgutkarauthor=R.+G.+Kurumbailauthor=R.+Millerauthor=C.+T.+Salattoauthor=J.+Wardauthor=J.+M.+Withkaauthor=S.+K.+Bhattacharyaauthor=M.+Boehmauthor=K.+A.+Borzilleriauthor=J.+A.+Brownauthor=M.+Calabreseauthor=N.+L.+Caspersauthor=E.+Cokorinosauthor=E.+L.+Connauthor=M.+S.+Dowlingauthor=D.+J.+Edmondsauthor=H.+Engauthor=D.+P.+Fernandoauthor=R.+Frisbieauthor=D.+Hepworthauthor=J.+Landroauthor=Y.+Maoauthor=F.+Rajamohanauthor=A.+R.+Reyesauthor=C.+R.+Roseauthor=T.+Ryderauthor=A.+Shavnyaauthor=A.+C.+Smithauthor=M.+Tuauthor=A.+C.+Wolfordauthor=J.+Xiao&title=Discovery+and+preclinical+characterization+of+6-chloro-5-%5B4-%281-hydroxycyclobutyl%29phenyl%5D-1H-indole-3-carboxylic+acid+%28PF-06409577%29%2C+a+direct+activator+of+adenosine+monophosphate-activated+protein+kinase+%28AMPK%29%2C+for+the+potential+treatment+of+diabetic+nephropathy&doi=10.1021%2Facs.jmedchem.6b00866"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1H-indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy</span></div><div class="casAuthors">Cameron, Kimberly O.; Kung, Daniel W.; Kalgutkar, Amit S.; Kurumbail, Ravi G.; Miller, Russell; Salatto, Christopher T.; Ward, Jessica; Withka, Jane M.; Bhattacharya, Samit K.; Boehm, Markus; Borzilleri, Kris A.; Brown, Janice A.; Calabrese, Matthew; Caspers, Nicole L.; Cokorinos, Emily; Conn, Edward L.; Dowling, Matthew S.; Edmonds, David J.; Eng, Heather; Fernando, Dilinie P.; Frisbie, Richard; Hepworth, David; Landro, James; Mao, Yuxia; Rajamohan, Francis; Reyes, Allan R.; Rose, Colin R.; Ryder, Tim; Shavnya, Andre; Smith, Aaron C.; Tu, Meihua; Wolford, Angela C.; Xiao, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8068-8081</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Adenosine monophosphate-activated protein kinase (AMPK) is a protein kinase involved in maintaining energy homeostasis within cells.  On the basis of human genetic assocn. data, AMPK activators were pursued for the treatment of diabetic nephropathy.  Identification of an indazole amide high throughput screening (HTS) hit followed by truncation to its minimal pharmacophore provided an indazole acid lead compd.  Optimization of the core and aryl appendage improved oral absorption and culminated in the identification of indole acid, PF-06409577 (7).  Compd. 7 was advanced to first-in-human trials for the treatment of diabetic nephropathy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJUC3BGd-8kbVg90H21EOLACvtfcHk0lj2tsWfCGmNjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht12gtb%252FI&md5=0b70014081c86df1cf3d713ab943d39c</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00866&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00866%26sid%3Dliteratum%253Aachs%26aulast%3DCameron%26aufirst%3DK.%2BO.%26aulast%3DKung%26aufirst%3DD.%2BW.%26aulast%3DKalgutkar%26aufirst%3DA.%2BS.%26aulast%3DKurumbail%26aufirst%3DR.%2BG.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DSalatto%26aufirst%3DC.%2BT.%26aulast%3DWard%26aufirst%3DJ.%26aulast%3DWithka%26aufirst%3DJ.%2BM.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBoehm%26aufirst%3DM.%26aulast%3DBorzilleri%26aufirst%3DK.%2BA.%26aulast%3DBrown%26aufirst%3DJ.%2BA.%26aulast%3DCalabrese%26aufirst%3DM.%26aulast%3DCaspers%26aufirst%3DN.%2BL.%26aulast%3DCokorinos%26aufirst%3DE.%26aulast%3DConn%26aufirst%3DE.%2BL.%26aulast%3DDowling%26aufirst%3DM.%2BS.%26aulast%3DEdmonds%26aufirst%3DD.%2BJ.%26aulast%3DEng%26aufirst%3DH.%26aulast%3DFernando%26aufirst%3DD.%2BP.%26aulast%3DFrisbie%26aufirst%3DR.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DLandro%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DY.%26aulast%3DRajamohan%26aufirst%3DF.%26aulast%3DReyes%26aufirst%3DA.%2BR.%26aulast%3DRose%26aufirst%3DC.%2BR.%26aulast%3DRyder%26aufirst%3DT.%26aulast%3DShavnya%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWolford%26aufirst%3DA.%2BC.%26aulast%3DXiao%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520preclinical%2520characterization%2520of%25206-chloro-5-%255B4-%25281-hydroxycyclobutyl%2529phenyl%255D-1H-indole-3-carboxylic%2520acid%2520%2528PF-06409577%2529%252C%2520a%2520direct%2520activator%2520of%2520adenosine%2520monophosphate-activated%2520protein%2520kinase%2520%2528AMPK%2529%252C%2520for%2520the%2520potential%2520treatment%2520of%2520diabetic%2520nephropathy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8068%26epage%3D8081%26doi%3D10.1021%2Facs.jmedchem.6b00866" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clairmont, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commerford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forster, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilmore, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwak, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szklennik, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tedesco, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Truong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Wu, M. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable benzimidazole diacylglycerol acyltransferase 1 (DGAT1) inhibitor that suppresses body weight gain in diet-induced obese dogs and postprandial triglycerides in humans</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4657</span>– <span class="NLM_lpage">4664</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00173</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00173" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wmt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4657-4664&author=K.+Nakajimaauthor=R.+Chatelainauthor=K.+B.+Clairmontauthor=R.+Commerfordauthor=G.+M.+Coppolaauthor=T.+Danielsauthor=C.+J.+Forsterauthor=T.+A.+Gilmoreauthor=Y.+Gongauthor=M.+Jainauthor=A.+Kanterauthor=Y.+Kwakauthor=J.+Liauthor=C.+D.+Meyersauthor=A.+D.+Neubertauthor=P.+Szklennikauthor=V.+Tedescoauthor=J.+Thompsonauthor=D.+Truongauthor=Q.+Yangauthor=B.+K.+Hubbardauthor=M.+H.+Serrano-Wu&title=Discovery+of+an+orally+bioavailable+benzimidazole+diacylglycerol+acyltransferase+1+%28DGAT1%29+inhibitor+that+suppresses+body+weight+gain+in+diet-induced+obese+dogs+and+postprandial+triglycerides+in+humans&doi=10.1021%2Facs.jmedchem.7b00173"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable Benzimidazole Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitor That Suppresses Body Weight Gain in Diet-Induced Obese Dogs and Postprandial Triglycerides in Humans</span></div><div class="casAuthors">Nakajima, Katsumasa; Chatelain, Ricardo; Clairmont, Kevin B.; Commerford, Renee; Coppola, Gary M.; Daniels, Thomas; Forster, Cornelia J.; Gilmore, Thomas A.; Gong, Yongjin; Jain, Monish; Kanter, Aaron; Kwak, Youngshin; Li, Jingzhou; Meyers, Charles D.; Neubert, Alan D.; Szklennik, Paul; Tedesco, Vivienne; Thompson, James; Truong, David; Yang, Qing; Hubbard, Brian K.; Serrano-Wu, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4657-4664</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modification of a gut restricted class of benzimidazole DGAT1 inhibitor I led to II with good oral bioavailability.  The key structural changes to I include bioisosteric replacement of the amide with oxadiazole and α,α-dimethylation of the carboxylic acid, improving DGAT1 potency and gut permeability.  Since DGAT1 is expressed in the small intestine, both I and II can suppress postprandial triglycerides during acute oral lipid challenges in rats and dogs.  Interestingly, only II was found to be effective in suppressing body wt. gain relative to control in a diet induced obese dog model, suggesting the importance of systemic inhibition of DGAT1 for body wt. control. II has advanced to clin. investigation and successfully suppressed postprandial triglycerides during an acute meal challenge in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0TGwRfGzoarVg90H21EOLACvtfcHk0lj2tsWfCGmNjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wmt7Y%253D&md5=2583c74a8cf9478075df49cacc72864b</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00173&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00173%26sid%3Dliteratum%253Aachs%26aulast%3DNakajima%26aufirst%3DK.%26aulast%3DChatelain%26aufirst%3DR.%26aulast%3DClairmont%26aufirst%3DK.%2BB.%26aulast%3DCommerford%26aufirst%3DR.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DDaniels%26aufirst%3DT.%26aulast%3DForster%26aufirst%3DC.%2BJ.%26aulast%3DGilmore%26aufirst%3DT.%2BA.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DKanter%26aufirst%3DA.%26aulast%3DKwak%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DMeyers%26aufirst%3DC.%2BD.%26aulast%3DNeubert%26aufirst%3DA.%2BD.%26aulast%3DSzklennik%26aufirst%3DP.%26aulast%3DTedesco%26aufirst%3DV.%26aulast%3DThompson%26aufirst%3DJ.%26aulast%3DTruong%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DHubbard%26aufirst%3DB.%2BK.%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%2520benzimidazole%2520diacylglycerol%2520acyltransferase%25201%2520%2528DGAT1%2529%2520inhibitor%2520that%2520suppresses%2520body%2520weight%2520gain%2520in%2520diet-induced%2520obese%2520dogs%2520and%2520postprandial%2520triglycerides%2520in%2520humans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4657%26epage%3D4664%26doi%3D10.1021%2Facs.jmedchem.7b00173" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serrano-Wu, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coppola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neubert, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatelain, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clairmont, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commerford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cosker, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juedes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mullarkey, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocheford, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sung, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, B. K.</span></span> <span> </span><span class="NLM_article-title">Intestinally targeted diacylglycerol acyltransferase 1 (DGAT1) inhibitors robustly suppress postprandial triglycerides</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1021/ml3000512</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3000512" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFWktLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=411-415&author=M.+H.+Serrano-Wuauthor=G.+M.+Coppolaauthor=Y.+Gongauthor=A.+D.+Neubertauthor=R.+Chatelainauthor=K.+B.+Clairmontauthor=R.+Commerfordauthor=T.+Coskerauthor=T.+Danielsauthor=Y.+Houauthor=M.+Jainauthor=M.+Juedesauthor=L.+Liauthor=T.+Mullarkeyauthor=E.+Rochefordauthor=M.+J.+Sungauthor=A.+Tylerauthor=Q.+Yangauthor=T.+Yoonauthor=B.+K.+Hubbard&title=Intestinally+targeted+diacylglycerol+acyltransferase+1+%28DGAT1%29+inhibitors+robustly+suppress+postprandial+triglycerides&doi=10.1021%2Fml3000512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Intestinally Targeted Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors Robustly Suppress Postprandial Triglycerides</span></div><div class="casAuthors">Serrano-Wu, Michael H.; Coppola, Gary M.; Gong, Yongjin; Neubert, Alan D.; Chatelain, Ricardo; Clairmont, Kevin B.; Commerford, Renee; Cosker, Theresa; Daniels, Thomas; Hou, Ying; Jain, Monish; Juedes, Marlene; Li, Lisha; Mullarkey, Tara; Rocheford, Erik; Sung, Moo Je; Tyler, Andrew; Yang, Qing; Yoon, Taeyoung; Hubbard, Brian K.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-415</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">High DGAT1 expression levels in the small intestine highlight the crit. role this enzyme plays in nutrient absorption.  Identification of inhibitors which predominantly inhibit DGAT1 in the gut is an attractive drug discovery strategy with anticipated benefits of reduced systemic toxicity.  In this report we describe our discovery and optimization of DGAT1 inhibitors whose plasma exposure is minimized by the action of transporters, including the P-glycoprotein transporter.  The impact of this unique absorption profile on efficacy in rat and dog efficacy models is presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0ukV18hQAlrVg90H21EOLACvtfcHk0ljjE3d02ntUtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFWktLk%253D&md5=4296446fcf69fdf96acf38156c84b950</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fml3000512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000512%26sid%3Dliteratum%253Aachs%26aulast%3DSerrano-Wu%26aufirst%3DM.%2BH.%26aulast%3DCoppola%26aufirst%3DG.%2BM.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DNeubert%26aufirst%3DA.%2BD.%26aulast%3DChatelain%26aufirst%3DR.%26aulast%3DClairmont%26aufirst%3DK.%2BB.%26aulast%3DCommerford%26aufirst%3DR.%26aulast%3DCosker%26aufirst%3DT.%26aulast%3DDaniels%26aufirst%3DT.%26aulast%3DHou%26aufirst%3DY.%26aulast%3DJain%26aufirst%3DM.%26aulast%3DJuedes%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DMullarkey%26aufirst%3DT.%26aulast%3DRocheford%26aufirst%3DE.%26aulast%3DSung%26aufirst%3DM.%2BJ.%26aulast%3DTyler%26aufirst%3DA.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DYoon%26aufirst%3DT.%26aulast%3DHubbard%26aufirst%3DB.%2BK.%26atitle%3DIntestinally%2520targeted%2520diacylglycerol%2520acyltransferase%25201%2520%2528DGAT1%2529%2520inhibitors%2520robustly%2520suppress%2520postprandial%2520triglycerides%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D411%26epage%3D415%26doi%3D10.1021%2Fml3000512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loefberg, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonsson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Unge, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Judkins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ploj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benthem, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linden, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennerberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fredenwall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gennemark, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogner, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of (3-(4-(2-oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone (AZD1979), a Melanin Concentrating Hormone Receptor 1 (MCHr1) antagonist with favorable physicochemical properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2497</span>– <span class="NLM_lpage">2511</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01654</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01654" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XktFCnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2497-2511&author=A.+Johanssonauthor=C.+Loefbergauthor=M.+Antonssonauthor=S.+von+Ungeauthor=M.+A.+Hayesauthor=R.+Judkinsauthor=K.+Plojauthor=L.+Benthemauthor=D.+Lindenauthor=P.+Brodinauthor=M.+Wennerbergauthor=M.+Fredenwallauthor=L.+Liauthor=J.+Perssonauthor=R.+Bergmanauthor=A.+Pettersenauthor=P.+Gennemarkauthor=A.+Hogner&title=Discovery+of+%283-%284-%282-oxa-6-azaspiro%5B3.3%5Dheptan-6-ylmethyl%29phenoxy%29azetidin-1-yl%29%285-%284-methoxyphenyl%29-1%2C3%2C4-oxadiazol-2-yl%29methanone+%28AZD1979%29%2C+a+Melanin+Concentrating+Hormone+Receptor+1+%28MCHr1%29+antagonist+with+favorable+physicochemical+properties&doi=10.1021%2Facs.jmedchem.5b01654"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of (3-(4-(2-Oxa-6-azaspiro[3.3]heptan-6-ylmethyl)phenoxy)azetidin-1-yl)(5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl)methanone (AZD1979), a Melanin Concentrating Hormone Receptor 1 (MCHr1) Antagonist with Favorable Physicochemical Properties</span></div><div class="casAuthors">Johansson, Anders; Loefberg, Christian; Antonsson, Madeleine; von Unge, Sverker; Hayes, Martin A.; Judkins, Robert; Ploj, Karolina; Benthem, Lambertus; Linden, Daniel; Brodin, Peter; Wennerberg, Marie; Fredenwall, Marlene; Li, Lanna; Persson, Joachim; Bergman, Rolf; Pettersen, Anna; Gennemark, Peter; Hogner, Anders</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2497-2511</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of melanin concg. hormone receptor 1 (MCHr1) antagonists were the starting point for a drug discovery program that culminated in the discovery of 103 (AZD1979).  The lead optimization program was conducted with a focus on reducing lipophilicity and understanding the physicochem. properties governing CNS exposure and undesired off-target pharmacol. such as hERG interactions.  An integrated approach was taken where the key assay was ex vivo receptor occupancy in mice.  The candidate compd. 103 displayed appropriate lipophilicity for a CNS indication and showed excellent permeability with no efflux.  Preclin. GLP toxicol. and safety pharmacol. studies were without major findings and 103 was taken into clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJJvE6-qb7C7Vg90H21EOLACvtfcHk0ljjE3d02ntUtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XktFCnsg%253D%253D&md5=98ac16f6fd4be62e681f2ebb094e985e</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01654%26sid%3Dliteratum%253Aachs%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DLoefberg%26aufirst%3DC.%26aulast%3DAntonsson%26aufirst%3DM.%26aulast%3Dvon%2BUnge%26aufirst%3DS.%26aulast%3DHayes%26aufirst%3DM.%2BA.%26aulast%3DJudkins%26aufirst%3DR.%26aulast%3DPloj%26aufirst%3DK.%26aulast%3DBenthem%26aufirst%3DL.%26aulast%3DLinden%26aufirst%3DD.%26aulast%3DBrodin%26aufirst%3DP.%26aulast%3DWennerberg%26aufirst%3DM.%26aulast%3DFredenwall%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DPersson%26aufirst%3DJ.%26aulast%3DBergman%26aufirst%3DR.%26aulast%3DPettersen%26aufirst%3DA.%26aulast%3DGennemark%26aufirst%3DP.%26aulast%3DHogner%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520%25283-%25284-%25282-oxa-6-azaspiro%255B3.3%255Dheptan-6-ylmethyl%2529phenoxy%2529azetidin-1-yl%2529%25285-%25284-methoxyphenyl%2529-1%252C3%252C4-oxadiazol-2-yl%2529methanone%2520%2528AZD1979%2529%252C%2520a%2520Melanin%2520Concentrating%2520Hormone%2520Receptor%25201%2520%2528MCHr1%2529%2520antagonist%2520with%2520favorable%2520physicochemical%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2497%26epage%3D2511%26doi%3D10.1021%2Facs.jmedchem.5b01654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, D. J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orwat, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quan, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lam, P. Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossi, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Apedo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bozarth, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toussaint, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stetsko, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudmundsson, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maxwell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crain, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lou, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harper, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chacko, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seiffert, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luettgen, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ewing, W. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of a parenteral small molecule coagulation factor XIa inhibitor clinical candidate (BMS-962212)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9703</span>– <span class="NLM_lpage">9723</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01171</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01171" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslent7bE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9703-9723&author=D.+J.+P.+Pintoauthor=M.+J.+Orwatauthor=L.+M.+Smithauthor=M.+L.+Quanauthor=P.+Y.+S.+Lamauthor=K.+A.+Rossiauthor=A.+Apedoauthor=J.+M.+Bozarthauthor=Y.+Wuauthor=J.+J.+Zhengauthor=B.+Xinauthor=N.+Toussaintauthor=P.+Stetskoauthor=O.+Gudmundssonauthor=B.+Maxwellauthor=E.+J.+Crainauthor=P.+C.+Wongauthor=Z.+Louauthor=T.+W.+Harperauthor=S.+A.+Chackoauthor=J.+E.+Myersauthor=S.+Sheriffauthor=H.+Zhangauthor=X.+Houauthor=A.+Mathurauthor=D.+A.+Seiffertauthor=R.+R.+Wexlerauthor=J.+M.+Luettgenauthor=W.+R.+Ewing&title=Discovery+of+a+parenteral+small+molecule+coagulation+factor+XIa+inhibitor+clinical+candidate+%28BMS-962212%29&doi=10.1021%2Facs.jmedchem.7b01171"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Parenteral Small Molecule Coagulation Factor XIa Inhibitor Clinical Candidate (BMS-962212)</span></div><div class="casAuthors">Pinto, Donald J. P.; Orwat, Michael J.; Smith, Leon M.; Quan, Mimi L.; Lam, Patrick Y. S.; Rossi, Karen A.; Apedo, Atsu; Bozarth, Jeffrey M.; Wu, Yiming; Zheng, Joanna J.; Xin, Baomin; Toussaint, Nathalie; Stetsko, Paul; Gudmundsson, Olafur; Maxwell, Brad; Crain, Earl J.; Wong, Pancras C.; Lou, Zhen; Harper, Timothy W.; Chacko, Silvi A.; Myers, Joseph E.; Sheriff, Steven; Zhang, Huiping; Hou, Xiaoping; Mathur, Arvind; Seiffert, Dietmar A.; Wexler, Ruth R.; Luettgen, Joseph M.; Ewing, William R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9703-9723</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Factor XIa (FXIa) is a blood coagulation enzyme that is involved in the amplification of thrombin generation.  Mounting evidence suggests that direct inhibition of FXIa can block pathol. thrombus formation while preserving normal hemostasis.  Preclin. studies using a variety of approaches to reduce FXIa activity, including direct inhibitors of FXIa, have demonstrated good antithrombotic efficacy without increasing bleeding.  Based on this potential, the authors targeted the efforts at identifying potent inhibitors of FXIa with a focus on discovering an acute antithrombotic agent for use in a hospital setting.  Herein the authors describe the discovery of a potent FXIa clin. candidate, I (FXIa Ki = 0.7 nM), with excellent preclin. efficacy in thrombosis models and aq. soly. suitable for i.v. administration.  BMS-962212 is a reversible, direct, and highly selective small mol. inhibitor of FXIa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDjxJ_bitf6rVg90H21EOLACvtfcHk0lid7zinT9eJ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslent7bE&md5=8873c054b79778fe7c45daa2eda64084</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01171&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01171%26sid%3Dliteratum%253Aachs%26aulast%3DPinto%26aufirst%3DD.%2BJ.%2BP.%26aulast%3DOrwat%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BM.%26aulast%3DQuan%26aufirst%3DM.%2BL.%26aulast%3DLam%26aufirst%3DP.%2BY.%2BS.%26aulast%3DRossi%26aufirst%3DK.%2BA.%26aulast%3DApedo%26aufirst%3DA.%26aulast%3DBozarth%26aufirst%3DJ.%2BM.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DJ.%2BJ.%26aulast%3DXin%26aufirst%3DB.%26aulast%3DToussaint%26aufirst%3DN.%26aulast%3DStetsko%26aufirst%3DP.%26aulast%3DGudmundsson%26aufirst%3DO.%26aulast%3DMaxwell%26aufirst%3DB.%26aulast%3DCrain%26aufirst%3DE.%2BJ.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DLou%26aufirst%3DZ.%26aulast%3DHarper%26aufirst%3DT.%2BW.%26aulast%3DChacko%26aufirst%3DS.%2BA.%26aulast%3DMyers%26aufirst%3DJ.%2BE.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DSeiffert%26aufirst%3DD.%2BA.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DLuettgen%26aufirst%3DJ.%2BM.%26aulast%3DEwing%26aufirst%3DW.%2BR.%26atitle%3DDiscovery%2520of%2520a%2520parenteral%2520small%2520molecule%2520coagulation%2520factor%2520XIa%2520inhibitor%2520clinical%2520candidate%2520%2528BMS-962212%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9703%26epage%3D9723%26doi%3D10.1021%2Facs.jmedchem.7b01171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Debenham, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Madsen-Duggan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clements, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, T. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuethe, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reibarkh, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salowe, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonatore, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajdu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milligan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Visco, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lingham, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stickens, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartino, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherer, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hale, J. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-[bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an orally active pan-inhibitor of hypoxia-inducible factor prolyl hydroxylase 1-3 (HIF PHD1-3) for the treatment of anemia</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">11039</span>– <span class="NLM_lpage">11049</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01242</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01242" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=11039-11049&author=J.+S.+Debenhamauthor=C.+Madsen-Dugganauthor=M.+J.+Clementsauthor=T.+F.+Walshauthor=J.+T.+Kuetheauthor=M.+Reibarkhauthor=S.+P.+Saloweauthor=L.+M.+Sonatoreauthor=R.+Hajduauthor=J.+A.+Milliganauthor=D.+M.+Viscoauthor=D.+Zhouauthor=R.+B.+Linghamauthor=D.+Stickensauthor=J.+A.+DeMartinoauthor=X.+Tongauthor=M.+Wolffauthor=J.+Pangauthor=R.+R.+Millerauthor=E.+C.+Shererauthor=J.+J.+Hale&title=Discovery+of+N-%5Bbis%284-methoxyphenyl%29methyl%5D-4-hydroxy-2-%28pyridazin-3-yl%29pyrimidine-5-carboxamide+%28MK-8617%29%2C+an+orally+active+pan-inhibitor+of+hypoxia-inducible+factor+prolyl+hydroxylase+1-3+%28HIF+PHD1-3%29+for+the+treatment+of+anemia&doi=10.1021%2Facs.jmedchem.6b01242"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia</span></div><div class="casAuthors">Debenham, John S.; Madsen-Duggan, Christina; Clements, Matthew J.; Walsh, Thomas F.; Kuethe, Jeffrey T.; Reibarkh, Mikhail; Salowe, Scott P.; Sonatore, Lisa M.; Hajdu, Richard; Milligan, James A.; Visco, Denise M.; Zhou, Dan; Lingham, Russell B.; Stickens, Dominique; DeMartino, Julie A.; Tong, Xinchun; Wolff, Michael; Pang, Jianmei; Miller, Randy R.; Sherer, Edward C.; Hale, Jeffrey J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11039-11049</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of novel 4-hydroxy-2-(heterocyclic)pyrimidine-5-carboxamide inhibitors of hypoxia-inducible factor (HIF) prolyl hydroxylases (PHD) are described.  These are potent, selective, orally bioavailable across several species and are active in stimulating erythropoiesis.  Mouse and rat studies showed hematol. changes with elevations of plasma EPO and circulating reticulocytes following single oral dose administration while 4 wk QD po administration in rat elevated Hb levels.  A major focus of the optimization process was to decrease the long half-life obsd. in higher species with early compds.  These efforts led to the identification of 28 (MK-8617) which has advanced to human clin. trials for anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhs63u66yCX7Vg90H21EOLACvtfcHk0lid7zinT9eJ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVaiurnN&md5=7acb236af3ca035b010a203f7234a5b7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01242%26sid%3Dliteratum%253Aachs%26aulast%3DDebenham%26aufirst%3DJ.%2BS.%26aulast%3DMadsen-Duggan%26aufirst%3DC.%26aulast%3DClements%26aufirst%3DM.%2BJ.%26aulast%3DWalsh%26aufirst%3DT.%2BF.%26aulast%3DKuethe%26aufirst%3DJ.%2BT.%26aulast%3DReibarkh%26aufirst%3DM.%26aulast%3DSalowe%26aufirst%3DS.%2BP.%26aulast%3DSonatore%26aufirst%3DL.%2BM.%26aulast%3DHajdu%26aufirst%3DR.%26aulast%3DMilligan%26aufirst%3DJ.%2BA.%26aulast%3DVisco%26aufirst%3DD.%2BM.%26aulast%3DZhou%26aufirst%3DD.%26aulast%3DLingham%26aufirst%3DR.%2BB.%26aulast%3DStickens%26aufirst%3DD.%26aulast%3DDeMartino%26aufirst%3DJ.%2BA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DWolff%26aufirst%3DM.%26aulast%3DPang%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DR.%2BR.%26aulast%3DSherer%26aufirst%3DE.%2BC.%26aulast%3DHale%26aufirst%3DJ.%2BJ.%26atitle%3DDiscovery%2520of%2520N-%255Bbis%25284-methoxyphenyl%2529methyl%255D-4-hydroxy-2-%2528pyridazin-3-yl%2529pyrimidine-5-carboxamide%2520%2528MK-8617%2529%252C%2520an%2520orally%2520active%2520pan-inhibitor%2520of%2520hypoxia-inducible%2520factor%2520prolyl%2520hydroxylase%25201-3%2520%2528HIF%2520PHD1-3%2529%2520for%2520the%2520treatment%2520of%2520anemia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D11039%26epage%3D11049%26doi%3D10.1021%2Facs.jmedchem.6b01242" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Desroy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housseman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joncour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labeguere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rondet, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassot, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Picolet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annoot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjardet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakselman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncoroni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tallec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanque, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottereaux, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandervoort, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auberval, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrvacic, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ralic, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oste, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Aar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckmann, B.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-<i>a</i>]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a first-in-class autotaxin inhibitor undergoing clinical evaluation for the treatment of idiopathic pulmonary fibrosis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3580</span>– <span class="NLM_lpage">3590</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00032</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00032" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtFCntL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3580-3590&author=N.+Desroyauthor=C.+Houssemanauthor=X.+Bockauthor=A.+Joncourauthor=N.+Bienvenuauthor=L.+Cherelauthor=V.+Labeguereauthor=E.+Rondetauthor=C.+Peixotoauthor=J.-M.+Grassotauthor=O.+Picoletauthor=D.+Annootauthor=N.+Triballeauauthor=A.+Monjardetauthor=E.+Wakselmanauthor=V.+Roncoroniauthor=S.+Le+Tallecauthor=R.+Blanqueauthor=C.+Cottereauxauthor=N.+Vandervoortauthor=T.+Christopheauthor=P.+Mollatauthor=M.+Lamersauthor=M.+Aubervalauthor=B.+Hrvacicauthor=J.+Ralicauthor=L.+Osteauthor=E.+van+der%0AAarauthor=R.+Brysauthor=B.+Heckmann&title=Discovery+of+2-%5B%5B2-ethyl-6-%5B4-%5B2-%283-hydroxyazetidin-1-yl%29-2-oxoethyl%5Dpiperazin-1-yl%5D-8-methylimidazo%5B1%2C2-a%5Dpyridin-3-yl%5Dmethylamino%5D-4-%284-fluorophenyl%29thiazole-5-carbonitrile+%28GLPG1690%29%2C+a+first-in-class+autotaxin+inhibitor+undergoing+clinical+evaluation+for+the+treatment+of+idiopathic+pulmonary+fibrosis&doi=10.1021%2Facs.jmedchem.7b00032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis</span></div><div class="casAuthors">Desroy, Nicolas; Housseman, Christopher; Bock, Xavier; Joncour, Agnes; Bienvenu, Natacha; Cherel, Laetitia; Labeguere, Virginie; Rondet, Emilie; Peixoto, Christophe; Grassot, Jean-Marie; Picolet, Olivier; Annoot, Denis; Triballeau, Nicolas; Monjardet, Alain; Wakselman, Emanuelle; Roncoroni, Veronique; Le Tallec, Sandrine; Blanque, Roland; Cottereaux, Celine; Vandervoort, Nele; Christophe, Thierry; Mollat, Patrick; Lamers, Marieke; Auberval, Marielle; Hrvacic, Boska; Ralic, Jovica; Oste, Line; van der Aar, Ellen; Brys, Reginald; Heckmann, Bertrand</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3580-3590</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin is a circulating enzyme with a major role in the prodn. of lysophosphatic acid (LPA) species in blood.  A role for the autotaxin/LPA axis has been suggested in many disease areas including pulmonary fibrosis.  Structural modifications of the known autotaxin inhibitor lead compd. 1, to attenuate hERG inhibition, remove CYP3A4 time-dependent inhibition, and improve pharmacokinetic properties, led to the identification of clin. candidate GLPG1690 (11).  Compd. 11 was able to cause a sustained redn. of LPA levels in plasma in vivo and was shown to be efficacious in a bleomycin-induced pulmonary fibrosis model in mice and in reducing extracellular matrix deposition in the lung while also reducing LPA 18:2 content in bronchoalveolar lavage fluid.  Compd. 11 is currently being evaluated in an exploratory phase 2a study in idiopathic pulmonary fibrosis patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMGaRp0Gq5ErVg90H21EOLACvtfcHk0lhtKt_4dddLWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtFCntL8%253D&md5=1038c79f5085e5719e9f1f2141941bb6</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00032%26sid%3Dliteratum%253Aachs%26aulast%3DDesroy%26aufirst%3DN.%26aulast%3DHousseman%26aufirst%3DC.%26aulast%3DBock%26aufirst%3DX.%26aulast%3DJoncour%26aufirst%3DA.%26aulast%3DBienvenu%26aufirst%3DN.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DLabeguere%26aufirst%3DV.%26aulast%3DRondet%26aufirst%3DE.%26aulast%3DPeixoto%26aufirst%3DC.%26aulast%3DGrassot%26aufirst%3DJ.-M.%26aulast%3DPicolet%26aufirst%3DO.%26aulast%3DAnnoot%26aufirst%3DD.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3DMonjardet%26aufirst%3DA.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DRoncoroni%26aufirst%3DV.%26aulast%3DLe%2BTallec%26aufirst%3DS.%26aulast%3DBlanque%26aufirst%3DR.%26aulast%3DCottereaux%26aufirst%3DC.%26aulast%3DVandervoort%26aufirst%3DN.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DMollat%26aufirst%3DP.%26aulast%3DLamers%26aufirst%3DM.%26aulast%3DAuberval%26aufirst%3DM.%26aulast%3DHrvacic%26aufirst%3DB.%26aulast%3DRalic%26aufirst%3DJ.%26aulast%3DOste%26aufirst%3DL.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DHeckmann%26aufirst%3DB.%26atitle%3DDiscovery%2520of%25202-%255B%255B2-ethyl-6-%255B4-%255B2-%25283-hydroxyazetidin-1-yl%2529-2-oxoethyl%255Dpiperazin-1-yl%255D-8-methylimidazo%255B1%252C2-a%255Dpyridin-3-yl%255Dmethylamino%255D-4-%25284-fluorophenyl%2529thiazole-5-carbonitrile%2520%2528GLPG1690%2529%252C%2520a%2520first-in-class%2520autotaxin%2520inhibitor%2520undergoing%2520clinical%2520evaluation%2520for%2520the%2520treatment%2520of%2520idiopathic%2520pulmonary%2520fibrosis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3580%26epage%3D3590%26doi%3D10.1021%2Facs.jmedchem.7b00032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Joncour, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desroy, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Housseman, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bienvenu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labeguere, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Annoot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepissier, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hengeveld, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilzak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monjardet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakselman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roncoroni, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Tallec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galien, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandervoort, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christophe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conrath, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jans, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wohlkonig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soror, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steyaert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Touitou, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleury, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercheval, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollat, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Triballeau, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Aar, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brys, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckmann, B.</span></span> <span> </span><span class="NLM_article-title">Discovery, structure-activity relationship, and binding mode of an imidazo[1,2-<i>a</i>]pyridine series of autotaxin inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7371</span>– <span class="NLM_lpage">7392</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1WitLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7371-7392&author=A.+Joncourauthor=N.+Desroyauthor=C.+Houssemanauthor=X.+Bockauthor=N.+Bienvenuauthor=L.+Cherelauthor=V.+Labeguereauthor=C.+Peixotoauthor=D.+Annootauthor=L.+Lepissierauthor=J.+Heiermannauthor=W.+J.+Hengeveldauthor=G.+Pilzakauthor=A.+Monjardetauthor=E.+Wakselmanauthor=V.+Roncoroniauthor=S.+Le+Tallecauthor=R.+Galienauthor=C.+Davidauthor=N.+Vandervoortauthor=T.+Christopheauthor=K.+Conrathauthor=M.+Jansauthor=A.+Wohlkonigauthor=S.+Sororauthor=J.+Steyaertauthor=R.+Touitouauthor=D.+Fleuryauthor=L.+Verchevalauthor=P.+Mollatauthor=N.+Triballeauauthor=E.+van+der+Aarauthor=R.+Brysauthor=B.+Heckmann&title=Discovery%2C+structure-activity+relationship%2C+and+binding+mode+of+an+imidazo%5B1%2C2-a%5Dpyridine+series+of+autotaxin+inhibitors&doi=10.1021%2Facs.jmedchem.7b00647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors</span></div><div class="casAuthors">Joncour, Agnes; Desroy, Nicolas; Housseman, Christopher; Bock, Xavier; Bienvenu, Natacha; Cherel, Laetitia; Labeguere, Virginie; Peixoto, Christophe; Annoot, Denis; Lepissier, Luce; Heiermann, Jorg; Hengeveld, Willem Jan; Pilzak, Gregor; Monjardet, Alain; Wakselman, Emanuelle; Roncoroni, Veronique; Le Tallec, Sandrine; Galien, Rene; David, Christelle; Vandervoort, Nele; Christophe, Thierry; Conrath, Katja; Jans, Mia; Wohlkonig, Alexandre; Soror, Sameh; Steyaert, Jan; Touitou, Robert; Fleury, Damien; Vercheval, Lionel; Mollat, Patrick; Triballeau, Nicolas; van der Aar, Ellen; Brys, Reginald; Heckmann, Bertrand</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7371-7392</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Autotaxin (ATX) is a secreted enzyme playing a major role in the prodn. of lysophosphatidic acid (LPA) in blood through hydrolysis of lysophosphatidyl choline (LPC).  The ATX-LPA signaling axis arouses a high interest in the drug discovery industry as it has been implicated in several diseases including cancer, fibrotic diseases and inflammation among others.  An imidazo[1,2-a]pyridine series of ATX inhibitors was identified out of a high throughput screening (HTS).  A co-crystal structure with one of these compds. and ATX revealed a novel binding mode with occupancy of the hydrophobic pocket and channel of ATX but no interaction with zinc ions of the catalytic site.  Exploration of the structure-activity relationship led to compds. displaying high activity in biochem. and plasma assays, exemplified by compd. I.  Compd. I was also able to decrease the plasma LPA levels upon oral administration to rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpY6dK8UCSEyLVg90H21EOLACvtfcHk0lhtKt_4dddLWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1WitLvN&md5=2c08b3017e0bc0183c9e8e1911ddab0d</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00647%26sid%3Dliteratum%253Aachs%26aulast%3DJoncour%26aufirst%3DA.%26aulast%3DDesroy%26aufirst%3DN.%26aulast%3DHousseman%26aufirst%3DC.%26aulast%3DBock%26aufirst%3DX.%26aulast%3DBienvenu%26aufirst%3DN.%26aulast%3DCherel%26aufirst%3DL.%26aulast%3DLabeguere%26aufirst%3DV.%26aulast%3DPeixoto%26aufirst%3DC.%26aulast%3DAnnoot%26aufirst%3DD.%26aulast%3DLepissier%26aufirst%3DL.%26aulast%3DHeiermann%26aufirst%3DJ.%26aulast%3DHengeveld%26aufirst%3DW.%2BJ.%26aulast%3DPilzak%26aufirst%3DG.%26aulast%3DMonjardet%26aufirst%3DA.%26aulast%3DWakselman%26aufirst%3DE.%26aulast%3DRoncoroni%26aufirst%3DV.%26aulast%3DLe%2BTallec%26aufirst%3DS.%26aulast%3DGalien%26aufirst%3DR.%26aulast%3DDavid%26aufirst%3DC.%26aulast%3DVandervoort%26aufirst%3DN.%26aulast%3DChristophe%26aufirst%3DT.%26aulast%3DConrath%26aufirst%3DK.%26aulast%3DJans%26aufirst%3DM.%26aulast%3DWohlkonig%26aufirst%3DA.%26aulast%3DSoror%26aufirst%3DS.%26aulast%3DSteyaert%26aufirst%3DJ.%26aulast%3DTouitou%26aufirst%3DR.%26aulast%3DFleury%26aufirst%3DD.%26aulast%3DVercheval%26aufirst%3DL.%26aulast%3DMollat%26aufirst%3DP.%26aulast%3DTriballeau%26aufirst%3DN.%26aulast%3Dvan%2Bder%2BAar%26aufirst%3DE.%26aulast%3DBrys%26aufirst%3DR.%26aulast%3DHeckmann%26aufirst%3DB.%26atitle%3DDiscovery%252C%2520structure-activity%2520relationship%252C%2520and%2520binding%2520mode%2520of%2520an%2520imidazo%255B1%252C2-a%255Dpyridine%2520series%2520of%2520autotaxin%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7371%26epage%3D7392%26doi%3D10.1021%2Facs.jmedchem.7b00647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lönn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Käck, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van de Poël, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swallow, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardiner, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Connolly, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Root, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wikell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenvall, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johannesson, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of second generation reversible covalent DPPP1 inhibitors leading to an oxazepan amdidoacetonitrile based clinical candidate (AZD7986)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9457</span>– <span class="NLM_lpage">9472</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9457-9472&author=K.+Doyleauthor=H.+L%C3%B6nnauthor=H.+K%C3%A4ckauthor=A.+Van+de+Po%C3%ABlauthor=S.+Swallowauthor=P.+Gardinerauthor=S.+Connollyauthor=J.+Rootauthor=C.+Wikellauthor=G.+Dahlauthor=K.+Stenvallauthor=P.+Johannesson&title=Discovery+of+second+generation+reversible+covalent+DPPP1+inhibitors+leading+to+an+oxazepan+amdidoacetonitrile+based+clinical+candidate+%28AZD7986%29&doi=10.1021%2Facs.jmedchem.6b01127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01127%26sid%3Dliteratum%253Aachs%26aulast%3DDoyle%26aufirst%3DK.%26aulast%3DL%25C3%25B6nn%26aufirst%3DH.%26aulast%3DK%25C3%25A4ck%26aufirst%3DH.%26aulast%3DVan%2Bde%2BPo%25C3%25ABl%26aufirst%3DA.%26aulast%3DSwallow%26aufirst%3DS.%26aulast%3DGardiner%26aufirst%3DP.%26aulast%3DConnolly%26aufirst%3DS.%26aulast%3DRoot%26aufirst%3DJ.%26aulast%3DWikell%26aufirst%3DC.%26aulast%3DDahl%26aufirst%3DG.%26aulast%3DStenvall%26aufirst%3DK.%26aulast%3DJohannesson%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520second%2520generation%2520reversible%2520covalent%2520DPPP1%2520inhibitors%2520leading%2520to%2520an%2520oxazepan%2520amdidoacetonitrile%2520based%2520clinical%2520candidate%2520%2528AZD7986%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9457%26epage%3D9472%26doi%3D10.1021%2Facs.jmedchem.6b01127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Biggadike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ball, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalmas
Wilk, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbon, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hardy, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermitage, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hessey, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hillegas, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarides, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewell, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallett, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priest, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quint, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sitaram, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trivedi, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsitoura, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weller, V.</span></span> <span> </span><span class="NLM_article-title">Discovery of 6-amino-2-{[(1<i>S</i>)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a highly potent and selective intranasal Toll-Like Receptor 7 agonist for the treatment of asthma</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1711</span>– <span class="NLM_lpage">1726</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit1aksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1711-1726&author=K.+Biggadikeauthor=M.+Ahmedauthor=D.+I.+Ballauthor=D.+M.+Coeauthor=D.+A.+Dalmas%0AWilkauthor=C.+D.+Edwardsauthor=B.+H.+Gibbonauthor=C.+J.+Hardyauthor=S.+A.+Hermitageauthor=J.+O.+Hesseyauthor=A.+E.+Hillegasauthor=S.+C.+Hughesauthor=L.+Lazaridesauthor=X.+Q.+Lewellauthor=A.+Lucasauthor=D.+N.+Mallettauthor=M.+A.+Priceauthor=F.+M.+Priestauthor=D.+J.+Quintauthor=P.+Shahauthor=A.+Sitaramauthor=S.+A.+Smithauthor=R.+Stockerauthor=N.+A.+Trivediauthor=D.+C.+Tsitouraauthor=V.+Weller&title=Discovery+of+6-amino-2-%7B%5B%281S%29-1-methylbutyl%5Doxy%7D-9-%5B5-%281-piperidinyl%29pentyl%5D-7%2C9-dihydro-8H-purin-8-one+%28GSK2245035%29%2C+a+highly+potent+and+selective+intranasal+Toll-Like+Receptor+7+agonist+for+the+treatment+of+asthma&doi=10.1021%2Facs.jmedchem.5b01647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 6-Amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)pentyl]-7,9-dihydro-8H-purin-8-one (GSK2245035), a Highly Potent and Selective Intranasal Toll-Like Receptor 7 Agonist for the Treatment of Asthma</span></div><div class="casAuthors">Biggadike, Keith; Ahmed, Mahbub; Ball, Doug I.; Coe, Diane M.; Dalmas Wilk, Deidre A.; Edwards, Chris D.; Gibbon, Bob H.; Hardy, Charlotte J.; Hermitage, Stephen A.; Hessey, Joanne O.; Hillegas, Aimee E.; Hughes, Stephen C.; Lazarides, Linos; Lewell, Xiao Q.; Lucas, Amanda; Mallett, David N.; Price, Mark A.; Priest, Fiona M.; Quint, Diana J.; Shah, Poonam; Sitaram, Anesh; Smith, Stephen A.; Stocker, Richard; Trivedi, Naimisha A.; Tsitoura, Daphne C.; Weller, Victoria</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1711-1726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Induction of IFNα in the upper airways via activation of TLR7 represents a novel immunomodulatory approach to the treatment of allergic asthma.  Exploration of 8-oxoadenine derivs. bearing satd. oxygen or nitrogen heterocycles in the N-9 substituent has revealed a remarkable selective enhancement in IFNα inducing potency in the nitrogen series.  Further potency enhancement was achieved with the novel (S)-pentyloxy substitution at C-2 leading to the selection of GSK2245035 (32) as an intranasal development candidate.  In human cell cultures, compd. 32 resulted in suppression of Th2 cytokine responses to allergens, while in vivo intranasal administration at very low doses led to local upregulation of TLR7-mediated cytokines (IP-10).  Target engagement was confirmed in humans following single intranasal doses of 32 of ≥20 ng, and reproducible pharmacol. response was demonstrated following repeat intranasal dosing at weekly intervals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFXegjfTmmgLVg90H21EOLACvtfcHk0lgghajWxKOOGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit1aksrk%253D&md5=adab143ac46a049054d9ee4f52cf6292</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01647%26sid%3Dliteratum%253Aachs%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DAhmed%26aufirst%3DM.%26aulast%3DBall%26aufirst%3DD.%2BI.%26aulast%3DCoe%26aufirst%3DD.%2BM.%26aulast%3DDalmas%2BWilk%26aufirst%3DD.%2BA.%26aulast%3DEdwards%26aufirst%3DC.%2BD.%26aulast%3DGibbon%26aufirst%3DB.%2BH.%26aulast%3DHardy%26aufirst%3DC.%2BJ.%26aulast%3DHermitage%26aufirst%3DS.%2BA.%26aulast%3DHessey%26aufirst%3DJ.%2BO.%26aulast%3DHillegas%26aufirst%3DA.%2BE.%26aulast%3DHughes%26aufirst%3DS.%2BC.%26aulast%3DLazarides%26aufirst%3DL.%26aulast%3DLewell%26aufirst%3DX.%2BQ.%26aulast%3DLucas%26aufirst%3DA.%26aulast%3DMallett%26aufirst%3DD.%2BN.%26aulast%3DPrice%26aufirst%3DM.%2BA.%26aulast%3DPriest%26aufirst%3DF.%2BM.%26aulast%3DQuint%26aufirst%3DD.%2BJ.%26aulast%3DShah%26aufirst%3DP.%26aulast%3DSitaram%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DS.%2BA.%26aulast%3DStocker%26aufirst%3DR.%26aulast%3DTrivedi%26aufirst%3DN.%2BA.%26aulast%3DTsitoura%26aufirst%3DD.%2BC.%26aulast%3DWeller%26aufirst%3DV.%26atitle%3DDiscovery%2520of%25206-amino-2-%257B%255B%25281S%2529-1-methylbutyl%255Doxy%257D-9-%255B5-%25281-piperidinyl%2529pentyl%255D-7%252C9-dihydro-8H-purin-8-one%2520%2528GSK2245035%2529%252C%2520a%2520highly%2520potent%2520and%2520selective%2520intranasal%2520Toll-Like%2520Receptor%25207%2520agonist%2520for%2520the%2520treatment%2520of%2520asthma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1711%26epage%3D1726%26doi%3D10.1021%2Facs.jmedchem.5b01647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elzein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koltun, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhill, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corkey, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notte, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataramani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guerrero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Bizri, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirakawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahlig, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhalla, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soohoo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lepist, E.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rhodes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belardinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, M. C.</span></span> <span> </span><span class="NLM_article-title">Discovery of dihydrobenzoxazepinone (GS-6615) late sodium current inhibitor (Late <i>I</i><sub>Na</sub>i), a phase II agent with demonstrated preclinical anti-ischemic and antiarrhythmic properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9005</span>– <span class="NLM_lpage">9017</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00939</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00939" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9005-9017&author=J.+A.+Zablockiauthor=E.+Elzeinauthor=X.+Liauthor=D.+O.+Koltunauthor=E.+Q.+Parkhillauthor=T.+Kobayashiauthor=R.+Martinezauthor=B.+Corkeyauthor=H.+Jiangauthor=T.+Perryauthor=R.+Kallaauthor=G.+T.+Notteauthor=O.+Saundersauthor=M.+Graupeauthor=Y.+Luauthor=C.+Venkataramaniauthor=J.+Guerreroauthor=J.+Perryauthor=M.+Osierauthor=R.+Strickleyauthor=G.+Liuauthor=W.-Q.+Wangauthor=L.+Huauthor=X.-J.+Liauthor=N.+El-Bizriauthor=R.+Hirakawaauthor=K.+Kahligauthor=C.+Xieauthor=C.+H.+Liauthor=A.+K.+Dhallaauthor=S.+Rajamaniauthor=N.+Mollovaauthor=D.+Soohooauthor=E.-I.+Lepistauthor=B.+Murrayauthor=G.+Rhodesauthor=L.+Belardinelliauthor=M.+C.+Desai&title=Discovery+of+dihydrobenzoxazepinone+%28GS-6615%29+late+sodium+current+inhibitor+%28Late+INai%29%2C+a+phase+II+agent+with+demonstrated+preclinical+anti-ischemic+and+antiarrhythmic+properties&doi=10.1021%2Facs.jmedchem.6b00939"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00939%26sid%3Dliteratum%253Aachs%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DKoltun%26aufirst%3DD.%2BO.%26aulast%3DParkhill%26aufirst%3DE.%2BQ.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DCorkey%26aufirst%3DB.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DPerry%26aufirst%3DT.%26aulast%3DKalla%26aufirst%3DR.%26aulast%3DNotte%26aufirst%3DG.%2BT.%26aulast%3DSaunders%26aufirst%3DO.%26aulast%3DGraupe%26aufirst%3DM.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DVenkataramani%26aufirst%3DC.%26aulast%3DGuerrero%26aufirst%3DJ.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DOsier%26aufirst%3DM.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DW.-Q.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.-J.%26aulast%3DEl-Bizri%26aufirst%3DN.%26aulast%3DHirakawa%26aufirst%3DR.%26aulast%3DKahlig%26aufirst%3DK.%26aulast%3DXie%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DC.%2BH.%26aulast%3DDhalla%26aufirst%3DA.%2BK.%26aulast%3DRajamani%26aufirst%3DS.%26aulast%3DMollova%26aufirst%3DN.%26aulast%3DSoohoo%26aufirst%3DD.%26aulast%3DLepist%26aufirst%3DE.-I.%26aulast%3DMurray%26aufirst%3DB.%26aulast%3DRhodes%26aufirst%3DG.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DDesai%26aufirst%3DM.%2BC.%26atitle%3DDiscovery%2520of%2520dihydrobenzoxazepinone%2520%2528GS-6615%2529%2520late%2520sodium%2520current%2520inhibitor%2520%2528Late%2520INai%2529%252C%2520a%2520phase%2520II%2520agent%2520with%2520demonstrated%2520preclinical%2520anti-ischemic%2520and%2520antiarrhythmic%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9005%26epage%3D9017%26doi%3D10.1021%2Facs.jmedchem.6b00939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Koltun, D. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkhill, E. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elzein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notte, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avila, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith-Maxwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhalla, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stafford, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belardinelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zablocki, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of triazolopyridinone GS-462808, a late sodium current inhibitor (Late <i>I</i><sub>Na</sub>i) of the cardiac Nav1.5 channel with improved efficacy and potency relative to ranolazine</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3202</span>– <span class="NLM_lpage">3206</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.03.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2016.03.101" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3202-3206&author=D.+O.+Koltunauthor=E.+Q.+Parkhillauthor=E.+Elzeinauthor=T.+Kobayashiauthor=G.+T.+Notteauthor=R.+Kallaauthor=R.+H.+Jiangauthor=X.+Liauthor=T.+D.+Perryauthor=B.+Avilaauthor=W.-Q.+Wangauthor=C.+Smith-Maxwellauthor=A.+K.+Dhallaauthor=S.+Rajamaniauthor=B.+Staffordauthor=J.+Tangauthor=N.+Mollovaauthor=L.+Belardinelliauthor=J.+A.+Zablocki&title=Discovery+of+triazolopyridinone+GS-462808%2C+a+late+sodium+current+inhibitor+%28Late+INai%29+of+the+cardiac+Nav1.5+channel+with+improved+efficacy+and+potency+relative+to+ranolazine&doi=10.1016%2Fj.bmcl.2016.03.101"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.03.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.03.101%26sid%3Dliteratum%253Aachs%26aulast%3DKoltun%26aufirst%3DD.%2BO.%26aulast%3DParkhill%26aufirst%3DE.%2BQ.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DNotte%26aufirst%3DG.%2BT.%26aulast%3DKalla%26aufirst%3DR.%26aulast%3DJiang%26aufirst%3DR.%2BH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DPerry%26aufirst%3DT.%2BD.%26aulast%3DAvila%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DW.-Q.%26aulast%3DSmith-Maxwell%26aufirst%3DC.%26aulast%3DDhalla%26aufirst%3DA.%2BK.%26aulast%3DRajamani%26aufirst%3DS.%26aulast%3DStafford%26aufirst%3DB.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DMollova%26aufirst%3DN.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520triazolopyridinone%2520GS-462808%252C%2520a%2520late%2520sodium%2520current%2520inhibitor%2520%2528Late%2520INai%2529%2520of%2520the%2520cardiac%2520Nav1.5%2520channel%2520with%2520improved%2520efficacy%2520and%2520potency%2520relative%2520to%2520ranolazine%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3202%26epage%3D3206%26doi%3D10.1016%2Fj.bmcl.2016.03.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gunaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mummadi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhondi, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hennan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subray, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayaram, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajugowda, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, K. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumaraguru, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandal, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beldona, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adisechen, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yadav, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warrier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sale, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Putlur, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimalakonda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandlekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conder, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampulla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, H. J.</span></span> <span> </span><span class="NLM_article-title">Selective I<sub>Kur</sub> inhibitors for the potential treatment of atrial fibrillation: optimization of the phenyl quinazoline series leading to clinical candidate 5-[5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3795</span>– <span class="NLM_lpage">3803</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01889</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01889" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmt1amurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3795-3803&author=P.+Gunagaauthor=J.+Lloydauthor=S.+Mummadiauthor=A.+Banerjeeauthor=N.+K.+Dhondiauthor=J.+Hennanauthor=V.+Subrayauthor=R.+Jayaramauthor=N.+Rajugowdaauthor=K.+U.+Reddyauthor=D.+Kumaraguruauthor=U.+Mandalauthor=D.+Beldonaauthor=A.+K.+Adisechenauthor=N.+Yadavauthor=J.+Warrierauthor=J.+A.+Johnsonauthor=H.+Saleauthor=S.+P.+Putlurauthor=A.+Saxenaauthor=A.+Chimalakondaauthor=S.+Mandlekarauthor=M.+Conderauthor=D.+Xingauthor=A.+K.+Guptaauthor=A.+Guptaauthor=R.+Rampullaauthor=A.+Mathurauthor=P.+Levesqueauthor=R.+R.+Wexlerauthor=H.+J.+Finlay&title=Selective+IKur+inhibitors+for+the+potential+treatment+of+atrial+fibrillation%3A+optimization+of+the+phenyl+quinazoline+series+leading+to+clinical+candidate+5-%5B5-phenyl-4-%28pyridin-2-ylmethylamino%29quinazolin-2-yl%5Dpyridine-3-sulfonamide&doi=10.1021%2Facs.jmedchem.6b01889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Selective IKur Inhibitors for the Potential Treatment of Atrial Fibrillation: Optimization of the Phenyl Quinazoline Series Leading to Clinical Candidate 5-[5-Phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl]pyridine-3-sulfonamide</span></div><div class="casAuthors">Gunaga, Prashantha; Lloyd, John; Mummadi, Somanadham; Banerjee, Abhisek; Dhondi, Naveen Kumar; Hennan, James; Subray, Veena; Jayaram, Ramya; Rajugowda, Nagendra; Umamaheshwar Reddy, Kommuri; Kumaraguru, Duraimurugan; Mandal, Umasankar; Beldona, Dasthagiri; Adisechen, Ashok Kumar; Yadav, Navnath; Warrier, Jayakumar; Johnson, James A.; Sale, Harinath; Putlur, Siva Prasad; Saxena, Ajay; Chimalakonda, Anjaneya; Mandlekar, Sandhya; Conder, MaryLee; Xing, Dezhi; Gupta, Arun Kumar; Gupta, Anuradha; Rampulla, Richard; Mathur, Arvind; Levesque, Paul; Wexler, Ruth R.; Finlay, Heather J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3795-3803</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have recently disclosed 5-phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine (I) as a potent IKur current blocker with selectivity vs. hERG, Na and Ca channels and an acceptable preclin. PK profile.  On further characterization in vivo, Compd. I demonstrated an unacceptable level of brain penetration.  In an effort to reduce the level of brain penetration while maintaining the overall profile, SAR was developed at the C2' position for a series of close analogs by employing hydrogen bond donors.  As a result, 5-(5-phenyl-4-(pyridin-2-ylmethylamino)quinazolin-2-yl)pyridine-3-sulfonamide (II) was identified as the lead compd. in this series.  Compd. II showed robust effects in rabbit and canine pharmacodynamic models and an acceptable cross-species pharmacokinetic profile and was advanced as the clin. candidate.  Further optimization of II to mitigate pH dependent absorption resulted in identification of the corresponding phosphoramide prodrug (29) with an improved soly. and pharmacokinetic profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrV9CqURuGN1bVg90H21EOLACvtfcHk0lhxLYzHvlZwsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmt1amurY%253D&md5=b7ed8bdb99e632bcd42107f2b913d7e8</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01889%26sid%3Dliteratum%253Aachs%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DLloyd%26aufirst%3DJ.%26aulast%3DMummadi%26aufirst%3DS.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DDhondi%26aufirst%3DN.%2BK.%26aulast%3DHennan%26aufirst%3DJ.%26aulast%3DSubray%26aufirst%3DV.%26aulast%3DJayaram%26aufirst%3DR.%26aulast%3DRajugowda%26aufirst%3DN.%26aulast%3DReddy%26aufirst%3DK.%2BU.%26aulast%3DKumaraguru%26aufirst%3DD.%26aulast%3DMandal%26aufirst%3DU.%26aulast%3DBeldona%26aufirst%3DD.%26aulast%3DAdisechen%26aufirst%3DA.%2BK.%26aulast%3DYadav%26aufirst%3DN.%26aulast%3DWarrier%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26aulast%3DSale%26aufirst%3DH.%26aulast%3DPutlur%26aufirst%3DS.%2BP.%26aulast%3DSaxena%26aufirst%3DA.%26aulast%3DChimalakonda%26aufirst%3DA.%26aulast%3DMandlekar%26aufirst%3DS.%26aulast%3DConder%26aufirst%3DM.%26aulast%3DXing%26aufirst%3DD.%26aulast%3DGupta%26aufirst%3DA.%2BK.%26aulast%3DGupta%26aufirst%3DA.%26aulast%3DRampulla%26aufirst%3DR.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DLevesque%26aufirst%3DP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26atitle%3DSelective%2520IKur%2520inhibitors%2520for%2520the%2520potential%2520treatment%2520of%2520atrial%2520fibrillation%253A%2520optimization%2520of%2520the%2520phenyl%2520quinazoline%2520series%2520leading%2520to%2520clinical%2520candidate%25205-%255B5-phenyl-4-%2528pyridin-2-ylmethylamino%2529quinazolin-2-yl%255Dpyridine-3-sulfonamide%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3795%26epage%3D3803%26doi%3D10.1021%2Facs.jmedchem.6b01889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Finlay, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neels, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhondi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chimalakonda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mandlekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conder, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sale, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xing, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wexler, R. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of 5-phenyl-<i>N</i>-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a potent I<sub>Kur</sub> inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">831</span>– <span class="NLM_lpage">834</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00117</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00117" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFejsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=831-834&author=H.+J.+Finlayauthor=J.+A.+Johnsonauthor=J.+L.+Lloydauthor=J.+Jiangauthor=J.+Neelsauthor=P.+Gunagaauthor=A.+Banerjeeauthor=N.+Dhondiauthor=A.+Chimalakondaauthor=S.+Mandlekarauthor=M.+L.+Conderauthor=H.+Saleauthor=D.+Xingauthor=P.+Levesqueauthor=R.+R.+Wexler&title=Discovery+of+5-phenyl-N-%28pyridin-2-ylmethyl%29-2-%28pyrimidin-5-yl%29quinazolin-4-amine+as+a+potent+IKur+inhibitor&doi=10.1021%2Facsmedchemlett.6b00117"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine as a Potent IKur Inhibitor</span></div><div class="casAuthors">Finlay, Heather J.; Johnson, James A.; Lloyd, John L.; Jiang, Ji; Neels, James; Gunaga, Prashantha; Banerjee, Abhisek; Dhondi, Naveen; Chimalakonda, Anjaneya; Mandlekar, Sandhya; Conder, Mary Lee; Sale, Harinath; Xing, Dezhi; Levesque, Paul; Wexler, Ruth R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">831-834</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of phenylquinazoline inhibitors of Kv 1.5 is disclosed.  The series was optimized for Kv 1.5 potency, selectivity vs. hERG, pharmacokinetic exposure, and pharmacodynamic potency. 5-Phenyl-N-(pyridin-2-ylmethyl)-2-(pyrimidin-5-yl)quinazolin-4-amine (13k) was identified as a potent and ion channel selective inhibitor with robust efficacy in the preclin. rat ventricular effective refractory period (VERP) model and the rabbit atrial effective refractory period (AERP) model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowoHx2-YhyXrVg90H21EOLACvtfcHk0lhxLYzHvlZwsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFejsLs%253D&md5=ed5e06e1f6e389b05da7f1ae780063e7</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00117&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00117%26sid%3Dliteratum%253Aachs%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DJohnson%26aufirst%3DJ.%2BA.%26aulast%3DLloyd%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DNeels%26aufirst%3DJ.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DDhondi%26aufirst%3DN.%26aulast%3DChimalakonda%26aufirst%3DA.%26aulast%3DMandlekar%26aufirst%3DS.%26aulast%3DConder%26aufirst%3DM.%2BL.%26aulast%3DSale%26aufirst%3DH.%26aulast%3DXing%26aufirst%3DD.%26aulast%3DLevesque%26aufirst%3DP.%26aulast%3DWexler%26aufirst%3DR.%2BR.%26atitle%3DDiscovery%2520of%25205-phenyl-N-%2528pyridin-2-ylmethyl%2529-2-%2528pyrimidin-5-yl%2529quinazolin-4-amine%2520as%2520a%2520potent%2520IKur%2520inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D831%26epage%3D834%26doi%3D10.1021%2Facsmedchemlett.6b00117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tran, T.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, Y.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vallar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatman, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sage, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharbaoui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishnan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shakya, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garrido Montalban, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behan, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shifrina, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blackburn, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leakakos, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadeque, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unett, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaidarov, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, H.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tung, S.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Semple, G.</span></span> <span> </span><span class="NLM_article-title">Discovery of 2-(((1<i>r</i>,4<i>r</i>)-4-(((4-chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate (ralinepag): an orally active prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">913</span>– <span class="NLM_lpage">927</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00871</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00871" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXms12gsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=913-927&author=T.-A.+Tranauthor=B.+Kramerauthor=Y.-J.+Shinauthor=P.+Vallarauthor=P.+D.+Boatmanauthor=N.+Zouauthor=C.+R.+Sageauthor=T.+Gharbaouiauthor=A.+Krishnanauthor=B.+Palauthor=S.+R.+Shakyaauthor=A.+Garrido+Montalbanauthor=J.+W.+Adamsauthor=J.+Ramirezauthor=D.+P.+Behanauthor=A.+Shifrinaauthor=A.+Blackburnauthor=T.+Leakakosauthor=Y.+Shiauthor=M.+Morganauthor=A.+Sadequeauthor=W.+Chenauthor=D.+J.+Unettauthor=I.+Gaidarovauthor=X.+Chenauthor=S.+Changauthor=H.-H.+Shuauthor=S.-F.+Tungauthor=G.+Semple&title=Discovery+of+2-%28%28%281r%2C4r%29-4-%28%28%284-chlorophenyl%29%28phenyl%29carbamoyl%29oxy%29methyl%29cyclohexyl%29methoxy%29acetate+%28ralinepag%29%3A+an+orally+active+prostacyclin+receptor+agonist+for+the+treatment+of+pulmonary+arterial+hypertension&doi=10.1021%2Facs.jmedchem.6b00871"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 2-(((1r,4r)-4-(((4-Chlorophenyl)(phenyl)carbamoyl)oxy)methyl)cyclohexyl)methoxy)acetate (Ralinepag): An Orally Active Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension</span></div><div class="casAuthors">Tran, Thuy-Anh; Kramer, Bryan; Shin, Young-Jun; Vallar, Pureza; Boatman, P. Douglas; Zou, Ning; Sage, Carleton R.; Gharbaoui, Tawfik; Krishnan, Ashwin; Pal, Biman; Shakya, Sagar R.; Garrido Montalban, Antonio; Adams, John W.; Ramirez, Juan; Behan, Dominic P.; Shifrina, Anna; Blackburn, Anthony; Leakakos, Tina; Shi, Yunqing; Morgan, Michael; Sadeque, Abu; Chen, Weichao; Unett, David J.; Gaidarov, Ibragim; Chen, Xiaohua; Chang, Steve; Shu, Hsin-Hui; Tung, Shiu-Feng; Semple, Graeme</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">913-927</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design and synthesis of a new series of potent non-prostanoid IP receptor agonists that showed oral efficacy in the rat monocrotaline model of pulmonary arterial hypertension (PAH) are described.  Detailed profiling of a no. of analogs resulted in the identification of 5c (ralinepag) that has good selectivity in both binding and functional assays with respect to most members of the prostanoid receptor family and a more modest 30- to 50-fold selectivity over the EP3 receptor.  In the authors' hands, its potency and efficacy are comparable or superior to MRE269 (the active metabolite of the clin. compd. NS-304) with respect to in vitro IP receptor dependent cAMP accumulation assays.  Ralinepag had an excellent PK profile across species.  Enterohepatic recirculation most probably contributes to a concn.-time profile after oral administration in the cynomolgus monkey that showed a very low peak-to-trough ratio.  Following the identification of an acceptable solid form, ralinepag was selected for further development for the treatment of PAH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXvfp2ZN4i1bVg90H21EOLACvtfcHk0ljU_I6GKZt4sQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXms12gsw%253D%253D&md5=f37ba4106466f0ed724cd78db4b5b366</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00871&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00871%26sid%3Dliteratum%253Aachs%26aulast%3DTran%26aufirst%3DT.-A.%26aulast%3DKramer%26aufirst%3DB.%26aulast%3DShin%26aufirst%3DY.-J.%26aulast%3DVallar%26aufirst%3DP.%26aulast%3DBoatman%26aufirst%3DP.%2BD.%26aulast%3DZou%26aufirst%3DN.%26aulast%3DSage%26aufirst%3DC.%2BR.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DKrishnan%26aufirst%3DA.%26aulast%3DPal%26aufirst%3DB.%26aulast%3DShakya%26aufirst%3DS.%2BR.%26aulast%3DGarrido%2BMontalban%26aufirst%3DA.%26aulast%3DAdams%26aufirst%3DJ.%2BW.%26aulast%3DRamirez%26aufirst%3DJ.%26aulast%3DBehan%26aufirst%3DD.%2BP.%26aulast%3DShifrina%26aufirst%3DA.%26aulast%3DBlackburn%26aufirst%3DA.%26aulast%3DLeakakos%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DMorgan%26aufirst%3DM.%26aulast%3DSadeque%26aufirst%3DA.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DUnett%26aufirst%3DD.%2BJ.%26aulast%3DGaidarov%26aufirst%3DI.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DShu%26aufirst%3DH.-H.%26aulast%3DTung%26aufirst%3DS.-F.%26aulast%3DSemple%26aufirst%3DG.%26atitle%3DDiscovery%2520of%25202-%2528%2528%25281r%252C4r%2529-4-%2528%2528%25284-chlorophenyl%2529%2528phenyl%2529carbamoyl%2529oxy%2529methyl%2529cyclohexyl%2529methoxy%2529acetate%2520%2528ralinepag%2529%253A%2520an%2520orally%2520active%2520prostacyclin%2520receptor%2520agonist%2520for%2520the%2520treatment%2520of%2520pulmonary%2520arterial%2520hypertension%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D913%26epage%3D927%26doi%3D10.1021%2Facs.jmedchem.6b00871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Walker, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ancellin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaufils, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bergeal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binnie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouillot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clapham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haslam, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holmes, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liddle, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBride, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirguet, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mowat, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowland, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tiberghien, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trottet, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uings, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webster, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mole, D. J.</span></span> <span> </span><span class="NLM_article-title">Development of a series of kynurenine 3-monooxygenase inhibitors leading to a clinical candidate for the treatment of acute pancreatitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3383</span>– <span class="NLM_lpage">3404</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00055</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00055" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3383-3404&author=A.+L.+Walkerauthor=N.+Ancellinauthor=B.+Beaufilsauthor=M.+Bergealauthor=M.+Binnieauthor=A.+Bouillotauthor=D.+Claphamauthor=A.+Denisauthor=C.+P.+Haslamauthor=D.+S.+Holmesauthor=J.+P.+Hutchinsonauthor=J.+Liddleauthor=A.+McBrideauthor=O.+Mirguetauthor=C.+G.+Mowatauthor=P.+Rowlandauthor=N.+Tiberghienauthor=L.+Trottetauthor=I.+Uingsauthor=S.+P.+Websterauthor=X.+Zhengauthor=D.+J.+Mole&title=Development+of+a+series+of+kynurenine+3-monooxygenase+inhibitors+leading+to+a+clinical+candidate+for+the+treatment+of+acute+pancreatitis&doi=10.1021%2Facs.jmedchem.7b00055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00055%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DA.%2BL.%26aulast%3DAncellin%26aufirst%3DN.%26aulast%3DBeaufils%26aufirst%3DB.%26aulast%3DBergeal%26aufirst%3DM.%26aulast%3DBinnie%26aufirst%3DM.%26aulast%3DBouillot%26aufirst%3DA.%26aulast%3DClapham%26aufirst%3DD.%26aulast%3DDenis%26aufirst%3DA.%26aulast%3DHaslam%26aufirst%3DC.%2BP.%26aulast%3DHolmes%26aufirst%3DD.%2BS.%26aulast%3DHutchinson%26aufirst%3DJ.%2BP.%26aulast%3DLiddle%26aufirst%3DJ.%26aulast%3DMcBride%26aufirst%3DA.%26aulast%3DMirguet%26aufirst%3DO.%26aulast%3DMowat%26aufirst%3DC.%2BG.%26aulast%3DRowland%26aufirst%3DP.%26aulast%3DTiberghien%26aufirst%3DN.%26aulast%3DTrottet%26aufirst%3DL.%26aulast%3DUings%26aufirst%3DI.%26aulast%3DWebster%26aufirst%3DS.%2BP.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DMole%26aufirst%3DD.%2BJ.%26atitle%3DDevelopment%2520of%2520a%2520series%2520of%2520kynurenine%25203-monooxygenase%2520inhibitors%2520leading%2520to%2520a%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520acute%2520pancreatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3383%26epage%3D3404%26doi%3D10.1021%2Facs.jmedchem.7b00055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanoff, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walters, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gourdet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barton, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unitt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaton, E.</span></span> <span> </span><span class="NLM_article-title">Identification of the clinical candidate (<i>R</i>)-(1-(4-fluorophenyl)-6-((1-methyl-1<i>H</i>-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1<i>H</i>-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone (CORT125134): A selective glucocorticoid receptor (GR) antagonist</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3405</span>– <span class="NLM_lpage">3421</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00162</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00162" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3405-3421&author=H.+J.+Huntauthor=J.+K.+Belanoffauthor=I.+Waltersauthor=B.+Gourdetauthor=J.+Thomasauthor=N.+Bartonauthor=J.+Unittauthor=T.+Phillipsauthor=D.+Swiftauthor=E.+Eaton&title=Identification+of+the+clinical+candidate+%28R%29-%281-%284-fluorophenyl%29-6-%28%281-methyl-1H-pyrazol-4-yl%29sulfonyl%29-4%2C4a%2C5%2C6%2C7%2C8-hexahydro-1H-pyrazolo%5B3%2C4-g%5Disoquinolin-4a-yl%29%284-%28trifluoromethyl%29pyridin-2-yl%29methanone+%28CORT125134%29%3A+A+selective+glucocorticoid+receptor+%28GR%29+antagonist&doi=10.1021%2Facs.jmedchem.7b00162"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00162&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00162%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DH.%2BJ.%26aulast%3DBelanoff%26aufirst%3DJ.%2BK.%26aulast%3DWalters%26aufirst%3DI.%26aulast%3DGourdet%26aufirst%3DB.%26aulast%3DThomas%26aufirst%3DJ.%26aulast%3DBarton%26aufirst%3DN.%26aulast%3DUnitt%26aufirst%3DJ.%26aulast%3DPhillips%26aufirst%3DT.%26aulast%3DSwift%26aufirst%3DD.%26aulast%3DEaton%26aufirst%3DE.%26atitle%3DIdentification%2520of%2520the%2520clinical%2520candidate%2520%2528R%2529-%25281-%25284-fluorophenyl%2529-6-%2528%25281-methyl-1H-pyrazol-4-yl%2529sulfonyl%2529-4%252C4a%252C5%252C6%252C7%252C8-hexahydro-1H-pyrazolo%255B3%252C4-g%255Disoquinolin-4a-yl%2529%25284-%2528trifluoromethyl%2529pyridin-2-yl%2529methanone%2520%2528CORT125134%2529%253A%2520A%2520selective%2520glucocorticoid%2520receptor%2520%2528GR%2529%2520antagonist%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3405%26epage%3D3421%26doi%3D10.1021%2Facs.jmedchem.7b00162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clark, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaney, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crackett, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurley, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dyke, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clark, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lockey, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belanoff, J. K.</span></span> <span> </span><span class="NLM_article-title">8-Benzensulfonyl-8<i>a</i>-benzyl-hexahydro-2<i>H</i>-isoquinoline-6-ones as selective glucocorticoid receptor antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">5704</span>– <span class="NLM_lpage">5708</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.07.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2007.07.055" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=5704-5708&author=R.+D.+Clarkauthor=N.+C.+Rayauthor=P.+Blaneyauthor=P.+H.+Crackettauthor=C.+Hurleyauthor=K.+Williamsauthor=H.+J.+Dykeauthor=D.+E.+Clarkauthor=P.+M.+Lockeyauthor=R.+Devosauthor=M.+Wongauthor=A.+Whiteauthor=J.+K.+Belanoff&title=8-Benzensulfonyl-8a-benzyl-hexahydro-2H-isoquinoline-6-ones+as+selective+glucocorticoid+receptor+antagonists&doi=10.1016%2Fj.bmcl.2007.07.055"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.07.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.07.055%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DR.%2BD.%26aulast%3DRay%26aufirst%3DN.%2BC.%26aulast%3DBlaney%26aufirst%3DP.%26aulast%3DCrackett%26aufirst%3DP.%2BH.%26aulast%3DHurley%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DK.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DClark%26aufirst%3DD.%2BE.%26aulast%3DLockey%26aufirst%3DP.%2BM.%26aulast%3DDevos%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DA.%26aulast%3DBelanoff%26aufirst%3DJ.%2BK.%26atitle%3D8-Benzensulfonyl-8a-benzyl-hexahydro-2H-isoquinoline-6-ones%2520as%2520selective%2520glucocorticoid%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D5704%26epage%3D5708%26doi%3D10.1016%2Fj.bmcl.2007.07.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable, brain-penetrating, in vivo active phosphodiesterase 2A inhibitor lead series for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7658</span>– <span class="NLM_lpage">7676</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GhurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7658-7676&author=S.+Mikamiauthor=S.+Sasakiauthor=Y.+Asanoauthor=O.+Ujikawaauthor=S.+Fukumotoauthor=K.+Nakashimaauthor=H.+Okiauthor=N.+Kamiguchiauthor=H.+Imadaauthor=H.+Iwashitaauthor=T.+Taniguchi&title=Discovery+of+an+orally+bioavailable%2C+brain-penetrating%2C+in+vivo+active+phosphodiesterase+2A+inhibitor+lead+series+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Facs.jmedchem.7b00709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable, Brain-Penetrating, in Vivo Active Phosphodiesterase 2A Inhibitor Lead Series for the Treatment of Cognitive Disorders</span></div><div class="casAuthors">Mikami, Satoshi; Sasaki, Shigekazu; Asano, Yasutomi; Ujikawa, Osamu; Fukumoto, Shoji; Nakashima, Kosuke; Oki, Hideyuki; Kamiguchi, Naomi; Imada, Haruka; Iwashita, Hiroki; Taniguchi, Takahiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7658-7676</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the authors describe the discovery of a potent, selective, brain-penetrating, in vivo active phosphodiesterase (PDE) 2A inhibitor lead series.  To identify high-quality leads suitable for optimization and enable validation of the physiol. function of PDE2A in vivo, structural modifications of the high-throughput screening hit were performed.  The lead generation efforts revealed three key potency-enhancing functionalities with minimal increases in mol. wt. (MW) and no change in topol. polar surface area (TPSA).  Combining these structural elements led to the identification of 6-methyl-N-((1R)-1-(4-(trifluoromethoxy)phenyl)propyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (38a), a mol. with the desired balance of preclin. properties.  Further characterization by cocrystal structure anal. of (38a) bound to PDE2A uncovered a unique binding mode and provided insights into its obsd. potency and PDE selectivity.  Compd. (38a) significantly elevated 3',5'-cGMP levels in mouse brain following oral administration, thus validating this compd. as a useful pharmacol. tool and an attractive lead for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXk4ZjO3RKAbVg90H21EOLACvtfcHk0lj4o27o6A4Z3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GhurrO&md5=361f9ce22899da731673ed86ade3f8aa</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00709%26sid%3Dliteratum%253Aachs%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DFukumoto%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DImada%26aufirst%3DH.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%252C%2520brain-penetrating%252C%2520in%2520vivo%2520active%2520phosphodiesterase%25202A%2520inhibitor%2520lead%2520series%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7658%26epage%3D7676%26doi%3D10.1021%2Facs.jmedchem.7b00709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokubo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate <i>N</i>-((1<i>S</i>)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1<i>H</i>)-carboxamide (TAK-915): A highly potent, selective, and brain-penetrating phosphodiesterase 2A inhibitor for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7677</span>– <span class="NLM_lpage">7702</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSmtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7677-7702&author=S.+Mikamiauthor=S.+Nakamuraauthor=T.+Ashizawaauthor=I.+Nomuraauthor=M.+Kawasakiauthor=S.+Sasakiauthor=H.+Okiauthor=H.+Kokuboauthor=I.+D.+Hoffmanauthor=H.+Zouauthor=N.+Uchiyamaauthor=K.+Nakashimaauthor=N.+Kamiguchiauthor=H.+Imadaauthor=N.+Suzukiauthor=H.+Iwashitaauthor=T.+Taniguchi&title=Discovery+of+clinical+candidate+N-%28%281S%29-1-%283-fluoro-4-%28trifluoromethoxy%29phenyl%29-2-methoxyethyl%29-7-methoxy-2-oxo-2%2C3-dihydropyrido%5B2%2C3-b%5Dpyrazine-4%281H%29-carboxamide+%28TAK-915%29%3A+A+highly+potent%2C+selective%2C+and+brain-penetrating+phosphodiesterase+2A+inhibitor+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Facs.jmedchem.7b00807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders</span></div><div class="casAuthors">Mikami, Satoshi; Nakamura, Shinji; Ashizawa, Tomoko; Nomura, Izumi; Kawasaki, Masanori; Sasaki, Shigekazu; Oki, Hideyuki; Kokubo, Hironori; Hoffman, Isaac D.; Zou, Hua; Uchiyama, Noriko; Nakashima, Kosuke; Kamiguchi, Naomi; Imada, Haruka; Suzuki, Noriko; Iwashita, Hiroki; Taniguchi, Takahiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7677-7702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) 2A inhibitors have emerged as a novel mechanism with potential therapeutic option to ameliorate cognitive dysfunction in schizophrenia or Alzheimer's disease through upregulation of cyclic nucleotides in the brain, and thereby achieve potentiation of cyclic nucleotide signaling pathways.  This article details the expedited optimization of the authors' recently disclosed pyrazolo[1,5-a]pyrimidine lead compd. 4b, leading to the discovery of clin. candidate 36 (I) (TAK-915), which demonstrates an appropriate combination of potency, PDE selectivity, and favorable pharmacokinetic (PK) properties, including brain penetration.  Successful identification of 36 was realized through application of structure-based drug design (SBDD) to further improve potency and PDE selectivity, coupled with prospective design focused on physicochem. properties to deliver brain penetration.  Oral administration of 36 demonstrated significant elevation of 3',5'-cGMP levels in mouse brains, and improved cognitive performance in a novel object recognition task in rats.  Consequently, compd. 36 was advanced into human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCUw5grC_66rVg90H21EOLACvtfcHk0lj4o27o6A4Z3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSmtL3I&md5=f87cb3ac86b6299fc90e336b88ea2a21</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00807%26sid%3Dliteratum%253Aachs%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DAshizawa%26aufirst%3DT.%26aulast%3DNomura%26aufirst%3DI.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKokubo%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DI.%2BD.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DImada%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%2520N-%2528%25281S%2529-1-%25283-fluoro-4-%2528trifluoromethoxy%2529phenyl%2529-2-methoxyethyl%2529-7-methoxy-2-oxo-2%252C3-dihydropyrido%255B2%252C3-b%255Dpyrazine-4%25281H%2529-carboxamide%2520%2528TAK-915%2529%253A%2520A%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrating%2520phosphodiesterase%25202A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7677%26epage%3D7702%26doi%3D10.1021%2Facs.jmedchem.7b00807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyser, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1149-1164&author=P.+Liauthor=H.+Zhengauthor=J.+Zhaoauthor=L.+Zhangauthor=W.+Yaoauthor=H.+Zhuauthor=J.+D.+Beardauthor=K.+Idaauthor=W.+Laneauthor=G.+Snellauthor=S.+Sogabeauthor=C.+J.+Heyserauthor=G.+L.+Snyderauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+E.+Davisauthor=L.+P.+Wennogle&title=Discovery+of+potent+and+selective+inhibitors+of+phosphodiesterase+1+for+the+treatment+of+cognitive+impairment+associated+with+neurodegenerative+and+neuropsychiatric+diseases&doi=10.1021%2Facs.jmedchem.5b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases</span></div><div class="casAuthors">Li, Peng; Zheng, Hailin; Zhao, Jun; Zhang, Lei; Yao, Wei; Zhu, Hongwen; Beard, J. David; Ida, Koh; Lane, Weston; Snell, Gyorgy; Sogabe, Satoshi; Heyser, Charles J.; Snyder, Gretchen L.; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert E.; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1149-1164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A diverse set of 3-aminopyrazolo[3,4-d]pyrimidinones was designed and synthesized.  The structure-activity relationships of these polycyclic compds. as phosphodiesterase 1 (PDE1) inhibitors were studied along with their physicochem. and pharmacokinetic properties.  Systematic optimizations of this novel scaffold culminated in the identification of a clin. candidate I, which exhibited picomolar inhibitory potency for PDE1, demonstrated excellent selectivity against all other PDE families and showed good efficacy in vivo.  Currently, this investigational new drug is in Phase I clin. development and being considered for the treatment of several indications including cognitive deficits assocd. with schizophrenia and Alzheimer's disease, movement disorders, attention deficit and hyperactivity disorders, and other central nervous system (CNS) and non-CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqQuMoLsXnbVg90H21EOLACvtfcHk0lgBmzaQEv6nGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D&md5=73741521722dc906869ffa3504ceaf2e</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01751%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DBeard%26aufirst%3DJ.%2BD.%26aulast%3DIda%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DHeyser%26aufirst%3DC.%2BJ.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosphodiesterase%25201%2520for%2520the%2520treatment%2520of%2520cognitive%2520impairment%2520associated%2520with%2520neurodegenerative%2520and%2520neuropsychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1149%26epage%3D1164%26doi%3D10.1021%2Facs.jmedchem.5b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chackalamannil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czarniecki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vaccaro, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleven, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fawzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watkins, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of polycyclic pyrazolo[3,4-<i>d</i>]pyrimidines as PDE1 and PDE5 cGMP phosphodiesterase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">4372</span>– <span class="NLM_lpage">4377</span>, <span class="refDoi"> DOI: 10.1021/jm970495b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970495b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=4372-4377&author=Y.+Xiaauthor=S.+Chackalamannilauthor=M.+Czarnieckiauthor=H.+Tsaiauthor=H.+Vaccaroauthor=R.+Clevenauthor=J.+Cookauthor=A.+Fawziauthor=R.+Watkinsauthor=H.+Zhang&title=Synthesis+and+evaluation+of+polycyclic+pyrazolo%5B3%2C4-d%5Dpyrimidines+as+PDE1+and+PDE5+cGMP+phosphodiesterase+inhibitors&doi=10.1021%2Fjm970495b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fjm970495b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970495b%26sid%3Dliteratum%253Aachs%26aulast%3DXia%26aufirst%3DY.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DH.%26aulast%3DVaccaro%26aufirst%3DH.%26aulast%3DCleven%26aufirst%3DR.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DFawzi%26aufirst%3DA.%26aulast%3DWatkins%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520polycyclic%2520pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520PDE1%2520and%2520PDE5%2520cGMP%2520phosphodiesterase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D4372%26epage%3D4377%26doi%3D10.1021%2Fjm970495b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nirogi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shinde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kambhampati, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saraf, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badange, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyala, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhatta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojja, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reballi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanian, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benade, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacharla, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhyrapuneni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayarajan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goyal, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasti, V.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1<i>H</i>-indole dimesylate monohydrate (SUVN-502): A novel, potent, selective and orally active serotonin 6 (5-HT6) receptor antagonist for potential treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1843</span>– <span class="NLM_lpage">1859</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01662</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01662" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1843-1859&author=R.+Nirogiauthor=A.+Shindeauthor=R.+S.+Kambhampatiauthor=A.+R.+Mohammedauthor=S.+K.+Sarafauthor=R.+K.+Badangeauthor=T.+R.+Bandyalaauthor=V.+Bhattaauthor=K.+Bojjaauthor=V.+Reballiauthor=R.+Subramanianauthor=V.+Benadeauthor=R.+C.+Palacharlaauthor=G.+Bhyrapuneniauthor=P.+Jayarajanauthor=V.+Goyalauthor=V.+Jasti&title=Discovery+and+development+of+1-%5B%282-bromophenyl%29sulfonyl%5D-5-methoxy-3-%5B%284-methyl-1-piperazinyl%29methyl%5D-1H-indole+dimesylate+monohydrate+%28SUVN-502%29%3A+A+novel%2C+potent%2C+selective+and+orally+active+serotonin+6+%285-HT6%29+receptor+antagonist+for+potential+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b01662"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Development of 1-[(2-Bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole Dimesylate Monohydrate (SUVN-502): A Novel, Potent, Selective and Orally Active Serotonin 6 (5-HT6) Receptor Antagonist for Potential Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Nirogi, Ramakrishna; Shinde, Anil; Kambhampati, Rama Sastry; Mohammed, Abdul Rasheed; Saraf, Sangram Keshari; Badange, Rajesh kumar; Bandyala, Thrinath Reddy; Bhatta, Venugopalarao; Bojja, Kumar; Reballi, Veena; Subramanian, Ramkumar; Benade, Vijay; Palacharla, Raghava Choudary; Bhyrapuneni, Gopinadh; Jayarajan, Pradeep; Goyal, Vinod; Jasti, Venkat</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1843-1859</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Optimization of a novel series of 3-(piperazinylmethyl) indole derivs. as 5-hydroxytryptamine-6 receptor (5-HT6R) antagonists resulted in identification of 1-[(2-bromophenyl)sulfonyl]-5-methoxy-3-[(4-methyl-1-piperazinyl)methyl]-1H-indole dimesylate monohydrate (5al, SUVN-502) as a clin. candidate for potential treatment of cognitive disorders.  It has high affinity at human 5-HT6R (Ki = 2.04 nM) and selectivity over 100 target sites which include receptors, enzymes, peptides, growth factors, ion channels, steroids, immunol. factors, second messengers, and prostaglandins.  It has high selectivity over 5-HT2A receptor.  It is orally bioavailable and brain penetrant with robust preclin. efficacy.  The combination of 5al, donepezil, and memantine (triple combination) produces synergistic effects in extracellular levels of acetylcholine in the ventral hippocampus.  Preclin. efficacy in triple combination and high selectivity over 5-HT2A receptors are the differentiating features which culminated in selection of 5al for further development.  The Phase-1 evaluation of safety and pharmacokinetics has been completed, allowing for the initiation of a Phase-2 proof of concept study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_gw476vRgPbVg90H21EOLACvtfcHk0lgBmzaQEv6nGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXislyqsLk%253D&md5=26e4f0c1c34255ce2c2ef3bbf3c06a85</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01662&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01662%26sid%3Dliteratum%253Aachs%26aulast%3DNirogi%26aufirst%3DR.%26aulast%3DShinde%26aufirst%3DA.%26aulast%3DKambhampati%26aufirst%3DR.%2BS.%26aulast%3DMohammed%26aufirst%3DA.%2BR.%26aulast%3DSaraf%26aufirst%3DS.%2BK.%26aulast%3DBadange%26aufirst%3DR.%2BK.%26aulast%3DBandyala%26aufirst%3DT.%2BR.%26aulast%3DBhatta%26aufirst%3DV.%26aulast%3DBojja%26aufirst%3DK.%26aulast%3DReballi%26aufirst%3DV.%26aulast%3DSubramanian%26aufirst%3DR.%26aulast%3DBenade%26aufirst%3DV.%26aulast%3DPalacharla%26aufirst%3DR.%2BC.%26aulast%3DBhyrapuneni%26aufirst%3DG.%26aulast%3DJayarajan%26aufirst%3DP.%26aulast%3DGoyal%26aufirst%3DV.%26aulast%3DJasti%26aufirst%3DV.%26atitle%3DDiscovery%2520and%2520development%2520of%25201-%255B%25282-bromophenyl%2529sulfonyl%255D-5-methoxy-3-%255B%25284-methyl-1-piperazinyl%2529methyl%255D-1H-indole%2520dimesylate%2520monohydrate%2520%2528SUVN-502%2529%253A%2520A%2520novel%252C%2520potent%252C%2520selective%2520and%2520orally%2520active%2520serotonin%25206%2520%25285-HT6%2529%2520receptor%2520antagonist%2520for%2520potential%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1843%26epage%3D1859%26doi%3D10.1021%2Facs.jmedchem.6b01662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scott, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunskill, A. P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hodgson, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyde, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iserloh, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazakevich, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuvelkar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meredith, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misiaszek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orth, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossiter, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slater, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stone, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickland, C. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Voigt, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greenlee, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamford, A. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of the 3-imino-1,2,4-thiadiazinane 1,1-dioxide derivative verubecestat (MK-8931)-a β-site amyloid precursor protein cleaving enzyme 1 inhibitor for the treatment of Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10435</span>– <span class="NLM_lpage">10450</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00307</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00307" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10435-10450&author=J.+D.+Scottauthor=S.+W.+Liauthor=A.+P.+J.+Brunskillauthor=X.+Chenauthor=K.+Coxauthor=J.+N.+Cummingauthor=M.+Formanauthor=E.+J.+Gilbertauthor=R.+A.+Hodgsonauthor=L.+A.+Hydeauthor=Q.+Jiangauthor=U.+Iserlohauthor=I.+Kazakevichauthor=R.+Kuvelkarauthor=H.+Meiauthor=J.+Meredithauthor=J.+Misiaszekauthor=P.+Orthauthor=L.+M.+Rossiterauthor=M.+Slaterauthor=J.+Stoneauthor=C.+O.+Stricklandauthor=J.+H.+Voigtauthor=G.+Wangauthor=H.+Wangauthor=Y.+Wuauthor=W.+J.+Greenleeauthor=E.+M.+Parkerauthor=M.+E.+Kennedyauthor=A.+W.+Stamford&title=Discovery+of+the+3-imino-1%2C2%2C4-thiadiazinane+1%2C1-dioxide+derivative+verubecestat+%28MK-8931%29-a+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+inhibitor+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.6b00307"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)-A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Scott, Jack D.; Li, Sarah W.; Brunskill, Andrew P. J.; Chen, Xia; Cox, Kathleen; Cumming, Jared N.; Forman, Mark; Gilbert, Eric J.; Hodgson, Robert A.; Hyde, Lynn A.; Jiang, Qin; Iserloh, Ulrich; Kazakevich, Irina; Kuvelkar, Reshma; Mei, Hong; Meredith, John; Misiaszek, Jeffrey; Orth, Peter; Rossiter, Lana M.; Slater, Meagan; Stone, Julie; Strickland, Corey O.; Voigt, Johannes H.; Wang, Ganfeng; Wang, Hongwu; Wu, Yusheng; Greenlee, William J.; Parker, Eric M.; Kennedy, Matthew E.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">10435-10450</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Verubecestat (MK-8931), a diaryl amide substituted 3-imino-1,2,4-thiadiazinane 1,1-dioxide deriv., is a high-affinity β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor currently undergoing Phase 3 clin. evaluation for the treatment of mild to moderate and prodromal Alzheimer's disease.  Although not selective over the closely related aspartyl protease BACE2, verubecesat has high selectivity for BACE1 over other key aspartyl proteases, notably cathepsin D, and profoundly lowers CSF and brain Aβ levels in rats and nonhuman primates, and CSF Aβ levels in humans.  In this annotation, the authors describe the discovery of verubecesat, including design, validation, and selected SAR around the novel iminothiadiazinane dioxide core, as well as aspects of its preclin. and Phase 1 clin. characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpN5wdoirs8rVg90H21EOLACvtfcHk0lihiG9sVx1C7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVKnsLnI&md5=517155e2d4f186261b1451ff4556a621</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBrunskill%26aufirst%3DA.%2BP.%2BJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DForman%26aufirst%3DM.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DJiang%26aufirst%3DQ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DMei%26aufirst%3DH.%26aulast%3DMeredith%26aufirst%3DJ.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DRossiter%26aufirst%3DL.%2BM.%26aulast%3DSlater%26aufirst%3DM.%26aulast%3DStone%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%2BO.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDiscovery%2520of%2520the%25203-imino-1%252C2%252C4-thiadiazinane%25201%252C1-dioxide%2520derivative%2520verubecestat%2520%2528MK-8931%2529-a%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520inhibitor%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10435%26epage%3D10450%26doi%3D10.1021%2Facs.jmedchem.6b00307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez
Botella, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salituro, F. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrison, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beresis, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfort, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loya, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ackley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Althaus, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grossman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span> <span> </span><span class="NLM_article-title">Neuroactive steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1<i>H</i>-pyrazol-1′-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A clinical next generation neuroactive steroid positive allosteric modulator of the (γ-aminobutyric acid)<sub>A</sub> receptor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7810</span>– <span class="NLM_lpage">7819</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00846</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00846" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A280%3ADC%252BC1cfitFSgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7810-7819&author=G.+Martinez%0ABotellaauthor=F.+G.+Salituroauthor=B.+L.+Harrisonauthor=R.+T.+Beresisauthor=Z.+Baiauthor=M.-J.+Blancoauthor=G.+M.+Belfortauthor=J.+Daiauthor=C.+M.+Loyaauthor=M.+A.+Ackleyauthor=A.+L.+Althausauthor=S.+J.+Grossmanauthor=E.+Hoffmannauthor=J.+J.+Dohertyauthor=A.+J.+Robichaud&title=Neuroactive+steroids.+2.+3%CE%B1-Hydroxy-3%CE%B2-methyl-21-%284-cyano-1H-pyrazol-1%E2%80%B2-yl%29-19-nor-5%CE%B2-pregnan-20-one+%28SAGE-217%29%3A+A+clinical+next+generation+neuroactive+steroid+positive+allosteric+modulator+of+the+%28%CE%B3-aminobutyric+acid%29A+receptor&doi=10.1021%2Facs.jmedchem.7b00846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)A Receptor</span></div><div class="casAuthors">Martinez Botella Gabriel; Salituro Francesco G; Harrison Boyd L; Blanco Maria-Jesus; Belfort Gabriel M; Dai Jing; Loya Carlos M; Ackley Michael A; Althaus Alison L; Grossman Scott J; Hoffmann Ethan; Doherty James J; Robichaud Albert J; Beresis Richard T; Bai Zhu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7810-7819</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Certain classes of neuroactive steroids (NASs) are positive allosteric modulators (PAM) of synaptic and extrasynaptic GABAA receptors.  Herein, we report new SAR insights in a series of 5β-nor-19-pregnan-20-one analogues bearing substituted pyrazoles and triazoles at C-21, culminating in the discovery of 3α-hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217, 3), a potent GABAA receptor modulator at both synaptic and extrasynaptic receptor subtypes, with excellent oral DMPK properties.  Compound 3 has completed a phase 1 single ascending dose (SAD) and multiple ascending dose (MAD) clinical trial and is currently being studied in parallel phase 2 clinical trials for the treatment of postpartum depression (PPD), major depressive disorder (MDD), and essential tremor (ET).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTiySZLUBmmmoUSrryheKE6fW6udTcc2ebX9mR4_vZOLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cfitFSgsg%253D%253D&md5=d9cb22ed2087152aa0e67d0906faa583</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00846%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%2BBotella%26aufirst%3DG.%26aulast%3DSalituro%26aufirst%3DF.%2BG.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DBeresis%26aufirst%3DR.%2BT.%26aulast%3DBai%26aufirst%3DZ.%26aulast%3DBlanco%26aufirst%3DM.-J.%26aulast%3DBelfort%26aufirst%3DG.%2BM.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DLoya%26aufirst%3DC.%2BM.%26aulast%3DAckley%26aufirst%3DM.%2BA.%26aulast%3DAlthaus%26aufirst%3DA.%2BL.%26aulast%3DGrossman%26aufirst%3DS.%2BJ.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DNeuroactive%2520steroids.%25202.%25203%25CE%25B1-Hydroxy-3%25CE%25B2-methyl-21-%25284-cyano-1H-pyrazol-1%25E2%2580%25B2-yl%2529-19-nor-5%25CE%25B2-pregnan-20-one%2520%2528SAGE-217%2529%253A%2520A%2520clinical%2520next%2520generation%2520neuroactive%2520steroid%2520positive%2520allosteric%2520modulator%2520of%2520the%2520%2528%25CE%25B3-aminobutyric%2520acid%2529A%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7810%26epage%3D7819%26doi%3D10.1021%2Facs.jmedchem.7b00846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swain, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batchelor, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bechle, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradley, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butcher, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butt, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapman, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denton, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ellis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galan, S. R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaulier, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greener, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Groot, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glossop, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurrell, I. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hannam, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markworth, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Millan, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Printzenhoff, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rawson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ransley, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reister, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, C. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 4-[2-(5-amino-1<i>H</i>-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-<i>N</i>-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): design and optimization of diaryl ether aryl sulfonamides as selective inhibitors of NaV1.7</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7029</span>– <span class="NLM_lpage">7042</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00598</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00598" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7029-7042&author=N.+A.+Swainauthor=D.+Batchelorauthor=S.+Beaudoinauthor=B.+M.+Bechleauthor=P.+A.+Bradleyauthor=A.+D.+Brownauthor=B.+Brownauthor=K.+J.+Butcherauthor=R.+P.+Buttauthor=M.+L.+Chapmanauthor=S.+Dentonauthor=D.+Ellisauthor=S.+R.+G.+Galanauthor=S.+M.+Gaulierauthor=B.+S.+Greenerauthor=M.+J.+de+Grootauthor=M.+S.+Glossopauthor=I.+K.+Gurrellauthor=J.+Hannamauthor=M.+S.+Johnsonauthor=Z.+Linauthor=C.+J.+Markworthauthor=B.+E.+Marronauthor=D.+S.+Millanauthor=S.+Nakagawaauthor=A.+Pikeauthor=D.+Printzenhoffauthor=D.+J.+Rawsonauthor=S.+J.+Ransleyauthor=S.+M.+Reisterauthor=K.+Sasakiauthor=R.+I.+Storerauthor=P.+A.+Stuppleauthor=C.+W.+West&title=Discovery+of+clinical+candidate+4-%5B2-%285-amino-1H-pyrazol-4-yl%29-4-chlorophenoxy%5D-5-chloro-2-fluoro-N-1%2C3-thiazol-4-ylbenzenesulfonamide+%28PF-05089771%29%3A+design+and+optimization+of+diaryl+ether+aryl+sulfonamides+as+selective+inhibitors+of+NaV1.7&doi=10.1021%2Facs.jmedchem.7b00598"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of NaV1.7</span></div><div class="casAuthors">Swain, Nigel. A.; Batchelor, Dave; Beaudoin, Serge; Bechle, Bruce M.; Bradley, Paul A.; Brown, Alan D.; Brown, Bruce; Butcher, Ken J.; Butt, Richard P.; Chapman, Mark L.; Denton, Stephen; Ellis, David; Galan, Sebastien R. G.; Gaulier, Steven M.; Greener, Ben S.; de Groot, Marcel J.; Glossop, Mel S.; Gurrell, Ian K.; Hannam, Jo; Johnson, Matthew S.; Lin, Zhixin; Markworth, Christopher J.; Marron, Brian E.; Millan, David S.; Nakagawa, Shoko; Pike, Andy; Printzenhoff, David; Rawson, David J.; Ransley, Sarah J.; Reister, Steven M.; Sasaki, Kosuke; Storer, R. Ian; Stupple, Paul A.; West, Christopher W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">7029-7042</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of acidic diaryl ether heterocyclic sulfonamides that are potent and sub-type selective NaV1.7 inhibitors is described.  Optimization of early lead matter focused on removal of structural alerts, improving metabolic stability and reducing cytochrome P 450 inhibition driven drug-drug interaction concerns to deliver the desired balance of preclin. in vitro properties.  Concerns over non-metabolic routes of clearance, variable clearance in pre-clin. species and subsequent low confidence human pharmacokinetic predictions led to the decision to conduct a human microdose study to det. clin. pharmacokinetics.  The design strategies and results from pre-clin. PK and clin. human microdose PK data are described leading to the discovery of the first sub-type selective NaV1.7 inhibitor clin. candidate PF-05089771 (34) which binds to a site in the voltage sensing domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpST6i8wDUALbVg90H21EOLACvtfcHk0ljl_kwHbFEacQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFagu7jM&md5=93761c8e8e16cea4db2c9cff6e315e57</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00598%26sid%3Dliteratum%253Aachs%26aulast%3DSwain%26aufirst%3DN.%2BA.%26aulast%3DBatchelor%26aufirst%3DD.%26aulast%3DBeaudoin%26aufirst%3DS.%26aulast%3DBechle%26aufirst%3DB.%2BM.%26aulast%3DBradley%26aufirst%3DP.%2BA.%26aulast%3DBrown%26aufirst%3DA.%2BD.%26aulast%3DBrown%26aufirst%3DB.%26aulast%3DButcher%26aufirst%3DK.%2BJ.%26aulast%3DButt%26aufirst%3DR.%2BP.%26aulast%3DChapman%26aufirst%3DM.%2BL.%26aulast%3DDenton%26aufirst%3DS.%26aulast%3DEllis%26aufirst%3DD.%26aulast%3DGalan%26aufirst%3DS.%2BR.%2BG.%26aulast%3DGaulier%26aufirst%3DS.%2BM.%26aulast%3DGreener%26aufirst%3DB.%2BS.%26aulast%3Dde%2BGroot%26aufirst%3DM.%2BJ.%26aulast%3DGlossop%26aufirst%3DM.%2BS.%26aulast%3DGurrell%26aufirst%3DI.%2BK.%26aulast%3DHannam%26aufirst%3DJ.%26aulast%3DJohnson%26aufirst%3DM.%2BS.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DMarkworth%26aufirst%3DC.%2BJ.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DMillan%26aufirst%3DD.%2BS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DPike%26aufirst%3DA.%26aulast%3DPrintzenhoff%26aufirst%3DD.%26aulast%3DRawson%26aufirst%3DD.%2BJ.%26aulast%3DRansley%26aufirst%3DS.%2BJ.%26aulast%3DReister%26aufirst%3DS.%2BM.%26aulast%3DSasaki%26aufirst%3DK.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DStupple%26aufirst%3DP.%2BA.%26aulast%3DWest%26aufirst%3DC.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25204-%255B2-%25285-amino-1H-pyrazol-4-yl%2529-4-chlorophenoxy%255D-5-chloro-2-fluoro-N-1%252C3-thiazol-4-ylbenzenesulfonamide%2520%2528PF-05089771%2529%253A%2520design%2520and%2520optimization%2520of%2520diaryl%2520ether%2520aryl%2520sulfonamides%2520as%2520selective%2520inhibitors%2520of%2520NaV1.7%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7029%26epage%3D7042%26doi%3D10.1021%2Facs.jmedchem.7b00598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skerratt, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrews, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bagal, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilsland, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bungay, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morao, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nedderman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryckmans, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stupple, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldron, G.</span></span> <span> </span><span class="NLM_article-title">The discovery of a potent, selective, and peripherally restricted Pan-Trk inhibitor (PF-06273340) for the treatment of pain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10084</span>– <span class="NLM_lpage">10099</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00850</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00850" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWjsbfL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10084-10099&author=S.+E.+Skerrattauthor=M.+Andrewsauthor=S.+K.+Bagalauthor=J.+Bilslandauthor=D.+Brownauthor=P.+J.+Bungayauthor=S.+Coleauthor=K.+R.+Gibsonauthor=R.+Jonesauthor=I.+Moraoauthor=A.+Neddermanauthor=K.+Omotoauthor=C.+Robinsonauthor=T.+Ryckmansauthor=K.+Skinnerauthor=P.+Stuppleauthor=G.+Waldron&title=The+discovery+of+a+potent%2C+selective%2C+and+peripherally+restricted+Pan-Trk+inhibitor+%28PF-06273340%29+for+the+treatment+of+pain&doi=10.1021%2Facs.jmedchem.6b00850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of Pain</span></div><div class="casAuthors">Skerratt, Sarah E.; Andrews, Mark; Bagal, Sharan K.; Bilsland, James; Brown, David; Bungay, Peter J.; Cole, Susan; Gibson, Karl R.; Jones, Russell; Morao, Inaki; Nedderman, Angus; Omoto, Kiyoyuki; Robinson, Colin; Ryckmans, Thomas; Skinner, Kimberly; Stupple, Paul; Waldron, Gareth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10084-10099</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The neurotrophin family of growth factors, comprised of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT3) and neurotrophin 4 (NT4), is implicated in the physiol. of chronic pain.  Given the clin. efficacy of anti-NGF monoclonal antibody (mAb) therapies, there is significant interest in the development of small mol. modulators of neurotrophin activity.  Neurotrophins signal through the tropomyosin related kinase (Trk) family of tyrosine kinase receptors, hence Trk kinase inhibition represents a potentially "druggable" point of intervention.  To deliver the safety profile required for chronic, non-life threatening pain indications, highly kinase-selective Trk inhibitors with minimal brain availability are sought.  Herein the authors describe how the use of SBDD, 2D QSAR models and Matched Mol. Pair data in compd. design enabled the delivery of the highly potent, kinase-selective and peripherally restricted clin. candidate PF-06273340.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo67CFmGAkmRrVg90H21EOLACvtfcHk0ljl_kwHbFEacQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWjsbfL&md5=f8c904a92c1716062c217fefe2374ce6</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00850%26sid%3Dliteratum%253Aachs%26aulast%3DSkerratt%26aufirst%3DS.%2BE.%26aulast%3DAndrews%26aufirst%3DM.%26aulast%3DBagal%26aufirst%3DS.%2BK.%26aulast%3DBilsland%26aufirst%3DJ.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DBungay%26aufirst%3DP.%2BJ.%26aulast%3DCole%26aufirst%3DS.%26aulast%3DGibson%26aufirst%3DK.%2BR.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DMorao%26aufirst%3DI.%26aulast%3DNedderman%26aufirst%3DA.%26aulast%3DOmoto%26aufirst%3DK.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DSkinner%26aufirst%3DK.%26aulast%3DStupple%26aufirst%3DP.%26aulast%3DWaldron%26aufirst%3DG.%26atitle%3DThe%2520discovery%2520of%2520a%2520potent%252C%2520selective%252C%2520and%2520peripherally%2520restricted%2520Pan-Trk%2520inhibitor%2520%2528PF-06273340%2529%2520for%2520the%2520treatment%2520of%2520pain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10084%26epage%3D10099%26doi%3D10.1021%2Facs.jmedchem.6b00850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson Gray, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tantawy, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luscombe, V. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-(5-fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A novel negative allosteric modulator of metabotropic glutamate receptor subtype 5 selected for clinical evaluation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5072</span>– <span class="NLM_lpage">5085</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00410</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00410" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotFOrsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5072-5085&author=A.+S.+Feltsauthor=A.+L.+Rodriguezauthor=A.+L.+Blobaumauthor=R.+D.+Morrisonauthor=B.+S.+Batesauthor=A.+Thompson+Grayauthor=J.+M.+Rookauthor=M.+N.+Tantawyauthor=F.+W.+Byersauthor=S.+Changauthor=D.+F.+Venableauthor=V.+B.+Luscombeauthor=G.+D.+Tamagnanauthor=C.+M.+Niswenderauthor=J.+S.+Danielsauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitte&title=Discovery+of+N-%285-fluoropyridin-2-yl%29-6-methyl-4-%28pyrimidin-5-yloxy%29picolinamide+%28VU0424238%29%3A+A+novel+negative+allosteric+modulator+of+metabotropic+glutamate+receptor+subtype+5+selected+for+clinical+evaluation&doi=10.1021%2Facs.jmedchem.7b00410"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation</span></div><div class="casAuthors">Felts, Andrew S.; Rodriguez, Alice L.; Blobaum, Anna L.; Morrison, Ryan D.; Bates, Brittney S.; Thompson Gray, Analisa; Rook, Jerri M.; Tantawy, Mohammed N.; Byers, Frank W.; Chang, Sichen; Venable, Daryl F.; Luscombe, Vincent B.; Tamagnan, Gilles D.; Niswender, Colleen M.; Daniels, J. Scott; Jones, Carrie K.; Conn, P. Jeffrey; Lindsley, Craig W.; Emmitte, Kyle A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5072-5085</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Preclin. evidence in support of the potential utility of mGlu5 NAMs for the treatment of a variety of psychiatric and neurodegenerative disorders is extensive, and multiple such mols. have entered clin. trials.  Despite some promising results from clin. studies, no small mol. mGlu5 NAM has yet to reach market.  Here the authors present the discovery and evaluation of N-(5-fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (27, VU0424238), a compd. selected for clin. evaluation.  Compd. 27 is more than 900-fold selective for mGlu5 vs. the other mGlu receptors, and binding studies established a Ki value of 4.4 nM at a known allosteric binding site.  Compd. 27 had a clearance of 19.3 and 15.5 mL/min/kg in rats and cynomolgus monkeys, resp.  Imaging studies using a known mGlu5 PET ligand demonstrated 50% receptor occupancy at an oral dose of 0.8 mg/kg in rats and an i.v. dose of 0.06 mg/kg in baboons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDMhcNY9dn7LVg90H21EOLACvtfcHk0lirZe4yqxAx_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotFOrsrc%253D&md5=e08ce58e7194b36bd5bd7b1e2f59e897</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00410%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DThompson%2BGray%26aufirst%3DA.%26aulast%3DRook%26aufirst%3DJ.%2BM.%26aulast%3DTantawy%26aufirst%3DM.%2BN.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DChang%26aufirst%3DS.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DLuscombe%26aufirst%3DV.%2BB.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520N-%25285-fluoropyridin-2-yl%2529-6-methyl-4-%2528pyrimidin-5-yloxy%2529picolinamide%2520%2528VU0424238%2529%253A%2520A%2520novel%2520negative%2520allosteric%2520modulator%2520of%2520metabotropic%2520glutamate%2520receptor%2520subtype%25205%2520selected%2520for%2520clinical%2520evaluation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5072%26epage%3D5085%26doi%3D10.1021%2Facs.jmedchem.7b00410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felts, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morrison, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venable, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manka, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bates, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blobaum, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Byers, F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Daniels, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niswender, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conn, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsley, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Emmitte, K. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of VU0409106: A negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">5779</span>– <span class="NLM_lpage">5785</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2013.09.001" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=5779-5785&author=A.+S.+Feltsauthor=A.+L.+Rodriguezauthor=R.+D.+Morrisonauthor=D.+F.+Venableauthor=J.+T.+Mankaauthor=B.+S.+Batesauthor=A.+L.+Blobaumauthor=F.+W.+Byersauthor=J.+S.+Danielsauthor=C.+M.+Niswenderauthor=C.+K.+Jonesauthor=P.+J.+Connauthor=C.+W.+Lindsleyauthor=K.+A.+Emmitte&title=Discovery+of+VU0409106%3A+A+negative+allosteric+modulator+of+mGlu5+with+activity+in+a+mouse+model+of+anxiety&doi=10.1016%2Fj.bmcl.2013.09.001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DFelts%26aufirst%3DA.%2BS.%26aulast%3DRodriguez%26aufirst%3DA.%2BL.%26aulast%3DMorrison%26aufirst%3DR.%2BD.%26aulast%3DVenable%26aufirst%3DD.%2BF.%26aulast%3DManka%26aufirst%3DJ.%2BT.%26aulast%3DBates%26aufirst%3DB.%2BS.%26aulast%3DBlobaum%26aufirst%3DA.%2BL.%26aulast%3DByers%26aufirst%3DF.%2BW.%26aulast%3DDaniels%26aufirst%3DJ.%2BS.%26aulast%3DNiswender%26aufirst%3DC.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BK.%26aulast%3DConn%26aufirst%3DP.%2BJ.%26aulast%3DLindsley%26aufirst%3DC.%2BW.%26aulast%3DEmmitte%26aufirst%3DK.%2BA.%26atitle%3DDiscovery%2520of%2520VU0409106%253A%2520A%2520negative%2520allosteric%2520modulator%2520of%2520mGlu5%2520with%2520activity%2520in%2520a%2520mouse%2520model%2520of%2520anxiety%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D5779%26epage%3D5785%26doi%3D10.1016%2Fj.bmcl.2013.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis, SAR and pharmacological characterization of brain penetrant P2X7 receptor antagonists</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">671</span>– <span class="NLM_lpage">676</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00089</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00089" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=671-676&author=B.+M.+Savallauthor=D.+Wuauthor=M.+De+Angelisauthor=N.+I.+Carruthersauthor=H.+Aoauthor=Q.+Wangauthor=B.+Lordauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=Synthesis%2C+SAR+and+pharmacological+characterization+of+brain+penetrant+P2X7+receptor+antagonists&doi=10.1021%2Facsmedchemlett.5b00089"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00089%26sid%3Dliteratum%253Aachs%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DSynthesis%252C%2520SAR%2520and%2520pharmacological%2520characterization%2520of%2520brain%2520penetrant%2520P2X7%2520receptor%2520antagonists%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D671%26epage%3D676%26doi%3D10.1021%2Facsmedchemlett.5b00089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allison, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaventure, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryant, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ceusters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorak, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudriakova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovenberg, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otieno, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wickenden, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span> <span> </span><span class="NLM_article-title">4-Methyl-6,7-dihydro-4<i>H</i>-triazolo[4,5-c]pyridine-based P2X7 receptor antagonists: optimization of pharmacokinetic properties leading to the identification of a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4559</span>– <span class="NLM_lpage">4572</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4559-4572&author=M.+A.+Letavicauthor=B.+M.+Savallauthor=B.+D.+Allisonauthor=L.+Aluisioauthor=J.+I.+Andresauthor=M.+De+Angelisauthor=H.+Aoauthor=D.+A.+Beauchampauthor=P.+Bonaventureauthor=S.+Bryantauthor=N.+I.+Carruthersauthor=M.+Ceustersauthor=K.+J.+Coeauthor=C.+A.+Dvorakauthor=I.+C.+Fraserauthor=C.+F.+Gelinauthor=T.+Koudriakovaauthor=J.+Liangauthor=B.+Lordauthor=T.+W.+Lovenbergauthor=M.+A.+Otienoauthor=F.+Schoetensauthor=D.+M.+Swansonauthor=Q.+Wangauthor=A.+D.+Wickendenauthor=A.+Bhattacharya&title=4-Methyl-6%2C7-dihydro-4H-triazolo%5B4%2C5-c%5Dpyridine-based+P2X7+receptor+antagonists%3A+optimization+of+pharmacokinetic+properties+leading+to+the+identification+of+a+clinical+candidate&doi=10.1021%2Facs.jmedchem.7b00408"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">4-Methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridine-Based P2X7 Receptor Antagonists: Optimization of Pharmacokinetic Properties Leading to the Identification of a Clinical Candidate</span></div><div class="casAuthors">Letavic, Michael A.; Savall, Brad M.; Allison, Brett D.; Aluisio, Leah; Andres, Jose Ignacio; De Angelis, Meri; Ao, Hong; Beauchamp, Derek A.; Bonaventure, Pascal; Bryant, Stewart; Carruthers, Nicholas I.; Ceusters, Marc; Coe, Kevin J.; Dvorak, Curt A.; Fraser, Ian C.; Gelin, Christine F.; Koudriakova, Tatiana; Liang, Jimmy; Lord, Brian; Lovenberg, Timothy W.; Otieno, Monicah A.; Schoetens, Freddy; Swanson, Devin M.; Wang, Qi; Wickenden, Alan D.; Bhattacharya, Anindya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4559-4572</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis and preclin. characterization of novel 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are potent and selective brain penetrant P2X7 antagonists are described.  Optimization efforts based on previously disclosed unsubstituted 6,7-dihydro-4H-triazolo[4,5-c]pyridines, Me substituted 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyrazines, and several other series lead to the identification of a series of 4-(R)-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridines that are selective P2X7 antagonists with potency at the rodent and human P2X7 ion channels.  These novel P2X7 antagonists have suitable physicochem. properties, and several analogs have an excellent pharmacokinetic profile, good partitioning into the CNS and show robust in vivo target engagement after oral dosing.  Improvements in metabolic stability led to the identification of JNJ-54175446 (I) as a candidate for clin. development.  The drug discovery efforts and strategies that resulted in the identification of the clin. candidate are described herein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkx8e5Sq5aYbVg90H21EOLACvtfcHk0lgWgvmLVCqhLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXns1Wms7Y%253D&md5=5b5465d8f64d527da6647997efe34aee</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00408%26sid%3Dliteratum%253Aachs%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26aulast%3DAllison%26aufirst%3DB.%2BD.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAo%26aufirst%3DH.%26aulast%3DBeauchamp%26aufirst%3DD.%2BA.%26aulast%3DBonaventure%26aufirst%3DP.%26aulast%3DBryant%26aufirst%3DS.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DCeusters%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DFraser%26aufirst%3DI.%2BC.%26aulast%3DGelin%26aufirst%3DC.%2BF.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DLovenberg%26aufirst%3DT.%2BW.%26aulast%3DOtieno%26aufirst%3DM.%2BA.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DSwanson%26aufirst%3DD.%2BM.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWickenden%26aufirst%3DA.%2BD.%26aulast%3DBhattacharya%26aufirst%3DA.%26atitle%3D4-Methyl-6%252C7-dihydro-4H-triazolo%255B4%252C5-c%255Dpyridine-based%2520P2X7%2520receptor%2520antagonists%253A%2520optimization%2520of%2520pharmacokinetic%2520properties%2520leading%2520to%2520the%2520identification%2520of%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4559%26epage%3D4572%26doi%3D10.1021%2Facs.jmedchem.7b00408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dean, D. K.</span>; <span class="NLM_string-name">Munoz-Muriedas, J.</span>; <span class="NLM_string-name">Sime, M.</span>; <span class="NLM_string-name">Steadman, J. G. A.</span>; <span class="NLM_string-name">Thewlis, R. E. A.</span>; <span class="NLM_string-name">Trani, G.</span>; <span class="NLM_string-name">Walter, D. S.</span></span> <span> </span><span class="NLM_article-title">Preparation of Tetrahydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazine Derivatives for use as P2X7 Modulators</span>. <span class="NLM_patent">WO 2010125102 A1</span>, November 4, <span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=D.+K.+Dean&author=J.+Munoz-Muriedas&author=M.+Sime&author=J.+G.+A.+Steadman&author=R.+E.+A.+Thewlis&author=G.+Trani&author=D.+S.+Walter&title=Preparation+of+Tetrahydro%5B1%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dpyrazine+Derivatives+for+use+as+P2X7+Modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDean%26aufirst%3DD.%2BK.%26atitle%3DPreparation%2520of%2520Tetrahydro%255B1%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dpyrazine%2520Derivatives%2520for%2520use%2520as%2520P2X7%2520Modulators%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rech, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savall, B. M.</span></span> <span> </span><span class="NLM_article-title">The evolution of P2X7 antagonists with a focus on CNS indications</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3838</span>– <span class="NLM_lpage">3845</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.06.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2016.06.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=27426304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFOitL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2016&pages=3838-3845&author=J.+C.+Rechauthor=A.+Bhattacharyaauthor=M.+A.+Letavicauthor=B.+M.+Savall&title=The+evolution+of+P2X7+antagonists+with+a+focus+on+CNS+indications&doi=10.1016%2Fj.bmcl.2016.06.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">The evolution of P2X7 antagonists with a focus on CNS indications</span></div><div class="casAuthors">Rech, Jason C.; Bhattacharya, Anindya; Letavic, Michael A.; Savall, Brad M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3838-3845</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The P2X7 receptor is an ATP-gated nonselective cation channel that has been linked to a no. of inflammatory diseases.  Activation of the P2X7 receptor by elevated levels of ATP results in the release of proinflammatory cytokines and elevated levels of these cytokines has been assocd. with a variety of disease states.  A no. of research groups in both industry and academia have explored the identification of P2X7R antagonists as therapeutic agents.  Much of this early effort focused on the treatment of diseases related to peripheral inflammation and resulted in several clin. candidates, none of which were advanced to market.  The emerging role of the P2X7 receptor in neuroinflammation and related diseases has resulted in a shift in medicinal chem. efforts toward the development of centrally penetrant antagonists.  This review will highlight the biol. supporting the role of P2X7 in diseases related to neuroinflammation and review the recent medicinal chem. efforts to identify centrally penetrant antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdaLGUAKgul7Vg90H21EOLACvtfcHk0lgWgvmLVCqhLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFOitL3L&md5=04046ec16457c856c96dd50632b96efe</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.06.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.06.048%26sid%3Dliteratum%253Aachs%26aulast%3DRech%26aufirst%3DJ.%2BC.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26aulast%3DSavall%26aufirst%3DB.%2BM.%26atitle%3DThe%2520evolution%2520of%2520P2X7%2520antagonists%2520with%2520a%2520focus%2520on%2520CNS%2520indications%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D26%26spage%3D3838%26epage%3D3845%26doi%3D10.1016%2Fj.bmcl.2016.06.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chrovian, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soyode-Johnson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peterson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gelin, C. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvorak, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carruthers, N. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lord, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fraser, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aluisio, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koudriakova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoetens, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sepassi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallacher, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Letavic, M. A.</span></span> <span> </span><span class="NLM_article-title">A dipolar cycloaddition reaction to access 6-methyl-4,5,6,7-tetrahydro-1<i>H</i>-[1,2,3]triazolo[4,5-c]pyridines enables the discovery synthesis and preclinical profiling of a P2X7 antagonist clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">207</span>– <span class="NLM_lpage">223</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01279</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01279" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=207-223&issue=1&author=C.+C.+Chrovianauthor=A.+Soyode-Johnsonauthor=A.+A.+Petersonauthor=C.+F.+Gelinauthor=X.+Dengauthor=C.+A.+Dvorakauthor=N.+I.+Carruthersauthor=B.+Lordauthor=I.+Fraserauthor=L.+Aluisioauthor=K.+J.+Coeauthor=B.+Scottauthor=T.+Koudriakovaauthor=F.+Schoetensauthor=K.+Sepassiauthor=D.+J.+Gallacherauthor=A.+Bhattacharyaauthor=M.+A.+Letavic&title=A+dipolar+cycloaddition+reaction+to+access+6-methyl-4%2C5%2C6%2C7-tetrahydro-1H-%5B1%2C2%2C3%5Dtriazolo%5B4%2C5-c%5Dpyridines+enables+the+discovery+synthesis+and+preclinical+profiling+of+a+P2X7+antagonist+clinical+candidate&doi=10.1021%2Facs.jmedchem.7b01279"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01279%26sid%3Dliteratum%253Aachs%26aulast%3DChrovian%26aufirst%3DC.%2BC.%26aulast%3DSoyode-Johnson%26aufirst%3DA.%26aulast%3DPeterson%26aufirst%3DA.%2BA.%26aulast%3DGelin%26aufirst%3DC.%2BF.%26aulast%3DDeng%26aufirst%3DX.%26aulast%3DDvorak%26aufirst%3DC.%2BA.%26aulast%3DCarruthers%26aufirst%3DN.%2BI.%26aulast%3DLord%26aufirst%3DB.%26aulast%3DFraser%26aufirst%3DI.%26aulast%3DAluisio%26aufirst%3DL.%26aulast%3DCoe%26aufirst%3DK.%2BJ.%26aulast%3DScott%26aufirst%3DB.%26aulast%3DKoudriakova%26aufirst%3DT.%26aulast%3DSchoetens%26aufirst%3DF.%26aulast%3DSepassi%26aufirst%3DK.%26aulast%3DGallacher%26aufirst%3DD.%2BJ.%26aulast%3DBhattacharya%26aufirst%3DA.%26aulast%3DLetavic%26aufirst%3DM.%2BA.%26atitle%3DA%2520dipolar%2520cycloaddition%2520reaction%2520to%2520access%25206-methyl-4%252C5%252C6%252C7-tetrahydro-1H-%255B1%252C2%252C3%255Dtriazolo%255B4%252C5-c%255Dpyridines%2520enables%2520the%2520discovery%2520synthesis%2520and%2520preclinical%2520profiling%2520of%2520a%2520P2X7%2520antagonist%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26issue%3D1%26spage%3D207%26epage%3D223%26doi%3D10.1021%2Facs.jmedchem.7b01279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ratni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weetall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naryshkin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paushkin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turpoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woll, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazirani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinard, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David-Pierson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuerck, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poirier, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muster, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirchner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, F.</span></span> <span> </span><span class="NLM_article-title">Specific correction of alternative survival motor neuron 2 splicing by small molecules: discovery of a potential novel medicine to treat spinal muscular atrophy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6086</span>– <span class="NLM_lpage">6100</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00459</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00459" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWgurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6086-6100&author=H.+Ratniauthor=G.+M.+Karpauthor=M.+Weetallauthor=N.+A.+Naryshkinauthor=S.+V.+Paushkinauthor=K.+S.+Chenauthor=K.+D.+McCarthyauthor=H.+Qiauthor=A.+Turpoffauthor=M.+G.+Wollauthor=X.+Zhangauthor=N.+Zhangauthor=T.+Yangauthor=A.+Dakkaauthor=P.+Vaziraniauthor=X.+Zhaoauthor=E.+Pinardauthor=L.+Greenauthor=P.+David-Piersonauthor=D.+Tuerckauthor=A.+Poirierauthor=W.+Musterauthor=S.+Kirchnerauthor=L.+Muellerauthor=I.+Gerlachauthor=F.+Metzger&title=Specific+correction+of+alternative+survival+motor+neuron+2+splicing+by+small+molecules%3A+discovery+of+a+potential+novel+medicine+to+treat+spinal+muscular+atrophy&doi=10.1021%2Facs.jmedchem.6b00459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Specific Correction of Alternative Survival Motor Neuron 2 Splicing by Small Molecules: Discovery of a Potential Novel Medicine To Treat Spinal Muscular Atrophy</span></div><div class="casAuthors">Ratni, Hasane; Karp, Gary M.; Weetall, Marla; Naryshkin, Nikolai A.; Paushkin, Sergey V.; Chen, Karen S.; McCarthy, Kathleen D.; Qi, Hongyan; Turpoff, Anthony; Woll, Matthew G.; Zhang, Xiaoyan; Zhang, Nanjing; Yang, Tianle; Dakka, Amal; Vazirani, Priya; Zhao, Xin; Pinard, Emmanuel; Green, Luke; David-Pierson, Pascale; Tuerck, Dietrich; Poirier, Agnes; Muster, Wolfgang; Kirchner, Stephan; Mueller, Lutz; Gerlach, Irene; Metzger, Friedrich</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6086-6100</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Spinal muscular atrophy (SMA) is the leading genetic cause of infant and toddler mortality, and there is currently no approved therapy available.  SMA is caused by mutation or deletion of the survival motor neuron 1 (SMN1) gene.  These mutations or deletions result in low levels of functional SMN protein.  SMN2, a paralogous gene to SMN1, undergoes alternative splicing and exclusion of exon 7, producing an unstable, truncated SMNΔ7 protein.  Herein, we report the identification of a pyridopyrimidinone series of small mols. that modify the alternative splicing of SMN2, increasing the prodn. of full-length SMN2 mRNA.  Upon oral administration of our small mols., the levels of full-length SMN protein were restored in two mouse models of SMA.  In-depth lead optimization in the pyridopyrimidinone series culminated in the selection of compd. 3 (RG7800) (I), the first small mol. SMN2 splicing modifier to enter human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDRpxc7_n787Vg90H21EOLACvtfcHk0ljTJo7b51TuOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWgurw%253D&md5=14431b4127804cc623c2365298ad849b</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00459%26sid%3Dliteratum%253Aachs%26aulast%3DRatni%26aufirst%3DH.%26aulast%3DKarp%26aufirst%3DG.%2BM.%26aulast%3DWeetall%26aufirst%3DM.%26aulast%3DNaryshkin%26aufirst%3DN.%2BA.%26aulast%3DPaushkin%26aufirst%3DS.%2BV.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DMcCarthy%26aufirst%3DK.%2BD.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DTurpoff%26aufirst%3DA.%26aulast%3DWoll%26aufirst%3DM.%2BG.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DDakka%26aufirst%3DA.%26aulast%3DVazirani%26aufirst%3DP.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DGreen%26aufirst%3DL.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DTuerck%26aufirst%3DD.%26aulast%3DPoirier%26aufirst%3DA.%26aulast%3DMuster%26aufirst%3DW.%26aulast%3DKirchner%26aufirst%3DS.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DGerlach%26aufirst%3DI.%26aulast%3DMetzger%26aufirst%3DF.%26atitle%3DSpecific%2520correction%2520of%2520alternative%2520survival%2520motor%2520neuron%25202%2520splicing%2520by%2520small%2520molecules%253A%2520discovery%2520of%2520a%2520potential%2520novel%2520medicine%2520to%2520treat%2520spinal%2520muscular%2520atrophy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6086%26epage%3D6100%26doi%3D10.1021%2Facs.jmedchem.6b00459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naryshkin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weetall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, K. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woll, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbeta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazirani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharyya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furia, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheedy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turpoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifillis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colacino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Babiak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almstead, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peltz, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mull, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynes, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubin, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontoura, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santarelli, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haehnke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmucki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebeling, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sivaramakrishnan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ko, C.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paushkin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ratni, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerlach, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghosh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metzger, F.</span></span> <span> </span><span class="NLM_article-title">SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>345</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">693</span>, <span class="refDoi"> DOI: 10.1126/science.1250127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1126%2Fscience.1250127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=25104390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht12gtLfO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=345&publication_year=2014&pages=688-693&author=N.+A.+Naryshkinauthor=M.+Weetallauthor=A.+Dakkaauthor=J.+Narasimhanauthor=X.+Zhaoauthor=Z.+Fengauthor=K.+K.+Y.+Lingauthor=G.+M.+Karpauthor=H.+Qiauthor=M.+G.+Wollauthor=G.+Chenauthor=N.+Zhangauthor=V.+Gabbetaauthor=P.+Vaziraniauthor=A.+Bhattacharyyaauthor=B.+Furiaauthor=N.+Risherauthor=J.+Sheedyauthor=R.+Kongauthor=J.+Maauthor=A.+Turpoffauthor=C.-S.+Leeauthor=X.+Zhangauthor=Y.-C.+Moonauthor=P.+Trifillisauthor=E.+M.+Welchauthor=J.+M.+Colacinoauthor=J.+Babiakauthor=N.+G.+Almsteadauthor=S.+W.+Peltzauthor=L.+A.+Engauthor=K.+S.+Chenauthor=J.+L.+Mullauthor=M.+S.+Lynesauthor=L.+L.+Rubinauthor=P.+Fontouraauthor=L.+Santarelliauthor=D.+Haehnkeauthor=K.+D.+McCarthyauthor=R.+Schmuckiauthor=M.+Ebelingauthor=M.+Sivaramakrishnanauthor=C.-P.+Koauthor=S.+V.+Paushkinauthor=H.+Ratniauthor=I.+Gerlachauthor=A.+Ghoshauthor=F.+Metzger&title=SMN2+splicing+modifiers+improve+motor+function+and+longevity+in+mice+with+spinal+muscular+atrophy&doi=10.1126%2Fscience.1250127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy</span></div><div class="casAuthors">Naryshkin, Nikolai A.; Weetall, Marla; Dakka, Amal; Narasimhan, Jana; Zhao, Xin; Feng, Zhihua; Ling, Karen K. Y.; Karp, Gary M.; Qi, Hongyan; Woll, Matthew G.; Chen, Guangming; Zhang, Nanjing; Gabbeta, Vijayalakshmi; Vazirani, Priya; Bhattacharyya, Anuradha; Furia, Bansri; Risher, Nicole; Sheedy, Josephine; Kong, Ronald; Ma, Jiyuan; Turpoff, Anthony; Lee, Chang-Sun; Zhang, Xiaoyan; Moon, Young-Choon; Trifillis, Panayiota; Welch, Ellen M.; Colacino, Joseph M.; Babiak, John; Almstead, Neil G.; Peltz, Stuart W.; Eng, Loren A.; Chen, Karen S.; Mull, Jesse L.; Lynes, Maureen S.; Rubin, Lee L.; Fontoura, Paulo; Santarelli, Luca; Haehnke, Daniel; McCarthy, Kathleen D.; Schmucki, Roland; Ebeling, Martin; Sivaramakrishnan, Manaswini; Ko, Chien-Ping; Paushkin, Sergey V.; Ratni, Hasane; Gerlach, Irene; Ghosh, Anirvan; Metzger, Friedrich</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">345</span>
        (<span class="NLM_cas:issue">6197</span>),
    <span class="NLM_cas:pages">688-693</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Spinal muscular atrophy (SMA) is a genetic disease caused by mutation or deletion of the survival of motor neuron 1 (SMN1) gene.  A paralogous gene in humans, SMN2, produces low, insufficient levels of functional SMN protein due to alternative splicing that truncates the transcript.  The decreased levels of SMN protein lead to progressive neuromuscular degeneration and high rates of mortality.  Through chem. screening and optimization, we identified orally available small mols. that shift the balance of SMN2 splicing toward the prodn. of full-length SMN2 mRNA with high selectivity.  Administration of these compds. to Δ7 mice, a model of severe SMA, led to an increase in SMN protein levels, improvement of motor function, and protection of the neuromuscular circuit.  These compds. also extended the life span of the mice.  Selective SMN2 splicing modifiers may have therapeutic potential for patients with SMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxZ8QSg5KSzLVg90H21EOLACvtfcHk0lid0YitUn8tAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht12gtLfO&md5=f321c411bb384f95a9fe4d4debcbb195</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1126%2Fscience.1250127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1250127%26sid%3Dliteratum%253Aachs%26aulast%3DNaryshkin%26aufirst%3DN.%2BA.%26aulast%3DWeetall%26aufirst%3DM.%26aulast%3DDakka%26aufirst%3DA.%26aulast%3DNarasimhan%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DFeng%26aufirst%3DZ.%26aulast%3DLing%26aufirst%3DK.%2BK.%2BY.%26aulast%3DKarp%26aufirst%3DG.%2BM.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DWoll%26aufirst%3DM.%2BG.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DGabbeta%26aufirst%3DV.%26aulast%3DVazirani%26aufirst%3DP.%26aulast%3DBhattacharyya%26aufirst%3DA.%26aulast%3DFuria%26aufirst%3DB.%26aulast%3DRisher%26aufirst%3DN.%26aulast%3DSheedy%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DTurpoff%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DC.-S.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoon%26aufirst%3DY.-C.%26aulast%3DTrifillis%26aufirst%3DP.%26aulast%3DWelch%26aufirst%3DE.%2BM.%26aulast%3DColacino%26aufirst%3DJ.%2BM.%26aulast%3DBabiak%26aufirst%3DJ.%26aulast%3DAlmstead%26aufirst%3DN.%2BG.%26aulast%3DPeltz%26aufirst%3DS.%2BW.%26aulast%3DEng%26aufirst%3DL.%2BA.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DMull%26aufirst%3DJ.%2BL.%26aulast%3DLynes%26aufirst%3DM.%2BS.%26aulast%3DRubin%26aufirst%3DL.%2BL.%26aulast%3DFontoura%26aufirst%3DP.%26aulast%3DSantarelli%26aufirst%3DL.%26aulast%3DHaehnke%26aufirst%3DD.%26aulast%3DMcCarthy%26aufirst%3DK.%2BD.%26aulast%3DSchmucki%26aufirst%3DR.%26aulast%3DEbeling%26aufirst%3DM.%26aulast%3DSivaramakrishnan%26aufirst%3DM.%26aulast%3DKo%26aufirst%3DC.-P.%26aulast%3DPaushkin%26aufirst%3DS.%2BV.%26aulast%3DRatni%26aufirst%3DH.%26aulast%3DGerlach%26aufirst%3DI.%26aulast%3DGhosh%26aufirst%3DA.%26aulast%3DMetzger%26aufirst%3DF.%26atitle%3DSMN2%2520splicing%2520modifiers%2520improve%2520motor%2520function%2520and%2520longevity%2520in%2520mice%2520with%2520spinal%2520muscular%2520atrophy%26jtitle%3DScience%26date%3D2014%26volume%3D345%26spage%3D688%26epage%3D693%26doi%3D10.1126%2Fscience.1250127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Woll, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turpoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almstead, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naryshkin, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dakka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narasimhan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabbeta, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welch, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Risher, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheedy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weetall, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karp, G. M.</span></span> <span> </span><span class="NLM_article-title">Discovery and optimization of small molecule splicing modifiers of survival motor neuron 2 as a treatment for spinal muscular atrophy</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6070</span>– <span class="NLM_lpage">6085</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00460</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00460" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XpslWgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6070-6085&author=M.+G.+Wollauthor=H.+Qiauthor=A.+Turpoffauthor=N.+Zhangauthor=X.+Zhangauthor=G.+Chenauthor=C.+Liauthor=S.+Huangauthor=T.+Yangauthor=Y.-C.+Moonauthor=C.-S.+Leeauthor=S.+Choiauthor=N.+G.+Almsteadauthor=N.+A.+Naryshkinauthor=A.+Dakkaauthor=J.+Narasimhanauthor=V.+Gabbetaauthor=E.+Welchauthor=X.+Zhaoauthor=N.+Risherauthor=J.+Sheedyauthor=M.+Weetallauthor=G.+M.+Karp&title=Discovery+and+optimization+of+small+molecule+splicing+modifiers+of+survival+motor+neuron+2+as+a+treatment+for+spinal+muscular+atrophy&doi=10.1021%2Facs.jmedchem.6b00460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of Small Molecule Splicing Modifiers of Survival Motor Neuron 2 as a Treatment for Spinal Muscular Atrophy</span></div><div class="casAuthors">Woll, Matthew G.; Qi, Hongyan; Turpoff, Anthony; Zhang, Nanjing; Zhang, Xiaoyan; Chen, Guangming; Li, Chunshi; Huang, Song; Yang, Tianle; Moon, Young-Choon; Lee, Chang-Sun; Choi, Soongyu; Almstead, Neil G.; Naryshkin, Nikolai A.; Dakka, Amal; Narasimhan, Jana; Gabbeta, Vijayalakshmi; Welch, Ellen; Zhao, Xin; Risher, Nicole; Sheedy, Josephine; Weetall, Marla; Karp, Gary M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6070-6085</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The underlying cause of spinal muscular atrophy (SMA) is a deficiency of the survival motor neuron (SMN) protein.  Starting from hits identified in a high-throughput screening campaign and through structure-activity relationship investigations, we have developed small mols. that potently shift the alternative splicing of the SMN2 exon 7, resulting in increased prodn. of the full-length SMN mRNA and protein.  Three novel chem. series, represented by compds. 9, 14, and 20, have been optimized to increase the level of SMN protein by >50% in SMA patient-derived fibroblasts at concns. of <160 nM.  Daily administration of these compds. to severe SMA Δ7 mice results in an increased prodn. of SMN protein in disease-relevant tissues and a significant increase in median survival time in a dose-dependent manner.  Our work supports the development of an orally administered small mol. for the treatment of patients with SMA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF6iU-0q9serVg90H21EOLACvtfcHk0lid0YitUn8tAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpslWgur0%253D&md5=9b32bd7380625b6ddd3e97479f98e79b</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00460%26sid%3Dliteratum%253Aachs%26aulast%3DWoll%26aufirst%3DM.%2BG.%26aulast%3DQi%26aufirst%3DH.%26aulast%3DTurpoff%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DMoon%26aufirst%3DY.-C.%26aulast%3DLee%26aufirst%3DC.-S.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DAlmstead%26aufirst%3DN.%2BG.%26aulast%3DNaryshkin%26aufirst%3DN.%2BA.%26aulast%3DDakka%26aufirst%3DA.%26aulast%3DNarasimhan%26aufirst%3DJ.%26aulast%3DGabbeta%26aufirst%3DV.%26aulast%3DWelch%26aufirst%3DE.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DRisher%26aufirst%3DN.%26aulast%3DSheedy%26aufirst%3DJ.%26aulast%3DWeetall%26aufirst%3DM.%26aulast%3DKarp%26aufirst%3DG.%2BM.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520small%2520molecule%2520splicing%2520modifiers%2520of%2520survival%2520motor%2520neuron%25202%2520as%2520a%2520treatment%2520for%2520spinal%2520muscular%2520atrophy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6070%26epage%3D6085%26doi%3D10.1021%2Facs.jmedchem.6b00460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kurata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumi, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otsuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurono, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komiya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizuno, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shioya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ono, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takada, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tominaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunoya, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiyoshi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komeno, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakade, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habashita, H.</span></span> <span> </span><span class="NLM_article-title">Discovery of a 1-methyl-3,4-dihydronaphthalene-based sphingosine-1-phosphate (S1P) receptor agonist ceralifimod (ONO-4641). A S<sub>1</sub>P<sub>1</sub> and S1P<sub>5</sub> selective agonist for the treatment of autoimmune diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9508</span>– <span class="NLM_lpage">9530</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00785</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00785" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9508-9530&author=H.+Kurataauthor=K.+Kusumiauthor=K.+Otsukiauthor=R.+Suzukiauthor=M.+Kuronoauthor=T.+Komiyaauthor=H.+Hagiyaauthor=H.+Mizunoauthor=H.+Shioyaauthor=T.+Onoauthor=Y.+Takadaauthor=T.+Maedaauthor=N.+Matsunagaauthor=T.+Kondoauthor=S.+Tominagaauthor=K.+Nunoyaauthor=H.+Kiyoshiauthor=M.+Komenoauthor=S.+Nakadeauthor=H.+Habashita&title=Discovery+of+a+1-methyl-3%2C4-dihydronaphthalene-based+sphingosine-1-phosphate+%28S1P%29+receptor+agonist+ceralifimod+%28ONO-4641%29.+A+S1P1+and+S1P5+selective+agonist+for+the+treatment+of+autoimmune+diseases&doi=10.1021%2Facs.jmedchem.7b00785"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00785%26sid%3Dliteratum%253Aachs%26aulast%3DKurata%26aufirst%3DH.%26aulast%3DKusumi%26aufirst%3DK.%26aulast%3DOtsuki%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DKurono%26aufirst%3DM.%26aulast%3DKomiya%26aufirst%3DT.%26aulast%3DHagiya%26aufirst%3DH.%26aulast%3DMizuno%26aufirst%3DH.%26aulast%3DShioya%26aufirst%3DH.%26aulast%3DOno%26aufirst%3DT.%26aulast%3DTakada%26aufirst%3DY.%26aulast%3DMaeda%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DN.%26aulast%3DKondo%26aufirst%3DT.%26aulast%3DTominaga%26aufirst%3DS.%26aulast%3DNunoya%26aufirst%3DK.%26aulast%3DKiyoshi%26aufirst%3DH.%26aulast%3DKomeno%26aufirst%3DM.%26aulast%3DNakade%26aufirst%3DS.%26aulast%3DHabashita%26aufirst%3DH.%26atitle%3DDiscovery%2520of%2520a%25201-methyl-3%252C4-dihydronaphthalene-based%2520sphingosine-1-phosphate%2520%2528S1P%2529%2520receptor%2520agonist%2520ceralifimod%2520%2528ONO-4641%2529.%2520A%2520S1P1%2520and%2520S1P5%2520selective%2520agonist%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9508%26epage%3D9530%26doi%3D10.1021%2Facs.jmedchem.7b00785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bezençon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Remeň, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capeleto, B.</span></span> <span> </span><span class="NLM_article-title">Discovery and evaluation of Ca<sub>V</sub>3.1-selective T-type calcium channel blockers</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">5322</span>– <span class="NLM_lpage">5325</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.09.063</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2017.09.063" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=29066309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs12lu7jK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=5322-5325&author=O.+Bezen%C3%A7onauthor=L.+Reme%C5%88author=S.+Richardauthor=C.+Rochauthor=M.+Kesslerauthor=R.+Moonauthor=J.+Mawetauthor=E.+A.+Ertelauthor=T.+Pfeiferauthor=B.+Capeleto&title=Discovery+and+evaluation+of+CaV3.1-selective+T-type+calcium+channel+blockers&doi=10.1016%2Fj.bmcl.2017.09.063"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and evaluation of Cav3.1-selective T-type calcium channel blockers</span></div><div class="casAuthors">Bezencon, Olivier; Remen, Lubos; Richard, Sylvia; Roch, Catherine; Kessler, Melanie; Moon, Richard; Mawet, Jacques; Ertel, Eric A.; Pfeifer, Thomas; Capeleto, Bruno</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">5322-5325</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The authors identified and characterized a series of pyrazole amides as potent, selective Cav3.1-blockers.  This series culminated with the identification of pyrazole amides (I) and (II), with excellent potencies and/or selectivities toward the Cav3.2- and Cav3.3-channels.  This compd. displays poor DMPK properties, making its use difficult for in vivo applications.  Nevertheless, this compd. as well as analogous ones are well-suited for in vitro studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-J6_wLd5WF7Vg90H21EOLACvtfcHk0lgO5wvhiHgfbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs12lu7jK&md5=c64ab553e9c4b62d8f25573538ebfa6d</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.09.063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.09.063%26sid%3Dliteratum%253Aachs%26aulast%3DBezen%25C3%25A7on%26aufirst%3DO.%26aulast%3DReme%25C5%2588%26aufirst%3DL.%26aulast%3DRichard%26aufirst%3DS.%26aulast%3DRoch%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DM.%26aulast%3DMoon%26aufirst%3DR.%26aulast%3DMawet%26aufirst%3DJ.%26aulast%3DErtel%26aufirst%3DE.%2BA.%26aulast%3DPfeifer%26aufirst%3DT.%26aulast%3DCapeleto%26aufirst%3DB.%26atitle%3DDiscovery%2520and%2520evaluation%2520of%2520CaV3.1-selective%2520T-type%2520calcium%2520channel%2520blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D5322%26epage%3D5325%26doi%3D10.1016%2Fj.bmcl.2017.09.063" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bezençon, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heidmann, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegrist, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stamm, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richard, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pozzi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corminboeuf, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ertel, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymond, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Kanter, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toeroek-Schafroth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moccia, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mawet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capeleto, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fournier, E.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent, selective T-type calcium channel blocker as a drug candidate for the treatment of generalized epilepsies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">9769</span>– <span class="NLM_lpage">9789</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01236</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01236" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslyrsL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=9769-9789&author=O.+Bezen%C3%A7onauthor=B.+Heidmannauthor=R.+Siegristauthor=S.+Stammauthor=S.+Richardauthor=D.+Pozziauthor=O.+Corminboeufauthor=C.+Rochauthor=M.+Kesslerauthor=E.+A.+Ertelauthor=I.+Reymondauthor=T.+Pfeiferauthor=R.+de+Kanterauthor=M.+Toeroek-Schafrothauthor=L.+G.+Mocciaauthor=J.+Mawetauthor=R.+Moonauthor=M.+Reyauthor=B.+Capeletoauthor=E.+Fournier&title=Discovery+of+a+potent%2C+selective+T-type+calcium+channel+blocker+as+a+drug+candidate+for+the+treatment+of+generalized+epilepsies&doi=10.1021%2Facs.jmedchem.7b01236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent, Selective T-type Calcium Channel Blocker as a Drug Candidate for the Treatment of Generalized Epilepsies</span></div><div class="casAuthors">Bezencon, Olivier; Heidmann, Bibia; Siegrist, Romain; Stamm, Simon; Richard, Sylvia; Pozzi, Davide; Corminboeuf, Olivier; Roch, Catherine; Kessler, Melanie; Ertel, Eric A.; Reymond, Isabelle; Pfeifer, Thomas; de Kanter, Ruben; Toeroek-Schafroth, Michael; Moccia, Luca G.; Mawet, Jacques; Moon, Richard; Rey, Markus; Capeleto, Bruno; Fournier, Elvire</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9769-9789</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors report the discovery and pharmacol. characterization of N-(1-benzyl-1H-pyrazol-3-yl)-2-phenylacetamide derivs. as potent, selective, brain-penetrating T-type calcium channel blockers.  Optimization focused mainly on soly., brain penetration, and the search for an aminopyrazole metabolite that would be neg. in an Ames test.  This resulted in the prepn. and complete characterization of compd. 66b (ACT-709478 (N-(1-((5-cyanopyridin-2-yl)methyl)-1H-pyrazol-3-yl)-2-(4-(1-(trifluoromethyl)cyclopropyl)phenyl)acetamide)), which has been selected as a clin. candidate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJoSIvutRz1bVg90H21EOLACvtfcHk0lgO5wvhiHgfbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslyrsL7L&md5=78907d325d5476978c4b37ec86bc2f11</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01236%26sid%3Dliteratum%253Aachs%26aulast%3DBezen%25C3%25A7on%26aufirst%3DO.%26aulast%3DHeidmann%26aufirst%3DB.%26aulast%3DSiegrist%26aufirst%3DR.%26aulast%3DStamm%26aufirst%3DS.%26aulast%3DRichard%26aufirst%3DS.%26aulast%3DPozzi%26aufirst%3DD.%26aulast%3DCorminboeuf%26aufirst%3DO.%26aulast%3DRoch%26aufirst%3DC.%26aulast%3DKessler%26aufirst%3DM.%26aulast%3DErtel%26aufirst%3DE.%2BA.%26aulast%3DReymond%26aufirst%3DI.%26aulast%3DPfeifer%26aufirst%3DT.%26aulast%3Dde%2BKanter%26aufirst%3DR.%26aulast%3DToeroek-Schafroth%26aufirst%3DM.%26aulast%3DMoccia%26aufirst%3DL.%2BG.%26aulast%3DMawet%26aufirst%3DJ.%26aulast%3DMoon%26aufirst%3DR.%26aulast%3DRey%26aufirst%3DM.%26aulast%3DCapeleto%26aufirst%3DB.%26aulast%3DFournier%26aufirst%3DE.%26atitle%3DDiscovery%2520of%2520a%2520potent%252C%2520selective%2520T-type%2520calcium%2520channel%2520blocker%2520as%2520a%2520drug%2520candidate%2520for%2520the%2520treatment%2520of%2520generalized%2520epilepsies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D9769%26epage%3D9789%26doi%3D10.1021%2Facs.jmedchem.7b01236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, K.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beno, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parcella, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bender, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grant-Young, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nickel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunaga, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anjanappa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bora, R. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigat, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lemm, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheriff, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanumegowda, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhuo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, Y.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haskell, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colston, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raybon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santone, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soars, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span> <span> </span><span class="NLM_article-title">Discovery of a hepatitis C virus NS5B replicase palm site allosteric inhibitor (BMS-929075) advanced to phase 1 clinical studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">4369</span>– <span class="NLM_lpage">4385</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00328</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00328" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmsFWqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=4369-4385&author=K.-S.+Yeungauthor=B.+R.+Benoauthor=K.+Parcellaauthor=J.+A.+Benderauthor=K.+A.+Grant-Youngauthor=A.+Nickelauthor=P.+Gunagaauthor=P.+Anjanappaauthor=R.+O.+Boraauthor=K.+Selvakumarauthor=K.+Rigatauthor=Y.-K.+Wangauthor=M.+Liuauthor=J.+Lemmauthor=K.+Mosureauthor=S.+Sheriffauthor=C.+Wanauthor=M.+Witmerauthor=K.+Kishauthor=U.+Hanumegowdaauthor=X.+Zhuoauthor=Y.-Z.+Shuauthor=D.+Parkerauthor=R.+Haskellauthor=A.+Ngauthor=Q.+Gaoauthor=E.+Colstonauthor=J.+Raybonauthor=D.+M.+Graselaauthor=K.+Santoneauthor=M.+Gaoauthor=N.+A.+Meanwellauthor=M.+Sinzauthor=M.+G.+Soarsauthor=J.+O.+Knipeauthor=S.+B.+Robertsauthor=J.+F.+Kadow&title=Discovery+of+a+hepatitis+C+virus+NS5B+replicase+palm+site+allosteric+inhibitor+%28BMS-929075%29+advanced+to+phase+1+clinical+studies&doi=10.1021%2Facs.jmedchem.7b00328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Hepatitis C Virus NS5B Replicase Palm Site Allosteric Inhibitor (BMS-929075) Advanced to Phase 1 Clinical Studies</span></div><div class="casAuthors">Yeung, Kap-Sun; Beno, Brett R.; Parcella, Kyle; Bender, John A.; Grant-Young, Katherine A.; Nickel, Andrew; Gunaga, Prashantha; Anjanappa, Prakash; Bora, Rajesh Onkardas; Selvakumar, Kumaravel; Rigat, Karen; Wang, Ying-Kai; Liu, Mengping; Lemm, Julie; Mosure, Kathy; Sheriff, Steven; Wan, Changhong; Witmer, Mark; Kish, Kevin; Hanumegowda, Umesh; Zhuo, Xiaoliang; Shu, Yue-Zhong; Parker, Dawn; Haskell, Roy; Ng, Alicia; Gao, Qi; Colston, Elizabeth; Raybon, Joseph; Grasela, Dennis M.; Santone, Kenneth; Gao, Min; Meanwell, Nicholas A.; Sinz, Michael; Soars, Matthew G.; Knipe, Jay O.; Roberts, Susan B.; Kadow, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4369-4385</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The hepatitis C virus (HCV) NS5B replicase is a prime target for the development of direct-acting antiviral drugs for the treatment of chronic HCV infection.  Inspired by the overlay of bound structures of three structurally distinct NS5B palm site allosteric inhibitors, the high-throughput screening hit anthranilic acid 4, the known benzofuran analog 5, and the benzothiadiazine deriv. 6, an optimization process utilizing the simple benzofuran template 7 as a starting point for a fragment growing approach was pursued.  A delicate balance of mol. properties achieved via disciplined lipophilicity changes was essential to achieve both high affinity binding and a stringent targeted absorption, distribution, metab., and excretion profile.  These efforts led to the discovery of BMS-929075 (37), which maintained ligand efficiency relative to early leads, demonstrated efficacy in a triple combination regimen in HCV replicon cells, and exhibited consistently high oral bioavailability and pharmacokinetic parameters across preclin. animal species.  The human PK properties from the Phase I clin. studies of 37 were better than anticipated and suggest promising potential for QD administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ0KsD9y5uorVg90H21EOLACvtfcHk0lgeJqWQ2r_9Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmsFWqtbY%253D&md5=354b41a850bfa225b52baeddb1cb59b0</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00328%26sid%3Dliteratum%253Aachs%26aulast%3DYeung%26aufirst%3DK.-S.%26aulast%3DBeno%26aufirst%3DB.%2BR.%26aulast%3DParcella%26aufirst%3DK.%26aulast%3DBender%26aufirst%3DJ.%2BA.%26aulast%3DGrant-Young%26aufirst%3DK.%2BA.%26aulast%3DNickel%26aufirst%3DA.%26aulast%3DGunaga%26aufirst%3DP.%26aulast%3DAnjanappa%26aufirst%3DP.%26aulast%3DBora%26aufirst%3DR.%2BO.%26aulast%3DSelvakumar%26aufirst%3DK.%26aulast%3DRigat%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DLemm%26aufirst%3DJ.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSheriff%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DC.%26aulast%3DWitmer%26aufirst%3DM.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DHanumegowda%26aufirst%3DU.%26aulast%3DZhuo%26aufirst%3DX.%26aulast%3DShu%26aufirst%3DY.-Z.%26aulast%3DParker%26aufirst%3DD.%26aulast%3DHaskell%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DColston%26aufirst%3DE.%26aulast%3DRaybon%26aufirst%3DJ.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DSantone%26aufirst%3DK.%26aulast%3DGao%26aufirst%3DM.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DSinz%26aufirst%3DM.%26aulast%3DSoars%26aufirst%3DM.%2BG.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DRoberts%26aufirst%3DS.%2BB.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DDiscovery%2520of%2520a%2520hepatitis%2520C%2520virus%2520NS5B%2520replicase%2520palm%2520site%2520allosteric%2520inhibitor%2520%2528BMS-929075%2529%2520advanced%2520to%2520phase%25201%2520clinical%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D4369%26epage%3D4385%26doi%3D10.1021%2Facs.jmedchem.7b00328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selyutin, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dwyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nair, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sha, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruck, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, I. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrawal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curry, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McMonagle, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bystol, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lahser, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rokosz, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingravallo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, K.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cartwright, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asante-Appiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of ruzasvir (MK-8408): a potent, pan-genotype HCV NS5A inhibitor with optimized activity against common resistance-associated polymorphisms</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">306</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01310</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01310" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslygt7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=290-306&author=L.+Tongauthor=W.+Yuauthor=L.+Chenauthor=O.+Selyutinauthor=M.+P.+Dwyerauthor=A.+G.+Nairauthor=R.+Mazzolaauthor=J.-H.+Kimauthor=D.+Shaauthor=J.+Yinauthor=R.+T.+Ruckauthor=I.+W.+Daviesauthor=B.+Huauthor=B.+Zhongauthor=J.+Haoauthor=T.+Jiauthor=S.+Zanauthor=R.+Liuauthor=S.+Agrawalauthor=E.+Xiaauthor=S.+Curryauthor=P.+McMonagleauthor=K.+Bystolauthor=F.+Lahserauthor=D.+Carrauthor=L.+Rokoszauthor=P.+Ingravalloauthor=S.+Chenauthor=K.-I.+Fengauthor=M.+Cartwrightauthor=E.+Asante-Appiahauthor=J.+A.+Kozlowski&title=Discovery+of+ruzasvir+%28MK-8408%29%3A+a+potent%2C+pan-genotype+HCV+NS5A+inhibitor+with+optimized+activity+against+common+resistance-associated+polymorphisms&doi=10.1021%2Facs.jmedchem.6b01310"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Ruzasvir (MK-8408): A Potent, Pan-Genotype HCV NS5A Inhibitor with Optimized Activity against Common Resistance-Associated Polymorphisms</span></div><div class="casAuthors">Tong, Ling; Yu, Wensheng; Chen, Lei; Selyutin, Oleg; Dwyer, Michael P.; Nair, Anilkumar G.; Mazzola, Robert; Kim, Jae-Hun; Sha, Deyou; Yin, Jingjun; Ruck, Rebecca T.; Davies, Ian W.; Hu, Bin; Zhong, Bin; Hao, Jinglai; Ji, Tao; Zan, Shuai; Liu, Rong; Agrawal, Sony; Xia, Ellen; Curry, Stephanie; McMonagle, Patricia; Bystol, Karin; Lahser, Frederick; Carr, Donna; Rokosz, Laura; Ingravallo, Paul; Chen, Shiying; Feng, Kung-I.; Cartwright, Mark; Asante-Appiah, Ernest; Kozlowski, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">290-306</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the research that led to the discovery of compd. 40 (ruzasvir, MK-8408), a pan-genotypic HCV nonstructural protein 5A (NS5A) inhibitor with a "flat" GT1 mutant profile.  This NS5A inhibitor contains a unique tetracyclic indole core, while maintaining the imidazole-proline-valine Moc motifs of the authors' previous NS5A inhibitors.  Compd. 40 is currently in early clin. trials and is under evaluation as part of an all-oral DAA regimen for the treatment of chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5FD27q2S7fLVg90H21EOLACvtfcHk0lgeJqWQ2r_9Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslygt7jN&md5=6224e41b940abfb96cda518ecebf3e0f</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01310%26sid%3Dliteratum%253Aachs%26aulast%3DTong%26aufirst%3DL.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DSelyutin%26aufirst%3DO.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DNair%26aufirst%3DA.%2BG.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DSha%26aufirst%3DD.%26aulast%3DYin%26aufirst%3DJ.%26aulast%3DRuck%26aufirst%3DR.%2BT.%26aulast%3DDavies%26aufirst%3DI.%2BW.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DT.%26aulast%3DZan%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DCurry%26aufirst%3DS.%26aulast%3DMcMonagle%26aufirst%3DP.%26aulast%3DBystol%26aufirst%3DK.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DCarr%26aufirst%3DD.%26aulast%3DRokosz%26aufirst%3DL.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DFeng%26aufirst%3DK.-I.%26aulast%3DCartwright%26aufirst%3DM.%26aulast%3DAsante-Appiah%26aufirst%3DE.%26aulast%3DKozlowski%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%2520ruzasvir%2520%2528MK-8408%2529%253A%2520a%2520potent%252C%2520pan-genotype%2520HCV%2520NS5A%2520inhibitor%2520with%2520optimized%2520activity%2520against%2520common%2520resistance-associated%2520polymorphisms%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D290%26epage%3D306%26doi%3D10.1021%2Facs.jmedchem.6b01310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coburn, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meinke, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fandozzi, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kargman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozlowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCauley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomeir, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soll, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vacca, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludmerer, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of MK-8742: An HCV NS5A inhibitor with broad genotype activity</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1930</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300343</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2Fcmdc.201300343" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=24127258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1SkurzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=1930-1940&author=C.+A.+Coburnauthor=P.+T.+Meinkeauthor=W.+Changauthor=C.+M.+Fandozziauthor=D.+J.+Grahamauthor=B.+Huauthor=Q.+Huangauthor=S.+Kargmanauthor=J.+Kozlowskiauthor=R.+Liuauthor=J.+A.+McCauleyauthor=A.+A.+Nomeirauthor=R.+M.+Sollauthor=J.+P.+Vaccaauthor=D.+Wangauthor=H.+Wuauthor=B.+Zhongauthor=D.+B.+Olsenauthor=S.+W.+Ludmerer&title=Discovery+of+MK-8742%3A+An+HCV+NS5A+inhibitor+with+broad+genotype+activity&doi=10.1002%2Fcmdc.201300343"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of MK-8742: An HCV NS5A inhibitor with broad genotype activity</span></div><div class="casAuthors">Coburn, Craig A.; Meinke, Peter T.; Chang, Wei; Fandozzi, Christine M.; Graham, Donald J.; Hu, Bin; Huang, Qian; Kargman, Stacia; Kozlowski, Joseph; Liu, Rong; McCauley, John A.; Nomeir, Amin A.; Soll, Richard M.; Vacca, Joseph P.; Wang, Dahai; Wu, Hao; Zhong, Bin; Olsen, David B.; Ludmerer, Steven W.</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1930-1940</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">The NS5A protein plays a crit. role in the replication of HCV and has been the focus of numerous research efforts over the past few years.  NS5A inhibitors have shown impressive in vitro potency profiles in HCV replicon assays, making them attractive components for inclusion in all oral combination regimens.  Early work in the NS5A arena led to the discovery of our first clin. candidate, MK-4882 [2-((S)-pyrrolidin-2-yl)-5-(2-(4-(5-((S)-pyrrolidin-2-yl)-1H-imidazol-2-yl)phenyl)benzofuran-5-yl)-1H-imidazole].  While preclin. proof-of-concept studies in HCV-infected chimpanzees harboring chronic genotype 1 infections resulted in significant decreases in viral load after both single- and multiple-dose treatments, viral breakthrough proved to be a concern, thus necessitating the development of compds. with increased potency against a no. of genotypes and NS5A resistance mutations.  Modification of the MK-4882 core scaffold by introduction of a cyclic constraint afforded a series of tetracyclic inhibitors, which showed improved virol. profiles.  Herein we describe the research efforts that led to the discovery of MK-8742, a tetracyclic indole-based NS5A inhibitor, which is currently in phase 2b clin. trials as part of an all-oral, interferon-free regimen for the treatment of HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqknZKO01aZlLVg90H21EOLACvtfcHk0ljiaSUR9DwarA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1SkurzN&md5=2f2b3ed2281c43e39b24d4197b9f57ee</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300343%26sid%3Dliteratum%253Aachs%26aulast%3DCoburn%26aufirst%3DC.%2BA.%26aulast%3DMeinke%26aufirst%3DP.%2BT.%26aulast%3DChang%26aufirst%3DW.%26aulast%3DFandozzi%26aufirst%3DC.%2BM.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHu%26aufirst%3DB.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DKargman%26aufirst%3DS.%26aulast%3DKozlowski%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DNomeir%26aufirst%3DA.%2BA.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26aulast%3DWang%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZhong%26aufirst%3DB.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520MK-8742%253A%2520An%2520HCV%2520NS5A%2520inhibitor%2520with%2520broad%2520genotype%2520activity%26jtitle%3DChemMedChem%26date%3D2013%26volume%3D8%26spage%3D1930%26epage%3D1940%26doi%3D10.1002%2Fcmdc.201300343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conte, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giuliano, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ercolani, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narjes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francesco, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neddermann, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Migliaccio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stansfield, I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and SAR of piperazinyl-N-phenlybenzamides as inhibitors of hepatitis C RNA replication in cell culture</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1779</span>– <span class="NLM_lpage">1783</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.01.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2009.01.066" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1779-1783&author=I.+Conteauthor=C.+Giulianoauthor=C.+Ercolaniauthor=F.+Narjesauthor=U.+Kochauthor=M.+Rowleyauthor=S.+Altamuraauthor=R.+D.+Francescoauthor=P.+Neddermannauthor=G.+Migliaccioauthor=I.+Stansfield&title=Synthesis+and+SAR+of+piperazinyl-N-phenlybenzamides+as+inhibitors+of+hepatitis+C+RNA+replication+in+cell+culture&doi=10.1016%2Fj.bmcl.2009.01.066"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.01.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.01.066%26sid%3Dliteratum%253Aachs%26aulast%3DConte%26aufirst%3DI.%26aulast%3DGiuliano%26aufirst%3DC.%26aulast%3DErcolani%26aufirst%3DC.%26aulast%3DNarjes%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DRowley%26aufirst%3DM.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DFrancesco%26aufirst%3DR.%2BD.%26aulast%3DNeddermann%26aufirst%3DP.%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DStansfield%26aufirst%3DI.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520piperazinyl-N-phenlybenzamides%2520as%2520inhibitors%2520of%2520hepatitis%2520C%2520RNA%2520replication%2520in%2520cell%2520culture%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1779%26epage%3D1783%26doi%3D10.1016%2Fj.bmcl.2009.01.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mull, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Andrea, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venables, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sit, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cocuzza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bilder, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampulla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palani, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friborg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheaffer, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knipe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schartman, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donoso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mosure, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinz, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zvyaga, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajamani, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kish, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tredup, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klei, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mueller, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levesque, P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cockett, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McPhee, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scola, P. M.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent acyclic, tripeptidic, acyl sulfonamide inhibitor of Hepatitis C Virus NS3 protease as a back-up to Asunaprevir with the potential for once-daily dosing</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">8042</span>– <span class="NLM_lpage">8060</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00821</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00821" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhtl2rsrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=8042-8060&author=L.-Q.+Sunauthor=E.+Mullauthor=B.+Zhengauthor=S.+D%E2%80%99Andreaauthor=Q.+Zhaoauthor=A.+X.+Wangauthor=N.+Sinauthor=B.+L.+Venablesauthor=S.-Y.+Sitauthor=Y.+Chenauthor=J.+Chenauthor=A.+Cocuzzaauthor=D.+M.+Bilderauthor=A.+Mathurauthor=R.+Rampullaauthor=B.-C.+Chenauthor=T.+Palaniauthor=S.+Ganesanauthor=P.+N.+Arunachalamauthor=P.+Falkauthor=S.+Levineauthor=C.+Chenauthor=J.+Friborgauthor=F.+Yuauthor=D.+Hernandezauthor=A.+K.+Sheafferauthor=J.+O.+Knipeauthor=Y.-H.+Hanauthor=R.+Schartmanauthor=M.+Donosoauthor=K.+Mosureauthor=M.+W.+Sinzauthor=T.+Zvyagaauthor=R.+Rajamaniauthor=K.+Kishauthor=J.+Tredupauthor=H.+E.+Kleiauthor=Q.+Gaoauthor=A.+Ngauthor=L.+Muellerauthor=D.+M.+Graselaauthor=S.+Adamsauthor=J.+Loyauthor=P.+C.+Levesqueauthor=H.+Sunauthor=H.+Shiauthor=L.+Sunauthor=W.+Warnerauthor=D.+Liauthor=J.+Zhuauthor=Y.-K.+Wangauthor=H.+Fangauthor=M.+I.+Cockettauthor=N.+A.+Meanwellauthor=F.+McPheeauthor=P.+M.+Scola&title=Discovery+of+a+potent+acyclic%2C+tripeptidic%2C+acyl+sulfonamide+inhibitor+of+Hepatitis+C+Virus+NS3+protease+as+a+back-up+to+Asunaprevir+with+the+potential+for+once-daily+dosing&doi=10.1021%2Facs.jmedchem.6b00821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing</span></div><div class="casAuthors">Sun, Li-Qiang; Mull, Eric; Zheng, Barbara; D'Andrea, Stanley; Zhao, Qian; Wang, Alan Xiangdong; Sin, Ny; Venables, Brian L.; Sit, Sing-Yuen; Chen, Yan; Chen, Jie; Cocuzza, Anthony; Bilder, Donna M.; Mathur, Arvind; Rampulla, Richard; Chen, Bang-Chi; Palani, Theerthagiri; Ganesan, Sivakumar; Arunachalam, Pirama Nayagam; Falk, Paul; Levine, Steven; Chen, Chaoqun; Friborg, Jacques; Yu, Fei; Hernandez, Dennis; Sheaffer, Amy K.; Knipe, Jay O.; Han, Yong-Hae; Schartman, Richard; Donoso, Maria; Mosure, Kathy; Sinz, Michael W.; Zvyaga, Tatyana; Rajamani, Ramkumar; Kish, Kevin; Tredup, Jeffrey; Klei, Herbert E.; Gao, Qi; Ng, Alicia; Mueller, Luciano; Grasela, Dennis M.; Adams, Stephen; Loy, James; Levesque, Paul C.; Sun, Huabin; Shi, Hong; Sun, Lucy; Warner, William; Li, Danshi; Zhu, Jialong; Wang, Ying-Kai; Fang, Hua; Cockett, Mark I.; Meanwell, Nicholas A.; McPhee, Fiona; Scola, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">8042-8060</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery of a back-up to the hepatitis C virus NS3 protease inhibitor asunaprevir is described.  The objective of this work was the identification of a drug with antiviral properties and toxicol. parameters similar to asunaprevir, but with a preclin. pharmacokinetic (PK) profile that was predictive of once-daily dosing.  Crit. to this discovery process was the employment of an ex vivo cardiovascular (CV) model which served to identify compds. that, like asunaprevir, were free of the CV liabilities that resulted in the discontinuation of BMS-605339 from clin. trials.  Structure-activity relationships (SARs) at each of the structural subsites in asunaprevir were explored with substantial improvement in PK through modifications at the P1 site, while potency gains were found with small, but rationally designed structural changes to P4.  Addnl. modifications at P3 were required to optimize the CV profile, and these combined SARs led to the discovery of BMS-890068 I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAfdJwdSryH7Vg90H21EOLACvtfcHk0lhfwT0E7ynhpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhtl2rsrnK&md5=9d87037fcf23ef830e7ea02a6c6f2f8b</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00821%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DL.-Q.%26aulast%3DMull%26aufirst%3DE.%26aulast%3DZheng%26aufirst%3DB.%26aulast%3DD%25E2%2580%2599Andrea%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DA.%2BX.%26aulast%3DSin%26aufirst%3DN.%26aulast%3DVenables%26aufirst%3DB.%2BL.%26aulast%3DSit%26aufirst%3DS.-Y.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DCocuzza%26aufirst%3DA.%26aulast%3DBilder%26aufirst%3DD.%2BM.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DRampulla%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DB.-C.%26aulast%3DPalani%26aufirst%3DT.%26aulast%3DGanesan%26aufirst%3DS.%26aulast%3DArunachalam%26aufirst%3DP.%2BN.%26aulast%3DFalk%26aufirst%3DP.%26aulast%3DLevine%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DFriborg%26aufirst%3DJ.%26aulast%3DYu%26aufirst%3DF.%26aulast%3DHernandez%26aufirst%3DD.%26aulast%3DSheaffer%26aufirst%3DA.%2BK.%26aulast%3DKnipe%26aufirst%3DJ.%2BO.%26aulast%3DHan%26aufirst%3DY.-H.%26aulast%3DSchartman%26aufirst%3DR.%26aulast%3DDonoso%26aufirst%3DM.%26aulast%3DMosure%26aufirst%3DK.%26aulast%3DSinz%26aufirst%3DM.%2BW.%26aulast%3DZvyaga%26aufirst%3DT.%26aulast%3DRajamani%26aufirst%3DR.%26aulast%3DKish%26aufirst%3DK.%26aulast%3DTredup%26aufirst%3DJ.%26aulast%3DKlei%26aufirst%3DH.%2BE.%26aulast%3DGao%26aufirst%3DQ.%26aulast%3DNg%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DL.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DAdams%26aufirst%3DS.%26aulast%3DLoy%26aufirst%3DJ.%26aulast%3DLevesque%26aufirst%3DP.%2BC.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DWarner%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-K.%26aulast%3DFang%26aufirst%3DH.%26aulast%3DCockett%26aufirst%3DM.%2BI.%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DMcPhee%26aufirst%3DF.%26aulast%3DScola%26aufirst%3DP.%2BM.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520acyclic%252C%2520tripeptidic%252C%2520acyl%2520sulfonamide%2520inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520NS3%2520protease%2520as%2520a%2520back-up%2520to%2520Asunaprevir%2520with%2520the%2520potential%2520for%2520once-daily%2520dosing%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D8042%26epage%3D8060%26doi%3D10.1021%2Facs.jmedchem.6b00821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hui, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doerffler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neville, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carra, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lew, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolfe, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jordan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloveva, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perron, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stray, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barauskas, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rheingold, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swaminathan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, W. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bavari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cihlar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warren, T. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mackman, R. L.</span></span> <span> </span><span class="NLM_article-title">Discovery and synthesis of a phosphoramidate prodrug of a pyrrolo[2,1-<i>f</i>][triazin-4-amino] adenine C-nucleoside (GS-5734) for the treatment of Ebola and emerging viruses</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1648</span>– <span class="NLM_lpage">1661</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01594</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01594" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1648-1661&author=D.+Siegelauthor=H.+C.+Huiauthor=E.+Doerfflerauthor=M.+O.+Clarkeauthor=K.+Chunauthor=L.+Zhangauthor=S.+Nevilleauthor=E.+Carraauthor=W.+Lewauthor=B.+Rossauthor=Q.+Wangauthor=L.+Wolfeauthor=R.+Jordanauthor=V.+Solovevaauthor=J.+Knoxauthor=J.+Perryauthor=M.+Perronauthor=K.+M.+Strayauthor=O.+Barauskasauthor=J.+Y.+Fengauthor=Y.+Xuauthor=G.+Leeauthor=A.+L.+Rheingoldauthor=A.+S.+Rayauthor=R.+Bannisterauthor=R.+Strickleyauthor=S.+Swaminathanauthor=W.+A.+Leeauthor=S.+Bavariauthor=T.+Cihlarauthor=M.+K.+Loauthor=T.+K.+Warrenauthor=R.+L.+Mackman&title=Discovery+and+synthesis+of+a+phosphoramidate+prodrug+of+a+pyrrolo%5B2%2C1-f%5D%5Btriazin-4-amino%5D+adenine+C-nucleoside+%28GS-5734%29+for+the+treatment+of+Ebola+and+emerging+viruses&doi=10.1021%2Facs.jmedchem.6b01594"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses</span></div><div class="casAuthors">Siegel, Dustin; Hui, Hon C.; Doerffler, Edward; Clarke, Michael O.; Chun, Kwon; Zhang, Lijun; Neville, Sean; Carra, Ernest; Lew, Willard; Ross, Bruce; Wang, Queenie; Wolfe, Lydia; Jordan, Robert; Soloveva, Veronica; Knox, John; Perry, Jason; Perron, Michel; Stray, Kirsten M.; Barauskas, Ona; Feng, Joy Y.; Xu, Yili; Lee, Gary; Rheingold, Arnold L.; Ray, Adrian S.; Bannister, Roy; Strickley, Robert; Swaminathan, Swami; Lee, William A.; Bavari, Sina; Cihlar, Tomas; Lo, Michael K.; Warren, Travis K.; Mackman, Richard L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1648-1661</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent Ebola virus (EBOV) outbreak in West Africa was the largest recorded in history with over 28,000 cases, resulting in >11,000 deaths including >500 healthcare workers.  A focused screening and lead optimization effort identified 4b (GS-5734) with anti-EBOV EC50 = 86 nM in macrophages as the clin. candidate.  Structure activity relationships established that the 1'-CN group and C-linked nucleobase were crit. for optimal anti-EBOV potency and selectivity against host polymerases.  A robust diastereoselective synthesis provided sufficient quantities of 4b to enable preclin. efficacy in a non-human-primate EBOV challenge model.  Once-daily 10 mg/kg iv treatment on days 3-14 postinfection had a significant effect on viremia and mortality, resulting in 100% survival of infected treated animals [ Nature 2016, 531, 381-385].  A phase 2 study (PREVAIL IV) is currently enrolling and will evaluate the effect of 4b on viral shedding from sanctuary sites in EBOV survivors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfWkPjn__gILVg90H21EOLACvtfcHk0lhfwT0E7ynhpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Gjsb4%253D&md5=b2a05cfeb4fd30fbca0d1d584ddcc220</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01594%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DHui%26aufirst%3DH.%2BC.%26aulast%3DDoerffler%26aufirst%3DE.%26aulast%3DClarke%26aufirst%3DM.%2BO.%26aulast%3DChun%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNeville%26aufirst%3DS.%26aulast%3DCarra%26aufirst%3DE.%26aulast%3DLew%26aufirst%3DW.%26aulast%3DRoss%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWolfe%26aufirst%3DL.%26aulast%3DJordan%26aufirst%3DR.%26aulast%3DSoloveva%26aufirst%3DV.%26aulast%3DKnox%26aufirst%3DJ.%26aulast%3DPerry%26aufirst%3DJ.%26aulast%3DPerron%26aufirst%3DM.%26aulast%3DStray%26aufirst%3DK.%2BM.%26aulast%3DBarauskas%26aufirst%3DO.%26aulast%3DFeng%26aufirst%3DJ.%2BY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DG.%26aulast%3DRheingold%26aufirst%3DA.%2BL.%26aulast%3DRay%26aufirst%3DA.%2BS.%26aulast%3DBannister%26aufirst%3DR.%26aulast%3DStrickley%26aufirst%3DR.%26aulast%3DSwaminathan%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DW.%2BA.%26aulast%3DBavari%26aufirst%3DS.%26aulast%3DCihlar%26aufirst%3DT.%26aulast%3DLo%26aufirst%3DM.%2BK.%26aulast%3DWarren%26aufirst%3DT.%2BK.%26aulast%3DMackman%26aufirst%3DR.%2BL.%26atitle%3DDiscovery%2520and%2520synthesis%2520of%2520a%2520phosphoramidate%2520prodrug%2520of%2520a%2520pyrrolo%255B2%252C1-f%255D%255Btriazin-4-amino%255D%2520adenine%2520C-nucleoside%2520%2528GS-5734%2529%2520for%2520the%2520treatment%2520of%2520Ebola%2520and%2520emerging%2520viruses%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1648%26epage%3D1661%26doi%3D10.1021%2Facs.jmedchem.6b01594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meanwell, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nowicka-Sans, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conlon, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastgate, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grasela, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmins, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadow, J. F.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of HIV-1 attachment: The discovery and development of Temsavir and its prodrug Fostemsavir</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">62</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01337</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01337" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVWnt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=62-80&author=N.+A.+Meanwellauthor=M.+R.+Krystalauthor=B.+Nowicka-Sansauthor=D.+R.+Langleyauthor=D.+A.+Conlonauthor=M.+D.+Eastgateauthor=D.+M.+Graselaauthor=P.+Timminsauthor=T.+Wangauthor=J.+F.+Kadow&title=Inhibitors+of+HIV-1+attachment%3A+The+discovery+and+development+of+Temsavir+and+its+prodrug+Fostemsavir&doi=10.1021%2Facs.jmedchem.7b01337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir</span></div><div class="casAuthors">Meanwell, Nicholas A.; Krystal, Mark R.; Nowicka-Sans, Beata; Langley, David R.; Conlon, David A.; Eastgate, Martin D.; Grasela, Dennis M.; Timmins, Peter; Wang, Tao; Kadow, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">62-80</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Human immunodeficiency virus-1 (HIV-1) infection currently requires lifelong therapy with drugs that are used in combination to control viremia.  The indole-3-glyoxamide 6 was discovered as an inhibitor of HIV-1 infectivity using a phenotypic screen and derivs. of this compd. were found to interfere with the HIV-1 entry process by stabilizing a conformation of the virus gp120 protein not recognized by the host cell CD4 receptor.  An extensive optimization program led to the identification of temsavir (31), which exhibited an improved antiviral and pharmacokinetic profile compared to 6 and was explored in phase 3 clin. trials as the phosphonooxymethyl deriv. fostemsavir (35), a prodrug designed to address dissoln.- and soly.-limited absorption issues.  In this drug annotation, the authors summarize the structure-activity and structure-liability studies leading to the discovery of 31 and the clin. studies conducted with 35 that entailed the development of an extended release formulation suitable for phase 3 clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOcSXTLXS7p7Vg90H21EOLACvtfcHk0lj1pplelGUDaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVWnt7fP&md5=e36e5e0ac4ec79860c757a3bce6d0837</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01337%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26aulast%3DKrystal%26aufirst%3DM.%2BR.%26aulast%3DNowicka-Sans%26aufirst%3DB.%26aulast%3DLangley%26aufirst%3DD.%2BR.%26aulast%3DConlon%26aufirst%3DD.%2BA.%26aulast%3DEastgate%26aufirst%3DM.%2BD.%26aulast%3DGrasela%26aufirst%3DD.%2BM.%26aulast%3DTimmins%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DKadow%26aufirst%3DJ.%2BF.%26atitle%3DInhibitors%2520of%2520HIV-1%2520attachment%253A%2520The%2520discovery%2520and%2520development%2520of%2520Temsavir%2520and%2520its%2520prodrug%2520Fostemsavir%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D62%26epage%3D80%26doi%3D10.1021%2Facs.jmedchem.7b01337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dousson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, F.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amador, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaric, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caillet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Costa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lioure, M.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosinovsky, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maldonado, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayes, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poddesu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargiu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liuzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moussa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakubik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standring, D.</span></span> <span> </span><span class="NLM_article-title">Discovery of the aryl-phospho-indole IDX899, a highly potent anti-HIV non-nucleoside reverse transcriptase inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1891</span>– <span class="NLM_lpage">1898</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01430</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01430" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlWlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1891-1898&author=C.+Doussonauthor=F.-R.+Alexandreauthor=A.+Amadorauthor=S.+Bonaricauthor=S.+Botauthor=C.+Cailletauthor=T.+Convardauthor=D.+da+Costaauthor=M.-P.+Lioureauthor=A.+Rolandauthor=E.+Rosinovskyauthor=S.+Maldonadoauthor=C.+Parsyauthor=C.+Trochetauthor=R.+Storerauthor=A.+Stewartauthor=J.+Wangauthor=B.+A.+Mayesauthor=C.+Musiuauthor=B.+Poddesuauthor=L.+Vargiuauthor=M.+Liuzziauthor=A.+Moussaauthor=J.+Jakubikauthor=L.+Hubbardauthor=M.+Seiferauthor=D.+Standring&title=Discovery+of+the+aryl-phospho-indole+IDX899%2C+a+highly+potent+anti-HIV+non-nucleoside+reverse+transcriptase+inhibitor&doi=10.1021%2Facs.jmedchem.5b01430"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of the Aryl-phospho-indole IDX899, a Highly Potent Anti-HIV Non-nucleoside Reverse Transcriptase Inhibitor</span></div><div class="casAuthors">Dousson, Cyril; Alexandre, Francois-Rene; Amador, Agnes; Bonaric, Severine; Bot, Stephanie; Caillet, Catherine; Convard, Thierry; da Costa, Daniel; Lioure, Marie-Pierre; Roland, Arlene; Rosinovsky, Elodie; Maldonado, Sebastien; Parsy, Christophe; Trochet, Christophe; Storer, Richard; Stewart, Alistair; Wang, Jingyang; Mayes, Benjamin A.; Musiu, Chiara; Poddesu, Barbara; Vargiu, Luana; Liuzzi, Michel; Moussa, Adel; Jakubik, Jocelyn; Hubbard, Luke; Seifer, Maria; Standring, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1891-1898</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Here, we describe the design, synthesis, biol. evaluation, and identification of a clin. candidate non-nucleoside reverse transcriptase inhibitors (NNRTIs) with a novel aryl-phospho-indole (APhI) scaffold.  NNRTIs are recommended components of highly active antiretroviral therapy (HAART) for the treatment of HIV-1.  Since a major problem assocd. with NNRTI treatment is the emergence of drug resistant virus, this work focused on optimization of the APhI against clin. relevant HIV-1 Y181C and K103N mutants and the Y181C/K103N double mutant.  Optimization of the phosphinate aryl substituent led to the discovery of the 3-Me,5-acrylonitrile-Ph analog RP-13s (IDX899) having an EC50 of 11 nM against the Y181C/K103N double mutant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf8LXVc78xiLVg90H21EOLACvtfcHk0lj1pplelGUDaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlWlur0%253D&md5=48e69317dd5bd8d677eb9ccf59ebdbe0</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01430&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01430%26sid%3Dliteratum%253Aachs%26aulast%3DDousson%26aufirst%3DC.%26aulast%3DAlexandre%26aufirst%3DF.-R.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBonaric%26aufirst%3DS.%26aulast%3DBot%26aufirst%3DS.%26aulast%3DCaillet%26aufirst%3DC.%26aulast%3DConvard%26aufirst%3DT.%26aulast%3Dda%2BCosta%26aufirst%3DD.%26aulast%3DLioure%26aufirst%3DM.-P.%26aulast%3DRoland%26aufirst%3DA.%26aulast%3DRosinovsky%26aufirst%3DE.%26aulast%3DMaldonado%26aufirst%3DS.%26aulast%3DParsy%26aufirst%3DC.%26aulast%3DTrochet%26aufirst%3DC.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DStewart%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DMayes%26aufirst%3DB.%2BA.%26aulast%3DMusiu%26aufirst%3DC.%26aulast%3DPoddesu%26aufirst%3DB.%26aulast%3DVargiu%26aufirst%3DL.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DMoussa%26aufirst%3DA.%26aulast%3DJakubik%26aufirst%3DJ.%26aulast%3DHubbard%26aufirst%3DL.%26aulast%3DSeifer%26aufirst%3DM.%26aulast%3DStandring%26aufirst%3DD.%26atitle%3DDiscovery%2520of%2520the%2520aryl-phospho-indole%2520IDX899%252C%2520a%2520highly%2520potent%2520anti-HIV%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1891%26epage%3D1898%26doi%3D10.1021%2Facs.jmedchem.5b01430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, F.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amador, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bot, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caillet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Convard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakubik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musiu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poddesu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargiu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liuzzi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seifer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Standring, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dousson, C. B.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of aryl-phospho-indole as novel HIV-1 non-nucleoside reverse transcriptase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">395</span>, <span class="refDoi"> DOI: 10.1021/jm101142k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm101142k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFCrtL%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=392-395&author=F.-R.+Alexandreauthor=A.+Amadorauthor=S.+Botauthor=C.+Cailletauthor=T.+Convardauthor=J.+Jakubikauthor=C.+Musiuauthor=B.+Poddesuauthor=L.+Vargiuauthor=M.+Liuzziauthor=A.+Rolandauthor=M.+Seiferauthor=D.+Standringauthor=R.+Storerauthor=C.+B.+Dousson&title=Synthesis+and+biological+evaluation+of+aryl-phospho-indole+as+novel+HIV-1+non-nucleoside+reverse+transcriptase+inhibitors&doi=10.1021%2Fjm101142k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Aryl-phospho-indole as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors</span></div><div class="casAuthors">Alexandre, Francois-Rene; Amador, Agnes; Bot, Stephanie; Caillet, Catherine; Convard, Thierry; Jakubik, Jocelyn; Musiu, Chiara; Poddesu, Barbara; Vargiu, Luana; Liuzzi, Michel; Roland, Arlene; Seifer, Maria; Standring, David; Storer, Richard; Dousson, Cyril B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">392-395</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">3-Aryl-phospho-indole (API) non-nucleoside reverse transcriptase inhibitors of HIV-1 were developed.  Chem. variation in the P linker led to the discovery of Me 2-(aminocarbonyl)-5-chloro-1H-indol-3-yl(phenyl)phosphinate (14; shown as I), which possessed excellent potency against wild-type HIV-1 as well as viruses bearing K103N and Y181C single mutants in the reverse transcriptase gene.  Chiral sepn. of the enantiomers of 14 showed that only the R enantiomer retained the activity.  The pharmacokinetic, soly., and metabolic properties of 14 were assessed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG8eWrOof4XLVg90H21EOLACvtfcHk0lg8p6LREjPvfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFCrtL%252FF&md5=59af41ba5ed16faa28921c793ceb404f</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1021%2Fjm101142k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101142k%26sid%3Dliteratum%253Aachs%26aulast%3DAlexandre%26aufirst%3DF.-R.%26aulast%3DAmador%26aufirst%3DA.%26aulast%3DBot%26aufirst%3DS.%26aulast%3DCaillet%26aufirst%3DC.%26aulast%3DConvard%26aufirst%3DT.%26aulast%3DJakubik%26aufirst%3DJ.%26aulast%3DMusiu%26aufirst%3DC.%26aulast%3DPoddesu%26aufirst%3DB.%26aulast%3DVargiu%26aufirst%3DL.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DRoland%26aufirst%3DA.%26aulast%3DSeifer%26aufirst%3DM.%26aulast%3DStandring%26aufirst%3DD.%26aulast%3DStorer%26aufirst%3DR.%26aulast%3DDousson%26aufirst%3DC.%2BB.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520aryl-phospho-indole%2520as%2520novel%2520HIV-1%2520non-nucleoside%2520reverse%2520transcriptase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D392%26epage%3D395%26doi%3D10.1021%2Fjm101142k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamaraj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bulbule, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, F. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dhanasekaran, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hein, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papastogiannidis, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Urwyler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, W. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matile, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vennerstrom, J. L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship of the antimalarial ozonide artefenomel (OZ439)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2654</span>– <span class="NLM_lpage">2668</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01586</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01586" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkslaitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=2654-2668&author=Y.+Dongauthor=X.+Wangauthor=S.+Kamarajauthor=V.+J.+Bulbuleauthor=F.+C.+K.+Chiuauthor=J.+Cholletauthor=M.+Dhanasekaranauthor=C.+D.+Heinauthor=P.+Papastogiannidisauthor=J.+Morizziauthor=D.+M.+Shacklefordauthor=H.+Barkerauthor=E.+Ryanauthor=C.+Scheurerauthor=Y.+Tangauthor=Q.+Zhaoauthor=L.+Zhouauthor=K.+L.+Whiteauthor=H.+Urwylerauthor=W.+N.+Charmanauthor=H.+Matileauthor=S.+Wittlinauthor=S.+A.+Charmanauthor=J.+L.+Vennerstrom&title=Structure-activity+relationship+of+the+antimalarial+ozonide+artefenomel+%28OZ439%29&doi=10.1021%2Facs.jmedchem.6b01586"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439)</span></div><div class="casAuthors">Dong, Yuxiang; Wang, Xiaofang; Kamaraj, Sriraghavan; Bulbule, Vivek J.; Chiu, Francis C. K.; Chollet, Jacques; Dhanasekaran, Manickam; Hein, Christopher D.; Papastogiannidis, Petros; Morizzi, Julia; Shackleford, David M.; Barker, Helena; Ryan, Eileen; Scheurer, Christian; Tang, Yuanqing; Zhao, Qingjie; Zhou, Lin; White, Karen L.; Urwyler, Heinrich; Charman, William N.; Matile, Hugues; Wittlin, Sergio; Charman, Susan A.; Vennerstrom, Jonathan L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2654-2668</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Building on insights gained from the discovery of the antimalarial ozonide arterolane (OZ277), we now describe the structure-activity relationship (SAR) of the antimalarial ozonide artefenomel (OZ439).  Primary and secondary amino ozonides had higher metabolic stabilities than tertiary amino ozonides, consistent with their higher pKa and lower log D7.4 values.  For primary amino ozonides, addn. of polar functional groups decreased in vivo antimalarial efficacy.  For secondary amino ozonides, addnl. functional groups had variable effects on metabolic stability and efficacy, but the most effective members of this series also had the highest log D7.4 values.  For tertiary amino ozonides, addn. of polar functional groups with H-bond donors increased metabolic stability but decreased in vivo antimalarial efficacy.  Primary and tertiary amino ozonides with cycloalkyl and heterocycle substructures were superior to their acyclic counterparts.  The high curative efficacy of these ozonides was most often assocd. with high and prolonged plasma exposure, but exposure on its own did not explain the presence or absence of either curative efficacy or in vivo toxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoblykxGQ8NbVg90H21EOLACvtfcHk0lg8p6LREjPvfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkslaitQ%253D%253D&md5=132212a3a83d1065f72151984f7c4c27</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01586&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01586%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DKamaraj%26aufirst%3DS.%26aulast%3DBulbule%26aufirst%3DV.%2BJ.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DDhanasekaran%26aufirst%3DM.%26aulast%3DHein%26aufirst%3DC.%2BD.%26aulast%3DPapastogiannidis%26aufirst%3DP.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DBarker%26aufirst%3DH.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DUrwyler%26aufirst%3DH.%26aulast%3DCharman%26aufirst%3DW.%2BN.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DVennerstrom%26aufirst%3DJ.%2BL.%26atitle%3DStructure-activity%2520relationship%2520of%2520the%2520antimalarial%2520ozonide%2520artefenomel%2520%2528OZ439%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D2654%26epage%3D2668%26doi%3D10.1021%2Facs.jmedchem.6b01586" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, Y. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemparte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of a potent and specific <i>M. tuberculosis</i> leucyl-tRNA synthetase inhibitor: (<i>S</i>)-3-(aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[<i>c</i>][1,2]oxaborol-1(3H)-ol (GSK656)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8011</span>– <span class="NLM_lpage">8026</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00631</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00631" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8011-8026&author=X.+Liauthor=V.+Hernandezauthor=F.+L.+Rockauthor=W.+Choiauthor=Y.+S.+L.+Makauthor=M.+Mohanauthor=W.+Maoauthor=Y.+Zhouauthor=E.+E.+Easomauthor=J.+J.+Plattnerauthor=W.+Zouauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=I.+Giordanoauthor=A.+Mendoza-Losanaauthor=C.+Alemparteauthor=J.+Rullasauthor=I.+Angulo-Barturenauthor=S.+Crouchauthor=F.+Ortegaauthor=D.+Barrosauthor=M.+R.+K.+Alley&title=Discovery+of+a+potent+and+specific+M.+tuberculosis+leucyl-tRNA+synthetase+inhibitor%3A+%28S%29-3-%28aminomethyl%29-4-chloro-7-%282-hydroxyethoxy%29benzo%5Bc%5D%5B1%2C2%5Doxaborol-1%283H%29-ol+%28GSK656%29&doi=10.1021%2Facs.jmedchem.7b00631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and specific M. tuberculosis leucyl-tRNA synthetase inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)</span></div><div class="casAuthors">Li, Xianfeng; Hernandez, Vincent; Rock, Fernando L.; Choi, Wai; Mak, Yvonne S. L.; Mohan, Manisha; Mao, Weimin; Zhou, Yasheen; Easom, Eric E.; Plattner, Jacob J.; Zou, Wuxin; Perez-Herran, Esther; Giordano, Ilaria; Mendoza-Losana, Alfonso; Alemparte, Carlos; Rullas, Joaquin; Angulo-Barturen, Inigo; Crouch, Sabrinia; Ortega, Fatima; Barros, David; Alley, M. R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8011-8026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic boronate monoesters I (X = Cl, Br; R1, R2 = alkoxy, aryloxy, 2-hydroxyethyl; R1R2 = OCH2O, OCH2CH2O) were prepd. by cyclization of substituted 2-boronobenzaldehydes with nitromethane with subsequent nitro-group redn. and examd. in vitro for their inhibition of M. tuberculosis leucyl-tRNA synthetase (Mtb LeuRS) and in vivo in a mouse model of acute TB infection.  There is an urgent need to develop new and safer antitubercular agents that possess a novel mode of action.  We synthesized and evaluated a novel series of 3-aminomethyl 4-halogen benzoxaboroles as Mycobacterium tuberculosis (Mtb) leucyl-tRNA synthetase (LeuRS) inhibitors.  A no. of Mtb LeuRS inhibitors were identified that demonstrated good antitubercular activity with high selectivity over human mitochondrial and cytoplasmic LeuRS.  Further evaluation of these Mtb LeuRS inhibitors by in vivo pharmacokinetics (PK) and murine tuberculosis (TB) efficacy models led to the discovery of GSK3036656 (abbreviated as GSK656).  This mol. shows potent inhibition of Mtb LeuRS (IC50 = 0.20 μM) and in vitro antitubercular activity (Mtb H37Rv MIC = 0.08 μM).  Addnl., it is highly selective for the Mtb LeuRS enzyme with IC50 of >300 μM and 132 μM for human mitochondrial LeuRS and human cytoplasmic LeuRS, resp.  In addn., it exhibits remarkable PK profiles and efficacy against Mtb in mouse TB infection models with superior tolerability over initial leads.  This compd. has been progressed to clin. development for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2t6WBCJKOrVg90H21EOLACvtfcHk0liVX5hJVJR4Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ&md5=c5626f1a1028f79e175a07cb6c01ec44</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00631%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DMak%26aufirst%3DY.%2BS.%2BL.%26aulast%3DMohan%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DAlemparte%26aufirst%3DC.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DCrouch%26aufirst%3DS.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DDiscovery%2520of%2520a%2520potent%2520and%2520specific%2520M.%2520tuberculosis%2520leucyl-tRNA%2520synthetase%2520inhibitor%253A%2520%2528S%2529-3-%2528aminomethyl%2529-4-chloro-7-%25282-hydroxyethoxy%2529benzo%255Bc%255D%255B1%252C2%255Doxaborol-1%25283H%2529-ol%2520%2528GSK656%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8011%26epage%3D8026%26doi%3D10.1021%2Facs.jmedchem.7b00631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lynch, A. S.</span></span> <span> </span><span class="NLM_article-title">Development of a dual-acting antibacterial agent (TNP-2092) for the treatment of persistent bacterial infections</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6645</span>– <span class="NLM_lpage">6657</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00485</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00485" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVGjtLvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6645-6657&author=Z.+Maauthor=A.+S.+Lynch&title=Development+of+a+dual-acting+antibacterial+agent+%28TNP-2092%29+for+the+treatment+of+persistent+bacterial+infections&doi=10.1021%2Facs.jmedchem.6b00485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections</span></div><div class="casAuthors">Ma, Zhenkun; Lynch, Anthony Simon</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6645-6657</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The clin. management of prosthetic joint infections and other persistent bacterial infections represents a major unmet medical need.  The rifamycins are one of the most potent antibiotic classes against persistent bacterial infections, but bacteria can develop resistance to rifamycins rapidly and the clin. utility of the rifamycin class is typically limited to antibiotic combinations to minimize the development of resistance.  To develop a better therapy against persistent bacterial infections, a series of rifamycin based bifunctional mols. were designed, synthesized, and evaluated with the goal to identify a dual-acting drug that maintains the potent activity of rifamycins against persistent pathogens and at the same time minimize the development of rifamycin resistance.  TNP-2092 was identified as a drug candidate and is currently in an early stage of clin. development for the treatment of prosthetic joint infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohWz-3Ax6Pr7Vg90H21EOLACvtfcHk0liVX5hJVJR4Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVGjtLvK&md5=ab1dbd2eefc19496ed12d695bc093285</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00485%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DLynch%26aufirst%3DA.%2BS.%26atitle%3DDevelopment%2520of%2520a%2520dual-acting%2520antibacterial%2520agent%2520%2528TNP-2092%2529%2520for%2520the%2520treatment%2520of%2520persistent%2520bacterial%2520infections%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6645%26epage%3D6657%26doi%3D10.1021%2Facs.jmedchem.6b00485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thorarensen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banker, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juba, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jussif, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Czerwinski, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casimiro-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unwalla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trujillo, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balbo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Che, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montgomery, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soucy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langille, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telliez, J.-B.</span></span> <span> </span><span class="NLM_article-title">Design of a janus kinase 3 (JAK3) specific inhibitor 1-((2<i>S</i>,5<i>R</i>)-5-((7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) allowing for the interrogation of JAK3 signaling in humans</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1971</span>– <span class="NLM_lpage">1993</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01694</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01694" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1971-1993&author=A.+Thorarensenauthor=M.+E.+Dowtyauthor=M.+E.+Bankerauthor=B.+Jubaauthor=J.+Jussifauthor=T.+Linauthor=F.+Vincentauthor=R.+M.+Czerwinskiauthor=A.+Casimiro-Garciaauthor=R.+Unwallaauthor=J.+I.+Trujilloauthor=S.+Liangauthor=P.+Balboauthor=Y.+Cheauthor=A.+M.+Gilbertauthor=M.+F.+Brownauthor=M.+Haywardauthor=J.+Montgomeryauthor=L.+Leungauthor=X.+Yangauthor=S.+Soucyauthor=M.+Hegenauthor=J.+Coeauthor=J.+Langilleauthor=F.+Vajdosauthor=J.+Chrencikauthor=J.-B.+Telliez&title=Design+of+a+janus+kinase+3+%28JAK3%29+specific+inhibitor+1-%28%282S%2C5R%29-5-%28%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29amino%29-2-methylpiperidin-1-yl%29prop-2-en-1-one+%28PF-06651600%29+allowing+for+the+interrogation+of+JAK3+signaling+in+humans&doi=10.1021%2Facs.jmedchem.6b01694"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans</span></div><div class="casAuthors">Thorarensen, Atli; Dowty, Martin E.; Banker, Mary Ellen; Juba, Brian; Jussif, Jason; Lin, Tsung; Vincent, Fabien; Czerwinski, Robert M.; Casimiro-Garcia, Agustin; Unwalla, Ray; Trujillo, John I.; Liang, Sidney; Balbo, Paul; Che, Ye; Gilbert, Adam M.; Brown, Matthew F.; Hayward, Matthew; Montgomery, Justin; Leung, Louis; Yang, Xin; Soucy, Sarah; Hegen, Martin; Coe, Jotham; Langille, Jonathan; Vajdos, Felix; Chrencik, Jill; Telliez, Jean-Baptiste</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1971-1993</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Significant work has been dedicated to the discovery of JAK kinase inhibitors resulting in several compds. entering clin. development and two FDA approved NMEs.  However, despite significant effort during the past two decades, identification of highly selective JAK3 inhibitors has eluded the scientific community.  A significant effort within the research organization has resulted in the identification of the first orally active JAK3 specific inhibitor, which achieves JAK isoform specificity through covalent interaction with a unique JAK3 residue Cys-909.  The relatively rapid resynthesis rate of the JAK3 enzyme presented a unique challenge in the design of covalent inhibitors with appropriate pharmacodynamics properties coupled with limited unwanted off-target reactivity.  This effort resulted in the identification of PF-06651600 I, a potent and low clearance compd. with demonstrated in vivo efficacy.  The favorable efficacy and safety profile of this specific JAK3 inhibitor I led to its evaluation in several human clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodS6VFIL07nrVg90H21EOLACvtfcHk0liVX5hJVJR4Qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVykt7c%253D&md5=d1ab749203fae07f89463f97518e3db8</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01694&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01694%26sid%3Dliteratum%253Aachs%26aulast%3DThorarensen%26aufirst%3DA.%26aulast%3DDowty%26aufirst%3DM.%2BE.%26aulast%3DBanker%26aufirst%3DM.%2BE.%26aulast%3DJuba%26aufirst%3DB.%26aulast%3DJussif%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DT.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DCzerwinski%26aufirst%3DR.%2BM.%26aulast%3DCasimiro-Garcia%26aufirst%3DA.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DTrujillo%26aufirst%3DJ.%2BI.%26aulast%3DLiang%26aufirst%3DS.%26aulast%3DBalbo%26aufirst%3DP.%26aulast%3DChe%26aufirst%3DY.%26aulast%3DGilbert%26aufirst%3DA.%2BM.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DHayward%26aufirst%3DM.%26aulast%3DMontgomery%26aufirst%3DJ.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DSoucy%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DLangille%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DChrencik%26aufirst%3DJ.%26aulast%3DTelliez%26aufirst%3DJ.-B.%26atitle%3DDesign%2520of%2520a%2520janus%2520kinase%25203%2520%2528JAK3%2529%2520specific%2520inhibitor%25201-%2528%25282S%252C5R%2529-5-%2528%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529amino%2529-2-methylpiperidin-1-yl%2529prop-2-en-1-one%2520%2528PF-06651600%2529%2520allowing%2520for%2520the%2520interrogation%2520of%2520JAK3%2520signaling%2520in%2520humans%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1971%26epage%3D1993%26doi%3D10.1021%2Facs.jmedchem.6b01694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storer, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabnis, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakenhut, F. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitlock, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mukaiyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortum, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chrencik, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeoh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of a pan-janus kinase inhibitor clinical candidate (PF-06263276) suitable for inhaled and topical delivery for the treatment of inflammatory diseases of the lungs and skin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">767</span>– <span class="NLM_lpage">786</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01634</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01634" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFSnsr3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=767-786&author=P.+Jonesauthor=R.+I.+Storerauthor=Y.+A.+Sabnisauthor=F.+M.+Wakenhutauthor=G.+A.+Whitlockauthor=K.+S.+Englandauthor=T.+Mukaiyamaauthor=C.+M.+Dehnhardtauthor=J.+W.+Coeauthor=S.+W.+Kortumauthor=J.+E.+Chrencikauthor=D.+G.+Brownauthor=R.+M.+Jonesauthor=J.+R.+Murphyauthor=T.+Yeohauthor=P.+Morganauthor=I.+Kilty&title=Design+and+synthesis+of+a+pan-janus+kinase+inhibitor+clinical+candidate+%28PF-06263276%29+suitable+for+inhaled+and+topical+delivery+for+the+treatment+of+inflammatory+diseases+of+the+lungs+and+skin&doi=10.1021%2Facs.jmedchem.6b01634"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of a Pan-Janus Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin</span></div><div class="casAuthors">Jones, Peter; Storer, R. Ian; Sabnis, Yogesh A.; Wakenhut, Florian M.; Whitlock, Gavin A.; England, Katherine S.; Mukaiyama, Takasuke; Dehnhardt, Christoph M.; Coe, Jotham W.; Kortum, Steve W.; Chrencik, Jill E.; Brown, David G.; Jones, Rhys M.; Murphy, John R.; Yeoh, Thean; Morgan, Paul; Kilty, Iain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">767-786</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using a structure-based computational method for identification of structurally novel JAK inhibitors predicted to bind beyond the ATP binding site, a potent series of indazoles was identified as selective pan-JAK inhibitors with a type 1.5 binding mode.  Optimization of the series for potency and increased duration of action commensurate with inhaled or topical delivery resulted in PF-06263276 which was advanced into clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEt2oMBlGsBbVg90H21EOLACvtfcHk0lg-1bDHSvwZYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFSnsr3J&md5=a69247c21ff53a3b7d9c63cf0af72101</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01634%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DP.%26aulast%3DStorer%26aufirst%3DR.%2BI.%26aulast%3DSabnis%26aufirst%3DY.%2BA.%26aulast%3DWakenhut%26aufirst%3DF.%2BM.%26aulast%3DWhitlock%26aufirst%3DG.%2BA.%26aulast%3DEngland%26aufirst%3DK.%2BS.%26aulast%3DMukaiyama%26aufirst%3DT.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DCoe%26aufirst%3DJ.%2BW.%26aulast%3DKortum%26aufirst%3DS.%2BW.%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DJones%26aufirst%3DR.%2BM.%26aulast%3DMurphy%26aufirst%3DJ.%2BR.%26aulast%3DYeoh%26aufirst%3DT.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DKilty%26aufirst%3DI.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520a%2520pan-janus%2520kinase%2520inhibitor%2520clinical%2520candidate%2520%2528PF-06263276%2529%2520suitable%2520for%2520inhaled%2520and%2520topical%2520delivery%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%2520of%2520the%2520lungs%2520and%2520skin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D767%26epage%3D786%26doi%3D10.1021%2Facs.jmedchem.6b01634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harris, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeong, J. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagilla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bandyopadhyay, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campobasso, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capriotti, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dare, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eidam, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finger, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasparcova, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">King, B. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehr, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leister, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lich, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouellette, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pao, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reilly, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivera, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sehon, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singhaus, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swift, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totoritis, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vossenkamper, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wisnoski, D. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marquis, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gough, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of a first-in-class receptor interacting protein 1 (RIP1) kinase specific clinical candidate (GSK2982772) for the treatment of inflammatory diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1247</span>– <span class="NLM_lpage">1261</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=1247-1261&author=P.+A.+Harrisauthor=S.+B.+Bergerauthor=J.+U.+Jeongauthor=R.+Nagillaauthor=D.+Bandyopadhyayauthor=N.+Campobassoauthor=C.+A.+Capriottiauthor=J.+A.+Coxauthor=L.+Dareauthor=X.+Dongauthor=P.+M.+Eidamauthor=J.+N.+Fingerauthor=S.+J.+Hoffmanauthor=J.+Kangauthor=V.+Kasparcovaauthor=B.+W.+Kingauthor=R.+Lehrauthor=Y.+Lanauthor=L.+K.+Leisterauthor=J.+D.+Lichauthor=T.+T.+MacDonaldauthor=N.+A.+Millerauthor=M.+T.+Ouelletteauthor=C.+S.+Paoauthor=A.+Rahmanauthor=M.+A.+Reillyauthor=A.+R.+Rendinaauthor=E.+J.+Riveraauthor=M.+C.+Schaefferauthor=C.+A.+Sehonauthor=R.+R.+Singhausauthor=H.+H.+Sunauthor=B.+A.+Swiftauthor=R.+D.+Totoritisauthor=A.+Vossenkamperauthor=P.+Wardauthor=D.+D.+Wisnoskiauthor=D.+Zhangauthor=R.+W.+Marquisauthor=P.+J.+Goughauthor=J.+Bertin&title=Discovery+of+a+first-in-class+receptor+interacting+protein+1+%28RIP1%29+kinase+specific+clinical+candidate+%28GSK2982772%29+for+the+treatment+of+inflammatory+diseases&doi=10.1021%2Facs.jmedchem.6b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases</span></div><div class="casAuthors">Harris, Philip A.; Berger, Scott B.; Jeong, Jae U.; Nagilla, Rakesh; Bandyopadhyay, Deepak; Campobasso, Nino; Capriotti, Carol A.; Cox, Julie A.; Dare, Lauren; Dong, Xiaoyang; Eidam, Patrick M.; Finger, Joshua N.; Hoffman, Sandra J.; Kang, James; Kasparcova, Viera; King, Bryan W.; Lehr, Ruth; Lan, Yunfeng; Leister, Lara K.; Lich, John D.; MacDonald, Thomas T.; Miller, Nathan A.; Ouellette, Michael T.; Pao, Christina S.; Rahman, Attiq; Reilly, Michael A.; Rendina, Alan R.; Rivera, Elizabeth J.; Schaeffer, Michelle C.; Sehon, Clark A.; Singhaus, Robert R.; Sun, Helen H.; Swift, Barbara A.; Totoritis, Rachel D.; Vossenkamper, Anna; Ward, Paris; Wisnoski, David D.; Zhang, Daohua; Marquis, Robert W.; Gough, Peter J.; Bertin, John</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1247-1261</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">RIP1 regulates necroptosis and inflammation and may play an important role in contributing to a variety of human pathologies, including immune-mediated inflammatory diseases.  Small-mol. inhibitors of RIP1 kinase that are suitable for advancement into the clinic have yet to be described.  Herein, the authors report the lead optimization of a benzoxazepinone hit from a DNA-encoded library and the discovery and profile of clin. candidate GSK2982772 (compd. I), currently in phase 2a clin. studies for psoriasis, rheumatoid arthritis, and ulcerative colitis.  Compd. I potently binds to RIP1 with exquisite kinase specificity and has excellent activity in blocking many TNF-dependent cellular responses.  Highlighting its potential as a novel anti-inflammatory agent, the inhibitor was also able to reduce spontaneous prodn. of cytokines from human ulcerative colitis explants.  The highly favorable physicochem. and ADMET properties of I, combined with high potency, led to a predicted low oral dose in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZGRDTQv-vs7Vg90H21EOLACvtfcHk0lg-1bDHSvwZYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVeksLk%253D&md5=ee0c3c60bb1351dff696490ac9edb1cc</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01751%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DP.%2BA.%26aulast%3DBerger%26aufirst%3DS.%2BB.%26aulast%3DJeong%26aufirst%3DJ.%2BU.%26aulast%3DNagilla%26aufirst%3DR.%26aulast%3DBandyopadhyay%26aufirst%3DD.%26aulast%3DCampobasso%26aufirst%3DN.%26aulast%3DCapriotti%26aufirst%3DC.%2BA.%26aulast%3DCox%26aufirst%3DJ.%2BA.%26aulast%3DDare%26aufirst%3DL.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DEidam%26aufirst%3DP.%2BM.%26aulast%3DFinger%26aufirst%3DJ.%2BN.%26aulast%3DHoffman%26aufirst%3DS.%2BJ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DKasparcova%26aufirst%3DV.%26aulast%3DKing%26aufirst%3DB.%2BW.%26aulast%3DLehr%26aufirst%3DR.%26aulast%3DLan%26aufirst%3DY.%26aulast%3DLeister%26aufirst%3DL.%2BK.%26aulast%3DLich%26aufirst%3DJ.%2BD.%26aulast%3DMacDonald%26aufirst%3DT.%2BT.%26aulast%3DMiller%26aufirst%3DN.%2BA.%26aulast%3DOuellette%26aufirst%3DM.%2BT.%26aulast%3DPao%26aufirst%3DC.%2BS.%26aulast%3DRahman%26aufirst%3DA.%26aulast%3DReilly%26aufirst%3DM.%2BA.%26aulast%3DRendina%26aufirst%3DA.%2BR.%26aulast%3DRivera%26aufirst%3DE.%2BJ.%26aulast%3DSchaeffer%26aufirst%3DM.%2BC.%26aulast%3DSehon%26aufirst%3DC.%2BA.%26aulast%3DSinghaus%26aufirst%3DR.%2BR.%26aulast%3DSun%26aufirst%3DH.%2BH.%26aulast%3DSwift%26aufirst%3DB.%2BA.%26aulast%3DTotoritis%26aufirst%3DR.%2BD.%26aulast%3DVossenkamper%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DWisnoski%26aufirst%3DD.%2BD.%26aulast%3DZhang%26aufirst%3DD.%26aulast%3DMarquis%26aufirst%3DR.%2BW.%26aulast%3DGough%26aufirst%3DP.%2BJ.%26aulast%3DBertin%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520a%2520first-in-class%2520receptor%2520interacting%2520protein%25201%2520%2528RIP1%2529%2520kinase%2520specific%2520clinical%2520candidate%2520%2528GSK2982772%2529%2520for%2520the%2520treatment%2520of%2520inflammatory%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D1247%26epage%3D1261%26doi%3D10.1021%2Facs.jmedchem.6b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albrecht, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unger, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of N-{4-[5-(4-fluorophenyl)-3-methyl-2-methylsulfanyl-3<i>H</i>-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a dual p38α MAPK/PDE-4 inhibitor with activity against TNFα-related diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5290</span>– <span class="NLM_lpage">5305</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01647</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01647" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVSjtrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5290-5305&author=W.+Albrechtauthor=A.+Ungerauthor=S.+M.+Bauerauthor=S.+A.+Laufer&title=Discovery+of+N-%7B4-%5B5-%284-fluorophenyl%29-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl%5D-pyridin-2-yl%7D-acetamide+%28CBS-3595%29%2C+a+dual+p38%CE%B1+MAPK%2FPDE-4+inhibitor+with+activity+against+TNF%CE%B1-related+diseases&doi=10.1021%2Facs.jmedchem.6b01647"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of N-{4-[5-(4-Fluorophenyl)-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-acetamide (CBS-3595), a Dual p38α MAPK/PDE-4 Inhibitor with Activity against TNFα-Related Diseases</span></div><div class="casAuthors">Albrecht, Wolfgang; Unger, Anke; Bauer, Silke M.; Laufer, Stefan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5290-5305</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The anti-inflammatory potential of p38 mitogen-activated protein kinase (MAPK) inhibitors was coincidentally expanded to a dual inhibition of p38α MAPK and phosphodiesterase 4 (PDE4), and the potential benefits arising from the blockage of both inflammation-related enzymes were thoroughly investigated.  The most promising compd., CBS-3595 (1), was successively evaluated in in vitro expts. as well as in ex vivo and in vivo preclin. studies after administration of 1 to rodents, dogs, and monkeys.  The resulting data clearly indicated a potent suppression of tumor necrosis factor alpha release.  For reconfirming the findings of the animal studies when administering 1 to healthy human volunteers, a phase I clin. trial was conducted.  Apart from further information regarding the pharmacokinetic and pharmacodynamic characteristics of 1, it was demonstrated that dual inhibition of p38α MAPK and PDE4 is able to synergistically attenuate the excessive anti-inflammatory response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpn0tCfKq3bG7Vg90H21EOLACvtfcHk0lhFqFemeYzZvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVSjtrvL&md5=fb0a040161db70ade8a3032b0c978537</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01647&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01647%26sid%3Dliteratum%253Aachs%26aulast%3DAlbrecht%26aufirst%3DW.%26aulast%3DUnger%26aufirst%3DA.%26aulast%3DBauer%26aufirst%3DS.%2BM.%26aulast%3DLaufer%26aufirst%3DS.%2BA.%26atitle%3DDiscovery%2520of%2520N-%257B4-%255B5-%25284-fluorophenyl%2529-3-methyl-2-methylsulfanyl-3H-imidazol-4-yl%255D-pyridin-2-yl%257D-acetamide%2520%2528CBS-3595%2529%252C%2520a%2520dual%2520p38%25CE%25B1%2520MAPK%252FPDE-4%2520inhibitor%2520with%2520activity%2520against%2520TNF%25CE%25B1-related%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5290%26epage%3D5305%26doi%3D10.1021%2Facs.jmedchem.6b01647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambler, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boscoe, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bree, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodfuehrer, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curran, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Day, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehnhardt, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dower, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drozda, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrin, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldberg, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hope, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamtekar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilty, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lowe, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathias, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papaioannou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patny, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pierce, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, V. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saiah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samardjiev, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samas, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, M. W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soutter, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohbach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Symanowicz, P. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomason, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trzupek, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, S. W.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate 1-{[(2<i>S</i>,3<i>S</i>,4<i>S</i>)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a potent, selective inhibitor of interleukin-1 receptor associated kinase 4 (IRAK4), by fragment-based drug design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">5521</span>– <span class="NLM_lpage">5542</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00231</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00231" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=5521-5542&author=K.+L.+Leeauthor=C.+M.+Amblerauthor=D.+R.+Andersonauthor=B.+P.+Boscoeauthor=A.+G.+Breeauthor=J.+I.+Brodfuehrerauthor=J.+S.+Changauthor=C.+Choiauthor=S.+Chungauthor=K.+J.+Curranauthor=J.+E.+Dayauthor=C.+M.+Dehnhardtauthor=K.+Dowerauthor=S.+E.+Drozdaauthor=R.+K.+Frisbieauthor=L.+K.+Gavrinauthor=J.+A.+Goldbergauthor=S.+Hanauthor=M.+Hegenauthor=D.+Hepworthauthor=H.+R.+Hopeauthor=S.+Kamtekarauthor=I.+C.+Kiltyauthor=A.+Leeauthor=L.-L.+Linauthor=F.+E.+Loveringauthor=M.+D.+Loweauthor=J.+P.+Mathiasauthor=H.+M.+Morganauthor=E.+A.+Murphyauthor=N.+Papaioannouauthor=A.+Patnyauthor=B.+S.+Pierceauthor=V.+R.+Raoauthor=E.+Saiahauthor=I.+J.+Samardjievauthor=B.+M.+Samasauthor=M.+W.+H.+Shenauthor=J.+H.+Shinauthor=H.+H.+Soutterauthor=J.+W.+Strohbachauthor=P.+T.+Symanowiczauthor=J.+R.+Thomasonauthor=J.+D.+Trzupekauthor=R.+Vargasauthor=F.+Vincentauthor=J.+Yanauthor=C.+W.+Zapfauthor=S.+W.+Wright&title=Discovery+of+clinical+candidate+1-%7B%5B%282S%2C3S%2C4S%29-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%5Dmethoxy%7D-7-methoxyisoquinoline-6-carboxamide+%28PF-06650833%29%2C+a+potent%2C+selective+inhibitor+of+interleukin-1+receptor+associated+kinase+4+%28IRAK4%29%2C+by+fragment-based+drug+design&doi=10.1021%2Facs.jmedchem.7b00231"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate 1-{[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy}-7-methoxyisoquinoline-6-carboxamide (PF-06650833), a Potent, Selective Inhibitor of Interleukin-1 Receptor Associated Kinase 4 (IRAK4), by Fragment-Based Drug Design</span></div><div class="casAuthors">Lee, Katherine L.; Ambler, Catherine M.; Anderson, David R.; Boscoe, Brian P.; Bree, Andrea G.; Brodfuehrer, Joanne I.; Chang, Jeanne S.; Choi, Chulho; Chung, Seungwon; Curran, Kevin J.; Day, Jacqueline E.; Dehnhardt, Christoph M.; Dower, Ken; Drozda, Susan E.; Frisbie, Richard K.; Gavrin, Lori K.; Goldberg, Joel A.; Han, Seungil; Hegen, Martin; Hepworth, David; Hope, Heidi R.; Kamtekar, Satwik; Kilty, Iain C.; Lee, Arthur; Lin, Lih-Ling; Lovering, Frank E.; Lowe, Michael D.; Mathias, John P.; Morgan, Heidi M.; Murphy, Elizabeth A.; Papaioannou, Nikolaos; Patny, Akshay; Pierce, Betsy S.; Rao, Vikram R.; Saiah, Eddine; Samardjiev, Ivan J.; Samas, Brian M.; Shen, Marina W. H.; Shin, Julia H.; Soutter, Holly H.; Strohbach, Joseph W.; Symanowicz, Peter T.; Thomason, Jennifer R.; Trzupek, John D.; Vargas, Richard; Vincent, Fabien; Yan, Jiangli; Zapf, Christoph W.; Wright, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5521-5542</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through fragment-based drug design focused on engaging the active site of IRAK4 and leveraging three-dimensional topol. in a ligand-efficient manner, a micromolar hit identified from a screen of a Pfizer fragment library was optimized to afford IRAK4 inhibitors with nanomolar potency in cellular assays.  The medicinal chem. effort featured the judicious placement of lipophilicity, informed by cocrystal structures with IRAK4 and optimization of ADME properties to deliver clin. candidate I.  This compd. benefitted from a 5-unit increase in lipophilic efficiency from the fragment hit, excellent kinase selectivity, and pharmacokinetic properties suitable for oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYrCep64bhMbVg90H21EOLACvtfcHk0lhFqFemeYzZvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXnslGqu7c%253D&md5=9771ad2d33089f6ef3dba3556536ff1a</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00231%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.%2BL.%26aulast%3DAmbler%26aufirst%3DC.%2BM.%26aulast%3DAnderson%26aufirst%3DD.%2BR.%26aulast%3DBoscoe%26aufirst%3DB.%2BP.%26aulast%3DBree%26aufirst%3DA.%2BG.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%2BI.%26aulast%3DChang%26aufirst%3DJ.%2BS.%26aulast%3DChoi%26aufirst%3DC.%26aulast%3DChung%26aufirst%3DS.%26aulast%3DCurran%26aufirst%3DK.%2BJ.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DDehnhardt%26aufirst%3DC.%2BM.%26aulast%3DDower%26aufirst%3DK.%26aulast%3DDrozda%26aufirst%3DS.%2BE.%26aulast%3DFrisbie%26aufirst%3DR.%2BK.%26aulast%3DGavrin%26aufirst%3DL.%2BK.%26aulast%3DGoldberg%26aufirst%3DJ.%2BA.%26aulast%3DHan%26aufirst%3DS.%26aulast%3DHegen%26aufirst%3DM.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DHope%26aufirst%3DH.%2BR.%26aulast%3DKamtekar%26aufirst%3DS.%26aulast%3DKilty%26aufirst%3DI.%2BC.%26aulast%3DLee%26aufirst%3DA.%26aulast%3DLin%26aufirst%3DL.-L.%26aulast%3DLovering%26aufirst%3DF.%2BE.%26aulast%3DLowe%26aufirst%3DM.%2BD.%26aulast%3DMathias%26aufirst%3DJ.%2BP.%26aulast%3DMorgan%26aufirst%3DH.%2BM.%26aulast%3DMurphy%26aufirst%3DE.%2BA.%26aulast%3DPapaioannou%26aufirst%3DN.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DPierce%26aufirst%3DB.%2BS.%26aulast%3DRao%26aufirst%3DV.%2BR.%26aulast%3DSaiah%26aufirst%3DE.%26aulast%3DSamardjiev%26aufirst%3DI.%2BJ.%26aulast%3DSamas%26aufirst%3DB.%2BM.%26aulast%3DShen%26aufirst%3DM.%2BW.%2BH.%26aulast%3DShin%26aufirst%3DJ.%2BH.%26aulast%3DSoutter%26aufirst%3DH.%2BH.%26aulast%3DStrohbach%26aufirst%3DJ.%2BW.%26aulast%3DSymanowicz%26aufirst%3DP.%2BT.%26aulast%3DThomason%26aufirst%3DJ.%2BR.%26aulast%3DTrzupek%26aufirst%3DJ.%2BD.%26aulast%3DVargas%26aufirst%3DR.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DZapf%26aufirst%3DC.%2BW.%26aulast%3DWright%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%25201-%257B%255B%25282S%252C3S%252C4S%2529-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl%255Dmethoxy%257D-7-methoxyisoquinoline-6-carboxamide%2520%2528PF-06650833%2529%252C%2520a%2520potent%252C%2520selective%2520inhibitor%2520of%2520interleukin-1%2520receptor%2520associated%2520kinase%25204%2520%2528IRAK4%2529%252C%2520by%2520fragment-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D5521%26epage%3D5542%26doi%3D10.1021%2Facs.jmedchem.7b00231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Watterson, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Lucca, G. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langevine, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudoin Bertrand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yip, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traeger, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pattoli, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skala, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermeier, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vickery, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Discenza, L. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Arienzo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heimrich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillooly, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pulicicchio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McIntyre, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galella, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckelbauer, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rampulla, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathur, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter-Cid, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of 6-fluoro-5-(<i>R</i>)-(3-(<i>S</i>)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4<i>H</i>)-yl)-2-methylphenyl)-2-(<i>S</i>)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1<i>H</i>-carbazole-8-carboxamide (BMS-986142): A reversible inhibitor of Bruton’s tyrosine kinase (BTK) conformationally constrained by two locked atropisomers</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">9173</span>– <span class="NLM_lpage">9200</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01088</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01088" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVKjsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=9173-9200&author=S.+H.+Wattersonauthor=G.+V.+De+Luccaauthor=Q.+Shiauthor=C.+M.+Langevineauthor=Q.+Liuauthor=D.+G.+Battauthor=M.+Beaudoin+Bertrandauthor=H.+Gongauthor=J.+Daiauthor=S.+Yipauthor=P.+Liauthor=D.+Sunauthor=D.-R.+Wuauthor=C.+Wangauthor=Y.+Zhangauthor=S.+C.+Traegerauthor=M.+A.+Pattoliauthor=S.+Skalaauthor=L.+Chengauthor=M.+T.+Obermeierauthor=R.+Vickeryauthor=L.+N.+Discenzaauthor=C.+J.+D%E2%80%99Arienzoauthor=Y.+Zhangauthor=E.+Heimrichauthor=K.+M.+Gilloolyauthor=T.+L.+Taylorauthor=C.+Pulicicchioauthor=K.+W.+McIntyreauthor=M.+A.+Galellaauthor=A.+J.+Tebbenauthor=J.+K.+Muckelbauerauthor=C.+Y.+Changauthor=R.+Rampullaauthor=A.+Mathurauthor=L.+Salter-Cidauthor=J.+C.+Barrishauthor=P.+H.+Carterauthor=A.+Furaauthor=J.+R.+Burkeauthor=J.+A.+Tino&title=Discovery+of+6-fluoro-5-%28R%29-%283-%28S%29-%288-fluoro-1-methyl-2%2C4-dioxo-1%2C2-dihydroquinazolin-3%284H%29-yl%29-2-methylphenyl%29-2-%28S%29-%282-hydroxypropan-2-yl%29-2%2C3%2C4%2C9-tetrahydro-1H-carbazole-8-carboxamide+%28BMS-986142%29%3A+A+reversible+inhibitor+of+Bruton%E2%80%99s+tyrosine+kinase+%28BTK%29+conformationally+constrained+by+two+locked+atropisomers&doi=10.1021%2Facs.jmedchem.6b01088"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 6-Fluoro-5-(R)-(3-(S)-(8-fluoro-1-methyl-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)-2-methylphenyl)-2-(S)-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide (BMS-986142): A Reversible Inhibitor of Bruton's Tyrosine Kinase (BTK) Conformationally Constrained by Two Locked Atropisomers</span></div><div class="casAuthors">Watterson, Scott H.; De Lucca, George V.; Shi, Qing; Langevine, Charles M.; Liu, Qingjie; Batt, Douglas G.; Beaudoin Bertrand, Myra; Gong, Hua; Dai, Jun; Yip, Shiuhang; Li, Peng; Sun, Dawn; Wu, Dauh-Rurng; Wang, Chunlei; Zhang, Yingru; Traeger, Sarah C.; Pattoli, Mark A.; Skala, Stacey; Cheng, Lihong; Obermeier, Mary T.; Vickery, Rodney; Discenza, Lorell N.; D'Arienzo, Celia J.; Zhang, Yifan; Heimrich, Elizabeth; Gillooly, Kathleen M.; Taylor, Tracy L.; Pulicicchio, Claudine; McIntyre, Kim W.; Galella, Michael A.; Tebben, Andy J.; Muckelbauer, Jodi K.; Chang, ChiehYing; Rampulla, Richard; Mathur, Arvind; Salter-Cid, Luisa; Barrish, Joel C.; Carter, Percy H.; Fura, Aberra; Burke, James R.; Tino, Joseph A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">9173-9200</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Bruton's tyrosine kinase (BTK), a nonreceptor tyrosine kinase, is a member of the Tec family of kinases.  BTK plays an essential role in B cell receptor (BCR)-mediated signaling as well as Fcγ receptor signaling in monocytes and Fcε receptor signaling in mast cells and basophils, all of which have been implicated in the pathophysiol. of autoimmune disease.  As a result, inhibition of BTK is anticipated to provide an effective strategy for the clin. treatment of autoimmune diseases such as lupus and rheumatoid arthritis.  This article details the structure-activity relationships (SAR) leading to a novel series of highly potent and selective carbazole and tetrahydrocarbazole based, reversible inhibitors of BTK.  Of particular interest is that two atropisomeric centers were rotationally locked to provide a single, stable atropisomer, resulting in enhanced potency and selectivity as well as a redn. in safety liabilities.  With significantly enhanced potency and selectivity, excellent in vivo properties and efficacy, and a very desirable tolerability and safety profile, 14f (BMS-986142) was advanced into clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmpBAygRAsYrVg90H21EOLACvtfcHk0lifCNfhE1S9Zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVKjsrfF&md5=91098abc802521b9ad91563d20ac5893</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01088%26sid%3Dliteratum%253Aachs%26aulast%3DWatterson%26aufirst%3DS.%2BH.%26aulast%3DDe%2BLucca%26aufirst%3DG.%2BV.%26aulast%3DShi%26aufirst%3DQ.%26aulast%3DLangevine%26aufirst%3DC.%2BM.%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DBatt%26aufirst%3DD.%2BG.%26aulast%3DBeaudoin%2BBertrand%26aufirst%3DM.%26aulast%3DGong%26aufirst%3DH.%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DYip%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWu%26aufirst%3DD.-R.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DTraeger%26aufirst%3DS.%2BC.%26aulast%3DPattoli%26aufirst%3DM.%2BA.%26aulast%3DSkala%26aufirst%3DS.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DObermeier%26aufirst%3DM.%2BT.%26aulast%3DVickery%26aufirst%3DR.%26aulast%3DDiscenza%26aufirst%3DL.%2BN.%26aulast%3DD%25E2%2580%2599Arienzo%26aufirst%3DC.%2BJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHeimrich%26aufirst%3DE.%26aulast%3DGillooly%26aufirst%3DK.%2BM.%26aulast%3DTaylor%26aufirst%3DT.%2BL.%26aulast%3DPulicicchio%26aufirst%3DC.%26aulast%3DMcIntyre%26aufirst%3DK.%2BW.%26aulast%3DGalella%26aufirst%3DM.%2BA.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DChang%26aufirst%3DC.%2BY.%26aulast%3DRampulla%26aufirst%3DR.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DSalter-Cid%26aufirst%3DL.%26aulast%3DBarrish%26aufirst%3DJ.%2BC.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DFura%26aufirst%3DA.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DTino%26aufirst%3DJ.%2BA.%26atitle%3DDiscovery%2520of%25206-fluoro-5-%2528R%2529-%25283-%2528S%2529-%25288-fluoro-1-methyl-2%252C4-dioxo-1%252C2-dihydroquinazolin-3%25284H%2529-yl%2529-2-methylphenyl%2529-2-%2528S%2529-%25282-hydroxypropan-2-yl%2529-2%252C3%252C4%252C9-tetrahydro-1H-carbazole-8-carboxamide%2520%2528BMS-986142%2529%253A%2520A%2520reversible%2520inhibitor%2520of%2520Bruton%25E2%2580%2599s%2520tyrosine%2520kinase%2520%2528BTK%2529%2520conformationally%2520constrained%2520by%2520two%2520locked%2520atropisomers%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D9173%26epage%3D9200%26doi%3D10.1021%2Facs.jmedchem.6b01088" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batt, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippy, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surti, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tebben, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muckelbauer, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokross, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carter, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tino, J. A.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of carbazole carboxamides as promising inhibitors of Bruton’s tyrosine kinase (BTK) and janus kinase (JAK2)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4265</span>– <span class="NLM_lpage">4269</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.07.102</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.bmcl.2015.07.102" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4265-4269&author=Q.+Liuauthor=D.+G.+Battauthor=J.+S.+Lippyauthor=N.+Surtiauthor=A.+J.+Tebbenauthor=J.+K.+Muckelbauerauthor=L.+Chenauthor=Y.+Anauthor=C.+Changauthor=M.+Pokrossauthor=Z.+Yangauthor=H.+Wangauthor=J.+R.+Burkeauthor=P.+H.+Carterauthor=J.+A.+Tino&title=Design+and+synthesis+of+carbazole+carboxamides+as+promising+inhibitors+of+Bruton%E2%80%99s+tyrosine+kinase+%28BTK%29+and+janus+kinase+%28JAK2%29&doi=10.1016%2Fj.bmcl.2015.07.102"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.07.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.07.102%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DQ.%26aulast%3DBatt%26aufirst%3DD.%2BG.%26aulast%3DLippy%26aufirst%3DJ.%2BS.%26aulast%3DSurti%26aufirst%3DN.%26aulast%3DTebben%26aufirst%3DA.%2BJ.%26aulast%3DMuckelbauer%26aufirst%3DJ.%2BK.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DAn%26aufirst%3DY.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DPokross%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBurke%26aufirst%3DJ.%2BR.%26aulast%3DCarter%26aufirst%3DP.%2BH.%26aulast%3DTino%26aufirst%3DJ.%2BA.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520carbazole%2520carboxamides%2520as%2520promising%2520inhibitors%2520of%2520Bruton%25E2%2580%2599s%2520tyrosine%2520kinase%2520%2528BTK%2529%2520and%2520janus%2520kinase%2520%2528JAK2%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4265%26epage%3D4269%26doi%3D10.1016%2Fj.bmcl.2015.07.102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Newman, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cragg, G. M.</span></span> <span> </span><span class="NLM_article-title">Natural products as sources of new drugs over 30 years from 1981 to 2010</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">311</span>– <span class="NLM_lpage">335</span>, <span class="refDoi"> DOI: 10.1021/np200906s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np200906s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2012&pages=311-335&author=D.+J.+Newmanauthor=G.+M.+Cragg&title=Natural+products+as+sources+of+new+drugs+over+30+years+from+1981+to+2010&doi=10.1021%2Fnp200906s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1021%2Fnp200906s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp200906s%26sid%3Dliteratum%253Aachs%26aulast%3DNewman%26aufirst%3DD.%2BJ.%26aulast%3DCragg%26aufirst%3DG.%2BM.%26atitle%3DNatural%2520products%2520as%2520sources%2520of%2520new%2520drugs%2520over%252030%2520years%2520from%25201981%2520to%25202010%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2012%26volume%3D75%26spage%3D311%26epage%3D335%26doi%3D10.1021%2Fnp200906s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macarron, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bojanic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burns, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cirovic, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garyantes, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, D. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertzberg, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janzen, W. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paslay, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schopfer, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sittampalam, G. S.</span></span> <span> </span><span class="NLM_article-title">Impact of high-throughput screening in biomedical research</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">188</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1038/nrd3368</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd3368" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=21358738" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=188-195&author=R.+Macarronauthor=M.+N.+Banksauthor=D.+Bojanicauthor=D.+J.+Burnsauthor=D.+A.+Cirovicauthor=T.+Garyantesauthor=D.+V.+S.+Greenauthor=R.+P.+Hertzbergauthor=W.+P.+Janzenauthor=J.+W.+Paslayauthor=U.+Schopferauthor=G.+S.+Sittampalam&title=Impact+of+high-throughput+screening+in+biomedical+research&doi=10.1038%2Fnrd3368"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of high-throughput screening in biomedical research</span></div><div class="casAuthors">Macarron, Ricardo; Banks, Martyn N.; Bojanic, Dejan; Burns, David J.; Cirovic, Dragan A.; Garyantes, Tina; Green, Darren V. S.; Hertzberg, Robert P.; Janzen, William P.; Paslay, Jeff W.; Schopfer, Ulrich; Sittampalam, G. Sitta</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">188-195</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  High-throughput screening (HTS) has been postulated in several quarters to be a contributory factor to the decline in productivity in the pharmaceutical industry.  Moreover, it has been blamed for stifling the creativity that drug discovery demands.  In this article, we aim to dispel these myths and present the case for the use of HTS as part of a proven scientific tool kit, the wider use of which is essential for the discovery of new chemotypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLnrSVehADbLVg90H21EOLACvtfcHk0ljdgeDBWsAXjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFensbY%253D&md5=cb9853227506f3a3d774791cff9fd79d</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1038%2Fnrd3368&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3368%26sid%3Dliteratum%253Aachs%26aulast%3DMacarron%26aufirst%3DR.%26aulast%3DBanks%26aufirst%3DM.%2BN.%26aulast%3DBojanic%26aufirst%3DD.%26aulast%3DBurns%26aufirst%3DD.%2BJ.%26aulast%3DCirovic%26aufirst%3DD.%2BA.%26aulast%3DGaryantes%26aufirst%3DT.%26aulast%3DGreen%26aufirst%3DD.%2BV.%2BS.%26aulast%3DHertzberg%26aufirst%3DR.%2BP.%26aulast%3DJanzen%26aufirst%3DW.%2BP.%26aulast%3DPaslay%26aufirst%3DJ.%2BW.%26aulast%3DSchopfer%26aufirst%3DU.%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26atitle%3DImpact%2520of%2520high-throughput%2520screening%2520in%2520biomedical%2520research%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D188%26epage%3D195%26doi%3D10.1038%2Fnrd3368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wassermann, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camargo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auld, D. S.</span></span> <span> </span><span class="NLM_article-title">Composition and applications of focus libraries to phenotypic assays</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.3389/fphar.2014.00164</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.3389%2Ffphar.2014.00164" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=24478702" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=1-12&author=A.+M.+Wassermannauthor=L.+M.+Camargoauthor=D.+S.+Auld&title=Composition+and+applications+of+focus+libraries+to+phenotypic+assays&doi=10.3389%2Ffphar.2014.00164"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2014.00164&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2014.00164%26sid%3Dliteratum%253Aachs%26aulast%3DWassermann%26aufirst%3DA.%2BM.%26aulast%3DCamargo%26aufirst%3DL.%2BM.%26aulast%3DAuld%26aufirst%3DD.%2BS.%26atitle%3DComposition%2520and%2520applications%2520of%2520focus%2520libraries%2520to%2520phenotypic%2520assays%26jtitle%3DFront.%2520Pharmacol.%26date%3D2014%26volume%3D5%26spage%3D1%26epage%3D12%26doi%3D10.3389%2Ffphar.2014.00164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-lead medicincal chemistry publications in 2015</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">99</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01123</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01123" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=89-99&author=C.+N.+Johnsonauthor=D.+A.+Erlansonauthor=C.+W.+Murrayauthor=D.+C.+Rees&title=Fragment-to-lead+medicincal+chemistry+publications+in+2015&doi=10.1021%2Facs.jmedchem.6b01123"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01123%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DFragment-to-lead%2520medicincal%2520chemistry%2520publications%2520in%25202015%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D89%26epage%3D99%26doi%3D10.1021%2Facs.jmedchem.6b01123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, C. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erlanson, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jahnke, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mortenson, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span> <span> </span><span class="NLM_article-title">Fragment-to-lead medicinal chemistry publications in 2016</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1774</span>– <span class="NLM_lpage">1784</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslentrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1774-1784&author=C.+N.+Johnsonauthor=D.+A.+Erlansonauthor=W.+Jahnkeauthor=P.+N.+Mortensonauthor=D.+C.+Rees&title=Fragment-to-lead+medicinal+chemistry+publications+in+2016&doi=10.1021%2Facs.jmedchem.7b01298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Fragment-to-Lead Medicinal Chemistry Publications in 2016</span></div><div class="casAuthors">Johnson, Christopher N.; Erlanson, Daniel A.; Jahnke, Wolfgang; Mortenson, Paul N.; Rees, David C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1774-1784</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The popularity of fragment-based drug discovery (FBDD) is demonstrated by the no. of recent successful fragment-to-lead (F2L) publications.  This Miniperspective provides a tabulated summary of the F2L literature published in the year 2016, along with discussion of general trends.  It uses the same format as our summary of the 2015 literature and is intended to be a resource for both FBDD practitioners and medicinal chemists in general.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDiwnepXDgrbVg90H21EOLACvtfcHk0linlTDVuM32zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslentrfP&md5=861d9adf1530250a060fc254ca7b493c</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01298%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BN.%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26aulast%3DJahnke%26aufirst%3DW.%26aulast%3DMortenson%26aufirst%3DP.%2BN.%26aulast%3DRees%26aufirst%3DD.%2BC.%26atitle%3DFragment-to-lead%2520medicinal%2520chemistry%2520publications%2520in%25202016%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1774%26epage%3D1784%26doi%3D10.1021%2Facs.jmedchem.7b01298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, R. K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiez-Vandal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenker, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edman, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggeler, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooke, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumelin, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doré, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geschwindner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grebner, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermansson, N.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jazayeri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prihandoko, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rappas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soutter, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snijder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sundström, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tehan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thornton, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Troast, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiggin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhukov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, N.</span></span> <span> </span><span class="NLM_article-title">Structural insight into allosteric modulation of protease-activated receptor-2</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>545</i></span>,  <span class="NLM_fpage">112</span>– <span class="NLM_lpage">115</span>, <span class="refDoi"> DOI: 10.1038/nature22309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnature22309" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=545&publication_year=2017&pages=112-115&author=R.+K.+Y.+Chengauthor=C.+Fiez-Vandalauthor=O.+Schlenkerauthor=K.+Edmanauthor=B.+Aggelerauthor=D.+G.+Brownauthor=G.+Brownauthor=R.+Cookeauthor=C.+E.+Dumelinauthor=A.+S.+Dor%C3%A9author=S.+Geschwindnerauthor=C.+Grebnerauthor=N.-O.+Hermanssonauthor=A.+Jazayeriauthor=P.+Johanssonauthor=L.+Leongauthor=R.+Prihandokoauthor=M.+Rappasauthor=H.+Soutterauthor=A.+Snijderauthor=L.+Sundstr%C3%B6mauthor=B.+Tehanauthor=P.+Thorntonauthor=D.+Troastauthor=G.+Wigginauthor=A.+Zhukovauthor=F.+H.+Marshallauthor=N.+Dekker&title=Structural+insight+into+allosteric+modulation+of+protease-activated+receptor-2&doi=10.1038%2Fnature22309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1038%2Fnature22309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature22309%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DR.%2BK.%2BY.%26aulast%3DFiez-Vandal%26aufirst%3DC.%26aulast%3DSchlenker%26aufirst%3DO.%26aulast%3DEdman%26aufirst%3DK.%26aulast%3DAggeler%26aufirst%3DB.%26aulast%3DBrown%26aufirst%3DD.%2BG.%26aulast%3DBrown%26aufirst%3DG.%26aulast%3DCooke%26aufirst%3DR.%26aulast%3DDumelin%26aufirst%3DC.%2BE.%26aulast%3DDor%25C3%25A9%26aufirst%3DA.%2BS.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DGrebner%26aufirst%3DC.%26aulast%3DHermansson%26aufirst%3DN.-O.%26aulast%3DJazayeri%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DLeong%26aufirst%3DL.%26aulast%3DPrihandoko%26aufirst%3DR.%26aulast%3DRappas%26aufirst%3DM.%26aulast%3DSoutter%26aufirst%3DH.%26aulast%3DSnijder%26aufirst%3DA.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DL.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DThornton%26aufirst%3DP.%26aulast%3DTroast%26aufirst%3DD.%26aulast%3DWiggin%26aufirst%3DG.%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DDekker%26aufirst%3DN.%26atitle%3DStructural%2520insight%2520into%2520allosteric%2520modulation%2520of%2520protease-activated%2520receptor-2%26jtitle%3DNature%26date%3D2017%26volume%3D545%26spage%3D112%26epage%3D115%26doi%3D10.1038%2Fnature22309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Belyanskaya, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Callahan, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazaar, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Israel, D. I.</span></span> <span> </span><span class="NLM_article-title">Discovering drugs with DNA-encoded library technology: From concept to clinic with an inhibitor of soluble epoxide hydrolase</span>. <i>ChemBioChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">842</span>, <span class="refDoi"> DOI: 10.1002/cbic.201700014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2Fcbic.201700014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=28281333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=837-842&author=S.+L.+Belyanskayaauthor=Y.+Dingauthor=J.+F.+Callahanauthor=A.+L.+Lazaarauthor=D.+I.+Israel&title=Discovering+drugs+with+DNA-encoded+library+technology%3A+From+concept+to+clinic+with+an+inhibitor+of+soluble+epoxide+hydrolase&doi=10.1002%2Fcbic.201700014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase</span></div><div class="casAuthors">Belyanskaya, Svetlana L.; Ding, Yun; Callahan, James F.; Lazaar, Aili L.; Israel, David I.</div><div class="citationInfo"><span class="NLM_cas:title">ChemBioChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">837-842</span>CODEN:
                <span class="NLM_cas:coden">CBCHFX</span>;
        ISSN:<span class="NLM_cas:issn">1439-4227</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">DNA-encoded chem. library technol. was developed with the vision of its becoming a transformational platform for drug discovery.  The hope was that a new paradigm for the discovery of low-mol.-wt. drugs would be enabled by combining the vast mol. diversity achievable with combinatorial chem., the information-encoding attributes of DNA, the power of mol. biol., and a streamlined selection-based discovery process.  Here, we describe the discovery and early clin. development of GSK2256294, an inhibitor of sol. epoxide hydrolase (sEH, EPHX2), by using encoded-library technol. (ELT).  GSK2256294 is an orally bioavailable, potent and selective inhibitor of sEH that has a long half life and produced no serious adverse events in a first-time-in-human clin. study.  To our knowledge, GSK2256294 is the first mol. discovered from this technol. to enter human clin. testing and represents a realization of the vision that DNA-encoded chem. library technol. can efficiently yield mols. with favorable properties that can be readily progressed into high-quality drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7WTPZp2SE0rVg90H21EOLACvtfcHk0linlTDVuM32zg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVWjurk%253D&md5=a34e28c8817864356f6ff689e9236940</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1002%2Fcbic.201700014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcbic.201700014%26sid%3Dliteratum%253Aachs%26aulast%3DBelyanskaya%26aufirst%3DS.%2BL.%26aulast%3DDing%26aufirst%3DY.%26aulast%3DCallahan%26aufirst%3DJ.%2BF.%26aulast%3DLazaar%26aufirst%3DA.%2BL.%26aulast%3DIsrael%26aufirst%3DD.%2BI.%26atitle%3DDiscovering%2520drugs%2520with%2520DNA-encoded%2520library%2520technology%253A%2520From%2520concept%2520to%2520clinic%2520with%2520an%2520inhibitor%2520of%2520soluble%2520epoxide%2520hydrolase%26jtitle%3DChemBioChem%26date%3D2017%26volume%3D18%26spage%3D837%26epage%3D842%26doi%3D10.1002%2Fcbic.201700014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Franzini, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, C.</span></span> <span> </span><span class="NLM_article-title">Chemical space of DNA-encoded libraries</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">6629</span>– <span class="NLM_lpage">6644</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01874</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01874" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC28XjtVOlsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=6629-6644&author=R.+M.+Franziniauthor=C.+Randolph&title=Chemical+space+of+DNA-encoded+libraries&doi=10.1021%2Facs.jmedchem.5b01874"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Chemical Space of DNA-Encoded Libraries</span></div><div class="casAuthors">Franzini, Raphael M.; Randolph, Cassie</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6629-6644</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In recent years, DNA-encoded chem. libraries (DECLs) have attracted considerable attention as a potential discovery tool in drug development.  Screening encoded libraries may offer advantages over conventional hit discovery approaches and has the potential to complement such methods in pharmaceutical research.  As a result of the increased application of encoded libraries in drug discovery, a growing no. of hit compds. are emerging in scientific literature.  In this review we evaluate reported encoded library-derived structures and identify general trends of these compds. in relation to library design parameters.  We in particular emphasize the combinatorial nature of these libraries.  Generally, the reported mols. demonstrate the ability of this technol. to afford hits suitable for further lead development, and on the basis of them, we derive guidelines for DECL design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLvieeEe9dd7Vg90H21EOLACvtfcHk0lgfYHT9Z6k1qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjtVOlsbg%253D&md5=f037f9866a0161730c9f34a105ca34c8</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01874%26sid%3Dliteratum%253Aachs%26aulast%3DFranzini%26aufirst%3DR.%2BM.%26aulast%3DRandolph%26aufirst%3DC.%26atitle%3DChemical%2520space%2520of%2520DNA-encoded%2520libraries%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D6629%26epage%3D6644%26doi%3D10.1021%2Facs.jmedchem.5b01874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moffat, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prunotto, M.</span></span> <span> </span><span class="NLM_article-title">Opportunities and challenges in phenotypic drug discovery; an industry perspective</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">543</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd.2017.111" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=531-543&author=J.+G.+Moffatauthor=F.+Vincentauthor=J.+A.+Leeauthor=J.+Ederauthor=M.+Prunotto&title=Opportunities+and+challenges+in+phenotypic+drug+discovery%3B+an+industry+perspective&doi=10.1038%2Fnrd.2017.111"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.111%26sid%3Dliteratum%253Aachs%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DEder%26aufirst%3DJ.%26aulast%3DPrunotto%26aufirst%3DM.%26atitle%3DOpportunities%2520and%2520challenges%2520in%2520phenotypic%2520drug%2520discovery%253B%2520an%2520industry%2520perspective%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D531%26epage%3D543%26doi%3D10.1038%2Fnrd.2017.111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berg, E. L.</span></span> <span> </span><span class="NLM_article-title">Neoclassic drug discovery: The case for lead generation using phenotypic and functional approaches</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1143</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1177/1087057113506118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1177%2F1087057113506118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=24080259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslWitrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=1143-1155&author=J.+A.+Leeauthor=E.+L.+Berg&title=Neoclassic+drug+discovery%3A+The+case+for+lead+generation+using+phenotypic+and+functional+approaches&doi=10.1177%2F1087057113506118"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Neoclassic drug discovery: the case for lead generation using phenotypic and functional approaches</span></div><div class="casAuthors">Lee, Jonathan A.; Berg, Ellen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1143-1155, 13</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">A review.  Innovation and new mol. entity prodn. by the pharmaceutical industry has been below expectations.  Surprisingly, more first-in-class small-mol. drugs approved by the U.S.  Food and Drug Administration (FDA) between 1999 and 2008 were identified by functional phenotypic lead generation strategies reminiscent of pre-genomics pharmacol. than contemporary mol. targeted strategies that encompass the vast majority of lead generation efforts.  This observation, in conjunction with the difficulty in validating mol. targets for drug discovery, has diminished the impact of the "genomics revolution" and has led to a growing grassroots movement and now broader trend in pharma to reconsider the use of modern physiol.-based or phenotypic drug discovery (PDD) strategies.  This "From the Guest Editors" column provides an introduction and overview of the two-part special issues of Journal of Biomol. Screening on PDD.  Terminol. and the business case for use of PDD are defined.  Key issues such as assay performance, chem. optimization, target identification, and challenges to the organization and implementation of PDD are discussed.  Possible solns. for these challenges and a new neoclassic vision for PDD that combines phenotypic and functional approaches with technol. innovations resulting from the genomics-driven era of target-based drug discovery (TDD) are also described.  Finally, an overview of the manuscripts in this special edition is provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGlmN5UDYSTrVg90H21EOLACvtfcHk0lgfYHT9Z6k1qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslWitrrK&md5=dca3c682cd685cd7a24d8784c8aec8c4</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1177%2F1087057113506118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057113506118%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DJ.%2BA.%26aulast%3DBerg%26aufirst%3DE.%2BL.%26atitle%3DNeoclassic%2520drug%2520discovery%253A%2520The%2520case%2520for%2520lead%2520generation%2520using%2520phenotypic%2520and%2520functional%2520approaches%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2013%26volume%3D18%26spage%3D1143%26epage%3D1155%26doi%3D10.1177%2F1087057113506118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexander, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">March, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satterthwaite, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pangalos, M. N.</span></span> <span> </span><span class="NLM_article-title">Lessons learned from the fate of AstraZeneca’s drug pipeline: a five-dimensional framework</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">419</span>– <span class="NLM_lpage">431</span>, <span class="refDoi"> DOI: 10.1038/nrd4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd4309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=24833294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotVyqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=419-431&author=D.+Cookauthor=D.+Brownauthor=R.+Alexanderauthor=R.+Marchauthor=P.+Morganauthor=G.+Satterthwaiteauthor=M.+N.+Pangalos&title=Lessons+learned+from+the+fate+of+AstraZeneca%E2%80%99s+drug+pipeline%3A+a+five-dimensional+framework&doi=10.1038%2Fnrd4309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework</span></div><div class="casAuthors">Cook, David; Brown, Dearg; Alexander, Robert; March, Ruth; Morgan, Paul; Satterthwaite, Gemma; Pangalos, Menelas N.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">419-431</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Maintaining research and development (R&D) productivity at a sustainable level is one of the main challenges currently facing the pharmaceutical industry.  In this article, we discuss the results of a comprehensive longitudinal review of AstraZeneca's small-mol. drug projects from 2005 to 2010.  The anal. allowed us to establish a framework based on the five most important tech. determinants of project success and pipeline quality, which we describe as the five 'R's: the right target, the right patient, the right tissue, the right safety and the right com. potential.  A sixth factor - the right culture - is also crucial in encouraging effective decision-making based on these tech. determinants.  AstraZeneca is currently applying this framework to guide its R&D teams, and although it is too early to demonstrate whether this has improved the company's R&D productivity, we present our data and anal. here in the hope that it may assist the industry overall in addressing this key challenge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4yhPFZOUNO7Vg90H21EOLACvtfcHk0lgfYHT9Z6k1qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotVyqtrw%253D&md5=746a86c7223f170f7e6c4f9817760e5b</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1038%2Fnrd4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4309%26sid%3Dliteratum%253Aachs%26aulast%3DCook%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DD.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMarch%26aufirst%3DR.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DSatterthwaite%26aufirst%3DG.%26aulast%3DPangalos%26aufirst%3DM.%2BN.%26atitle%3DLessons%2520learned%2520from%2520the%2520fate%2520of%2520AstraZeneca%25E2%2580%2599s%2520drug%2520pipeline%253A%2520a%2520five-dimensional%2520framework%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D419%26epage%3D431%26doi%3D10.1038%2Fnrd4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dandapani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosse, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Southall, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvino, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span> <span> </span><span class="NLM_article-title">Selecting, acquiring, and using small molecule libraries for high-throughput screening</span>. <i>Curr. Protoc. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">191</span>, <span class="refDoi"> DOI: 10.1002/9780470559277.ch110252</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1002%2F9780470559277.ch110252" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=26705509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A280%3ADC%252BC2srjvVOktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=177-191&author=S.+Dandapaniauthor=G.+Rosseauthor=N.+Southallauthor=J.+M.+Salvinoauthor=C.+J.+Thomas&title=Selecting%2C+acquiring%2C+and+using+small+molecule+libraries+for+high-throughput+screening&doi=10.1002%2F9780470559277.ch110252"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Selecting, Acquiring, and Using Small Molecule Libraries for High-Throughput Screening</span></div><div class="casAuthors">Dandapani Sivaraman; Rosse Gerard; Southall Noel; Thomas Craig J; Salvino Joseph M</div><div class="citationInfo"><span class="NLM_cas:title">Current protocols in chemical biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-191</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The selection, acquisition and use of high quality small molecule libraries for screening is an essential aspect of drug discovery and chemical biology programs.  Screening libraries continue to evolve as researchers gain a greater appreciation of the suitability of small molecules for specific biological targets, processes and environments.  The decisions surrounding the make-up of any given small molecule library is informed by a multitude of variables and opinions vary on best-practices.  The fitness of any collection relies upon upfront filtering to avoiding problematic compounds, assess appropriate physicochemical properties, install the ideal level of structural uniqueness and determine the desired extent of molecular complexity.  These criteria are under constant evaluation and revision as academic and industrial organizations seek out collections that yield ever improving results from their screening portfolios.  Practical questions including cost, compound management, screening sophistication and assay objective also play a significant role in the choice of library composition.  This overview attempts to offer advice to all organizations engaged in small molecule screening based upon current best practices and theoretical considerations in library selection and acquisition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRQOmw0z6h9kY3yKPtYViAGfW6udTcc2ea8ka7BwrcDzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2srjvVOktQ%253D%253D&md5=1658f6aed4b38cc1274ab5721c819e6c</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1002%2F9780470559277.ch110252&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470559277.ch110252%26sid%3Dliteratum%253Aachs%26aulast%3DDandapani%26aufirst%3DS.%26aulast%3DRosse%26aufirst%3DG.%26aulast%3DSouthall%26aufirst%3DN.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26atitle%3DSelecting%252C%2520acquiring%252C%2520and%2520using%2520small%2520molecule%2520libraries%2520for%2520high-throughput%2520screening%26jtitle%3DCurr.%2520Protoc.%2520Chem.%2520Biol.%26date%3D2012%26volume%3D4%26spage%3D177%26epage%3D191%26doi%3D10.1002%2F9780470559277.ch110252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baker, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tropsha, A.</span></span> <span> </span><span class="NLM_article-title">A bibliometric review of drug repurposing</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">661</span>– <span class="NLM_lpage">672</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2018.01.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.drudis.2018.01.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=29330123" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsF2itr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=661-672&author=N.+C.+Bakerauthor=S.+Ekinsauthor=A.+J.+Williamsauthor=A.+Tropsha&title=A+bibliometric+review+of+drug+repurposing&doi=10.1016%2Fj.drudis.2018.01.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">A bibliometric review of drug repurposing</span></div><div class="casAuthors">Baker, Nancy C.; Ekins, Sean; Williams, Antony J.; Tropsha, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">661-672</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  We have conducted a bibliometric review of drug repurposing by scanning >25 million papers in PubMed and using text-mining methods to gather, count and analyze chem.-disease therapeutic relationships.  We find that > 60% of the ∼35,000 drugs or drug candidates identified in our study have been tried in more than one disease, including 189 drugs that have been tried in > 300 diseases each.  Whereas in the majority of cases these drugs were applied in therapeutic areas close to their original use, there have been striking, and perhaps instructive, successful attempts of drug repurposing for unexpected, novel therapeutic areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqognIZ9tedorVg90H21EOLACvtfcHk0lgD5PWwmzpNfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsF2itr0%253D&md5=23c110face2733b9d84d4d7c51a49409</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2018.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2018.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DBaker%26aufirst%3DN.%2BC.%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DA.%2BJ.%26aulast%3DTropsha%26aufirst%3DA.%26atitle%3DA%2520bibliometric%2520review%2520of%2520drug%2520repurposing%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2018%26volume%3D23%26spage%3D661%26epage%3D672%26doi%3D10.1016%2Fj.drudis.2018.01.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DiMasi, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faden, L. B.</span></span> <span> </span><span class="NLM_article-title">Competitiveness in follow on drug R&D: A race or limitation?</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1038/nrd3296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd3296" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=23-27&author=J.+A.+DiMasiauthor=L.+B.+Faden&title=Competitiveness+in+follow+on+drug+R%26D%3A+A+race+or+limitation%3F&doi=10.1038%2Fnrd3296"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1038%2Fnrd3296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3296%26sid%3Dliteratum%253Aachs%26aulast%3DDiMasi%26aufirst%3DJ.%2BA.%26aulast%3DFaden%26aufirst%3DL.%2BB.%26atitle%3DCompetitiveness%2520in%2520follow%2520on%2520drug%2520R%2526D%253A%2520A%2520race%2520or%2520limitation%253F%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D23%26epage%3D27%26doi%3D10.1038%2Fnrd3296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giordanetto, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boström, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrchan, C.</span></span> <span> </span><span class="NLM_article-title">Follow-on drugs: How far should chemists look?</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">732</span>, <span class="refDoi"> DOI: 10.1016/j.drudis.2011.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.drudis.2011.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=21658467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A280%3ADC%252BC3MjlsFOmtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2011&pages=722-732&author=F.+Giordanettoauthor=J.+Bostr%C3%B6mauthor=C.+Tyrchan&title=Follow-on+drugs%3A+How+far+should+chemists+look%3F&doi=10.1016%2Fj.drudis.2011.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Follow-on drugs: how far should chemists look?</span></div><div class="casAuthors">Giordanetto Fabrizio; Bostrom Jonas; Tyrchan Christian</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">15-16</span>),
    <span class="NLM_cas:pages">722-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A major remark made by observers relates to the focus of the pharmaceutical industry on 'me-too' drugs rather than 'first-in-class' drugs, the latter are considered to be 'truly' innovative medicines.  Although the subject is heavily debated, chemists in project teams around the globe are routinely following up compounds from competitors.  An important strategic consideration is the degree of chemical modification of the original structure required for success.  Here, we present an analysis of the DiMasi and Faden set of first-in-class and follow-on drug pairs (n=74); showing that 70% of them are structurally very similar, meaning that they are characterized by minimal structural variations.  This highlights the fact that even simple atomic variations can cause drastic changes in molecular properties responsible for therapeutic advantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT9-qG0lyy9NOLt9HypzAgQfW6udTcc2ea8ka7BwrcDzrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MjlsFOmtQ%253D%253D&md5=dd6c836d380d44bb7c704e3bd39cc99e</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2011.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2011.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DGiordanetto%26aufirst%3DF.%26aulast%3DBostr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DTyrchan%26aufirst%3DC.%26atitle%3DFollow-on%2520drugs%253A%2520How%2520far%2520should%2520chemists%2520look%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2011%26volume%3D16%26spage%3D722%26epage%3D732%26doi%3D10.1016%2Fj.drudis.2011.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nassar, A-E. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamel, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarimont, C.</span></span> <span> </span><span class="NLM_article-title">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span>. <i>Drug Discovery Today</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1020</span>– <span class="NLM_lpage">1028</span>, <span class="refDoi"> DOI: 10.1016/S1359-6446(04)03280-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2FS1359-6446%2804%2903280-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=15574318" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=1020-1028&author=A-E.+F.+Nassarauthor=A.+M.+Kamelauthor=C.+Clarimont&title=Improving+the+decision-making+process+in+the+structural+modification+of+drug+candidates%3A+enhancing+metabolic+stability&doi=10.1016%2FS1359-6446%2804%2903280-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Improving the decision-making process in the structural modification of drug candidates: enhancing metabolic stability</span></div><div class="casAuthors">Nassar, Alaa-Eldin F.; Kamel, Amin M.; Clarimont, Caroline</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">1020-1028</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.  The activity-exposure-toxicity relationship, which can be described as the rule of three', presents the single most difficult challenge in the design of drug candidates and their subsequent advancement to the development stage.  ADME studies are widely used in drug discovery to optimize the balance of properties necessary to convert lead candidates into drugs that are safe and effective for humans.  Metabolite characterization has become one of the key drivers of the drug discovery process, helping to optimize ADME properties and increase the success rate for drugs.  Various strategies can influence drug design in the decision-making process in the structural modification of drug candidates to reduce metabolic instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokn5ucRSES-rVg90H21EOLACvtfcHk0lgQ2TPxXp9U6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClsL%252FL&md5=67a85a167b62f0ea4e9f43d25f3e0866</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903280-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903280-5%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA-E.%2BF.%26aulast%3DKamel%26aufirst%3DA.%2BM.%26aulast%3DClarimont%26aufirst%3DC.%26atitle%3DImproving%2520the%2520decision-making%2520process%2520in%2520the%2520structural%2520modification%2520of%2520drug%2520candidates%253A%2520enhancing%2520metabolic%2520stability%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D1020%26epage%3D1028%26doi%3D10.1016%2FS1359-6446%2804%2903280-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Springthorpe, B.</span></span> <span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">890</span>, <span class="refDoi"> DOI: 10.1038/nrd2445</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd2445" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=17971784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry&doi=10.1038%2Fnrd2445"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of drug-like concepts on decision-making in medicinal chemistry</span></div><div class="casAuthors">Leeson, Paul D.; Springthorpe, Brian</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">881-890</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the wide acceptance of drug-like principles such as the 'rule of five', this anal. of mols. currently being synthesized in leading pharmaceutical companies reveals that their phys. properties differ significantly from those of recently discovered oral drugs.  The marked increase in lipophilicity in particular could increase the likelihood of attrition in drug development.  The application of guidelines linked to the concept of drug-likeness, such as the 'rule of five', has gained wide acceptance as an approach to reduce attrition in drug discovery and development.  However, despite this acceptance, anal. of recent trends reveals that the phys. properties of mols. that are currently being synthesized in leading drug discovery companies differ significantly from those of recently discovered oral drugs and compds. in clin. development.  The consequences of the marked increase in lipophilicity - the most important drug-like phys. property - include a greater likelihood of lack of selectivity and attrition in drug development.  Tackling the threat of compd.-related toxicol. attrition needs to move to the mainstream of medicinal chem. decision-making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTUeonLD6iebVg90H21EOLACvtfcHk0lgQ2TPxXp9U6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1els7rL&md5=5665a9e2dc266a1ee096e20625757ef7</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1038%2Fnrd2445&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2445%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890%26doi%3D10.1038%2Fnrd2445" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span></span> <span> </span><span class="NLM_article-title">Molecular property design: does everyone get it?</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">722</span>– <span class="NLM_lpage">725</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00157</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00157" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=722-725&author=P.+D.+Leesonauthor=R.+J.+Young&title=Molecular+property+design%3A+does+everyone+get+it%3F&doi=10.1021%2Facsmedchemlett.5b00157"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Property Design: Does Everyone Get It?</span></div><div class="casAuthors">Leeson, Paul D.; Young, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">722-725</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The principles of mol. property optimization in drug design have been understood for decades, yet much drug discovery activity today is conducted at the periphery of historical druglike property space.  Lead optimization trajectories aimed at reducing physicochem. risk, assisted by ligand efficiency metrics, could help to reduce clin. attrition rates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_t8gIn79arVg90H21EOLACvtfcHk0lgQ2TPxXp9U6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptVGksr4%253D&md5=5a807a8d049ce8cf4adc186891a9234d</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00157&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00157%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DMolecular%2520property%2520design%253A%2520does%2520everyone%2520get%2520it%253F%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D722%26epage%3D725%26doi%3D10.1021%2Facsmedchemlett.5b00157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullard, A.</span></span> <span> </span><span class="NLM_article-title">FDA approves first deuterated drug</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">305</span>, <span class="refDoi"> DOI: 10.1038/nrd.2017.89</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd.2017.89" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVCjtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=305&author=A.+Mullard&title=FDA+approves+first+deuterated+drug&doi=10.1038%2Fnrd.2017.89"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">FDA approves dupilumab for severe eczema</span></div><div class="casAuthors">Mullard, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">305</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUum9oBjWLmbVg90H21EOLACvtfcHk0lgQ2TPxXp9U6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVCjtbo%253D&md5=361e2f015369489f80b032336b38d849</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1038%2Fnrd.2017.89&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd.2017.89%26sid%3Dliteratum%253Aachs%26aulast%3DMullard%26aufirst%3DA.%26atitle%3DFDA%2520approves%2520first%2520deuterated%2520drug%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2017%26volume%3D16%26spage%3D305%26doi%3D10.1038%2Fnrd.2017.89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramesh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, D. S.</span></span> <span> </span><span class="NLM_article-title">Quest for novel chemical entities through incorporation of silicon in drug scaffolds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">3779</span>– <span class="NLM_lpage">3798</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00718</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00718" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsbvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=3779-3798&author=R.+Rameshauthor=D.+S.+Reddy&title=Quest+for+novel+chemical+entities+through+incorporation+of+silicon+in+drug+scaffolds&doi=10.1021%2Facs.jmedchem.7b00718"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds</span></div><div class="casAuthors">Ramesh, Remya; Reddy, D. Srinivasa</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3779-3798</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to optimize a lead mol. for further development, bioisosteric replacements are generally adopted as one of the strategies.  Silicon appears to be the right choice as a carbon isostere because of the similarity in chem. properties.  Silicon can be strategically introduced in a mol. to modulate its druglike properties, providing medicinal chemists with an unconventional strategy for replacing a carbon atom.  Silicon can also be introduced to replace other heteroatoms and can act as a surrogate of functional groups such as olefin and amide as well.  The present Perspective focuses on the opportunities that silicon incorporation offers in drug discovery, with an emphasis on case studies where introduction of silicon has created a benefit over its analog.  We have tried to highlight all the recent developments in the field and briefly discuss the challenges assocd. with them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjk4JZC1BTKLVg90H21EOLACvtfcHk0lgFFrqQgiYvGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1KnsbvM&md5=fa3da0fddb955d156d410eb68030e78a</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00718%26sid%3Dliteratum%253Aachs%26aulast%3DRamesh%26aufirst%3DR.%26aulast%3DReddy%26aufirst%3DD.%2BS.%26atitle%3DQuest%2520for%2520novel%2520chemical%2520entities%2520through%2520incorporation%2520of%2520silicon%2520in%2520drug%2520scaffolds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D3779%26epage%3D3798%26doi%3D10.1021%2Facs.jmedchem.7b00718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdolmaleki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghasemi, J. B.</span></span> <span> </span><span class="NLM_article-title">Dual-acting of hybrid compounds – A new dawn in the discovery of multi-target drugs: lead generation approaches</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1096</span>– <span class="NLM_lpage">1114</span>, <span class="refDoi"> DOI: 10.2174/1568026616666160927151144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.2174%2F1568026616666160927151144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=27697056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXivVOqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=1096-1114&author=A.+Abdolmalekiauthor=J.+B.+Ghasemi&title=Dual-acting+of+hybrid+compounds+%E2%80%93+A+new+dawn+in+the+discovery+of+multi-target+drugs%3A+lead+generation+approaches&doi=10.2174%2F1568026616666160927151144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Dual-acting of Hybrid Compounds - A New Dawn in the Discovery of Multi-target Drugs: Lead Generation Approaches</span></div><div class="casAuthors">Abdolmaleki, Azizeh; Ghasemi, Jahan B.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1096-1114</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Finding high quality beginning compds. is a crit. job at the start of the lead generation stage for multi-target drug discovery (MTDD).  Designing hybrid compds. as selective multitarget chem. entity is a challenge, opportunity, and new idea to better act against specific multiple targets.  One hybrid mol. is formed by two (or more) pharmacophore group's participation.  So, these new compds. often exhibit two or more activities going about as multi-target drugs (mtdrugs) and may have superior safety or efficacy.  Application of integrating a range of information and sophisticated new in silico, bioinformatics, structural biol., pharmacogenomics methods may be useful to discover/design, and synthesis of the new hybrid mols.  In this regard, many rational and screening approaches have followed by medicinal chemists for the lead generation in MTDD.  Here, we review some popular lead generation approaches that have been used for designing multiple ligands (DMLs).  This paper focuses on dual- acting chem. entities that incorporate a part of two drugs or bioactive compds. to compose hybrid mols.  Also, it presents some of key concepts and limitations/strengths of lead generation methods by comparing combination framework method with screening approaches.  Besides, a no. of examples to represent applications of hybrid mols. in the drug discovery are included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm8Nd5jc8EqrVg90H21EOLACvtfcHk0lgFFrqQgiYvGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXivVOqtro%253D&md5=c80d6ba718dd9695d538842adec6a7f7</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.2174%2F1568026616666160927151144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026616666160927151144%26sid%3Dliteratum%253Aachs%26aulast%3DAbdolmaleki%26aufirst%3DA.%26aulast%3DGhasemi%26aufirst%3DJ.%2BB.%26atitle%3DDual-acting%2520of%2520hybrid%2520compounds%2520%25E2%2580%2593%2520A%2520new%2520dawn%2520in%2520the%2520discovery%2520of%2520multi-target%2520drugs%253A%2520lead%2520generation%2520approaches%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2017%26volume%3D17%26spage%3D1096%26epage%3D1114%26doi%3D10.2174%2F1568026616666160927151144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cromm, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crews, C. M.</span></span> <span> </span><span class="NLM_article-title">Targeted protein degradation: from chemical biology to drug discovery</span>. <i>Cell Chem. Bio.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1181</span>– <span class="NLM_lpage">1190</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.05.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1016%2Fj.chembiol.2017.05.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=28648379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtrrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1181-1190&author=P.+M.+Crommauthor=C.+M.+Crews&title=Targeted+protein+degradation%3A+from+chemical+biology+to+drug+discovery&doi=10.1016%2Fj.chembiol.2017.05.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Targeted Protein Degradation: from Chemical Biology to Drug Discovery</span></div><div class="casAuthors">Cromm, Philipp M.; Crews, Craig M.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1181-1190</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  Traditional pharmaceutical drug discovery is almost exclusively focused on directly controlling protein activity to cure diseases.  Modulators of protein activity, esp. inhibitors, are developed and applied at high concn. to achieve maximal effects.  Thereby, reduced bioavailability and off-target effects can hamper compd. efficacy.  Nucleic acid-based strategies that control protein function by affecting expression have emerged as an alternative.  However, metabolic stability and broad bioavailability represent development hurdles that remain to be overcome for these approaches.  More recently, utilizing the cell's own protein destruction machinery for selective degrdn. of essential drivers of human disorders has opened up a new and exciting area of drug discovery.  Small-mol.-induced proteolysis of selected substrates offers the potential of reaching beyond the limitations of the current pharmaceutical paradigm to expand the druggable target space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrosuhmnPE0RrVg90H21EOLACvtfcHk0lgFFrqQgiYvGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVOjtrrO&md5=3c8c6d9488396d5eb08ca51cee20bbf4</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.05.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.05.024%26sid%3Dliteratum%253Aachs%26aulast%3DCromm%26aufirst%3DP.%2BM.%26aulast%3DCrews%26aufirst%3DC.%2BM.%26atitle%3DTargeted%2520protein%2520degradation%253A%2520from%2520chemical%2520biology%2520to%2520drug%2520discovery%26jtitle%3DCell%2520Chem.%2520Bio.%26date%3D2017%26volume%3D24%26spage%3D1181%26epage%3D1190%26doi%3D10.1016%2Fj.chembiol.2017.05.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><a href="http://arvinas.com/press-releases/arvinas-nominates-oral-clinical-candidate-androgen-receptor-degrader-program/" class="extLink">http://arvinas.com/press-releases/arvinas-nominates-oral-clinical-candidate-androgen-receptor-degrader-program/</a> (accessed Feb 21, <span class="NLM_year">2018</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=http%3A%2F%2Farvinas.com%2Fpress-releases%2Farvinas-nominates-oral-clinical-candidate-androgen-receptor-degrader-program%2F+%28accessed+Feb+21%2C+2018%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sternbach, L. H.</span></span> <span> </span><span class="NLM_article-title">The benzodiazepine story</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1979</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">6</span>, <span class="refDoi"> DOI: 10.1021/jm00187a001</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00187a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADyaE1MXkvVSjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1979&pages=1-6&author=L.+H.+Sternbach&title=The+benzodiazepine+story&doi=10.1021%2Fjm00187a001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">The benzodiazepine story</span></div><div class="casAuthors">Sternbach, Leo H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A lecture on the development of centrally acting 1,4-benzodiazepines with 24 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoO04EjgluwzLVg90H21EOLACvtfcHk0lgFFrqQgiYvGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXkvVSjsA%253D%253D&md5=27408ad7dcf65729a97a2d48a8158949</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1021%2Fjm00187a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00187a001%26sid%3Dliteratum%253Aachs%26aulast%3DSternbach%26aufirst%3DL.%2BH.%26atitle%3DThe%2520benzodiazepine%2520story%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1979%26volume%3D22%26spage%3D1%26epage%3D6%26doi%3D10.1021%2Fjm00187a001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Widen, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harki, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brummond, K. M.</span></span> <span> </span><span class="NLM_article-title">Covalent modifiers: A chemical perspective on the reactivity of α-β-unsaturated thiols via hetero-Michael addition reactions</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">839</span>– <span class="NLM_lpage">885</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b00788</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b00788" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=839-885&author=P.+A.+Jacksonauthor=J.+C.+Widenauthor=D.+A.+Harkiauthor=K.+M.+Brummond&title=Covalent+modifiers%3A+A+chemical+perspective+on+the+reactivity+of+%CE%B1-%CE%B2-unsaturated+thiols+via+hetero-Michael+addition+reactions&doi=10.1021%2Facs.jmedchem.6b00788"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b00788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b00788%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DP.%2BA.%26aulast%3DWiden%26aufirst%3DJ.%2BC.%26aulast%3DHarki%26aufirst%3DD.%2BA.%26aulast%3DBrummond%26aufirst%3DK.%2BM.%26atitle%3DCovalent%2520modifiers%253A%2520A%2520chemical%2520perspective%2520on%2520the%2520reactivity%2520of%2520%25CE%25B1-%25CE%25B2-unsaturated%2520thiols%2520via%2520hetero-Michael%2520addition%2520reactions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D839%26epage%3D885%26doi%3D10.1021%2Facs.jmedchem.6b00788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keserü, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makara, G. M.</span></span> <span> </span><span class="NLM_article-title">The influence of lead discovery strategies on the properties of drug candidates</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">212</span>, <span class="refDoi"> DOI: 10.1038/nrd2796</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=10.1038%2Fnrd2796" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=19247303" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisVShtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=203-212&author=G.+M.+Keser%C3%BCauthor=G.+M.+Makara&title=The+influence+of+lead+discovery+strategies+on+the+properties+of+drug+candidates&doi=10.1038%2Fnrd2796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">The influence of lead discovery strategies on the properties of drug candidates</span></div><div class="casAuthors">Keserue, Gyoergy M.; Makara, Gergely M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">203-212</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Despite the widespread acceptance of guidelines related to desirable physicochem. properties of potential small-mol. drugs, key properties - such as lipophilicity - of recently developed clin. candidates and advanced lead compds. have been shown to differ significantly from those of historical leads and drugs.  By analyzing the physicochem. properties of a large database of hits and corresponding leads identified in the past decade, we show that this undesirable phenomenon can be traced back to the nature of high-throughput screening hits and hit-to-lead optimization practices.  Conceptual and organizational adjustments may be required to enable a smooth lead-evolution process that reduces the chance of high compd.-related attrition in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm799LMqiX77Vg90H21EOLACvtfcHk0lgd2iR7F7dfjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisVShtbk%253D&md5=568338bed79969979b8590cd03bb4481</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1038%2Fnrd2796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2796%26sid%3Dliteratum%253Aachs%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DMakara%26aufirst%3DG.%2BM.%26atitle%3DThe%2520influence%2520of%2520lead%2520discovery%2520strategies%2520on%2520the%2520properties%2520of%2520drug%2520candidates%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2009%26volume%3D8%26spage%3D203%26epage%3D212%26doi%3D10.1038%2Fnrd2796" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morphy, R.</span></span> <span> </span><span class="NLM_article-title">The influence of target family and functional activity on the physicochemical properties of pre-clinical compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">2969</span>– <span class="NLM_lpage">2978</span>, <span class="refDoi"> DOI: 10.1021/jm0512185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0512185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtlOit7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=2969-2978&author=R.+Morphy&title=The+influence+of+target+family+and+functional+activity+on+the+physicochemical+properties+of+pre-clinical+compounds&doi=10.1021%2Fjm0512185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">The Influence of Target Family and Functional Activity on the Physicochemical Properties of Pre-Clinical Compounds</span></div><div class="casAuthors">Morphy, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2969-2978</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The target families of greatest interest in drug discovery can be differentiated on the basis of the physicochem. properties of their preclin. ligands.  The ligands for peptidergic targets, such as peptide G protein-coupled receptors (GPCRs) and integrin receptors, possess significantly higher median property values than those for aminergic targets, such as monoamine transporters and GPCRs.  The ligands for peptide GPCRs were found to be less efficient, in terms of their binding energy per unit of mol. wt. or lipophilicity, than ligands for monoamine GPCRs.  The changes in the property values during the optimization process were found to vary only slightly across the target families, with the main determinant of the drug-likeness of the optimized compds. being the profile of the starting compds.  Agonists for monoamine GPCRs, opioid receptors and ion channels were typically smaller and less lipophilic than the antagonists, but there was no difference between the agonists and the antagonists for peptide GPCRs and nuclear receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0EegclZUHNbVg90H21EOLACvtfcHk0lgd2iR7F7dfjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtlOit7g%253D&md5=fcf63bff570d58d56492b46ddecb5eb1</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1021%2Fjm0512185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0512185%26sid%3Dliteratum%253Aachs%26aulast%3DMorphy%26aufirst%3DR.%26atitle%3DThe%2520influence%2520of%2520target%2520family%2520and%2520functional%2520activity%2520on%2520the%2520physicochemical%2520properties%2520of%2520pre-clinical%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D2969%26epage%3D2978%26doi%3D10.1021%2Fjm0512185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Young, R. J.</span>; <span class="NLM_string-name">Leeson, P. D.</span></span> <span> </span><span class="NLM_article-title">Mapping the efficiency and physicochemical trajectories of successful optimizations</span>.  <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00180</span> .</span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00180" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=R.+J.+Young&author=P.+D.+Leeson&title=Mapping+the+efficiency+and+physicochemical+trajectories+of+successful+optimizations&doi=10.1021%2Facs.jmedchem.8b00180"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26aulast%3DYoung%26aufirst%3DR.%2BJ.%26atitle%3DMapping%2520the%2520efficiency%2520and%2520physicochemical%2520trajectories%2520of%2520successful%2520optimizations%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26doi%3D10.1021%2Facs.jmedchem.8b00180" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pennington, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moustakas, D. T.</span></span> <span> </span><span class="NLM_article-title">The necessary nitrogen atom: a versatile high-impact design element for multiparameter optimization</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3552</span>– <span class="NLM_lpage">3579</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3552-3579&author=L.+D.+Penningtonauthor=D.+T.+Moustakas&title=The+necessary+nitrogen+atom%3A+a+versatile+high-impact+design+element+for+multiparameter+optimization&doi=10.1021%2Facs.jmedchem.6b01807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">The Necessary Nitrogen Atom: A Versatile High-Impact Design Element for Multiparameter Optimization</span></div><div class="casAuthors">Pennington, Lewis D.; Moustakas, Demetri T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3552-3579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  There is a continued desire in biomedical research to reduce the no. and duration of design cycles required to optimize lead compds. into high-quality chem. probes or safe and efficacious drug candidates.  The insightful application of impactful mol. design elements is one approach toward achieving this goal.  The replacement of a CH group with a N atom in arom. and heteroarom. ring systems can have many important effects on mol. and physicochem. properties and intra- and intermol. interactions that can translate to improved pharmacol. profiles.  In this Perspective, the "necessary nitrogen atom" is shown to be a versatile high-impact design element for multiparameter optimization, wherein ≥10-, 100-, or 1000-fold improvement in a variety of key pharmacol. parameters can be realized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8ZLKZMgt6IbVg90H21EOLACvtfcHk0lgd2iR7F7dfjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit1yit74%253D&md5=002aaee48995e7954647a1f75183db4d</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01807%26sid%3Dliteratum%253Aachs%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DMoustakas%26aufirst%3DD.%2BT.%26atitle%3DThe%2520necessary%2520nitrogen%2520atom%253A%2520a%2520versatile%2520high-impact%2520design%2520element%2520for%2520multiparameter%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3552%26epage%3D3579%26doi%3D10.1021%2Facs.jmedchem.6b01807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i18"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00675">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_41203"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b00675">10.1021/acs.jmedchem.8b00675</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Tabulated changes in properties for entries 1–66 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b00675/suppl_file/jm8b00675_si_001.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b00675/suppl_file/jm8b00675_si_001.pdf">jm8b00675_si_001.pdf (411.6 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00675&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-21%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00675%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00675" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"677ae1f64e4f3ca6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
